Citrus Sinensis ID: 016913
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.828 | 0.690 | 0.677 | 1e-137 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.671 | 0.602 | 0.753 | 1e-114 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.610 | 0.560 | 0.745 | 1e-101 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.589 | 0.454 | 0.603 | 3e-74 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.578 | 0.448 | 0.600 | 6e-73 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.589 | 0.546 | 0.599 | 1e-71 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.6 | 0.535 | 0.571 | 1e-69 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.607 | 0.593 | 0.547 | 2e-69 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.628 | 0.580 | 0.537 | 4e-69 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.6 | 0.535 | 0.567 | 9e-69 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 488 bits (1255), Expect = e-137, Method: Compositional matrix adjust.
Identities = 254/375 (67%), Positives = 279/375 (74%), Gaps = 60/375 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE LDWN RMKIAAG
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLE+LHDKANPPVIYRD KSSNILLDEGFHPKLSDFGLAKLGP GDK+HVSTRVMGT
Sbjct: 194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLT+KSDVYSFGVVFLELITGRKAID+ P GE NLVAWARPLF DRR
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRR 313
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KF K+ADP L+GR+P R LYQALAVA+MC+QEQAATRPLI DVVTAL+YLA+Q YDP+
Sbjct: 314 KFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAYDPSK- 372
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
+ RNRD+R
Sbjct: 373 --------DDSRRNRDER------------------------------------------ 382
Query: 301 GAEL-SRNETGGGSGRKWLGDDLERQESQRDSPVNTGRARQSPRNRDLDRERAVAAAKVW 359
GA L +RN+ GGGSG K+ DLE E + DSP T R NRD++RERAVA AK+W
Sbjct: 383 GARLITRNDDGGGSGSKF---DLEGSEKE-DSPRETARI----LNRDINRERAVAEAKMW 434
Query: 360 GENWREKKRANAMGS 374
GE+ REK+R + G+
Sbjct: 435 GESLREKRRQSEQGT 449
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1057), Expect = e-114, Method: Compositional matrix adjust.
Identities = 193/256 (75%), Positives = 217/256 (84%), Gaps = 1/256 (0%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
LSL H NLV LIG+CA+GDQRLLVYE+MP GSLEDHLH LP K+PLDWNTRMKIAAGA
Sbjct: 152 LSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGA 211
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
A+GLEYLHD+ PPVIYRDLK SNILL E + PKLSDFGLAK+GP GDKTHVSTRVMGTY
Sbjct: 212 ARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTY 271
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 181
GYCAP+YAMTGQLT KSD+YSFGVV LELITGRKAIDNT+ + NLV WARPLFKDRR
Sbjct: 272 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPLFKDRRN 331
Query: 182 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAAS 241
FPKM DPLLQG+YP+RGLYQALA++AMC+QEQ RP++ DVV AL +LAS YDPN+ S
Sbjct: 332 FPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASSKYDPNSPS 391
Query: 242 NLSNRVGPSTPRNRDD 257
+ S + PS R+RDD
Sbjct: 392 SSSGK-NPSFHRDRDD 406
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (947), Expect = e-101, Method: Compositional matrix adjust.
Identities = 173/232 (74%), Positives = 198/232 (85%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH +LVNLIGYCADGDQRLLVYE+M GSLEDHL DL PD+ PLDW+TR++IA G
Sbjct: 127 MLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALG 186
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AA GLEYLHDKANPPVIYRDLK++NILLD F+ KLSDFGLAKLGPVGDK HVS+RVMGT
Sbjct: 187 AAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGT 246
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEY TGQLT KSDVYSFGVV LELITGR+ ID TRP E NLV WA+P+FK+
Sbjct: 247 YGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPS 306
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232
+FP++ADP L+G +P + L QA+AVAAMCLQE+A RPL+ DVVTAL +L +
Sbjct: 307 RFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 137/227 (60%), Positives = 163/227 (71%), Gaps = 3/227 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
L L H NLV L+GYC + DQRLLVYEFMP GSLE+HL PL W+ RMKIA G
Sbjct: 199 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 255
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGL +LH++A PVIYRD K+SNILLD ++ KLSDFGLAK P KTHVSTRVMGT
Sbjct: 256 AAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGT 315
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGY APEY MTG LT KSDVYSFGVV LE++TGR+++D RP GEHNLV WARP D+R
Sbjct: 316 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKR 375
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
+F ++ DP L+G + ++G + +AA CL RP + DVV AL
Sbjct: 376 RFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEAL 422
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (701), Expect = 6e-73, Method: Compositional matrix adjust.
Identities = 134/223 (60%), Positives = 162/223 (72%), Gaps = 3/223 (1%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H NLV L+GYC + DQRLLVYEFMP GSLE+HL PL W+ RMKIA GAAKG
Sbjct: 197 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKG 253
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
L +LH++A PVIYRD K+SNILLD ++ KLSDFGLAK P KTHVSTRVMGTYGY
Sbjct: 254 LSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYA 313
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 184
APEY MTG LT KSDVYSFGVV LE++TGR+++D RP GEHNLV WARP D+R+F +
Sbjct: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYR 373
Query: 185 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
+ DP L+G + ++G + +AA CL + RP + +VV L
Sbjct: 374 LLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVL 416
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 136/227 (59%), Positives = 160/227 (70%), Gaps = 3/227 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
L L H NLV LIGYC + D RLLVYEFM GSLE+HL PL W+ RM IA G
Sbjct: 123 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHL--FRKTTAPLSWSRRMMIALG 180
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGL +LH+ A PVIYRD K+SNILLD + KLSDFGLAK GP GD+THVSTRVMGT
Sbjct: 181 AAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 239
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGY APEY MTG LT +SDVYSFGVV LE++TGRK++D TRP E NLV WARP D+R
Sbjct: 240 YGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKR 299
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
K ++ DP L+ +Y +R +A ++A CL + RPL+ DVV L
Sbjct: 300 KLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 346
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 132/231 (57%), Positives = 162/231 (70%), Gaps = 3/231 (1%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H NLV L+GYC +G+ RLLVYEFMP GSLE+HL +PL W RMK+A GA
Sbjct: 141 LGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHL--FRRGAQPLTWAIRMKVAIGA 198
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
AKGL +LHD A VIYRD K++NILLD F+ KLSDFGLAK GP GDKTHVST+VMGT+
Sbjct: 199 AKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTH 257
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 181
GY APEY TG+LT KSDVYSFGVV LEL++GR+A+D ++ E +LV WA P D+RK
Sbjct: 258 GYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYLGDKRK 317
Query: 182 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232
++ D L G+YP +G Y A ++A CL A RP + +V+ L L S
Sbjct: 318 LFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLES 368
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 127/232 (54%), Positives = 164/232 (70%), Gaps = 1/232 (0%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H NLV LIGYC + + RLLVYEFM GSLE+HL +PL WNTR+++A GA
Sbjct: 126 LGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGA 185
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
A+GL +LH+ A P VIYRD K+SNILLD ++ KLSDFGLA+ GP+GD +HVSTRVMGT
Sbjct: 186 ARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQ 244
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 181
GY APEY TG L++KSDVYSFGVV LEL++GR+AID +P GEHNLV WARP ++R+
Sbjct: 245 GYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRR 304
Query: 182 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233
++ DP LQG+Y + + +A C+ A +RP + ++V + L Q
Sbjct: 305 LLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQ 356
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 130/242 (53%), Positives = 164/242 (67%), Gaps = 3/242 (1%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L H NLV LIGYC + + RLLVYEFMP GSLE+HL +PL W R+K+A GA
Sbjct: 127 LGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGA 186
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
AKGL +LH+ A VIYRD K+SNILLD ++ KLSDFGLAK GP GDK+HVSTR+MGTY
Sbjct: 187 AKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTY 245
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 181
GY APEY TG LT KSDVYS+GVV LE+++GR+A+D RPPGE LV WARPL ++RK
Sbjct: 246 GYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRK 305
Query: 182 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAAS 241
++ D LQ +Y M + +A CL + RP + +VV+ L ++ QT +
Sbjct: 306 LFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHI--QTLNEAGGR 363
Query: 242 NL 243
N+
Sbjct: 364 NI 365
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (666), Expect = 9e-69, Method: Compositional matrix adjust.
Identities = 131/231 (56%), Positives = 162/231 (70%), Gaps = 3/231 (1%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H NLV L+GYCA+G+ RLLVYEFMP GSLE+HL +PL W RMK+A GA
Sbjct: 144 LGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHL--FRRGAQPLTWAIRMKVAVGA 201
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
AKGL +LH+ A VIYRD K++NILLD F+ KLSDFGLAK GP GD THVST+V+GT+
Sbjct: 202 AKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGTH 260
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 181
GY APEY TG+LT KSDVYSFGVV LELI+GR+A+DN+ E++LV WA P D+RK
Sbjct: 261 GYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYLGDKRK 320
Query: 182 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232
++ D L G+YP +G + A +A CL A RP + +V+ L L S
Sbjct: 321 LFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | ||||||
| 255551669 | 516 | receptor serine-threonine protein kinase | 0.997 | 0.734 | 0.907 | 0.0 | |
| 356557829 | 587 | PREDICTED: serine/threonine-protein kina | 0.984 | 0.637 | 0.897 | 0.0 | |
| 225432364 | 528 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.717 | 0.854 | 0.0 | |
| 449433375 | 514 | PREDICTED: serine/threonine-protein kina | 0.994 | 0.735 | 0.881 | 0.0 | |
| 356549075 | 513 | PREDICTED: serine/threonine-protein kina | 0.981 | 0.727 | 0.889 | 0.0 | |
| 357447401 | 507 | Protein kinase-like protein [Medicago tr | 0.976 | 0.731 | 0.889 | 0.0 | |
| 357447403 | 419 | Serine/threonine protein kinase [Medicag | 0.976 | 0.885 | 0.889 | 0.0 | |
| 357447405 | 371 | Serine/threonine protein kinase [Medicag | 0.976 | 1.0 | 0.889 | 0.0 | |
| 297736901 | 471 | unnamed protein product [Vitis vinifera] | 0.884 | 0.713 | 0.889 | 1e-173 | |
| 15238886 | 513 | protein kinase family protein [Arabidops | 0.992 | 0.734 | 0.816 | 1e-170 |
| >gi|255551669|ref|XP_002516880.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223543968|gb|EEF45494.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/380 (90%), Positives = 357/380 (93%), Gaps = 1/380 (0%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD P DKEPLDWNTRMKIAAG
Sbjct: 138 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDFPSDKEPLDWNTRMKIAAG 197
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDLKSSNILLDEG+HPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 198 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 257
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR PGEHNLVAWARPLFKDRR
Sbjct: 258 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRAPGEHNLVAWARPLFKDRR 317
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPN+A
Sbjct: 318 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNSA 377
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
N SNRVGPSTPRNRDDR+ MADG DSPDEHGR G HGSPST+KNSPDYR+R R+ ST
Sbjct: 378 -NQSNRVGPSTPRNRDDRKGMADGLDSPDEHGRGGWHGSPSTYKNSPDYRRRDPMRESST 436
Query: 301 GAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGRARQSPRNRDLDRERAVAAAKVWG 360
+EL R+ETGGGSGRKW DD ERQ+SQR SPVNT R R++PRNRDLDRERAVA AKVWG
Sbjct: 437 ASELGRSETGGGSGRKWGLDDSERQDSQRGSPVNTSRVRETPRNRDLDRERAVAEAKVWG 496
Query: 361 ENWREKKRANAMGSFDGTDE 380
ENWREKKRANAMGSFDGT+E
Sbjct: 497 ENWREKKRANAMGSFDGTNE 516
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557829|ref|XP_003547213.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 688 bits (1775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/380 (89%), Positives = 354/380 (93%), Gaps = 6/380 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG
Sbjct: 214 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 273
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDLKSSNILLDEG+HPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 274 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 333
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR GEHNLVAWARPLFKDRR
Sbjct: 334 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRAHGEHNLVAWARPLFKDRR 393
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA
Sbjct: 394 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 453
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
N SNRVGPSTPR+RDDRRSMAD DSPD HGR+ GSPSTH+NSPD+RKR RD ST
Sbjct: 454 -NQSNRVGPSTPRSRDDRRSMADSVDSPD-HGRL---GSPSTHRNSPDFRKRDS-RDPST 507
Query: 301 GAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGRARQSPRNRDLDRERAVAAAKVWG 360
EL R +TGGGSGRKW DD ERQ+SQRDSPVNT RAR++P NRDLDRERAVA AKVWG
Sbjct: 508 ATELGRIDTGGGSGRKWGLDDYERQDSQRDSPVNTARARETPWNRDLDRERAVAEAKVWG 567
Query: 361 ENWREKKRANAMGSFDGTDE 380
ENWREKK+ANA+GSFD T++
Sbjct: 568 ENWREKKKANAVGSFDATND 587
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432364|ref|XP_002275431.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/393 (85%), Positives = 353/393 (89%), Gaps = 14/393 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG
Sbjct: 135 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 194
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKA+PPVIYRDLKSSNILLDEG+HPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 195 AAKGLEYLHDKASPPVIYRDLKSSNILLDEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 254
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN R GEHNLVAWARPLFKDRR
Sbjct: 255 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNNRAAGEHNLVAWARPLFKDRR 314
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA
Sbjct: 315 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 374
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
S SNRVGPSTPR++DDRRS+ DG DSPD GR GR GSPSTHKNSPD+R+R RD ST
Sbjct: 375 SAQSNRVGPSTPRSKDDRRSLPDGLDSPDNPGRGGRLGSPSTHKNSPDFRRRDPLRDLST 434
Query: 301 GAELSRNETGGGSGRKWLGDDLERQESQ--------------RDSPVNTGRARQSPRNRD 346
+L R+E GGSGRKW D+LERQESQ RD P+++GRAR++PRNRD
Sbjct: 435 ATDLGRSEADGGSGRKWGLDELERQESQRDIPISAGRARDTERDIPISSGRARETPRNRD 494
Query: 347 LDRERAVAAAKVWGENWREKKRANAMGSFDGTD 379
LDRERAVA AKVWGENWREKKRAN +GSFDGT+
Sbjct: 495 LDRERAVAEAKVWGENWREKKRANVVGSFDGTN 527
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433375|ref|XP_004134473.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] gi|449495476|ref|XP_004159852.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/381 (88%), Positives = 353/381 (92%), Gaps = 3/381 (0%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG
Sbjct: 136 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 195
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDLKSSNILLDEG+HPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 196 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 255
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR PGEHNLVAWARPLFKDRR
Sbjct: 256 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRGPGEHNLVAWARPLFKDRR 315
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA
Sbjct: 316 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 375
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
++ SNR+G STPR RD+RRS DG DSPDE GR GR GSPS ++NSPDYRK+ R+ S
Sbjct: 376 ASQSNRMGGSTPRARDERRSFPDGLDSPDERGR-GR-GSPSNYRNSPDYRKKDFHRELSC 433
Query: 301 GA-ELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGRARQSPRNRDLDRERAVAAAKVW 359
G ELS+ +TGGGSGRKW D+LERQES RDSPV GRAR++PRNRDL+RERAVA AKVW
Sbjct: 434 GGTELSKIDTGGGSGRKWGLDELERQESLRDSPVYAGRARETPRNRDLNRERAVAEAKVW 493
Query: 360 GENWREKKRANAMGSFDGTDE 380
GENWRE+KRANA GSFDG+ E
Sbjct: 494 GENWRERKRANAQGSFDGSQE 514
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549075|ref|XP_003542923.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/380 (88%), Positives = 348/380 (91%), Gaps = 7/380 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG
Sbjct: 141 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 200
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDLKSSNILLDEG+HPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 201 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 260
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR GEHNLVAWARPLFKDRR
Sbjct: 261 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRAHGEHNLVAWARPLFKDRR 320
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY+PNAA
Sbjct: 321 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYEPNAA 380
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
N SNRVGPSTPR RDDRRSMADG DSPD R GSPSTH+NSPD+RKR RD S
Sbjct: 381 -NQSNRVGPSTPRIRDDRRSMADGVDSPDR-----RLGSPSTHRNSPDFRKRDS-RDPSA 433
Query: 301 GAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGRARQSPRNRDLDRERAVAAAKVWG 360
EL R + GGGSGRKW DD ERQESQRDSPVNT R R++P NRDLDRERAVA AKVWG
Sbjct: 434 ATELGRIDIGGGSGRKWGLDDNERQESQRDSPVNTARTRETPWNRDLDRERAVAEAKVWG 493
Query: 361 ENWREKKRANAMGSFDGTDE 380
ENWREKK+ANAMGSFD T++
Sbjct: 494 ENWREKKKANAMGSFDATND 513
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447401|ref|XP_003593976.1| Protein kinase-like protein [Medicago truncatula] gi|355483024|gb|AES64227.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/380 (88%), Positives = 349/380 (91%), Gaps = 9/380 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP+KEPLDWNTRMKIAAG
Sbjct: 137 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPEKEPLDWNTRMKIAAG 196
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 197 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 256
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR GEHNLVAWARPLFKDRR
Sbjct: 257 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRGHGEHNLVAWARPLFKDRR 316
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ +DPNAA
Sbjct: 317 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQAFDPNAA 376
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
N SNRVGPSTPR RDDRRSMAD DSPD R GSPST +NSPD RK RDG
Sbjct: 377 -NQSNRVGPSTPRLRDDRRSMADSVDSPDR----ARLGSPSTRRNSPDLRK----RDGRD 427
Query: 301 GAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGRARQSPRNRDLDRERAVAAAKVWG 360
+ELSR +TGGGSGRKW DDLER +SQRDSPVNTGRAR++PRNRDLDRERAVA A+VWG
Sbjct: 428 PSELSRIDTGGGSGRKWGVDDLERHDSQRDSPVNTGRARETPRNRDLDRERAVAEARVWG 487
Query: 361 ENWREKKRANAMGSFDGTDE 380
ENWREKKR NA+GSFDGT+E
Sbjct: 488 ENWREKKRGNAVGSFDGTNE 507
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447403|ref|XP_003593977.1| Serine/threonine protein kinase [Medicago truncatula] gi|355483025|gb|AES64228.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/380 (88%), Positives = 349/380 (91%), Gaps = 9/380 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP+KEPLDWNTRMKIAAG
Sbjct: 49 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPEKEPLDWNTRMKIAAG 108
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 109 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 168
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR GEHNLVAWARPLFKDRR
Sbjct: 169 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRGHGEHNLVAWARPLFKDRR 228
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ +DPNAA
Sbjct: 229 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQAFDPNAA 288
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
N SNRVGPSTPR RDDRRSMAD DSPD R GSPST +NSPD RK RDG
Sbjct: 289 -NQSNRVGPSTPRLRDDRRSMADSVDSPDR----ARLGSPSTRRNSPDLRK----RDGRD 339
Query: 301 GAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGRARQSPRNRDLDRERAVAAAKVWG 360
+ELSR +TGGGSGRKW DDLER +SQRDSPVNTGRAR++PRNRDLDRERAVA A+VWG
Sbjct: 340 PSELSRIDTGGGSGRKWGVDDLERHDSQRDSPVNTGRARETPRNRDLDRERAVAEARVWG 399
Query: 361 ENWREKKRANAMGSFDGTDE 380
ENWREKKR NA+GSFDGT+E
Sbjct: 400 ENWREKKRGNAVGSFDGTNE 419
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447405|ref|XP_003593978.1| Serine/threonine protein kinase [Medicago truncatula] gi|355483026|gb|AES64229.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/380 (88%), Positives = 349/380 (91%), Gaps = 9/380 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP+KEPLDWNTRMKIAAG
Sbjct: 1 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPEKEPLDWNTRMKIAAG 60
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR GEHNLVAWARPLFKDRR
Sbjct: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRGHGEHNLVAWARPLFKDRR 180
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ +DPNAA
Sbjct: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQAFDPNAA 240
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
N SNRVGPSTPR RDDRRSMAD DSPD R GSPST +NSPD RK RDG
Sbjct: 241 -NQSNRVGPSTPRLRDDRRSMADSVDSPDR----ARLGSPSTRRNSPDLRK----RDGRD 291
Query: 301 GAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGRARQSPRNRDLDRERAVAAAKVWG 360
+ELSR +TGGGSGRKW DDLER +SQRDSPVNTGRAR++PRNRDLDRERAVA A+VWG
Sbjct: 292 PSELSRIDTGGGSGRKWGVDDLERHDSQRDSPVNTGRARETPRNRDLDRERAVAEARVWG 351
Query: 361 ENWREKKRANAMGSFDGTDE 380
ENWREKKR NA+GSFDGT+E
Sbjct: 352 ENWREKKRGNAVGSFDGTNE 371
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736901|emb|CBI26102.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1584), Expect = e-173, Method: Compositional matrix adjust.
Identities = 299/336 (88%), Positives = 310/336 (92%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG
Sbjct: 135 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 194
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKA+PPVIYRDLKSSNILLDEG+HPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 195 AAKGLEYLHDKASPPVIYRDLKSSNILLDEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 254
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN R GEHNLVAWARPLFKDRR
Sbjct: 255 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNNRAAGEHNLVAWARPLFKDRR 314
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA
Sbjct: 315 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 374
Query: 241 SNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGST 300
S SNRVGPSTPR++DDRRS+ DG DSPD GR GR GSPSTHKNSPD+R+R RD ST
Sbjct: 375 SAQSNRVGPSTPRSKDDRRSLPDGLDSPDNPGRGGRLGSPSTHKNSPDFRRRDPLRDLST 434
Query: 301 GAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTG 336
+L R+E GGSGRKW D+LERQESQRD P+ G
Sbjct: 435 ATDLGRSEADGGSGRKWGLDELERQESQRDIPIKIG 470
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238886|ref|NP_197362.1| protein kinase family protein [Arabidopsis thaliana] gi|334187748|ref|NP_001190331.1| protein kinase family protein [Arabidopsis thaliana] gi|91806876|gb|ABE66165.1| protein kinase family protein [Arabidopsis thaliana] gi|332005202|gb|AED92585.1| protein kinase family protein [Arabidopsis thaliana] gi|332005203|gb|AED92586.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1557), Expect = e-170, Method: Compositional matrix adjust.
Identities = 315/386 (81%), Positives = 333/386 (86%), Gaps = 9/386 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYE+MPLGSLEDHLHDLPPDKEPLDW+TRM IAAG
Sbjct: 131 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIAAG 190
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDLKSSNILL +G+HPKLSDFGLAKLGPVGDKTHVSTRVMGT
Sbjct: 191 AAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 250
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN R PGEHNLVAWARPLFKDRR
Sbjct: 251 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWARPLFKDRR 310
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAA 240
KFPKMADP LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT+DPNA
Sbjct: 311 KFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTFDPNAP 370
Query: 241 SNLSNRVGPSTP--RNRDDRRSMADGQ--DSPDEHGRVGRHGSPSTHKNSPDYRKRSHPR 296
S ++R G P R RDDRRS+ DG DSP E R GSP+THKNSPDYR+R R
Sbjct: 371 SGQNSRSGSGPPFIRTRDDRRSLGDGSSLDSPAE--TRSRLGSPATHKNSPDYRRRDMVR 428
Query: 297 DGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGR-ARQSPRNRDLDRERAVAA 355
+ +ETGGGSGRKW DLE QESQR SP + GR +R +PRNRDLDRERAVA
Sbjct: 429 E-VNAGSEGGSETGGGSGRKWGLSDLEGQESQRGSPASVGRSSRGTPRNRDLDRERAVAE 487
Query: 356 AKVWGENWREKKRA-NAMGSFDGTDE 380
AKVWGENWRE+KRA N GSFD T++
Sbjct: 488 AKVWGENWRERKRATNGPGSFDSTND 513
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | ||||||
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.957 | 0.709 | 0.817 | 7.5e-160 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.807 | 0.673 | 0.687 | 8.1e-108 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.628 | 0.632 | 0.815 | 6.7e-104 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.573 | 0.564 | 0.776 | 8.1e-92 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.586 | 0.525 | 0.757 | 4.5e-91 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.642 | 0.589 | 0.672 | 3.9e-89 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.642 | 0.640 | 0.673 | 7.7e-87 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.639 | 0.624 | 0.648 | 3.8e-85 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.602 | 0.630 | 0.698 | 6.2e-85 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.573 | 0.560 | 0.720 | 3.1e-83 |
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1557 (553.2 bits), Expect = 7.5e-160, P = 7.5e-160
Identities = 305/373 (81%), Positives = 325/373 (87%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYE+MPLGSLEDHLHDLPPDKEPLDW+TRM IAAGAAKGLEYLHDKAN
Sbjct: 144 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKAN 203
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDLKSSNILL +G+HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ
Sbjct: 204 PPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 263
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LTLKSDVYSFGVVFLELITGRKAIDN R PGEHNLVAWARPLFKDRRKFPKMADP LQGR
Sbjct: 264 LTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGR 323
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTP- 252
YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT+DPNA S ++R G P
Sbjct: 324 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGPPF 383
Query: 253 -RNRDDRRSMADGQ--DSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNET 309
R RDDRRS+ DG DSP E R GSP+THKNSPDYR+R R+ + G+E +ET
Sbjct: 384 IRTRDDRRSLGDGSSLDSPAETR--SRLGSPATHKNSPDYRRRDMVREVNAGSE-GGSET 440
Query: 310 GGGSGRKWLGDDLERQESQRDSPVNTGRA-RQSPRNRDLDRERAVAAAKVWGENWREKKR 368
GGGSGRKW DLE QESQR SP + GR+ R +PRNRDLDRERAVA AKVWGENWRE+KR
Sbjct: 441 GGGSGRKWGLSDLEGQESQRGSPASVGRSSRGTPRNRDLDRERAVAEAKVWGENWRERKR 500
Query: 369 A-NAMGSFDGTDE 380
A N GSFD T++
Sbjct: 501 ATNGPGSFDSTND 513
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 224/326 (68%), Positives = 246/326 (75%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE LDWN RMKIAAGAAKGLE+LHDKAN
Sbjct: 147 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKAN 206
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD KSSNILLDEGFHPKLSDFGLAKLGP GDK+HVSTRVMGTYGYCAPEYAMTGQ
Sbjct: 207 PPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQ 266
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LT+KSDVYSFGVVFLELITGRKAID+ P GE NLVAWARPLF DRRKF K+ADP L+GR
Sbjct: 267 LTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGR 326
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPR 253
+P R LYQALAVA+MC+QEQAATRPLI DVVTAL+YLA+Q YDP S +R R
Sbjct: 327 FPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAYDP---SKDDSR------R 377
Query: 254 NRDDR--RSMADGQDSPDEHGRVGRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGG 311
NRD+R R + D + GS ++SP R RD + ++ + G
Sbjct: 378 NRDERGARLITRNDDGGGSGSKFDLEGSEK--EDSPRETARILNRDINRERAVAEAKMWG 435
Query: 312 GSGRKWLGDDLERQESQRDSPVN-TG 336
S R + RQ Q S N TG
Sbjct: 436 ESLR-----EKRRQSEQGTSESNSTG 456
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 6.7e-104, P = 6.7e-104
Identities = 195/239 (81%), Positives = 211/239 (88%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYE+MPLGSLEDHLHD+ P K+PLDWNTRMKIAAGAAKGLEYLHDK
Sbjct: 134 IGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTM 193
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDLK SNILLD+ + PKLSDFGLAKLGPVGDK+HVSTRVMGTYGYCAPEYAMTGQ
Sbjct: 194 PPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 253
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LTLKSDVYSFGVV LE+ITGRKAID++R GE NLVAWARPLFKDRRKF +MADP+LQG+
Sbjct: 254 LTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQ 313
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTP 252
YP RGLYQALAVAAMC+QEQ RPLI DVVTAL+YLASQ +DP A + P TP
Sbjct: 314 YPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDPLAQPVQGSLFAPGTP 372
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
Identities = 170/219 (77%), Positives = 197/219 (89%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE-PLDWNTRMKIAAGAAKGLEYLHDKA 72
+GYCADGDQR+LVYE+M GSLEDHL +L +K+ PLDW+TRMK+AAGAA+GLEYLH+ A
Sbjct: 143 VGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETA 202
Query: 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 132
+PPVIYRD K+SNILLDE F+PKLSDFGLAK+GP G +THVSTRVMGTYGYCAPEYA+TG
Sbjct: 203 DPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTG 262
Query: 133 QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 192
QLT+KSDVYSFGVVFLE+ITGR+ ID T+P E NLV WA PLFKDRRKF MADPLL+G
Sbjct: 263 QLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEG 322
Query: 193 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231
+YP++GLYQALAVAAMCLQE+AATRP++ DVVTAL YLA
Sbjct: 323 KYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLA 361
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
Identities = 169/223 (75%), Positives = 190/223 (85%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IG+CA+G QRLLVYE+MPLGSL++HLHDLP K PL WNTRMKIAAGAA+GLEYLHD
Sbjct: 159 IGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMK 218
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDLK SNIL+DEG+H KLSDFGLAK+GP G +THVSTRVMGTYGYCAP+YA+TGQ
Sbjct: 219 PPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQ 278
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LT KSDVYSFGVV LELITGRKA DNTR +LV WA PLFKDR+ F KM DPLL+G
Sbjct: 279 LTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLFKDRKNFKKMVDPLLEGD 338
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 236
YP+RGLYQALA+AAMC+QEQ + RP+I DVV AL +LAS YD
Sbjct: 339 YPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLASSKYD 381
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 862 (308.5 bits), Expect = 3.9e-89, Sum P(2) = 3.9e-89
Identities = 168/250 (67%), Positives = 198/250 (79%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYE+M GSLEDHL DL PD+ PLDW+TR++IA GAA GLEYLHDKAN
Sbjct: 140 IGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKAN 199
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDLK++NILLD F+ KLSDFGLAKLGPVGDK HVS+RVMGTYGYCAPEY TGQ
Sbjct: 200 PPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQ 259
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LT KSDVYSFGVV LELITGR+ ID TRP E NLV WA+P+FK+ +FP++ADP L+G
Sbjct: 260 LTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGV 319
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPR 253
+P + L QA+AVAAMCLQE+A RPL+ DVVTAL +L + P+ + ++ + P P
Sbjct: 320 FPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTA---PDGSISVPHYDDPPQP- 375
Query: 254 NRDDRRSMAD 263
D S+ D
Sbjct: 376 --SDETSVED 383
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 868 (310.6 bits), Expect = 7.7e-87, P = 7.7e-87
Identities = 167/248 (67%), Positives = 198/248 (79%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYC GDQRLLVYE+MP+GSLEDHL DL ++EPL WNTRMKIA GAA+G+EYLH AN
Sbjct: 138 IGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVGAARGIEYLHCTAN 197
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDLKS+NILLD+ F PKLSDFGLAKLGPVGD+THVSTRVMGTYGYCAPEYAM+G+
Sbjct: 198 PPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGTYGYCAPEYAMSGK 257
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LT+KSD+Y FGVV LELITGRKAID + GE NLV W+RP KD++KF + DP L+G+
Sbjct: 258 LTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQKKFGHLVDPSLRGK 317
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPR 253
YP R L A+A+ AMCL E+A RP IGD+V AL YLA+Q+ + A N+S+ PS
Sbjct: 318 YPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRS-HEARNVSS---PSPEI 373
Query: 254 NRDDRRSM 261
+R RR +
Sbjct: 374 SRTPRRDL 381
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 3.8e-85, P = 3.8e-85
Identities = 159/245 (64%), Positives = 200/245 (81%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYC DGDQRLLV+EFMPLGSLEDHL D+ ++PLDWN+R++IA GAAKGLEYLH+KAN
Sbjct: 132 IGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRIALGAAKGLEYLHEKAN 191
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD KSSNILL+ F KLSDFGLAKLG VGD +VS+RV+GTYGYCAPEY TGQ
Sbjct: 192 PPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSSRVVGTYGYCAPEYHKTGQ 251
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LT+KSDVYSFGVV LELITG++ ID TRP E NLV WA+P+F++ +FP++ADPLLQG
Sbjct: 252 LTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPIFREPNRFPELADPLLQGE 311
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPR 253
+P + L QA+A+AAMCLQE+ RPLI DVVTAL++++++T P+ + + + P +P+
Sbjct: 312 FPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTETGSPSGLTGTA--LNPLSPK 369
Query: 254 NRDDR 258
+D+
Sbjct: 370 TVEDQ 374
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 850 (304.3 bits), Expect = 6.2e-85, P = 6.2e-85
Identities = 160/229 (69%), Positives = 187/229 (81%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYE+MPLGSLEDHL DL P ++PLDWNTR+KIA GAAKG+EYLHD+A+
Sbjct: 108 IGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEAD 167
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDLKSSNILLD + KLSDFGLAKLGPVGD HVS+RVMGTYGYCAPEY TG
Sbjct: 168 PPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGY 227
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LT KSDVYSFGVV LELI+GR+ ID RP E NLV WA P+F+D ++ ++ADPLL+G
Sbjct: 228 LTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWALPIFRDPTRYWQLADPLLRGD 287
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASN 242
YP + L QA+AVAAMCL E+ RPL+ DV+TAL++L + + N SN
Sbjct: 288 YPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLGASSNSSNTGSN 336
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
Identities = 157/218 (72%), Positives = 179/218 (82%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYC + +QR+LVYEFMP GSLEDHL DLP LDW TRM+I GAAKGLEYLHD A+
Sbjct: 146 IGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTRMRIVHGAAKGLEYLHDYAD 205
Query: 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD K+SNILL F+ KLSDFGLA+LGP K HVSTRVMGTYGYCAPEYAMTGQ
Sbjct: 206 PPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVSTRVMGTYGYCAPEYAMTGQ 265
Query: 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 193
LT KSDVYSFGVV LE+I+GR+AID RP E NL++WA PL KDRR F ++ DP L G
Sbjct: 266 LTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEPLLKDRRMFAQIVDPNLDGN 325
Query: 194 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231
YP++GL+QALA+AAMCLQE+A TRPL+GDVVTAL +LA
Sbjct: 326 YPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLA 363
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 380 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 7e-45
Identities = 57/152 (37%), Positives = 80/152 (52%), Gaps = 10/152 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L+H N+V L G D + LV E+ GSL+D L + L + ++I
Sbjct: 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQ 100
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
+GLEYLH +I+RDLK NILLD KL+DFGL+KL + + ++G
Sbjct: 101 ILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVG 155
Query: 120 TYGYCAPE-YAMTGQLTLKSDVYSFGVVFLEL 150
T Y APE G + KSD++S GV+ EL
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 54/153 (35%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H N+V L+G C G+ +V E+MP G L D L E L +++A
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AKG+EYL K ++RDL + N L+ E K+SDFGL++ D
Sbjct: 111 IAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
+ APE G+ T KSDV+SFGV+ E+ T
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 7e-40
Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H N+V L+G C + + +V E+M G L +L + L + + A
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A+G+EYL K I+RDL + N L+ E K+SDFGL++ D
Sbjct: 111 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLP 166
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE G+ T KSDV+SFGV+ E+ T
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 53/152 (34%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H N+V L+G C + + ++V E+MP G L D+L + L + + A
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQ 111
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A+G+EYL K I+RDL + N L+ E K+SDFGL++ D V
Sbjct: 112 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLP 167
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE G+ T KSDV+SFGV+ E+ T
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 64/155 (41%), Positives = 83/155 (53%), Gaps = 10/155 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N+V LI D D LV E+ G L D+L PL + KIA
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQ 106
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+GLEYLH +I+RDLK NILLDE K++DFGLAK + + ++T V GT
Sbjct: 107 ILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GT 161
Query: 121 YGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
Y APE + G K DV+S GV+ EL+TG+
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 64/185 (34%), Positives = 87/185 (47%), Gaps = 19/185 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N+V L D D+ LV E+ G L D L E R
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE---AR-FYLRQ 105
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
LEYLH K +++RDLK NILLDE H KL+DFGLA+ + ++T V GT
Sbjct: 106 ILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GT 159
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKD 178
Y APE + D++S GV+ EL+TG +PP G+ L+ + + K
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG-------KPPFPGDDQLLELFKKIGKP 212
Query: 179 RRKFP 183
+ FP
Sbjct: 213 KPPFP 217
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 6e-38
Identities = 57/163 (34%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-----HDLPPDKEPLDWNTRM 55
++ L H N+V L+G C + + LV E+M G L D+L P+K L +
Sbjct: 49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
A AKG+EYL K ++RDL + N L+ E K+SDFGL++ D T
Sbjct: 109 SFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
Query: 116 ------RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
R M APE G T KSDV+SFGV+ E+ T
Sbjct: 166 GGKLPIRWM------APESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 1 MLSLLHHSNLVNLIGYC--ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL--DWNTRMK 56
+LS L H N+V G + + + E++ GSL L EP+ + TR
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQI 110
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
+ +GL YLH +++RD+K +NIL+D KL+DFG AK + +
Sbjct: 111 L-----EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
V GT + APE + +D++S G +E+ TG+
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L H N+V G D+ +V EF GSL+D L + L + +
Sbjct: 50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKE 106
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR--VM 118
KGLEYLH +I+RD+K++NILL KL DFGL+ + R ++
Sbjct: 107 LLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSA-----QLSDTKARNTMV 158
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT + APE K+D++S G+ +EL G+
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-24
Identities = 62/160 (38%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 62
SL H N+V L + D LV E++ GSLED L K PL + + I A
Sbjct: 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQIL 111
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKL----GPVGDKTHVSTRV 117
LEYLH K +I+RD+K NILLD G KL DFGLAKL G + +
Sbjct: 112 SALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 118 MGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGR 154
+GT GY APE + + SD++S G+ EL+TG
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 5e-24
Identities = 57/157 (36%), Positives = 75/157 (47%), Gaps = 15/157 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK-I 57
+LS ++H +V L + A + LV E+ P G L HL E R +
Sbjct: 46 ILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFY 98
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
AA LEYLH +IYRDLK NILLD H KL+DFGLAK + +T
Sbjct: 99 AAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y APE + D +S GV+ E++TG+
Sbjct: 155 -GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 5 LHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 62
L H N+V G C R L+ E++P GSL D+L ++ ++ + ++
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQIC 119
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST--RVMGT 120
KG++YL + I+RDL + NIL++ K+SDFGLAK+ P +
Sbjct: 120 KGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGE 165
+ Y APE T + + SDV+SFGV EL T G + PP E
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPPAE 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 40/224 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+++ + H ++V L+G C Q L+ + MPLG L D++ + K+ + +
Sbjct: 62 VMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AKG+ YL +K +++RDL + N+L+ H K++DFGLAKL V +K + +
Sbjct: 118 IAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLV---------- 169
+ A E + T KSDV+S+GV EL+T G K + +L+
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234
Query: 170 ------------AW-----ARPLFKD-RRKFPKMA-DPLLQGRY 194
W +RP FK+ +F KMA DP RY
Sbjct: 235 ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP---QRY 275
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 57/165 (34%), Positives = 85/165 (51%), Gaps = 14/165 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV L C++ + +V E+M GSL D L + + L + +AA A+G
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEG 115
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGY 123
+ YL + I+RDL + NIL+ E K++DFGLA+L + T + +
Sbjct: 116 MAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKW 170
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 167
APE A G+ T+KSDV+SFG++ E++T GR PG N
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGR-----VPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 59/157 (37%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L H N+V G C +R LV E++P GSL D+L +E LD + A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYA 114
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+ KG+EYL K ++RDL + NIL++ K+ DFGL K+ P DK + R
Sbjct: 115 SQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREP 170
Query: 119 G---TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
G + Y APE + ++ SDV+SFGVV EL T
Sbjct: 171 GESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 5e-21
Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 17/161 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L+H N++ + + +V E+ G L + + +P +
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
L+YLH + +++RD+K NI L KL DFG++K+ + ++ V+GT
Sbjct: 113 CLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTP 167
Query: 122 GYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGRKA 156
Y +PE Y KSD++S G V EL T +
Sbjct: 168 YYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-21
Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 17/154 (11%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H NLV L+G G+ +V E+M GSL D+L + + ++ A +G
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEG 114
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK---LGPVGDKTHVSTRVMGTY 121
+EYL +K ++RDL + N+L+ E K+SDFGLAK G K V
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK------- 164
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154
+ APE + + KSDV+SFG++ E+ + GR
Sbjct: 165 -WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 27/164 (16%)
Query: 2 LSLLH---HSNLVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
L L +V G + +G+ + V E+M GSL D L + EP+ I
Sbjct: 50 LKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPV----LAYI 104
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTR 116
A KGL+YLH K + +I+RD+K SN+L++ K++DFG++K L D+ + T
Sbjct: 105 ARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TF 160
Query: 117 VMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGR 154
V GT Y +PE Y+ +D++S G+ LE G+
Sbjct: 161 V-GTVTYMSPERIQGESYSY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 50/148 (33%), Positives = 83/148 (56%), Gaps = 7/148 (4%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H +L++L C+ G+ ++ E M GSL L P+ + L + + +A A+G
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEG 116
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+ YL ++ I+RDL + NIL+ E K++DFGLA+L + + ++S+ Y +
Sbjct: 117 MAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWT 171
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELIT 152
APE A G + KSDV+SFG++ E+ T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HD--------LPPDKEPLD 50
+L+ H N+V G C +GD ++V+E+M G L L H L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 51 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 110
+ ++IA A G+ YL A+ ++RDL + N L+ K+ DFG+++ D
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 111 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
V M + PE M + T +SDV+SFGVV E+ T
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 18/232 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H N+V LIG C L++E++ +L + L +L W R KIA G AK
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRRKIAIGIAKA 792
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
L +LH + +P V+ +L I++D P L L L K +S+ Y
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYV 845
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 184
APE T +T KSD+Y FG++ +EL+TG+ D ++V WAR + D
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCH-LDM 903
Query: 185 MADPLLQGRYPM--RGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234
DP ++G + + + + +A C RP DV+ L + +
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 28/164 (17%)
Query: 2 LSLLHHSNLVNLIGY---CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
L +LH N ++G+ + + E+M GSL+ L + + KIA
Sbjct: 50 LDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIA 106
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
KGL YLH+K +I+RD+K SNIL++ KL DFG VS +++
Sbjct: 107 VAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLV 152
Query: 119 --------GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y APE ++KSD++S G+ +EL TGR
Sbjct: 153 NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 15/162 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEP 48
++S L H N+V L+G C +++E++ G L + L P K
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
LD + + IA A G+EYL ++ ++RDL + N L+ EG K+SDFGL++
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 109 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150
D V ++ + + PE + G+ T +SD++SFGVV E+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 51/156 (32%), Positives = 70/156 (44%), Gaps = 12/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
+L L+H LVNL D + LV + + G L HL E ++K
Sbjct: 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWIC 107
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
LEYLH K +I+RD+K NILLDE H ++DF +A T T G
Sbjct: 108 EIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSG 161
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155
T GY APE ++ D +S GV E + G++
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 56/161 (34%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA- 59
+S +H N+V GD+ LV ++ GSL D+ P IA
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATV 107
Query: 60 --GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTH-VST 115
KGLEYLH I+RD+K+ NILL E K++DFG+ A L GD+T V
Sbjct: 108 LKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164
Query: 116 RVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGR 154
+GT + APE M K+D++SFG+ +EL TG
Sbjct: 165 TFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-19
Identities = 53/155 (34%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L+H N+V G C++ + L+ E++PLGSL D+L K L+ + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFA 113
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRV 117
+G+ YLH + I+RDL + N+LLD K+ DFGLAK P G + + V
Sbjct: 114 QQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ A E + + SDV+SFGV EL+T
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 52/157 (33%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLD--WNTRMKIA 58
M SL H NL+ L G ++V E PLGSL D L + + ++IA
Sbjct: 50 MHSL-DHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST--- 115
G+ YL K I+RDL + NILL K+ DFGL + P + +V
Sbjct: 108 ----NGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+V + +CAPE T + SDV+ FGV E+ T
Sbjct: 161 KV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 61/197 (30%), Positives = 88/197 (44%), Gaps = 30/197 (15%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA--- 58
L L H N+V IG D ++ E+ GSL + P E L +A
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYV 105
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRV 117
+GL YLH++ VI+RD+K++NIL + KL+DFG+A KL V V
Sbjct: 106 YQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---V 159
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 177
+GT + APE + SD++S G +EL+TG PP ++L LF+
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG-------NPP-YYDLNP-MAALFR 210
Query: 178 ----DRRKFPKMADPLL 190
D P+ P L
Sbjct: 211 IVQDDHPPLPEGISPEL 227
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-19
Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+LS L H N+V +G + D + E +P GSL L EP+ +I
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-- 112
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-- 118
GLEYLHD+ ++RD+K +NIL+D KL+DFG+AK V
Sbjct: 113 --LGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAK 159
Query: 119 ---GTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
G+ + APE G L +D++S G LE+ TG+
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-19
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L+ L S ++ D + +V E+ G L L PL + +
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
GL +LH K +++RD+KS N+ LD + K+ D G+AKL + D T+ + ++GT
Sbjct: 110 ILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGT 164
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y +PE KSDV++ GVV E TG+ D +N A
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD------ANNQGALIL------- 211
Query: 181 KFPKMADPLLQGRY-PMRGLY-QALA-VAAMCLQEQAATRP 218
+++G + P+ +Y Q LA + CL + RP
Sbjct: 212 -------KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H L+ L C + +V E M GSL ++L L + +AA A G
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASG 115
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL-------GPVGDKTHVSTRV 117
+ YL + I+RDL + N+L+ E K++DFGLA++ G K +
Sbjct: 116 MAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK--- 169
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154
+ APE A+ + ++KSDV+SFG++ E++T GR
Sbjct: 170 -----WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 53/159 (33%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
LS +V L Y G + L LV E++P G L L ++ LD + A
Sbjct: 47 LSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAE 101
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS------ 114
LEYLH + +I+RDLK NIL+D H KL+DFGL+K+G V + +++
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
R++GT Y APE + + D +S G + E + G
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 48/172 (27%), Positives = 69/172 (40%), Gaps = 25/172 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ L H ++ L D + V E+ P G L ++ LD AA
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAE 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVM- 118
LEYLH K +I+RDLK NILLD+ H K++DFG AK L P
Sbjct: 111 ILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 119 ----------------GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y +PE SD+++ G + +++TG+
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE-----------PL 49
+L++L H ++V G C +G L+V+E+M G L L PD + L
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 50 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 109
+ IA+ A G+ YL A+ ++RDL + N L+ +G K+ DFG+++ D
Sbjct: 120 TLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 110 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
V R M + PE + + T +SD++SFGVV E+ T
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEPLDWNTRMK 56
+L LL H N++ + ++V E+ P G+L +++ L + L + ++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP---KLSDFGLAKLGPVGDKTHV 113
+A L ++H K +++RDLK+ NILLD+ H K+ DFG++K+ + K+
Sbjct: 112 LA------LHHVHTKL---ILHRDLKTQNILLDK--HKMVVKIGDFGISKI--LSSKSKA 158
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163
T V+GT Y +PE KSD+++ G V EL + ++A + P
Sbjct: 159 YT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 6/147 (4%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 66
H N+V LIG C +V E +P GSL L K L ++++ AA G+E
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGME 107
Query: 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 126
YL K I+RDL + N L+ E K+SDFG+++ G T + AP
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164
Query: 127 EYAMTGQLTLKSDVYSFGVVFLELITG 153
E G+ T +SDV+S+G++ E +
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 70/237 (29%), Positives = 103/237 (43%), Gaps = 43/237 (18%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
++ H N+++L+G C + L+V +M G L + + P + I
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNP---TVKDLIGF 103
Query: 60 G--AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK------LGPVGDKT 111
G AKG+EYL A+ ++RDL + N +LDE F K++DFGLA+ V + T
Sbjct: 104 GLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH-NLVA 170
V + A E T + T KSDV+SFGV+ EL+T R A PP +
Sbjct: 161 GAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMT-RGA-----PPYPDVDSFD 210
Query: 171 WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP----LIGDV 223
L + RR LLQ Y LY+ V C + RP L+ +
Sbjct: 211 ITVYLLQGRR--------LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 20/155 (12%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
+ H NLV L+G C ++ EFM G+L D+L + +++ ++ + +A +
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSA 116
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL-------GPVGDKTHVSTRV 117
+EYL K I+RDL + N L+ E K++DFGL++L G K +
Sbjct: 117 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--- 170
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE + ++KSDV++FGV+ E+ T
Sbjct: 171 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 53/156 (33%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
L +H +V L Y D++ +Y E+ G L L D + D T
Sbjct: 47 LEECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRD----RGLFDEYTARFYI 99
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A EYLH++ +IYRDLK N+LLD + KL DFG AK G KT
Sbjct: 100 ACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FC 153
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y APE + D +S G++ EL+TGR
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK------EPLDWNTR 54
+L+ L H ++V G C DGD ++V+E+M G L L PD +P
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 55 M------KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
+ IA+ A G+ YL A+ ++RDL + N L+ K+ DFG+++
Sbjct: 120 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 109 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D V M + PE M + T +SDV+SFGV+ E+ T
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 56/156 (35%), Positives = 90/156 (57%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L ++ + +V E+M GSL D L D + L + +AA
Sbjct: 54 IMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMG 119
A G+ Y+ ++ N I+RDL+S+NIL+ +G K++DFGLA+L + D + + +
Sbjct: 111 VAAGMAYI-ERMN--YIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKF 165
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154
+ APE A+ G+ T+KSDV+SFG++ EL+T GR
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 1 MLSL--LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP---LDWNTRM 55
ML++ L H+ +V L+G C G LV + PLGSL DH+ +P L+W ++
Sbjct: 60 MLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
AKG+ YL + +++R+L + NILL +++DFG+A L DK + +
Sbjct: 119 ------AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPP 163
+ A E + G+ T +SDV+S+GV E+++ G + RP
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 50/154 (32%), Positives = 74/154 (48%), Gaps = 13/154 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H NLV L G C +V E+M G L ++L + K L + + + +
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEA 112
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
+EYL I+RDL + N L+ E K+SDFGLA+ V D + S+ GT
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPV 165
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155
+ PE + + KSDV+SFGV+ E+ + K
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 58/224 (25%), Positives = 85/224 (37%), Gaps = 33/224 (14%)
Query: 6 HHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRM------KI 57
+V G D + E+ GSL+ K+ R+ KI
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKI 110
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTR 116
A KGL YLH + +I+RD+K SNILL KL DFG++ +L T
Sbjct: 111 AESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--- 164
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI--DNTRPPGEHNLVAWARP 174
GT Y APE ++ SDV+S G+ LE+ R + P G L+++
Sbjct: 165 --GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV- 221
Query: 175 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
P++ D G + CL++ RP
Sbjct: 222 ----NMPNPELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------PLDWNTRMKIAA 59
HH +V L+G + G L+V E M G L+ +L P+ E P +++AA
Sbjct: 69 HH--VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
A G+ YL K ++RDL + N ++ E K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE G T KSDV+SFGVV E+ T
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 49/157 (31%), Positives = 67/157 (42%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKI- 57
+L + +V+L D LV M G L+ H+ P E R
Sbjct: 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA-----RAIFY 100
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
AA GLE+LH + ++YRDLK N+LLD+ + ++SD GLA G K
Sbjct: 101 AAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-- 155
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT GY APE D ++ G E+I GR
Sbjct: 156 -GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 53/157 (33%), Positives = 75/157 (47%), Gaps = 24/157 (15%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWN-TRMK---IAAG 60
H N+V+ GD+ +V E+M GSL D + N RM IA
Sbjct: 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYV 121
Query: 61 AA---KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTR 116
+GLEYLH + VI+RD+KS NILL + KL+DFG A+L K +
Sbjct: 122 CREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---S 175
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
V+GT + APE K D++S G++ +E+ G
Sbjct: 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 52/153 (33%), Positives = 81/153 (52%), Gaps = 12/153 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV L + ++ E+M GSL D L P+ L N + +AA A+G
Sbjct: 58 LQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEG 114
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY--G 122
+ ++ K I+RDL+++NIL+ E K++DFGLA+L + + R +
Sbjct: 115 MAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIK 168
Query: 123 YCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154
+ APE G T+KSDV+SFG++ E++T GR
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 13/134 (9%)
Query: 20 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79
D LV E++ G + L P DW + A G+E LH + +I+R
Sbjct: 69 KDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAK--QYIAEVVLGVEDLHQRG---IIHR 121
Query: 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 139
D+K N+L+D+ H KL+DFGL++ G + + +GT Y APE + SD
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 140 VYSFGVVFLELITG 153
+S G V E + G
Sbjct: 176 WWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 52/153 (33%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + H LVNL G D LV E++P G L HL + P R AA
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPV-ARF-YAAQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
LEYLH ++YRDLK N+LLD + K++DFG AK V +T+ + GT
Sbjct: 110 VVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGT 161
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
Y APE ++ D ++ G++ E++ G
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 2 LSLLHHSN---LVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
L ++H +V+ G + + + + EFM GSL+ P+ KI
Sbjct: 54 LQIMHECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSLDRIYKKG----GPIPVEILGKI 108
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
A +GL YL++ +++RD+K SNIL++ KL DFG++ G + + ++
Sbjct: 109 AVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTF 162
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+GT Y +PE G+ T+KSDV+S G+ +EL G+
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 6e-16
Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 27/164 (16%)
Query: 2 LSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
L L H N+V L + +V+E+M HDL L + +K
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD--------HDL----TGLLDSPEVKFTE 99
Query: 60 GAAK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 111
K GL+YLH +++RD+K SNIL++ KL+DFGLA+ +
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNS 155
Query: 112 HVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
T + T Y PE + + + D++S G + EL G+
Sbjct: 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 36/224 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED---HLHDLPPDKEPLDWNTRMKI 57
+LSLL H N++ + D + L+ E+ G+L D ++E + W +
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+A + Y+H KA +++RD+K+ NI L + KL DFG++K+ +G + ++ V
Sbjct: 112 SA-----VSYIH-KAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETV 161
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 177
+GT Y +PE + KSD+++ G V EL+T ++ D T P NLV
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV------- 211
Query: 178 DRRKFPKMADPLLQGRY-PMRGLYQA--LAVAAMCLQEQAATRP 218
++QG Y P+ +Y + +++ LQ+ RP
Sbjct: 212 ----------KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK---------EPLDW 51
+L+ L H ++V G C +GD ++V+E+M G L L PD L
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 52 NTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 111
+ + IA A G+ YL A+ ++RDL + N L+ E K+ DFG+++ D
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
V M + PE M + T +SDV+S GVV E+ T
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L+H N+V G C + L+ EF+P GSL+++L P +K ++ ++K A
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYA 115
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-- 116
KG++YL + ++RDL + N+L++ K+ DFGL K DK + + +
Sbjct: 116 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDD 171
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ + APE + + + SDV+SFGV EL+T
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 39/240 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH--LHDLPPDKEPLDWNTRMKIA 58
ML L H NLVNLI + LV+EF+ DH L DL LD + K
Sbjct: 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYL 106
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRV 117
+G+E+ H + +I+RD+K NIL+ + KL DFG A+ L G+ V T
Sbjct: 107 FQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDY 160
Query: 118 MGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGRKAIDNTRPPGEH---------- 166
+ T Y APE + ++ D+++ G + E++TG PG+
Sbjct: 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG-----EPLFPGDSDIDQLYHIIK 215
Query: 167 ---NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLY-----QALAVAAMCLQEQAATRP 218
NL+ + +F+ F M P ++ P+ + L +A CL+ RP
Sbjct: 216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP-LDWNTRMKIAA 59
M L +H N+VNL+G C G L++ E+ G L + L +E L + +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSY 148
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV---STR 116
AKG+ +L K I+RDL + N+LL G K+ DFGLA+ + D +V + R
Sbjct: 149 QVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNAR 204
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ + APE T +SDV+S+G++ E+ +
Sbjct: 205 L--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------------KE 47
+++ LHH N+V L+G +++E++ G L + L P K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 48 PLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 107
LD + IA A G+EYL ++ +++DL + NIL+ E H K+SD GL++
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 108 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D V + + + PE M G+ + SD++SFGVV E+ +
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L+H N++ L+ LV+EFM D + + L +
Sbjct: 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTH-VSTRV 117
+GL + H +++RDLK N+L++ KL+DFGLA+ PV TH V TR
Sbjct: 107 LLQGLAFCH-SHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR- 162
Query: 118 MGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154
Y APE + + D++S G +F EL++ R
Sbjct: 163 ----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 1 MLSLLHHSNLVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+++ L+H +++ ++G C D L V E+M GS+ L KE + N ++
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL- 113
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLA-KLGPVGDKT-HVSTR 116
+GL YLH+ +I+RD+K +N+L+D G +++DFG A +L G +
Sbjct: 114 ---RGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
++GT + APE Q DV+S G V +E+ T +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 6e-15
Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 22/160 (13%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H N+V L+ + LV+E+ + L+ +L P PL N I
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQL 107
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
+GL Y H +++RDLK NIL++ KL+DFGLA+ + +T+ + V+ T
Sbjct: 108 LRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TL 162
Query: 122 GYCAPEYAMTGQLTLKS-------DVYSFGVVFLELITGR 154
Y APE + L S D++S G +F E+ITG+
Sbjct: 163 WYRAPE------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 64/246 (26%), Positives = 93/246 (37%), Gaps = 49/246 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMP---LGSLEDHLHDLPPDK-EPLDWNTRMK 56
+L L H N+VNL + LV+E++ L LE LPPD W
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--- 109
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
+ + Y H +I+RD+K NIL+ E KL DFG A+ + ++
Sbjct: 110 -----LQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY 161
Query: 117 VMGTYGYCAPEYAMTGQLTLKS-------DVYSFGVVFLELITGR--------------- 154
V T Y APE L + DV++ G + EL+ G
Sbjct: 162 V-ATRWYRAPE------LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI 214
Query: 155 -KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP-LLQGRYPMRGLYQALAVAAMCLQE 212
K + P H + + P F FP+ + P L+ RYP + AL CL+
Sbjct: 215 QKCLGPLPP--SHQELFSSNPRFA-GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRM 271
Query: 213 QAATRP 218
R
Sbjct: 272 DPKERL 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-15
Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 13/159 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N+V +G D D + E++P GS+ L++ +E L N +I
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-- 116
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-----LGPVGDKTHVST 115
KGL YLH++ +I+RD+K +NIL+D K+SDFG++K +
Sbjct: 117 --KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ G+ + APE T K+D++S G + +E++TG+
Sbjct: 172 -LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 9e-15
Identities = 53/153 (34%), Positives = 88/153 (57%), Gaps = 9/153 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L ++ + +V EFM GSL D L + D + L + +AA
Sbjct: 54 IMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMG 119
A G+ Y+ ++ N I+RDL+++NIL+ + K++DFGLA+L + D + + +
Sbjct: 111 IADGMAYI-ERMN--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKF 165
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE A+ G+ T+KSDV+SFG++ EL+T
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 44/135 (32%), Positives = 64/135 (47%), Gaps = 20/135 (14%)
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVST 115
I KGLEYLH I+RD+K+ NILL+E KL+DFG++ +L K +
Sbjct: 104 ILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR------------KAIDNTRPP 163
V+GT + APE K+D++S G+ +E+ G+ I N PP
Sbjct: 159 -VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP 217
Query: 164 GEHNLVAWARPLFKD 178
+ W+ P F D
Sbjct: 218 TLSDPEKWS-PEFND 231
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 11/166 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N+V +G C D + + EF+P GS+ L+ P EP+ +I G
Sbjct: 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDG 114
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK----LGPVGDKTHVSTR 116
A YLH+ V++RD+K +N++L KL DFG A+ +G G +++
Sbjct: 115 VA----YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162
+ GT + APE KSD++S G E+ TG+ + +
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 21/170 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------------- 44
+++ H N+V L+G CA G L++E+M G L + L P
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 45 --DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 102
+ PL ++ IA A G+ YL ++ ++RDL + N L+ E K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 103 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ D S + PE + T +SDV+++GVV E+ +
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
LHH NLV L+G + +V E M G+L + L + ++ + A+G
Sbjct: 56 LHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEG 112
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG-DKTHVSTRVMGTYGY 123
+EYL K +++RDL + NIL+ E K+SDFGLA++G +G D + + + +
Sbjct: 113 MEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------W 163
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154
APE + + KSDV+S+GV+ E+ + GR
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 51/151 (33%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 7 HSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKG 64
H L L C RL V E++ G L H+ EP R + AA G
Sbjct: 55 HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLG 108
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
L++LH++ +IYRDLK N+LLD H K++DFG+ K G +G T ++ GT Y
Sbjct: 109 LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYI 163
Query: 125 APEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
APE ++ Q + D ++ GV+ E++ G+
Sbjct: 164 APE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 47/134 (35%), Positives = 66/134 (49%), Gaps = 9/134 (6%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
+ V EF+ G L H+ D K D AA GL++LH K +IYRD
Sbjct: 69 EHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRD 121
Query: 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDV 140
LK N++LD H K++DFG+ K GD ++ GT Y APE + T D
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 141 YSFGVVFLELITGR 154
+SFGV+ E++ G+
Sbjct: 180 WSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 50/139 (35%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D+ V E++ G L H+ + KEP + AA A GL +LH K +IYRD
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFFLHSKG---IIYRD 126
Query: 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTGQLTLKSD 139
LK N++LD H K++DFG+ K G KT TR GT Y APE D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 140 VYSFGVVFLELITGRKAID 158
++FGV+ E++ G+ D
Sbjct: 184 WWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 9/162 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV L G C + LV+EFM G L D+L + T + + +G
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEG 112
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+ YL VI+RDL + N L+ E K+SDFG+ + + D+ ST +
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWS 168
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGE 165
+PE + + KSDV+SFGV+ E+ + G+ +N R E
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 36/248 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEP---------- 48
+LS L N++ L+G C D D ++ E+M G L L H L +E
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 49 ---LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 105
+ +++ + +A A G++YL ++ ++RDL + N L+ E K++DFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 106 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165
GD + R + + A E + G+ T SDV++FGV E++ K +P GE
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE----QPYGE 244
Query: 166 ---HNLVAWARPLFKDRRKFPKMADPLLQGRYPM--RGLYQALAVAAMCLQEQAATRPLI 220
++ A F+D+ + + R P +GLY+ + C RP
Sbjct: 245 LTDEQVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELM---LQCWSRDCRERPSF 295
Query: 221 GDVVTALT 228
D+ LT
Sbjct: 296 SDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L + ++ E+M GSL D L K L + +A
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQ 111
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A+G+ Y+ K I+RDL+++N+L+ E K++DFGLA+ V + + R
Sbjct: 112 IAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAK 165
Query: 121 Y--GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ + APE G T+KSDV+SFG++ E++T
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEP 48
+ L HH N++NL+G C + + E+ P G+L D L L D
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L ++ A+ A G++YL +K I+RDL + N+L+ E K++DFGL++ G
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----G 168
Query: 109 DKTHVSTRVMGTYG--YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
++ +V + MG + A E T KSDV+SFGV+ E+++
Sbjct: 169 EEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 5e-14
Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEP 48
+ L HH N++NL+G C L E+ P G+L D L L D
Sbjct: 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 108
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L + AA A+G++YL K I+RDL + NIL+ E + K++DFGL++ G
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----G 161
Query: 109 DKTHVSTRVMGTYG--YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ +V + MG + A E T SDV+S+GV+ E+++
Sbjct: 162 QEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 51/150 (34%), Positives = 71/150 (47%), Gaps = 16/150 (10%)
Query: 7 HSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 65
H LVNL C + + V E+ G L H+H + + AA GL
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGL 114
Query: 66 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYGY 123
+YLH+ ++YRDLK N+LLD K++DFGL K +G GD+T ST GT +
Sbjct: 115 QYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTPEF 167
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
APE T D + GV+ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 55/164 (33%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPL---GSLEDHLHDLPPDKEPLDWNTRMKIA 58
L LL H NLV Y R VY FM G+LE+ L LD +
Sbjct: 53 LELLKHPNLV---KYYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYT 105
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRV 117
+GL YLH +++RD+K +NI LD KL DFG A L + T + V
Sbjct: 106 LQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN--NTTTMGEEV 160
Query: 118 ---MGTYGYCAPEYAMTGQLTLK---SDVYSFGVVFLELITGRK 155
GT Y APE G+ +D++S G V LE+ TG++
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-----HDLPPDKEPLDWNTRM 55
M L H N+V L+G C + + ++ E+ LG L+ L D PL ++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
+ A G+++L +N ++RDL + N L+ K+S L+K + +
Sbjct: 121 ALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLR 176
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ + APE + KSDV+SFGV+ E+ T
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 58/162 (35%), Positives = 81/162 (50%), Gaps = 26/162 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH--LHDLPPDKEP--LDWNTRMK 56
ML L H NLVNLI + LV+E+ DH L++L +K P + + K
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYC------DHTVLNEL--EKNPRGVPEHLIKK 104
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKT-HV 113
I + + + H K N I+RD+K NIL+ + KL DFG A++ GP D T +V
Sbjct: 105 IIWQTLQAVNFCH-KHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKS--DVYSFGVVFLELITG 153
+TR Y APE + G DV++ G VF EL+TG
Sbjct: 162 ATR-----WYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 21/155 (13%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAA 62
L H +V LIG C G+ +LV E PLG L +L P + + ++ A
Sbjct: 53 LDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------A 105
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
G+ YL K ++RDL + N+LL K+SDFG+++ G + +T T G
Sbjct: 106 MGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAG 158
Query: 123 -----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE G+ + KSDV+S+GV E +
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--------------------H 40
+L ++H +++ L G C+ LL+ E+ GSL L +
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 41 DLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 100
PD+ L + A ++G++YL A +++RDL + N+L+ EG K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 101 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
L++ D ++ + A E T +SDV+SFGV+ E++T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLL-VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK 63
L+H N+V L+ L V+E++P +L + L L ++
Sbjct: 35 LYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA----DGALPAGETGRLMLQVLD 90
Query: 64 GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGP-VGD----KTHVST 115
L H++ +++RDLK NI++ H K+ DFG+ L P V D +T
Sbjct: 91 ALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157
V+GT YCAPE +T SD+Y++G++FLE +TG++ +
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 5/91 (5%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
GL++LH K +IYRDLK N+LLD+ H K++DFG+ K G+ ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
APE + D +SFGV+ E++ G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L + ++ EFM GSL D L K+PL + +A
Sbjct: 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMG 119
A+G+ ++ + I+RDL+++NIL+ K++DFGLA++ + D + +
Sbjct: 111 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKF 165
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154
+ APE G T+KSDV+SFG++ +E++T GR
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHSNLVNLIGY---CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
+ S+ H N+I Y DG++ +V E+ P G L + ++ + +I
Sbjct: 53 LASVNHP----NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+GL+ LH++ +++RDLKS+NILL K+ D G++K+ K +++
Sbjct: 109 FIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQ 161
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+GT Y APE + KSD++S G + E+ T
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-13
Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 31/196 (15%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84
++ E++ GS D L + PLD I KGL+YLH + I+RD+K++
Sbjct: 79 IIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAA 130
Query: 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFG 144
N+LL E KL+DFG+A G + D +GT + APE K+D++S G
Sbjct: 131 NVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 188
Query: 145 VVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY--PMRGLYQA 202
+ +EL G PP H+ + + LF PK P L+G Y P++ +A
Sbjct: 189 ITAIELAKG-------EPP--HSELHPMKVLF----LIPKNNPPTLEGNYSKPLKEFVEA 235
Query: 203 LAVAAMCLQEQAATRP 218
CL ++ + RP
Sbjct: 236 ------CLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------PLDWNTRMKIAA 59
HH +V L+G + G L++ E M G L+ +L L P+ E P +++A
Sbjct: 69 HH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
A G+ YL+ AN ++RDL + N ++ E F K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ +PE G T SDV+SFGVV E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 12/160 (7%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
L L H N+V D + L V E+ G L + +++ ++ +I
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 60 GAAKGLEYLHDKANPP--VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD---KTHVS 114
L H++++P V++RDLK +NI LD + KL DFGLAK+ KT+V
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y +PE KSD++S G + EL
Sbjct: 172 ----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 54/177 (30%), Positives = 85/177 (48%), Gaps = 13/177 (7%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 66
H N+VN + GD+ +V E++ GSL D + + D+ + R + A LE
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LE 129
Query: 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCA 125
+LH VI+RD+KS NILL KL+DFG A++ P K + ++GT + A
Sbjct: 130 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMA 183
Query: 126 PEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW-ARPLFKDRRK 181
PE K D++S G++ +E++ G N P L+A P ++ K
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 42/95 (44%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A A L++LH +IYRDLK NILLDE H KL+DFGL+K +K S
Sbjct: 105 AELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FC 159
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
GT Y APE T +D +SFGV+ E++TG
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 40/104 (38%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVS 114
K+ K L YL +K VI+RD+K SNILLD + KL DFG++ +L V K
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK-- 171
Query: 115 TRVMGTYGYCAPEY----AMTGQLTLKSDVYSFGVVFLELITGR 154
TR G Y APE + +++DV+S G+ +EL TG+
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 17/165 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVY-EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+L L H +V G C D+ L ++ E+MP GS++D L E + TR K
Sbjct: 57 LLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTR 111
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVM 118
+G+EYLH +++RD+K +NIL D + KL DFG +K L + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163
GT + +PE K+DV+S G +E++T +PP
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-------EKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 44/114 (38%), Positives = 62/114 (54%), Gaps = 9/114 (7%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
KIA K LEYLH K + VI+RD+K SN+L++ KL DFG++ G + D T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 116 RVMGTYGYCAPEY---AMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165
G Y APE + + +KSDV+S G+ +EL TGR D+ + P +
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 5e-13
Identities = 53/152 (34%), Positives = 85/152 (55%), Gaps = 10/152 (6%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV L ++ + +V E+M GSL D L + L + +AA A G
Sbjct: 58 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASG 114
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGY 123
+ Y+ ++ N ++RDL+++NIL+ E K++DFGLA+L + D + + + +
Sbjct: 115 MAYV-ERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKW 169
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154
APE A+ G+ T+KSDV+SFG++ EL T GR
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 27/226 (11%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV L G C +V EFM G L L+ L + L + + + +G
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEG 112
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGY 123
+EYL + I+RDL + N L+ K+SDFG+ + V D + S+ +
Sbjct: 113 MEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKW 167
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKF 182
PE + + KSDV+SFGV+ E+ T G+ + + N R
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-----KSNYEVVEMISRGFRLYR 222
Query: 183 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228
PK+A V C E+ RP +++ A+T
Sbjct: 223 PKLAS------------MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 48/134 (35%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D LV M G L+ H++++ D + AA GLE LH + ++YRD
Sbjct: 73 DALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLHRER---IVYRD 127
Query: 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDV 140
LK NILLD+ H ++SD GLA P G+ + RV GT GY APE + T D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFSPDW 184
Query: 141 YSFGVVFLELITGR 154
+ G + E+I G+
Sbjct: 185 WGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+++ L HSNLV L+G + L +V E+M GSL D+L + L + +K +
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 109
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVM 118
+ +EYL +AN ++RDL + N+L+ E K+SDFGL K D + +
Sbjct: 110 DVCEAMEYL--EANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154
+ APE + + KSDV+SFG++ E+ + GR
Sbjct: 165 ----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 38/97 (39%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
AA GL++LH K ++YRDLK NILLD H K++DFG+ K +GD +
Sbjct: 102 AAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTF 156
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y APE + + D +SFGV+ E++ G+
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 9e-13
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 11/160 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP---LDWNTRMKI 57
++S +H N+V L+G C + + ++ E M G L +L D ++ L + I
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-----KLSDFGLAKLGPVGDKTH 112
AKG YL I+RDL + N L+ E + K+ DFGLA+ D
Sbjct: 112 CLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ + APE + G+ T +SDV+SFGV+ E++T
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH------------DLPPDKEPLDWNTR 54
H N++NL+G C +V E+ G+L D L D P +E L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ A A+G+E+L K I+RDL + N+L+ E K++DFGLA+ D +
Sbjct: 135 VSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
T + APE T +SDV+SFGV+ E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 52/155 (33%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL-VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-A 58
+LSL + + + C RL V EF+ G L H+ E R + A
Sbjct: 48 ILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYA 102
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A L +LHDK +IYRDLK N+LLD H KL+DFG+ K G KT ++
Sbjct: 103 AEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFC 157
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
GT Y APE D ++ GV+ E++ G
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV L G C +V E+M G L ++L + +P +++ +G
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEG 112
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
+ YL K I+RDL + N L+D+ K+SDFGL++ V D + S+ +G+
Sbjct: 113 MAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPV 165
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ PE + + + KSDV++FGV+ E+ +
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 22/155 (14%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAK 63
H N++ L G +++ E+M GSL+ L +D + + G A
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIAS 117
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG- 122
G++YL + ++RDL + NIL++ K+SDFGL++ + D T T G
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGG 168
Query: 123 -----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE + T SDV+SFG+V E+++
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------PLDWNTRMKIAA 59
HH +V L+G + G L+V E M G L+ +L L P+ E P +++AA
Sbjct: 69 HH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
A G+ YL+ K ++RDL + N ++ F K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE G T SD++SFGVV E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
L L H N+V +G+ + + E++P GS+ L +E L ++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-- 118
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+GL YLH K +++RDLK+ N+L+D K+SDFG++K + + G+
Sbjct: 119 --EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 121 YGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 178
+ APE + + K D++S G V LE+ GR RP + +A L
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKLGNK 227
Query: 179 RRKFP 183
R P
Sbjct: 228 RSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------DLPPDKEPLDWNTR 54
LS L N+ L+G C ++ E+M G L L L + + L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ +A A G+ YL + ++RDL + N L+ + + K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
R + A E + G+ T KSDV++FGV E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 48/143 (33%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 66
H N+V LIG C QR +Y M L D L L K+ L +K A AA G+
Sbjct: 51 HPNIVKLIGVCT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA 107
Query: 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 126
YL K I+RDL + N L+ E K+SDFG+++ G + + + + AP
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAP 163
Query: 127 EYAMTGQLTLKSDVYSFGVVFLE 149
E G+ + +SDV+S+G++ E
Sbjct: 164 EALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 26/158 (16%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
KGL+YLH + I+RD+K++N+LL E KL+DFG+A G + D +GT
Sbjct: 112 KGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166
Query: 123 YCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 182
+ APE K+D++S G+ +EL G + P R LF
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP---------MRVLF----LI 213
Query: 183 PKMADPLLQGRY--PMRGLYQALAVAAMCLQEQAATRP 218
PK + P L+G+Y P + +A CL + RP
Sbjct: 214 PKNSPPTLEGQYSKPFKEFVEA------CLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEP 48
+ L HH N++NL+G C L E+ P G+L D L L D
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L + AA A+G++YL K I+RDL + NIL+ E + K++DFGL++ G
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----G 173
Query: 109 DKTHVSTRVMGTYG--YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ +V + MG + A E T SDV+S+GV+ E+++
Sbjct: 174 QEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 51/145 (35%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 69
+VNL D LV M G L+ H++++ + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 70 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 129
+ +YRDLK NILLD+ H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 130 MTGQLTLKSDVYSFGVVFLELITGR 154
+ TL D + G + E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 19/164 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED------------HLHDLPPDKEP 48
++S L + N++ L+G C D ++ E+M G L H +++P
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS---- 125
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
+ + +A A G++YL A+ ++RDL + N L+ + K++DFG+++ G
Sbjct: 126 VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 109 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D + R + + A E + G+ T SDV++FGV E+ T
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTR 54
H N++NL+G C ++ E+ G+L ++L P E + +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ A+G+EYL A+ I+RDL + N+L+ E K++DFGLA+ D +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
T + APE T +SDV+SFGV+ E+ T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 36/93 (38%), Positives = 56/93 (60%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL+Y+H V++RDLK SNIL++E K+ DFGLA++ +VSTR
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 123 YCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGR 154
Y APE +T Q ++ D++S G +F E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 62/224 (27%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE-PLDWNTRMKIAA 59
LS + G G + ++ E+ GS D L K LD I
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILR 105
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR--- 116
GLEYLH++ I+RD+K++NILL E KL+DFG++ G T ++
Sbjct: 106 EVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNT 157
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARP 174
+GT + APE K+D++S G+ +EL G PP H + R
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG-------EPPLSDLHPM----RV 206
Query: 175 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
LF PK P L+G + + ++CL + RP
Sbjct: 207 LF----LIPKNNPPSLEGNKFSKPFKDFV---SLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-12
Identities = 48/128 (37%), Positives = 67/128 (52%), Gaps = 17/128 (13%)
Query: 28 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 87
EFM GSL D +P E + +IA KGL YL + +++RD+K SN+L
Sbjct: 79 EFMDGGSL-DVYRKIP---EHV----LGRIAVAVVKGLTYLW---SLKILHRDVKPSNML 127
Query: 88 LDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
++ KL DFG++ +L KT+V GT Y APE Q + SDV+S G+
Sbjct: 128 VNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYGIHSDVWSLGIS 182
Query: 147 FLELITGR 154
F+EL GR
Sbjct: 183 FMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 40/102 (39%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
KIA K L YL K +I+RD+K SNILLD + KL DFG++ G + D T
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI-AKT 165
Query: 116 RVMGTYGYCAPEYAMTGQLT---LKSDVYSFGVVFLELITGR 154
R G Y APE ++SDV+S G+ E+ TG+
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------DLPPD-----KEPLDWNTR 54
H N++NL+G C ++ E+ G+L + L D D +E L +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ A A+G+EYL + I+RDL + N+L+ E K++DFGLA+ D +
Sbjct: 137 VSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ + APE T +SDV+SFG++ E+ T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 24/183 (13%)
Query: 1 MLSLLHHSNLVNLI-GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+LS H N+V L Y + +L+ EF G+L+ + +L + L +
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCR 110
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
+ L +LH VI+RDLK+ NILL KL+DFG++ + + +G
Sbjct: 111 QMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIG 165
Query: 120 TYGYCAPEYAMTGQLT-----LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 174
T + APE K+D++S G+ +EL PP H+ + R
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQM-------EPP--HHELNPMRV 216
Query: 175 LFK 177
L K
Sbjct: 217 LLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 25/163 (15%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL---------HDLPPDKEP---LDWNTR 54
H N++NL+G C ++ E+ G+L ++L + P + P L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ A A+G+EYL A+ I+RDL + N+L+ E K++DFGLA+ D H+
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 194
Query: 115 TRVMGTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
T G + APE T +SDV+SFGV+ E+ T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 47/134 (35%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D LV M G L+ H++ + + + + AA GLE LH + ++YRD
Sbjct: 73 DALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRD 127
Query: 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDV 140
LK NILLD+ H ++SD GLA P G + RV GT GY APE + T D
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDW 184
Query: 141 YSFGVVFLELITGR 154
++ G + E+I G+
Sbjct: 185 WALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 46/139 (33%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D+ V E++ G L H+ + KEP + AA + GL +LH + +IYRD
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFFLHRRG---IIYRD 126
Query: 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTGQLTLKSD 139
LK N++LD H K++DFG+ K V V+TR GT Y APE D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 140 VYSFGVVFLELITGRKAID 158
+++GV+ E++ G+ D
Sbjct: 184 WWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L + H ++ L + + DQR L + E++P G L +L + +T + A
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYA 107
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+ LEYLH K ++YRDLK NILLD+ H KL+DFG AK + D+T +
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LC 159
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
GT Y APE + D ++ G++ E++ G
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 10/93 (10%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYG 122
L++LH +IYRD+K NILLD H L+DFGL+K L ++ + GT
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIE 171
Query: 123 YCAPEYAMTGQLTLKS--DVYSFGVVFLELITG 153
Y APE G D +S GV+ EL+TG
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L H N+V LIG C Q+ +Y M L D L L + L +++
Sbjct: 46 ILKQYSHPNIVRLIGVCT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVEN 102
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AA G+EYL K I+RDL + N L+ E K+SDFG+++ D + ST M
Sbjct: 103 AAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQ 157
Query: 121 --YGYCAPEYAMTGQLTLKSDVYSFGVVFLE 149
+ APE G+ + +SDV+SFG++ E
Sbjct: 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 48/134 (35%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D LV M G L+ H++++ D + AA GLE L + ++YRD
Sbjct: 73 DALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRD 127
Query: 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDV 140
LK NILLD+ H ++SD GLA P G+ V RV GT GY APE + T D
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTFSPDW 184
Query: 141 YSFGVVFLELITGR 154
+ G + E+I G+
Sbjct: 185 WGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL----LVYEFMPLGSLEDHLHDLPPDKEP-LDWNTRM 55
L + +N++ + G+ D L L+ E+ G L + L DKE L + T++
Sbjct: 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKDLSFKTKL 125
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
+A KGL L+ N P Y++L S + L+ E + K+ GL K+ +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159
V +Y ++ + T+K D+YS GVV E+ TG+ +N
Sbjct: 184 MVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 53/159 (33%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L + N+VN + GD+ +V E++ GSL D + + D+ + R + A
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA----- 127
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGY 123
LE+LH AN VI+RD+KS N+LL KL+DFG A++ P +++ ST V GT +
Sbjct: 128 LEFLH--ANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYW 181
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162
APE K D++S G++ +E++ G N P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 51/148 (34%), Positives = 70/148 (47%), Gaps = 20/148 (13%)
Query: 17 CADGDQRL-LVYEFMPLGSLEDHLH---DLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 72
C RL LV E++ G L H+ LP + AA L +LH++
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-------YAAEICIALNFLHERG 116
Query: 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYGYCAPEYAM 130
+IYRDLK N+LLD H KL+D+G+ K LGP GD T + GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEILR 169
Query: 131 TGQLTLKSDVYSFGVVFLELITGRKAID 158
+ D ++ GV+ E++ GR D
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 38/177 (21%)
Query: 1 MLSLLHHSNLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK-- 56
+L L H N+V + + ++ D+ +V E++ HDL K ++ MK
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE--------HDL---KSLME---TMKQP 102
Query: 57 IAAGAAK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
K G+ +LHD +++RDLK+SN+LL+ K+ DFGLA+ G
Sbjct: 103 FLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYG 157
Query: 109 DKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELIT------GRKAID 158
T+++ T Y APE + + + D++S G +F EL+T G+ ID
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 41/159 (25%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLD-------WNT 53
++S L N++ L+ C D ++ E+M G L L P + ++T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV 113
+ +A A G++YL ++ ++RDL + N L+ + + K++DFG+++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
R + + + E + G+ T SDV++FGV E++T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 2 LSLLHHSNLVNLIGY----CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
L +LH N ++G+ +DG+ + + E M GSL+ L E + KI
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENI----LGKI 104
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+ +GL YL +K +++RD+K SNIL++ KL DFG++ G + D ++
Sbjct: 105 SIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 158
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 168
+GT Y +PE T++SD++S G+ +E+ GR I PP L
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 11/97 (11%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY- 121
+GL+Y+H AN V++RDLK SN+LL+ K+ DFGLA+ + D H T + Y
Sbjct: 117 RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLTEYV 170
Query: 122 ---GYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
Y APE + + K+ D++S G + E+++ R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+++ + H +LV L+G C +L V + MP G L D++H+ K+ + +
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AKG+ YL ++ +++RDL + N+L+ H K++DFGLA+L +K + +
Sbjct: 118 IAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158
+ A E + T +SDV+S+GV EL+T G K D
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 53/159 (33%), Positives = 76/159 (47%), Gaps = 22/159 (13%)
Query: 8 SNLVNLIGY--CADGDQRL-LVYEFMPLGSLEDHLH---DLPPDKEPLDWNTRMKIAAGA 61
SN L+G C + RL V EF+ G L H+ LP + + R +A
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEE------HARF-YSAEI 105
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMG 119
+ L +LH++ +IYRDLK N+LLD H KL+D+G+ K + P GD T + G
Sbjct: 106 SLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT---STFCG 158
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158
T Y APE D ++ GV+ E++ GR D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 41/108 (37%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
AA L +LH VIYRDLK NILLD H KL+DFG+ K G + T +T
Sbjct: 102 AAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTF 156
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165
GT Y APE + D ++ GV+ E++ G +PP E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG-------QPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---PLDWNTRMKI 57
++S +H N+V LIG + R ++ E M G L+ L + P E L +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVS 114
A AKG +YL + I+RD+ + N LL G K++DFG+A+
Sbjct: 122 ARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150
R M + PE + G T K+DV+SFGV+ E+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 66
H N++ L G +++ E+M G+L+ +L D + ++ G A G++
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMK 121
Query: 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGY 123
YL D ++RDL + NIL++ K+SDFGL+++ P G T ++ +
Sbjct: 122 YLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRW 176
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 183
APE + T SDV+SFG+V E+++ RP + + + + R
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKAINDGFRLPA 231
Query: 184 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230
M P +YQ + C Q+ A RP D+V L L
Sbjct: 232 PMDCP--------SAVYQLM---LQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 21 DQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78
D+ + + M G L HL H + +KE + T + + GLE++H++ V+Y
Sbjct: 70 DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHNRF---VVY 120
Query: 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 138
RDLK +NILLDE H ++SD GLA K H S +GT+GY APE G S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGTAYDSS 176
Query: 139 -DVYSFGVVFLELITGRKAIDNTRPPGEHNL 168
D +S G + +L+ G + +H +
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 58/201 (28%), Positives = 82/201 (40%), Gaps = 37/201 (18%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIA- 58
ML H N+V G D+ +V E+ GSL+D P E IA
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ-------IAY 105
Query: 59 --AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
KGL YLH+ I+RD+K +NILL E KL+DFG++ T +
Sbjct: 106 VCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAK 157
Query: 117 ---VMGTYGYCAPEYA---MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA 170
+GT + APE A G K D+++ G+ +EL + + + P
Sbjct: 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-------- 209
Query: 171 WARPLF---KDRRKFPKMADP 188
R LF K PK+ D
Sbjct: 210 -MRALFLISKSNFPPPKLKDK 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 63/239 (26%), Positives = 95/239 (39%), Gaps = 35/239 (14%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD------LPPDKEPLDWNTRMKIA 58
L+H N++ +G C + LLV EF PLG L+++L K+ ++A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD-----VLQRMA 106
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A GL +LH +A+ I+ DL N L K+ D+GLA D
Sbjct: 107 CEVASGLLWLH-QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHA 163
Query: 119 GTYGYCAPEYA-------MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP-PGEHNLVA 170
+ APE + T KS+++S GV EL T +P P +
Sbjct: 164 VPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQV 218
Query: 171 WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229
+ + + K PK P L +Y R Y+ + + TRP +V LTY
Sbjct: 219 LKQVVREQDIKLPK---PQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 5 LHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHLH----DLPPDKEPLDWNTR 54
H N++ LIG C + +++ FM G L L P+K PL T
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTL 115
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD---KT 111
+K A G+EYL +N I+RDL + N +L E ++DFGL+K GD +
Sbjct: 116 LKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
++ + + A E T KSDV++FGV E+ T
Sbjct: 173 RIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 50/137 (36%), Positives = 70/137 (51%), Gaps = 18/137 (13%)
Query: 21 DQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKANPPVI 77
D+ + + M G L HL H + + E M+ AA GLE++H++ V+
Sbjct: 70 DKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHMHNRF---VV 119
Query: 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 137
YRDLK +NILLDE H ++SD GLA K H S +GT+GY APE G
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDS 175
Query: 138 S-DVYSFGVVFLELITG 153
S D +S G + +L+ G
Sbjct: 176 SADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEPLDWNTR 54
H N++NL+G C ++ E+ G+L ++L P +E L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ A A+G+EYL A+ I+RDL + N+L+ E K++DFGLA+ D +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
T + APE T +SDV+SFGV+ E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N+V L + L++EF+ + L+ +L LP + +D
Sbjct: 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MDAELVKSYLYQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+G+ + H + V++RDLK N+L+D KL+DFGLA+ G V T + T
Sbjct: 110 ILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVT 164
Query: 121 YGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
Y APE + + D++S G +F E+ T +
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 40/130 (30%), Positives = 59/130 (45%), Gaps = 5/130 (3%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84
LV M G L H++++ + A GLE+LH + +IYRDLK
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPE 126
Query: 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFG 144
N+LLD + ++SD GLA + D + GT G+ APE + D ++ G
Sbjct: 127 NVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALG 184
Query: 145 VVFLELITGR 154
V E+I R
Sbjct: 185 VTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 65
HH N+V++ GD+ +V EF+ G+L D + ++E + + + L
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRAL 131
Query: 66 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 125
YLH++ VI+RD+KS +ILL KLSDFG V + ++GT + A
Sbjct: 132 SYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMA 186
Query: 126 PEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162
PE + D++S G++ +E+I G N P
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 68
N+VN + GD+ +V E++ GSL D + + D+ + R + A LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LEFL 132
Query: 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE 127
H VI+RD+KS NILL KL+DFG A++ P K + ++GT + APE
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPE 186
Query: 128 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162
K D++S G++ +E+I G N P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 14/150 (9%)
Query: 13 LIGYCADGDQRLLVYEFMPLGSLEDHLH---DLPPDKEPLDWNTRMKIAAGAAKGLEYLH 69
L+G C +L V + MP G L D++ D ++ L+W ++ AKG+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 70 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 129
+ +++RDL + N+L+ H K++DFGLA+L + + + + + A E
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 130 MTGQLTLKSDVYSFGVVFLELIT-GRKAID 158
+ + T +SDV+S+GV EL+T G K D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 51/161 (31%), Positives = 73/161 (45%), Gaps = 30/161 (18%)
Query: 5 LHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHD-----LPPDKEPLDWNTRMKI 57
L H N++ L+ + + LV+EFM LE + D P D + T
Sbjct: 59 LKHPNIIGLLDVFGHK--SNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT---- 111
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDK-TH-VS 114
+GLEYLH +++RDLK +N+L+ KL+DFGLA+ G K TH V
Sbjct: 112 ----LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 115 TRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
TR Y APE + D++S G +F EL+
Sbjct: 165 TRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 9/154 (5%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L H +V L+ G +LV E+MP L + L D PL
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRML 108
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
KG+ Y+H +++RDLK +N+L+ K++DFGLA+L + S +V T
Sbjct: 109 LKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATR 164
Query: 122 GYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGR 154
Y APE + D+++ G +F EL+ G
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+LS + G G + ++ E++ GS D L P D+ T +K
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--FQIATMLK---E 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
KGL+YLH + I+RD+K++N+LL E KL+DFG+A G + D +GT
Sbjct: 110 ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGT 164
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
+ APE K+D++S G+ +EL G + P R LF
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP---------MRVLF---- 211
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
PK P L G + ++ A CL + + RP
Sbjct: 212 LIPKNNPPTLTGEFSKP--FKEFIDA--CLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 14/162 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH---DLPPDKEPLDWNTRMKI 57
+++ + + ++ L+G C +L + + MP G L D++ D + L+W ++
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
AKG+ YL ++ +++RDL + N+L+ H K++DFGLAKL +K + +
Sbjct: 119 ----AKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158
+ A E + T +SDV+S+GV EL+T G K D
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 53/174 (30%), Positives = 77/174 (44%), Gaps = 37/174 (21%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL----------LVYEFMP---LGSLEDHLHDLPPD-- 45
+L L+H N+VNL D L LV+E+M +G LE L D
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 46 ----KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 101
K+ L+ GL Y H K ++RD+K SNILL+ KL+DFGL
Sbjct: 119 KSFMKQLLE-------------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL 162
Query: 102 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
A+L + + +V+ T Y PE + + + DV+S G + EL T +
Sbjct: 163 ARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 53/167 (31%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM 55
+L L H N++ L+ +V E M E LH + +PL + +
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHI 105
Query: 56 K-IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG-----PVGD 109
+ +GL+YLH AN VI+RDLK SNIL++ K+ DFGLA+ G
Sbjct: 106 QYFLYQILRGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 110 KT-HVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGR 154
T +V TR Y APE ++ T D++S G +F EL+T +
Sbjct: 163 LTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM---KIAA--- 59
H N+V + GD+ +V EF+ G+L D + +TRM +IA
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCL 122
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
K L +LH + VI+RD+KS +ILL KLSDFG V + ++G
Sbjct: 123 AVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVG 177
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162
T + APE + D++S G++ +E++ G N P
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 50/171 (29%), Positives = 71/171 (41%), Gaps = 33/171 (19%)
Query: 4 LLHHSNLVNLIGY---------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
L +SN N+ + + DQ LV E GS+ D + L R
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL------RKKGKR 109
Query: 55 MK------IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPV 107
+K I +GL YLH+ VI+RD+K NILL + KL DFG+ A+L
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166
Query: 108 GDKTHVSTRVMGTYGYCAPE-----YAMTGQLTLKSDVYSFGVVFLELITG 153
+ + GT + APE +SDV+S G+ +EL G
Sbjct: 167 LGRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 39/96 (40%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
AA A L YLH +IYRDLK NILLD H L+DFGL K G KT ++
Sbjct: 102 AAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTF 156
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
GT Y APE D + G V E++ G
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 55/161 (34%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H N + G LV E+ LGS D L K+PL I GA
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGA 130
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
+GL YLH +I+RD+K+ NILL E KL+DFG A K+ + +GT
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTP 181
Query: 122 GYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDN 159
+ APE + GQ K DV+S G+ +EL + + N
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 51/129 (39%), Positives = 65/129 (50%), Gaps = 16/129 (12%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84
LV E+ LGS D L K+PL I GA +GL YLH + I+RD+K+
Sbjct: 92 LVMEYC-LGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAG 144
Query: 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--YAM-TGQLTLKSDVY 141
NILL E KL+DFG A L + +GT + APE AM GQ K DV+
Sbjct: 145 NILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 142 SFGVVFLEL 150
S G+ +EL
Sbjct: 199 SLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLD----WNTRMKIAAG 60
L H N+V + D+ +V + + L +H + L K+ WN +++
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
L YLH + +++RDL +NI+L E ++DFGLAK K T V+GT
Sbjct: 126 ----LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGT 176
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
Y PE K+DV++FG + ++ T
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 52/156 (33%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEPLDWNTRMKI 57
+L L H +VN++ D ++ + EF+ G L HL P D
Sbjct: 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-------Y 123
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
A EYLH K +IYRDLK N+LLD H K++DFG AK V D+T +
Sbjct: 124 HAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---L 175
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
GT Y APE + D ++ GV+ E I G
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 37/103 (35%), Positives = 60/103 (58%), Gaps = 17/103 (16%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL---GPVGDKT----HVST 115
+GL+Y+H AN VI+RDLK SN+L++E ++ DFG+A+ P K +V+T
Sbjct: 118 RGLKYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 116 RVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAI 157
R Y APE ++ + T D++S G +F E++ GR+ +
Sbjct: 175 R-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 48/154 (31%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 7 HSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIA 58
H N++ LIG C + +++ FM G L L P T+M K
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A G+EYL K+ I+RDL + N +L+E + ++DFGL+K GD
Sbjct: 119 TDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ A E T KSDV+SFGV E+ T
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL+YLH+ +I+RDLK SN+LL + K++DFGLA+ G T + T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLW 173
Query: 123 YCAPE--YAMTGQLTLKSDVYSFGVVFLELITGR 154
Y APE T T D+++ G + EL+ +
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 6 HHSNLVNLIGYCADGDQRLL-VYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAA 62
+H LV L C + RL V E++ G L H+ P++ ++ + +A
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA---- 108
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG-PVGDKTHVSTRVMGTY 121
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G GD T + GT
Sbjct: 109 --LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTP 160
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158
Y APE D ++ GV+ E++ GR D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEPLDWNTRMKIA 58
S L H N+V +G ++ + E +P GSL L L +++ + + T+ +
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL- 118
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLD--EGFHPKLSDFG----LAKLGPVGDKTH 112
+GL+YLHD +++RD+K N+L++ G K+SDFG LA + P
Sbjct: 119 ----EGLKYLHDNQ---IVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINP------ 164
Query: 113 VSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGR 154
+ GT Y APE G +D++S G +E+ TG+
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 68
+VNL Y + L LV M G L+ H++++ + L+ + +A G+ +L
Sbjct: 55 IVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHL 111
Query: 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 128
H ++YRD+K N+LLD+ + +LSD GLA G T+ GT GY APE
Sbjct: 112 HSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEI 165
Query: 129 AMTGQLTLKSDVYSFGVVFLELITGR 154
+ D ++ G E++ GR
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEPLDWNTRMK 56
+L+ + H N+V + + +V E+ G L ++ L + + L W ++
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVST 115
+ GL+++HD+ +++RD+KS NI L + G KL DFG+A+ + D ++
Sbjct: 112 L------GLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY 160
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+GT Y +PE K+D++S G V EL T
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------DK----- 46
M S L H N+V L+G +++ + L + L P DK
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 47 -EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 105
EP D+ + I A G+E+L ++ V+++DL + N+L+ + + K+SD GL +
Sbjct: 121 LEPADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 106 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D + + + +PE M G+ ++ SD++S+GVV E+ +
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 50/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 68
N+VN + GD+ +V E++ GSL D + + D+ + R + A L++L
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LDFL 131
Query: 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE 127
H VI+RD+KS NILL KL+DFG A++ P +++ ST V GT + APE
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPE 185
Query: 128 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162
K D++S G++ +E++ G N P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 15/141 (10%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D+ V E++ G L + + KEP + AA A GL +LH K +IYRD
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLHSKG---IIYRD 126
Query: 81 LKSSNILLDEGFHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 137
LK N++LD H K++DFG+ K V KT GT Y APE
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-----GTPDYIAPEIIAYQPYGKS 181
Query: 138 SDVYSFGVVFLELITGRKAID 158
D ++FGV+ E++ G+ +
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 19/179 (10%)
Query: 2 LSLLHHSNLVNLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
L +LH N ++G+ +DG+ + + E M GSL+ L + E + K+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEI----LGKV 108
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+ +GL YL +K +++RD+K SNIL++ KL DFG++ G + D ++
Sbjct: 109 SIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA-WARPL 175
+GT Y +PE +++SD++S G+ +EL GR I PP L A + RP+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP---PPDAKELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 43/134 (32%), Positives = 68/134 (50%), Gaps = 15/134 (11%)
Query: 28 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 87
E+M GSL D L+ E + + +I KGL++L ++ N +I+RD+K +N+L
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 88 LDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY----AMTGQLT--LKSDV 140
++ KL DFG++ L KT++ G Y APE T ++SDV
Sbjct: 136 VNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQNPTYTVQSDV 190
Query: 141 YSFGVVFLELITGR 154
+S G+ LE+ GR
Sbjct: 191 WSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 38/90 (42%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGY 123
LE+LH + +IYRDLK NILLD H KL+DFGL K G TH GT Y
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEY 166
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
APE M D +S G + +++TG
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 2 LSLLHHSNLVNLIGYCADG--DQRL---LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
L H N+V L+ CA D+ LV+E + L +L +PP P + T
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKD 112
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS-T 115
+ +GL++LH +++RDLK NIL+ G KL+DFGLA++ ++ T
Sbjct: 113 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALT 165
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150
V+ T Y APE + D++S G +F E+
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 13/187 (6%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 65
H N+V + GD+ +V EF+ G+L D + ++E + + K L
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKAL 129
Query: 66 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 125
LH + VI+RD+KS +ILL KLSDFG V + ++GT + A
Sbjct: 130 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMA 184
Query: 126 PEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 185
PE + D++S G++ +E++ G N P ++ R + K
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHK 241
Query: 186 ADPLLQG 192
P L+G
Sbjct: 242 VSPSLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L+H N+V L+ ++ LV+EF+ L+ + P PL
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPL--PLIKSYLFQ 108
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+GL + H V++RDLK N+L++ KL+DFGLA+ V +T+ V T
Sbjct: 109 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--T 163
Query: 121 YGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAI 157
Y APE + + + D++S G +F E++T R+A+
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 36/90 (40%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
L YLH V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELITGR 154
APE D + GVV E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 9e-10
Identities = 53/176 (30%), Positives = 75/176 (42%), Gaps = 53/176 (30%)
Query: 4 LLHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L H N+V L+ A+ D+ + LV+E+M E LH + I A
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANI 103
Query: 62 -------------AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL---G 105
K L+Y+H N VI+RDLK SNILL+ KL+DFGLA+
Sbjct: 104 LEDVHKRYIMYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 106 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 154
+ V T + T Y APE + L S Y+ GV + E++ G+
Sbjct: 161 EENPENPVLTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 52/152 (34%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H N + G LV E+ LGS D L K+PL + GA
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAVTHGA 124
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
+GL YLH + +I+RD+K+ NILL E KL DFG A + + +GT
Sbjct: 125 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTP 175
Query: 122 GYCAPEYAMT---GQLTLKSDVYSFGVVFLEL 150
+ APE + GQ K DV+S G+ +EL
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 54/143 (37%), Positives = 68/143 (47%), Gaps = 20/143 (13%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
LE LH K N VIYRDLK NILLD H L DFGL KL D + GT Y
Sbjct: 106 LENLH-KFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYL 160
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP-GEHNLVAWARPLFKDRRKFP 183
APE + T D ++ GV+ E++TG PP + N+ R + ++ +FP
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG-------LPPFYDENVNEMYRKILQEPLRFP 213
Query: 184 ----KMADPLLQG---RYPMRGL 199
+ A LL G R P R L
Sbjct: 214 DGFDRDAKDLLIGLLSRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
LEYLH + V+YRD+K N++LD+ H K++DFGL K G + D + T GT Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELITGR 154
APE D + GVV E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 53/163 (32%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 1 MLSLLHHSNLVNL--IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
+L L+H N+V L + + + +L LV+EF+ L L+ ++ D PL I
Sbjct: 51 LLKELNHPNIVRLLDVVHS---ENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLI 101
Query: 58 AA---GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LG-PVGDKTH 112
+ +G+ Y H V++RDLK N+L+D KL+DFGLA+ G PV TH
Sbjct: 102 KSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158
Query: 113 VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154
V+ T Y APE + Q + D++S G +F E++ R
Sbjct: 159 ---EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 33/165 (20%)
Query: 1 MLSLLHHSNLVN-------------LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 47
+L+ + H N+V ++ YC GD + ++ L P+
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFPEDT 101
Query: 48 PLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 107
L W +M + G++++H+K V++RD+KS NI L + KL DFG A+L +
Sbjct: 102 ILQWFVQMCL------GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL--L 150
Query: 108 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ +GT Y PE KSD++S G + EL T
Sbjct: 151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
A L+YLH + N V+YRDLK N++LD+ H K++DFGL K G + D + T
Sbjct: 101 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-F 156
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y APE D + GVV E++ GR
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 44/172 (25%), Positives = 84/172 (48%), Gaps = 34/172 (19%)
Query: 1 MLSLLHHSNLVN--------------LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 46
+LS L H N+V ++G+C GD +Y L++ L P+
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPEN 102
Query: 47 EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 106
+ ++W ++ +A L+YLH+K +++RDLK+ N+ L K+ D G+A++
Sbjct: 103 QVVEWFVQIAMA------LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV-- 151
Query: 107 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158
+ ++ +++ ++GT Y +PE KSDV++ G E+ T + A +
Sbjct: 152 LENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H N+V L ++ +LV+E+M L+ ++ D + LD NT KG
Sbjct: 55 LKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKG 112
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+ + H+ V++RDLK N+L+++ KL+DFGLA+ + T + V T Y
Sbjct: 113 IAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYR 167
Query: 125 APEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
AP+ + + S D++S G + E+ITGR
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 46/159 (28%), Positives = 68/159 (42%), Gaps = 19/159 (11%)
Query: 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLE 66
N+V L Y D LV + G L H+ P++ W M +A L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG-LAKLGPVGDKTHVSTRVMGTYGYCA 125
LH + ++ RDL +NILLD+ H +L+ F +++ D V YCA
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 126 PEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164
PE + T D +S G + EL+TG K + P G
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 11/115 (9%)
Query: 44 PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 103
P+ + LDW ++ +A L+++HD+ +++RD+KS NI L + KL DFG+A+
Sbjct: 99 PEDQILDWFVQICLA------LKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
Query: 104 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158
+ + ++ +GT Y +PE KSD+++ G V E+ T + A +
Sbjct: 150 V--LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++S L H +LV L G C D+ ++V E++ G L+ LH + L W ++ +A
Sbjct: 54 LMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILL-----DEGFHP--KLSDFGLAKLGPVGDKTHV 113
A L YL DK +++ ++ NIL+ +EG+ P KLSD G+ V +
Sbjct: 110 LASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREER 164
Query: 114 STRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165
R+ + APE GQ LT+ +D +SFG LE+ + + +T E
Sbjct: 165 VERI----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 52/152 (34%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L + H N + G LV E+ LGS D L K+PL I GA
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGA 134
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
+GL YLH +I+RD+K+ NILL E KL+DFG A + + +GT
Sbjct: 135 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTP 185
Query: 122 GYCAPEYAMT---GQLTLKSDVYSFGVVFLEL 150
+ APE + GQ K DV+S G+ +EL
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 69
+V +IG C + + +LV E G L L K+ + + +++ + G++YL
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLE 112
Query: 70 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY--GYCAP 126
K ++RDL + N+LL + K+SDFGL+K LG D ++ R G + + AP
Sbjct: 113 GKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAP 167
Query: 127 EYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPP 163
E + + +SDV+S+G+ E + G+K + P
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L H +V G D +++ L E+MP GS++D L E N +
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE----NVTRRYT 112
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK------LGPVGDKTH 112
+G+ YLH +++RD+K +NIL D + KL DFG +K + G K+
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS- 168
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
V GT + +PE K+DV+S +E++T
Sbjct: 169 ----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 45/131 (34%), Positives = 61/131 (46%), Gaps = 14/131 (10%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
LE+LH +IYRD+K NILLD H L+DFGL+K D+ + GT Y
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEY 172
Query: 124 CAPEYAMTGQLTLKS--DVYSFGVVFLELITGRK--AIDNTRPPGEHNLVA-WARPLFKD 178
AP+ G D +S GV+ EL+TG +D GE N A +R + K
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD-----GEKNSQAEISRRILKS 227
Query: 179 RRKFPKMADPL 189
+P+ L
Sbjct: 228 EPPYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL+YLH A +++RD+K N+L++ K+ DFGLA++ + H++ V+ Y
Sbjct: 114 RGLKYLH-SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 123 YCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGR 154
Y APE M + T D++S G +F EL+ R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 19/166 (11%)
Query: 2 LSLLHHSNLVNLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
L +LH N ++G+ +DG+ + + E M GSL+ L E + K+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQI----LGKV 108
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+ KGL YL +K +++RD+K SNIL++ KL DFG++ G + D ++
Sbjct: 109 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163
+GT Y +PE +++SD++S G+ +E+ GR I PP
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 33/178 (18%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQ-RL-LVYEFMPLGSLEDHLHDLPPD-KEPLDWNTRMKI 57
+ L H N++ LI D RL LV+E M + +L++L K PL
Sbjct: 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSY 105
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK----THV 113
K L+++H + +RD+K NIL+ + KL+DFG + + K ++
Sbjct: 106 MYQLLKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI 159
Query: 114 STRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRP--PGEHNL 168
STR Y APE +T G K D+++ G VF E+++ P PG + L
Sbjct: 160 STR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS-------LFPLFPGTNEL 205
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLV--YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L H +V G D ++ L E+MP GS++D L E + TR K
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV---TR-KYT 112
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-V 117
+G+ YLH +++RD+K +NIL D + KL DFG +K + R V
Sbjct: 113 RQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT + +PE K+DV+S G +E++T +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 34/166 (20%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE--PLDWNTRMKIAA 59
L H N+V L + D+ V+E+M E +L+ L D++ P + I
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIY 106
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK----THVST 115
+GL ++H K +RDLK N+L+ K++DFGLA+ + + +VST
Sbjct: 107 QILQGLAHIH-KHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVST 161
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYS-------FGVVFLELITGR 154
R Y APE + L+S YS G + EL T R
Sbjct: 162 R-----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 53/155 (34%), Positives = 67/155 (43%), Gaps = 13/155 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
+L + H LV L ++ V +F+ G L HL EP R + AA
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAA 103
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG-PVGDKTHVSTRVM 118
A L YLH + ++YRDLK NILLD H L+DFGL K G D T T
Sbjct: 104 EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFC 157
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
GT Y APE D + G V E++ G
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 20/162 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L H +V G D +R L E MP GS++D L E N K
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE----NVTRKYT 112
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK------LGPVGDKTH 112
+G+ YLH +++RD+K +NIL D + KL DFG +K L G K+
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS- 168
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
V GT + +PE K+D++S G +E++T +
Sbjct: 169 ----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL+Y+H A +I+RDLK SNI ++E K+ DFGLA+ +V+TR
Sbjct: 129 RGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 123 YCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154
Y APE + D++S G + EL+TG+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 22/154 (14%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
L+Y+H VI+RD+K++NIL+ + KL DFG+A L + + + +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWM 168
Query: 125 APEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 183
APE G+ K+D++S G+ E+ TG PP ++ V F+ P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG-------NPP--YSDV----DAFRAMMLIP 215
Query: 184 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217
K P L+ + L + + A CL E+ R
Sbjct: 216 KSKPPRLEDNGYSKLLREFV---AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 39/96 (40%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL+Y+H AN V++RDLK SN+LL+ K+ DFGLA+ +K T + T
Sbjct: 119 RGLKYIH-SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 123 YCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAI 157
Y APE + + T DV+S G +F EL+ GRK +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 36/90 (40%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
LE+LH ++YRDLK NILLD H L DFGL+K +KT + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 125 APEYAMTGQ-LTLKSDVYSFGVVFLELITG 153
APE + + T D +S GV+ E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 13/152 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L + +V +IG C + + +LV E LG L L +K + N ++
Sbjct: 49 VMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQK---NKHVTEKNI-TELVHQ 103
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMG 119
+ G++YL + ++RDL + N+LL + K+SDFGL+K LG D+ + + G
Sbjct: 104 VSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHG 158
Query: 120 TY--GYCAPEYAMTGQLTLKSDVYSFGVVFLE 149
+ + APE + + KSDV+SFGV+ E
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 48/170 (28%), Positives = 64/170 (37%), Gaps = 42/170 (24%)
Query: 16 YCADGDQRLL--VYEFMPLGSLEDHL---HDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 70
Y + D+ L V E+MP G L + L P + R IA L+ +H
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET------ARFYIAELVL-ALDSVHK 119
Query: 71 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT------------------- 111
I+RD+K NIL+D H KL+DFGL K
Sbjct: 120 LG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 112 ---HVSTRVM-----GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
H RV GT Y APE L+ D +S GV+ E++ G
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKG 64
H N+++L G ++V E+M GSL+ L HD L + + G A G
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASG 118
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG---TY 121
++YL D ++RDL + NIL++ K+SDFGL+++ + D + G
Sbjct: 119 MKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI 173
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 181
+ APE + T SDV+S+G+V E+++ RP E + + + + R
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY-----GERPYWEMSNQDVIKAIEEGYRL 228
Query: 182 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230
M P L+Q + C Q+ RP +V+ L L
Sbjct: 229 PAPMDCPA--------ALHQLM---LDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
H ++V LIG + + +V E PLG L +L +K LD + + + +
Sbjct: 64 FDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTA 119
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGY 123
L YL K ++RD+ + N+L+ KL DFGL++ + D+++ +++ +
Sbjct: 120 LAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKW 174
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELI 151
APE + T SDV+ FGV E++
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 51/177 (28%), Positives = 76/177 (42%), Gaps = 35/177 (19%)
Query: 1 MLSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM 55
+L L H N+V LI + +R VY P HDL L N +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-----HDL----SGLLENPSV 110
Query: 56 KIAAGAAK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--- 104
K+ K G+ YLH+ +++RD+K++NIL+D K++DFGLA+
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 105 ------GPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
G G T T ++ T Y PE + + T D++ G VF E+ T R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 20/163 (12%)
Query: 1 MLSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHD--LPPDKEPLDWNTR--M 55
+L L H N++ ++ C DG+ ++Y +M G+L+ L L P +T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGP-----VGD 109
+A A G+ YLH + VI++D+ + N ++DE K++D L++ L P +GD
Sbjct: 121 HMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 110 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ + M A E + + + SDV+SFGV+ EL+T
Sbjct: 178 NENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 45/135 (33%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKANPPVIYR 79
D+ V E++ G L HL +E + R + A L+YLH ++YR
Sbjct: 68 DRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYR 119
Query: 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 139
DLK N++LD+ H K++DFGL K G + D + T GT Y APE D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDNDYGRAVD 177
Query: 140 VYSFGVVFLELITGR 154
+ GVV E++ GR
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 35/216 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
M+ HSN+V G D+ + EF GSL+D H PL + ++
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRE 114
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+GL YLH K ++RD+K +NILL + H KL+DFG++ + +GT
Sbjct: 115 TLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGT 169
Query: 121 YGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAI--------------DNTRPP 163
+ APE A G D+++ G+ +EL + + N +PP
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
Query: 164 GEHNLVAWAR--------PLFKDRRKFPKMADPLLQ 191
+ + W+ L K+ +K P A+ LLQ
Sbjct: 230 KLKDKMKWSNSFHHFVKMALTKNPKKRP-TAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 51/154 (33%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
+L L H LV L ++ V +++ G L HL EP R + AA
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAA 103
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
A + YLH +IYRDLK NILLD H L+DFGL K G ++T ++ G
Sbjct: 104 EVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCG 158
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
T Y APE D + G V E++ G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEPLDWNTRMKIAAGAAK 63
L HSNL+ +G C + LLV EF PLG L+ +L + D T ++A A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
GL +LH K N I+ DL N LL K+ D+GL+ D ++ +
Sbjct: 112 GLLHLH-KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 124 CAPEYA--MTGQL-----TLKSDVYSFGVVFLEL 150
APE + G L T +S+V+S GV EL
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 32/229 (13%)
Query: 3 SLLHHSNLVNLIG--YCAD---GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
SL +H N+V G Y AD G Q LV E GS+ + + L + LD I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTR 116
GA GL++LH N +I+RD+K +NILL KL DFG+ A+L + + S
Sbjct: 134 LYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-- 188
Query: 117 VMGTYGYCAPEYAMTGQ-----LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 171
+GT + APE Q + DV+S G+ +EL G + + P
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--------- 238
Query: 172 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220
+ LF K P+ P L +P + + CL + RP +
Sbjct: 239 VKTLF----KIPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSV 281
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 36/119 (30%), Positives = 47/119 (39%), Gaps = 32/119 (26%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV---------- 113
LEYLH ++YRDLK NILL E H LSDF L+K V
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 114 --------------STRVM---GTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGR 154
S R GT Y APE ++G D ++ G++ E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 2 LSLLHHSNLVNLIGYCA----DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
L H N+V L C D + +L LV+E + L +L +P P + T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTE--TIKD 114
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
+ +GL++LH V++RDLK NIL+ KL+DFGLA++ T
Sbjct: 115 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTS 168
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
V+ T Y APE + D++S G +F E+ +
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 37/98 (37%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK---LGPVGDKTHVSTRVMGT 120
GL+Y+H AN V++RDLK N+L++ K+ DFGLA+ P + + T + T
Sbjct: 117 GLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 121 YGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGRKAI 157
Y APE ++ Q K+ DV+S G + EL+ GRK +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 9/149 (6%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 66
H N+++L G +++ EFM G+L+ L + + + G A G++
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMK 120
Query: 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYGY 123
YL + ++RDL + NIL++ K+SDFGL++ T +G +
Sbjct: 121 YLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
APE + T SDV+S+G+V E+++
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 5 LHHSNLVNLIGYC--ADGDQRL----LVYEFMPLGSLEDHLHDLPPDKEP--LDWNTRMK 56
H N++ LIG + RL ++ FM G L L +EP L T ++
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
A G+EYL K I+RDL + N +L+E ++DFGL+K GD
Sbjct: 118 FMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ A E T SDV++FGV E++T
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 27/227 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L+H N++ + + ++ +V E G L + K + T K
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+E++H + V++RD+K +N+ + KL D GL + KT + ++GT
Sbjct: 115 LCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y +PE KSD++S G + E + A P + D+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKM 211
Query: 181 KFPKMADPLLQGRY---PMRGLYQAL-AVAAMCLQEQAATRPLIGDV 223
+ + Q Y P + L + +MC+ RP IG V
Sbjct: 212 NLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 27/227 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N++ + + ++ +V E G L + K + T K
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
LE++H K +++RD+K +N+ + KL D GL + KT + ++GT
Sbjct: 115 LCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y +PE KSD++S G + E+ A+ + + NL + L K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYS----LCKKIE 221
Query: 181 K--FPKMADPLLQGRY--PMRGLYQALAVAAMCLQEQAATRPLIGDV 223
K +P PL Y +R L + C+ RP I V
Sbjct: 222 KCDYP----PLPADHYSEELRDL------VSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 45/143 (31%), Positives = 65/143 (45%), Gaps = 15/143 (10%)
Query: 19 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78
D D LV E+ P G L L L ++ D + A + +H ++
Sbjct: 72 DKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVH 125
Query: 79 RDLKSSNILLDEGFHPKLSDFG-LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------ 131
RD+K N+L+D H KL+DFG A+L +K S +GT Y APE T
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 132 GQLTLKSDVYSFGVVFLELITGR 154
G ++ D +S GV+ E+I GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 65
H N+V + G++ ++ EF+ G+L D + ++E + + + L
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQAL 130
Query: 66 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 125
YLH + VI+RD+KS +ILL KLSDFG + ++GT + A
Sbjct: 131 CYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMA 185
Query: 126 PEYAMTGQLTLKSDVYSFGVVFLELITG 153
PE + D++S G++ +E++ G
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 6/93 (6%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL Y H + V++RDLK N+L++E KL+DFGLA+ V KT+ + V T
Sbjct: 115 RGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLW 169
Query: 123 YCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
Y P+ + + + + + D++ G +F E+ +GR
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-------STR- 116
LEYLH N +++RDLK N+L+ H KL+DFGL+K+G + T++ TR
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 117 -----VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
V GT Y APE + D ++ G++ E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 47/146 (32%), Positives = 64/146 (43%), Gaps = 35/146 (23%)
Query: 1 MLSLLHHSNLVNLIGYC---ADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEPLDWN 52
+L LL H N+VNLI C A R LV+EF HDL L N
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLA----GLLSN 111
Query: 53 TRMKIAAGAAK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK- 103
+K K GL Y+H +++RD+K++NIL+ + KL+DFGLA+
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168
Query: 104 --LGPVGDKTHVSTRVMGTYGYCAPE 127
L + RV+ T Y PE
Sbjct: 169 FSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL Y H + V++RDLK N+L++E KL+DFGLA+ + KT+ + V T
Sbjct: 115 RGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLW 169
Query: 123 YCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
Y P+ + + + + D++ G +F E+ TGR
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 24/163 (14%)
Query: 1 MLSLLHHSNLVNL--IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM-- 55
+L + H N+V L + + ++RL LV+E++ L L+ H+ D PD N R+
Sbjct: 54 LLKEMQHGNIVRLQDVVHS---EKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIK 105
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK-LG-PVGDKTH 112
+G+ Y H V++RDLK N+L+D + KL+DFGLA+ G PV TH
Sbjct: 106 TYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 113 VSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
T Y APE + + + D++S G +F E++ +
Sbjct: 163 EVV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 37/111 (33%), Positives = 52/111 (46%), Gaps = 10/111 (9%)
Query: 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 136
I+RDLK N L+D H KL+DFGL+K G T+ ++ V+G+ Y APE
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANS-VVGSPDYMAPEVLRGKGYDF 177
Query: 137 KSDVYSFGVVFLELITGRKAIDNTRPPGEH-NLVAWA----RPLFKDRRKF 182
D +S G + E + G + P NL W RP++ D R
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 31/83 (37%), Positives = 45/83 (54%)
Query: 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 135
+I+RD+KS+NILL KL DFG +K+ V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 136 LKSDVYSFGVVFLELITGRKAID 158
K+D++S GV+ EL+T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 60/199 (30%), Positives = 83/199 (41%), Gaps = 25/199 (12%)
Query: 3 SLLHHSNLVNLIG--YCAD---GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 57
+L H N+V G Y D GDQ LV E GS+ D + E ++ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
A GL++LH I+RD+K +NILL KL DFG++ +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTS 184
Query: 118 MGTYGYCAPEY-AMTGQL----TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 172
+GT + APE A QL + DV+S G+ +EL G + + P
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---------M 235
Query: 173 RPLFK-DRRKFPKMADPLL 190
R LFK R P + P L
Sbjct: 236 RALFKIPRNPPPTLHQPEL 254
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 5/150 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L+H N++ + ++ +V E G L + K + T K
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
LE++H + V++RD+K +N+ + KL D GL + KT + ++GT
Sbjct: 115 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150
Y +PE KSD++S G + E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 24/171 (14%)
Query: 6 HHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
HH N+ G DQ LV EF GS+ D + + + +W I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTR-- 116
+GL +LH VI+RD+K N+LL E KL DFG+ A+L D+T V R
Sbjct: 119 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNT 170
Query: 117 VMGTYGYCAPEYAMTGQ-----LTLKSDVYSFGVVFLELITGRKAIDNTRP 162
+GT + APE + KSD++S G+ +E+ G + + P
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 10/90 (11%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+G+++LH +++RDLK NIL+ K++DFGLA+ + T V+ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLW 171
Query: 123 YCAPEYAMTGQLTLKS--DVYSFGVVFLEL 150
Y APE + Q + + D++S G +F EL
Sbjct: 172 YRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL Y H + V++RDLK N+L+ E KL+DFGLA+ V KT+ + V T
Sbjct: 114 RGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLW 168
Query: 123 YCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
Y P+ + + + + D++ G +F E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 46/147 (31%), Positives = 67/147 (45%), Gaps = 21/147 (14%)
Query: 16 YCADGDQRLL--VYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 71
+ A D + L V E+MP G L + + +D+P W R A L+ +H
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----W-ARFYTAE-VVLALDAIHSM 161
Query: 72 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAM 130
I+RD+K N+LLD+ H KL+DFG K+ G T V GT Y +PE
Sbjct: 162 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLK 216
Query: 131 T----GQLTLKSDVYSFGVVFLELITG 153
+ G + D +S GV E++ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 24/171 (14%)
Query: 6 HHSNLVNLIGY------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
HH N+ G DQ LV EF GS+ D + + + DW I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICR 128
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTR-- 116
+GL +LH VI+RD+K N+LL E KL DFG+ A+L D+T V R
Sbjct: 129 EILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNT 180
Query: 117 VMGTYGYCAPEYAMTGQ-----LTLKSDVYSFGVVFLELITGRKAIDNTRP 162
+GT + APE + +SD++S G+ +E+ G + + P
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 45/131 (34%), Positives = 62/131 (47%), Gaps = 13/131 (9%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYG 122
LE+LH ++YRD+K NILLD H L+DFGL+K L ++T+ GT
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIE 171
Query: 123 YCAPEYAMTGQLTLKS-DVYSFGVVFLELITGRKAIDNTRPPGEHNLVA-WARPLFKDRR 180
Y APE K+ D +S G++ EL+TG GE N + +R + K
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT---LEGERNTQSEVSRRILKCDP 228
Query: 181 KFPKMADPLLQ 191
FP P Q
Sbjct: 229 PFPSFIGPEAQ 239
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL Y H + +++RDLK N+L++E KL+DFGLA+ V KT+ + V T
Sbjct: 114 RGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLW 168
Query: 123 YCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
Y P+ + + + + D++ G + E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEPLDWNTRMKI 57
+L+ ++H VNL G D LV EF+ G L P D
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-------Y 136
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
AA EYL ++YRDLK N+LLD+ K++DFG AK+ V +T+ +
Sbjct: 137 AAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYT---L 188
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
GT Y APE + +D ++ G+ E++ G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 49/154 (31%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
+L + H LV L D+ V +++ G L HL +E R + AA
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAA 103
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
A L YLH + ++YRDLK NILLD H L+DFGL K + T ++ G
Sbjct: 104 EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCG 158
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
T Y APE D + G V E++ G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS-TRVMGTY 121
+ L+Y+H AN V +RDLK NIL + K+ DFGLA++ T + T + T
Sbjct: 114 RALKYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 122 GYCAPEY--AMTGQLTLKSDVYSFGVVFLELITGR 154
Y APE + + T D++S G +F E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL+Y+H + +I+RDLK SN+ ++E K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 123 YCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160
Y APE + D++S G + EL+TGR T
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 74/218 (33%)
Query: 1 MLSLLHHSNLVNLIGYC-ADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDW------- 51
+L L H N+V+L+ D+ + L++++ HDL W
Sbjct: 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--------HDL--------WQIIKFHR 98
Query: 52 -NTRMKIAAGAAK--------GLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSD 98
R+ I K G+ YLH V++RDLK +NIL+ E K+ D
Sbjct: 99 QAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGD 155
Query: 99 FGLAKL--GPV-----GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLEL 150
GLA+L P+ D V+ T Y APE + + K+ D+++ G +F EL
Sbjct: 156 LGLARLFNAPLKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
Query: 151 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 188
+T P+FK R K ++P
Sbjct: 210 LT-------------------LEPIFKGREAKIKKSNP 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 46 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KL 104
PL + I + L YLH + +I+RD+K+ NI LDE + L DFG A KL
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 105 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150
D GT +PE K+D++S G+V E+
Sbjct: 236 DAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA-- 58
M+ H N+V G ++ + E+ GSL+D H P E ++IA
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-------LQIAYV 111
Query: 59 -AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+GL YLH K ++RD+K +NILL + KL+DFG+A +
Sbjct: 112 CRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSF 166
Query: 118 MGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLEL 150
+GT + APE A G D+++ G+ +EL
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 44/125 (35%), Positives = 62/125 (49%), Gaps = 12/125 (9%)
Query: 34 SLEDHLHDLPPD---KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE 90
SL D D D KEPL + + A+G+E+L A+ I+RDL + NILL E
Sbjct: 152 SLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSE 208
Query: 91 GFHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVF 147
K+ DFGLA+ D +V R+ + APE T +SDV+SFGV+
Sbjct: 209 NNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLL 265
Query: 148 LELIT 152
E+ +
Sbjct: 266 WEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 13/113 (11%)
Query: 45 DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104
D+ LD + + AKG+ +L K I+RDL + NILL G K+ DFGLA+
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR- 262
Query: 105 GPVGDKTHVSTRVMGTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D + S V+ + APE T +SDV+S+G++ E+ +
Sbjct: 263 ----DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
G+++LH + +I+RDLK SNI++ K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
APE + D++S G + E+I G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG---SLEDHLHDLPPDKEPLDWNTRMKI 57
+L L H+N+V L + LV+E++ ++ H L P+ N ++ +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE------NVKLFL 109
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+GL Y+H + +++RDLK N+L+ + KL+DFGLA+ V T+ + V
Sbjct: 110 FQ-LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165
Query: 118 MGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGRKA 156
T Y P+ + + + + D++ G +F+E+I G A
Sbjct: 166 --TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 35/113 (30%), Positives = 62/113 (54%), Gaps = 11/113 (9%)
Query: 44 PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 103
D PLD + ++ ++ A+G+++L K I+RD+ + N+LL +G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 104 LGPVGDKTHVSTRVMGT----YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ D +V V G + APE T++SDV+S+G++ E+ +
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H+N+V L + V+E+M L ++ P P +N R+ +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP--YNVRLFMFQ- 111
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+GL Y+H + +++RDLK N+L+ KL+DFGLA+ + +T+ S V T
Sbjct: 112 LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--T 166
Query: 121 YGYCAPEYAMTGQLTLKS--DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 171
Y P+ + G S D++ G +F+E++ G+ A E W
Sbjct: 167 LWYRPPD-VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
KGL+Y+H +I+RDLK N+ ++E K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 123 YCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154
Y APE + T D++S G + E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 7/127 (5%)
Query: 27 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 86
Y+ +++ L D E L + A+G+E+L A+ ++RDL + N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 87 LLDEGFHPKLSDFGLAKLGPVGDKTHVST-RVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 145
LL +G K+ DFGLA+ + D +VS + APE T SDV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 146 VFLELIT 152
+ E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+LS L H +V + D ++ E+ L+ L +L + L N +
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
G+ Y+H + +++RDLK+ NI L K+ DFG+++L + ++T GT
Sbjct: 115 LLLGVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGT 168
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150
Y +PE KSD++S G + E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 40/119 (33%), Positives = 61/119 (51%), Gaps = 16/119 (13%)
Query: 44 PDKEPLD-WNTRMKI------AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 96
P +E D W + + + + A+G+E+L A+ I+RDL + NILL E K+
Sbjct: 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKI 215
Query: 97 SDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
DFGLA+ D +V S R+ + APE T +SDV+SFGV+ E+ +
Sbjct: 216 CDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 32/117 (27%), Positives = 54/117 (46%), Gaps = 6/117 (5%)
Query: 48 PLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 107
PL + + I +GL YLH + +I+RD+K+ NI +++ + D G A+ PV
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PV 208
Query: 108 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164
+ + GT APE + K+D++S G+V E++ I P
Sbjct: 209 VAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV---STRVM 118
AKG+E+L A+ I+RDL + NILL E K+ DFGLA+ D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE T++SDV+SFGV+ E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST-RVMGT 120
A G+E+L A+ ++RDL + N+L+ EG K+ DFGLA+ + D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE T SDV+SFG++ E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
GL+Y+H +I+RDLK N+ ++E K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 123 YCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154
Y APE + D++S G + E++TG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 29/77 (37%), Positives = 43/77 (55%)
Query: 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 135
+++RDLKS+NI L KL DFG +K V++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 136 LKSDVYSFGVVFLELIT 152
K+D++S GV+ EL+T
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 33/169 (19%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK------IA 58
+ H N++ L+ +GD LV + M DL K+ +D R+ I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA--------SDL---KKVVDRKIRLTESQVKCIL 125
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-------LGPVGDKT 111
GL LH ++RDL +NI ++ K++DFGLA+ +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 112 HVSTRVMGTYG-----YCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154
+ R T Y APE M + D++S G +F EL+TG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 44/146 (30%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 16 YCADGDQRLL--VYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAAGAAKGLEYLHDKA 72
+CA D + L V E+MP G L + + + P+K + + +A A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMT 131
RD+K N+LLD+ H KL+DFG K+ G T V GT Y +PE +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV-GTPDYISPEVLKS 217
Query: 132 ----GQLTLKSDVYSFGVVFLELITG 153
G + D +S GV E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
M+S L H +LV G C GD+ ++V E++ GSL+ +L + + W ++++A
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQ 108
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILL------DEGFHP--KLSDFGLAKLGPVGDKTH 112
A L +L DK + + ++ + N+LL G P KLSD G++ V K
Sbjct: 109 LAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI--TVLPKEI 163
Query: 113 VSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITG 153
+ R+ + PE Q L+L +D +SFG E+ +G
Sbjct: 164 LLERI----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 66
HSN+V L G G+ ++V E+M G+L+ L + L M + G A G++
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMK 121
Query: 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG---Y 123
YL + +++ L + +L++ K+S F + DK+ M +
Sbjct: 122 YLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLW 174
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
APE + SDV+SFG+V E+++
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 11/110 (10%)
Query: 48 PLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLG- 105
PL T KG+ + H V++RDLK N+L+D + K++D GL +
Sbjct: 106 PLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
Query: 106 -PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITG 153
PV TH + T Y APE + + D++S G +F E+
Sbjct: 163 IPVKSYTH----EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 2 LSLLHHS-----NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
++ LH++ NL ++ Y GD L+ +F ED L P+ + M
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMV 112
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
IA + L Y+H RD+K NIL+D H +L+DFG + L + D T S+
Sbjct: 113 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV 162
Query: 117 VMGTYGYCAPEY--AM---TGQLTLKSDVYSFGVVFLELITG 153
+GT Y +PE AM G+ + D +S GV E++ G
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 1 MLSLLHHSNLVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+L+ +H +V L+G + DG +++ EF P G+++ + +L D+ + ++ I
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLEL--DRGLTEPQIQV-ICR 117
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
+ L+YLH +I+RDLK+ N+LL KL+DFG++ + S +G
Sbjct: 118 QMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIG 172
Query: 120 TYGYCAPEYAMTGQLT-----LKSDVYSFGVVFLEL 150
T + APE M + K+D++S G+ +E+
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 45/174 (25%), Positives = 70/174 (40%), Gaps = 32/174 (18%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMP------LGSLEDHLHDLPPDKEPLDWNTRMK-- 56
L H +V + C+DGD VY MP L SL + + L T +
Sbjct: 59 LIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 57 --IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA------------ 102
I +EY+H K V++RDLK NILL + D+G A
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 103 -KLGPVGDKTHVST---RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ T +++GT Y APE + + +D+Y+ GV+ +++T
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 22/155 (14%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLED-HLHDLPPDKEPLDWNTRMKIAAGAAKGL 65
H N+V + ++ EFM GSLE H+ D E + +I +G A
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD-----EQFLADVARQILSGIA--- 182
Query: 66 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYC 124
YLH + +++RD+K SN+L++ + K++DFG+++ L D + S +GT Y
Sbjct: 183 -YLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYM 235
Query: 125 APEYAMT----GQLT-LKSDVYSFGVVFLELITGR 154
+PE T G D++S GV LE GR
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 34/110 (30%), Positives = 61/110 (55%), Gaps = 13/110 (11%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAK-LGP-VGDKTHVSTRVMG 119
+GL+Y+H AN V++RDLK +N+ ++ E K+ DFGLA+ + P K ++S ++
Sbjct: 125 RGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 120 TYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 168
+ Y +P ++ T D+++ G +F E++TG+ G H L
Sbjct: 182 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-----PLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 28/80 (35%), Positives = 42/80 (52%), Gaps = 7/80 (8%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84
LV E++ G ++ LH E +K + A L+YLH +I+RDLK
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEE----MAVKYISEVALALDYLHRHG---IIHRDLKPD 133
Query: 85 NILLDEGFHPKLSDFGLAKL 104
N+L+ H KL+DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 47/150 (31%), Positives = 69/150 (46%), Gaps = 25/150 (16%)
Query: 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 68
NL ++ Y GD L+ +F ED L P D + M +A + L Y+
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKF------EDRL---PEDMARF-YLAEMVLAIDSVHQLGYV 124
Query: 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 128
H RD+K N+LLD+ H +L+DFG + L + D T S +GT Y +PE
Sbjct: 125 H---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 129 --AM---TGQLTLKSDVYSFGVVFLELITG 153
AM G+ + D +S GV E++ G
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L+ H N+V L+ + ++ EF G+++ + +L + PL +
Sbjct: 55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQ 111
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR---V 117
+ L YLH+ +I+RDLK+ NIL KL+DFG++ T R
Sbjct: 112 TLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSF 163
Query: 118 MGTYGYCAPEYAMTGQ-----LTLKSDVYSFGVVFLEL 150
+GT + APE M K+DV+S G+ +E+
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
+GL+Y+H +I+RDLK SN+ ++E ++ DFGLA+ +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 123 YCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154
Y APE + D++S G + EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 42/173 (24%), Positives = 70/173 (40%), Gaps = 22/173 (12%)
Query: 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL---HDLPPDKEPLDWNTRMKIAAG 60
+L H N++ +G C + LLV+E+ LG L+ +L + + L ++A
Sbjct: 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACE 107
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A G+ ++H K N ++ DL N L K+ D+G+ D
Sbjct: 108 IAAGVTHMH-KHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 121 YGYCAPEYA-------MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH 166
+ APE +T + T S+V++ GV EL +N P H
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK--LGPVGDKTHVSTRVMG 119
+ L Y+H K + +RDLK N+L+D H KL DFG AK L +++ +R
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-- 235
Query: 120 TYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITG 153
Y APE + T D++S G + E+I G
Sbjct: 236 ---YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 32/117 (27%), Positives = 44/117 (37%), Gaps = 44/117 (37%)
Query: 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG-DKTHVST-------------------- 115
I+RD+K N+LLD H KLSDFGL G K+H +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 116 --------------RVM-----GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
R + GT Y APE + + D +S GV+ E++ G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 30/212 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMP---LGSLEDHLHDLPPDKEPLDWNTRMKI 57
ML L N+V L + LV+E++ L LE+ + +PP+K R I
Sbjct: 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK------VRSYI 106
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
K + + H +++RD+K N+L+ KL DFG A+ G + T
Sbjct: 107 YQ-LIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEY 161
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE------LITGRKAIDNTRP--------P 163
+ T Y +PE + D++S G + E L G ID P
Sbjct: 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221
Query: 164 GEHNLVAWARPLFKDRRKFPKMADP-LLQGRY 194
E + ++ P F R FP + P L+ RY
Sbjct: 222 AEQMKLFYSNPRFHGLR-FPAVNHPQSLERRY 252
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY--AM---T 131
++RD+K N+LLD H +L+DFG + L D T S+ +GT Y +PE AM
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 132 GQLTLKSDVYSFGVVFLELITG 153
G+ + D +S GV E++ G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 42/164 (25%), Positives = 64/164 (39%), Gaps = 26/164 (15%)
Query: 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA---AG 60
L H N++ + + +V M GS ED L P+ P + IA
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKD 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA--------KLGPVGDKTH 112
L+Y+H K I+R +K+S+ILL LS + + V D
Sbjct: 110 VLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166
Query: 113 VSTRVMGTYGYCAPEY---AMTGQLTLKSDVYSFGVVFLELITG 153
S + + + +PE + G KSD+YS G+ EL G
Sbjct: 167 SSVKNLP---WLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
G+++LH +I+RDLK SNI++ K+ DFGLA+ + T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
APE + D++S G + EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 23/138 (16%)
Query: 25 LVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83
+V E+MP G L + + + P+K + + +A A + ++H RD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKP 170
Query: 84 SNILLDEGFHPKLSDFG----LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT----GQLT 135
N+LLD+ H KL+DFG + K G V T V GT Y +PE + G
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYG 225
Query: 136 LKSDVYSFGVVFLELITG 153
+ D +S GV E++ G
Sbjct: 226 RECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
M+ + H ++V L G C + ++V EF+ G L+ +H + L + K+A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQ 113
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILL-DEGFHPKLSDFGLAKLGPVGDKTHVSTR--V 117
A L YL DK +++ ++ + NILL EG + F KL G V +R
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQEC 168
Query: 118 MGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLEL 150
+ + APE + L++ +D +SFG E+
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 11/110 (10%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
G+++LH +I+RDLK SNI++ K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 173
APE + D++S G + E+I G PG ++ W +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF-----PGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 28/177 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE----PLDWNTRMK 56
++S + H +L + G C G + ++V EF+ G L+ L KE P+ W ++
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-----KEKGRVPVAW--KIT 121
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNIL-----LDEGFHP--KLSDFGLAKLGPVGD 109
+A A L YL DK +++ ++ + NIL L EG P KLSD G++ +
Sbjct: 122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSR 177
Query: 110 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165
+ V R+ + APE G L+ +D +SFG LE+ + R P E
Sbjct: 178 EERVE-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 17/26 (65%), Positives = 21/26 (80%)
Query: 77 IYRDLKSSNILLDEGFHPKLSDFGLA 102
I+RD+K NIL+D G H KLSDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
G+++LH +I+RDLK SNI++ K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELI------TGRKAID 158
APE + D++S G + E++ GR ID
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 10/106 (9%)
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK---LSDFGLAKLGPVGDKT 111
+ I + ++YLH+ +I+RD+K+ NI ++ HP L DFG A PV
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGDVCLGDFGAACF-PVDINA 237
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157
+ GT APE D++S G+V E+ T ++
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N+V L + LV+E+ L+ + D +D
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGD---IDPEIVKSFMFQ 107
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
KGL + H V++RDLK N+L+++ KL+DFGLA+ + + + S V+ T
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-T 162
Query: 121 YGYCAPEYAMTGQLTLKS-DVYSFGVVFLEL 150
Y P+ +L S D++S G +F EL
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 51/169 (30%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--KEPLDWNTRMKIA 58
+ H N++ G ++ FM GS L P+ E L N I
Sbjct: 52 LSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----IL 107
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV---GDKTHV-- 113
GA +GL YLH I+R++K+S+IL+ LS GL+ L + G K V
Sbjct: 108 FGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY 162
Query: 114 -----STRVMGTYGYCAPEYA---MTGQLTLKSDVYSFGVVFLELITGR 154
ST V+ + +PE + G +KSD+YS G+ EL TGR
Sbjct: 163 DFPQFSTSVLP---WLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 17/99 (17%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAK-----LGPVGDKTHVS 114
G+ YLH V++RDLK +NIL+ E K++D G A+ L P+ D V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELIT 152
T+ Y APE + + K+ D+++ G +F EL+T
Sbjct: 177 V----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 17/99 (17%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAK-----LGPVGDKTHVS 114
G+ YLH V++RDLK +NIL+ E K++D G A+ L P+ D V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELIT 152
T+ Y APE + + K+ D+++ G +F EL+T
Sbjct: 177 V----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 37/131 (28%), Positives = 56/131 (42%), Gaps = 27/131 (20%)
Query: 48 PLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA----- 102
PL TR I +EY+HDK +I+RD+K NI L+ L DFG A
Sbjct: 264 PLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 103 -----KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR--K 155
G VG S ++ GYC ++T D++S G++ L++++
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYC--------EIT---DIWSCGLILLDMLSHDFCP 368
Query: 156 AIDNTRPPGEH 166
D PG+
Sbjct: 369 IGDGGGKPGKQ 379
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 41/164 (25%), Positives = 60/164 (36%), Gaps = 44/164 (26%)
Query: 25 LVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82
L+ EF+P G + L D ++ + +A A L ++H RD+K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RDIK 128
Query: 83 SSNILLDEGFHPKLSDFGLA---------------KLGPVGD------------------ 109
N+LLD H KLSDFGL P D
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188
Query: 110 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
+ ++ +GT Y APE M D +S GV+ E++ G
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 35/153 (22%), Positives = 56/153 (36%), Gaps = 45/153 (29%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL----------------------- 101
+E +H I+RD+K NIL+D H KL+DFGL
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 102 -------AKLGPVGDKTHVSTRV-----------MGTYGYCAPEYAMTGQLTLKSDVYSF 143
+++ K R +GT Y APE + T D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 144 GVVFLELITGRKA-IDNTRPPGEHNLVAWARPL 175
GV+ E++ G+ + +T + ++ W L
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 40/162 (24%), Positives = 58/162 (35%), Gaps = 40/162 (24%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84
L+ EF+P G + L K+ L A ++ +H I+RD+K
Sbjct: 78 LIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPD 130
Query: 85 NILLDEGFHPKLSDFGLAKLGPVGDKT--------------------------------- 111
N+LLD H KLSDFGL +T
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
++ +GT Y APE M D +S GV+ E++ G
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (90), Expect = 0.004
Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 28/175 (16%)
Query: 5 LHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 62
L H N+V I + +Q+L ++ EF G L ++ ++ + + I
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 63 KGLEYLHDKANPP----VIYRDLKSSNILLDEGFH-----------------PKLSDFGL 101
L Y H+ + P V++RDLK NI L G K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 102 AKLGPVGDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVFLELITGR 154
+K + H +GT Y +PE + T KSD+++ G + EL +G+
Sbjct: 189 SKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.98 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.6 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.57 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.52 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.39 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.34 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.25 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.18 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.15 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.85 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.71 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.71 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.7 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.69 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.33 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.69 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.86 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.65 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.55 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.54 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.02 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.8 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.54 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.41 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.63 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.54 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.37 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.78 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.57 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.35 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.31 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 91.9 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.92 | |
| PLN02236 | 344 | choline kinase | 90.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 90.24 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.05 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 89.14 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 89.12 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.56 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 88.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 85.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 85.13 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 84.65 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 84.55 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 84.18 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 83.86 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 83.08 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 82.69 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 81.97 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=358.97 Aligned_cols=228 Identities=61% Similarity=1.022 Sum_probs=201.1
Q ss_pred CccCCCCCCcccceEEEEeCC-eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++++|||||+|+|||.+.+ +.+||||||++|+|.++|+..... .|+|.++++|+.++|.||+|||....|+||||
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr 201 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHR 201 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence 467899999999999999998 599999999999999999873211 89999999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||++|||||+++.+||+|||+|+..+.. .........||.+|++||++..+.++.|+|||||||||+||+||+.+.+.
T Consensus 202 DiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 202 DIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred CCCHHHeeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 99999999999999999999999764431 11111111899999999999999999999999999999999999999998
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCcccc-CCCCh-hhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ-GRYPM-RGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
..+.....++.|+++.+... .+.+++|+.+. +.++. ++...+..++.+|++.+|..||+|.||+++|..+..
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 77777778999998888776 78899999988 77775 688899999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.40 Aligned_cols=213 Identities=35% Similarity=0.513 Sum_probs=175.1
Q ss_pred CccCCCCCCcccceEEEEeCC-eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
||++++|||||+++|+|.+.. .++||||||++|+|..+++.. .+..|++..++.|+.+||.||+|||+++. ||||
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHr 167 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHR 167 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeec
Confidence 467899999999999999987 799999999999999999872 46789999999999999999999999974 8999
Q ss_pred CCCCCcEEEcCCC-CeEEeecCCcccCCCCCCccccccccccccccchhhhh--cCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 80 DLKSSNILLDEGF-HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 80 DIkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||||+||||+.++ .+||+|||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.|
T Consensus 168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 168 DLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred ccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 9999999999997 99999999998643321 2233478999999999999 56999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccC
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 235 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 235 (380)
|....+......+. .. ..+...+......+..|+..||..||..||++.+|+..|+.+.....
T Consensus 246 f~~~~~~~~~~~v~-----~~-----------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 246 FEDLAPVQVASAVV-----VG-----------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCHHHHHHHHH-----hc-----------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 98765421111110 01 11111222345678899999999999999999999999998865444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.44 Aligned_cols=202 Identities=26% Similarity=0.397 Sum_probs=168.2
Q ss_pred CccCCCCCCcccceEEEEeCC-eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH 78 (380)
||+..+|||||++||.|..+. ..+|+||||++|||++++.. .+++++...-+|+.++++||.|||+ .+ |||
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIH 202 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIH 202 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eee
Confidence 456779999999999999998 59999999999999999987 3779999999999999999999996 77 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||||+||||+..|.+||||||.+...... ......||..|||||.+.+..|+.++||||||++++|+.+|+.||.
T Consensus 203 RDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred ccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCC
Confidence 999999999999999999999999875332 4456889999999999999999999999999999999999999997
Q ss_pred CCCC--CCCcchhhhhhhcccccCCCCCCCCccccCCCCh-hhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 159 NTRP--PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPM-RGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 159 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.... .+...++.++. .... | ..|. .+..++..++..||++||.+|||+.|+++.-
T Consensus 279 ~~~~~~~~~~~Ll~~Iv--~~pp--------P----~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 279 PPNPPYLDIFELLCAIV--DEPP--------P----RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CcCCCCCCHHHHHHHHh--cCCC--------C----CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 5421 12222222221 0011 1 1122 2567889999999999999999999998643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=314.67 Aligned_cols=197 Identities=26% Similarity=0.407 Sum_probs=165.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++|+|||||+++++|+..+..|||||||+||.|.+.+.. ++.+.+..-..++.|++.||.|||+.| |+|||
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRD 301 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRD 301 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---ccccc
Confidence 58999999999999999999999999999999999999987 677888888999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC---CCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLDEG---FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL---TLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDV~SlGvvl~elltG~ 154 (380)
|||+|||+..+ ..+||+|||+|+... ........+||+.|.|||++.+..+ ..+.|+||+|||+|-+|+|.
T Consensus 302 iKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 302 IKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred CCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence 99999999765 678999999999643 4455677899999999999987643 34789999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCC------ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY------PMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+||....... .+.+..+++.| ..+...+.++||.+||..||+.|||+.|+++.
T Consensus 379 pPFS~~~~~~-------------------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 379 PPFSEEYTDP-------------------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred CCcccccCCc-------------------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 9997432211 11111222222 23456789999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=304.44 Aligned_cols=207 Identities=25% Similarity=0.367 Sum_probs=172.4
Q ss_pred CccCCCCCCcccceE-EEEeCCe-EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-CCCeE
Q 016913 1 MLSLLHHSNLVNLIG-YCADGDQ-RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA-NPPVI 77 (380)
Q Consensus 1 iL~~l~HpnIv~l~~-~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-~~~ii 77 (380)
||++|+|||||++++ .|.++.+ ++||||||.+|+|...++.+...+..+++.++|+++.|+|.||..+|.+- ..-|+
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 588999999999999 5666666 89999999999999999998888999999999999999999999999931 11299
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||||||.||+|+.+|.+||+|||+++.+. .++......+||+.||+||.+....|+.+|||||+||++|||..-+.||
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999999843 2334456688999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCC---C-hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY---P-MRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~-~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
... ++...-+. +-++.+ | ..++..+.+||..|+..||..||+.-.++..+..
T Consensus 229 ~g~------n~~~L~~K--------------I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 229 YGD------NLLSLCKK--------------IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ccc------cHHHHHHH--------------HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 864 22222211 112222 2 4567889999999999999999997666655544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=317.98 Aligned_cols=199 Identities=26% Similarity=0.407 Sum_probs=171.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|.+.|+|||||+++++|++.+++|||.|+|..++|..+++. .+.|++..+..++.||+.||.|||+.+ |||||
T Consensus 71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRD 143 (592)
T KOG0575|consen 71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRD 143 (592)
T ss_pred HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 46789999999999999999999999999999999999986 688999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||..|+||+++..+||+|||||.... .........+||+.|+|||++.....+..+||||+|||||-||.|++||+..
T Consensus 144 LKLGNlfL~~~~~VKIgDFGLAt~le--~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 144 LKLGNLFLNENMNVKIGDFGLATQLE--YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred cchhheeecCcCcEEecccceeeeec--CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 99999999999999999999998743 2334456689999999999999999999999999999999999999999865
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...+..+.+ ......++. .....+.+||.++|+.||.+|||+.+|+..
T Consensus 222 ~vkety~~I------k~~~Y~~P~------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 222 TVKETYNKI------KLNEYSMPS------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred hHHHHHHHH------HhcCccccc------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 433332222 222222222 334678899999999999999999999964
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=313.27 Aligned_cols=209 Identities=31% Similarity=0.433 Sum_probs=174.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++|+|+|||+++++|..++.+|||||||+.|+|.+||.. ..+..+...+.+.++.|||+|++||++++ +||||
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRD 328 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRD 328 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchh
Confidence 57899999999999999998899999999999999999987 46778999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|...||||+++..+||+|||||+...+.. ........-...|.|||.+....|+.|||||||||+||||+| |+.|+..
T Consensus 329 LAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 329 LAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred hhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 99999999999999999999999533222 222333445678999999999999999999999999999998 6677764
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
....+ .+ +.++...+-+.|..++..+.+|+..||..+|++|||++.+...|+.+..
T Consensus 408 msn~e------v~-----------~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 408 MSNEE------VL-----------ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCHHH------HH-----------HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 43221 11 1122222334456678899999999999999999999999999987654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=300.10 Aligned_cols=152 Identities=32% Similarity=0.502 Sum_probs=139.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||+.|+|||||.+++++..++.+|||||||+||+|.+|++. .+.+++.++..++.||+.||++||+++ |||||
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRD 134 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRD 134 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 58899999999999999999999999999999999999987 568999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC------CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLDEG------FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~~~------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||+||||+.. -.+||+|||+|+.+.. .......+|++.|||||++....|+.|+|+||+|+|+|++++|+
T Consensus 135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred CCcceEEeccCCCCCCCceEEecccchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCC
Confidence 99999999764 4589999999997642 23345688999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 016913 155 KAIDNTRP 162 (380)
Q Consensus 155 ~p~~~~~~ 162 (380)
.||+...+
T Consensus 212 ~Pf~a~t~ 219 (429)
T KOG0595|consen 212 PPFDAETP 219 (429)
T ss_pred CCccccCH
Confidence 99985544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.40 Aligned_cols=191 Identities=29% Similarity=0.374 Sum_probs=161.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||..++||.||+++..|.+.+.+|+|+||+.||.|..+|+. ...+++..+..++..|+.||.|||+++ |||||
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRD 150 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRD 150 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 57789999999999999999999999999999999999986 678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+..|.++|+||||++..- .....+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||...
T Consensus 151 lKPENILLd~~GHi~LtDFgL~k~~~--~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 151 LKPENILLDEQGHIKLTDFGLCKEDL--KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred CCHHHeeecCCCcEEEeccccchhcc--cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 99999999999999999999998632 2223445589999999999999999999999999999999999999999865
Q ss_pred CCCCCcchhhhhhhccccc-CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 161 RPPGEHNLVAWARPLFKDR-RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
+. ..+...+.... ...+.. ....+.+++.++|+.+|++|-
T Consensus 229 ~~------~~~~~~I~~~k~~~~p~~------------ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 229 DV------KKMYDKILKGKLPLPPGY------------LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cH------HHHHHHHhcCcCCCCCcc------------CCHHHHHHHHHHhccCHHHhc
Confidence 33 22233333222 111111 235778999999999999995
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.88 Aligned_cols=202 Identities=27% Similarity=0.390 Sum_probs=174.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++|+||||+.+.|+|...--+|||||||..|-|...|+. ...+.......|..+||.|+.|||.+. ||||||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDL 238 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDL 238 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---Hhhhcc
Confidence 6789999999999999999999999999999999999987 678999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
|.-||||.-+..+||+|||.++..... .....+.||..|||||++.....++|.|||||||||||||||..||.+-.
T Consensus 239 KSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 239 KSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred CCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 999999999999999999999863322 34456889999999999999999999999999999999999999996432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
. . ..+|..+ ...|.-..|..++..+.-|+..||+..|..||+|.+|+..|+-
T Consensus 316 s----s-----AIIwGVG-------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 316 S----S-----AIIWGVG-------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred h----h-----eeEEecc-------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 1 1 1122222 2233344566778889999999999999999999999998853
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=296.88 Aligned_cols=199 Identities=28% Similarity=0.394 Sum_probs=168.3
Q ss_pred CccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|+.++ ||||+++++++.....+|+|||||.||.|.+++.. .+++.+..+..++.|++.||+|||+++ |+||
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HR 144 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHR 144 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeC
Confidence 356778 99999999999999999999999999999999986 678999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCC-CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC-CC-CcCceeehHHHHHHHHhCCCC
Q 016913 80 DLKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LT-LKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 80 DIkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDV~SlGvvl~elltG~~p 156 (380)
||||+|||++.+ +.+||+|||++..+. .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|..|
T Consensus 145 DLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 145 DLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred CCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 999999999999 999999999999753 2223445688999999999999977 86 789999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|+.... ......+......++..+. ...+..|+.+||..+|..|+|+.+|++
T Consensus 223 F~d~~~------~~l~~ki~~~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 223 FDDSNV------PNLYRKIRKGEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCCccH------HHHHHHHhcCCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 987322 2222223333333333331 457889999999999999999999993
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=299.93 Aligned_cols=201 Identities=27% Similarity=0.408 Sum_probs=168.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+-++|+|||.+++.|..++++|+|||||+||+|.+.+.. ..+++.++..|+.+++.||+|||.++ |+|||
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrD 394 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRD 394 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeec
Confidence 36678999999999999889999999999999999999976 56999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||.+|||++.++.+||+|||+|..+.... ......+||+.|||||+.....|+++.||||||++++||+.|++||-..
T Consensus 395 IKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE 472 (550)
T KOG0578|consen 395 IKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE 472 (550)
T ss_pred cccceeEeccCCcEEEeeeeeeecccccc--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC
Confidence 99999999999999999999998643322 2345578999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.+.....++. ..+ .+++ ..+......+.+++.+||+.|+.+|+++.|+|+.
T Consensus 473 ~PlrAlyLIa------~ng--~P~l-------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 473 NPLRALYLIA------TNG--TPKL-------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ChHHHHHHHh------hcC--CCCc-------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 4432222221 111 1111 1233445678899999999999999999999974
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=287.31 Aligned_cols=211 Identities=26% Similarity=0.341 Sum_probs=167.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++..|..+..+|+||.||.+||+.++++.. ....+++..+..|+.++++||.|||.+| .|||||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdv 152 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQNG---HIHRDV 152 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhcC---ceeccc
Confidence 67899999999999999999999999999999999999984 3455999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCcc-cc-ccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VS-TRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|+.||||+.+|.+||+|||....+-...... .. ....||++|||||+++. ..|+.|+||||||++.+||.+|..||
T Consensus 153 KAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 153 KAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred ccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 9999999999999999999876543322111 11 45789999999999653 47999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....+..... ..+- ...+......+...-.......+.+++..||++||.+|||+++++.
T Consensus 233 ~k~pPmkvLl-----~tLq---n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 233 SKYPPMKVLL-----LTLQ---NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHHHH-----HHhc---CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 8765532111 1111 1111111111221112234457889999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=293.09 Aligned_cols=212 Identities=28% Similarity=0.407 Sum_probs=164.1
Q ss_pred ccCC-CCCCcccceEEEEeCC-eEEEEEeccCCCCHHHHHhcCCC-----------------------------------
Q 016913 2 LSLL-HHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPP----------------------------------- 44 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~----------------------------------- 44 (380)
|+++ +|||||+++++|...+ .+++||||+++|+|.+++.....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred HHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 4456 8999999999887644 58999999999999999975211
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 016913 45 -----------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 101 (380)
Q Consensus 45 -----------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGl 101 (380)
....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~ 220 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 220 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccc
Confidence 1245889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccC
Q 016913 102 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRR 180 (380)
Q Consensus 102 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 180 (380)
++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ..... .....
T Consensus 221 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~----~~~~~ 294 (338)
T cd05102 221 ARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQR----LKDGT 294 (338)
T ss_pred ccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHH----HhcCC
Confidence 976432221112223446678999999999999999999999999999997 999997543211 11111 11110
Q ss_pred CCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 181 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.. ..+......+.+|+.+||+.+|++|||+.||++.|+.+..
T Consensus 295 ~~----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 295 RM----------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 1122334678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=288.45 Aligned_cols=208 Identities=28% Similarity=0.411 Sum_probs=162.9
Q ss_pred CccCCCCCCcccceEEEEeCC--eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
||++|+|||||+++|...... .++|+|||+++|+|.+++... +..|++..+..++.||+.||+|||+++ |||
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH 140 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKG---IVH 140 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 578899999999999854444 689999999999999999872 227999999999999999999999999 999
Q ss_pred cCCCCCcEEEcC-CCCeEEeecCCcccCCC-CCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCC
Q 016913 79 RDLKSSNILLDE-GFHPKLSDFGLAKLGPV-GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 79 rDIkp~NILl~~-~~~~kL~DFGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||||+||||+. ++.+||+|||++..... ...........||+.|||||++..+ ....++|||||||++.||+||..
T Consensus 141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 999999999999 79999999999986432 1112223457899999999999953 34459999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
||... ......+-++ ... ...+ ..|......+.+++.+|++.+|+.|||+.+++....-
T Consensus 221 PW~~~--~~~~~~~~~i---g~~-~~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 221 PWSEF--FEEAEALLLI---GRE-DSLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cchhh--cchHHHHHHH---hcc-CCCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 99853 1111111110 000 0111 2233345678899999999999999999999986643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=285.64 Aligned_cols=203 Identities=22% Similarity=0.397 Sum_probs=164.4
Q ss_pred CccCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCC
Q 016913 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ 75 (380)
+|++++|||||++++++.+ ....++||||+++|+|.+++.. ...+++...+.++.+++.||.|||.. +
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~--- 143 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN--- 143 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---
Confidence 3678999999999999877 3468999999999999999976 45789999999999999999999985 7
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHhC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG 153 (380)
++||||||+|||+++++.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|
T Consensus 144 ~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g 218 (283)
T PHA02988 144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218 (283)
T ss_pred CCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC
Confidence 889999999999999999999999999764321 123567899999999976 6899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
..||...... .... .+......+ ..+......+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 219 ~~Pf~~~~~~---~~~~---~i~~~~~~~----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 219 KIPFENLTTK---EIYD---LIINKNNSL----------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCCHH---HHHH---HHHhcCCCC----------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999754321 1111 111111110 112234567889999999999999999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=297.41 Aligned_cols=199 Identities=27% Similarity=0.345 Sum_probs=169.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||+.|.|||++.+|++++++.++|+|.||+++|-|.+|+-. +++|++..+.+++.||+.||.|+|..+ |+|||
T Consensus 65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRD 137 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRD 137 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceecc
Confidence 68899999999999999999999999999999999999987 789999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCC-CcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
+||+|+||+..+.+||+|||+|.+-. ....-..-+|.++|.|||++.+..|. .++||||+|||||.||+|+.||++
T Consensus 138 LKpENlLLd~~~nIKIADFGMAsLe~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 138 LKPENLLLDVKNNIKIADFGMASLEV---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred CCchhhhhhcccCEeeeccceeeccc---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999997632 22334557899999999999999884 789999999999999999999985
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.+.......|.. ... .+|...+.++-+|+.+||..||+.|.|++||++.-
T Consensus 215 dNir~LLlKV~~------G~f------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 215 DNIRVLLLKVQR------GVF------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ccHHHHHHHHHc------Ccc------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 443222222211 111 12334456788999999999999999999998865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.52 Aligned_cols=201 Identities=26% Similarity=0.338 Sum_probs=169.1
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|.+| .||.|++||..|.+...+|+|+||+++|.|.++|+. .+.|++..+..++.+|+.||+|||.+| |||||
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRD 199 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRD 199 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 4456 899999999999999999999999999999999987 578999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc---------ccc--ccccccccccchhhhhcCCCCCcCceeehHHHHHH
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT---------HVS--TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~e 149 (380)
|||+||||++++.++|+|||.|+.+...... ... ..++||..|.+||++.....+..+|||+||||+|+
T Consensus 200 lKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQ 279 (604)
T KOG0592|consen 200 LKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQ 279 (604)
T ss_pred CChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHH
Confidence 9999999999999999999999986533222 111 44889999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
|+.|.+||...+... .++.+...... ++...+..+.+|+.+.|..||.+|+|..+|-+..
T Consensus 280 mlaG~PPFra~Neyl------iFqkI~~l~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 280 MLAGQPPFRAANEYL------IFQKIQALDYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HhcCCCCCccccHHH------HHHHHHHhccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 999999998654321 12222222222 2333346788999999999999999998887654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=270.95 Aligned_cols=187 Identities=30% Similarity=0.419 Sum_probs=163.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||+.+.||.|+++++.|.+.+.+|+||||++||-|.++++. .+++++..+..++.+|+.||+|||..+ |++||
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRD 169 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRD 169 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeecc
Confidence 57889999999999999999999999999999999999987 578999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+||+|||||.+|.+||+|||+|+.. ...+...+||+.|+|||++....|+.++|-|+|||++|||+.|.+||...
T Consensus 170 LKPENiLlD~~G~iKitDFGFAK~v-----~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 170 LKPENLLLDQNGHIKITDFGFAKRV-----SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred CChHHeeeccCCcEEEEeccceEEe-----cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 9999999999999999999999863 22355689999999999999999999999999999999999999999876
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
++. .....+......++..+. ..+.+|+.+.|+.|-.+|
T Consensus 245 ~~~------~iY~KI~~~~v~fP~~fs------------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 245 NPI------QIYEKILEGKVKFPSYFS------------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ChH------HHHHHHHhCcccCCcccC------------HHHHHHHHHHHhhhhHhh
Confidence 552 223333444444444444 466799999999998888
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=273.78 Aligned_cols=215 Identities=26% Similarity=0.330 Sum_probs=169.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++|+|||||.++++|.....++||+|||+ -++.+-|.. ....++...+.++++|++.|+.|+|+++ +||||
T Consensus 54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~d-hTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRD 126 (396)
T KOG0593|consen 54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCD-HTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRD 126 (396)
T ss_pred HHHhcccchHHHHHHHHHhcceeEEEeeecc-hHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eeccc
Confidence 6899999999999999999999999999997 455555554 3566899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+||||+.++.+||||||+|+.... .....+.-+.|.+|.|||.+.+ ..|+...|||++|||+.||++|++.|.+
T Consensus 127 IKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 127 IKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred CChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 999999999999999999999998543 2334455678999999999988 6899999999999999999999999987
Q ss_pred CCCCCCcchhh--------hhhhcccccCCCCCCCCccc------cCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVA--------WARPLFKDRRKFPKMADPLL------QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....+....+. ....+|....-|..+.-|.. ...|| ....-+++++..||+.||.+|++.++++.
T Consensus 205 ~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 205 RSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 65544333322 11222332222222222222 22232 23447889999999999999999999974
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=285.26 Aligned_cols=216 Identities=23% Similarity=0.279 Sum_probs=172.0
Q ss_pred ccCCC-CCCcccceEEEEeCC-eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLH-HSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++|+ |||||++.+++.+.+ .+|+|||||+ .+|.+++++. +..|++..+..|+.||+.||+|+|.+| +.||
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHR 134 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHR 134 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccc
Confidence 56788 999999999998888 9999999996 9999999983 788999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-cCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|+||+|||+.....+||+|||+|+.... ....+.-+-|.+|.|||++. ...|+.+.|+|++|||++||.+-++.|.
T Consensus 135 DlKPENiLi~~~~~iKiaDFGLARev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP 211 (538)
T KOG0661|consen 135 DLKPENILISGNDVIKIADFGLAREVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP 211 (538)
T ss_pred cCChhheEecccceeEeccccccccccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence 9999999999888999999999996432 22334456789999999986 4689999999999999999999999998
Q ss_pred CCCCCCCcchhhhhhhccc-------------ccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFK-------------DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+....+....+--+..... ..-.++.+....+..-.+. ...++++|+..|+++||.+|||+.++++
T Consensus 212 G~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 212 GASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred CCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 7766444332211110000 0112223322233323333 6788999999999999999999999998
Q ss_pred HHH
Q 016913 226 ALT 228 (380)
Q Consensus 226 ~L~ 228 (380)
.--
T Consensus 291 ~pf 293 (538)
T KOG0661|consen 291 HPF 293 (538)
T ss_pred Ccc
Confidence 654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=278.71 Aligned_cols=215 Identities=25% Similarity=0.404 Sum_probs=164.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC---------------CCCCCCCHHHHHHHHHHHHHHH
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---------------PDKEPLDWNTRMKIAAGAAKGL 65 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~l~~~~~~~i~~qia~aL 65 (380)
+|.+++||||+++++++.+.+..++||||+++++|.+++.... .....+++..++.++.||+.||
T Consensus 72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 151 (304)
T cd05096 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM 151 (304)
T ss_pred HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 3678899999999999999999999999999999999986521 1123478899999999999999
Q ss_pred HHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHH
Q 016913 66 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 145 (380)
Q Consensus 66 ~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGv 145 (380)
.|||+.+ |+|+||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+
T Consensus 152 ~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 152 KYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred HHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 9999999 9999999999999999999999999997543332222233345678899999999889999999999999
Q ss_pred HHHHHHh--CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHH
Q 016913 146 VFLELIT--GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223 (380)
Q Consensus 146 vl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev 223 (380)
++|||++ +..||...... .........+........ ...+...+..+.+|+.+||+.+|++|||+.+|
T Consensus 229 ~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDE---QVIENAGEFFRDQGRQVY-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred HHHHHHHccCCCCCCcCCHH---HHHHHHHHHhhhcccccc-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 9999987 45666643221 111111111111000000 01122345678999999999999999999999
Q ss_pred HHHHH
Q 016913 224 VTALT 228 (380)
Q Consensus 224 l~~L~ 228 (380)
++.|+
T Consensus 299 ~~~l~ 303 (304)
T cd05096 299 HAFLT 303 (304)
T ss_pred HHHHh
Confidence 99885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=300.80 Aligned_cols=205 Identities=23% Similarity=0.304 Sum_probs=166.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|..++..||||||+++++|.+++........++++..+..++.||+.||.|||+.+ |+|||
T Consensus 118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrD 194 (478)
T PTZ00267 118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRD 194 (478)
T ss_pred HHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECC
Confidence 367899999999999999999999999999999999988753334567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 195 lkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654332222334567999999999999999999999999999999999999999643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... .......... . . ..+......+.+|+.+||+.+|+.||++.+++.
T Consensus 275 ~~~------~~~~~~~~~~--~----~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 275 SQR------EIMQQVLYGK--Y----D-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CHH------HHHHHHHhCC--C----C-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 221 1111111100 0 0 011223457889999999999999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=281.50 Aligned_cols=200 Identities=27% Similarity=0.305 Sum_probs=161.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||++++++|...+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrD 118 (312)
T cd05585 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRD 118 (312)
T ss_pred HHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCC
Confidence 35678999999999999999999999999999999999975 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 119 lkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 119 LKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred CCHHHeEECCCCcEEEEECcccccCccC--CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 9999999999999999999999753211 12233457899999999999999999999999999999999999999743
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.. ............. ++......+.+++.+||+.||.+||++..+.+.|
T Consensus 197 ~~------~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 197 NV------NEMYRKILQEPLR------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CH------HHHHHHHHcCCCC------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 21 1111222211111 1223345788999999999999998654444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=282.94 Aligned_cols=198 Identities=27% Similarity=0.338 Sum_probs=162.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|..++..||||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|||
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrD 120 (323)
T cd05571 48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRD 120 (323)
T ss_pred HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCC
Confidence 35788999999999999999999999999999999999975 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||+++.... .........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 121 lkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 121 LKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 999999999999999999999874211 112223457999999999999999999999999999999999999999643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
... ... ..+..... .++......+.+++.+||+.||++|| ++.++++
T Consensus 199 ~~~---~~~---~~~~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 199 DHE---KLF---ELILMEEI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHH---HHH---HHHHcCCC------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 211 111 11111111 11223456788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=275.98 Aligned_cols=208 Identities=30% Similarity=0.492 Sum_probs=167.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHh
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLH 69 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH 69 (380)
|+.++||||+++++++...+..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999976311 1156889999999999999999999
Q ss_pred hCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHH
Q 016913 70 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 70 ~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~e 149 (380)
+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||++....++.++|||||||++||
T Consensus 142 ~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 SHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred hCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 999 99999999999999999999999999976433322222334456789999999998899999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 150 LIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 150 llt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|++ |..||...... .....+. .. ... ..+...+..+.+|+.+||+.+|.+||++.||++.|+
T Consensus 219 l~~~g~~p~~~~~~~---~~~~~i~----~~-~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 219 IFSYGLQPYYGFSNQ---EVIEMIR----SR-QLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHcCCCCCCCCCCHH---HHHHHHH----cC-CcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 998 99998754322 1111111 00 000 112344578899999999999999999999999997
Q ss_pred H
Q 016913 229 Y 229 (380)
Q Consensus 229 ~ 229 (380)
.
T Consensus 282 ~ 282 (283)
T cd05048 282 S 282 (283)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=288.19 Aligned_cols=202 Identities=25% Similarity=0.321 Sum_probs=171.8
Q ss_pred CccCCCCCCcccceEEEEeCCe-EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQ-RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++++|||||.+++.|+.++. .+|||+||+||+|.+.+... .+..++++.++.|+.|++.||.|||++. |+||
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHR 130 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHR 130 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcc
Confidence 4788999999999999998888 89999999999999999983 3577999999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+.|||++++..++|+|||+++.+.... .......||+.|++||.+.+.+|+.|+|||||||++|||++-+++|..
T Consensus 131 DlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 131 DLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred cchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 999999999999999999999999864332 244567899999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.+... .+..+.. ... .+.|..+...+..|+..||+.+|..||++.++|..
T Consensus 209 ~~m~~------Li~ki~~------~~~-----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 209 SNMSE------LILKINR------GLY-----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cchHH------HHHHHhh------ccC-----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 43221 1111111 111 22344567789999999999999999999999976
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.82 Aligned_cols=212 Identities=29% Similarity=0.486 Sum_probs=177.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC----------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD----------KEPLDWNTRMKIAAGAAKGLEYLHD 70 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~----------~~~l~~~~~~~i~~qia~aL~~LH~ 70 (380)
+|..|+|||||+++|+|.+++-+|+|+|||..|+|.++|....+. +.+|+..+.+.|+.|||.|++||-+
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999999999999999999999999999864211 3348999999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHH
Q 016913 71 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 71 ~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~el 150 (380)
+. +|||||...|+||.++..|||+|||+++-....+........+-..+||+||.+..++|+.+|||||||||||||
T Consensus 622 ~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 622 HH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred Cc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence 99 999999999999999999999999999976555555444445557899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 151 IT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 151 lt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
++ |..||...... .++..+ ..+.. -..|..++..+.+|+..||+.+|++||++.||-.+|+.
T Consensus 699 FsyG~QPy~glSn~---EVIe~i----~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 699 FSYGKQPYYGLSNQ---EVIECI----RAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hccccCcccccchH---HHHHHH----HcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 97 77888754332 222221 12111 12456778899999999999999999999999999998
Q ss_pred hhh
Q 016913 230 LAS 232 (380)
Q Consensus 230 ~~~ 232 (380)
...
T Consensus 762 ~~~ 764 (774)
T KOG1026|consen 762 WAQ 764 (774)
T ss_pred HHh
Confidence 643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=282.76 Aligned_cols=198 Identities=28% Similarity=0.376 Sum_probs=171.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|++.|+|||||.++++|+...++|+|+||+. |+|..+|.. .+.|+++.+..++.+++.||.|||+.+ |+|||
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~-g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd 125 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAV-GDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRD 125 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhh-hhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---ccccc
Confidence 4678999999999999999999999999997 599999976 788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+||.|||++..+.+|+||||+|+.+.. .+...+.+.||+.|||||...+..|+..+|+||||||+||++.|++||...
T Consensus 126 ~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 126 MKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred CCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 999999999999999999999998654 345567788999999999999999999999999999999999999999632
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.+...++.+..+.. .+|......+..++...|++||..|.|..+++..
T Consensus 204 ------si~~Lv~~I~~d~v------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 204 ------SITQLVKSILKDPV------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------HHHHHHHHHhcCCC------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 23333333333321 1234567788999999999999999999999853
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=275.21 Aligned_cols=211 Identities=27% Similarity=0.439 Sum_probs=168.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHh
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLH 69 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH 69 (380)
|+.++||||+++++++...+..++||||+++++|.+++..... ....+++..++.++.||+.||+|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999999999999999999999999999975321 2345899999999999999999999
Q ss_pred hCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHH
Q 016913 70 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 70 ~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~e 149 (380)
+++ ++|+||||+|||++.++.++|+|||++................++..|+|||++.+..++.++||||||+++||
T Consensus 141 ~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 999 99999999999999999999999999975433222222334556788999999999899999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 150 LIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 150 llt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|++ |..||....... ..... ... .... .+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 218 l~t~g~~p~~~~~~~~---~~~~~----~~~-~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 218 IFTYGKQPWFQLSNTE---VIECI----TQG-RVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HHhCCCCCCCCCCHHH---HHHHH----hCC-CCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 998 999986543211 11111 110 0000 11123457889999999999999999999999999
Q ss_pred Hhhh
Q 016913 229 YLAS 232 (380)
Q Consensus 229 ~~~~ 232 (380)
.+..
T Consensus 281 ~~~~ 284 (291)
T cd05094 281 ALGK 284 (291)
T ss_pred HHHh
Confidence 8854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=288.07 Aligned_cols=211 Identities=27% Similarity=0.428 Sum_probs=164.0
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC-------------------------------------
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------------------------------- 43 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------- 43 (380)
|+.+ +|||||+++++|...+..++|||||++|+|.+++....
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 4566 89999999999999999999999999999999986421
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCe
Q 016913 44 -----------------------------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 94 (380)
Q Consensus 44 -----------------------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~ 94 (380)
....++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~ 251 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVA 251 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeE
Confidence 01235889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 016913 95 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWAR 173 (380)
Q Consensus 95 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 173 (380)
||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||....... ......
T Consensus 252 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~- 328 (374)
T cd05106 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMV- 328 (374)
T ss_pred EEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHH-
Confidence 9999999975432221112222345678999999998899999999999999999997 999997543211 111111
Q ss_pred hcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 174 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
.... ....+...+..+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus 329 ---~~~~----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 329 ---KRGY----------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---Hccc----------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1100 00011122467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=280.03 Aligned_cols=196 Identities=30% Similarity=0.379 Sum_probs=160.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..++..|+||||+.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|||
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 143 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRD 143 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 36788999999999999999999999999999999999976 467899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 144 lkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 144 LKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred CCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999764221 22356899999999999999999999999999999999999999643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~ 226 (380)
... .....+......+ +......+.+|+.+||+.||.+||+ +.+|+..
T Consensus 219 ~~~------~~~~~i~~~~~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 219 TPF------RIYEKILAGRLKF------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CHH------HHHHHHhcCCcCC------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 221 1111111111111 1122356789999999999999996 5666643
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=275.66 Aligned_cols=198 Identities=28% Similarity=0.360 Sum_probs=161.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|..++..|+||||+++++|.+++.. ...+.+..+..++.||+.||.|||+.+ |+|||
T Consensus 53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 125 (323)
T cd05584 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRD 125 (323)
T ss_pred HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 36788999999999999999999999999999999999975 466889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||+++..... ........|++.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 126 LKPENILLDAQGHVKLTDFGLCKESIHE--GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred CCHHHeEECCCCCEEEeeCcCCeecccC--CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999998743221 11223456899999999999888999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
... .....+...... .+......+.+++.+||+.+|++|| ++.++++
T Consensus 204 ~~~------~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 204 NRK------KTIDKILKGKLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHH------HHHHHHHcCCCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 321 111111111111 1222345788999999999999999 7887766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=278.96 Aligned_cols=199 Identities=25% Similarity=0.328 Sum_probs=162.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..++..||||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 48 ~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 120 (328)
T cd05593 48 VLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRD 120 (328)
T ss_pred HHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 36788999999999999999999999999999999999875 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 121 ikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 121 LKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 9999999999999999999998752211 11223456899999999999889999999999999999999999999653
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
... .....+..... .++......+.+++.+||+.||.+|| ++.+|++.
T Consensus 199 ~~~------~~~~~~~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 199 DHE------KLFELILMEDI------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHH------HHHHHhccCCc------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 221 11111111111 11223346788999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=286.35 Aligned_cols=209 Identities=27% Similarity=0.418 Sum_probs=162.8
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------------------------------
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------------------------ 44 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------------------ 44 (380)
|+.+ +|||||+++++|..++..++|||||++|+|.+++.....
T Consensus 92 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 92 LSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred HHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 4456 899999999999999999999999999999999965210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEc
Q 016913 45 -----------------------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD 89 (380)
Q Consensus 45 -----------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~ 89 (380)
....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~ 248 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLT 248 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEE
Confidence 1235889999999999999999999999 99999999999999
Q ss_pred CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCCCCCCCcch
Q 016913 90 EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNL 168 (380)
Q Consensus 90 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~~~~~~~~~ 168 (380)
.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 249 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~ 326 (375)
T cd05104 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKF 326 (375)
T ss_pred CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHH
Confidence 999999999999976433221112222345678999999999999999999999999999998 88888653221 111
Q ss_pred hhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 169 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
..... .... . ..+......+.+|+.+||+.+|++||++.||++.|+.
T Consensus 327 ~~~~~----~~~~---~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 327 YKMIK----EGYR---M-------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHH----hCcc---C-------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11111 1100 0 0111224578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.53 Aligned_cols=203 Identities=23% Similarity=0.313 Sum_probs=163.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..||||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 127 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDL 127 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678899999999999999999999999999999999975 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++..... ......|++.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 128 kp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 128 KPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred CHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 99999999999999999999975322 2334578999999999999999999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.......+.... .....+...++. ......+.+++.+||+.+|.+||++.+|++.
T Consensus 203 ~~~~~~~i~~~~----~~~~~~~~~~~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 203 PNETWENLKYWK----ETLQRPVYDDPR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHhcc----ccccCCCCCccc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 321111111000 000001111100 1235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=286.29 Aligned_cols=210 Identities=29% Similarity=0.472 Sum_probs=172.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++-+|.||+-++|||..... .||+-+|+|-+|+.+|+. ....|+..+.+.|+.|||.|+.|||.++ |||+|
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrD 513 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRD 513 (678)
T ss_pred HHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhh
Confidence 3678899999999999998877 999999999999999997 4577999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC---CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||..||||.++++|||+||||+................|...|||||+++-+ +|++.+|||+||+|+|||++|..||
T Consensus 514 LKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 514 LKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred ccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 9999999999999999999999864443333334456788999999999743 7999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCC--CCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRK--FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
... ..+. . +|..++. .+..... ..++...+.+|+..||.+++++||.+.+|+..|..+..
T Consensus 594 si~-~~dq--I------ifmVGrG~l~pd~s~~------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 594 SIQ-NRDQ--I------IFMVGRGYLMPDLSKI------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred CCC-Chhh--e------EEEecccccCccchhh------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 832 2211 1 1222222 1121111 12457789999999999999999999999999987754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.35 Aligned_cols=204 Identities=28% Similarity=0.380 Sum_probs=163.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|+||+++++++.+++..++||||+++++|..++... ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 127 (285)
T cd05631 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRD 127 (285)
T ss_pred HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 367789999999999999999999999999999999888652 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||+++++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 128 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 128 LKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred CCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997643221 223456899999999999999999999999999999999999999865
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~ 226 (380)
........+. ..+... ...++......+.+|+.+||+.+|.+||+ ++++++.
T Consensus 205 ~~~~~~~~~~--~~~~~~------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 205 KERVKREEVD--RRVKED------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CcchhHHHHH--HHhhcc------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 4322111111 000000 01122334567889999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=279.19 Aligned_cols=199 Identities=27% Similarity=0.341 Sum_probs=161.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|...+..||||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 120 (323)
T cd05595 48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRD 120 (323)
T ss_pred HHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 36778999999999999999999999999999999999875 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||++...... ........|++.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 121 IKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998742111 11223456899999999999999999999999999999999999999654
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
... .... ........ ++......+.+++.+||+.+|.+|| ++.++++.
T Consensus 199 ~~~---~~~~---~~~~~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 199 DHE---RLFE---LILMEEIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHH---HHHH---HHhcCCCC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 221 1111 11111111 1223345778999999999999998 78888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=270.71 Aligned_cols=205 Identities=22% Similarity=0.356 Sum_probs=163.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~di 133 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGL 133 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeccc
Confidence 5678999999999999999999999999999999999976 2357899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.++|+|||.+....... ........++..|+|||++.+..++.++|||||||++||+++ |..||...
T Consensus 134 kp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 134 AAHKVLVNSDLVCKISGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cHhhEEEcCCCcEEECCCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 9999999999999999999876422111 111112345678999999999999999999999999999875 99999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
... ...... ...... ..+...+..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 213 ~~~---~~~~~~----~~~~~~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 213 SGQ---DVIKAV----EDGFRL----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CHH---HHHHHH----HCCCCC----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 321 111111 111000 11223456788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=280.91 Aligned_cols=214 Identities=23% Similarity=0.310 Sum_probs=163.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHr 79 (380)
+|+.++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+|+
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~ 128 (331)
T cd06649 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHR 128 (331)
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcC
Confidence 36788999999999999999999999999999999999976 45689999999999999999999985 5 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||||+|||++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 129 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred CCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998754221 22335689999999999998999999999999999999999999964
Q ss_pred CCCCCCcchhhhhh-hcccccCCCCC----------------------------CCCccc----cCCCChhhHHHHHHHH
Q 016913 160 TRPPGEHNLVAWAR-PLFKDRRKFPK----------------------------MADPLL----QGRYPMRGLYQALAVA 206 (380)
Q Consensus 160 ~~~~~~~~~~~~~~-~~~~~~~~~~~----------------------------~~~~~l----~~~~~~~~~~~l~~li 206 (380)
..... +..... ........... +.+... ...........+.+|+
T Consensus 205 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 281 (331)
T cd06649 205 PDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFV 281 (331)
T ss_pred CCHHH---HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHH
Confidence 33211 110000 00000000000 000000 0000112456789999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHH
Q 016913 207 AMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 207 ~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.+||+.||++|||+.||++...
T Consensus 282 ~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 282 NKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred HHHccCCcccCCCHHHHhcChH
Confidence 9999999999999999997643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=271.22 Aligned_cols=207 Identities=28% Similarity=0.464 Sum_probs=164.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.+.||||+++++++. +...++|+||+++++|.+++.. ....+++..++.|+.||+.||.|||+.+ ++|+||
T Consensus 63 l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dl 135 (279)
T cd05111 63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNL 135 (279)
T ss_pred HhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---Eecccc
Confidence 46789999999999986 4567899999999999999975 3457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||+++...............++..|++||++.+..++.++||||||+++|||++ |..||...
T Consensus 136 kp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986433322222334556778999999998899999999999999999998 99998754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... .... ....... ..+ ......+.+++.+||..+|+.|||+.||++.|..+..
T Consensus 216 ~~~~---~~~~----~~~~~~~---~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 216 RPHE---VPDL----LEKGERL---AQP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CHHH---HHHH----HHCCCcC---CCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 3211 1111 1111111 011 1123467789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=273.05 Aligned_cols=211 Identities=27% Similarity=0.436 Sum_probs=167.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------DKEPLDWNTRMKIAAGAAKGLEYLHDKA 72 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~ 72 (380)
|++++||||+++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5688999999999999999999999999999999999975321 1235899999999999999999999999
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
++||||||+|||+++++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++
T Consensus 141 ---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 141 ---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred ---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999975432222222233446778999999998899999999999999999998
Q ss_pred -CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 153 -GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 153 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
|..||....... .... +... . ... .+......+.+|+.+||+.+|.+|||+.+|++.|+.+.
T Consensus 218 ~g~~p~~~~~~~~---~~~~---i~~~-~-~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 218 YGKQPWYQLSNNE---VIEC---ITQG-R-VLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCCCCCCCCCHHH---HHHH---HHcC-C-cCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 888886443211 1111 1110 0 000 01123457899999999999999999999999999876
Q ss_pred h
Q 016913 232 S 232 (380)
Q Consensus 232 ~ 232 (380)
.
T Consensus 281 ~ 281 (288)
T cd05093 281 K 281 (288)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=275.89 Aligned_cols=196 Identities=27% Similarity=0.348 Sum_probs=161.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 126 (291)
T cd05612 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRD 126 (291)
T ss_pred HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 36788999999999999999999999999999999999976 457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 127 lkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 127 LKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred CCHHHeEECCCCCEEEEecCcchhccC-----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999975422 122356899999999999989999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~ 226 (380)
.... ....+...... ++......+.+|+.+||+.||.+||+ +.++++.
T Consensus 202 ~~~~------~~~~i~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 202 NPFG------IYEKILAGKLE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CHHH------HHHHHHhCCcC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 3211 11111111111 12223457789999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=276.86 Aligned_cols=208 Identities=25% Similarity=0.424 Sum_probs=164.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|... ..++|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dl 135 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDL 135 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eecccc
Confidence 5788999999999999865 57899999999999999986 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 136 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 136 AARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred chhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986543222212222334678999999999999999999999999999997 99998753
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
... ..... ......+ ..+......+.+++.+||+.+|.+||++.+|+..|..+...
T Consensus 216 ~~~---~~~~~----~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 216 PAS---EISSI----LEKGERL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CHH---HHHHH----HhCCCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 211 11111 1111111 01122345788999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=278.35 Aligned_cols=198 Identities=27% Similarity=0.334 Sum_probs=160.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrD 80 (380)
|+.++||||+++++++...+..||||||+++++|..++.. ...+++..+..++.||+.||.|||+ .+ |+|||
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrD 121 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRD 121 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 5678999999999999999999999999999999999875 4579999999999999999999997 78 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||+++..... ........||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 122 ikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 122 LKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred CCCCeEEECCCCCEEEecCCCCeecCCC--CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 9999999999999999999998742211 11223456999999999999999999999999999999999999999653
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
.... . .......... ++......+.+|+.+||+.||++|+ ++.++++.
T Consensus 200 ~~~~---~---~~~i~~~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 200 DHEK---L---FELILMEEIR------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHH---H---HHHHhcCCCC------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2211 1 1111111111 1222345788999999999999996 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=278.91 Aligned_cols=196 Identities=24% Similarity=0.302 Sum_probs=161.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||++++++.+++..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 156 (340)
T PTZ00426 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRD 156 (340)
T ss_pred HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccC
Confidence 36778999999999999999999999999999999999976 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 157 Lkp~NILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 157 LKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCHHHEEECCCCCEEEecCCCCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 999999999999999999999976421 123457899999999999988999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
.... ....+...... ++......+.+++.+||+.+|++|+ ++.+|++.
T Consensus 232 ~~~~------~~~~i~~~~~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 232 EPLL------IYQKILEGIIY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CHHH------HHHHHhcCCCC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 3211 11111111111 1222345678999999999999995 78887754
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=272.55 Aligned_cols=210 Identities=28% Similarity=0.408 Sum_probs=166.2
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------PDKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
++.+ +||||++++++|..++..++||||+++++|..++.... .....+++..++.++.|++.||+||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 3456 79999999999999999999999999999999997521 2345689999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ |+|+||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 149 H~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 149 ASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred HHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 9999 9999999999999999999999999998643322222222334567899999998889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++ |..||........ ... ...... ...+......+.+|+.+||+.+|++|||+.||++.|
T Consensus 226 el~~~g~~p~~~~~~~~~---~~~----~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 226 EIFTLGGSPYPGIPVEEL---FKL----LKEGYR----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHhcCCCCCCCCCCHHHH---HHH----HHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 9997 8888864322111 111 001000 011223456788999999999999999999999999
Q ss_pred HHhh
Q 016913 228 TYLA 231 (380)
Q Consensus 228 ~~~~ 231 (380)
..+.
T Consensus 289 ~~~~ 292 (293)
T cd05053 289 DRML 292 (293)
T ss_pred HHhh
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=274.74 Aligned_cols=204 Identities=33% Similarity=0.535 Sum_probs=157.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||++++|+|...+..++||||+++++|.++|.. .....+++..++.|+.||+.||.|||+.+ ++|++|
T Consensus 55 l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l 129 (259)
T PF07714_consen 55 LRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKS--KNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNL 129 (259)
T ss_dssp HHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHH--TCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred cccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccc---cccccc
Confidence 5678999999999999988889999999999999999998 23567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
+++|||++.++.+||+|||++....................|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 130 ~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 130 SPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999987532222233344557789999999999999999999999999999999 67887644
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.. .... ..+... .. ...+......+.+|+..||..+|++|||+.+|++.|
T Consensus 210 ~~---~~~~---~~~~~~-~~----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 DN---EEII---EKLKQG-QR----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp CH---HHHH---HHHHTT-EE----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc---cccc---cccccc-cc----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 21 1111 111111 10 011122356788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=275.02 Aligned_cols=196 Identities=28% Similarity=0.379 Sum_probs=158.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..|+||||+++++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdl 127 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDL 127 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCC
Confidence 4577899999999999999999999999999999998864 56999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++..... .........|+..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 128 kp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 128 KLDNLLLDTEGFVKIADFGLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CHHHeEECCCCcEEeCcccCCccCCC--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999874221 1122234678999999999999999999999999999999999999997542
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 225 (380)
.. .....+..... .++......+.+++.+||+.||.+||+ +.++++
T Consensus 206 ~~------~~~~~i~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 206 EE------EVFDSIVNDEV------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HH------HHHHHHHhCCC------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 21 11111111111 112233467789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=272.84 Aligned_cols=193 Identities=27% Similarity=0.307 Sum_probs=158.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++...+..|+||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 50 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~di 122 (323)
T cd05575 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDL 122 (323)
T ss_pred HhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCC
Confidence 4678999999999999999999999999999999999975 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 123 KPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred CHHHeEECCCCcEEEeccCCCccccc--CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 99999999999999999999874221 1122334578999999999999999999999999999999999999997542
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
.. .....+...... .+......+.+++.+||+.+|.+||++.
T Consensus 201 ~~------~~~~~i~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 201 TA------EMYDNILNKPLR------------LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HH------HHHHHHHcCCCC------------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 21 111111111100 1112346788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=278.64 Aligned_cols=195 Identities=28% Similarity=0.335 Sum_probs=159.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 123 (318)
T cd05582 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRD 123 (318)
T ss_pred HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCC
Confidence 36788999999999999999999999999999999999965 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||++...... ........|+..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 124 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 124 LKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CCHHHeEECCCCcEEEeeccCCcccCCC--CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 9999999999999999999998753222 12223467899999999999888999999999999999999999999753
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
... .. ...+...... .+......+.+|+.+||+.||.+||++.+
T Consensus 202 ~~~---~~---~~~i~~~~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 202 DRK---ET---MTMILKAKLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHH---HH---HHHHHcCCCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 221 11 1111111111 12223456789999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.63 Aligned_cols=211 Identities=25% Similarity=0.407 Sum_probs=167.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHHH
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------------------DKEPLDWNTRMKIAAGA 61 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi 61 (380)
|+.++||||++++++|...+..++||||+.+++|.+++..... ....+++.+++.++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 5788999999999999999999999999999999999875211 12358899999999999
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCcee
Q 016913 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVY 141 (380)
Q Consensus 62 a~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~ 141 (380)
+.||.|||+.+ ++|+||||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 137 ~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 137 SRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred HHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999999 999999999999999999999999999754322211112234456789999999888999999999
Q ss_pred ehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 142 SFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 142 SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
|||+++|||++ |..||....+. .+..... .. .....+......+.+++.+||+.+|++||++
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~ 276 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPE---RLFNLLK----TG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----CC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 99999999998 99998654322 1111111 00 0011122344678899999999999999999
Q ss_pred HHHHHHHHHhhh
Q 016913 221 GDVVTALTYLAS 232 (380)
Q Consensus 221 ~evl~~L~~~~~ 232 (380)
.+|++.|+++..
T Consensus 277 ~~i~~~l~~~~~ 288 (290)
T cd05045 277 ADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHHh
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=267.91 Aligned_cols=205 Identities=25% Similarity=0.356 Sum_probs=161.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 119 (252)
T cd05084 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119 (252)
T ss_pred HHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 36788999999999999999999999999999999999965 2456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+|||++.++.+||+|||++.................+..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 120 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred cchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999875332111111111223457999999998889999999999999999997 8888864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
..... ..... ... .....+...+..+.+|+.+||+.+|++|||+.+|+++|+
T Consensus 200 ~~~~~---~~~~~----~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 200 LSNQQ---TREAI----EQG----------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCHHH---HHHHH----HcC----------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 32211 11110 000 001112233567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=267.69 Aligned_cols=206 Identities=26% Similarity=0.395 Sum_probs=164.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..++..++||||+++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 130 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 130 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeeccc
Confidence 5678999999999999999999999999999999999975 23456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||++++++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred CcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999999764322111 1112234568999999999999999999999999999998 88888643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
... .....+... .....+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 210 ~~~------~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 210 DLS------QVYELLEKG-----------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CHH------HHHHHHHCC-----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 221 111111100 01111223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.42 Aligned_cols=214 Identities=28% Similarity=0.403 Sum_probs=174.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
+|++++|||||+++|+|.+....+||+|||++|+|..||.+... ....|+....+.++.+||+|+.||+++. +|
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fv 824 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FV 824 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---Cc
Confidence 47899999999999999999999999999999999999998321 2456999999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCC
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKA 156 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p 156 (380)
||||...|+||++...+||+|||+|+.+...+.......-+-...|||||.+..+.|+.|+|||||||++|||+| |..|
T Consensus 825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 825 HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 999999999999999999999999995444443333333344578999999999999999999999999999998 6788
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhcc
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 234 (380)
|...........+ ...+ .+ ..|..++..+.+|+..||+.+|++||++..|++.+..+....
T Consensus 905 Y~~~~n~~v~~~~------~~gg----RL-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 905 YPSRSNFEVLLDV------LEGG----RL-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCCcchHHHHHHH------HhCC----cc-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 8765443221111 1111 11 234456778889999999999999999999999888775433
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=269.85 Aligned_cols=208 Identities=26% Similarity=0.432 Sum_probs=165.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP----------PDKEPLDWNTRMKIAAGAAKGLEYLHD 70 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~~~~l~~~~~~~i~~qia~aL~~LH~ 70 (380)
+|+.++||||+++++++..+...++||||+++++|.+++.... .....+++..+..++.|++.||.|||+
T Consensus 61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 140 (280)
T cd05049 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140 (280)
T ss_pred HHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 3677899999999999999999999999999999999997631 223458899999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHH
Q 016913 71 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 71 ~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~el 150 (380)
.+ ++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||
T Consensus 141 ~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 141 QH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred CC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 99 999999999999999999999999998753222211222334467889999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 151 IT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 151 lt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
++ |..||...... ..+.... . .... ..+......+.+++.+||+.+|++||++.||++.|+
T Consensus 218 ~~~g~~p~~~~~~~---~~~~~~~----~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 218 FTYGKQPWYGLSNE---EVIECIT----Q-GRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HhcCCCCCCCCCHH---HHHHHHH----c-CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 98 99998644321 1111111 0 0000 011223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=270.51 Aligned_cols=217 Identities=22% Similarity=0.248 Sum_probs=160.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|..++..++||||++++.|..+... ...+++..++.++.||+.||.|||+.+ |+|+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 125 (287)
T cd07848 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRD 125 (287)
T ss_pred HHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 35788999999999999999999999999987766654432 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||+++.++.+||+|||++........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 126 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 126 IKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred CCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986432211 1223356899999999999889999999999999999999999999754
Q ss_pred CCCCCcchhhhh-hhc-------ccccCCCCCCCCcccc------CCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWA-RPL-------FKDRRKFPKMADPLLQ------GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~l~------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
........+... .++ +.....+.....+... ..+.......+.+|+.+||+.||++|||++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 205 SEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 321111100000 000 0000000000001000 0111123457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=267.05 Aligned_cols=206 Identities=24% Similarity=0.412 Sum_probs=165.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di 132 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDL 132 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5688999999999999999999999999999999999976 3347899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||+++++.++|+|||++................++..|+|||.+....++.++||||||+++|+|++ |..||...
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred CcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 99999999999999999999987542222222223345678999999998899999999999999999998 98888643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
... ....... ..... ..+...+..+.+|+.+||+.+|++||++.+|++.|..+
T Consensus 213 ~~~---~~~~~~~----~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 213 SNQ---DVIKAVE----DGYRL----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHH---HHHHHHH----cCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 211 1111111 10000 01123456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.69 Aligned_cols=207 Identities=24% Similarity=0.423 Sum_probs=162.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------KEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
++.++||||+++++++..+...++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--- 139 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999999999999999999999999999763211 234678899999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~ 154 (380)
++|+||||+||++++++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999875432222111222345778999999998899999999999999999998 67
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.||...... ...... ... .... .+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 220 ~p~~~~~~~---~~~~~~---~~~--~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 220 QPYQGMSNE---QVLRFV---MEG--GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHH---HHHHHH---HcC--CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 888654221 111111 000 0000 11223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=267.23 Aligned_cols=221 Identities=26% Similarity=0.394 Sum_probs=166.0
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+|+.++||||++++++|... ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H 130 (283)
T cd05080 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIH 130 (283)
T ss_pred HHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 36788999999999998653 468999999999999999975 45999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
+||||+|||++.++.++|+|||++.......... ......++..|+|||++....++.++||||||+++|+|++|..||
T Consensus 131 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 210 (283)
T cd05080 131 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210 (283)
T ss_pred cccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998654322111 112234566799999998888999999999999999999999998
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
....... ............ ...+....+.......+...+..+.+|+..||+.+|++|||+.+|++.|+.+.
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 211 QSPPKKF-EEMIGPKQGQMT-VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCcchh-hhhhcccccccc-hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 6432210 011100000000 00011111111112223345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=273.61 Aligned_cols=194 Identities=27% Similarity=0.387 Sum_probs=154.7
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||||++++++|...+..|||||||++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 126 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDN 126 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHH
Confidence 799999999999999999999999999999999865 467999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCC-
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG- 164 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~- 164 (380)
||++.++.+||+|||+++.... .........||..|+|||++.+..++.++|||||||++|+|++|..||+......
T Consensus 127 ili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~ 204 (329)
T cd05588 127 VLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204 (329)
T ss_pred eEECCCCCEEECcCcccccccc--CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc
Confidence 9999999999999999874211 1122234578999999999999999999999999999999999999997432221
Q ss_pred -Ccchhhhhhh-cccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 165 -EHNLVAWARP-LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 165 -~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
......+... +..... ..|......+.+++.+||+.||.+|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 205 PDQNTEDYLFQVILEKQI------------RIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ccccchHHHHHHHHcCCC------------CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1111111111 111111 1122334578899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=275.23 Aligned_cols=198 Identities=26% Similarity=0.269 Sum_probs=160.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDl 122 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDL 122 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 4678999999999999999999999999999999999975 456888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 123 kp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 123 KPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred CHHHeEECCCCCEEEccCCCCccccc--CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999874321 1122334579999999999999999999999999999999999999997533
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
... ....+..... . .+......+.+++.+||+.+|.+||++.+.+..
T Consensus 201 ~~~------~~~~i~~~~~----~--------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 201 TAE------MYDNILNKPL----Q--------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHH------HHHHHHhCCc----C--------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 211 1111111100 0 112234578899999999999999998765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=269.89 Aligned_cols=208 Identities=22% Similarity=0.343 Sum_probs=165.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------PDKEPLDWNTRMKIAAGAAKGLEYLH 69 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~~LH 69 (380)
++.++||||+++++++......++++||+.+++|.+++.... .....+++..++.++.|++.||.|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999999999999999999999999985311 12345889999999999999999999
Q ss_pred hCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHH
Q 016913 70 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 70 ~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~e 149 (380)
+.+ |+||||||+|||+++++.+||+|||+++...............+++.|+|||++....++.++|||||||++||
T Consensus 142 ~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 142 SHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred HcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 999 99999999999999999999999999886433222222233456789999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 150 LIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 150 llt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|++ |..||...... ...... ... .. ..++...+..+.+|+..||+.+|.+||++.+|+..|+
T Consensus 219 l~~~g~~p~~~~~~~---~~~~~i---~~~--~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 219 VFSYGLQPYCGYSNQ---DVIEMI---RNR--QV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHcCCCCCCCCCCHH---HHHHHH---HcC--Cc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 998 77788653221 111111 110 00 1123345567889999999999999999999999986
Q ss_pred H
Q 016913 229 Y 229 (380)
Q Consensus 229 ~ 229 (380)
.
T Consensus 282 ~ 282 (283)
T cd05091 282 T 282 (283)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=268.18 Aligned_cols=206 Identities=25% Similarity=0.325 Sum_probs=163.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..++..++||||+++++|..++.........+++..+..++.||+.||.|||+.+ |+|+|
T Consensus 46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 122 (280)
T cd05608 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRD 122 (280)
T ss_pred HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 367889999999999999999999999999999999988654334567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 123 lkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 123 LKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCHHHEEECCCCCEEEeeCccceecCCCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997543221 1223356899999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
...... ........... ..++......+.+++.+||+.+|++|| +++++++
T Consensus 201 ~~~~~~--~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 201 GEKVEN--KELKQRILNDS------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcchhH--HHHHHhhcccC------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 321111 01111111100 012233456788999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=273.09 Aligned_cols=196 Identities=27% Similarity=0.385 Sum_probs=156.0
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
.++||||+++++++...+..|+||||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp 124 (329)
T cd05618 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKL 124 (329)
T ss_pred cCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCH
Confidence 34899999999999999999999999999999998865 467999999999999999999999999 99999999
Q ss_pred CcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCC
Q 016913 84 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163 (380)
Q Consensus 84 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~ 163 (380)
+|||++.++.+||+|||+++.... .........||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 125 ~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (329)
T cd05618 125 DNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202 (329)
T ss_pred HHEEECCCCCEEEeeCCccccccC--CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCc
Confidence 999999999999999999874221 112223467899999999999999999999999999999999999999632221
Q ss_pred CC--cchhhhhhh-cccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 164 GE--HNLVAWARP-LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 164 ~~--~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.. .....+... ...... .+|......+.+++.+||+.||++||++
T Consensus 203 ~~~~~~~~~~~~~~i~~~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 203 DNPDQNTEDYLFQVILEKQI------------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCcccccHHHHHHHHhcCCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11 111111111 111111 1223345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=270.29 Aligned_cols=193 Identities=26% Similarity=0.296 Sum_probs=157.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+.+..|+||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 50 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dl 122 (321)
T cd05603 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDL 122 (321)
T ss_pred HHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999998865 466899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||||+.++.+||+|||++...... ........|++.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 123 KPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999998752211 122334568999999999999899999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
. ......+..... ..+......+.+++.+||+.+|.+||+..
T Consensus 201 ~------~~~~~~i~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 201 V------SQMYDNILHKPL------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred H------HHHHHHHhcCCC------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1 111111111100 12223456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=265.35 Aligned_cols=205 Identities=27% Similarity=0.425 Sum_probs=166.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+|
T Consensus 55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~d 129 (261)
T cd05148 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRD 129 (261)
T ss_pred HHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 367889999999999999999999999999999999999862 3456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|+|+||+++.++.+||+|||++....... .......++..|++||++....++.++||||||+++|+|++ |..||..
T Consensus 130 l~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 130 LAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred cCcceEEEcCCceEEEccccchhhcCCcc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999999997643221 11223445678999999988899999999999999999998 8899965
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... ....... .. . ....+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 208 ~~~~---~~~~~~~---~~-~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 208 MNNH---EVYDQIT---AG-Y----------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCHH---HHHHHHH---hC-C----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 4321 1111111 00 0 001122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=273.23 Aligned_cols=191 Identities=27% Similarity=0.372 Sum_probs=156.3
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
.+||||+++++++...+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~ 125 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLD 125 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHH
Confidence 4799999999999999999999999999999999976 457999999999999999999999999 999999999
Q ss_pred cEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 85 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
|||++.++.+||+|||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 126 NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~- 202 (320)
T cd05590 126 NVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED- 202 (320)
T ss_pred HeEECCCCcEEEeeCCCCeecCcC--CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-
Confidence 999999999999999998753211 12233457899999999999989999999999999999999999999754321
Q ss_pred CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
.....+...... ++......+.+++.+||+.||++||++.+
T Consensus 203 -----~~~~~i~~~~~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 203 -----DLFEAILNDEVV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -----HHHHHHhcCCCC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 111111111111 11223457889999999999999999844
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=272.69 Aligned_cols=195 Identities=26% Similarity=0.358 Sum_probs=158.3
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
.+||||+++++++..++..|+||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~ 125 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLD 125 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 4899999999999999999999999999999999975 457899999999999999999999999 999999999
Q ss_pred cEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 85 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
|||++.++.+||+|||++...... ........|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 126 Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~- 202 (321)
T cd05591 126 NILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED- 202 (321)
T ss_pred HeEECCCCCEEEeecccceecccC--CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999998753211 12233456899999999999989999999999999999999999999754321
Q ss_pred CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-------CHHHHHHH
Q 016913 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-------LIGDVVTA 226 (380)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-------t~~evl~~ 226 (380)
. ....+...... ++......+.+++.+||+.+|++|| ++.++++.
T Consensus 203 --~---~~~~i~~~~~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 203 --D---LFESILHDDVL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --H---HHHHHHcCCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 11111111111 1112245788999999999999999 66776643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=271.73 Aligned_cols=192 Identities=27% Similarity=0.406 Sum_probs=156.7
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
.++||||+++++++..++..|+||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp 124 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKL 124 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence 45899999999999999999999999999999999975 457999999999999999999999999 99999999
Q ss_pred CcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCC
Q 016913 84 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163 (380)
Q Consensus 84 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~ 163 (380)
+|||++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 125 ~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 125 DNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred HHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999997532211 2233457899999999999989999999999999999999999999754321
Q ss_pred CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 164 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
.. ...+..... .++......+.+++.+||+.+|.+||++.+
T Consensus 203 ---~~---~~~i~~~~~------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 203 ---EL---FDSILNDRP------------HFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred ---HH---HHHHHcCCC------------CCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 11 111111111 112223456789999999999999998863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=268.83 Aligned_cols=207 Identities=27% Similarity=0.417 Sum_probs=165.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------KEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||+++++++......++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 139 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--- 139 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56789999999999999999999999999999999999763221 234789999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~ 154 (380)
++|+||||+|||++.++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |.
T Consensus 140 i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 99999999999999999999999999875433222222233456789999999998889999999999999999998 88
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.||...... ....... ... .. ..+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 220 ~p~~~~~~~---~~~~~~~----~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 220 QPYQGLSNE---EVLKFVI----DGG-HL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCccCCHH---HHHHHHh----cCC-CC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 888643221 1111111 100 00 112223567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=268.22 Aligned_cols=214 Identities=24% Similarity=0.392 Sum_probs=165.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------DKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
|+.++||||++++++|..++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-- 150 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-- 150 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 6788999999999999999999999999999999999976321 1236899999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh--
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-- 152 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-- 152 (380)
++|+||||+||+++.++.++|+|||++................++..|+|||++....++.++|||||||++|||++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred -ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 99999999999999999999999999876433322222334556788999999998889999999999999999998
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
+..||..... ..........+........ ...+...+..+.+|+.+||+.+|.+|||+.+|++.|+
T Consensus 230 ~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 230 REQPYEHLTD---QQVIENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCcCh---HHHHHHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 5667754322 1112221111111100000 0112233467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=270.90 Aligned_cols=216 Identities=22% Similarity=0.311 Sum_probs=159.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..++..++||||++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+|||
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 128 (288)
T cd07871 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRD 128 (288)
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 3678899999999999999999999999997 599999875 3446889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||+++...... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 129 lkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 129 LKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999997532211 12233567899999999875 5689999999999999999999999975
Q ss_pred CCCCCCcchhhhhh--------hcccccCCCCCCCCccccCC----CChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWAR--------PLFKDRRKFPKMADPLLQGR----YPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.........+.... +.......+.....+..... ........+.+|+.+||+.||.+|||+.|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 43322111110000 00000000000111110000 01123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=265.36 Aligned_cols=206 Identities=25% Similarity=0.415 Sum_probs=164.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+++.++||||+++++++...+..++||||+++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~d 128 (261)
T cd05072 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRD 128 (261)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 35678999999999999999999999999999999999976 23456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.++|+|||++........ .......++..|+|||++....++.++|||||||++|+|++ |..||..
T Consensus 129 l~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 129 LRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred cchhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 999999999999999999999986433221 11223345678999999988889999999999999999998 8999864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... ........ .... + .....+..+.+++.+||..+|++||++.+|+++|+.
T Consensus 208 ~~~~---~~~~~~~~----~~~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 208 MSNS---DVMSALQR----GYRM-----P-----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCHH---HHHHHHHc----CCCC-----C-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3221 11111110 0000 0 111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=267.80 Aligned_cols=214 Identities=23% Similarity=0.328 Sum_probs=157.9
Q ss_pred ccCCCCCCcccceEEEEe-----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|+.++||||++++++|.. ....++||||++ ++|.+++... ....+++..++.++.||+.||.|||+.+ |
T Consensus 58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i 131 (290)
T cd07862 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---V 131 (290)
T ss_pred hcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 345689999999999853 346899999996 7999999762 3345899999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
+||||||+|||++.++.+||+|||++...... .......|+..|+|||++....++.++|||||||++|||++|.+|
T Consensus 132 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~ 208 (290)
T cd07862 132 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208 (290)
T ss_pred eeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999764322 223345689999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCC---CCCccccC-------CCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPK---MADPLLQG-------RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~-------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|......+....+....... ....++. .....+.. .........+.+++.+||+.+|++|||+.|+++
T Consensus 209 f~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 209 FRGSSDVDQLGKILDVIGLP-GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cCCCCHHHHHHHHHHHhCCC-ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 97653321111110000000 0000000 00000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=268.41 Aligned_cols=209 Identities=28% Similarity=0.448 Sum_probs=164.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHH
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-------------PDKEPLDWNTRMKIAAGAAKGLEY 67 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~~l~~~~~~~i~~qia~aL~~ 67 (380)
+|+.++||||+++++++..++..|+||||+++++|.+++.... .....+++..++.++.|++.||.|
T Consensus 60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 139 (283)
T cd05090 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY 139 (283)
T ss_pred HHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 3678899999999999999999999999999999999986321 112458899999999999999999
Q ss_pred HhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHH
Q 016913 68 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVF 147 (380)
Q Consensus 68 LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl 147 (380)
||+.+ ++|+||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++
T Consensus 140 lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 140 LSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred HHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 99999 999999999999999999999999999764333222222334456789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 148 LELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 148 ~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
|||++ |..||...... ....... ....+ ..+......+.+++.+||+.+|++||++.+|++.
T Consensus 217 ~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 217 WEIFSFGLQPYYGFSNQ---EVIEMVR----KRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCCCCCCCCCHH---HHHHHHH----cCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 99998 88888643221 1111111 00000 0112234678899999999999999999999998
Q ss_pred HHH
Q 016913 227 LTY 229 (380)
Q Consensus 227 L~~ 229 (380)
|..
T Consensus 280 l~~ 282 (283)
T cd05090 280 LRS 282 (283)
T ss_pred hhc
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.40 Aligned_cols=210 Identities=24% Similarity=0.261 Sum_probs=167.3
Q ss_pred CccCCC-CCCcccceE-EEEe------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 016913 1 MLSLLH-HSNLVNLIG-YCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 72 (380)
Q Consensus 1 iL~~l~-HpnIv~l~~-~~~~------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 72 (380)
+|++|+ |+|||.+++ .... .-+++|+||||.||+|-+++..+. ...|++.++++|+.++|+||.+||..
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~- 163 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL- 163 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-
Confidence 467787 999999999 3221 136899999999999999998743 34499999999999999999999999
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccc-------cccccccccccchhhhh---cCCCCCcCceee
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-------STRVMGTYGYCAPEYAM---TGQLTLKSDVYS 142 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S 142 (380)
.|||||||||-+||||+.++..||||||-+........... .-...-|+.|.|||.+. +...++|+|||+
T Consensus 164 ~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA 243 (738)
T KOG1989|consen 164 KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA 243 (738)
T ss_pred CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence 58999999999999999999999999999864222211110 01234689999999885 557899999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 143 FGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 143 lGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
|||+||-|+....||+..... .+++..+..+..+.+...+.+||..||+.||.+||++.+
T Consensus 244 LGclLYkLCy~t~PFe~sg~l--------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 244 LGCLLYKLCYFTTPFEESGKL--------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred HHHHHHHHHHhCCCcCcCcce--------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 999999999999999854221 122222222233567889999999999999999999999
Q ss_pred HHHHHHHhhhc
Q 016913 223 VVTALTYLASQ 233 (380)
Q Consensus 223 vl~~L~~~~~~ 233 (380)
|+..+..++..
T Consensus 304 v~~~~~~l~~~ 314 (738)
T KOG1989|consen 304 VLEEIFELANK 314 (738)
T ss_pred HHHHHHHHhcC
Confidence 99999877543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=274.34 Aligned_cols=216 Identities=23% Similarity=0.298 Sum_probs=166.6
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
||++|+||||++|.+...+. ..+|||+|||+ -+|.-++.. ..-.|++.++..++.||+.||+|+|.++ |+|
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlH 241 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLH 241 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eee
Confidence 68899999999999998877 68999999997 788888865 4557999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||||.+|||||.+|.+||+|||||+++..... ...+..+-|.+|.|||.+.+. .|+.+.|+||.||||.||+.|++.|
T Consensus 242 RDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 242 RDIKGSNILIDNNGVLKIADFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred ccccccceEEcCCCCEEeccccceeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence 99999999999999999999999997644332 234556789999999999986 7999999999999999999999999
Q ss_pred CCCCCCCCcchhhhh-----hhcccccCCCCC--CCCc------cccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 016913 158 DNTRPPGEHNLVAWA-----RPLFKDRRKFPK--MADP------LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 224 (380)
..........++-.. ...+. ...++. .+.+ .+.+. -.......++|+..+|..||.+|.|+.+++
T Consensus 321 ~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 321 QGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 876543322222100 00000 011111 1111 11110 112345688999999999999999999988
Q ss_pred HH
Q 016913 225 TA 226 (380)
Q Consensus 225 ~~ 226 (380)
..
T Consensus 399 ~s 400 (560)
T KOG0600|consen 399 QS 400 (560)
T ss_pred cC
Confidence 64
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=263.54 Aligned_cols=211 Identities=21% Similarity=0.302 Sum_probs=168.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..++..++||||+++++|.+++.........+++..++.++.+|+.||.|||+.+ ++|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 132 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDI 132 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 56789999999999999999999999999999999998754344567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 133 KPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CHHHEEEcCCCCEEECcchhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9999999999999999999987643221 12233568889999999998889999999999999999999999986432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
.. .......+. ....+.+ .+......+.+++.+||+.+|.+|||+.+|++++.++.
T Consensus 211 ~~----~~~~~~~~~-------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 211 MN----LYSLCKKIE-------QCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ch----HHHHhhhhh-------cCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11 111111000 0000000 11234567889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=263.93 Aligned_cols=203 Identities=26% Similarity=0.409 Sum_probs=161.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|...+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 125 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125 (256)
T ss_pred HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36788999999999999999999999999999999999975 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|+|++ |..||..
T Consensus 126 l~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred cCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999875422111 11122345568999999988889999999999999999999 8889865
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.... ..+.... ... .... +......+.+|+.+||+.+|.+||++.+|++.|
T Consensus 205 ~~~~---~~~~~i~---~~~----~~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 205 KSNY---EVVEMIS---RGF----RLYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHH---HHHHHHH---CCC----CCCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 4321 1111111 100 0011 111235788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=286.05 Aligned_cols=213 Identities=28% Similarity=0.378 Sum_probs=171.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++++++|||||++||++.....++||||+|.||+|.+||.. .+..++..+.+.++.++|.||+|||.++ +||||
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRD 287 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRD 287 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---Ccchh
Confidence 46789999999999999999999999999999999999997 3446999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|-..|+|++.++.+||+|||+++...... .......-...|+|||++....|+.++|||||||++||+++ |..||..
T Consensus 288 IAARNcL~~~~~~vKISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 288 IAARNCLYSKKGVVKISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred HhHHHheecCCCeEEeCccccccCCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC
Confidence 99999999999999999999998532111 11111234578999999999999999999999999999998 7788876
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccCCC
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDP 237 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 237 (380)
...... ..++ ... ..+-..+...+..+..++.+||..+|++||+|.+|.+.|+.+......+
T Consensus 366 ~~~~~v---~~kI---~~~----------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 366 MKNYEV---KAKI---VKN----------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred CCHHHH---HHHH---Hhc----------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 543211 1111 011 1111222345667888999999999999999999999999987655443
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=264.15 Aligned_cols=205 Identities=26% Similarity=0.386 Sum_probs=163.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++...+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 129 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 56789999999999999999999999999999999999762 2356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.++|+|||++........ ........+..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 130 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 130 AARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred CcceEEEcCCCCEEECCcceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999986532211 11112223457999999998899999999999999999999 99998643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
... ...... ...... ..+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 209 ~~~---~~~~~~----~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 209 TNA---EVLQQV----DQGYRM----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CHH---HHHHHH----HcCCCC----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 221 111111 000000 1122335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=275.16 Aligned_cols=148 Identities=28% Similarity=0.410 Sum_probs=132.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrD 80 (380)
|+.++||||++++++|..++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+|+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~d 129 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRD 129 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 6788999999999999999999999999999999999975 45689999999999999999999974 6 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 130 lkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999998753221 123356899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=274.13 Aligned_cols=212 Identities=27% Similarity=0.403 Sum_probs=163.6
Q ss_pred ccCC-CCCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhcCCCC----------------------------------
Q 016913 2 LSLL-HHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPPD---------------------------------- 45 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~---------------------------------- 45 (380)
+.++ +||||++++++|... ...++||||+++++|.+++......
T Consensus 64 ~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred HHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 3455 799999999988654 5688999999999999998642110
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCc
Q 016913 46 -----------------------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 102 (380)
Q Consensus 46 -----------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla 102 (380)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a 220 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLA 220 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccc
Confidence 236899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCC
Q 016913 103 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRK 181 (380)
Q Consensus 103 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (380)
................++..|+|||++.+..++.++|||||||++|||++ |..||....... ..... .....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~----~~~~~- 293 (337)
T cd05054 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRR----LKEGT- 293 (337)
T ss_pred hhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHH----HhccC-
Confidence 86433222222233455678999999999999999999999999999998 999986532211 11111 11100
Q ss_pred CCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 182 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 182 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
. ...+......+.+|+.+||+.+|++||++.||++.|..+..
T Consensus 294 ~---------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 294 R---------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred C---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 01112334678899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=281.76 Aligned_cols=211 Identities=24% Similarity=0.355 Sum_probs=165.1
Q ss_pred ccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------------------------------
Q 016913 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------------------------ 44 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------------------ 44 (380)
|+++. |||||+++++|...+..|||||||++|+|.+++.....
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 94 MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred HHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 55675 99999999999999999999999999999999875210
Q ss_pred --------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 45 --------------------------------------------------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 45 --------------------------------------------------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
....+++..+..++.||+.||.||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 013588899999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ |+|+||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 254 H~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ 330 (400)
T cd05105 254 ASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330 (400)
T ss_pred HhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999999999999999997643322222223345678899999999889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++ |..||........ .... ....... ..+......+.+++.+||+.+|++|||+.+|+++|
T Consensus 331 ellt~g~~P~~~~~~~~~--~~~~----~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 331 EIFSLGGTPYPGMIVDST--FYNK----IKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHHHCCCCCCcccchhHH--HHHH----HhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 9997 8889865322111 1110 0110000 11223356788999999999999999999999999
Q ss_pred HHhh
Q 016913 228 TYLA 231 (380)
Q Consensus 228 ~~~~ 231 (380)
+.+.
T Consensus 395 ~~l~ 398 (400)
T cd05105 395 ESLL 398 (400)
T ss_pred HHHc
Confidence 8753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=265.16 Aligned_cols=206 Identities=23% Similarity=0.296 Sum_probs=162.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..+...++||||+++++|.+++.. .....+++..++.++.|++.||+|||+.+ |+|+|
T Consensus 46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 120 (277)
T cd05607 46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRD 120 (277)
T ss_pred HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEcc
Confidence 36788999999999999999999999999999999998865 23445899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||+++.++.++|+|||++...... .......|+..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 121 ikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 121 MKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998754322 1223456899999999999888999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
..... ............ ... . .......+.+|+.+||+.||++||+++|+++.+
T Consensus 198 ~~~~~--~~~~~~~~~~~~------~~~-~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 198 KEKVA--KEELKRRTLEDE------VKF-E----HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cchhh--HHHHHHHhhccc------ccc-c----cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 32111 111111111110 000 0 012345788999999999999999998876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=273.70 Aligned_cols=198 Identities=26% Similarity=0.303 Sum_probs=160.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++...+..|+||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dl 122 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDL 122 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCC
Confidence 5678999999999999999999999999999999999875 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++..... .........|+..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 123 kp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 123 KPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred CHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 99999999999999999999874211 1122334578999999999999999999999999999999999999997542
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. .......... .. .+......+.+++.+||+.+|.+||++.+.++.
T Consensus 201 ~~------~~~~~~~~~~----~~--------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 201 VA------EMYDNILHKP----LV--------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HH------HHHHHHHcCC----cc--------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 21 1111111110 00 111234578899999999999999988754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=263.25 Aligned_cols=204 Identities=25% Similarity=0.384 Sum_probs=161.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.+.||||+++++++. .+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|+|
T Consensus 49 ~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~d 120 (257)
T cd05116 49 VMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRD 120 (257)
T ss_pred HHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecc
Confidence 356789999999999986 4567899999999999999965 356899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||.||+++.++.+||+|||++.......... ......++..|+|||.+....++.++|||||||++|||++ |..||.
T Consensus 121 lkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 200 (257)
T cd05116 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200 (257)
T ss_pred cchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999997643322211 1122334578999999988889999999999999999998 999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
..... ....... .... ...+...+..+.+|+.+||+.+|++||++.+|++.|+.
T Consensus 201 ~~~~~---~~~~~i~----~~~~----------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 201 GMKGN---EVTQMIE----SGER----------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCHH---HHHHHHH----CCCC----------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 54321 1111111 1000 01122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=269.66 Aligned_cols=211 Identities=25% Similarity=0.398 Sum_probs=166.6
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
++.+ +||||+++++++......++||||+++++|.+++..... ....+++.+++.++.||+.||.||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 4556 799999999999999999999999999999999976321 124588999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ ++|+||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|
T Consensus 154 H~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 154 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred HHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999999999999999998653322222223344667899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+|++ |..||..... ......+... ... ..+......+.+|+.+||+.+|.+|||+.||++.|
T Consensus 231 el~~~g~~p~~~~~~------~~~~~~~~~~-~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 231 EIFTLGGSPYPGIPV------EELFKLLKEG-HRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHcCCCCCcccCCH------HHHHHHHHcC-CcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 9998 7777754321 1111111111 000 01123456788999999999999999999999999
Q ss_pred HHhhh
Q 016913 228 TYLAS 232 (380)
Q Consensus 228 ~~~~~ 232 (380)
..+..
T Consensus 294 ~~~~~ 298 (304)
T cd05101 294 DRILT 298 (304)
T ss_pred HHHHH
Confidence 88754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=270.19 Aligned_cols=208 Identities=25% Similarity=0.393 Sum_probs=164.5
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+++ +||||++++++|...+..++||||+.+++|.+++... ....+++.+++.++.+++.||.|||+.+ ++|+|
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~d 166 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRD 166 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhh
Confidence 5567 7999999999999999999999999999999999751 2234899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+|||++.++.++|+|||++................++..|+|||++....++.++|||||||++|+|++ |..||..
T Consensus 167 lkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 167 LAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred hccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 999999999999999999999976433222112223346778999999998899999999999999999998 8899864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
..... ..... ...... ...+......+.+++.+||+.+|++|||+.||++.|.++
T Consensus 247 ~~~~~--~~~~~----~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 247 MPVDS--KFYKL----IKEGYR----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCchH--HHHHH----HHcCCc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 43211 11111 111000 001112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=277.78 Aligned_cols=219 Identities=22% Similarity=0.246 Sum_probs=165.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||++++++......|+|||++. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrD 210 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRD 210 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678999999999999999999999999995 799999854 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.++|+|||++................||..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred CCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999997644333333334567999999999999999999999999999999999999999765
Q ss_pred CCCCCcchhhhhhhcccc-cCCCCCC-----------CCccccCCCC-------hhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 161 RPPGEHNLVAWARPLFKD-RRKFPKM-----------ADPLLQGRYP-------MRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~-~~~~~~~-----------~~~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
...........+...+.. ...++.. ........+. ......+.+++.+||+.+|++|||+.
T Consensus 291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~ 370 (392)
T PHA03207 291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370 (392)
T ss_pred CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence 443221111111100000 0000000 0000000000 11234677899999999999999999
Q ss_pred HHHHHH
Q 016913 222 DVVTAL 227 (380)
Q Consensus 222 evl~~L 227 (380)
||+..-
T Consensus 371 e~l~~p 376 (392)
T PHA03207 371 DILSLP 376 (392)
T ss_pred HHhhCc
Confidence 999753
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=271.79 Aligned_cols=202 Identities=25% Similarity=0.304 Sum_probs=158.8
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|..+ +||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrD 130 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRD 130 (332)
T ss_pred HHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecC
Confidence 4556 599999999999999999999999999999999975 466999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||+++....... .......||..|+|||++.+. .++.++||||||||+|||++|..||..
T Consensus 131 lkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 999999999999999999999975422211 122345689999999999865 478899999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
.........+ ...+.... + .++......+.+++.+||+.||++|| ++.++++
T Consensus 210 ~~~~~~~~~~--~~~~~~~~--------~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 210 EGERNTQSEV--SRRILKCD--------P----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCHHHH--HHHHhcCC--------C----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 4332221111 11111111 1 11223345778999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=263.77 Aligned_cols=209 Identities=26% Similarity=0.376 Sum_probs=164.3
Q ss_pred ccCCCCCCcccceEEEEeCCe------EEEEEeccCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQ------RLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~------~~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
|+.++||||+++++++..... .++||||+++++|..++.... .....+++..++.++.|++.||.|||+.+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~- 133 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN- 133 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 567899999999998866554 799999999999999986532 12346899999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT- 152 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt- 152 (380)
++|+||||+||++++++.+||+|||+++.+.............++..|+|||++....++.++|||||||++|||++
T Consensus 134 --i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 134 --FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred --eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999999999999999999986533322222222345678999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
|..||...... ....+.. . ... ...+......+.+++.+||+.+|.+|||+.||++.|+.+
T Consensus 212 g~~p~~~~~~~---~~~~~~~---~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 212 GQTPYPGVENH---EIYDYLR---H-GNR----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCCHH---HHHHHHH---c-CCC----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88888653321 1111111 0 000 011223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=262.80 Aligned_cols=206 Identities=23% Similarity=0.391 Sum_probs=162.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++.. ...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 48 ~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 120 (257)
T cd05115 48 IMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRD 120 (257)
T ss_pred HHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecc
Confidence 3678899999999999864 578999999999999999975 3457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccc-cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||+|||++.++.+||+|||++........... .....++..|+|||++....++.++||||||+++|+|++ |..||.
T Consensus 121 lkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred cchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 999999999999999999999975432221111 122233578999999988889999999999999999996 999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
...... ..... ..... ...+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 201 ~~~~~~---~~~~~----~~~~~----------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 201 KMKGPE---VMSFI----EQGKR----------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCHHH---HHHHH----HCCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 543221 11111 11100 111223456888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=267.95 Aligned_cols=213 Identities=26% Similarity=0.410 Sum_probs=166.1
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
|+.+ +||||++++++|...+..++||||+++++|.+++..... ....+++.+++.++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 3455 699999999999999999999999999999999976321 124589999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ ++|+||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|
T Consensus 151 H~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 151 ESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred HHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 9999 9999999999999999999999999998643222111112223456799999999889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+|++ |..||....... ..... ..... ...+......+.+++.+||+.+|++|||+.+|++.|
T Consensus 228 el~~~g~~p~~~~~~~~---~~~~~----~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 228 EIFTLGGSPYPGIPVEE---LFKLL----REGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHhCCCCCCCCCCHHH---HHHHH----HcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999 888886432211 11111 01000 011223456788999999999999999999999999
Q ss_pred HHhhhcc
Q 016913 228 TYLASQT 234 (380)
Q Consensus 228 ~~~~~~~ 234 (380)
..+....
T Consensus 291 ~~~~~~~ 297 (314)
T cd05099 291 DKVLAAV 297 (314)
T ss_pred HHHHHHh
Confidence 9886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=266.28 Aligned_cols=207 Identities=25% Similarity=0.366 Sum_probs=161.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
|+.++||||+++++++.+.+..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ ++|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH 139 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIH 139 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eee
Confidence 5688999999999999999999999999999999999976321 1235899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCC---CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CC
Q 016913 79 RDLKSSNILLDEGF---HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154 (380)
Q Consensus 79 rDIkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~ 154 (380)
+||||+|||++.++ .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 140 ~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~ 219 (277)
T cd05036 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219 (277)
T ss_pred cccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999998654 589999999986422211111122334568999999999999999999999999999997 88
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.||....... ..... ... . ....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 220 ~pf~~~~~~~---~~~~~---~~~-~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 220 MPYPGRTNQE---VMEFV---TGG-G----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHH---HHHHH---HcC-C----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9987543221 11111 000 0 00112234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=264.59 Aligned_cols=207 Identities=28% Similarity=0.417 Sum_probs=161.2
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
++++ +||||++++++|...+..++||||+++++|.+++..... ....+++.+++.++.|++.||+||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4566 799999999999999999999999999999999976321 123588999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ ++|+||||+|||+++++.+||+|||++..... .........+..|+|||++....++.++||||||+++|
T Consensus 129 H~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 129 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred HHCC---EeecccccceEEEcCCCeEEECCCCCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 9999 99999999999999999999999999863211 11111123356799999998889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++ |..||...... ...... ... ... ..+......+.+|+.+||+.+|.+|||+.+|++.|
T Consensus 203 el~~~g~~pf~~~~~~---~~~~~~---~~~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 203 EIVSLGGTPYCGMTCA---ELYEKL---PQG-YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred HHHcCCCCCccccCHH---HHHHHH---hCC-CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 9997 99998643221 111111 000 000 01112345688999999999999999999999999
Q ss_pred HHhh
Q 016913 228 TYLA 231 (380)
Q Consensus 228 ~~~~ 231 (380)
..+.
T Consensus 266 ~~~~ 269 (270)
T cd05047 266 NRML 269 (270)
T ss_pred HHhh
Confidence 8763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=276.77 Aligned_cols=199 Identities=29% Similarity=0.374 Sum_probs=170.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++++||.++|+.+..+..++|+||||.||++.++|.. +..+++..+.-++.+++.||.|||.++ .+|||
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrD 136 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRD 136 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eeccc
Confidence 36788999999999999999999999999999999999976 455588888899999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+.||||.+++.+||+|||++..+.... .....++||+.|||||++....|+.|+||||||++.+||.+|.+|+...
T Consensus 137 IKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 137 IKAANILLSESGDVKLADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred ccccceeEeccCcEEEEecceeeeeechh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 99999999999999999999998654322 2335688999999999999889999999999999999999999999887
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.+.-. + ..+++-..|.+.+ .....+.+++..||.+||+.||++.++++
T Consensus 215 hPmrv---------l----flIpk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 215 HPMRV---------L----FLIPKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CcceE---------E----EeccCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 76321 1 1234444555554 33567889999999999999999999985
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=261.35 Aligned_cols=207 Identities=31% Similarity=0.419 Sum_probs=167.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-----KEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
++.++|+||+++++++..+...++||||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ +
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i 126 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---F 126 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---c
Confidence 56788999999999999999999999999999999999873211 477999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~ 155 (380)
+|+||+|+||+++.++.++|+|||.+................++..|+|||.+....++.++||||||+++|+|++ |..
T Consensus 127 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987544332223344567889999999998899999999999999999999 589
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
||...... ...... .. .. ....+...+..+.+++.+||+.+|.+|||+.+|+..|+
T Consensus 207 p~~~~~~~---~~~~~~---~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 207 PYPGLSNE---EVLEYL---RK-GY----------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCHH---HHHHHH---Hc-CC----------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 98765221 111111 10 00 01112233568889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=264.04 Aligned_cols=211 Identities=21% Similarity=0.336 Sum_probs=168.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 131 (267)
T cd08228 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRD 131 (267)
T ss_pred HHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCC
Confidence 367889999999999999999999999999999999998754444566899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 132 l~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 132 IKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 99999999999999999999987643211 1122356888999999999888999999999999999999999998543
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
.. ....+...+.. ...+. . .+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 210 ~~----~~~~~~~~~~~--~~~~~----~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 210 KM----NLFSLCQKIEQ--CDYPP----L----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred cc----cHHHHHHHHhc--CCCCC----C----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 21 11111111110 00111 1 1122346788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=264.07 Aligned_cols=207 Identities=26% Similarity=0.382 Sum_probs=163.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
|+.++||||++++++|...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H 129 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIH 129 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 5788999999999999999999999999999999999975321 2245889999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCC-----CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-
Q 016913 79 RDLKSSNILLDEGF-----HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT- 152 (380)
Q Consensus 79 rDIkp~NILl~~~~-----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt- 152 (380)
+||||+||+++.++ .++|+|||++................++..|+|||++.+..++.++|||||||++|+|++
T Consensus 130 ~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~ 209 (269)
T cd05044 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209 (269)
T ss_pred CCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHc
Confidence 99999999999877 899999999975433222222233456788999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|..||...... ....... .... ...+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 210 g~~p~~~~~~~---~~~~~~~----~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 210 GQQPYPALNNQ---EVLQHVT----AGGR----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCCCCcccCHH---HHHHHHh----cCCc----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99998643221 1111110 0000 0112234567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=277.98 Aligned_cols=216 Identities=19% Similarity=0.212 Sum_probs=159.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.|+|||||+++++|..+...++|+|++. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrD 207 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRD 207 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 4678999999999999999999999999995 899998865 457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|||++|..||-..
T Consensus 208 iKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 208 IKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred CChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 99999999999999999999997532111 11223457999999999999989999999999999999999999776432
Q ss_pred CCCCC----cchhhhhhhcccc-cCCCCC-----------------CCCccccCCC--ChhhHHHHHHHHHHhhhhCCCC
Q 016913 161 RPPGE----HNLVAWARPLFKD-RRKFPK-----------------MADPLLQGRY--PMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 161 ~~~~~----~~~~~~~~~~~~~-~~~~~~-----------------~~~~~l~~~~--~~~~~~~l~~li~~cl~~~P~~ 216 (380)
..... ......+...... ...++. ...+...... .......+.+|+.+||+.||.+
T Consensus 287 ~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~ 366 (391)
T PHA03212 287 DGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHH 366 (391)
T ss_pred ccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhh
Confidence 21110 0000000000000 000000 0000000000 0123457889999999999999
Q ss_pred CCCHHHHHH
Q 016913 217 RPLIGDVVT 225 (380)
Q Consensus 217 RPt~~evl~ 225 (380)
|||+.|+++
T Consensus 367 Rpta~elL~ 375 (391)
T PHA03212 367 RPSAEALLD 375 (391)
T ss_pred CCCHHHHhc
Confidence 999999986
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=269.62 Aligned_cols=194 Identities=27% Similarity=0.411 Sum_probs=157.3
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
.++||||+++++++.+++..|+||||+.+++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp 124 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKL 124 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCH
Confidence 45899999999999999999999999999999999975 467899999999999999999999999 99999999
Q ss_pred CcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCC
Q 016913 84 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163 (380)
Q Consensus 84 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~ 163 (380)
+|||++.++.++|+|||+++..... ........||..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 125 DNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred HHeEECCCCCEEeCccCCCeecccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999998742211 12233467899999999999999999999999999999999999999743221
Q ss_pred CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 016913 164 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG-DVV 224 (380)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-evl 224 (380)
... ..+..... .++......+.+++.+||+.||.+||++. +|+
T Consensus 203 ---~~~---~~~~~~~~------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 203 ---ELF---ESIRVDTP------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---HHH---HHHHhCCC------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111 11111111 11122345778999999999999999985 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=265.97 Aligned_cols=214 Identities=23% Similarity=0.399 Sum_probs=163.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------KEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
|+.++||||+++++++..++..++||||+++++|.+++...... ...+++.+++.++.|++.||+|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-- 150 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-- 150 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 56789999999999999999999999999999999999763211 234788999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh--
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-- 152 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-- 152 (380)
++|+||||+|||++.++.++|+|||++..+.............++..|++||+.....++.++|||||||++|||++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred -eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999975432221112222344678999999988899999999999999999998
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|..||........ +......+..... ... ...+...+..+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 230 ~~~p~~~~~~~~~---~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 230 KEQPYSQLSDEQV---IENTGEFFRDQGR--QVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCccccChHHH---HHHHHHHHhhccc--ccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 6677764322111 1111111111000 000 0111233467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.09 Aligned_cols=207 Identities=29% Similarity=0.479 Sum_probs=163.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-----------KEPLDWNTRMKIAAGAAKGLEYLHD 70 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~ 70 (380)
|+.++||||+++++++..++..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 57789999999999999999999999999999999999763211 1358999999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHH
Q 016913 71 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 71 ~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~el 150 (380)
.+ ++|+||||+|||+++++.+||+|||++................++..|+|||++.+..++.++|||||||++|||
T Consensus 141 ~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 141 LH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred CC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 99 999999999999999999999999999754322221222333456789999999998999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 151 IT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 151 lt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
++ |..||........ .... ...... ..+...+..+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 218 ~~~g~~p~~~~~~~~~---~~~~----~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 218 FTYGKQPWYQLSNTEA---IECI----TQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCCCCCCccCCHHHH---HHHH----HcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 98 8888864332211 1111 000000 011123456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.38 Aligned_cols=212 Identities=23% Similarity=0.375 Sum_probs=176.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||.++.||||++|.|++....-+.||+|||++|+|+.+|.. +.+.|++.++..++.+|+.|++||-+.+ +||||
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRD 756 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRD 756 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhh
Confidence 67899999999999999999999999999999999999987 4566999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccc-cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|...||||+.+..+||+|||+++...+...... +....-..+|.|||.+..++++.++|||||||||||+++ |..||=
T Consensus 757 LAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred hhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 999999999999999999999997654432222 222333579999999999999999999999999999986 777764
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccC
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 235 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 235 (380)
.+... +++.. ++.-++-+.|++++..|.+|++.|||++-..||++.+|+.+|.++..+..
T Consensus 837 dmSNQ---dVIka--------------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 837 DMSNQ---DVIKA--------------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ccchH---HHHHH--------------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 33221 22211 11222334566788999999999999999999999999999999876543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=262.74 Aligned_cols=203 Identities=26% Similarity=0.394 Sum_probs=161.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 125 (256)
T cd05059 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125 (256)
T ss_pred HHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 35778999999999999999999999999999999999975 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.+||+|||+++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 126 l~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred ccHhhEEECCCCcEEECCcccceeccccc-ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 99999999999999999999997543211 111122234567999999998899999999999999999998 7888875
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
..... ..... ... + ....+...+..+.+|+.+||..+|++|||+.+|++.|
T Consensus 205 ~~~~~---~~~~~---~~~---~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 205 FSNSE---VVESV---SAG---Y--------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHH---HHHHH---HcC---C--------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 43211 11111 000 0 0011122456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=280.92 Aligned_cols=219 Identities=21% Similarity=0.261 Sum_probs=160.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++|+|||||++++++..++..++|||++. ++|.+++.. ....+++..++.|+.||+.||.|||+.+ |||||
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrD 285 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRD 285 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECc
Confidence 4678999999999999999999999999995 899998865 2347999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC-C
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID-N 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~-~ 159 (380)
|||+||||+.++.+||+|||+++...............||..|+|||++.+..++.++||||||||+|||++|..++- .
T Consensus 286 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred CCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccC
Confidence 999999999999999999999976433222222334679999999999999999999999999999999999876543 2
Q ss_pred CCCCCC----cchhhhhhhcccccCCCCCCCCc------------cccCCCC-------hhhHHHHHHHHHHhhhhCCCC
Q 016913 160 TRPPGE----HNLVAWARPLFKDRRKFPKMADP------------LLQGRYP-------MRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 160 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~------------~l~~~~~-------~~~~~~l~~li~~cl~~~P~~ 216 (380)
...... ..+...+.........++..... ....... ......+.+|+.+||+.||.+
T Consensus 366 ~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~ 445 (461)
T PHA03211 366 SRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGAR 445 (461)
T ss_pred CcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhh
Confidence 211111 11111111100000001100000 0000000 012236788999999999999
Q ss_pred CCCHHHHHHH
Q 016913 217 RPLIGDVVTA 226 (380)
Q Consensus 217 RPt~~evl~~ 226 (380)
|||+.||++.
T Consensus 446 RPsa~elL~h 455 (461)
T PHA03211 446 RPSAAELLRL 455 (461)
T ss_pred CcCHHHHhhC
Confidence 9999999974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=262.72 Aligned_cols=211 Identities=22% Similarity=0.303 Sum_probs=158.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|......|+||||+++++|.+++.........+++..++.++.||+.||+|||+.+ ++|+||
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~di 125 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDL 125 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 56789999999999999999999999999999999999863333445778888999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-------CCCCCcCceeehHHHHHHHHhC-
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVFLELITG- 153 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~SlGvvl~elltG- 153 (380)
||+|||++.++.++|+|||++................++..|+|||++.. ..++.++||||||+++|||+++
T Consensus 126 kp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 126 ALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred ccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 99999999999999999999864222111112234567889999998753 2457899999999999999974
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
..||....... ........ ......++.+.. .....+.+++..|| .+|.+||++.+|++.|.
T Consensus 206 ~~p~~~~~~~~------~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 206 AQPYSHLSDRE------VLNHVIKD--QQVKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCCHHH------HHHHHHhh--cccccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 56775432211 11111111 111222232222 23456778999999 67999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=270.43 Aligned_cols=193 Identities=27% Similarity=0.411 Sum_probs=157.3
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||||+++++++...+..|+||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~N 126 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDN 126 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHH
Confidence 799999999999999999999999999999999876 457999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~ 165 (380)
||+++++.+||+|||++...... ........|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 127 ill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-- 202 (318)
T cd05570 127 VLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-- 202 (318)
T ss_pred eEECCCCcEEecccCCCeecCcC--CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--
Confidence 99999999999999998642111 11223356899999999999999999999999999999999999999743211
Q ss_pred cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 016913 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI-----GDVVT 225 (380)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 225 (380)
.....+...... ++......+.+|+.+||+.+|.+||++ .+++.
T Consensus 203 ----~~~~~i~~~~~~------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 203 ----ELFQSILEDEVR------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ----HHHHHHHcCCCC------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111111111111 122234678899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=263.62 Aligned_cols=211 Identities=26% Similarity=0.334 Sum_probs=157.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++.++||||++++++|.+....++||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ |+|||
T Consensus 49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 125 (269)
T cd05042 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSD 125 (269)
T ss_pred HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---Eeccc
Confidence 4678999999999999999999999999999999999976332 1234578889999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-------CCCCCcCceeehHHHHHHHHh-
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVFLELIT- 152 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~SlGvvl~ellt- 152 (380)
|||+|||++.++.+||+|||++................++..|+|||++.. ..++.++|||||||++|||++
T Consensus 126 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05042 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205 (269)
T ss_pred ccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhC
Confidence 999999999999999999999875322211111233445678999999753 356889999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|..||....... ..... .... ......+.+ +......+.+++..|+ .+|++|||+++|++.|.
T Consensus 206 ~~~p~~~~~~~~---~~~~~--~~~~---~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 206 ADQPYPDLSDEQ---VLKQV--VREQ---DIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCCCcCCHHH---HHHHH--hhcc---CccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 777886442211 11100 0000 111112222 2233456677888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=274.84 Aligned_cols=201 Identities=25% Similarity=0.305 Sum_probs=162.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|..++||||+++++++.+++..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||..+ |+||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dl 127 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDI 127 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5678999999999999999999999999999999999976 367999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCC---------------------------CccccccccccccccchhhhhcCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGD---------------------------KTHVSTRVMGTYGYCAPEYAMTGQL 134 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 134 (380)
||+||||+.++.+||+|||++....... .........||+.|+|||++.+..+
T Consensus 128 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (350)
T cd05573 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY 207 (350)
T ss_pred CHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC
Confidence 9999999999999999999997643322 0011234568999999999999999
Q ss_pred CCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhccc--ccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhh
Q 016913 135 TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK--DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQE 212 (380)
Q Consensus 135 s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~ 212 (380)
+.++|||||||++|||++|..||........ ...+.. ....++.. ......+.+|+.+||+
T Consensus 208 ~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~~p~~----------~~~~~~~~~li~~ll~- 270 (350)
T cd05573 208 GLECDWWSLGVILYEMLYGFPPFYSDTLQET------YNKIINWKESLRFPPD----------PPVSPEAIDLICRLLC- 270 (350)
T ss_pred CCceeeEecchhhhhhccCCCCCCCCCHHHH------HHHHhccCCcccCCCC----------CCCCHHHHHHHHHHcc-
Confidence 9999999999999999999999975432111 111111 00011110 1134678899999997
Q ss_pred CCCCCCC-HHHHHHH
Q 016913 213 QAATRPL-IGDVVTA 226 (380)
Q Consensus 213 ~P~~RPt-~~evl~~ 226 (380)
+|.+||+ +.+|++.
T Consensus 271 dp~~R~~s~~~ll~h 285 (350)
T cd05573 271 DPEDRLGSFEEIKSH 285 (350)
T ss_pred ChhhcCCCHHHHhcC
Confidence 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=270.14 Aligned_cols=212 Identities=27% Similarity=0.413 Sum_probs=165.3
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
++.+ +||||++++++|...+..|+||||+++++|.+++..... ....+++.+++.++.|++.||+||
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4455 799999999999999999999999999999999976321 123589999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ ++|+||||+|||++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|
T Consensus 157 H~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 157 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred HHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999987543221111122233456899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+|++ |..||...... .... .+ ..... ...+......+.+|+.+||..+|.+|||+.+|++.|
T Consensus 234 el~~~g~~p~~~~~~~---~~~~---~~-~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 234 EIFTLGGSPYPGVPVE---ELFK---LL-KEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHcCCCCCCCcCCHH---HHHH---HH-HcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9998 78888643211 1111 11 00000 011223356788999999999999999999999999
Q ss_pred HHhhhc
Q 016913 228 TYLASQ 233 (380)
Q Consensus 228 ~~~~~~ 233 (380)
..+...
T Consensus 297 ~~~~~~ 302 (307)
T cd05098 297 DRILAL 302 (307)
T ss_pred HHHHHH
Confidence 987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=262.91 Aligned_cols=211 Identities=27% Similarity=0.360 Sum_probs=159.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++.++||||+++++++.+....++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 125 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSD 125 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---Eeccc
Confidence 5678999999999999999999999999999999999975322 2235678888999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-------CCCCcCceeehHHHHHHHHh-
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-------QLTLKSDVYSFGVVFLELIT- 152 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~SlGvvl~ellt- 152 (380)
|||+||+++.++.++|+|||++................++..|+|||++... .++.++||||||+++|||++
T Consensus 126 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05087 126 LALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205 (269)
T ss_pred cCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhC
Confidence 9999999999999999999999753322221222335577889999998642 35789999999999999996
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|..||....... ...... .. .......+.+. ......+.+|+.+|+ .+|++|||+.||+..|+
T Consensus 206 g~~p~~~~~~~~---~~~~~~--~~---~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 206 GSQPYRHLSDEQ---VLTYTV--RE---QQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCCChHH---HHHHHh--hc---ccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 999997543221 111110 00 01111222221 122346778999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=270.28 Aligned_cols=211 Identities=26% Similarity=0.394 Sum_probs=165.5
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
++++ +||||++++++|..++..++||||+++++|.+++..... ....+++.+++.++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4556 799999999999999999999999999999999976321 123588999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ ++|+||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|
T Consensus 151 H~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 151 ASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred HHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 9999 9999999999999999999999999997643222111222233456899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++ |..||..... ......+.. ... ...+......+.+|+.+||+.+|.+|||+.||++.|
T Consensus 228 el~~~g~~p~~~~~~------~~~~~~~~~-~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 228 EIFTLGGSPYPGIPV------EELFKLLKE-GHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHhcCCCCCCCCCH------HHHHHHHHc-CCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9998 7888864322 111111111 000 011223346788999999999999999999999999
Q ss_pred HHhhh
Q 016913 228 TYLAS 232 (380)
Q Consensus 228 ~~~~~ 232 (380)
..+..
T Consensus 291 ~~~~~ 295 (334)
T cd05100 291 DRVLT 295 (334)
T ss_pred HHHhh
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=262.54 Aligned_cols=202 Identities=25% Similarity=0.398 Sum_probs=161.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|...+..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 126 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDL 126 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 6788999999999999998999999999999999999975 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||.||+++.++.+||+|||+++....... .......++..|++||++.+..++.++||||||+++|+|++ |..||...
T Consensus 127 ~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred CcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999999999875432211 11122345678999999998889999999999999999998 88998654
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.... ..... ...... ..+......+.+++.+||+.+|.+||++.+|++.|
T Consensus 206 ~~~~---~~~~~---~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 206 NNSE---TVEKV---SQGLRL-----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CHHH---HHHHH---hcCCCC-----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 3211 11111 111000 01112346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=269.60 Aligned_cols=194 Identities=28% Similarity=0.413 Sum_probs=157.1
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
.++||||+++++++.+.+.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp 124 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKL 124 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCH
Confidence 35899999999999999999999999999999999975 457899999999999999999999999 99999999
Q ss_pred CcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCC
Q 016913 84 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163 (380)
Q Consensus 84 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~ 163 (380)
+|||++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (316)
T cd05619 125 DNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202 (316)
T ss_pred HHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999987422111 1223456899999999999989999999999999999999999999754321
Q ss_pred CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 016913 164 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG-DVV 224 (380)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-evl 224 (380)
...... .... +. ++......+.+++.+||+.+|++||++. ++.
T Consensus 203 ---~~~~~i---~~~~--------~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 203 ---ELFQSI---RMDN--------PC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ---HHHHHH---HhCC--------CC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111111 1010 10 1112335678999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=262.80 Aligned_cols=206 Identities=26% Similarity=0.396 Sum_probs=164.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl 133 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDL 133 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 5788999999999999999999999999999999999975 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccc-cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
||+||+++.++.++|+|||++........... ......+..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 134 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 134 AARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred chhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999976432221111 111223457999999998899999999999999999997 9999864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
.... ...... . ..... ..+......+.+++.+||+.+|++||++.+|++.|..+
T Consensus 214 ~~~~---~~~~~i---~-~~~~~----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 214 MSNH---EVMKAI---N-DGFRL----------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCHH---HHHHHH---h-cCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3221 111111 1 10000 11123356788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=269.46 Aligned_cols=195 Identities=27% Similarity=0.351 Sum_probs=155.4
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||||+.+++++...+.+|+||||+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~N 126 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDN 126 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 799999999999999999999999999999999875 457999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~ 165 (380)
||++.++.+||+|||++..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 127 ili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~ 204 (327)
T cd05617 127 VLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204 (327)
T ss_pred EEEeCCCCEEEeccccceeccC--CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc
Confidence 9999999999999999874211 11222346789999999999999999999999999999999999999974332221
Q ss_pred cchhhhhhhcc-cccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 166 HNLVAWARPLF-KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 166 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
.....+..... .... ..|......+.+++.+||+.||.+|+++.
T Consensus 205 ~~~~~~~~~~~~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 205 MNTEDYLFQVILEKPI------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred cccHHHHHHHHHhCCC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11111111111 1111 11222345678999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=258.05 Aligned_cols=201 Identities=26% Similarity=0.344 Sum_probs=163.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl 127 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDI 127 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 67889999999999999999999999999999999999862 2457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 128 ~~~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred CcceEEEeCCCCEEEcccccceeccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987643221 12233568889999999999999999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. ...... .. ...+. .+......+.+++.+||+.+|++||++.+|++.
T Consensus 206 ~~---~~~~~~---~~--~~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 206 QG---ALILKI---IR--GVFPP---------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HH---HHHHHH---Hc--CCCCC---------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11 111111 11 00111 111234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=272.95 Aligned_cols=217 Identities=23% Similarity=0.324 Sum_probs=157.0
Q ss_pred CccCCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|++++||||+++++++...+ ..|+|||||. ++|.+++.. ...+++..+..++.||+.||.|||+.+
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--- 123 (338)
T cd07859 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN--- 123 (338)
T ss_pred HHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 367889999999999886432 4799999995 799999875 456999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHh
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~ellt 152 (380)
|+||||||+|||++.++.+||+|||+++........ .......|+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 124 ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc
Confidence 999999999999999999999999999753222111 11234578999999999876 678999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhh---------hhcccc--c---CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 153 GRKAIDNTRPPGEHNLVAWA---------RPLFKD--R---RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~---------~~~~~~--~---~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
|+.||...........+... ..+... . ..+.......+...+ ......+.+++.+||+.+|++||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp 282 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRP 282 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCC
Confidence 99999754321110000000 000000 0 000000000000000 12235678999999999999999
Q ss_pred CHHHHHHH
Q 016913 219 LIGDVVTA 226 (380)
Q Consensus 219 t~~evl~~ 226 (380)
|+.||++.
T Consensus 283 t~~e~l~h 290 (338)
T cd07859 283 TAEEALAD 290 (338)
T ss_pred CHHHHhcC
Confidence 99999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=267.55 Aligned_cols=208 Identities=27% Similarity=0.404 Sum_probs=162.3
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
++++ +||||+++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456 799999999999999999999999999999999975321 123588999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ ++|+||||+|||++.++.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|
T Consensus 136 H~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 136 SEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred HHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 9999 999999999999999999999999998642111 0111122345799999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++ |..||....... ... .+... +....+......+.+|+.+||+.+|.+||++++|++.|
T Consensus 210 el~t~g~~pf~~~~~~~---~~~---~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 210 EIVSLGGTPYCGMTCAE---LYE---KLPQG-----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred HHHcCCCCCCCCCCHHH---HHH---HHhcC-----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9997 999996543211 111 11000 00011122346788999999999999999999999999
Q ss_pred HHhhh
Q 016913 228 TYLAS 232 (380)
Q Consensus 228 ~~~~~ 232 (380)
..+..
T Consensus 273 ~~~~~ 277 (297)
T cd05089 273 SRMLE 277 (297)
T ss_pred HHHHH
Confidence 87754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=263.92 Aligned_cols=211 Identities=26% Similarity=0.416 Sum_probs=167.0
Q ss_pred ccCCCCCCcccceEEEEe-CCeEEEEEeccCCCCHHHHHhcCCCCC----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDK----EPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~----~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|+.++||||+++++++.. +...++++||+++++|.+++....... ..+++.+++.++.|++.||+|||+.+ +
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i 138 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---V 138 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999998776 467899999999999999997632221 56899999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~ 155 (380)
+|+||||+||++++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++||+++ |..
T Consensus 139 ~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 218 (280)
T cd05043 139 IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218 (280)
T ss_pred eecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCC
Confidence 9999999999999999999999999986533322222233456778999999998899999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
||....+. ....+.. ....+. .+...+..+.+++.+||+.+|++|||+.+|++.|..+..
T Consensus 219 p~~~~~~~---~~~~~~~----~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 219 PYVEIDPF---EMAAYLK----DGYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CcCcCCHH---HHHHHHH----cCCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99754332 1121111 110000 111234578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=262.97 Aligned_cols=209 Identities=25% Similarity=0.359 Sum_probs=161.1
Q ss_pred ccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
|+.++||||+++++++... ...++||||+.+++|.+++.... .....+++..++.++.|++.||.|||+.+
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~- 132 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS- 132 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5678999999999987542 24689999999999999885321 22355899999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT- 152 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt- 152 (380)
|+|+||||+|||+++++.++|+|||++..+.............++..|++||++....++.++||||||+++|||++
T Consensus 133 --i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 133 --FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred --eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999986533222111223345678999999999899999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
|..||...... ...... ...... ..+......+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 211 g~~p~~~~~~~---~~~~~~----~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 211 GQTPYPGVENS---EIYDYL----RQGNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCHH---HHHHHH----HcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 78888643221 111111 111110 01123345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=266.14 Aligned_cols=214 Identities=22% Similarity=0.309 Sum_probs=157.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++.+++..++||||+. ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+|||
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 128 (303)
T cd07869 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRD 128 (303)
T ss_pred HHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 3578899999999999999999999999995 788888865 3456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||++...... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 129 lkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 129 LKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCHHHEEECCCCCEEECCCCcceeccCC--CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998753221 112233567899999999875 4588899999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccc--------cCCCCCCCCccccCCCC---------hhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 160 TRPPGEHNLVAWARPLFKD--------RRKFPKMADPLLQGRYP---------MRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~~~~---------~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
.... ............. ....+......+....+ ......+.+|+.+||+.||++|||+.|
T Consensus 207 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~ 284 (303)
T cd07869 207 MKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA 284 (303)
T ss_pred CccH--HHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH
Confidence 4221 1111100000000 00000000000000000 012346789999999999999999999
Q ss_pred HHH
Q 016913 223 VVT 225 (380)
Q Consensus 223 vl~ 225 (380)
+++
T Consensus 285 ~l~ 287 (303)
T cd07869 285 ALS 287 (303)
T ss_pred Hhc
Confidence 986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=273.09 Aligned_cols=205 Identities=28% Similarity=0.383 Sum_probs=161.2
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
||++++|||||+|+++..+. +.+|||+|||..|.+...- ..+..|++.++.+++.+++.||+|||.++ |||
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiH 233 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIH 233 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eec
Confidence 58999999999999998664 5789999999988775432 22333999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCC---CccccccccccccccchhhhhcCC----CCCcCceeehHHHHHHHH
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~SlGvvl~ell 151 (380)
|||||+|+||++++.+||+|||.+..+..+. .........||+.|+|||...++. -+.+.||||+||+||.|+
T Consensus 234 RDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll 313 (576)
T KOG0585|consen 234 RDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL 313 (576)
T ss_pred cccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence 9999999999999999999999998753332 112234578999999999988742 357899999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 152 TGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 152 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.|+.||-... .......+..+.-.++. ..+....+.+||.+||++||+.|.++.+|.....
T Consensus 314 fG~~PF~~~~------~~~l~~KIvn~pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 314 FGQLPFFDDF------ELELFDKIVNDPLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred hccCCcccch------HHHHHHHHhcCcccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 9999996432 22222222332222222 2244678889999999999999999999977653
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=260.63 Aligned_cols=204 Identities=26% Similarity=0.448 Sum_probs=162.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.+.|||||++++++. .+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||..+ ++|+||
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di 121 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDL 121 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCc
Confidence 56789999999999876 4568999999999999999976 347899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccc-cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
||+|||++.++.+||+|||+++.......... .....++..|+|||.+....++.++||||||+++|+|++ |..||..
T Consensus 122 ~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred ccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999986533222111 112234567999999998899999999999999999998 9999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
... .....+... ... . ..+......+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 202 ~~~---~~~~~~~~~----~~~---~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 202 MKG---AEVIAMLES----GER---L-------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCH---HHHHHHHHc----CCc---C-------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 432 122222211 000 0 11223346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=263.59 Aligned_cols=214 Identities=21% Similarity=0.362 Sum_probs=162.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------DKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
|++++||||+++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 149 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN- 149 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 6789999999999999999999999999999999999965210 1124789999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT- 152 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt- 152 (380)
++|+||||+||+++.++.+||+|||++................++..|+|||++....++.++|||||||++|+|++
T Consensus 150 --i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 150 --FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred --eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999976433222222233445778999999998899999999999999999998
Q ss_pred -CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 153 -GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 153 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
+..||...... ..+......+......... ..+...+..+.+|+.+||+.+|++||++.+|++.|+
T Consensus 228 ~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 228 CKEQPYSLLSDE---QVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCCcccChH---HHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 55666543221 1111111111100000000 011123468999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=272.86 Aligned_cols=202 Identities=25% Similarity=0.269 Sum_probs=159.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+.+..||||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dl 128 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDI 128 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccC
Confidence 5678999999999999999999999999999999999976 2357999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh------cCCCCCcCceeehHHHHHHHHhCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM------TGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
||+|||++.++.+||+|||++........ .......||+.|+|||++. ...++.++|||||||++|||++|..
T Consensus 129 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 129 KPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred chHheEECCCCCEEeccCCCCeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence 99999999999999999999976432221 1223457899999999987 4567899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
||....... ....+..... .... +........+.+|+.+||+ +|.+|||+.+++.
T Consensus 208 Pf~~~~~~~------~~~~i~~~~~-~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 208 PFHEGTSAK------TYNNIMNFQR-FLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCHHH------HHHHHHcCCC-ccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 997543211 1111111100 0000 0111234678899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=263.81 Aligned_cols=207 Identities=25% Similarity=0.415 Sum_probs=163.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.. ...+++|||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 63 l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dl 135 (279)
T cd05109 63 MAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDL 135 (279)
T ss_pred HHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 467899999999999975 457899999999999999975 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 136 kp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 136 AARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986533222111222345678999999998899999999999999999998 88888643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
... ....+.. .....+ .+......+.+++.+||+.+|+.||++.+++..|..++.
T Consensus 216 ~~~---~~~~~~~----~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 216 PAR---EIPDLLE----KGERLP----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CHH---HHHHHHH----CCCcCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 221 1111111 100000 111234578899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=271.38 Aligned_cols=204 Identities=23% Similarity=0.296 Sum_probs=159.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|.+++..|||||||++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|||
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~D 126 (364)
T cd05599 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRD 126 (364)
T ss_pred HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 36678999999999999999999999999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCcc------------------------------------cccccccccccc
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH------------------------------------VSTRVMGTYGYC 124 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~------------------------------------~~~~~~gt~~y~ 124 (380)
|||+|||++.++.++|+|||++..+....... ......||+.|+
T Consensus 127 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 206 (364)
T cd05599 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI 206 (364)
T ss_pred CCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCcccc
Confidence 99999999999999999999987532211000 011246999999
Q ss_pred chhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHH
Q 016913 125 APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALA 204 (380)
Q Consensus 125 aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 204 (380)
|||++....++.++|||||||++|||++|..||........ . ..+......+ .. .........+.+
T Consensus 207 aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~---~---~~i~~~~~~~-~~-------~~~~~~s~~~~~ 272 (364)
T cd05599 207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET---Y---RKIINWKETL-QF-------PDEVPLSPEAKD 272 (364)
T ss_pred CHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH---H---HHHHcCCCcc-CC-------CCCCCCCHHHHH
Confidence 99999999999999999999999999999999975432111 1 1111100000 00 001122457788
Q ss_pred HHHHhhhhCCCCCCC---HHHHHHH
Q 016913 205 VAAMCLQEQAATRPL---IGDVVTA 226 (380)
Q Consensus 205 li~~cl~~~P~~RPt---~~evl~~ 226 (380)
++.+|+. +|.+|++ +.++++.
T Consensus 273 li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 273 LIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999996 9999998 7777663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=267.74 Aligned_cols=208 Identities=28% Similarity=0.406 Sum_probs=162.6
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
|.++ +||||+++++++..++..++||||+++++|.+++..... ....+++.+++.++.|++.||+||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 4556 899999999999999999999999999999999975321 123689999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ ++||||||+|||++.++.+||+|||++...... .......++..|+|||++....++.++|||||||++|
T Consensus 141 H~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 141 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred HhCC---ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 9999 999999999999999999999999998632110 1111223456899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++ |..||...... ..... .. ... ....+......+.+|+.+||+.+|++||++.++++.|
T Consensus 215 ellt~g~~p~~~~~~~---~~~~~---~~-~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 215 EIVSLGGTPYCGMTCA---ELYEK---LP-QGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred HHHhcCCCCcccCChH---HHHHH---Hh-cCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9998 99998643221 11111 10 000 0011122345688999999999999999999999999
Q ss_pred HHhhh
Q 016913 228 TYLAS 232 (380)
Q Consensus 228 ~~~~~ 232 (380)
..+..
T Consensus 278 ~~~~~ 282 (303)
T cd05088 278 NRMLE 282 (303)
T ss_pred HHHHH
Confidence 87643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=252.88 Aligned_cols=217 Identities=25% Similarity=0.318 Sum_probs=169.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+.++++|.+.+.+.||+|||+ .+|+..+++ ....|+...+..++.++++||+|||.+. |+|||
T Consensus 54 ~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRD 126 (318)
T KOG0659|consen 54 LLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRD 126 (318)
T ss_pred HHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhccc
Confidence 3678899999999999999999999999996 899999987 6678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||.|+|++.+|.+||+|||+++.+...+.. .+..+-|.+|.|||.+.+. .|+...|+||.|||+.||+-+.+.|.+
T Consensus 127 lKPnNLLis~~g~lKiADFGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG 204 (318)
T KOG0659|consen 127 LKPNNLLISSDGQLKIADFGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG 204 (318)
T ss_pred CCccceEEcCCCcEEeecccchhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence 9999999999999999999999986543322 2334779999999999875 799999999999999999999888876
Q ss_pred CCCCCCcchhhhhh-----hcccccCCCCCC------CCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWAR-----PLFKDRRKFPKM------ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~------~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
....+....+=.+. ..+.+-..++.. ..+.+.. +-..+...+++|+.+||.+||.+|+++.|++++=
T Consensus 205 ~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 205 DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred CchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 54432222211110 001111111111 1111111 2234556779999999999999999999998764
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=260.66 Aligned_cols=196 Identities=25% Similarity=0.433 Sum_probs=156.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+|||
T Consensus 52 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 125 (258)
T cd05078 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGN 125 (258)
T ss_pred HHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 35678999999999999999999999999999999999976 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCC--------eEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHH
Q 016913 81 LKSSNILLDEGFH--------PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 81 Ikp~NILl~~~~~--------~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~ell 151 (380)
|||+||+++.++. ++|+|||++..... .....++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 126 lkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~ 199 (258)
T cd05078 126 VCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF 199 (258)
T ss_pred CccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999987654 68999998864321 123457888999999986 45799999999999999999
Q ss_pred hCC-CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 152 TGR-KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 152 tG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+|. .||........ .. ...... .++......+.+|+.+||+.+|++|||+.+|++.|
T Consensus 200 ~g~~~~~~~~~~~~~---~~----~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 200 SGGDKPLSALDSQKK---LQ----FYEDRH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cCCCCChhhccHHHH---HH----HHHccc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 985 55543322110 11 011111 11222345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=250.76 Aligned_cols=213 Identities=23% Similarity=0.313 Sum_probs=169.6
Q ss_pred cCCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 3 SLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
++++||||++++++...+. +.||+++|+..|||.+.+....-.+..+++.+++.|+.+|++||++||+.. ||+.
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yA 151 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYA 151 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-Cccc
Confidence 5789999999999875443 489999999999999999987667778999999999999999999999985 7899
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccc-------cccccccccccchhhhhcC---CCCCcCceeehHHHH
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-------STRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVF 147 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlGvvl 147 (380)
||||||.|||+.+++.++|.|||.+......-.... ......|..|.|||.+... ..+++.|||||||++
T Consensus 152 H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 152 HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 999999999999999999999999976432211111 1235688999999998654 678999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 148 LELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
|.|+.|..||+.-...+..- ......+.+..+.....++.+.+|+.+||+.||.+||++.+++..+
T Consensus 232 Ya~mf~~sPfe~~~~~GgSl--------------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQQGGSL--------------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred HHHHHcCCcchHHhhcCCeE--------------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 99999999997432211100 0011222222222334678999999999999999999999999998
Q ss_pred HHh
Q 016913 228 TYL 230 (380)
Q Consensus 228 ~~~ 230 (380)
+.+
T Consensus 298 d~L 300 (302)
T KOG2345|consen 298 DDL 300 (302)
T ss_pred Hhh
Confidence 875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=259.84 Aligned_cols=202 Identities=29% Similarity=0.403 Sum_probs=160.1
Q ss_pred CccCCCCCCcccceEEEE-eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|+.++|+||+++++++. .++..++||||+++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++|+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 126 (256)
T cd05082 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126 (256)
T ss_pred HHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eecc
Confidence 367889999999999764 45678999999999999999976 22345899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
||||+||+++.++.+||+|||++...... .....++..|+|||++....++.++|||||||++|+|++ |..||.
T Consensus 127 dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 127 DLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred ccchheEEEcCCCcEEecCCccceecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998753221 122334568999999998899999999999999999997 888886
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... ........ .. .. ...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 202 ~~~~---~~~~~~~~---~~---~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 202 RIPL---KDVVPRVE---KG---YK--------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCH---HHHHHHHh---cC---CC--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 4321 11111111 00 00 01122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=259.34 Aligned_cols=201 Identities=26% Similarity=0.384 Sum_probs=163.6
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+++ -||||+++.++|+.+..+++|+|.|+.|.|.+||.. .-.+++.....|+.|+..|++|||..+ |||||
T Consensus 76 LRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRD 148 (411)
T KOG0599|consen 76 LRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRD 148 (411)
T ss_pred HHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcc
Confidence 4444 499999999999999999999999999999999976 678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC------CCCCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||+|||++++..+||+|||++.....+. .....+||++|+|||++.+. .|+...|+|++|||||-||.|.
T Consensus 149 LKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 149 LKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred cChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999998755433 34557899999999999764 5888999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+||-.... ++ ..+.+...... +-.| --.+......+||.+||+.||.+|.|++|+++.
T Consensus 226 pPFwHRkQ-----ml-MLR~ImeGkyq---F~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 226 PPFWHRKQ-----ML-MLRMIMEGKYQ---FRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred CchhHHHH-----HH-HHHHHHhcccc---cCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 99954311 11 11111111111 1111 112445678899999999999999999999864
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=258.35 Aligned_cols=209 Identities=22% Similarity=0.346 Sum_probs=168.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++|+||+++++++...+..++||||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl 132 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDI 132 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCc
Confidence 56789999999999999999999999999999999999764444567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 133 ~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 133 KPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 9999999999999999999987543221 11233567889999999998889999999999999999999999986432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCCh-hhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPM-RGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
. ........+.. .... ..+. .....+.+++.+||..+|++|||+.+|++.|+.+
T Consensus 211 ~----~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 211 M----NLYSLCKKIEK--CDYP---------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred c----cHHHHHhhhhc--CCCC---------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 11111111110 0011 1111 3345788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=260.50 Aligned_cols=202 Identities=25% Similarity=0.318 Sum_probs=161.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl 130 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDI 130 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5688999999999999999999999999999999999976 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccc-cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||+++.++.++|+|||++........... .....++..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 131 ~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 131 KGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred CHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 99999999999999999999875432111111 12345788999999999988999999999999999999999998643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
... ...... ... . .....+......+.+++.+||..+|.+|||+.+|++.
T Consensus 211 ~~~---~~~~~~---~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 211 EAM---AAIFKI---ATQ-P---------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred chH---HHHHHH---hcc-C---------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 221 111100 000 0 0011222345678899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=270.90 Aligned_cols=203 Identities=20% Similarity=0.253 Sum_probs=160.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++.+++..|+||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+|||
T Consensus 96 il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 167 (370)
T cd05596 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRD 167 (370)
T ss_pred HHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 35778999999999999999999999999999999999965 45889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC----CCCCcCceeehHHHHHHHHhCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||+|||++.++.+||+|||++........ .......||+.|+|||++... .++.++|||||||++|||++|..|
T Consensus 168 Lkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 246 (370)
T cd05596 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (370)
T ss_pred CCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence 999999999999999999999976422111 122345799999999998753 478999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTA 226 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 226 (380)
|...... .....+......+ .. .........+.+++.+||+.+|.. |+++.++++.
T Consensus 247 f~~~~~~------~~~~~i~~~~~~~-~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 247 FYADSLV------GTYSKIMDHKNSL-TF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCCCCHH------HHHHHHHcCCCcC-CC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 9754321 1111111111000 00 001123568889999999999987 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=258.17 Aligned_cols=203 Identities=27% Similarity=0.397 Sum_probs=161.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|...+..++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl 119 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDL 119 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccc
Confidence 5678999999999999999999999999999999999975 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 120 ~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 120 AARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred ChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999875322111 11122334567999999998899999999999999999998 88898644
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.... ...... . . . ....+...+..+.+|+.+||+.+|++||++.||++.|.
T Consensus 199 ~~~~---~~~~~~---~-~--~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 199 TNQQ---AREQVE---K-G--Y--------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHH---HHHHHH---c-C--C--------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2211 111110 0 0 0 00112234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=258.04 Aligned_cols=205 Identities=27% Similarity=0.386 Sum_probs=162.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++++++||||+++++++...+..++||||+.+++|.+++.. ....+++..++.++.+++.||.|||+.+ ++|+|
T Consensus 45 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~d 118 (251)
T cd05041 45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118 (251)
T ss_pred HHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eehhh
Confidence 36788999999999999999999999999999999999975 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|+|+|||++.++.++|+|||++.................+..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 119 i~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred cCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 999999999999999999999975432111111122234567999999988899999999999999999998 7888865
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
......... . .... ....+...+..+.+|+.+||+.+|.+|||+.||++.|+
T Consensus 199 ~~~~~~~~~---~----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 199 MSNQQTRER---I----ESGY----------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHH---H----hcCC----------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 432211111 1 0000 01112234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=260.88 Aligned_cols=206 Identities=24% Similarity=0.421 Sum_probs=162.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.++...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl 132 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDL 132 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeccc
Confidence 5678999999999999999999999999999999999975 2456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCcccccccc---ccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM---GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~ 157 (380)
||+||+++.++.++|+|||++................ .+..|+|||++.+..++.++|||||||++||+++ |..||
T Consensus 133 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred ChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 9999999999999999999987543222111111111 2457999999998899999999999999999886 99998
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
...... ....++.. . ... ..+...+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 213 ~~~~~~---~~~~~i~~---~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 213 WDMSNQ---DVINAIEQ---D-YRL----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCHH---HHHHHHHc---C-CcC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 644321 11211110 0 000 01123345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=261.84 Aligned_cols=195 Identities=24% Similarity=0.406 Sum_probs=154.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|..+...++||||+++++|..++.. ....+++..++.++.||+.||+|||+.+ |+||||
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dl 143 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNV 143 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCC
Confidence 5788999999999999999999999999999999999865 3457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCC-------CeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHH-h
Q 016913 82 KSSNILLDEGF-------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELI-T 152 (380)
Q Consensus 82 kp~NILl~~~~-------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~ell-t 152 (380)
||+|||++..+ .++|+|||++..... .....++..|+|||++.+ ..++.++||||||+++|||+ +
T Consensus 144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~ 217 (274)
T cd05076 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217 (274)
T ss_pred CcccEEEeccCcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999997643 379999998864211 112356788999998875 56899999999999999995 6
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
|..||....+..... .. .....++ ......+.+|+.+||+.+|++|||+.+|++.|
T Consensus 218 g~~p~~~~~~~~~~~---~~----~~~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 218 GEVPLKERTPSEKER---FY----EKKHRLP------------EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCCccccChHHHHH---HH----HhccCCC------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 888887543321111 10 1100111 11124678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=263.09 Aligned_cols=203 Identities=28% Similarity=0.362 Sum_probs=162.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 128 (285)
T cd05605 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDL 128 (285)
T ss_pred HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCC
Confidence 5678999999999999999999999999999999998865 23356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||++++++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 129 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 129 KPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred CHHHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 9999999999999999999997643221 2233568999999999998899999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
...... .....+... ...++......+.+|+.+||+.||++|| ++.+++..
T Consensus 206 ~~~~~~--~~~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 206 EKVKRE--EVERRVKED------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hhhHHH--HHHHHhhhc------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 221110 010101000 0112233456788999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=259.99 Aligned_cols=195 Identities=22% Similarity=0.384 Sum_probs=154.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..+...++||||+++++|..++.. ....+++..++.++.||+.||+|||+.+ |+|+||
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dl 131 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNV 131 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCC
Confidence 5678999999999999999999999999999999998865 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC-------eEEeecCCcccCCCCCCccccccccccccccchhhhh-cCCCCCcCceeehHHHHHHHH-h
Q 016913 82 KSSNILLDEGFH-------PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELI-T 152 (380)
Q Consensus 82 kp~NILl~~~~~-------~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlGvvl~ell-t 152 (380)
||+|||++.++. ++++|||++..... .....++..|+|||++. +..++.++|||||||++|||+ +
T Consensus 132 kp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 132 CTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CcccEEEecCCccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 999999986654 89999999865321 12245778899999887 467899999999999999998 5
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
|..||........ .. ..... . ... ......+.+|+.+||+.+|.+||++.+|++.|
T Consensus 206 ~~~p~~~~~~~~~---~~----~~~~~--~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 206 GEIPLKDKTLAEK---ER----FYEGQ--C-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCCCcchhHH---HH----HHhcC--c-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 7777764322111 00 00000 0 001 11235678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=272.94 Aligned_cols=199 Identities=25% Similarity=0.359 Sum_probs=153.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..++..++||||+++++|... ..+.+..+..++.||+.||.|||+.+ |+|||
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 193 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH---IVHRD 193 (353)
T ss_pred HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecC
Confidence 36788999999999999999999999999999998643 23567788899999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----CCCCCcCceeehHHHHHHHHhCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||+||||+.++.+||+|||++...... ........|+..|+|||++.. ...+.++|||||||++|||++|+.
T Consensus 194 lkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 194 IKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred CCHHHEEEcCCCCEEEcccccceecccc--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999764321 112234578999999998743 234568999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||..........+.... .... . ...+......+.+|+.+||+.+|++|||+.||++.
T Consensus 272 pf~~~~~~~~~~~~~~~--~~~~----~--------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 272 PFGVGRQGDWASLMCAI--CMSQ----P--------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCCccHHHHHHHH--hccC----C--------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99733221111111100 0000 0 01122334678899999999999999999999974
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=272.18 Aligned_cols=147 Identities=24% Similarity=0.395 Sum_probs=129.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..+...++||||+. ++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+|||
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 182 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRD 182 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4678999999999999999999999999995 799998865 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+|||++.++.+||+|||+++.... ........||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 183 lkp~Nill~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 183 VKTENIFINDVDQVCIGDLGAAQFPVV---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCHHHEEECCCCCEEEecCcccccccc---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999999999999999999974221 11223456899999999999999999999999999999999866554
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=260.31 Aligned_cols=206 Identities=24% Similarity=0.392 Sum_probs=164.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dl 132 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDL 132 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeehhh
Confidence 5678999999999999999999999999999999999976 2356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccc-cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
||+|||++.++.++|+|||++........... .....++..|++||++.+..++.++||||||+++|++++ |..||..
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 133 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred chhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 99999999999999999999986533221111 112233568999999998899999999999999999886 9999865
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
.... ....... ....+ ..+...+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 213 ~~~~---~~~~~~~----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 213 MSNQ---DVIKAIE----EGYRL----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHH---HHHHHHh----CCCcC----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 4321 1111111 10000 01122345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=273.06 Aligned_cols=204 Identities=24% Similarity=0.334 Sum_probs=157.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||++++++.+.+..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||..+ |+|||
T Consensus 54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrD 126 (381)
T cd05626 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRD 126 (381)
T ss_pred HHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 36778999999999999999999999999999999999976 457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc---------------------------------------------cccc
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT---------------------------------------------HVST 115 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~---------------------------------------------~~~~ 115 (380)
|||+||||+.++.+||+|||++......... ....
T Consensus 127 lKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (381)
T cd05626 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206 (381)
T ss_pred CcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccc
Confidence 9999999999999999999997532100000 0012
Q ss_pred cccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcc-hhhhhhhcccccCCCCCCCCccccCCC
Q 016913 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN-LVAWARPLFKDRRKFPKMADPLLQGRY 194 (380)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~ 194 (380)
...||..|+|||++.+..++.++|||||||++|||++|..||.......... ...| .....++ .
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-----~~~~~~~----------~ 271 (381)
T cd05626 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW-----ENTLHIP----------P 271 (381)
T ss_pred cccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc-----ccccCCC----------C
Confidence 3469999999999999899999999999999999999999997543221110 0000 0000000 0
Q ss_pred ChhhHHHHHHHHHH--hhhhCCCCCCCHHHHHHH
Q 016913 195 PMRGLYQALAVAAM--CLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 195 ~~~~~~~l~~li~~--cl~~~P~~RPt~~evl~~ 226 (380)
.......+.+|+.+ |+..++..||++.+|+..
T Consensus 272 ~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 272 QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11234567788877 455666679999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=271.43 Aligned_cols=204 Identities=24% Similarity=0.289 Sum_probs=157.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+.+..||||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrD 126 (377)
T cd05629 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRD 126 (377)
T ss_pred HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 35678999999999999999999999999999999999975 467899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc---------------------------------------------cccc
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT---------------------------------------------HVST 115 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~---------------------------------------------~~~~ 115 (380)
|||+|||++.++.+||+|||+++.+...... ....
T Consensus 127 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (377)
T cd05629 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAY 206 (377)
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc
Confidence 9999999999999999999998642111000 0001
Q ss_pred cccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCC
Q 016913 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 195 (380)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 195 (380)
...||+.|+|||++.+..++.++|||||||++|||++|..||........ . ..+......+ .+.+ .
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~---~~i~~~~~~~-~~p~-------~ 272 (377)
T cd05629 207 STVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET---Y---RKIINWRETL-YFPD-------D 272 (377)
T ss_pred ccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH---H---HHHHccCCcc-CCCC-------C
Confidence 24699999999999998999999999999999999999999975432111 1 1111100000 0000 0
Q ss_pred hhhHHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q 016913 196 MRGLYQALAVAAMCLQEQAATR---PLIGDVVTA 226 (380)
Q Consensus 196 ~~~~~~l~~li~~cl~~~P~~R---Pt~~evl~~ 226 (380)
......+.+++.+||+ +|.+| +++.|++..
T Consensus 273 ~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 273 IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 1224567899999997 77765 588888864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.53 Aligned_cols=216 Identities=24% Similarity=0.317 Sum_probs=159.9
Q ss_pred CccCCCCCCcccceEEEEeC--------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG--------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 72 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 72 (380)
+|+.++|||||++++++... ..+++||||++ ++|.+++.........+++..+..++.||+.||.|||+.+
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~ 190 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46789999999999987432 24679999996 6888888654445677999999999999999999999999
Q ss_pred CCCeEecCCCCCcEEEcCCC-CeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHH
Q 016913 73 NPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~el 150 (380)
|+||||||+||||+.++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||
T Consensus 191 ---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 264 (440)
T PTZ00036 191 ---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264 (440)
T ss_pred ---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999998664 69999999998643221 22235679999999998764 689999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcccc--------------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLFKD--------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~ 216 (380)
++|.+||........ +..... .... ...++......+...++...+..+.+|+.+||+.+|.+
T Consensus 265 ltG~~pf~~~~~~~~--~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~ 341 (440)
T PTZ00036 265 ILGYPIFSGQSSVDQ--LVRIIQ-VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLK 341 (440)
T ss_pred HhCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhH
Confidence 999999975433211 111100 0000 00111111111222233345568999999999999999
Q ss_pred CCCHHHHHHH
Q 016913 217 RPLIGDVVTA 226 (380)
Q Consensus 217 RPt~~evl~~ 226 (380)
|||+.|+++.
T Consensus 342 R~ta~e~l~h 351 (440)
T PTZ00036 342 RLNPIEALAD 351 (440)
T ss_pred CcCHHHHhCC
Confidence 9999999854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=275.92 Aligned_cols=208 Identities=24% Similarity=0.370 Sum_probs=171.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+-|+|||+|+|+|+|..+-.+|||+|||..|+|.+||.. -++..++....+.++.||+.|++||..++ +||||
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRD 390 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRD 390 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhh
Confidence 46789999999999999999999999999999999999987 35566888899999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|...|+||.++..+||+||||+++|..... ..........-|.|||-+....|+.|+|||+|||+||||.| |-.||..
T Consensus 391 LAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 391 LAARNCLVGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhccccccceEEeeccchhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999999754322 22333345678999999999999999999999999999987 4456653
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
... .+++. ++.+-++-.-|..++..+.+|++.||+.+|.+||+++||-++|+.+.
T Consensus 470 idl---SqVY~--------------LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 470 IDL---SQVYG--------------LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccH---HHHHH--------------HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 211 11111 22222333345567789999999999999999999999999998763
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=258.88 Aligned_cols=205 Identities=28% Similarity=0.418 Sum_probs=163.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.. ...++||||+++++|.+++.... ...+++..++.++.|++.||.|||..+ ++|+||
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di 123 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDL 123 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhCC---cccccc
Confidence 678999999999999988 88999999999999999998732 156899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
+|+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 124 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 124 AARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred CcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998653322211 1223456789999999998899999999999999999998 9999864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
..... ..... ..... .. ..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 204 ~~~~~---~~~~~---~~~~~---~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 204 LSGSQ---ILKKI---DKEGE---RL-------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHH---HHHHH---HhcCC---cC-------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 32211 11111 11100 00 011223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=260.55 Aligned_cols=207 Identities=28% Similarity=0.439 Sum_probs=165.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|.. ...++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di 135 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDL 135 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeccc
Confidence 567899999999999987 788999999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++||+++ |..||...
T Consensus 136 ~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 136 AARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred CcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999986543222111122234568999999988899999999999999999998 99999764
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ...... ....+ ..+......+.+++.+||..+|..||++.++++.|..+..
T Consensus 216 ~~~~---~~~~~~----~~~~~----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 216 PAVE---IPDLLE----KGERL----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CHHH---HHHHHh----CCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3221 111111 11000 1111234568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=263.02 Aligned_cols=218 Identities=23% Similarity=0.311 Sum_probs=166.7
Q ss_pred CccCCCCCCcccceEEEEe-----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|+.++|+||+.+++.+.. -+.+|+|+|+| +.+|...++. +..|+...+..+++||++||.|+|+.+
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn--- 145 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN--- 145 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---
Confidence 4678899999999999865 34689999999 5999999986 455999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||.|+|++.+..+||||||+|+...........+.-+.|.+|.|||++.. ..|+.+.||||.|||+.||++|+
T Consensus 146 ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk 225 (359)
T KOG0660|consen 146 VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK 225 (359)
T ss_pred ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence 99999999999999999999999999997543212223355677999999999875 48999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhccc--------------ccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFK--------------DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
+.|.+.+......++........ .-..++......+...+| .....+++|+.+||.+||.+|+|+
T Consensus 226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita 304 (359)
T KOG0660|consen 226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITA 304 (359)
T ss_pred CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCH
Confidence 99987655433322211100000 000111111111111222 455688999999999999999999
Q ss_pred HHHHHHH
Q 016913 221 GDVVTAL 227 (380)
Q Consensus 221 ~evl~~L 227 (380)
+|.++.-
T Consensus 305 ~eAL~hP 311 (359)
T KOG0660|consen 305 EEALAHP 311 (359)
T ss_pred HHHhcCh
Confidence 9998743
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=263.65 Aligned_cols=210 Identities=25% Similarity=0.399 Sum_probs=164.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
++.++||||+++++++...+..|+||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--- 139 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999999999999999999999999999975321 1234577889999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~ 154 (380)
|+|+||||+|||++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 140 i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~ 219 (288)
T cd05061 140 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219 (288)
T ss_pred CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975432222112222345678999999998899999999999999999998 67
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
.||...... ...... ... . .. ..+......+.+|+.+||+.+|.+|||+.++++.|+...
T Consensus 220 ~p~~~~~~~---~~~~~~---~~~-~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 220 QPYQGLSNE---QVLKFV---MDG-G-YL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCHH---HHHHHH---HcC-C-CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 888643221 111111 100 0 00 011223467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=272.88 Aligned_cols=203 Identities=21% Similarity=0.228 Sum_probs=155.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+++..|+|||||++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|||
T Consensus 54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrD 126 (382)
T cd05625 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRD 126 (382)
T ss_pred HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 46788999999999999999999999999999999999976 356899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCC---------------------------------------------ccccc
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDK---------------------------------------------THVST 115 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~---------------------------------------------~~~~~ 115 (380)
|||+|||++.++.+||+|||++..+..... .....
T Consensus 127 lKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (382)
T cd05625 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206 (382)
T ss_pred CCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccc
Confidence 999999999999999999999753210000 00012
Q ss_pred cccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCC
Q 016913 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 195 (380)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 195 (380)
...||+.|+|||++.+..++.++|||||||++|||++|..||....+... .. .+......+. .+..
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~---~i~~~~~~~~--------~p~~ 272 (382)
T cd05625 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLET---QM---KVINWQTSLH--------IPPQ 272 (382)
T ss_pred ccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHH---HH---HHHccCCCcC--------CCCc
Confidence 34689999999999999999999999999999999999999975433211 10 0010000000 0001
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 016913 196 MRGLYQALAVAAMCLQEQAATRPL---IGDVVT 225 (380)
Q Consensus 196 ~~~~~~l~~li~~cl~~~P~~RPt---~~evl~ 225 (380)
......+.+++.+|+ .+|.+|++ +.+|+.
T Consensus 273 ~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 273 AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 122356677777765 59999997 776664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=265.69 Aligned_cols=219 Identities=19% Similarity=0.212 Sum_probs=158.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+++.++|||||+++++|..++..++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~d 126 (327)
T cd08227 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRS 126 (327)
T ss_pred HHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCC
Confidence 356789999999999999999999999999999999999652 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCC-----ccccccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHhC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDK-----THVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG 153 (380)
|||+|||++.++.++++||+.+........ ........++..|+|||++.+ ..++.++|||||||++|||++|
T Consensus 127 lkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 127 VKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred CChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999986543211110 011122356778999999976 4689999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhccc---ccC------------------CCCC---------CCCccccCCCChhhHHHHH
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFK---DRR------------------KFPK---------MADPLLQGRYPMRGLYQAL 203 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~---~~~------------------~~~~---------~~~~~l~~~~~~~~~~~l~ 203 (380)
..||........ .......... +.. .+.. .........+.......+.
T Consensus 207 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (327)
T cd08227 207 HVPFKDMPATQM--LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFH 284 (327)
T ss_pred CCCCCCcchhHH--HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHH
Confidence 999974322110 0000000000 000 0000 0000000011223345788
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 016913 204 AVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 204 ~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+|+.+||+.||++|||+.||++.
T Consensus 285 ~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 285 HFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred HHHHHHHhhCchhcCCHHHHhcC
Confidence 99999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=274.51 Aligned_cols=204 Identities=22% Similarity=0.240 Sum_probs=157.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|.+++.+|||||||++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|||
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrD 126 (376)
T cd05598 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRD 126 (376)
T ss_pred HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 46778999999999999999999999999999999999976 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCC-----------------------------------------ccccccccc
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDK-----------------------------------------THVSTRVMG 119 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~-----------------------------------------~~~~~~~~g 119 (380)
|||+|||++.++.+||+|||++..+..... ........|
T Consensus 127 lkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 206 (376)
T cd05598 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVG 206 (376)
T ss_pred CCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCC
Confidence 999999999999999999999753210000 000123469
Q ss_pred cccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhH
Q 016913 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGL 199 (380)
Q Consensus 120 t~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 199 (380)
|+.|+|||++.+..++.++|||||||++|||++|..||....+......+ ......+ .........
T Consensus 207 t~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~~~--------~~~~~~~~s 272 (376)
T cd05598 207 TPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV------INWETTL--------HIPSQAKLS 272 (376)
T ss_pred CccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHH------hccCccc--------cCCCCCCCC
Confidence 99999999999999999999999999999999999999765432111110 0000000 000111234
Q ss_pred HHHHHHHHHhhhhCCCCCC---CHHHHHHH
Q 016913 200 YQALAVAAMCLQEQAATRP---LIGDVVTA 226 (380)
Q Consensus 200 ~~l~~li~~cl~~~P~~RP---t~~evl~~ 226 (380)
..+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 273 ~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 273 REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 56777888876 5999999 88888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=261.28 Aligned_cols=204 Identities=27% Similarity=0.338 Sum_probs=166.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||+.+.||.|++||..|+.++..|+|||||+||+|..+++. +..+.|++..+..++..++.||+|||..| ||+||
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRD 204 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRD 204 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeecc
Confidence 68899999999999999999999999999999999999998 45677999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCC---------------------------------CCCc----------------
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPV---------------------------------GDKT---------------- 111 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~---------------------------------~~~~---------------- 111 (380)
|||+||||.++|.+.|+||.|+..... ....
T Consensus 205 LKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 205 LKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred CCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 999999999999999999998754211 0000
Q ss_pred -----cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCC
Q 016913 112 -----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 186 (380)
Q Consensus 112 -----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (380)
..+...+||-.|+|||++.+..-+.+.|.|.|||++||||.|..||.+.+...... +++.....++..
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~------NIv~~~l~Fp~~- 357 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR------NIVGQPLKFPEE- 357 (459)
T ss_pred cCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH------HHhcCCCcCCCC-
Confidence 01123679999999999999999999999999999999999999998665433211 112221222221
Q ss_pred CccccCCCChhhHHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 016913 187 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL----IGDVVT 225 (380)
Q Consensus 187 ~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt----~~evl~ 225 (380)
...+..+.+||.+.|.+||.+|-- ++||-+
T Consensus 358 ---------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 358 ---------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ---------CcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 144678999999999999999987 666643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=270.68 Aligned_cols=201 Identities=26% Similarity=0.333 Sum_probs=162.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||....+|+||+||..|.+.+.+||||||++||++..+|.. ...|++..+..++.+++.|++.||+.| +||||
T Consensus 194 iL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRD 266 (550)
T KOG0605|consen 194 ILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRD 266 (550)
T ss_pred HhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence 35567899999999999999999999999999999999987 788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCC--------------------C--CCcc----cc-------------------c
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPV--------------------G--DKTH----VS-------------------T 115 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~--------------------~--~~~~----~~-------------------~ 115 (380)
|||+|+|||..|.+||+||||+.-+.. . +... .. .
T Consensus 267 IKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 267 IKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred CChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 999999999999999999999853111 0 0000 00 1
Q ss_pred cccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCc-chhhhhhhcccccCCCCCCCCccccCCC
Q 016913 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH-NLVAWARPLFKDRRKFPKMADPLLQGRY 194 (380)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 194 (380)
..+||+.|||||++.+..|+..+|.|||||||||||.|.+||....+...- .++.|...+ .++...
T Consensus 347 StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-----~fP~~~-------- 413 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-----KFPEEV-------- 413 (550)
T ss_pred cccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-----cCCCcC--------
Confidence 146999999999999999999999999999999999999999877665432 333343211 112211
Q ss_pred ChhhHHHHHHHHHHhhhhCCCCCCC---HHHHH
Q 016913 195 PMRGLYQALAVAAMCLQEQAATRPL---IGDVV 224 (380)
Q Consensus 195 ~~~~~~~l~~li~~cl~~~P~~RPt---~~evl 224 (380)
....++.+||.+||. ||+.|-- +.||-
T Consensus 414 --~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 414 --DLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred --cccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 223688899999999 9999964 55554
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=268.69 Aligned_cols=202 Identities=20% Similarity=0.251 Sum_probs=157.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+++..|+|||||++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDL 168 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDV 168 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 5678999999999999999999999999999999999965 45899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC----CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||+|||+++++.+||+|||++........ .......||+.|+|||++... .++.++|||||||++|+|++|..||
T Consensus 169 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 169 KPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred CHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 99999999999999999999976432111 122346799999999999764 3789999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTA 226 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 226 (380)
...... .....+......+. . +........+.+++..||+.++.. |+++.|+++.
T Consensus 248 ~~~~~~------~~~~~i~~~~~~~~-~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 248 YADSLV------GTYSKIMDHKNSLN-F-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCHH------HHHHHHHhCCcccC-C-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 754321 11111111111110 0 001123456778899999855543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=257.63 Aligned_cols=207 Identities=27% Similarity=0.425 Sum_probs=159.2
Q ss_pred ccCCCCCCcccceEEEE-eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++.++||||+++++++. .++..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 123 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRD 123 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 67889999999999875 45568999999999999999975 2345778888999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhC-CCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG-RKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG-~~p~ 157 (380)
|||+|||++.++.+||+|||+++........ .......++..|+|||++....++.++|||||||++|||++| .+||
T Consensus 124 lk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 124 LAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred cCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999754321110 111234457789999999988999999999999999999995 5556
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
...... ...... ... ... . .+...+..+.+++.+||+.+|++||++.+|+..|+.+.
T Consensus 204 ~~~~~~---~~~~~~---~~~-~~~------~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 204 PDVDSF---DITVYL---LQG-RRL------L----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCHH---HHHHHH---hcC-CCC------C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 533211 111111 110 000 0 01112357889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=255.91 Aligned_cols=195 Identities=27% Similarity=0.450 Sum_probs=156.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++.. ...++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 126 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGN 126 (259)
T ss_pred HHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeccc
Confidence 3678899999999999988 7789999999999999999862 236899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-------CeEEeecCCcccCCCCCCccccccccccccccchhhhhcC--CCCCcCceeehHHHHHHHH
Q 016913 81 LKSSNILLDEGF-------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 81 Ikp~NILl~~~~-------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlGvvl~ell 151 (380)
|||+|||++.++ .+||+|||++..... .....++..|+|||++... .++.++||||||+++|+|+
T Consensus 127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred CccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999999887 799999999975322 2224466789999999876 7899999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 152 T-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 152 t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+ |..||........ ..+.. ... ..+......+.+++.+||+.+|.+|||+.+|++.|
T Consensus 201 ~~~~~p~~~~~~~~~---~~~~~----~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 201 SNGEEPLSTLSSSEK---ERFYQ----DQH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hCCCCCcccCCchhH---HHHHh----cCC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9 4677765432111 11110 000 00111126788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=270.40 Aligned_cols=153 Identities=28% Similarity=0.360 Sum_probs=134.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|..++||||+++++++.++...|||||||++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDl 127 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDI 127 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCC
Confidence 5678999999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCc---------------------------------cccccccccccccchhh
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKT---------------------------------HVSTRVMGTYGYCAPEY 128 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~ 128 (380)
||+||||+.++.+||+|||+++........ .......||+.|+|||+
T Consensus 128 Kp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 207 (363)
T cd05628 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEV 207 (363)
T ss_pred CHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHH
Confidence 999999999999999999998753211100 00123579999999999
Q ss_pred hhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 129 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 129 ~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+.+..++.++|||||||++|||++|..||....
T Consensus 208 ~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred HcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=277.99 Aligned_cols=198 Identities=26% Similarity=0.400 Sum_probs=161.1
Q ss_pred CccCCCCCCcccceEEEEeCCe--EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQ--RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~--~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
||+.|+|||||++|+++.+... ..+|+|+|..|+|..|+++ .+.++...+..|+.||++||.|||++ .|||||
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIH 168 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIH 168 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccc
Confidence 5899999999999999877655 7799999999999999987 57799999999999999999999998 599999
Q ss_pred cCCCCCcEEEcCC-CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||||.+||||+.+ |.|||+|+|||.++... ......||+.|||||... ..|++..||||||+.|+||+|+..||
T Consensus 169 RDLKCDNIFinG~~G~VKIGDLGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY 243 (632)
T KOG0584|consen 169 RDLKCDNIFVNGNLGEVKIGDLGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY 243 (632)
T ss_pred cccccceEEEcCCcCceeecchhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh
Confidence 9999999999865 88999999999874322 223478999999999987 78999999999999999999999999
Q ss_pred CCCCCCC-CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPG-EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....... .+..|.-.. ....+..+-| ..+.+||.+||.. ..+|||+.|+|.
T Consensus 244 sEC~n~AQIYKKV~SGi----KP~sl~kV~d------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 244 SECTNPAQIYKKVTSGI----KPAALSKVKD------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhhCCHHHHHHHHHcCC----CHHHhhccCC------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 7543321 111111000 0111222333 3566899999999 999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.69 Aligned_cols=197 Identities=24% Similarity=0.363 Sum_probs=167.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||+.|+||||+.+|.+|++.+..+|||||..+|.|++|+.. ...|++..+..++.||..|+.|+|.++ ++|||
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRD 178 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRD 178 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecc
Confidence 57899999999999999999999999999999999999987 678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCC-CcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||.+|||||.++.+||+|||++.++... .....++|++.|.+||++.+..|. +..|.|||||+||-|+.|..||++
T Consensus 179 LKLENILLD~N~NiKIADFGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 179 LKLENILLDQNNNIKIADFGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred cchhheeecCCCCeeeeccchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 9999999999999999999999875433 344668999999999999998874 789999999999999999999986
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY-PMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
... ..++..+ -.+.| .+..+..+.-||.+||-.||+.|.|+.+|....
T Consensus 256 ~Dh---k~lvrQI-----------------s~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 256 RDH---KRLVRQI-----------------SRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred chH---HHHHHHh-----------------hcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 532 1222211 11111 112245667899999999999999999997665
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=262.91 Aligned_cols=207 Identities=25% Similarity=0.441 Sum_probs=161.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC------------------CCCCCCCHHHHHHHHHHHHH
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------------PDKEPLDWNTRMKIAAGAAK 63 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qia~ 63 (380)
|+.++||||++++++|.+++..++||||+++++|.+++.... .....+++..++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 567899999999999999999999999999999999997521 11234789999999999999
Q ss_pred HHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeeh
Q 016913 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 143 (380)
Q Consensus 64 aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~Sl 143 (380)
||+|||..+ ++|+||||+|||++.++.++|+|||++.................+..|+|||.+.+..++.++|||||
T Consensus 142 aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 142 GMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred HHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 999999999 99999999999999999999999999875322211111222334667999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 144 GVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 144 Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
||++|||++ |..||...... ...... . ... .. ..+...+..+.+|+.+||+.+|.+|||+.|
T Consensus 219 G~il~el~~~~~~p~~~~~~~---~~~~~~---~-~~~-~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 219 GVVLWEIFSYGMQPYYGMAHE---EVIYYV---R-DGN-VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHH---HHHHHH---h-cCC-CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 999999997 77787543221 111111 0 100 00 011233467889999999999999999999
Q ss_pred HHHHHH
Q 016913 223 VVTALT 228 (380)
Q Consensus 223 vl~~L~ 228 (380)
|++.|+
T Consensus 282 l~~~l~ 287 (288)
T cd05050 282 INRILQ 287 (288)
T ss_pred HHHHhh
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=257.80 Aligned_cols=201 Identities=22% Similarity=0.304 Sum_probs=161.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..|+||||+++++|.+++.. .....++...++.++.|++.||.|||+.+ ++|+||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 126 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDI 126 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 5678999999999999999999999999999999999865 23456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.++|+|||++...... ........++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 127 ~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 127 KSKNIFLTQNGKVKLGDFGSARLLTSP--GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred CcceEEECCCCcEEEcccCcceeeccc--ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 999999999999999999999764321 112233568889999999998899999999999999999999999997432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. .....+... ... ..+......+.+|+.+||+.+|++||++.+|+..
T Consensus 205 ~~------~~~~~~~~~--~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 205 WK------NLILKVCQG--SYK---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HH------HHHHHHhcC--CCC---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 21 111111110 000 0112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=265.40 Aligned_cols=192 Identities=28% Similarity=0.399 Sum_probs=153.8
Q ss_pred ccCCCC-CCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|..+.| ++|+++++++...+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 54 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 126 (324)
T cd05587 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRD 126 (324)
T ss_pred HHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 345555 5688899999999999999999999999999975 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||++...... ........||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 127 lkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 127 LKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CCHHHeEEcCCCCEEEeecCcceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998742211 11223456899999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
... .... .+..... .++......+.+++.+||+.+|.+|++.
T Consensus 205 ~~~---~~~~---~i~~~~~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 205 DED---ELFQ---SIMEHNV------------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CHH---HHHH---HHHcCCC------------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 221 1111 1111111 1122234578899999999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=283.73 Aligned_cols=205 Identities=22% Similarity=0.259 Sum_probs=163.6
Q ss_pred ccCCCCCCcccceEEEEeCC--------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGD--------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~--------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
|..++|+||+++++.+...+ .+++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+
T Consensus 85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~- 163 (496)
T PTZ00283 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH- 163 (496)
T ss_pred HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 55789999999988775432 368999999999999999764445567999999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhC
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG 153 (380)
|+||||||+||||+.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 164 --IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 164 --MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred --EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999999865433223333456799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..||...... ......... ... ..+......+.+|+.+||+.+|.+||++.+|+..
T Consensus 242 ~~Pf~~~~~~------~~~~~~~~~------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 242 KRPFDGENME------EVMHKTLAG------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCHH------HHHHHHhcC------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 9999753221 111111110 000 1222345678899999999999999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=264.60 Aligned_cols=188 Identities=26% Similarity=0.362 Sum_probs=154.5
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||+|+++++++...+..|+||||+++++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 131 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHH
Confidence 689999999999999999999999999999999975 456999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~ 165 (380)
||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 132 ill~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-- 207 (323)
T cd05616 132 VMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-- 207 (323)
T ss_pred eEECCCCcEEEccCCCceecCCC--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--
Confidence 99999999999999999753211 11223457899999999999999999999999999999999999999754321
Q ss_pred cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.... .+..... .++......+.+|+.+||+.+|.+|++.
T Consensus 208 -~~~~---~i~~~~~------------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 208 -ELFQ---SIMEHNV------------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -HHHH---HHHhCCC------------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111 1111111 1222345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=257.08 Aligned_cols=205 Identities=29% Similarity=0.446 Sum_probs=161.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++. ....++||||+++++|.+++.. .....+++.+++.++.+++.||.|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 127 (260)
T cd05070 54 IMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127 (260)
T ss_pred HHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 367889999999999885 4568999999999999999976 23456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||++++++.++|+|||++......... ......++..|+|||++....++.++||||||+++|+|++ |..||..
T Consensus 128 i~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 128 LRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred CccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999764332211 1122335668999999988899999999999999999999 8888864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... ....... . .. ....+......+.+|+.+||+.+|.+|||+.++++.|+.
T Consensus 207 ~~~~---~~~~~~~---~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 207 MNNR---EVLEQVE---R-GY----------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHH---HHHHHHH---c-CC----------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3221 1111111 0 00 011223345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=262.18 Aligned_cols=200 Identities=27% Similarity=0.362 Sum_probs=160.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..+...|+||||+++++|.+++.. ..+++..++.++.|++.||.|||..+ |+|+||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dL 142 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 142 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999965 45899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 143 kp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred CHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987532211 11233468889999999998889999999999999999999999996543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+... ..... ... .+. + ..+......+.+++.+||+.+|++||++.+|+..
T Consensus 221 ~~~~--~~~~~----~~~--~~~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 221 PLRA--LYLIA----TNG--TPE-----L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHh--HHHHh----cCC--CCC-----C--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2111 11100 000 000 0 1122334568899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=261.15 Aligned_cols=216 Identities=22% Similarity=0.317 Sum_probs=161.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrD 80 (380)
|+.++||||++++++|..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~d 125 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRD 125 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECC
Confidence 5678999999999999999999999999999999999976 3678999999999999999999997 57 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.++|+|||++...... ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 126 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred CChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999998753221 123356889999999998888999999999999999999999998644
Q ss_pred CCCCCcchhhhhhhcccccCC------C-C---------CCCCcccc---CCCC-hhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 161 RPPGEHNLVAWARPLFKDRRK------F-P---------KMADPLLQ---GRYP-MRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~------~-~---------~~~~~~l~---~~~~-~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
..................... . . ...+.... ...+ ......+.+|+.+||+.+|++|||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 281 (308)
T cd06615 202 DAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL 281 (308)
T ss_pred chhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence 322111111000000000000 0 0 00000000 0000 0134568899999999999999999
Q ss_pred HHHHHHHH
Q 016913 221 GDVVTALT 228 (380)
Q Consensus 221 ~evl~~L~ 228 (380)
.+|++..-
T Consensus 282 ~~ll~~~~ 289 (308)
T cd06615 282 KELTKHPF 289 (308)
T ss_pred HHHhcChh
Confidence 99997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=260.47 Aligned_cols=213 Identities=29% Similarity=0.398 Sum_probs=159.8
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.++||||+++++++... ...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~ 132 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHR 132 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 5788999999999987543 468999999999999999975 2356899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccc-cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+||+++.++.++|+|||++........... .....++..|+|||++.+..++.++||||||+++|||++|..++.
T Consensus 133 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 133 DLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 9999999999999999999999986543222111 112223456999999998889999999999999999999876653
Q ss_pred CCCCCCCc---------chhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 159 NTRPPGEH---------NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 159 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.....-.. ............ ......+......+.+|+.+||+.+|++|||+.||++.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 213 SPPAEFMRMMGNDKQGQMIVYHLIELLKN----------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred CcchhhhhhcccccccccchHHHHHHHhc----------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 22110000 000000000000 00011122345678999999999999999999999999986
Q ss_pred h
Q 016913 230 L 230 (380)
Q Consensus 230 ~ 230 (380)
+
T Consensus 283 ~ 283 (284)
T cd05081 283 I 283 (284)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=256.32 Aligned_cols=205 Identities=25% Similarity=0.334 Sum_probs=160.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+|
T Consensus 59 ~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 131 (267)
T cd06646 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRD 131 (267)
T ss_pred HHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 35678999999999999999999999999999999999875 457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+. ...++.++|||||||++|||++|..||
T Consensus 132 l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~ 209 (267)
T cd06646 132 IKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred CCHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence 99999999999999999999997642211 1122346788999999885 345788999999999999999999998
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
....+..... ... .. ....+.+. ........+.+++.+||+.+|++|||+++|++.|
T Consensus 210 ~~~~~~~~~~--~~~----~~-----~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 210 FDLHPMRALF--LMS----KS-----NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccchhhhhe--eee----cC-----CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 6443221110 000 00 00001111 0112346788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=263.64 Aligned_cols=206 Identities=28% Similarity=0.440 Sum_probs=162.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|... ..++|+||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 63 ~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~di 135 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDL 135 (303)
T ss_pred HHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eecccc
Confidence 5678999999999998764 56799999999999999975 3446899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 136 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 136 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred ccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986433222212223445678999999998899999999999999999997 88888643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
... ....+. .....++ .+......+.+++..||..+|++||++.+|++.|..+.
T Consensus 216 ~~~---~~~~~~----~~~~~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 216 PTR---EIPDLL----EKGERLP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CHH---HHHHHH----HCCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 211 111111 1111111 01123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=256.05 Aligned_cols=205 Identities=29% Similarity=0.429 Sum_probs=161.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++. .+..++||||+.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 127 (260)
T cd05069 54 IMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127 (260)
T ss_pred HHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecc
Confidence 367889999999999875 45689999999999999999762 3345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||++++++.++|+|||++......... ......++..|+|||+.....++.++||||||+++|+|++ |..||..
T Consensus 128 l~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 128 LRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999764322211 1122345678999999988899999999999999999999 8888865
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... ....+.. .. ... ..+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus 207 ~~~~---~~~~~~~----~~--~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 207 MVNR---EVLEQVE----RG--YRM--------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCHH---HHHHHHH----cC--CCC--------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3221 1111111 00 000 1122335678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=273.92 Aligned_cols=211 Identities=26% Similarity=0.379 Sum_probs=164.3
Q ss_pred ccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------------------------------
Q 016913 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------------------------ 44 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------------------ 44 (380)
|.++. |||||+++++|...+..++|||||++|+|.++++....
T Consensus 94 l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred HHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 55676 99999999999999999999999999999999975311
Q ss_pred ----------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHH
Q 016913 45 ----------------------------------------------------------DKEPLDWNTRMKIAAGAAKGLE 66 (380)
Q Consensus 45 ----------------------------------------------------------~~~~l~~~~~~~i~~qia~aL~ 66 (380)
....+++..++.++.||+.||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 1134778889999999999999
Q ss_pred HHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHH
Q 016913 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146 (380)
Q Consensus 67 ~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvv 146 (380)
|||+.+ ++|+||||+|||+++++.+||+|||+++...............++..|+|||++....++.++|||||||+
T Consensus 254 ~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvi 330 (401)
T cd05107 254 FLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330 (401)
T ss_pred HHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHH
Confidence 999999 99999999999999999999999999975432221112223456788999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 147 FLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 147 l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+|||++ |..||........ .... +. .... ...+......+.+|+.+||+.+|.+||++.+|+.
T Consensus 331 l~e~l~~g~~P~~~~~~~~~--~~~~---~~-~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 331 LWEIFTLGGTPYPELPMNEQ--FYNA---IK-RGYR----------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHcCCCCCCCCCchHH--HHHH---HH-cCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 8888864322111 0000 00 0000 0112233567889999999999999999999999
Q ss_pred HHHHhh
Q 016913 226 ALTYLA 231 (380)
Q Consensus 226 ~L~~~~ 231 (380)
.|+.+.
T Consensus 395 ~L~~~~ 400 (401)
T cd05107 395 LVGDLL 400 (401)
T ss_pred HHHHHh
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=256.27 Aligned_cols=205 Identities=28% Similarity=0.403 Sum_probs=161.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.. +..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl 128 (262)
T cd05071 55 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128 (262)
T ss_pred HHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 567899999999998754 5689999999999999999752 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.++|+|||++......... ......++..|+|||+.....++.++||||||+++|+|++ |..||...
T Consensus 129 ~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 129 RAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred CcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999999764332211 1123346678999999988899999999999999999999 78888644
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
.... .. ...... ... ..+...+..+.+|+.+||+.+|++||++.++++.|+..
T Consensus 208 ~~~~---~~---~~~~~~-~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 208 VNRE---VL---DQVERG-YRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ChHH---HH---HHHhcC-CCC----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2211 11 111000 000 11223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=256.24 Aligned_cols=202 Identities=29% Similarity=0.459 Sum_probs=163.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|+||+++++++...+..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~d 127 (256)
T cd05039 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127 (256)
T ss_pred HHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchh
Confidence 356789999999999999999999999999999999999762 2236999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.++|+|||+++...... .....+..|+|||++....++.++||||||+++|+|++ |..||..
T Consensus 128 i~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred cccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999998642211 12334568999999998899999999999999999997 9999864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... .+..... .. .. ...+...+..+.+++.+||..+|++|||+.+|++.|+.
T Consensus 203 ~~~~---~~~~~~~----~~--~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 203 IPLK---DVVPHVE----KG--YR--------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCHH---HHHHHHh----cC--CC--------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 4221 1111110 00 00 01112335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=282.68 Aligned_cols=205 Identities=23% Similarity=0.342 Sum_probs=157.0
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----C
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN----P 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~ 74 (380)
+|++|+|||||+++++|... ..+||||||+++++|.++|.........|++..++.|+.||+.||.|||..+. .
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k 144 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence 46789999999999988553 56899999999999999997643445679999999999999999999998431 2
Q ss_pred CeEecCCCCCcEEEcCC-----------------CCeEEeecCCcccCCCCCCccccccccccccccchhhhhc--CCCC
Q 016913 75 PVIYRDLKSSNILLDEG-----------------FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLT 135 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~-----------------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s 135 (380)
+|||+||||+||||+.+ ..+||+|||++...... .......||+.|+|||++.. ..++
T Consensus 145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s 221 (1021)
T PTZ00266 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYD 221 (1021)
T ss_pred CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCC
Confidence 39999999999999642 34899999999764322 12234578999999999864 4588
Q ss_pred CcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCC
Q 016913 136 LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA 215 (380)
Q Consensus 136 ~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~ 215 (380)
.++||||||||||+|++|..||..... .......+ ... +.+. + ......+.+||..||+.+|.
T Consensus 222 ~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~qli~~l-k~~---p~lp---i-----~~~S~eL~dLI~~~L~~dPe 284 (1021)
T PTZ00266 222 DKSDMWALGCIIYELCSGKTPFHKANN-----FSQLISEL-KRG---PDLP---I-----KGKSKELNILIKNLLNLSAK 284 (1021)
T ss_pred chhHHHHHHHHHHHHHHCCCCCCcCCc-----HHHHHHHH-hcC---CCCC---c-----CCCCHHHHHHHHHHhcCChh
Confidence 999999999999999999999964322 11111111 111 1100 0 11246788999999999999
Q ss_pred CCCCHHHHHH
Q 016913 216 TRPLIGDVVT 225 (380)
Q Consensus 216 ~RPt~~evl~ 225 (380)
+||++.+++.
T Consensus 285 eRPSa~QlL~ 294 (1021)
T PTZ00266 285 ERPSALQCLG 294 (1021)
T ss_pred HCcCHHHHhc
Confidence 9999999984
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=265.60 Aligned_cols=203 Identities=20% Similarity=0.243 Sum_probs=157.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+++..|+||||+++++|.+++.. ..++...+..++.||+.||.|||+.+ |+||||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDL 168 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 168 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 5678999999999999999999999999999999999975 45899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC----CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||+|||++.++.+||+|||++........ .......||+.|+|||++... .++.++|||||||++|||++|..||
T Consensus 169 kp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 99999999999999999999976432211 122346799999999998754 3789999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTAL 227 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~L 227 (380)
...... .....+......+. + .........+.+++..||+.++.. |+++.+|++..
T Consensus 248 ~~~~~~------~~~~~i~~~~~~~~-~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 248 YADSLV------GTYSKIMNHKNSLT-F-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCHH------HHHHHHHcCCCccc-C-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 754321 11111111111110 0 011133567889999999844433 67888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=258.84 Aligned_cols=213 Identities=24% Similarity=0.432 Sum_probs=162.3
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+|+.++||||+++++++... ...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H 132 (284)
T cd05079 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVH 132 (284)
T ss_pred HHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 36788999999999998775 568999999999999999965 2346899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
+||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|+++..|.
T Consensus 133 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 999999999999999999999999864322211 1122345677899999998888999999999999999999987654
Q ss_pred CCCCCC---------CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 158 DNTRPP---------GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 158 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
...... ......... ....... ....+...+..+.+|+.+||+.+|.+|||+.+|++.|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 213 SSPMTLFLKMIGPTHGQMTVTRLV-RVLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred ccccchhhhhcccccccccHHHHH-HHHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 321100 000000000 0001000 01112234568999999999999999999999999998
Q ss_pred Hh
Q 016913 229 YL 230 (380)
Q Consensus 229 ~~ 230 (380)
.+
T Consensus 282 ~~ 283 (284)
T cd05079 282 AI 283 (284)
T ss_pred hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=252.16 Aligned_cols=201 Identities=25% Similarity=0.331 Sum_probs=162.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..+...|+|+||+.+++|.+++.. ....+++..++.++.|++.||.|||..+ ++|+||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl 125 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDI 125 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999975 3467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 126 ~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 126 KAGNILLNEEGQAKLADFGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred CcceEEECCCCcEEEcccccchhcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999999997643221 12233557889999999998899999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+...... .. ....+.+ ..+......+.+++.+||+.+|++|||+.||++
T Consensus 204 ~~~~~~~------~~-------~~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 204 PMRAIFM------IP-------NKPPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhhhhh------hc-------cCCCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2211000 00 0000001 011223457889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=258.19 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=159.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|..++..++||||+++++|..++.. ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl 129 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDL 129 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCC
Confidence 5678999999999999999999999999999999998865 3457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||+||+++.++.++|+|||++...... ........++..|+|||++. +..++.++|||||||++|+|++|..|
T Consensus 130 kp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 207 (282)
T cd06643 130 KAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207 (282)
T ss_pred CcccEEEccCCCEEEcccccccccccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence 999999999999999999998753221 11223356889999999984 34578899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
|....... ..... ... ....+. .+......+.+++.+||+.+|.+||++.+|++.
T Consensus 208 ~~~~~~~~--~~~~~----~~~--~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 208 HHELNPMR--VLLKI----AKS--EPPTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ccccCHHH--HHHHH----hhc--CCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 86432211 11111 000 000111 112234678899999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=259.21 Aligned_cols=213 Identities=28% Similarity=0.417 Sum_probs=164.0
Q ss_pred ccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.+.||||+++++++.. +...++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~ 133 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHR 133 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 567899999999999987 5678999999999999999976 2336999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+||+++.++.++|+|||++......... .......++..|++||.+....++.++||||||+++|||++|..|+.
T Consensus 134 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 99999999999999999999999865422111 11122345567999999988899999999999999999999998875
Q ss_pred CCCCCCCc--------chhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 159 NTRPPGEH--------NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 159 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
........ ............ ......+......+.+|+.+||+.+|++|||+.||+++|+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 214 SPPAEFLRMIGIAQGQMIVTRLLELLKE----------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccchhccccccccccccHHHHHHHHHc----------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 43221100 000000000110 001111223346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=257.41 Aligned_cols=199 Identities=27% Similarity=0.368 Sum_probs=161.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|..++..|+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~d 126 (277)
T cd06642 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRD 126 (277)
T ss_pred HHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccC
Confidence 35788999999999999999999999999999999999864 56899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|+|+||++++++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 127 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred CChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999997543221 1222346788999999999989999999999999999999999998644
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.+... .... .....+.+ +......+.+++.+||+.+|++||++.+|+..
T Consensus 205 ~~~~~---~~~~----------~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 205 HPMRV---LFLI----------PKNSPPTL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred chhhH---Hhhh----------hcCCCCCC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 32111 1000 00011111 12334678899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=256.03 Aligned_cols=214 Identities=22% Similarity=0.278 Sum_probs=156.2
Q ss_pred cCCCCCCcccceEEEEe-----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 3 SLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
+.++||||+++++++.. ....++||||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ |+
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---iv 130 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IV 130 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 34689999999998864 345799999997 6999998762 2345899999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|+||||+|||++.++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 131 H~dikp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred cCCCCHHHEEECCCCCEEECccCccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence 9999999999999999999999999764321 1223356789999999999889999999999999999999999999
Q ss_pred CCCCCCCCcch-hhhhhh----cccccCCCC-CCCCcccc---CCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNL-VAWARP----LFKDRRKFP-KMADPLLQ---GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~-~~~~~~----~~~~~~~~~-~~~~~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
........... ...... .+......+ ....+... ..........+.+++.+||+.||++|||+.|++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 208 CGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 65432211110 000000 000000000 00000000 0011133456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=256.36 Aligned_cols=201 Identities=25% Similarity=0.417 Sum_probs=161.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~d 131 (267)
T cd06628 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRD 131 (267)
T ss_pred HHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---ccccc
Confidence 36788999999999999999999999999999999999976 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc----cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|+|+||+++.++.++|+|||+++........ .......|+..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 132 i~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p 211 (267)
T cd06628 132 IKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211 (267)
T ss_pred CCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCC
Confidence 9999999999999999999998765321111 111234578899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|...... ..+. .... ...+ ..+......+.+++.+||+.+|.+||++.+|++
T Consensus 212 ~~~~~~~---~~~~---~~~~-------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 212 FPDCTQL---QAIF---KIGE-------NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCccHH---HHHH---HHhc-------cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 9753221 1110 0000 0011 112233467889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=256.92 Aligned_cols=204 Identities=26% Similarity=0.376 Sum_probs=163.8
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDL 81 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDI 81 (380)
+.++||||++++++|..++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl 140 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDL 140 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCC
Confidence 35799999999999999999999999999999999986543445679999999999999999999996 67 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|.||+++.++.++|+|||++....... ......++..|++||++.+..++.++||||||+++|+|++|..||....
T Consensus 141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 141 TPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred CHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9999999999999999999997643222 2334568899999999998889999999999999999999999986432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.. ......... ...+... ......+.+++.+||+.||++||++.||.++|.
T Consensus 218 ~~------~~~~~~~~~------~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 218 ML------SLATKIVEA------VYEPLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HH------HHHHHHhhc------cCCcCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 21 111111110 0011111 122457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=277.41 Aligned_cols=187 Identities=29% Similarity=0.423 Sum_probs=157.8
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||.|+.++.+|.+.+++|+||||+.||++..+.+ ...|++..+..++..|+.||+|||+++ |||||||.+|
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdN 498 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDN 498 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhh
Confidence 69999999999999999999999999999444333 377999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~ 165 (380)
||||.+|.+||+|||+++.... ....+..++||+.|||||++.+..|+.+.|.|+|||+|||||.|+.||...+..+.
T Consensus 499 iLLD~eGh~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~ 576 (694)
T KOG0694|consen 499 LLLDTEGHVKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV 576 (694)
T ss_pred eEEcccCcEEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999999986322 23355678999999999999999999999999999999999999999985433211
Q ss_pred cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
...+..+. ..||.-.+.++++|+.++|..+|++|--+
T Consensus 577 ------FdsI~~d~------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 ------FDSIVNDE------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------HHHHhcCC------------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11112221 13455567789999999999999999755
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=254.68 Aligned_cols=206 Identities=23% Similarity=0.365 Sum_probs=163.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.+.||||+++++++.+ +..++||||+++++|.+++.. ....+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl 133 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDI 133 (270)
T ss_pred HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 577899999999999876 567899999999999999976 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.++|+|||++........ .......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 134 ~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 134 AARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred ChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999976433211 11222334568999999988889999999999999999986 99999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ...... ..... ..+...+..+.+++.+|+..+|.+|||+.+++..|..+..
T Consensus 213 ~~~~---~~~~~~----~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 213 KNND---VIGRIE----NGERL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CHHH---HHHHHH----cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3221 111110 00000 0122334678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=255.34 Aligned_cols=205 Identities=28% Similarity=0.434 Sum_probs=163.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++......++||||+++++|.+++.. .....+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di 129 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDL 129 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 5788999999999999998999999999999999999976 23356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.++|+|||++....... .........+..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 130 ~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 130 AARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred chheEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987643211 111122334568999999998889999999999999999998 89998643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
... ...... ... +. ...+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 209 ~~~---~~~~~~---~~~---~~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 209 TNR---EVLEQV---ERG---YR--------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHH---HHHHHH---HcC---CC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 221 111111 100 00 01112224578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=266.42 Aligned_cols=194 Identities=25% Similarity=0.290 Sum_probs=153.6
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||||+++++++...+..|+||||+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~N 126 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPEN 126 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHH
Confidence 799999999999999999999999999999999875 567999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
||++.++.++|+|||++...... ........||..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 127 ili~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~- 203 (330)
T cd05586 127 ILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ- 203 (330)
T ss_pred eEECCCCCEEEecCCcCcCCCCC--CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-
Confidence 99999999999999998752221 1122345689999999998764 5899999999999999999999999653221
Q ss_pred CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 016913 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL----IGDVVT 225 (380)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt----~~evl~ 225 (380)
.....+......++ .. .....+.+++.+||+.+|.+||+ +.++++
T Consensus 204 -----~~~~~i~~~~~~~~---~~--------~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 204 -----QMYRNIAFGKVRFP---KN--------VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----HHHHHHHcCCCCCC---Cc--------cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11111111111111 00 12356779999999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=253.72 Aligned_cols=202 Identities=27% Similarity=0.376 Sum_probs=158.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 132 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDI 132 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999999999999999999999999975 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+||+++.++.++|+|||++...... ........|+..|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 133 KGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 999999999999999999998754221 12223456899999999975 4468899999999999999999999986
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...+....... . ... ...+.+.. .......+.+++.+||+.+|++||++.+|++
T Consensus 211 ~~~~~~~~~~~--~----~~~-----~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 211 DLHPMRALFLM--T----KSN-----FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccchhhHHhh--h----ccC-----CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 44321111000 0 000 00011110 0112346789999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=258.04 Aligned_cols=204 Identities=28% Similarity=0.386 Sum_probs=162.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|+||+.+++++.+++..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+|
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 127 (285)
T cd05630 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRD 127 (285)
T ss_pred HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 367889999999999999999999999999999999998652 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 128 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 128 LKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred CCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987543221 122356899999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~ 226 (380)
........... .... . ...++......+.+|+.+||+.+|++||| +.|+++.
T Consensus 205 ~~~~~~~~~~~---~~~~---~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 205 KKKIKREEVER---LVKE---V--------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CccchHHHHHh---hhhh---h--------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 32111111100 0000 0 00112233456889999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=253.02 Aligned_cols=204 Identities=27% Similarity=0.358 Sum_probs=162.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..++..|+||||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 126 (262)
T cd06613 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRD 126 (262)
T ss_pred HHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecC
Confidence 36788999999999999999999999999999999999876 2367999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC---CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|+|+||+++.++.++|+|||++...... ........++..|+|||.+... .++.++||||||+++|+|++|..||
T Consensus 127 l~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~ 204 (262)
T cd06613 127 IKGANILLTEDGDVKLADFGVSAQLTAT--IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204 (262)
T ss_pred CChhhEEECCCCCEEECccccchhhhhh--hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999998753221 1122335678899999999877 8899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....+... ..... .. . +..+.+ ..+......+.+++.+||+.+|.+|||+.+|+.
T Consensus 205 ~~~~~~~~--~~~~~----~~--~---~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 205 FDLHPMRA--LFLIS----KS--N---FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCCHHHH--HHHHH----hc--c---CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 75432111 11000 00 0 000111 112234567889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=254.49 Aligned_cols=205 Identities=28% Similarity=0.450 Sum_probs=162.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++. .+..++||||+.+++|.+++.. .....+++.+++.++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~d 127 (260)
T cd05067 54 LMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127 (260)
T ss_pred HHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccc
Confidence 367889999999999875 4578999999999999999875 23456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.++|+|||++........ .......++..|+|||++....++.++||||||+++|||++ |..||..
T Consensus 128 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 128 LRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred ccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976432111 11223345678999999998889999999999999999998 9999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... ..+.... ..... ..+...+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 207 ~~~~---~~~~~~~----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 207 MTNP---EVIQNLE----RGYRM----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CChH---HHHHHHH----cCCCC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 4321 1111110 00000 1112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=254.77 Aligned_cols=199 Identities=25% Similarity=0.309 Sum_probs=162.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.+.||||+++++++.+++..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl 127 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDI 127 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCC
Confidence 5678999999999999999999999999999999999864 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 128 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 128 KAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred ChhhEEEcCCCCEEEcccccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 9999999999999999999997643221 12233467889999999988889999999999999999999999987543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+......+ ........+......+.+++.+||+.+|++||++.+|+..-
T Consensus 206 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 206 PMRVLFLI-----------------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred hHhHhhhh-----------------hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 22110000 00001112234567788999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=252.99 Aligned_cols=217 Identities=22% Similarity=0.283 Sum_probs=169.6
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
||.+++|||||.+..+++.. +.+|||||||+ -+|..++... +.+|...++..++.|+++||+|||... |+|
T Consensus 128 iLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilH 200 (419)
T KOG0663|consen 128 ILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILH 200 (419)
T ss_pred HHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEe
Confidence 46788999999999987654 46899999996 8999999884 478999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||||++|+|++..|.+||+|||+|+.+... ....+..+-|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++.|
T Consensus 201 RDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf 278 (419)
T KOG0663|consen 201 RDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF 278 (419)
T ss_pred cccchhheeeccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence 999999999999999999999999986543 2334567789999999999875 6999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhh-----hcccc--------cCCCCCCCCccccCCCChh-hHHHHHHHHHHhhhhCCCCCCCHHHH
Q 016913 158 DNTRPPGEHNLVAWAR-----PLFKD--------RRKFPKMADPLLQGRYPMR-GLYQALAVAAMCLQEQAATRPLIGDV 223 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~-----~~~~~--------~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~ev 223 (380)
.+....+..+.+-... .++.. ...++......++..++.. ....-++|+..+|.+||.+|-|+.|.
T Consensus 279 ~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~ 358 (419)
T KOG0663|consen 279 PGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG 358 (419)
T ss_pred CCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh
Confidence 8765544333321100 01110 0111222222333333332 34678899999999999999999998
Q ss_pred HHH
Q 016913 224 VTA 226 (380)
Q Consensus 224 l~~ 226 (380)
|+.
T Consensus 359 L~h 361 (419)
T KOG0663|consen 359 LKH 361 (419)
T ss_pred hcc
Confidence 864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=296.02 Aligned_cols=215 Identities=31% Similarity=0.548 Sum_probs=172.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++|||||+++++|.+.+..|+|||||++++|.++++. ++|..+..++.|++.||+|||....++|+||||
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 809 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence 5788999999999999999999999999999999999953 899999999999999999999654445999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++..++. |+...... ......++..|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 810 kp~Nil~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 810 SPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred CHHhEEECCCCceEEE-eccccccc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 9999999998888775 66554311 1122367899999999999999999999999999999999999995432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccC--CCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQG--RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
. .....+.|.+..... ......+++.+.. ..+.++...+.+++.+||+.+|++||||.||++.|+.+..
T Consensus 883 ~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 883 G-VHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred C-CCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2 233455565443322 1223345555543 2345667788999999999999999999999999998754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=252.78 Aligned_cols=217 Identities=25% Similarity=0.339 Sum_probs=166.0
Q ss_pred CccCCCCCC-cccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 1 MLSLLHHSN-LVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 1 iL~~l~Hpn-Iv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
||+.|+|+| ||.+++++...+ .+++||||++ -+|..|+.........++...+..++.||+.||+|||+++
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~- 140 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG- 140 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 477899999 999999998887 7899999995 9999999885433356888999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHh
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~ellt 152 (380)
|+||||||+||||++++.+||+|||+|+.+..... ..+..++|.+|.|||++.+. .|+...||||+|||+.||++
T Consensus 141 --IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~ 216 (323)
T KOG0594|consen 141 --ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT 216 (323)
T ss_pred --eecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence 99999999999999999999999999997543332 24556789999999999987 79999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhc-------ccccCCCCCCCCccccCCC-Ch-------hhHHHHHHHHHHhhhhCCCCC
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPL-------FKDRRKFPKMADPLLQGRY-PM-------RGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~~-~~-------~~~~~l~~li~~cl~~~P~~R 217 (380)
++..|.+....+ ++...++.+ +.....++. .+..+.... +. .......+++.+||+.+|.+|
T Consensus 217 ~~~LFpG~se~~--ql~~If~~lGtP~e~~Wp~v~~~~~-~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 217 RRPLFPGDSEID--QLFRIFRLLGTPNEKDWPGVSSLPD-YKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred CCCCCCCCcHHH--HHHHHHHHcCCCCccCCCCcccccc-ccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 999998665421 111111100 000000000 011111111 11 111368899999999999999
Q ss_pred CCHHHHHHH
Q 016913 218 PLIGDVVTA 226 (380)
Q Consensus 218 Pt~~evl~~ 226 (380)
.|+..+++.
T Consensus 294 ~Sa~~al~h 302 (323)
T KOG0594|consen 294 ISAKGALTH 302 (323)
T ss_pred cCHHHHhcC
Confidence 999999986
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=253.23 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=159.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..+ ..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl 126 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 5678999999999998764 579999999999999999762 3346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.++|+|||++...... ......+..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 127 ~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 127 AARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred CcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 999999999999999999998753221 112334568999999988899999999999999999997 88998754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... ..... ..... ...+...+..+.+++.+||+.+|+.||++.+|++.|+.
T Consensus 202 ~~~~---~~~~~----~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 202 SLKE---VKECV----EKGYR----------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHH---HHHHH----hCCCC----------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 3221 11111 11000 01112334678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=261.93 Aligned_cols=214 Identities=24% Similarity=0.377 Sum_probs=159.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dl 130 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDL 130 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 567899999999999999999999999997 689998876 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.+||+|||++....... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 131 kp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 131 KPQNLLINERGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred CHHHEEECCCCCEEECccccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999997532211 12223467899999999865 46889999999999999999999999765
Q ss_pred CCCCCcchhhhhh--------hcccccC-----CCCCC-CCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWAR--------PLFKDRR-----KFPKM-ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~--------~~~~~~~-----~~~~~-~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...+....+.... +.+.... .++.. ..+.+. ........+.+++.+||+.||.+|||+.|++..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLIN--HAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhh--hccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 4322211111100 0000000 00000 000000 011234567899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=253.30 Aligned_cols=203 Identities=27% Similarity=0.439 Sum_probs=161.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++......++||||+++++|.+++.. ....+++..++.++.+++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~d 125 (256)
T cd05112 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125 (256)
T ss_pred HHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36788999999999999999999999999999999999975 3356899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 126 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cccceEEEcCCCeEEECCCcceeecccCc-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999999987542221 111222335678999999998899999999999999999998 8888864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.... .... .+... .....+ ......+.+|+.+||+.+|++|||+.+|++.|
T Consensus 205 ~~~~---~~~~---~~~~~----~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 205 RSNS---EVVE---TINAG----FRLYKP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHH---HHHH---HHhCC----CCCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 3221 1111 11110 001111 11246788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=252.71 Aligned_cols=205 Identities=25% Similarity=0.420 Sum_probs=162.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|+||+++++++.. ...++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~d 127 (260)
T cd05073 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127 (260)
T ss_pred HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 3678899999999999887 778999999999999999976 23456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.+||+|||++........ .......++..|+|||++....++.++|||||||++|++++ |..||..
T Consensus 128 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 128 LRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred cCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999976432211 11222345678999999998889999999999999999998 8889864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... ....+.. ..... ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 207 ~~~~---~~~~~~~----~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 207 MSNP---EVIRALE----RGYRM----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCHH---HHHHHHh----CCCCC----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3221 1111111 10000 1112344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=258.75 Aligned_cols=157 Identities=25% Similarity=0.348 Sum_probs=127.7
Q ss_pred CccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPP-----DKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~-----~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
+|+.++||||+++++++.. +...|+||||+. ++|.+++..... ....+++..+..++.||+.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 128 (317)
T cd07868 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678899999999998854 456899999995 799888764211 1235899999999999999999999999
Q ss_pred CCeEecCCCCCcEEE----cCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcC-CCCCcCceeehHHHH
Q 016913 74 PPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVF 147 (380)
Q Consensus 74 ~~iiHrDIkp~NILl----~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl 147 (380)
|+||||||+|||+ +..+.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++
T Consensus 129 --ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (317)
T cd07868 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHH
Confidence 9999999999999 45578999999999864322211 112345789999999999774 589999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 016913 148 LELITGRKAIDNTR 161 (380)
Q Consensus 148 ~elltG~~p~~~~~ 161 (380)
|+|++|..||....
T Consensus 207 ~el~~g~~~f~~~~ 220 (317)
T cd07868 207 AELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHhCCCCccCCc
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=267.03 Aligned_cols=202 Identities=23% Similarity=0.298 Sum_probs=155.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|..++||||+++++++.+++..|||||||++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||
T Consensus 55 l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDL 127 (360)
T cd05627 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDI 127 (360)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCC
Confidence 5678999999999999999999999999999999999975 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCc---------------------------------cccccccccccccchhh
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKT---------------------------------HVSTRVMGTYGYCAPEY 128 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~ 128 (380)
||+||||+.++.++|+|||++......... .......||+.|+|||+
T Consensus 128 kp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 207 (360)
T cd05627 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207 (360)
T ss_pred CHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHH
Confidence 999999999999999999998643211100 00123469999999999
Q ss_pred hhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHH
Q 016913 129 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAM 208 (380)
Q Consensus 129 ~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~ 208 (380)
+.+..++.++|||||||++|||++|..||....+..... .+......+ .+.+. ......+.+++.+
T Consensus 208 ~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~------~i~~~~~~~--~~p~~------~~~s~~~~~li~~ 273 (360)
T cd05627 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR------KVMNWKETL--VFPPE------VPISEKAKDLILR 273 (360)
T ss_pred HcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHH------HHHcCCCce--ecCCC------CCCCHHHHHHHHH
Confidence 999999999999999999999999999997543321111 111100000 00000 0123567788888
Q ss_pred hhhhCCCCCCC---HHHHHH
Q 016913 209 CLQEQAATRPL---IGDVVT 225 (380)
Q Consensus 209 cl~~~P~~RPt---~~evl~ 225 (380)
|+ .+|.+|++ +.+|++
T Consensus 274 l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 274 FC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred hc-cChhhcCCCCCHHHHhc
Confidence 76 49999986 445443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=259.26 Aligned_cols=216 Identities=24% Similarity=0.330 Sum_probs=164.5
Q ss_pred CccCCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
||+.+.|||||+++-+|.... ...+|||||+ .+|.++++.+-..+..++...+.-+.+||++||.|||..+
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--- 145 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--- 145 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---
Confidence 467899999999999885543 2358999997 8999999976556788999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCC-CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhC
Q 016913 76 VIYRDLKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 76 iiHrDIkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG 153 (380)
|+||||||+|||+|.+ +.+||||||.|+....+. ....-..|..|.|||.+.+. .|+.+.||||.|||+.||+.|
T Consensus 146 IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g 222 (364)
T KOG0658|consen 146 ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKG 222 (364)
T ss_pred cccCCCChheEEEcCCCCeEEeccCCcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcC
Confidence 9999999999999976 899999999998754332 22334467889999999875 799999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccc--------------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKD--------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
++.|.+....+. ++..++ ++.. ...++.+........+......++++|+.++|+++|.+|.+
T Consensus 223 ~plFpG~s~~dQ--L~eIik-~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~ 299 (364)
T KOG0658|consen 223 QPLFPGDSSVDQ--LVEIIK-VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS 299 (364)
T ss_pred CcccCCCCHHHH--HHHHHH-HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC
Confidence 999987543222 211111 0000 11111221111111133455678999999999999999999
Q ss_pred HHHHHHH
Q 016913 220 IGDVVTA 226 (380)
Q Consensus 220 ~~evl~~ 226 (380)
+.|++..
T Consensus 300 ~~~~l~h 306 (364)
T KOG0658|consen 300 ALEALAH 306 (364)
T ss_pred HHHHhcc
Confidence 9999853
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=255.23 Aligned_cols=214 Identities=25% Similarity=0.329 Sum_probs=158.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..|+||||++ ++|.+++.... .+..+++..++.++.||+.||.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl 127 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDL 127 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCC
Confidence 567899999999999999999999999997 79999887532 2356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||+++.++.++|+|||++...... ........++..|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 128 ~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 128 KPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CHHHEEEcCCCcEEECcccceeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999998753221 1122334578899999988754 5788999999999999999999999754
Q ss_pred CCCCCcchhhhhhh-------cccc-------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARP-------LFKD-------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~-------~~~~-------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... ....... .+.. ...++......+. .........+.+++.+||+.||.+|||+.+|+.
T Consensus 206 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 206 SEIDQ--LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CHHHH--HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 22110 0000000 0000 0000000000000 001123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=241.02 Aligned_cols=199 Identities=22% Similarity=0.276 Sum_probs=160.9
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
+.|+|||||++.+.+......|||+|+|.|+.|..-+-. ...+++..+-.++.||+.||.|+|.++ |||||+|
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvk 137 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLK 137 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCC
Confidence 468999999999999999999999999999999776655 366888899999999999999999999 9999999
Q ss_pred CCcEEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 83 SSNILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 83 p~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|.|+||.. ..-+||+|||+|.... .........||++|||||++...+|+..+|||+.|||||-||.|.+||..
T Consensus 138 P~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 138 PENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred hhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 99999954 3458999999998754 33445668899999999999999999999999999999999999999974
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... ......+......++ +++-....+.+.+|+.+||..||++|.|+.|.|.
T Consensus 215 ~~~------~rlye~I~~g~yd~~--------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 215 EDQ------HRLYEQIKAGAYDYP--------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccH------HHHHHHHhccccCCC--------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 211 111112222111111 1112234567889999999999999999998875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=254.83 Aligned_cols=201 Identities=26% Similarity=0.359 Sum_probs=155.8
Q ss_pred ccCC-CCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLL-HHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
|+.+ +||||++++++|... ...|+||||+.+++|.+++.. .....+++..+..++.|++.||.|||+.+
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~~-- 131 (272)
T cd06637 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQHK-- 131 (272)
T ss_pred HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3445 799999999998753 468999999999999999976 23456899999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHH
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~e 149 (380)
|+|+||||+||++++++.++|+|||++...... ........|+..|+|||++. ...++.++|||||||++||
T Consensus 132 -ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 132 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred -CccCCCCHHHEEECCCCCEEEccCCCceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999999998753221 11223456889999999986 3367889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|++|..||........ .... .. ...... .+......+.+|+.+||+.+|.+|||+.+|+.
T Consensus 209 l~~g~~p~~~~~~~~~-----~~~~-~~--~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 209 MAEGAPPLCDMHPMRA-----LFLI-PR--NPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHhCCCCccccCHHHH-----HHHH-hc--CCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 9999999964322111 1100 00 000011 11123457889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=252.04 Aligned_cols=206 Identities=26% Similarity=0.365 Sum_probs=161.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 134 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDL 134 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCC
Confidence 6778999999999999999999999999999999999976 357899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC--CCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
+|+||+++.++.++|+|||++................++..|+|||.+.... ++.++|+||||+++|++++|..||..
T Consensus 135 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 135 KADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999999999997643222222233456888999999987654 88999999999999999999999864
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.... .... ...... ....+.. .........+.+++.+||+.+|..||++.+|++.
T Consensus 215 ~~~~-----~~~~-~~~~~~--~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 215 EEAI-----AAMF-KLGNKR--SAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cchH-----HHHH-Hhhccc--cCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3211 1110 000000 0001111 1112235688899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=252.21 Aligned_cols=203 Identities=25% Similarity=0.386 Sum_probs=163.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|+||+++++++.+.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~d 126 (256)
T cd08221 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRD 126 (256)
T ss_pred HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 367889999999999999999999999999999999999762 2456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|+|+||+++.++.+||+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 127 l~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred CChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999976433221 223456889999999998888899999999999999999999998653
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.... .. ..... ..+... +......+.+++.+||+.+|.+||++.++++.+
T Consensus 205 ~~~~---~~---~~~~~--~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 205 NPLN---LV---VKIVQ--GNYTPV---------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHH---HH---HHHHc--CCCCCC---------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2211 11 11111 011110 122345788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=255.78 Aligned_cols=204 Identities=29% Similarity=0.390 Sum_probs=161.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|+||+.+++++..++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+|
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~d 127 (285)
T cd05632 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRD 127 (285)
T ss_pred HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 366889999999999999999999999999999999988752 2346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||+++.++.++|+|||++...... .......|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 128 ikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 128 LKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred CCHHHEEECCCCCEEEecCCcceecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998753221 1123356899999999999889999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~ 226 (380)
........+ ......... .++......+.+|+.+||+.+|++||+ +.+++..
T Consensus 205 ~~~~~~~~~--~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 205 KEKVKREEV--DRRVLETEE------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CHHHHHHHH--HHhhhcccc------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 321111111 111111000 112233456789999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=263.54 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=160.3
Q ss_pred ccCC-CCCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhcCCC-----------------------------------
Q 016913 2 LSLL-HHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPP----------------------------------- 44 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~----------------------------------- 44 (380)
|..+ +||||++++++|... ...++||||+++|+|.+++.....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred HHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 4556 689999999988654 467899999999999999875210
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEE
Q 016913 45 ----------------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 96 (380)
Q Consensus 45 ----------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL 96 (380)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl 220 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKI 220 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEE
Confidence 0134788999999999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhc
Q 016913 97 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPL 175 (380)
Q Consensus 97 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 175 (380)
+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 221 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~---- 294 (343)
T cd05103 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR---- 294 (343)
T ss_pred EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHH----
Confidence 99999976432221111222345678999999999899999999999999999997 888886532211 11111
Q ss_pred ccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 176 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
....... ..+......+.+++..||+.+|++|||+.||++.|+.+..
T Consensus 295 ~~~~~~~----------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 295 LKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HhccCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111000 0011123468899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=257.16 Aligned_cols=200 Identities=25% Similarity=0.360 Sum_probs=160.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL 141 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDI 141 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999965 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 142 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CHHHEEECCCCCEEECcCccceEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987542221 11233468889999999999889999999999999999999999996543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+....... .... .+.. ..+......+.+++.+||+.+|++||++.+|+..
T Consensus 220 ~~~~~~~~------~~~~--~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 220 PLRALYLI------ATNG--TPEL-------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cchheeee------ccCC--CCCC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21110000 0000 0000 0112234567899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=254.96 Aligned_cols=203 Identities=28% Similarity=0.426 Sum_probs=161.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.||+.||.+||+.+ ++|+||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~di 124 (260)
T PF00069_consen 52 LRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDI 124 (260)
T ss_dssp HHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSB
T ss_pred cccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccc---cccccc
Confidence 4567899999999999999999999999998899999973 467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-cCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||++++++.++|+|||++... ...........++..|+|||++. +..++.++||||||+++|+|++|..||...
T Consensus 125 kp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 125 KPENILLDENGEVKLIDFGSSVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SGGGEEESTTSEEEESSGTTTEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999753 11222334567899999999998 788999999999999999999999999854
Q ss_pred CCCCCcchhhhhhh-cccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARP-LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.............. ..... . .........+.+++.+||+.+|++||++.+|++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~----------~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 203 NSDDQLEIIEKILKRPLPSS----------S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHHHTHHHHH----------T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhhhhhhhhccccccccc----------c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111111000 00000 0 000011368899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=259.08 Aligned_cols=189 Identities=25% Similarity=0.382 Sum_probs=153.4
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+|++|+++++++...+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~N 131 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDN 131 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 567888999999999999999999999999999975 467999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~ 165 (380)
||++.++.+||+|||+++..... ........||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 132 ill~~~~~ikL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-- 207 (323)
T cd05615 132 VMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-- 207 (323)
T ss_pred eEECCCCCEEEeccccccccCCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--
Confidence 99999999999999998753211 11223456899999999999989999999999999999999999999754321
Q ss_pred cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
.... .+..... .++......+.+++.+||+.+|.+|++..
T Consensus 208 -~~~~---~i~~~~~------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 208 -ELFQ---SIMEHNV------------SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -HHHH---HHHhCCC------------CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1111 1111111 11223345778999999999999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=252.84 Aligned_cols=200 Identities=25% Similarity=0.334 Sum_probs=157.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||++++++|...+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 121 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDV 121 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCC
Confidence 56789999999999999999999999999999996542 3688899999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.++|+|||++...... ......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 122 kp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 122 KPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred CHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 999999999999999999999754221 2234578999999999998899999999999999999999999997532
Q ss_pred CCCCc-chhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEH-NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..... ............ ..+.+ ........+.+++.+||+.+|+.||++.||+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 198 KNQGSLMPLQLLQCIVDE-------DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ccccccchHHHHHHHhcc-------CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 21111 001111100000 00000 011234578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=266.91 Aligned_cols=214 Identities=24% Similarity=0.364 Sum_probs=160.1
Q ss_pred CccCCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|+.++||||+++++++...+ ..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+
T Consensus 52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~--- 123 (372)
T cd07853 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG--- 123 (372)
T ss_pred HHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 356789999999999998876 7899999996 788888865 467999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||+|||++.++.+||+|||++....... ........++..|+|||++.+. .++.++|||||||++|||++|+
T Consensus 124 ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 202 (372)
T cd07853 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202 (372)
T ss_pred eeCCCCChHHEEECCCCCEEeccccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCC
Confidence 9999999999999999999999999997643221 1122334678899999998874 5789999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhh----------------hh-cccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 155 KAIDNTRPPGEHNLVAWA----------------RP-LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~----------------~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
.||....+......+... .. +.......+. ..... .........+.+|+.+||+.||.+|
T Consensus 203 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R 279 (372)
T cd07853 203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS-LPVLY--TLSSQATHEAVHLLCRMLVFDPDKR 279 (372)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc-hHHhc--ccCCCCCHHHHHHHHHhCCCChhhC
Confidence 999765432211111000 00 0000000000 00000 1112235678899999999999999
Q ss_pred CCHHHHHHH
Q 016913 218 PLIGDVVTA 226 (380)
Q Consensus 218 Pt~~evl~~ 226 (380)
||+.|+++.
T Consensus 280 ~t~~e~l~h 288 (372)
T cd07853 280 ISAADALAH 288 (372)
T ss_pred cCHHHHhcC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=254.77 Aligned_cols=208 Identities=24% Similarity=0.372 Sum_probs=162.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK-----EPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|++++||||+++++++.+.+..++||||+++++|.+++....... ..+++..++.++.|++.||.|||+.+
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--- 137 (275)
T cd05046 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--- 137 (275)
T ss_pred HHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---
Confidence 3678899999999999999999999999999999999998632111 26899999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~ 154 (380)
|+|+||||+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred cccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999986432111 111223456778999999988889999999999999999998 77
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.||...... ..+.... .. .+. ...+...+..+.+++.+||+.+|.+|||+.+|+..|.
T Consensus 217 ~p~~~~~~~---~~~~~~~---~~--~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 217 LPFYGLSDE---EVLNRLQ---AG--KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCccccchH---HHHHHHH---cC--CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 888543221 1111110 00 000 0111233467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=257.49 Aligned_cols=199 Identities=25% Similarity=0.365 Sum_probs=160.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..++||||+++++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL 141 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDI 141 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999865 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 142 ~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred CHHHEEECCCCCEEEccCccchhccccc--ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987532221 11233468889999999998889999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... . . ..... .+... .+......+.+++.+||..+|.+||++.+|+.
T Consensus 220 ~~~~~--~-~---~~~~~--~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 220 PLRAL--Y-L---IATNG--TPELQ-------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHH--H-H---HHhcC--CcccC-------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 21111 0 0 00000 00000 11223456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=253.32 Aligned_cols=199 Identities=27% Similarity=0.358 Sum_probs=161.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.++...++|+||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl 124 (274)
T cd06609 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDI 124 (274)
T ss_pred HHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5678999999999999999999999999999999999975 37999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||++++++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 125 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 125 KAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred CHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 9999999999999999999997653321 22234567889999999998889999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+.. ..... .. ...+.+... .....+.+++.+||..+|++|||+++|+..
T Consensus 203 ~~~---~~~~~---~~-------~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 203 PMR---VLFLI---PK-------NNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hHH---HHHHh---hh-------cCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 211 11000 00 001111110 034568899999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=264.98 Aligned_cols=212 Identities=23% Similarity=0.297 Sum_probs=155.8
Q ss_pred ccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||+++++++... ...|+||||++ ++|.+++.. .+++..+..++.|++.||.|||+.+
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--- 139 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--- 139 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999988654 35799999996 678777743 4889999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|+||||||+|||++.++.+||+|||+++.... ........||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 140 ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (355)
T cd07874 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred cccCCCChHHEEECCCCCEEEeeCcccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975322 122234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchh-h---------------hhhhcccccCCCCCC-----C-Ccccc--CCCChhhHHHHHHHHHHhhh
Q 016913 156 AIDNTRPPGEHNLV-A---------------WARPLFKDRRKFPKM-----A-DPLLQ--GRYPMRGLYQALAVAAMCLQ 211 (380)
Q Consensus 156 p~~~~~~~~~~~~~-~---------------~~~~~~~~~~~~~~~-----~-~~~l~--~~~~~~~~~~l~~li~~cl~ 211 (380)
||...........+ . ..............+ . +.... ...+......+.+|+.+||+
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 296 (355)
T cd07874 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence 99754321110000 0 000000000000000 0 00000 01111234578899999999
Q ss_pred hCCCCCCCHHHHHHH
Q 016913 212 EQAATRPLIGDVVTA 226 (380)
Q Consensus 212 ~~P~~RPt~~evl~~ 226 (380)
.||++|||+.||++.
T Consensus 297 ~dP~~Rps~~ell~h 311 (355)
T cd07874 297 IDPAKRISVDEALQH 311 (355)
T ss_pred CCchhcCCHHHHhcC
Confidence 999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=252.40 Aligned_cols=202 Identities=27% Similarity=0.387 Sum_probs=161.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|+||++++++|...+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 128 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDI 128 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 5678999999999999999999999999999999999975 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCC----CccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
+|+||+++.++.++|+|||++....... .........++..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 129 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 208 (265)
T cd06631 129 KGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208 (265)
T ss_pred CHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcc
Confidence 9999999999999999999987532111 111123356889999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
........ ..... ...... +. .+......+.+++.+||+.+|.+||++.+|+.
T Consensus 209 ~~~~~~~~---~~~~~---~~~~~~-----~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 209 ASMDRLAA---MFYIG---AHRGLM-----PR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ccCChHHH---HHHhh---hccCCC-----CC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 74322111 00000 000001 11 12234567889999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=251.15 Aligned_cols=200 Identities=25% Similarity=0.344 Sum_probs=159.9
Q ss_pred ccCCCCCCcccceEEEEe-CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++.++||||+++++.+.. +...|+||||+++++|.+++.. .....+++.+++.++.+++.||.+||+.+ ++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~d 127 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRD 127 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 567899999999998764 4467999999999999999976 23456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||+++.++.++|+|||++...... ........++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 128 i~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 128 LKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred CCchhEEEecCCcEEEecccceEEeccc--CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999764321 12223456888999999999999999999999999999999999998743
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.. .......... .++ ..+......+.+++.+||+.+|.+|||+.+|++
T Consensus 206 ~~------~~~~~~~~~~--~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 206 DM------NSLVYRIIEG--KLP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CH------HHHHHHHHhc--CCC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 21 1111111111 010 112234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=254.28 Aligned_cols=213 Identities=19% Similarity=0.206 Sum_probs=156.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+.+..++|+||++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl 125 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDL 125 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCC
Confidence 567899999999999999999999999996 688888865 2456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||+++.++.++|+|||++....... .......++..|+|||++.+. .++.++|||||||++|+|++|..|+...
T Consensus 126 ~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 126 KPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999999999999999999997542221 112334578899999998765 4789999999999999999999886432
Q ss_pred CCCCCcchhhhhhh-----------cccccCCCC--CCCCcccc-CCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARP-----------LFKDRRKFP--KMADPLLQ-GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~-----------~~~~~~~~~--~~~~~~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.... ........ ......... ........ ..........+.+++.+||+.||.+|||+++|+.
T Consensus 204 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 204 NDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCHH--HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 2211 00000000 000000000 00000000 0111234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=252.18 Aligned_cols=203 Identities=26% Similarity=0.326 Sum_probs=163.0
Q ss_pred ccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCC
Q 016913 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-----DKANP 74 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH-----~~~~~ 74 (380)
|+.++||||+++++++.. +...++||||+++++|.+++.........+++..++.++.+|+.||.||| +.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-- 130 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-- 130 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--
Confidence 678899999999998764 45679999999999999999875444678999999999999999999999 777
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCC
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
++|+||+|+||+++.++.+||+|||++........ ......++..|+|||++....++.++||||||+++|+|++|.
T Consensus 131 -i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 207 (265)
T cd08217 131 -VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207 (265)
T ss_pred -ceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999986533221 123346889999999999888999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.||...... ....... . ... ...+......+.+++.+||+.+|++||++.+|++.
T Consensus 208 ~p~~~~~~~---~~~~~~~----~-~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 208 PPFTARNQL---QLASKIK----E-GKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CcccCcCHH---HHHHHHh----c-CCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 999754311 1111110 0 001 11222345688899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=253.23 Aligned_cols=216 Identities=27% Similarity=0.306 Sum_probs=159.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++......++||||+++++|..++.. ...+++..++.++.||+.||+|||+.+ ++|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~d 125 (286)
T cd07847 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRD 125 (286)
T ss_pred HHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 35678999999999999999999999999998888877654 356999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+||+++.++.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 126 VKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred CChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986433221 1223457789999999876 4678999999999999999999999975
Q ss_pred CCCCCCcch-hhhhhhccc-------ccCCCCCCCCccccCCCC-----hhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNL-VAWARPLFK-------DRRKFPKMADPLLQGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....+.... ......... .......+..+......+ ......+.+|+.+||+.+|++||++.|++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 433211110 110000000 000000000010000000 123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=254.17 Aligned_cols=206 Identities=27% Similarity=0.347 Sum_probs=157.8
Q ss_pred ccCC-CCCCcccceEEEE-----eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLL-HHSNLVNLIGYCA-----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
++.+ +||||++++++|. .++..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 144 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--- 144 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4455 6999999999884 345689999999999999988753334567899999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----CCCCCcCceeehHHHHHHH
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~el 150 (380)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.. ..++.++|||||||++|+|
T Consensus 145 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred ccccCCCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 9999999999999999999999999987643221 12233468899999998753 4578899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
++|..||........ .... .. ........ +......+.+|+.+||+.+|++|||+.||++.+
T Consensus 223 ~~g~~p~~~~~~~~~--~~~~----~~--~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 223 GDGDPPLADLHPMRA--LFKI----PR--NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hcCCCCCCCCchhHH--Hhhc----cc--cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 999999875432111 0000 00 00001111 111235688999999999999999999999753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=266.56 Aligned_cols=215 Identities=26% Similarity=0.391 Sum_probs=176.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|.+|+|||||.++|+|..++-+++|+|||++|+|.+|+.+.. ...+.-.....|+.||+.|++||.+.+ +||||
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahe--apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd 662 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHE--LPTAETAPGVSICTQIASGMAYLESLN---FVHRD 662 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhcc--CcccccchhHHHHHHHHHHHHHHHhhc---hhhcc
Confidence 4778999999999999999999999999999999999998832 222566677889999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHH--hCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI--TGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ell--tG~~p~~ 158 (380)
|.+.|||++.++++||+|||+++-...++........+-..+|||+|.+..++++.++|||+||+++||++ |.+.||.
T Consensus 663 ~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 663 LATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred ccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 99999999999999999999999777777777776777788999999999999999999999999999985 6778887
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
.... .+.+.-...++.......-+ ..|.-++..+.+++.+||..+-++||++++|...|+..
T Consensus 743 ~lt~---e~vven~~~~~~~~~~~~~l-------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 743 QLTD---EQVVENAGEFFRDQGRQVVL-------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhH---HHHHHhhhhhcCCCCcceec-------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 5422 23333222233222211111 22345678889999999999999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=256.85 Aligned_cols=215 Identities=22% Similarity=0.324 Sum_probs=158.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dl 130 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDL 130 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 568899999999999999999999999996 699999876 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.++|+|||++....... .......++..|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 131 kp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 131 KPQNLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred CHHHEEECCCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999997532211 112234568899999998754 5788999999999999999999999754
Q ss_pred CCCCCcchhhhhh--------hcccccCCCCCCCCccccC----CCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWAR--------PLFKDRRKFPKMADPLLQG----RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
............. +.......+.....+.... .........+.+|+.+||+.||.+|||+.||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 209 TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 3221110000000 0000000000000000000 011123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=252.32 Aligned_cols=201 Identities=23% Similarity=0.331 Sum_probs=157.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..++||||+++++|..++.. ....+++..++.++.|++.+|.|||+.+ ++|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 136 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDL 136 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCC
Confidence 5788999999999999999999999999999999988865 2456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||+||+++.++.++|+|||++...... ........++..|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 137 kp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 214 (292)
T cd06644 137 KAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214 (292)
T ss_pred CcceEEEcCCCCEEEccCccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence 999999999999999999998653221 11223356788999999985 34578899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|....+. ......... ..+... .+......+.+++.+||+.+|++||++.+|++
T Consensus 215 ~~~~~~~------~~~~~~~~~--~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 215 HHELNPM------RVLLKIAKS--EPPTLS-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CccccHH------HHHHHHhcC--CCccCC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 8653321 111111110 000000 11223457889999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=262.73 Aligned_cols=212 Identities=24% Similarity=0.302 Sum_probs=155.0
Q ss_pred ccCCCCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||+++++++...+ ..|+||||++ ++|.+++.. .+++..+..++.||+.||.|||+.+
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--- 143 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG--- 143 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56789999999999986543 4799999996 677777643 4888999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|+||||||+|||++.++.+||+|||++..... ........||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 144 ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 220 (359)
T cd07876 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220 (359)
T ss_pred cccCCCCHHHEEECCCCCEEEecCCCcccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975321 112234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcch----------------hhhhhhcccccCCCC-----CCCCccccC---CCChhhHHHHHHHHHHhhh
Q 016913 156 AIDNTRPPGEHNL----------------VAWARPLFKDRRKFP-----KMADPLLQG---RYPMRGLYQALAVAAMCLQ 211 (380)
Q Consensus 156 p~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~-----~~~~~~l~~---~~~~~~~~~l~~li~~cl~ 211 (380)
||........... ..............+ +.....+.. .........+.+|+.+||+
T Consensus 221 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 300 (359)
T cd07876 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300 (359)
T ss_pred CCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhc
Confidence 9975432110000 000000000000000 000000000 0011124568899999999
Q ss_pred hCCCCCCCHHHHHHH
Q 016913 212 EQAATRPLIGDVVTA 226 (380)
Q Consensus 212 ~~P~~RPt~~evl~~ 226 (380)
.||++|||+.|+++.
T Consensus 301 ~dP~~R~t~~e~l~h 315 (359)
T cd07876 301 IDPDKRISVDEALRH 315 (359)
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=257.21 Aligned_cols=200 Identities=24% Similarity=0.354 Sum_probs=160.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dl 144 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDI 144 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCC
Confidence 5678999999999999999999999999999999998854 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|||++|..||....
T Consensus 145 kp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 145 KSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred CHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987542221 12233568899999999988889999999999999999999999986432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. ........ .+ .+.+.. .......+.+++.+||+.+|.+|||+.+|++.
T Consensus 223 ~~---~~~~~~~~------~~----~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 223 PL---QAMRRIRD------NL----PPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HH---HHHHHHHh------cC----CCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 21 11111100 00 111111 11223467789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=257.65 Aligned_cols=156 Identities=26% Similarity=0.344 Sum_probs=126.8
Q ss_pred CccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLP-----PDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
+|+.++||||+++++++.. +...++||||+. ++|.+++.... .....+++..+..++.||+.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~- 128 (317)
T cd07867 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678899999999999854 457899999996 68888875321 12235889999999999999999999999
Q ss_pred CCeEecCCCCCcEEE----cCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcC-CCCCcCceeehHHHH
Q 016913 74 PPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVF 147 (380)
Q Consensus 74 ~~iiHrDIkp~NILl----~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl 147 (380)
|+||||||+|||+ +.++.+||+|||+++........ .......+|..|+|||++.+. .++.++|||||||++
T Consensus 129 --ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 206 (317)
T cd07867 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHH
Confidence 9999999999999 45678999999999864332211 112345689999999998764 589999999999999
Q ss_pred HHHHhCCCCCCCC
Q 016913 148 LELITGRKAIDNT 160 (380)
Q Consensus 148 ~elltG~~p~~~~ 160 (380)
|||++|..||...
T Consensus 207 ~el~tg~~~f~~~ 219 (317)
T cd07867 207 AELLTSEPIFHCR 219 (317)
T ss_pred HHHHhCCCCcccc
Confidence 9999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=252.43 Aligned_cols=207 Identities=24% Similarity=0.377 Sum_probs=163.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrD 80 (380)
|+.++||||+++++++...+..++||||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .+ ++|+|
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~d 129 (284)
T cd06620 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRD 129 (284)
T ss_pred HHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccC
Confidence 5678999999999999999999999999999999999875 4578999999999999999999997 57 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|+|+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 130 l~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 130 IKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred CCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999998643211 122356899999999998889999999999999999999999999854
Q ss_pred CCCCC-----cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 161 RPPGE-----HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 161 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
..... .....+........ .+.+. ....+..+.+|+.+||+.+|.+|||+.||+++..-
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 206 NIDDDGQDDPMGILDLLQQIVQEP-------PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred chhhhhhhhhhHHHHHHHHHhhcc-------CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 33211 11111111111110 00010 01134578899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=251.04 Aligned_cols=210 Identities=25% Similarity=0.316 Sum_probs=162.2
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+|+.++||||++++++|... +.+++||||+++++|.+++.........++...+..++.||+.||.|||+.+ ++|
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H 128 (287)
T cd06621 52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIH 128 (287)
T ss_pred HHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 36788999999999998654 4689999999999999988654444567899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 129 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred CCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987532211 123457889999999998899999999999999999999999997
Q ss_pred CCCC--CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRP--PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.... ........+.... ..+.+.+... ........+.+++.+||+.+|.+|||+.||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 205 PEGEPPLGPIELLSYIVNM-----PNPELKDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cccCCCCChHHHHHHHhcC-----CchhhccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 5432 1111222222110 0011110000 00123567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=263.87 Aligned_cols=212 Identities=24% Similarity=0.302 Sum_probs=155.9
Q ss_pred ccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||+++++++... ...|+||||++ ++|.+++.. .+++..+..++.|++.||.|||+++
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~--- 146 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--- 146 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 5678999999999987543 35799999996 688887743 4889999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|+||||||+|||++.++.+||+|||+++.... ........+|..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 147 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 223 (364)
T cd07875 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223 (364)
T ss_pred eecCCCCHHHEEECCCCcEEEEeCCCccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999975322 112234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhh----------------hhhcccccCCCCC-----CCCccc---cCCCChhhHHHHHHHHHHhhh
Q 016913 156 AIDNTRPPGEHNLVAW----------------ARPLFKDRRKFPK-----MADPLL---QGRYPMRGLYQALAVAAMCLQ 211 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~-----~~~~~l---~~~~~~~~~~~l~~li~~cl~ 211 (380)
||...........+.. ..........+.. .....+ ...........+.+|+.+||+
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 303 (364)
T cd07875 224 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303 (364)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcC
Confidence 9975432211110000 0000000000000 000000 001111234578899999999
Q ss_pred hCCCCCCCHHHHHHH
Q 016913 212 EQAATRPLIGDVVTA 226 (380)
Q Consensus 212 ~~P~~RPt~~evl~~ 226 (380)
.||.+|||+.++++.
T Consensus 304 ~dP~~R~t~~e~L~h 318 (364)
T cd07875 304 IDASKRISVDEALQH 318 (364)
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=258.02 Aligned_cols=205 Identities=20% Similarity=0.213 Sum_probs=154.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|.+++..|+||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 128 (331)
T cd05597 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDI 128 (331)
T ss_pred HHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCC
Confidence 4567999999999999999999999999999999999975 2456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----CCCCCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||+|||++.++.+||+|||++........ .......||+.|+|||++.. ..++.++|||||||++|+|++|..|
T Consensus 129 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 129 KPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred CHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 99999999999999999999865322211 12233568999999999873 4578899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCC--CCCCCHHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQA--ATRPLIGDVVTA 226 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P--~~RPt~~evl~~ 226 (380)
|...... .....+......+. + .+. .......+.+++.+||..++ ..||++.++++.
T Consensus 208 f~~~~~~------~~~~~i~~~~~~~~-~-~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 208 FYAESLV------ETYGKIMNHKEHFQ-F-PPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCCCHH------HHHHHHHcCCCccc-C-CCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9643221 11111111110000 0 000 01134567788888775433 347888888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=265.10 Aligned_cols=207 Identities=24% Similarity=0.368 Sum_probs=174.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++++|||||+++|+|.+ ...|||||+++.|-|..||+. ++..|+..+...++.||+.||.|||++. +||||
T Consensus 444 iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRD 516 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRD 516 (974)
T ss_pred HHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhh
Confidence 4788999999999999986 578999999999999999987 6788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|...||||....-+||+|||+++.+........+ ...-..-|||||-+....++.++|||.|||.||||++ |..||..
T Consensus 517 IAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 517 IAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 9999999999999999999999986554443333 3334568999999999999999999999999999975 8899975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
-...+.. ..+...-+-+.|++++..+..|+.+||.++|.+||++.+|...|..+..
T Consensus 596 vkNsDVI-----------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 596 VKNSDVI-----------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ccccceE-----------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 4332211 1122222335677788899999999999999999999999999987644
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=249.23 Aligned_cols=203 Identities=30% Similarity=0.434 Sum_probs=160.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl 129 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDL 129 (258)
T ss_pred HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeeccc
Confidence 56789999999999999999999999999999999999762 1122899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
+|+||+++.++.++|+|||++........... ....++..|+|||.+....++.++||||||+++++|++ |..||...
T Consensus 130 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 130 AARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999976543321111 12336789999999988889999999999999999998 77887642
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.. ....... .... .. ..+......+.+++.+||..+|++|||+.++++.|
T Consensus 209 ~~---~~~~~~~---~~~~--~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 209 SN---EEVLEYL---KKGY--RL---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CH---HHHHHHH---hcCC--CC---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 21 1111111 1110 00 01112356788999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=252.72 Aligned_cols=216 Identities=26% Similarity=0.337 Sum_probs=161.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++|+||+++++++..++..++||||++++.|..++.. ...+++..++.++.+|+.||.|||..+ ++|+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 126 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDI 126 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999999999999999987666655543 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||+++.++.++|+|||++........ .......++..|+|||++... .++.++||||||+++|+|++|..||...
T Consensus 127 ~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 127 KPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred CHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999876433322 122335678899999999888 8899999999999999999999999754
Q ss_pred CCCCCcchhhhh-h-------hcccccC-----CCCCCCCc-cccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWA-R-------PLFKDRR-----KFPKMADP-LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~-~-------~~~~~~~-----~~~~~~~~-~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...+........ . ..+.... .+.....+ .+...++......+.+++.+||..+|++||++.+|+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 206 SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 321110000000 0 0000000 00011000 0111223334678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=249.49 Aligned_cols=201 Identities=20% Similarity=0.332 Sum_probs=162.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..++||||+.+++|.+++.. .....+++.+++.++.|++.||.|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~ 126 (256)
T cd08218 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRD 126 (256)
T ss_pred HHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 36788999999999999999999999999999999999975 22346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|+|+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|||||||++++|++|..||...
T Consensus 127 l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred CCHHHEEEcCCCCEEEeeccceeecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 99999999999999999999997543221 1122345788999999999888999999999999999999999998643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... ......... ..+ ..+......+.+++.+||+.+|.+||++.+|++
T Consensus 205 ~~~------~~~~~~~~~--~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 205 NMK------NLVLKIIRG--SYP---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CHH------HHHHHHhcC--CCC---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 221 111111110 010 112234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=255.32 Aligned_cols=200 Identities=23% Similarity=0.314 Sum_probs=160.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..++..++||||+++++|..++.. ..+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl 143 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDI 143 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999998854 56899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|||++|..||....
T Consensus 144 ~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 144 KSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred CHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987533221 11233568899999999998889999999999999999999999996432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. ..+.... .. . .+... ........+.+++.+||+.+|.+||++.+|++.
T Consensus 222 ~~---~~~~~~~---~~--~-----~~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 222 PV---QAMKRLR---DS--P-----PPKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HH---HHHHHHh---cc--C-----CCCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 21 1111110 00 0 00000 011234568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=266.20 Aligned_cols=201 Identities=27% Similarity=0.406 Sum_probs=165.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL--DWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
.++|+|.|||+++|.|.++++.-|.||-++||+|.++|.. .=++| .+.++-.+..||++||.|||+.. ||||
T Consensus 626 H~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHR 699 (1226)
T KOG4279|consen 626 HSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHR 699 (1226)
T ss_pred HHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeec
Confidence 4678999999999999999999999999999999999986 33556 68899999999999999999999 9999
Q ss_pred CCCCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC--CCCCcCceeehHHHHHHHHhCCCC
Q 016913 80 DLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 80 DIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||-+||||+. .|.+||+|||.++.... ...++..+.||.-|||||++..+ .|+.++|||||||++.||.||++|
T Consensus 700 DIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP 777 (1226)
T KOG4279|consen 700 DIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP 777 (1226)
T ss_pred cccCCcEEEeeccceEEecccccchhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence 99999999975 68899999999976432 33455667899999999999865 699999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|-....+.. ..+....++ ...+.|.+....+..+|++|+..+|.+||++.+++.
T Consensus 778 F~ElgspqA---AMFkVGmyK------------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 778 FVELGSPQA---AMFKVGMYK------------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eeecCChhH---hhhhhccee------------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 964332211 000001111 112345677788999999999999999999999986
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=252.19 Aligned_cols=194 Identities=28% Similarity=0.396 Sum_probs=159.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl 127 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDL 127 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCC
Confidence 6778999999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|.|||++.++.+||+|||++...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 128 ~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 128 KPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999864322 233568899999999988888999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
.. ... ......... ++......+.+++.+||+.+|.+|+ +++|++.
T Consensus 203 ~~---~~~---~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 203 PI---QIY---EKILEGKVR------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HH---HHH---HHHhcCCcc------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11 111 111111111 1222346778999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=248.50 Aligned_cols=204 Identities=23% Similarity=0.358 Sum_probs=161.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i 129 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDV 129 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999975 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCC-CeEEeecCCcccCCCCCC--ccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGF-HPKLSDFGLAKLGPVGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~-~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+|+||+++.++ .++|+|||++........ ........++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 130 ~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 130 KGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred CHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999998775 599999999876432211 111233568889999999988889999999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
............ ..... ......+......+.+++.+||+.+|.+||++.+++.
T Consensus 210 ~~~~~~~~~~~~---~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 210 AEKHSNHLALIF---KIASA----------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCcchHHHHH---HHhcc----------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 543221111111 00000 0011222334567889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=248.94 Aligned_cols=201 Identities=26% Similarity=0.377 Sum_probs=156.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL--DWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.++||||+++++++..++..++||||+++++|.+++.. ....+ ++..+..++.||+.||.|||..+ |+|+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~ 132 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHR 132 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 5688999999999999999999999999999999999975 22345 88899999999999999999999 9999
Q ss_pred CCCCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC--CCCCcCceeehHHHHHHHHhCCCC
Q 016913 80 DLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 80 DIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||||+||+++. ++.++|+|||++....... .......++..|+|||++... .++.++||||||+++|+|++|..|
T Consensus 133 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p 210 (268)
T cd06624 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210 (268)
T ss_pred CCCHHHEEEcCCCCeEEEecchhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999976 6789999999987542211 112234578899999998664 378999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|....... ...+....... ....+......+.+++.+||+.+|.+|||+.+|+.
T Consensus 211 ~~~~~~~~---~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 211 FIELGEPQ---AAMFKVGMFKI------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CccccChh---hhHhhhhhhcc------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 86432111 11111100000 01122234467889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=257.67 Aligned_cols=205 Identities=20% Similarity=0.193 Sum_probs=156.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+..++|+||+++++++.+.+..|+||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDl 128 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDI 128 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 4578999999999999999999999999999999999975 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||+|||++.++.+||+|||++....... ........||+.|+|||++. ...++.++|||||||++|||++|..|
T Consensus 129 kp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 129 KPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred CHHHEEECCCCCEEEeecchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 9999999999999999999986532211 11223457999999999986 34688999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTA 226 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 226 (380)
|...... .....+......+. ... ........+.+|+.+||..++.. |+++.++++.
T Consensus 208 f~~~~~~------~~~~~i~~~~~~~~--~p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 208 FYAESLV------ETYGKIMNHKERFQ--FPA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCCCHH------HHHHHHhCCCcccc--CCC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9743221 11111111111000 000 01123457788899988654443 6788888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=251.94 Aligned_cols=203 Identities=24% Similarity=0.325 Sum_probs=160.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..+...|+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 128 (280)
T cd06611 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRD 128 (280)
T ss_pred HHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 36788999999999999999999999999999999999875 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|+|+||+++.++.++|+|||++...... ........++..|++||++. ...++.++||||||+++|+|++|..
T Consensus 129 l~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 129 LKAGNILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206 (280)
T ss_pred CChhhEEECCCCCEEEccCccchhhccc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999998653221 11223356889999999985 3457789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||....... ......... .+.+. .+......+.+++.+||+.+|.+||++.+|++.
T Consensus 207 p~~~~~~~~------~~~~~~~~~--~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 207 PHHELNPMR------VLLKILKSE--PPTLD-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcccCCHHH------HHHHHhcCC--CCCcC-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 997543211 111111100 00000 112234578899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=255.80 Aligned_cols=206 Identities=23% Similarity=0.304 Sum_probs=161.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 127 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDL 127 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999976 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCc-------------cccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKT-------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
||.||+++.++.++|+|||+++........ .......++..|+|||++....++.++||||||+++|
T Consensus 128 ~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~ 207 (305)
T cd05609 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207 (305)
T ss_pred chHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHH
Confidence 999999999999999999998642111100 0111245788999999998888999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 149 ELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 149 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
||++|..||...... ... ......... .+... ...+..+.+|+.+||+.+|++||++.++.+.|+
T Consensus 208 el~~g~~pf~~~~~~---~~~---~~~~~~~~~-----~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 208 EFLVGCVPFFGDTPE---ELF---GQVISDDIE-----WPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHhCCCCCCCCCHH---HHH---HHHHhcccC-----CCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 999999999643221 111 111110000 01110 123456789999999999999999887777776
Q ss_pred H
Q 016913 229 Y 229 (380)
Q Consensus 229 ~ 229 (380)
.
T Consensus 273 ~ 273 (305)
T cd05609 273 H 273 (305)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=258.55 Aligned_cols=197 Identities=23% Similarity=0.325 Sum_probs=167.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||||+||++......+|||.|+-++|+|.+|+.+ ....|.+..+.+++.||+.|+.|+|... +|||||
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDL 144 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDL 144 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccC
Confidence 5678999999999999999999999999999999999987 4577999999999999999999999999 999999
Q ss_pred CCCcEEEc-CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCC-CcCceeehHHHHHHHHhCCCCCCC
Q 016913 82 KSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 82 kp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||+||.+. +-|-+||.|||++..+..+. .....+|...|-|||++.+..|+ ++.||||||||||.|+||++||+.
T Consensus 145 KPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 145 KPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred CcceeEEeeecCceEeeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 99998775 45789999999998654433 33557899999999999999887 678999999999999999999986
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.+.... +..+.|... ..|.....+|.+||..||..+|++|.+.+||+.
T Consensus 222 ANDSET----------------LTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 222 ANDSET----------------LTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccchhh----------------hhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 544222 222333222 235566789999999999999999999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=238.61 Aligned_cols=198 Identities=26% Similarity=0.370 Sum_probs=166.5
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
+.|+||||+++|+||.+....||++||..+|+|...|.+ .....+++.....++.|+|.||.|+|.++ |||||||
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiK 151 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIK 151 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCC
Confidence 579999999999999999999999999999999999986 34567999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 83 SSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 83 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
|+|+|++..+.+||+|||-+...+ .......+||..|++||...+...+...|+|++|++.||++.|.+||.....
T Consensus 152 penlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~ 227 (281)
T KOG0580|consen 152 PENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH 227 (281)
T ss_pred HHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh
Confidence 999999999999999999987532 2233557899999999999999999999999999999999999999985431
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
. ... +.+.+..-.++ ......+.++|.+|+..+|.+|.+..||++.-
T Consensus 228 ~---etY---krI~k~~~~~p------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 228 S---ETY---KRIRKVDLKFP------------STISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred H---HHH---HHHHHccccCC------------cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1 111 12222222222 22345788999999999999999999998753
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=253.29 Aligned_cols=204 Identities=26% Similarity=0.334 Sum_probs=156.9
Q ss_pred cCC-CCCCcccceEEEEeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 3 SLL-HHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 3 ~~l-~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
.++ +||||++++++|... +..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ +
T Consensus 73 ~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 149 (291)
T cd06639 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---I 149 (291)
T ss_pred HHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 345 799999999998754 3589999999999999998754334567999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-----CCCCcCceeehHHHHHHHH
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~SlGvvl~ell 151 (380)
+|+||||+||+++.++.++|+|||++....... .......++..|+|||++... .++.++|||||||++|+|+
T Consensus 150 vH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred eccCCCHHHEEEcCCCCEEEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 999999999999999999999999987543211 112234678899999998653 3689999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 152 TGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 152 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+|..||....... .+..+. .. ..+.+.+ +......+.+++.+||+.+|++||++.||++.
T Consensus 228 ~g~~p~~~~~~~~--~~~~~~----~~--~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 228 DGDPPLFDMHPVK--TLFKIP----RN--PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hCCCCCCCCcHHH--HHHHHh----cC--CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 9999986543211 111110 00 0111111 12234568899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=249.42 Aligned_cols=201 Identities=26% Similarity=0.343 Sum_probs=154.3
Q ss_pred CccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+|+.++||||+++++++.+ ....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H 129 (266)
T cd06651 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVH 129 (266)
T ss_pred HHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3568899999999999875 3578899999999999999975 356899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
+||+|+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 130 ~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf 209 (266)
T cd06651 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209 (266)
T ss_pred CCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence 999999999999999999999998754221111 1112345788999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... ... ...... ...+. .+......+..++ .||..+|++||+++||+.
T Consensus 210 ~~~~~~-----~~~-~~~~~~------~~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 210 AEYEAM-----AAI-FKIATQ------PTNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cccchH-----HHH-HHHhcC------CCCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 743211 100 000000 00111 1122233455565 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=250.43 Aligned_cols=204 Identities=27% Similarity=0.391 Sum_probs=157.7
Q ss_pred ccCC-CCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLL-HHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
++++ .||||++++++|.... ..++||||+++++|.+++......+..+++..++.++.|++.||.|||+.+
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-- 133 (275)
T cd06608 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-- 133 (275)
T ss_pred HHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--
Confidence 4455 7999999999997644 589999999999999998764334567999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----CCCCCcCceeehHHHHHH
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~e 149 (380)
++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++.. ..++.++||||||+++|+
T Consensus 134 -i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~ 210 (275)
T cd06608 134 -VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210 (275)
T ss_pred -cccCCCCHHHEEEccCCeEEECCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHH
Confidence 999999999999999999999999998753221 122234568889999998854 346789999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|++|..||....... .... .... ..+.+ ..+......+.+|+.+||..||++|||+.+|++
T Consensus 211 l~~g~~p~~~~~~~~--~~~~----~~~~-------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 211 LADGKPPLCDMHPMR--ALFK----IPRN-------PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhCCCCccccchHH--HHHH----hhcc-------CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 999999996432211 1111 0000 00011 112234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=252.19 Aligned_cols=199 Identities=24% Similarity=0.330 Sum_probs=160.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..++|+||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 141 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDI 141 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999975 56899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++...... ........|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 142 ~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 142 KSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred ChhhEEEcCCCcEEEcccccchhhccC--CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 999999999999999999988653221 112233568899999999988889999999999999999999999986533
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+. .......... .+.+. .+......+.+++.+||+.+|++||++.++++
T Consensus 220 ~~------~~~~~~~~~~-------~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 220 PL------QAMKRIRDNL-------PPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HH------HHHHHHHhcC-------CCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 21 1111111110 01111 01123457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=246.03 Aligned_cols=207 Identities=29% Similarity=0.411 Sum_probs=163.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|+||+++++.+..++..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l 128 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDI 128 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999976211 246899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCcc--ccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+|+||++++++.++|+|||++.......... ......++..|++||++... .++.++|+||||+++|+|++|..||.
T Consensus 129 ~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred CHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 9999999999999999999987654332221 22345688999999998877 78999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY-PMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....... ...... .. .+.+.... .......+.+++.+||+.+|++||++.+|+.
T Consensus 209 ~~~~~~~--~~~~~~---~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 209 KYPPMKV--LMLTLQ---ND--------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccChhhh--HHHHhc---CC--------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 5433211 111110 00 00111000 1233567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=245.77 Aligned_cols=198 Identities=28% Similarity=0.399 Sum_probs=160.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..+...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 128 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDI 128 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999976 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC-CCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||+++.++.+||+|||++....... ......++..|++||.+.... ++.++|+||||+++|+|++|..||...
T Consensus 129 ~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 129 KGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred CHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 9999999999999999999987642221 223456888999999987766 899999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.... ...... . ....+ ..+......+.+++.+||+.+|.+||++.+++.
T Consensus 206 ~~~~--~~~~~~----~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 206 EGVA--AVFKIG----R-SKELP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cHHH--HHHHHH----h-cccCC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 3111 111100 0 00011 112223467789999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=253.07 Aligned_cols=219 Identities=22% Similarity=0.254 Sum_probs=161.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..+++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dl 127 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSV 127 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 56789999999999999999999999999999999999862 3346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCC-----ccccccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHhCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDK-----THVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG~ 154 (380)
||+||+++.++.++|+|||.+........ ........++..|+|||++.. ..++.++|||||||++|||++|.
T Consensus 128 k~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~ 207 (314)
T cd08216 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207 (314)
T ss_pred CcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCC
Confidence 99999999999999999998865322111 111123456788999999876 35889999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhh----ccc------ccCCCCC----CCCcc----ccCCCChhhHHHHHHHHHHhhhhCCCC
Q 016913 155 KAIDNTRPPGEHNLVAWARP----LFK------DRRKFPK----MADPL----LQGRYPMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~----~~~------~~~~~~~----~~~~~----l~~~~~~~~~~~l~~li~~cl~~~P~~ 216 (380)
.||....... ........ ... ....... ..++. ....+.......+.+++.+||+.+|++
T Consensus 208 ~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 285 (314)
T cd08216 208 VPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPES 285 (314)
T ss_pred CCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCc
Confidence 9997543211 01100000 000 0000000 00000 111122234567889999999999999
Q ss_pred CCCHHHHHHHH
Q 016913 217 RPLIGDVVTAL 227 (380)
Q Consensus 217 RPt~~evl~~L 227 (380)
|||+.++++.-
T Consensus 286 Rpt~~~ll~~p 296 (314)
T cd08216 286 RPSASQLLNHS 296 (314)
T ss_pred CcCHHHHhcCc
Confidence 99999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=257.27 Aligned_cols=205 Identities=20% Similarity=0.198 Sum_probs=156.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+..++|+||+.+++++.+++..|+||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDl 128 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDI 128 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccC
Confidence 4567999999999999999999999999999999999975 2457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----CCCCCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||+|||++.++.+||+|||++....... ........|++.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 129 kp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 129 KPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred chHHEEEcCCCCEEEEeccceeeccCCC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 9999999999999999999997643221 112233569999999999876 4678999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTA 226 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 226 (380)
|...... .....+......+ . +.+.+ ......+.+++.+||+..+.. |++++++++.
T Consensus 208 f~~~~~~------~~~~~i~~~~~~~-~-~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 208 FYAESLV------ETYGKIMNHEERF-Q-FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccCCCHH------HHHHHHHcCCCcc-c-CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9743321 1111111111000 0 00101 123467888999999865544 4577777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=261.29 Aligned_cols=202 Identities=23% Similarity=0.281 Sum_probs=158.1
Q ss_pred ccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|.+|+ |.+||.||+|=..++.+|+||||-+ .+|..+|... ...++.-.+..+..|++.|+.++|.++ |||.|
T Consensus 413 L~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSD 485 (677)
T KOG0596|consen 413 LNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSD 485 (677)
T ss_pred HHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecC
Confidence 34444 8999999999999999999999884 9999999872 222332388899999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC-----------CCCcCceeehHHHHHH
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-----------LTLKSDVYSFGVVFLE 149 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~sDV~SlGvvl~e 149 (380)
|||.|+|+.+ |.+||+|||+|..+......-.....+||+.||+||.+.... .+.++||||||||||+
T Consensus 486 LKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq 564 (677)
T KOG0596|consen 486 LKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ 564 (677)
T ss_pred CCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence 9999999985 589999999998765544444456789999999999986532 5688999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhh-HHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRG-LYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
|+.|++||.... +.... +..+.+|....+||.-- ...+++++..||+.||++||++.++|+.
T Consensus 565 MvYgktPf~~~~-----n~~aK----------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 565 MVYGKTPFGQII-----NQIAK----------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhcCCchHHHH-----HHHHH----------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 999999997431 11111 23344443333333211 2239999999999999999999999863
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=250.37 Aligned_cols=197 Identities=24% Similarity=0.291 Sum_probs=157.9
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
..+||||+.+++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp 125 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKP 125 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCH
Confidence 45799999999999999999999999999999999875 456999999999999999999999999 99999999
Q ss_pred CcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 84 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 84 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
+|||+++++.++|+|||++...... ......|+..|+|||.+.. ..++.++|||||||++|+|++|..||.....
T Consensus 126 ~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 126 ANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred HHEEECCCCCEEEccCCcceecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 9999999999999999998653221 1223468999999999864 5688999999999999999999999975433
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
......... ... .. ...+......+.+++.+||..||++|| ++.++++.
T Consensus 202 ~~~~~~~~~---~~~--------~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 202 KDKHEIDRM---TLT--------VN----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCHHHHHHH---hhc--------CC----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 221111100 000 01 112233456788999999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=245.78 Aligned_cols=198 Identities=24% Similarity=0.277 Sum_probs=158.0
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
..++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~ 124 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIK 124 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 356899999999999999999999999999999999975 456899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 83 SSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 83 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
|+||+++.++.++|+|||++..... .....++..|++||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 125 p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 125 PENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred HHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999999875322 2234578899999999888889999999999999999999999964322
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
. ... ..........+.. ........+.+++.+||+.+|++||++.++.+.|
T Consensus 199 ~---~~~---~~~~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 199 D---AVF---DNILSRRINWPEE--------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred H---HHH---HHHHhcccCCCCc--------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1 111 1111100001110 1112346788999999999999999776665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=251.90 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=154.6
Q ss_pred cCC-CCCCcccceEEEEe------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 3 SLL-HHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 3 ~~l-~HpnIv~l~~~~~~------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+++ +||||+++++++.. .+..|+||||+.+++|.+++... ....+++..++.++.||+.||.|||+.+
T Consensus 67 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~--- 141 (282)
T cd06636 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK--- 141 (282)
T ss_pred HHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 344 79999999999853 46789999999999999999762 2455889999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHH
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~el 150 (380)
|+|+||+|+||+++.++.++|+|||++...... ........|+..|+|||.+. ...++.++|||||||++|+|
T Consensus 142 ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el 219 (282)
T cd06636 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219 (282)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHH
Confidence 999999999999999999999999998753211 11223356889999999876 34678899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
++|..||....+........ .. ..+.+ ........+.+|+.+||+.+|.+|||+.||++
T Consensus 220 ~~g~~p~~~~~~~~~~~~~~---------~~----~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 220 AEGAPPLCDMHPMRALFLIP---------RN----PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhCCCCccccCHHhhhhhHh---------hC----CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 99999996543221111000 00 00000 01123467889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=259.93 Aligned_cols=200 Identities=25% Similarity=0.237 Sum_probs=166.9
Q ss_pred CccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
||++|. |||||.++++|++.+.+++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+.+ |+||
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHr 159 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHR 159 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceec
Confidence 467788 999999999999999999999999999999999873 3999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCC----CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 80 DLKSSNILLDEG----FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 80 DIkp~NILl~~~----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
||||+|+|+... +.+|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..
T Consensus 160 DlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 160 DLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred cCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 999999999543 4799999999987543 344566899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
||...........+ ..... .+...+-......+.+++..||..||..|+|+.++++
T Consensus 237 PF~~~~~~~~~~~i------~~~~~--------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 237 PFWGETEFEIFLAI------LRGDF--------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCcCCChhHHHHHH------HcCCC--------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 99754432221111 11111 1222223345678889999999999999999999998
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=251.22 Aligned_cols=214 Identities=23% Similarity=0.317 Sum_probs=156.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++.+++..++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+|
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~d 128 (291)
T cd07844 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRD 128 (291)
T ss_pred HHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 3678899999999999999999999999997 599999876 2347899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+||+++.++.+||+|||+++...... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 129 l~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 129 LKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred CCHHHEEEcCCCCEEECccccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999987432111 11122346789999999875 4688999999999999999999999965
Q ss_pred CCCCCCcchhhhhhhcccc--------cCC--------CCCCCCccccCCC-ChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 160 TRPPGEHNLVAWARPLFKD--------RRK--------FPKMADPLLQGRY-PMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~--------~~~--------~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
..... ..+......... ... ........+.... .......+.+++.+||+.+|.+|||+.+
T Consensus 207 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e 284 (291)
T cd07844 207 STDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284 (291)
T ss_pred CccHH--HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence 43110 000000000000 000 0000000000000 0111267789999999999999999999
Q ss_pred HHH
Q 016913 223 VVT 225 (380)
Q Consensus 223 vl~ 225 (380)
++.
T Consensus 285 ~l~ 287 (291)
T cd07844 285 AMK 287 (291)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=247.60 Aligned_cols=193 Identities=21% Similarity=0.272 Sum_probs=156.6
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||||++++++|...+..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 139 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLEN 139 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 699999999999999999999999999999999976 348999999999999999999999999 9999999999
Q ss_pred EEEcCCC-CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 86 ILLDEGF-HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 86 ILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
|+++.++ .++|+|||++...... ....++..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 140 il~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~- 212 (267)
T PHA03390 140 VLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE- 212 (267)
T ss_pred EEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-
Confidence 9999988 9999999998753211 2245788999999999989999999999999999999999999743221
Q ss_pred CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 016913 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-IGDVVT 225 (380)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~ 225 (380)
......+.... .. .. ..+......+.+++.+||+.+|.+||+ ++++++
T Consensus 213 ~~~~~~~~~~~-~~---~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 213 ELDLESLLKRQ-QK---KL---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhhHHHHHHhh-cc---cC---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11112221111 00 00 011134567889999999999999995 688874
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=246.43 Aligned_cols=200 Identities=28% Similarity=0.340 Sum_probs=161.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.++...++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl 119 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDL 119 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 5678999999999999999999999999999999999976 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... ......++..|++||.+....++.++|+||||+++|+|++|..||....
T Consensus 120 ~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 9999999999999999999998643321 2233467889999999988889999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 225 (380)
.. ........... .....++......+.+++.+||+.+|.+||+ ++|+++
T Consensus 197 ~~----~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 197 ED----PMEIYNDILKG----------NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CC----HHHHHHHHhcc----------CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 21 11111111100 0011122233567899999999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=252.14 Aligned_cols=215 Identities=25% Similarity=0.334 Sum_probs=158.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..++..++||||+++++|..+... ...+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l 126 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDI 126 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999998888887754 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||++++++.++|+|||++....... .......++..|+|||++.+ ..++.++||||||+++|||++|.+||...
T Consensus 127 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 127 KPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999987643222 22233457889999999875 35788999999999999999999988643
Q ss_pred CCCCCc-chhhhhhhccc-------c-----cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEH-NLVAWARPLFK-------D-----RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~-~~~~~~~~~~~-------~-----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... ....+...+.. . ...++..................+.+++.+||+.+|++||++.+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 221100 00000000000 0 00000000000000011233567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=255.28 Aligned_cols=203 Identities=27% Similarity=0.321 Sum_probs=159.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..|+||||+.+++|.+++.. .....+++..+..++.|++.||+|||..+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 129 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDL 129 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5678999999999999999999999999999999999975 23457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCc---------------------------cccccccccccccchhhhhcCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKT---------------------------HVSTRVMGTYGYCAPEYAMTGQL 134 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~ 134 (380)
||+||+++.++.++|+|||++......... .......|+..|+|||++.+..+
T Consensus 130 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 209 (316)
T cd05574 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209 (316)
T ss_pred ChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC
Confidence 999999999999999999998753221110 01112467889999999998889
Q ss_pred CCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCC
Q 016913 135 TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQA 214 (380)
Q Consensus 135 s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P 214 (380)
+.++||||||+++|+|++|..||........ + .........++. .......+.+++.+||+.+|
T Consensus 210 ~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-----~-~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 210 GSAVDWWTLGILLYEMLYGTTPFKGSNRDET-----F-SNILKKEVTFPG----------SPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred CchHHHHHHHHHHHHHhhCCCCCCCCchHHH-----H-HHHhcCCccCCC----------ccccCHHHHHHHHHHccCCH
Confidence 9999999999999999999999975432110 0 011111001110 11135788999999999999
Q ss_pred CCCCC----HHHHHH
Q 016913 215 ATRPL----IGDVVT 225 (380)
Q Consensus 215 ~~RPt----~~evl~ 225 (380)
++||+ +++|+.
T Consensus 274 ~~R~s~~~~~~~ll~ 288 (316)
T cd05574 274 SKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHCCCchhhHHHHHc
Confidence 99999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=251.47 Aligned_cols=203 Identities=26% Similarity=0.351 Sum_probs=158.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrD 80 (380)
++.++||||+++++++..++..|+||||++ ++|.+++.........+++..++.++.|++.||.|||++ + ++|+|
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~d 129 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRD 129 (283)
T ss_pred HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCC
Confidence 456789999999999999999999999996 899888876444456799999999999999999999997 7 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc----CCCCCcCceeehHHHHHHHHhCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||+||+++.++.+||+|||++..+... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus 130 lkp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 130 VKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred CCHHHEEECCCCCEEEeecccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence 9999999999999999999999764221 12233568889999998865 4568899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
|...... ...+. ..... ..+.+.. ...+..+.+++.+||+.+|++||++.+|++.
T Consensus 207 ~~~~~~~--~~~~~---~~~~~--~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 207 YDSWKTP--FQQLK---QVVEE--PSPQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCccccC--HHHHH---HHHhc--CCCCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9643211 01110 00000 0011100 1134578899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=269.38 Aligned_cols=208 Identities=19% Similarity=0.234 Sum_probs=151.8
Q ss_pred CCCCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCC
Q 016913 5 LHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLK 82 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDIk 82 (380)
..|++|++++++|..+ ..+|||||++ +++|.+++.. ...+++..+..++.||+.||+|||. .+ |||||||
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlK 259 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLK 259 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence 3566799999998765 5789999999 7899998875 4679999999999999999999998 48 9999999
Q ss_pred CCcEEEcCCC----------------CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHH
Q 016913 83 SSNILLDEGF----------------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146 (380)
Q Consensus 83 p~NILl~~~~----------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvv 146 (380)
|+||||+.++ .+||+|||++... ........||..|+|||++.+..|+.++|||||||+
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 334 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHH
Confidence 9999998765 4999999988642 122344679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhhhhh-----------------hcccccCCCCCCCCcc-----ccCC--CChhhHHHH
Q 016913 147 FLELITGRKAIDNTRPPGEHNLVAWAR-----------------PLFKDRRKFPKMADPL-----LQGR--YPMRGLYQA 202 (380)
Q Consensus 147 l~elltG~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~-----l~~~--~~~~~~~~l 202 (380)
+|||++|+.||+..........+.... .++.....+....++. .... ........+
T Consensus 335 l~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (467)
T PTZ00284 335 IYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414 (467)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHH
Confidence 999999999997654322111111000 0000000000000000 0000 000123467
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 016913 203 LAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 203 ~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.+||.+||+.||++|||+.|+++
T Consensus 415 ~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 415 CDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHHHhCCcChhhCCCHHHHhc
Confidence 79999999999999999999997
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=270.78 Aligned_cols=218 Identities=20% Similarity=0.200 Sum_probs=156.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++++|||||++++++...+..|+|++++. ++|.+++.... ..........+..++.||+.||.|||+++ ||||
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHr 291 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHR 291 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 3678899999999999999999999999995 78888876521 11223446678889999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC-CC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA-ID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p-~~ 158 (380)
||||+||||+.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|..+ |.
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 999999999999999999999998643221 1122346799999999999999999999999999999999998754 43
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCC-------------------CCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPK-------------------MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
.........+......+......++. .+.+.+. .......+.+++.+||+.||.+|||
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~kmL~~DP~~Rps 447 (501)
T PHA03210 371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR---NLGLPADFEYPLVKMLTFDWHLRPG 447 (501)
T ss_pred CCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH---hcCCChHHHHHHHHHhccCcccCcC
Confidence 32211111111111110000000110 0000010 0012345678899999999999999
Q ss_pred HHHHHHH
Q 016913 220 IGDVVTA 226 (380)
Q Consensus 220 ~~evl~~ 226 (380)
+.|++..
T Consensus 448 a~elL~h 454 (501)
T PHA03210 448 AAELLAL 454 (501)
T ss_pred HHHHhhC
Confidence 9999864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=248.46 Aligned_cols=210 Identities=24% Similarity=0.355 Sum_probs=161.0
Q ss_pred CccCCCCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKA 72 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 72 (380)
+|+.++||||+++++++.... ..++++||+.+++|..++.... .....+++..++.++.|++.||+|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 133 (273)
T cd05074 54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN 133 (273)
T ss_pred HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 367889999999999986542 2478999999999998875421 12235889999999999999999999999
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
|+|+||||+||+++.++.+||+|||+++...............++..|++||.+....++.++||||||+++|+|++
T Consensus 134 ---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 134 ---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred ---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence 99999999999999999999999999986432221111222345678999999998889999999999999999999
Q ss_pred -CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 153 -GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 153 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
|..||..... .....+... ...+. .+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 211 ~g~~p~~~~~~---~~~~~~~~~----~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 211 RGQTPYAGVEN---SEIYNYLIK----GNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCCCH---HHHHHHHHc----CCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8888864322 111111110 00000 1122346889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=259.66 Aligned_cols=208 Identities=22% Similarity=0.304 Sum_probs=154.4
Q ss_pred CccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|+.++||||+++++++... ...|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~-- 138 (343)
T cd07878 67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG-- 138 (343)
T ss_pred HHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 36788999999999988543 3578999998 7999988854 56999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhC
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG 153 (380)
|+||||||+|||++.++.+||+|||++..... ......|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 -ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (343)
T cd07878 139 -IIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212 (343)
T ss_pred -eecccCChhhEEECCCCCEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHC
Confidence 99999999999999999999999999986422 1233568999999999877 4689999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhccccc-----------------CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDR-----------------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~ 216 (380)
..||........ +..+. ...... ..++......+... .......+.+|+.+||+.||.+
T Consensus 213 ~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~ 288 (343)
T cd07878 213 KALFPGNDYIDQ--LKRIM-EVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDK 288 (343)
T ss_pred CCCCCCCCHHHH--HHHHH-HHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhh
Confidence 999975432111 00000 000000 00000000000000 0012345789999999999999
Q ss_pred CCCHHHHHHH
Q 016913 217 RPLIGDVVTA 226 (380)
Q Consensus 217 RPt~~evl~~ 226 (380)
|||+.|+++.
T Consensus 289 R~s~~ell~h 298 (343)
T cd07878 289 RISASEALAH 298 (343)
T ss_pred CCCHHHHhcC
Confidence 9999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=248.76 Aligned_cols=203 Identities=26% Similarity=0.326 Sum_probs=160.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..|+||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~d 120 (277)
T cd05577 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRD 120 (277)
T ss_pred HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 367889999999999999999999999999999999999762 2246899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|+|+||+++.++.++|+|||++..... ........++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 121 i~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 121 LKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999875432 11223345788999999998888999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
......... ....... ...++......+.+++.+||+.+|.+|| ++.+++.
T Consensus 198 ~~~~~~~~~--~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 198 KEKVEKEEL--KRRTLEM------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cccccHHHH--Hhccccc------------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 331111111 0101110 0112223356788999999999999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=246.11 Aligned_cols=200 Identities=26% Similarity=0.403 Sum_probs=160.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..++..++||||+++++|.+++... ....+++..++.++.+++.+|.|||+++ ++|+|
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~d 126 (256)
T cd08220 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRD 126 (256)
T ss_pred HHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 367889999999999999999999999999999999999762 2445899999999999999999999999 99999
Q ss_pred CCCCcEEEcCC-CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|+|+||+++.+ +.++|+|||++....... ......++..|+|||.+....++.++||||||+++|+|++|..||..
T Consensus 127 l~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 127 LKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred CCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 99999999865 457999999998643221 22235678899999999988899999999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... .... ... ..... .+......+.+++..||+.+|.+|||+.||++
T Consensus 204 ~~~~~---~~~~---~~~--~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 204 ANLPA---LVLK---IMS--GTFAP---------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CchHH---HHHH---HHh--cCCCC---------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 43221 1111 110 00111 11223457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=247.94 Aligned_cols=204 Identities=26% Similarity=0.400 Sum_probs=161.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrD 80 (380)
|+.++||||+++++++..++..++|+||+++++|.+++... ...+++..+..++.|++.||+|||+ .+ ++|+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~d 126 (265)
T cd06605 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRD 126 (265)
T ss_pred HHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCC
Confidence 56788999999999999999999999999999999999762 2678999999999999999999999 88 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 127 l~~~ni~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 127 VKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred CCHHHEEECCCCCEEEeecccchhhHHH----HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999998653211 111266888999999999889999999999999999999999999654
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.... .............. .+.+.. ......+.+++.+||..+|++|||+.+++..
T Consensus 203 ~~~~-~~~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 203 NDPP-DGIFELLQYIVNEP-------PPRLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cccc-ccHHHHHHHHhcCC-------CCCCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 2211 11111111111110 011100 0134578899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=255.44 Aligned_cols=218 Identities=22% Similarity=0.254 Sum_probs=158.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|..++..++||||+.+++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 53 ~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDl 127 (328)
T cd08226 53 SHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNI 127 (328)
T ss_pred HHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 45689999999999999999999999999999999999763 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhcC--CCCCcCceeehHHHHHHHHhCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlGvvl~elltG~ 154 (380)
||+|||++.++.++++||+.+.......... ......++..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 128 kp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 128 KASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207 (328)
T ss_pred CHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999998654321111100 01112345679999999763 5789999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhh-c--------ccc-------c---------------CCCCCCCCccccCCCChhhHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARP-L--------FKD-------R---------------RKFPKMADPLLQGRYPMRGLYQAL 203 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~-~--------~~~-------~---------------~~~~~~~~~~l~~~~~~~~~~~l~ 203 (380)
.||....... ........ . +.. . .....+....+....+......+.
T Consensus 208 ~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (328)
T cd08226 208 VPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285 (328)
T ss_pred CCCCCcChHH--HHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHH
Confidence 9997543211 00000000 0 000 0 000001111122222334567899
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 016913 204 AVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 204 ~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+|+.+||+.||++|||+.|+++.
T Consensus 286 ~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 286 NLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred HHHHHHccCCcccCCCHHHHhhC
Confidence 99999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=249.80 Aligned_cols=203 Identities=24% Similarity=0.336 Sum_probs=158.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrD 80 (380)
|++++||||+++++++...+..++||||+++++|..++... .....+++..+..++.+++.||.|||+ .+ |+|+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~d 128 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRD 128 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCC
Confidence 56789999999999999999999999999999999998752 123479999999999999999999997 47 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC------CCCCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||+||+++.++.++|+|||++...... ......++..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 129 l~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 204 (286)
T cd06622 129 VKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204 (286)
T ss_pred CCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCC
Confidence 9999999999999999999998753221 22334578899999998554 3588999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.||........ .......... .. ...+......+.+++.+||+.+|++||++.+++..
T Consensus 205 ~pf~~~~~~~~---~~~~~~~~~~--~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 205 YPYPPETYANI---FAQLSAIVDG--DP---------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCcchhhH---HHHHHHHhhc--CC---------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 99965322111 1111110000 00 01122345678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=278.28 Aligned_cols=214 Identities=21% Similarity=0.265 Sum_probs=163.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------DKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
++.++||||+++++++.+++..|+||||++|++|.+++..... ....+++..++.++.||+.||+|||+.+
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-- 133 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-- 133 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5678999999999999999999999999999999999874211 1234677889999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC----------------ccccccccccccccchhhhhcCCCCCcC
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK----------------THVSTRVMGTYGYCAPEYAMTGQLTLKS 138 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~s 138 (380)
|+||||||+|||++.++.++|+|||+++....... ........||+.|+|||++.+..++.++
T Consensus 134 -IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kS 212 (932)
T PRK13184 134 -VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST 212 (932)
T ss_pred -ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHh
Confidence 99999999999999999999999999976421100 0011235699999999999999999999
Q ss_pred ceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 139 DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 139 DV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
|||||||++|||++|..||........ . ... .... +....+ ....+..+.+++.+||+.+|++||
T Consensus 213 DIWSLGVILyELLTG~~PF~~~~~~ki---~-~~~-~i~~----P~~~~p------~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 213 DIYALGVILYQMLTLSFPYRRKKGRKI---S-YRD-VILS----PIEVAP------YREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred HHHHHHHHHHHHHHCCCCCCCcchhhh---h-hhh-hccC----hhhccc------cccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999975322111 0 000 0000 000000 012345678999999999999996
Q ss_pred -CHHHHHHHHHHhhhc
Q 016913 219 -LIGDVVTALTYLASQ 233 (380)
Q Consensus 219 -t~~evl~~L~~~~~~ 233 (380)
++.++++.|+.....
T Consensus 278 ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 278 SSVQELKQDLEPHLQG 293 (932)
T ss_pred CHHHHHHHHHHHHHhc
Confidence 677778888776543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=248.92 Aligned_cols=215 Identities=24% Similarity=0.270 Sum_probs=159.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+++.++||||+++++++.+.+..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+|
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 127 (298)
T cd07841 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRD 127 (298)
T ss_pred HHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 357789999999999999999999999999 8999999976 1237999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|.++|..
T Consensus 128 l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 128 LKPNNLLIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CChhhEEEcCCCCEEEccceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 99999999999999999999997643221 12233456788999999865 4678999999999999999999877764
Q ss_pred CCCCCCcchhhhhhhc-------ccccCCCCCCCCccccCC-----CChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPL-------FKDRRKFPKMADPLLQGR-----YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...... +....... +................. ........+.+++.+||+.+|++|||+.||+..
T Consensus 206 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 206 DSDIDQ--LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CccHHH--HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 332111 00000000 000000000000000001 112335678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=250.70 Aligned_cols=215 Identities=24% Similarity=0.302 Sum_probs=159.3
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++||||+++++++... +..|+||||++ ++|.+++.. ....+++..++.++.||+.||+|||+.+ ++|+
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~ 130 (293)
T cd07843 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHR 130 (293)
T ss_pred HHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 5678999999999999877 88999999997 699999876 2346999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.
T Consensus 131 dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 131 DLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred cCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998643321 112334578899999998754 46899999999999999999999997
Q ss_pred CCCCCCCcchhh-hh-------h----hccccc-CCCCCCCCccccCCCChh-hHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 016913 159 NTRPPGEHNLVA-WA-------R----PLFKDR-RKFPKMADPLLQGRYPMR-GLYQALAVAAMCLQEQAATRPLIGDVV 224 (380)
Q Consensus 159 ~~~~~~~~~~~~-~~-------~----~~~~~~-~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl 224 (380)
..........+. .. + .+.... ..........+...++.. ....+.+++.+||+.+|++|||+.|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 209 GKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred CCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 543221111100 00 0 000000 000111111112222222 356788999999999999999999998
Q ss_pred H
Q 016913 225 T 225 (380)
Q Consensus 225 ~ 225 (380)
.
T Consensus 289 ~ 289 (293)
T cd07843 289 K 289 (293)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=247.42 Aligned_cols=200 Identities=25% Similarity=0.289 Sum_probs=156.4
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.++||||+++++++.+. ..+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~ 130 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHR 130 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 5678999999999998764 467899999999999999975 356889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 131 dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 131 DIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred CCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999998754221111 11223458889999999988889999999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... ..... .... .. ....+......+.+++.+|+. +|++||+++||++
T Consensus 211 ~~~~~-----~~~~~-~~~~------~~----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 211 EFEAM-----AAIFK-IATQ------PT----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ccchH-----HHHHH-HhcC------CC----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 43111 11110 0000 00 111233445678889999985 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=251.87 Aligned_cols=221 Identities=22% Similarity=0.267 Sum_probs=159.5
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPD-KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
+|+.++||||+++++++... +..++||||++ ++|.+++...... ...+++..++.++.||+.||.|||+.+ |+
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 130 (316)
T cd07842 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VL 130 (316)
T ss_pred HHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 35778999999999999988 78999999996 6788877643222 237899999999999999999999999 99
Q ss_pred ecCCCCCcEEEcC----CCCeEEeecCCcccCCCCCC-ccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHH
Q 016913 78 YRDLKSSNILLDE----GFHPKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 78 HrDIkp~NILl~~----~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~ell 151 (380)
|+||||+||+++. ++.+||+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 131 h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 210 (316)
T cd07842 131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (316)
T ss_pred eCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999 89999999999986433222 1112334678899999988764 5789999999999999999
Q ss_pred hCCCCCCCCCCCCCc-------chhhhhhhc----------ccccCCCCCCCCccccCCCC---------h--hhHHHHH
Q 016913 152 TGRKAIDNTRPPGEH-------NLVAWARPL----------FKDRRKFPKMADPLLQGRYP---------M--RGLYQAL 203 (380)
Q Consensus 152 tG~~p~~~~~~~~~~-------~~~~~~~~~----------~~~~~~~~~~~~~~l~~~~~---------~--~~~~~l~ 203 (380)
+|..||......... .+......+ ......+....+......++ . .....+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (316)
T cd07842 211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290 (316)
T ss_pred hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence 999999755433200 000000000 00000000000000001111 1 3345788
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 016913 204 AVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 204 ~li~~cl~~~P~~RPt~~evl~ 225 (380)
+++.+||+.+|++|||+.||+.
T Consensus 291 ~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 291 DLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHhcCCcccCcCHHHHhc
Confidence 9999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=249.36 Aligned_cols=213 Identities=23% Similarity=0.316 Sum_probs=159.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..+...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 125 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDL 125 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCc
Confidence 56789999999999999999999999999 9999999976 2367999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||+++.++.++|+|||++........ .......++..|+|||++.+. .++.++||||||+++|+|++|.++|...
T Consensus 126 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 126 KPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 99999999999999999999986533221 112335688999999998654 4689999999999999999998877643
Q ss_pred CCCCCcchhhhhhhccccc-----CCCCC------CCCc-----cccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDR-----RKFPK------MADP-----LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~-----~~~~~------~~~~-----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 224 (380)
.... ........+... ..+.. ...+ .+. ....+....+.+++.+||+.+|.+|||+++|+
T Consensus 205 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l 280 (286)
T cd07832 205 NDIE---QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLE-EIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280 (286)
T ss_pred CHHH---HHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHH-HhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence 2211 010000000000 00000 0000 000 00113347889999999999999999999998
Q ss_pred HH
Q 016913 225 TA 226 (380)
Q Consensus 225 ~~ 226 (380)
..
T Consensus 281 ~h 282 (286)
T cd07832 281 RH 282 (286)
T ss_pred hC
Confidence 63
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=247.10 Aligned_cols=201 Identities=25% Similarity=0.365 Sum_probs=164.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++......++||||+++++|.+++......+..+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l 129 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDL 129 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 57789999999999999999999999999999999998764444567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|.||+++.++.+||+|||++...... ......++..|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 130 ~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 130 KSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred CcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999865332 2223457889999999999899999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. ...... ....++ ..+......+.+++.+||+.+|++||++.+|++.
T Consensus 206 ~~---~~~~~~-----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 206 MQ---DLRYKV-----QRGKYP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HH---HHHHHH-----hcCCCC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 21 111110 001111 1122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=249.82 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=160.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|...+..|+|+||+++++|.+++.. ..+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL 141 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccC
Confidence 5678999999999999999999999999999999999965 45889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... .......++..|++||++....++.++||||||+++|++++|..||....
T Consensus 142 ~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred CHHHEEEcCCCCEEEccCcceecccccc--cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999887543221 12233468889999999988889999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.......+ .... . +.+ ..+......+.+++.+||+.+|++||++.+|+..
T Consensus 220 ~~~~~~~~------~~~~--~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 220 PLRALYLI------ATNG--T-----PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred hhhheeeh------hcCC--C-----CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 32111100 0000 0 000 0112234568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=246.34 Aligned_cols=197 Identities=26% Similarity=0.308 Sum_probs=158.4
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
+...||||+++++++...+..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+|||
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~ 124 (278)
T cd05606 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLK 124 (278)
T ss_pred HhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCC
Confidence 345799999999999999999999999999999999865 457999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 83 SSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 83 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
|+||+++.++.++|+|||++...... ......|+..|+|||++.+. .++.++||||||+++|+|++|..||....
T Consensus 125 p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 125 PANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred HHHEEECCCCCEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998753221 12234689999999998754 68999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
........ ..... ... ..+......+.+++.+||..+|..|| ++.++++
T Consensus 201 ~~~~~~~~---~~~~~--------~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 201 TKDKHEID---RMTLT--------MAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccchHHHH---HHhhc--------cCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 22211110 00000 001 11222356788999999999999999 8999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=244.38 Aligned_cols=204 Identities=27% Similarity=0.387 Sum_probs=161.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..+...|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||
T Consensus 47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di 119 (265)
T cd05579 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDL 119 (265)
T ss_pred HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCC
Confidence 5678999999999999999999999999999999999976 347899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCC------ccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDK------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+|+||+++.++.++|+|||++........ ........++..|++||.+....++.++||||||+++|+|++|..
T Consensus 120 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 199 (265)
T cd05579 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199 (265)
T ss_pred CHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999875332211 112233567889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
||....... ............+.. ......+.+++.+||+.+|.+|||+..|.+.|.
T Consensus 200 p~~~~~~~~------~~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 200 PFHGETPEE------IFQNILNGKIEWPED----------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCCCCHHH------HHHHHhcCCcCCCcc----------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 997543211 111111100011110 012467889999999999999999966666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=263.45 Aligned_cols=202 Identities=21% Similarity=0.311 Sum_probs=165.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||....||+||+|++.|..++.++|+.|||.||-++..+-. ....|.+.++.-+++|++.||.|||+++ |||||
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRD 155 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRD 155 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhh
Confidence 57888999999999999889999999999999999999887 5678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----CCCCCcCceeehHHHHHHHHhCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
||..|||++-+|.++|+|||++-.. .........+.||+.|||||++++ .+|+.++||||||++|.||..+.+
T Consensus 156 LKAGNiL~TldGdirLADFGVSAKn--~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 156 LKAGNILLTLDGDIRLADFGVSAKN--KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred ccccceEEEecCcEeeecccccccc--hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 9999999999999999999998541 111122345789999999999876 478999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|....++. .....+.+. ..+.++. |......+.+++.+||.+||..||+++++++
T Consensus 234 PHhelnpM------RVllKiaKS--ePPTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 234 PHHELNPM------RVLLKIAKS--EPPTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CccccchH------HHHHHHhhc--CCCcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 88654432 111111111 1122222 3345678889999999999999999999975
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=240.80 Aligned_cols=197 Identities=24% Similarity=0.302 Sum_probs=157.0
Q ss_pred CCCCcccceEEEEeC----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 6 HHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
-|||||.++++|++. ..++||||+|+||.|...+.+ .....+++.++-.|+.||+.|+.|||+.+ |.||||
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDl 187 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDL 187 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccC
Confidence 599999999988553 356899999999999999988 45567999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|+|... +..+||+|||+|+... ........+.|+.|+|||++...+|+..+|+||+||+||-||||.+||.
T Consensus 188 KpENLLyt~t~~na~lKLtDfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 188 KPENLLYTTTSPNAPLKLTDFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ChhheeeecCCCCcceEecccccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999999964 4568999999998632 1223345678999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccC--CCCh----hhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG--RYPM----RGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~----~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...-.... +.+-..+-.+ .+|. ..++...++|..+|..+|.+|.|+.++++.
T Consensus 265 S~hg~ais----------------pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 265 SNHGLAIS----------------PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCCccCC----------------hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 54321110 0011111111 2232 345677889999999999999999999874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=243.04 Aligned_cols=202 Identities=25% Similarity=0.345 Sum_probs=164.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrD 80 (380)
++.++||||+++++++...+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~ 125 (264)
T cd06623 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRD 125 (264)
T ss_pred HHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCC
Confidence 5678899999999999999999999999999999999976 3679999999999999999999999 99 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+....++.++||||||+++|+|++|..||...
T Consensus 126 l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 126 IKPSNLLINSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CCHHHEEECCCCCEEEccCccceecccCC--CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999987643222 1122356788999999999989999999999999999999999999765
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChh-hHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMR-GLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
............. . ...+. .+.. ....+.+++..||..+|++||++.+|++.
T Consensus 204 ~~~~~~~~~~~~~---~-------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 204 GQPSFFELMQAIC---D-------GPPPS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCHHHHHHHHh---c-------CCCCC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 4322222222211 0 00011 1112 45688899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=247.26 Aligned_cols=198 Identities=26% Similarity=0.355 Sum_probs=160.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl 127 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDI 127 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCC
Confidence 5678999999999999999999999999999999999864 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|.||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 128 ~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 128 KAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred CHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999987543221 11223467889999999988889999999999999999999999986432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
... ... ..... . .+.+ +......+.+++.+||+.+|.+||++.+++..
T Consensus 206 ~~~---~~~---~~~~~--~-----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 206 PMK---VLF---LIPKN--N-----PPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred hHH---HHH---HHhcC--C-----CCCC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 211 111 00000 0 0111 12234678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=245.25 Aligned_cols=198 Identities=28% Similarity=0.333 Sum_probs=161.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++..++..++|+||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl 126 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDI 126 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 5688999999999999999999999999999999999976 357999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||++++++.++|+|||++....... ......++..|+|||++....++.++||||||+++|+|++|..||....
T Consensus 127 ~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 127 KPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred CHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987643221 2234568889999999998889999999999999999999999998654
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH--HHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI--GDVV 224 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~--~evl 224 (380)
......... .... .....+......+.+++.+||+.+|.+||++ .|++
T Consensus 204 ~~~~~~~~~----~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 204 RTIRDQIRA----KQET-----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccHHHHHHH----Hhcc-----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 321111111 1110 0011222334788899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=245.20 Aligned_cols=195 Identities=24% Similarity=0.339 Sum_probs=156.1
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
.||||++++++|..+...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+|
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~n 131 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAAN 131 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHH
Confidence 499999999999999999999999999999999865 37899999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
|+++.++.++|+|||++....... .......|+..|+|||++.+. .++.++||||||+++|+|++|..||.......
T Consensus 132 i~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 132 ILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred EEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 999999999999999997643322 122334688899999998754 57899999999999999999999997543211
Q ss_pred CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
. +... . ....+.+.. ......+.+++.+||+.+|++||++.+++..
T Consensus 210 ~---~~~~---~-------~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 210 A---MMLI---P-------KSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred h---hhcc---c-------cCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1 1000 0 000111111 1134678899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=241.36 Aligned_cols=203 Identities=27% Similarity=0.392 Sum_probs=159.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++|+||+++++++...+..++|+||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl 125 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDI 125 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999975 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccc--cccccccccccchhhhhcCC---CCCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV--STRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~s~~sDV~SlGvvl~elltG~~p 156 (380)
+|+||+++.++.+||+|||++........... .....++..|+|||++.... ++.++||||||+++|+|++|..|
T Consensus 126 ~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p 205 (264)
T cd06626 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205 (264)
T ss_pred CHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 99999999999999999999976433222111 11346788999999998766 88999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|...... .. ..+.. .......++. .......+.+++.+||+.+|.+|||+.+|+.
T Consensus 206 f~~~~~~--~~-~~~~~-~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 206 WSELDNE--FQ-IMFHV-GAGHKPPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccCCcch--HH-HHHHH-hcCCCCCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9744211 01 11100 0000000100 0112456789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=247.95 Aligned_cols=215 Identities=22% Similarity=0.265 Sum_probs=157.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+++..++||||+. ++|.+++.. .....+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l 126 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDL 126 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 578899999999999999999999999995 789999875 23456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC-CCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+.. ++.++||||||+++|+|++|..||...
T Consensus 127 ~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 127 KPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred CHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999987542221 1122345678999999886644 688999999999999999999999643
Q ss_pred CCCCCc-chhhhhhhc-----------ccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEH-NLVAWARPL-----------FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... ......... ......++......+.. ........+.+++.+||+.||.+|||+++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 205 SEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 221100 000000000 00000011110000000 00112346779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=244.22 Aligned_cols=200 Identities=21% Similarity=0.321 Sum_probs=159.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++......++|+||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl 127 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDI 127 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccC
Confidence 5778999999999999999999999999999999999976 22345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC-eEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFH-PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||++++++. ++|+|||++...... ........|+..|+|||++....++.++||||||+++|+|++|..||...
T Consensus 128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 128 KSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred CHHHEEEcCCCCeEEecccccchhccCC--cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 999999988754 699999998764321 11222345888999999998888999999999999999999999998643
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.. ..+....... .+.. .+......+.+++.+||+.+|++|||+.+|+.
T Consensus 206 ~~------~~~~~~~~~~--~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 206 NL------HQLVLKICQG--YFAP---------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cH------HHHHHHHhcc--cCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 22 1111111111 0111 11123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=241.05 Aligned_cols=202 Identities=26% Similarity=0.307 Sum_probs=163.5
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+++++||||+++++++... ...++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ ++|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~ 125 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHR 125 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5678999999999999988 889999999999999999976 338999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||+|+||+++.++.++|+|||.+................++..|++||.+.+..++.++||||||+++|+|++|..||..
T Consensus 126 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred CCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865433221123345688899999999988899999999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... .......... .......+......+.+++.+||+.+|.+||++.+++.
T Consensus 206 ~~~-----~~~~~~~~~~----------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 206 LGN-----PMAALYKIGS----------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCc-----hHHHHHhccc----------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 441 1111110000 00011122233567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=248.04 Aligned_cols=206 Identities=25% Similarity=0.303 Sum_probs=155.6
Q ss_pred ccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEe
Q 016913 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIY 78 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH 78 (380)
|.++. ||||+++++++..++..++||||+. ++|.++..... .....+++..+..++.+++.||+|||+. + ++|
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H 131 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIH 131 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eec
Confidence 34554 9999999999999999999999995 67766543211 1246799999999999999999999975 7 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC---CCCCcCceeehHHHHHHHHhCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||||+||+++.++.++|+|||++....... ......|+..|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 132 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 208 (288)
T cd06616 132 RDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208 (288)
T ss_pred cCCCHHHEEEccCCcEEEeecchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCC
Confidence 9999999999999999999999997532211 12334578899999999876 68999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||..... ........... ..+.+....+......+.+|+.+||+.+|++|||+.+|+..
T Consensus 209 p~~~~~~-----~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 209 PYPKWNS-----VFDQLTQVVKG-------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred Cchhcch-----HHHHHhhhcCC-------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9975431 11111111000 01111111222345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=246.60 Aligned_cols=215 Identities=22% Similarity=0.293 Sum_probs=155.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|+||+++++++..++..|+||||+. ++|.+++.. ....+++..+..++.|++.||.|||..+ |+|+||
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl 129 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDL 129 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 567899999999999999999999999995 788877764 2356888899999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.++|+|||+++...... .......++..|+|||++.+. .++.++||||||+++|+|++|..||+..
T Consensus 130 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 130 KPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ChHHEEEcCCCcEEEeccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999987532211 112234578899999998754 5788999999999999999999999754
Q ss_pred CCCCCcchhhhhh---h---cccccCCCCCCCCccccCCC---------ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWAR---P---LFKDRRKFPKMADPLLQGRY---------PMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~---~---~~~~~~~~~~~~~~~l~~~~---------~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..........|.. + .+.....++........... .......+.+++.+|++.+|.+|||+.|++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 208 SDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 3311100000000 0 00000000000000000000 0112457789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=243.96 Aligned_cols=208 Identities=25% Similarity=0.295 Sum_probs=155.0
Q ss_pred cCC-CCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 3 SLL-HHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 3 ~~l-~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
.++ .||||+++++++.++ +..++||||++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+
T Consensus 52 ~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~ 124 (282)
T cd07831 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHR 124 (282)
T ss_pred hhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 445 499999999999887 88999999996 688888865 2357899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|+||+++. +.+||+|||++....... ......++..|+|||++.. ..++.++|||||||++|||++|..||.
T Consensus 125 dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 125 DIKPENILIKD-DILKLADFGSCRGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred ccCHHHEEEcC-CCeEEEecccccccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 99999999999 999999999997643221 1123457889999997654 457889999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccc-----------cC----CCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKD-----------RR----KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~-----------~~----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev 223 (380)
.....+ .+......... .. .++......+. ......+..+.+|+.+||+.+|++||++.+|
T Consensus 201 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 276 (282)
T cd07831 201 GTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLR-KLLPNASAEGLDLLKKLLAYDPDERITAKQA 276 (282)
T ss_pred CCCHHH---HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHH-HHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence 643321 11111100000 00 00000000000 0011346789999999999999999999999
Q ss_pred HH
Q 016913 224 VT 225 (380)
Q Consensus 224 l~ 225 (380)
++
T Consensus 277 l~ 278 (282)
T cd07831 277 LR 278 (282)
T ss_pred hh
Confidence 86
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=248.23 Aligned_cols=217 Identities=24% Similarity=0.317 Sum_probs=155.4
Q ss_pred ccCCCCCCcccceEEEEeCC--------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGD--------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~--------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
+++++||||++++++|.... ..++||||+. ++|.+++.. ....+++.+++.++.||+.||.|||+.+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~- 139 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK- 139 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56889999999999987654 4599999996 689888865 2346899999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhcC-CCCCcCceeehHHHHHHH
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~el 150 (380)
++|+||||+||+++.++.+||+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|
T Consensus 140 --i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el 217 (310)
T cd07865 140 --ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217 (310)
T ss_pred --eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHH
Confidence 999999999999999999999999999764332211 112334578899999988764 478899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcc-----cccC--------CCCCCCCccccCCC-ChhhHHHHHHHHHHhhhhCCCC
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLF-----KDRR--------KFPKMADPLLQGRY-PMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~-----~~~~--------~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~~P~~ 216 (380)
++|..||...........+....... .... .++......+...+ +......+.+|+.+||+.||.+
T Consensus 218 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~ 297 (310)
T cd07865 218 WTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAK 297 (310)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhh
Confidence 99999997543321111111110000 0000 00000000000000 0112346779999999999999
Q ss_pred CCCHHHHHH
Q 016913 217 RPLIGDVVT 225 (380)
Q Consensus 217 RPt~~evl~ 225 (380)
|||++++++
T Consensus 298 R~t~~e~l~ 306 (310)
T cd07865 298 RIDADTALN 306 (310)
T ss_pred ccCHHHHhc
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=245.54 Aligned_cols=203 Identities=26% Similarity=0.361 Sum_probs=161.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|+||+++++++...+..++|+||+++++|.+++... ...+++..++.++.+++.||.|||..+ ++|+||
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl 142 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDI 142 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCC
Confidence 56789999999999999999999999999999999999872 237999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... .......++..|++||++.+..++.++||||||+++|+|++|..||....
T Consensus 143 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 143 KSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ChhhEEEcCCCCEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999886532211 12233457889999999988889999999999999999999999986432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+.. .... .... ....... +......+.+++.+||+.+|..||++.+|++..
T Consensus 221 ~~~---~~~~---~~~~--~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 221 PLR---ALFL---ITTK--GIPPLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHH---HHHH---HHhc--CCCCCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 211 0100 0000 0111111 111345788999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=244.60 Aligned_cols=204 Identities=14% Similarity=0.158 Sum_probs=155.1
Q ss_pred cCCCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 3 SLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
..+.|+||+++++++.... ..++++|++. .++.+++.. ...+++..+..++.|++.||+|||+.+ |+|
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH 149 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISH 149 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4578999999999876554 4578899884 678777764 234678889999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-----cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG 153 (380)
|||||+|||++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999764322111 111234699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCc-c--hhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 154 RKAIDNTRPPGEH-N--LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 154 ~~p~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
..||......... . ..++...+... .+. .......+.+++..|++.+|++||++.+|++.|
T Consensus 230 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 230 KLPWKGFGHNGNLIHAAKCDFIKRLHEG----------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCccccchHHHHHhHHHHHHHhhhh----------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999765322111 0 01111111110 000 112246788999999999999999999999876
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=256.33 Aligned_cols=208 Identities=22% Similarity=0.282 Sum_probs=158.0
Q ss_pred CCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEE
Q 016913 8 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 87 (380)
Q Consensus 8 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NIL 87 (380)
-|||++++||...++.|||+|++ ..+|.++++. +....|+...+..++.||+.||.+||+.+ |||+||||+|||
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENIL 321 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELL-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENIL 321 (586)
T ss_pred eeEEEeeeccccccceeeeehhh-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhhee
Confidence 38999999999999999999999 5999999998 56677999999999999999999999999 999999999999
Q ss_pred EcCC--CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCC
Q 016913 88 LDEG--FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165 (380)
Q Consensus 88 l~~~--~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~ 165 (380)
|..- ..+||+|||.+......-. .-..+..|.|||++.+..|+.+.|+||||||+.||++|.+.|.+.+..+.
T Consensus 322 L~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 322 LKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred eccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 9654 4699999999986322211 33456789999999999999999999999999999999988877655433
Q ss_pred cchhhhh---------------hhcccccCCCCCCCC--------------c-----cccCCC-----------ChhhHH
Q 016913 166 HNLVAWA---------------RPLFKDRRKFPKMAD--------------P-----LLQGRY-----------PMRGLY 200 (380)
Q Consensus 166 ~~~~~~~---------------~~~~~~~~~~~~~~~--------------~-----~l~~~~-----------~~~~~~ 200 (380)
...+..+ ...+.....++.... + ...... +...-.
T Consensus 397 l~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~ 476 (586)
T KOG0667|consen 397 LARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDK 476 (586)
T ss_pred HHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHH
Confidence 2222100 011111000000000 0 011011 113345
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 201 QALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 201 ~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.+++++.+||..||..|+|..+.++.
T Consensus 477 ~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 477 LFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred HHHHHHHHHhccCchhcCCHHHHhcC
Confidence 68999999999999999999999864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=245.42 Aligned_cols=216 Identities=24% Similarity=0.319 Sum_probs=158.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..+|||||++ ++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl 126 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDL 126 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCC
Confidence 567899999999999999999999999997 58999887532 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||++++++.++|+|||++...... ........++..|++||++.+. .++.++||||||+++|+|++|..||...
T Consensus 127 ~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 127 KPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred CHHHEEECCCCcEEEeecchhhhhcCC--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999753221 1112234578899999998664 5788999999999999999999999754
Q ss_pred CCCCCcchh-hhhhhc----cc---c----cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLV-AWARPL----FK---D----RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~-~~~~~~----~~---~----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
........+ ...... +. . ...++....... ..+.......+.+++.+||+.+|.+||++.+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 205 NNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 332111100 000000 00 0 000000000000 0011123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=240.86 Aligned_cols=202 Identities=24% Similarity=0.393 Sum_probs=164.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++|||++++++.+..++..++|+||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 53 l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl 129 (258)
T cd08215 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDI 129 (258)
T ss_pred HHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccC
Confidence 56789999999999999999999999999999999999874434578999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... .......++..|+|||.+....++.++||||||+++++|++|..||....
T Consensus 130 ~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 130 KPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred ChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999999999999999999997643221 12233568889999999988889999999999999999999999987543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... .. ..... .... ..+......+.+++.+||..+|++|||+.++++
T Consensus 208 ~~~---~~---~~~~~--~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 LLE---LA---LKILK--GQYP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHH---HH---HHHhc--CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 211 11 11111 0011 111233467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=240.64 Aligned_cols=184 Identities=24% Similarity=0.247 Sum_probs=149.5
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
...||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||
T Consensus 41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp 113 (237)
T cd05576 41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNP 113 (237)
T ss_pred hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCH
Confidence 34699999999999999999999999999999999976 346999999999999999999999999 99999999
Q ss_pred CcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCC
Q 016913 84 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163 (380)
Q Consensus 84 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~ 163 (380)
+||+++.++.++|+|||++...... .....++..|+|||++....++.++||||||+++|||++|..|+......
T Consensus 114 ~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~ 188 (237)
T cd05576 114 NNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG 188 (237)
T ss_pred HHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh
Confidence 9999999999999999988653221 12234567899999998888999999999999999999999877532110
Q ss_pred CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 164 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
. .. . .....+......+.+++.+||+.||++||++.
T Consensus 189 -~-----------~~------~----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 189 -I-----------NT------H----TTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -c-----------cc------c----cccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 0 00 0 00011222345788999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=248.86 Aligned_cols=197 Identities=31% Similarity=0.392 Sum_probs=156.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..++..++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl 141 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDI 141 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 567899999999999999999999999996 788787754 2456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+|+||+++.++.++|+|||++..... .....++..|+|||++. ...++.++||||||+++|||++|..||.
T Consensus 142 ~p~nIl~~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 142 KAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CcccEEECCCCCEEEeecCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999875321 12345788999999874 3568899999999999999999999986
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
....... .... ... ..+. + .+......+.+++.+||+.+|++||++.+|+...
T Consensus 216 ~~~~~~~---~~~~---~~~--~~~~-----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 216 NMNAMSA---LYHI---AQN--DSPT-----L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CccHHHH---HHHH---hcC--CCCC-----C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 4322111 1000 000 0000 0 0112345788999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=237.52 Aligned_cols=200 Identities=28% Similarity=0.393 Sum_probs=161.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++......++|+||+++++|.+++.. ....+++..+..++.+++.||.+||..+ ++|+||
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl 124 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDI 124 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCC
Confidence 5678999999999999999999999999999999999976 2257999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||.+........ .....++..|++||++....++.++||||||+++|+|++|..||....
T Consensus 125 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 125 KAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred CHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999976433221 334568889999999988889999999999999999999999987542
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... ...... . ........+ ......+.+++..||+.+|++|||+.+|++
T Consensus 202 ~~~---~~~~~~---~--~~~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 202 PMK---ALFKIA---T--NGPPGLRNP-------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred hHH---HHHHHH---h--cCCCCcCcc-------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 211 111000 0 111111111 112467889999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=246.06 Aligned_cols=213 Identities=27% Similarity=0.311 Sum_probs=158.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+++..++||||++ ++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl 125 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDL 125 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCC
Confidence 567899999999999999999999999995 7999999762 2246899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 126 ~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 126 KPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CHHHEEEcCCCcEEEeecccccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999997542221 112233568899999987654 5788999999999999999999999754
Q ss_pred CCCCCcchhhhhhhc---c-----------cccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPL---F-----------KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~---~-----------~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... +....... . .....++........ .........+.+++.+||+.+|.+|||+.||++
T Consensus 204 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 204 SEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CHHHH--HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 32111 11100000 0 000001111001000 112233467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=283.83 Aligned_cols=202 Identities=27% Similarity=0.311 Sum_probs=161.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|..|+|||||++||+=.+.+.++|.||||++|+|.+++.. ...+++....-+..|++.||.|||+.| |||||
T Consensus 1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRD 1359 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRD 1359 (1509)
T ss_pred HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecC
Confidence 35678999999999999999999999999999999999976 455777777788999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhcC---CCCCcCceeehHHHHHHHHhCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||.||||+.+|.+|++|||.|........+ ......+||+.|||||++.+. .-..++||||||||++||+||+.
T Consensus 1360 IK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1360 IKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred CCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 9999999999999999999999875433111 112457899999999999764 34578999999999999999999
Q ss_pred CCCCCCCC-CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPP-GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||...... ..+..|... ... ..|......-.+++..||+.||+.|.++.|+++.
T Consensus 1440 PW~~~dne~aIMy~V~~g-----h~P------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1440 PWAELDNEWAIMYHVAAG-----HKP------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhccchhHHHhHHhcc-----CCC------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99754332 122222211 111 1233445677899999999999999998888764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=252.33 Aligned_cols=212 Identities=24% Similarity=0.286 Sum_probs=156.8
Q ss_pred ccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|++++||||++++++|... ...|+||||+. ++|.+++.. .++...+..++.|++.||+|||..+
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g--- 138 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG--- 138 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999988644 35799999995 699998864 2899999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|+|+||||+||+++.++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 139 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred eeeCCCCHHHEEECCCCCEEEccCccceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence 999999999999999999999999999764221 11233457889999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchh-h---------------hhhhccccc-----CCCCCCCCc----cccCCCChhhHHHHHHHHHHhh
Q 016913 156 AIDNTRPPGEHNLV-A---------------WARPLFKDR-----RKFPKMADP----LLQGRYPMRGLYQALAVAAMCL 210 (380)
Q Consensus 156 p~~~~~~~~~~~~~-~---------------~~~~~~~~~-----~~~~~~~~~----~l~~~~~~~~~~~l~~li~~cl 210 (380)
||...........+ . ......... ..+...... ......+......+.+++.+||
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 295 (353)
T cd07850 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295 (353)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHc
Confidence 99754321110000 0 000000000 000011111 0111112234567889999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 016913 211 QEQAATRPLIGDVVTA 226 (380)
Q Consensus 211 ~~~P~~RPt~~evl~~ 226 (380)
+.||.+|||+.||+..
T Consensus 296 ~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 296 VIDPEKRISVDDALQH 311 (353)
T ss_pred CCChhhCcCHHHHhcC
Confidence 9999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=248.72 Aligned_cols=200 Identities=30% Similarity=0.408 Sum_probs=158.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..++..++||||+. ++|.+++.. ....+++..+..++.+++.||.|||+.+ |+|+||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL 151 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDI 151 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 567899999999999999999999999996 688887764 3466999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+|+||+++.++.++|+|||++..... .....++..|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 152 ~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 152 KAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999875321 22346788999999974 4568899999999999999999999986
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
....... ...+ .... .... ........+.+|+.+||+.+|.+||++.+|++.+..+
T Consensus 226 ~~~~~~~--~~~~----~~~~--~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 226 NMNAMSA--LYHI----AQNE--SPTL--------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CccHHHH--HHHH----Hhcc--CCCC--------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 4321110 0001 0000 0000 0112345688999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=245.23 Aligned_cols=199 Identities=24% Similarity=0.319 Sum_probs=158.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl 142 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDI 142 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999999999999999999999998854 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||++++++.++|+|||++...... ........++..|++||++....++.++||||||+++|+|++|..||....
T Consensus 143 ~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred CHHHEEECCCCCEEEcccccceecccc--cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998754321 112233567889999999988889999999999999999999999986432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.. ..+..... ..+..... .......+.+++.+||+.+|.+||++.+|+.
T Consensus 221 ~~---~~~~~~~~------~~~~~~~~------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 221 PL---KAMKMIRD------NLPPKLKN------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HH---HHHHHHHh------hCCcccCC------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 21 11111110 01111000 0112346778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=261.50 Aligned_cols=203 Identities=27% Similarity=0.384 Sum_probs=169.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|.+|+|||+|+|||++.+ ....+|||++++|+|.+.|++ ..+..|.......++.|||.|+.||..+. +|||||
T Consensus 165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDL 238 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDL 238 (1039)
T ss_pred HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhh
Confidence 568899999999999987 678899999999999999998 56677999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccc-cccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST-RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
...||||.....+||+||||.+-+.......... ...-.+.|||||.+....|+.++|||+|||+||||++ |+.||-+
T Consensus 239 AARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 239 AARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred hhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 9999999999899999999999877665555432 2334568999999999999999999999999999997 5689976
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.........++ ..-+-.-|..+++.+.+|+..||..+|++||||..|.+.+
T Consensus 319 ~~g~qIL~~iD-----------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 319 CRGIQILKNID-----------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCHHHHHHhcc-----------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 65432222221 1111123456788999999999999999999999998544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=243.64 Aligned_cols=201 Identities=23% Similarity=0.314 Sum_probs=160.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+....++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l 132 (260)
T cd08222 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDL 132 (260)
T ss_pred HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence 56789999999999999999999999999999999998764445567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++. +.++|+|||++....... .......++..|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus 133 ~~~nili~~-~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 133 KAKNIFLKN-NLLKIGDFGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred ChhheEeec-CCEeecccCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999975 569999999987643221 12233557889999999988888999999999999999999999986322
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
. ......... ...+ . .+......+.+++.+||+.+|++||++.+|++
T Consensus 210 ~------~~~~~~~~~--~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 F------LSVVLRIVE--GPTP-----S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred H------HHHHHHHHc--CCCC-----C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 111111111 0011 1 12234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=242.72 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=172.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+++.+.|++|++||.+.....+|||||||..|++.+.+.. .+++|++..+-.++...++||+|||... -||||
T Consensus 81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRD 154 (502)
T KOG0574|consen 81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRD 154 (502)
T ss_pred HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhh
Confidence 46788999999999999888999999999999999999986 5788999999999999999999999998 89999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||..||||+.+|.+||+|||++-...+ .......+.||+.|||||++..-.|+.++||||||++..||..|++||...
T Consensus 155 IKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 155 IKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred cccccEEEcccchhhhhhccccchhhh--hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 999999999999999999999976432 223345578999999999999999999999999999999999999999876
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.+. +.+|. ++....|+++ .|......+-+++..||-++|++|-|+-++++.
T Consensus 233 HPM---------RAIFM----IPT~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 233 HPM---------RAIFM----IPTKPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ccc---------ceeEe----ccCCCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 553 22222 2222333333 356677889999999999999999999888764
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=243.74 Aligned_cols=217 Identities=21% Similarity=0.267 Sum_probs=156.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++..+...|+||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~d 127 (294)
T PLN00009 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRD 127 (294)
T ss_pred HHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 3678899999999999999999999999996 6888888652 2334688899999999999999999999 99999
Q ss_pred CCCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|+|+||+++. ++.+||+|||++...... ........++..|+|||++.+. .++.++||||||+++|+|++|..||.
T Consensus 128 l~p~nill~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 128 LKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred CCcceEEEECCCCEEEEcccccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999985 557899999999753221 1112334578899999998764 57899999999999999999999997
Q ss_pred CCCCCCCcch-hhhhhh----cccccCC-------CCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNL-VAWARP----LFKDRRK-------FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~-~~~~~~----~~~~~~~-------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.....+.... ...... .+..... ++......+. .........+.+++.+||+.+|++||++.++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 206 GDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5432211100 000000 0000000 0000000000 0112234568899999999999999999999863
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=249.81 Aligned_cols=197 Identities=27% Similarity=0.338 Sum_probs=165.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++++.+.||.+-..|+..+.+|+|+..|.||+|.-+|... .+..|++..+..++.+|+.||++||... ||+||
T Consensus 238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRD 312 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRD 312 (591)
T ss_pred HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeecc
Confidence 578889999999999999999999999999999999999873 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+||+|||||+.|.++|+|+|||..++.+. .....+||.+|||||++.++.|+...|.|||||+||||+.|+.||...
T Consensus 313 LKPeNILLDd~GhvRISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 313 LKPENILLDDHGHVRISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CChhheeeccCCCeEeeccceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 99999999999999999999998765443 334458999999999999999999999999999999999999999765
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
.......-++. .... ....|+......+.+|+...|+.||++|--
T Consensus 390 KeKvk~eEvdr--r~~~------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 390 KEKVKREEVDR--RTLE------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hhhhhHHHHHH--HHhc------------chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 44322211111 0111 122456667788999999999999999963
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=237.99 Aligned_cols=211 Identities=24% Similarity=0.320 Sum_probs=156.8
Q ss_pred cCCCCCCcccceEEEEeCCe-----EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 3 SLLHHSNLVNLIGYCADGDQ-----RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~-----~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
+.++||||+++++++...+. .++||||+. ++|.+++... ....+++..++.++.|++.||.|||+.+ ++
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~ 129 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHR---IV 129 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 45679999999999988776 899999996 6899988762 2235899999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 130 h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~ 206 (287)
T cd07838 130 HRDLKPQNILVTSDGQVKIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206 (287)
T ss_pred eccCChhhEEEccCCCEEEeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence 99999999999999999999999997643221 112234788999999999889999999999999999999999998
Q ss_pred CCCCCCCCcchhhhhhhccc---c---------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFK---D---------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
........ .......... . ...+........ ..........+.+++.+||+.+|.+||++.+++.
T Consensus 207 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 207 RGTSEADQ--LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCChHHH--HHHHHHHcCCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 75432211 1111000000 0 000000000000 0001133467789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=235.01 Aligned_cols=198 Identities=28% Similarity=0.391 Sum_probs=160.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 125 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDI 125 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 5678999999999999999999999999999999999976 367999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++........ ......++..|+|||...+..++.++|||+||+++|+|++|..||....
T Consensus 126 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 126 KAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred CHHHEEECCCCCEEEeccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999986433221 1233567889999999988888999999999999999999999986432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
. .......... ... ..+......+.+++.+||..+|++|||+.+++.
T Consensus 204 ~-----~~~~~~~~~~---~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 204 P-----MAALFRIVQD---DHP---------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred H-----HHHHHHHhcc---CCC---------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1111100000 000 112233467889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=242.33 Aligned_cols=206 Identities=25% Similarity=0.290 Sum_probs=160.8
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|..+ +||||+++++++..+...++||||+++++|.+++.. ...+++..+..++.|++.||.|||..+ ++|+|
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~d 130 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRD 130 (288)
T ss_pred HHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 4456 699999999999999999999999999999999865 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC--CCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|+|.||+++.++.++|+|||++........ .......++..|++||.+.+.. .+.++||||||+++|+|++|..||.
T Consensus 131 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 131 IKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred CCHHHeEECCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 999999999999999999999876432211 1122345788999999987654 7889999999999999999999986
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
....... ............. ..+......+.+++.+||+.+|++|||+.++.+.|..
T Consensus 210 ~~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 210 VDGEQNS--QSEISRRILKSKP------------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCcccch--HHHHHHHHHccCC------------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 4322111 1111111111111 1112233567899999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=243.13 Aligned_cols=215 Identities=22% Similarity=0.254 Sum_probs=154.4
Q ss_pred ccCC-CCCCcccceEEEEeCCe-----EEEEEeccCCCCHHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQ-----RLLVYEFMPLGSLEDHLHDLPPD-KEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~-----~~lV~E~~~ggsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
|+.+ +||||+++++++...+. .|+||||++ ++|.+++...... ...+++..++.++.||+.||.|||+.+
T Consensus 54 l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-- 130 (295)
T cd07837 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-- 130 (295)
T ss_pred HHHccCCCCccceeeeEeecCCCCCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4455 47999999999987665 899999997 5899988763222 356899999999999999999999999
Q ss_pred CeEecCCCCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHh
Q 016913 75 PVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~ellt 152 (380)
|+|+||+|+||+++. ++.+||+|||++....... .......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 131 -i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 207 (295)
T cd07837 131 -VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207 (295)
T ss_pred -eeecCCChHHEEEecCCCeEEEeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc
Confidence 999999999999998 8899999999987542211 11122356788999998865 457899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhccc-ccCC------------CCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFK-DRRK------------FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~-~~~~------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
|..||......... ......+.. .... ++......+. .........+.+++.+||+.+|.+||+
T Consensus 208 g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~ 284 (295)
T cd07837 208 KQPLFPGDSELQQL--LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRIS 284 (295)
T ss_pred CCCCCCCCCHHHHH--HHHHHHhCCCChhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCC
Confidence 99999754322110 000000000 0000 0000000000 001124567889999999999999999
Q ss_pred HHHHHH
Q 016913 220 IGDVVT 225 (380)
Q Consensus 220 ~~evl~ 225 (380)
+.|++.
T Consensus 285 ~~eil~ 290 (295)
T cd07837 285 AKAALT 290 (295)
T ss_pred HHHHhc
Confidence 999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=243.45 Aligned_cols=214 Identities=25% Similarity=0.290 Sum_probs=160.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||++ ++|.+++.. ....+++..++.++.|++.||.|||..+ |+|+||
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 124 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDL 124 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCc
Confidence 567899999999999999999999999997 589888876 2357999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 125 ~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 125 KPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred CHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999997643322 112234578889999998876 7899999999999999999999999754
Q ss_pred CCCCCcchhhhh--hhcccc-----------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWA--RPLFKD-----------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~--~~~~~~-----------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...+........ ...... ...++....... ..........+.+++.+||+.+|.+||++.+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 203 SEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 332111110000 000000 000000000000 0111234568899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=257.04 Aligned_cols=191 Identities=25% Similarity=0.298 Sum_probs=155.9
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
.-.||||+++.+.+.++.+.|+|||++.|+-|.+.+.. +. .....+..|+.+|+.|+.|||+++ ||||||||
T Consensus 372 ~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp 443 (612)
T KOG0603|consen 372 VRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS----KP-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKP 443 (612)
T ss_pred hcCCCcceeecceecCCceeeeeehhccccHHHHHHHh----cc-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCCh
Confidence 34799999999999999999999999999988888865 23 333777789999999999999999 99999999
Q ss_pred CcEEE-cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 84 SNILL-DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 84 ~NILl-~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
+|||+ +..+.++|+|||.++..... ....+-|..|+|||+.....|++++|+||||++||+||+|..||.....
T Consensus 444 ~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 444 GNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred hheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 99999 58899999999999864332 2334567899999999999999999999999999999999999975432
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
. ..+.. ....+.+....+..+.+|+.+||+.+|.+||++.++...
T Consensus 519 ~--~ei~~-----------------~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 519 G--IEIHT-----------------RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred h--HHHHH-----------------hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2 11111 111111223446788899999999999999999999863
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=245.24 Aligned_cols=216 Identities=24% Similarity=0.301 Sum_probs=157.0
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++|+||+++++++... +..++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 132 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHR 132 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 5688999999999998765 46899999996 689998875 2367999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+||+++.++.+||+|||++....... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 133 dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 133 DLKVSNLLLTDKGCLKIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred CCCHHHEEECCCCCEEECccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998643321 11222345788999999875 467899999999999999999999997
Q ss_pred CCCCCCCcchhhhh-h----hcccccCCCCCCCCcccc-CCC------ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWA-R----PLFKDRRKFPKMADPLLQ-GRY------PMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~-~~~------~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..........+... . ..+......+....-.+. ..+ .......+.+++.+||+.||++|||+.+|+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 54332211111100 0 000000000000000000 000 01124567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=248.66 Aligned_cols=215 Identities=26% Similarity=0.291 Sum_probs=156.3
Q ss_pred ccCC-CCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLL-HHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
++++ +||||++++++|... ...|+||||++ ++|..++.. ..+++..++.++.||+.||.|||+.+ |+|
T Consensus 60 l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H 130 (337)
T cd07852 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIH 130 (337)
T ss_pred HHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 4577 999999999998654 36899999996 699999875 37899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc---cccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT---HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
+||||+||+++.++.+||+|||++......... .......++..|+|||++.. ..++.++||||||+++|+|++|.
T Consensus 131 ~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~ 210 (337)
T cd07852 131 RDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210 (337)
T ss_pred CCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCC
Confidence 999999999999999999999999764332211 12233568899999998765 45788999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcc----------cccC----CCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLF----------KDRR----KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~----------~~~~----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.||...........+....... .... .........+.... ......+.+++.+||+.+|.+|||+
T Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~ 289 (337)
T cd07852 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTA 289 (337)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCH
Confidence 9996543221111000000000 0000 00000000000001 1235678999999999999999999
Q ss_pred HHHHHH
Q 016913 221 GDVVTA 226 (380)
Q Consensus 221 ~evl~~ 226 (380)
.++++.
T Consensus 290 ~~il~~ 295 (337)
T cd07852 290 EEALEH 295 (337)
T ss_pred HHHhhC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=242.06 Aligned_cols=216 Identities=22% Similarity=0.245 Sum_probs=158.8
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
++.++||||+++++++... +..++||||++ ++|.+++.. ....+++..++.++.||+.||+|||..+ ++|+
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~ 124 (287)
T cd07840 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHR 124 (287)
T ss_pred HHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 5678999999999999888 88999999997 599998875 2357999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|+||++++++.++|+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 125 dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 125 DIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred cCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999976433221 11233456788999998765 467899999999999999999999997
Q ss_pred CCCCCCCcchhhh-hhhcccc-cCCCC-----------CCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAW-ARPLFKD-RRKFP-----------KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~-~~~~~~~-~~~~~-----------~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..........+.. ....... ...+. ......+...+...+...+.+++.+||+.+|.+||++.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 204 GSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 5443211111100 0000000 00000 000000111111112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=255.63 Aligned_cols=195 Identities=25% Similarity=0.375 Sum_probs=166.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.|+|||||+++.+.+....+|+||||+.+|.|.+|+.. .....+..+..++.|+..|++|||+++ |||||
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrd 180 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRD 180 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccc
Confidence 46789999999999999999999999999999999999987 566777899999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||.+||||+.+..+||+|||++..+. ........+|++-|.|||++.+..| ++.+|+||+|+|+|-|++|..||+.
T Consensus 181 Lk~eNilL~~~mnikIaDfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 181 LKAENILLDENMNIKIADFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred cchhhcccccccceeeeccccceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 99999999999999999999998653 3344566889999999999998876 5789999999999999999999985
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCC--ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY--PMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... +.+-+..+.+.+ |--....+-+|+.++|-.+|.+|+++.+|.+
T Consensus 258 ~~l--------------------k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 258 QNL--------------------KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccc--------------------ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 433 223333333322 2223457889999999999999999999864
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=240.28 Aligned_cols=215 Identities=23% Similarity=0.320 Sum_probs=158.4
Q ss_pred ccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++.++ ||||+++++++..++..++||||+ +++|.+++... ....+++..++.++.|++.+|.|||+.+ ++|+|
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~d 124 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRD 124 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 34667 999999999999999999999999 78999998762 2347899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-cCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|+|+||+++.++.++|+|||++....... ......++..|+|||++. ...++.++||||||+++|+|++|..||..
T Consensus 125 l~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 125 LKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred CChhhEEEcCCCCEEEeecccceeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 99999999999999999999997542211 122345788999999875 44678999999999999999999999965
Q ss_pred CCCCCCcchh-hhhhhc----cccc--------CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 160 TRPPGEHNLV-AWARPL----FKDR--------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~-~~~~~~----~~~~--------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
....+..... ...... +... ..++......+. .........+.+++.+||+.+|.+|||+.||+..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 202 SSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 4332111000 000000 0000 000000000010 0111224678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=242.77 Aligned_cols=198 Identities=30% Similarity=0.383 Sum_probs=156.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||++++++++...+..++||||+. ++|.+++.. ....+++.++..++.|++.||.|||+.+ ++|+||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl 141 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 141 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 577899999999999999999999999996 688887754 2456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+|+||+++.++.++|+|||++..... .....++..|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 142 ~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 142 KAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred CHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999875321 12345788999999985 3467889999999999999999999986
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
....... ...+. . ...+... +......+.+|+.+||+.+|.+||++.+|+....
T Consensus 216 ~~~~~~~--~~~~~----~--~~~~~~~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 216 NMNAMSA--LYHIA----Q--NESPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cccHHHH--HHHHh----h--cCCCCcC--------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 4321111 01010 0 0011100 1123456889999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=243.05 Aligned_cols=196 Identities=30% Similarity=0.413 Sum_probs=155.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+++..|+||||+. ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl 147 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDI 147 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 567899999999999999999999999996 688888764 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+|+||+++.++.++|+|||++.... ......|+..|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 148 ~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 148 KAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred ChhhEEECCCCCEEEeecCCCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999986421 122356888999999984 3568889999999999999999999986
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
....... .... .. ...+.... ......+.+++.+||+.+|.+||++.+++..
T Consensus 222 ~~~~~~~---~~~~---~~--~~~~~~~~--------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 222 NMNAMSA---LYHI---AQ--NDSPTLQS--------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCChHHH---HHHH---Hh--cCCCCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5432111 1100 00 00111111 1123467899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=237.90 Aligned_cols=200 Identities=23% Similarity=0.272 Sum_probs=156.9
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++||||+++++++.+. ...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~ 130 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHR 130 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 5678999999999998764 468899999999999999975 356899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCC-ccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+||+++.++.++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 131 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred CCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999976422111 111123468899999999998889999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... ....+. ... . .....+......+.+++.+||+ +|..||+..+++.
T Consensus 211 ~~~~~--~~~~~~----~~~--~--------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 211 EYEAM--AAIFKI----ATQ--P--------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ccCHH--HHHHHH----HcC--C--------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 43211 111110 000 0 0011233345678899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=234.07 Aligned_cols=194 Identities=32% Similarity=0.394 Sum_probs=158.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l 119 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDL 119 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5678999999999999999999999999999999999976 346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|+||+++.++.++|+|||++....... .......++..|++||...+..++.++|+||||+++|+|++|..||....
T Consensus 120 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 120 KPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999997643221 12334567889999999988888999999999999999999999996442
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
. ...... ...... ..+......+.+++.+||..+|+.||++++
T Consensus 198 ~---~~~~~~---~~~~~~------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 198 R---KEIYEK---ILKDPL------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred H---HHHHHH---HhcCCC------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2 111111 111111 112222467889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-31 Score=236.20 Aligned_cols=202 Identities=28% Similarity=0.395 Sum_probs=160.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.-.+|+||+.+|||..+..++|.||.| ...++.++.. .++++++..+-++...+++||.||.++.+ ||||||
T Consensus 145 ~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDv 218 (391)
T KOG0983|consen 145 LKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDV 218 (391)
T ss_pred hhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeeccc
Confidence 34446899999999999999999999999 4788888876 56789999999999999999999998653 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc---CCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|||+|+.|.+||||||++-.+.+. ...+...|-+.|||||-+.- ..|+..+||||||++++||.||+.||.
T Consensus 219 KPSNILlDe~GniKlCDFGIsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~ 295 (391)
T KOG0983|consen 219 KPSNILLDERGNIKLCDFGISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK 295 (391)
T ss_pred CccceEEccCCCEEeecccccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence 999999999999999999999754332 33455678899999998864 378899999999999999999999998
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.....- ..... +..+ ..|.+.+. ......+.+++..||++|+.+||.+.++++.
T Consensus 296 ~c~tdF--e~ltk---vln~-------ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 296 GCKTDF--EVLTK---VLNE-------EPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCccH--HHHHH---HHhc-------CCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 653321 11111 1111 11222221 1246788999999999999999999999874
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=239.73 Aligned_cols=202 Identities=26% Similarity=0.321 Sum_probs=156.8
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.+ +||||+++++++..+...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~d 130 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRD 130 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4556 599999999999999999999999999999999975 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC--CCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|+|+|||++.++.++|+|||++........ .......|+..|+|||.+... .++.++||||||+++|+|++|..||.
T Consensus 131 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred CCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999976432211 112235688899999998753 46789999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
....... ............. .++......+.+++.+||+.+|++|| ++.+++.
T Consensus 210 ~~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 210 VDGEKNS--QAEISRRILKSEP------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCcccc--HHHHHHHhhccCC------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 4322211 1111111111111 12223446778999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=238.84 Aligned_cols=198 Identities=26% Similarity=0.315 Sum_probs=164.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+..+||.+..+...|...+.+|+||||..||.|.-+|.. ...+++.....+...|+.||.|||+++ ||+||
T Consensus 221 VL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRD 293 (516)
T KOG0690|consen 221 VLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRD 293 (516)
T ss_pred HHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeee
Confidence 36778999999999999999999999999999999998876 677999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||.+|+||+++|.+||+|||+++. ...........+||+.|+|||++....|+.+.|.|.+|||||||+||+.||...
T Consensus 294 lKLENLlLDkDGHIKitDFGLCKE--~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 294 LKLENLLLDKDGHIKITDFGLCKE--EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred chhhhheeccCCceEeeecccchh--cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 999999999999999999999986 223344556789999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
..... +..+....-.++ .....++..|+.-.|.++|.+|- .+.||.+
T Consensus 372 dh~kL------FeLIl~ed~kFP------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 372 DHEKL------FELILMEDLKFP------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred chhHH------HHHHHhhhccCC------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 33211 111122222222 23345677899999999999995 4555543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=253.27 Aligned_cols=195 Identities=32% Similarity=0.413 Sum_probs=162.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|.+|+|||+|.+.|+|..+...||||||| -||-.+++.- .+++|.+..+..|+.+.+.||.|||+.+ .|||||
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDi 152 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDI 152 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhc
Confidence 67899999999999999999999999999 4898888876 5788999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|..||||++.+.|||+|||.|.++ .....++||+.|||||++. .+.|+-+.|||||||+..||...++|+-
T Consensus 153 KAGNILLse~g~VKLaDFGSAsi~------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 153 KAGNILLSEPGLVKLADFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred cccceEecCCCeeeeccccchhhc------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 999999999999999999999763 2334588999999999986 4689999999999999999999998875
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+.+.. +.+..+ ...-.|++. ..+....+..++-.||++-|.+|||.++++.
T Consensus 227 nMNAM---SALYHI----------AQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 227 NMNAM---SALYHI----------AQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CchHH---HHHHHH----------HhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 43221 111111 111223333 3456778899999999999999999998865
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=239.67 Aligned_cols=199 Identities=26% Similarity=0.364 Sum_probs=160.2
Q ss_pred ccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++++. ||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~d 127 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRD 127 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 45677 99999999999999999999999999999999976 347999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc------------------cccccccccccccchhhhhcCCCCCcCceee
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 142 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S 142 (380)
|+|+||+++.++.++|+|||++......... .......++..|+|||++....++.++||||
T Consensus 128 l~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~s 207 (280)
T cd05581 128 LKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207 (280)
T ss_pred CCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHH
Confidence 9999999999999999999998764332211 1123345788999999998888999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH--
Q 016913 143 FGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI-- 220 (380)
Q Consensus 143 lGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~-- 220 (380)
||++++++++|..||...... ... ........ .++......+.+++.+||+.+|.+||++
T Consensus 208 lG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 208 LGCIIYQMLTGKPPFRGSNEY---LTF---QKILKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred HHHHHHHHHhCCCCCCCccHH---HHH---HHHHhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 999999999999999754311 111 11111111 1122234678899999999999999999
Q ss_pred --HHHHH
Q 016913 221 --GDVVT 225 (380)
Q Consensus 221 --~evl~ 225 (380)
.+++.
T Consensus 270 ~~~~ll~ 276 (280)
T cd05581 270 GYDELKA 276 (280)
T ss_pred CHHHHhc
Confidence 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=248.11 Aligned_cols=218 Identities=22% Similarity=0.314 Sum_probs=157.8
Q ss_pred CccCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
+|+.++||||++++++|.. ....++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ +
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 128 (334)
T cd07855 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---V 128 (334)
T ss_pred HHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 3678899999999998753 346899999995 799999865 456999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG 153 (380)
+|+||||+||+++.++.+||+|||++......... .......++..|+|||++.. ..++.++|||||||++|+|++|
T Consensus 129 vH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g 208 (334)
T cd07855 129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGR 208 (334)
T ss_pred ecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcC
Confidence 99999999999999999999999999764322211 11234578899999999865 4688999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhh---------hhcccc-----cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 154 RKAIDNTRPPGEHNLVAWA---------RPLFKD-----RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~---------~~~~~~-----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
..||...........+... ...... ...+........ ..........+.+++.+||+.+|.+||+
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt 287 (334)
T cd07855 209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW-SKIFPKASPEALDLLSQMLQFDPEERIT 287 (334)
T ss_pred CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCH-HHHcccCCHHHHHHHHHHccCChhhCcC
Confidence 9999754321111000000 000000 000000000000 0001123567899999999999999999
Q ss_pred HHHHHHHH
Q 016913 220 IGDVVTAL 227 (380)
Q Consensus 220 ~~evl~~L 227 (380)
+.+++..-
T Consensus 288 ~~~~l~~~ 295 (334)
T cd07855 288 VEQALQHP 295 (334)
T ss_pred HHHHHhCh
Confidence 99998743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=246.43 Aligned_cols=214 Identities=22% Similarity=0.315 Sum_probs=155.4
Q ss_pred CccCCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|+.++||||+++++++.... ..|+|+||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~--- 126 (336)
T cd07849 56 ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN--- 126 (336)
T ss_pred HHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 356789999999999876543 5799999996 689888864 56999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC-ccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG 153 (380)
|+|+||||+|||++.++.+||+|||++........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 127 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G 206 (336)
T cd07849 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206 (336)
T ss_pred eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876432211 111233568899999998765 4688999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhccccc-------------CCCCCCC--Ccccc-CCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDR-------------RKFPKMA--DPLLQ-GRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~--~~~l~-~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
..||....... ............ ....... .+... ..........+.+++.+||+.+|++|
T Consensus 207 ~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 283 (336)
T cd07849 207 RPLFPGKDYLH---QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283 (336)
T ss_pred CCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhC
Confidence 99996532211 000000000000 0000000 00000 00001234568899999999999999
Q ss_pred CCHHHHHHH
Q 016913 218 PLIGDVVTA 226 (380)
Q Consensus 218 Pt~~evl~~ 226 (380)
||+.|+++.
T Consensus 284 pt~~e~l~h 292 (336)
T cd07849 284 ITVEEALAH 292 (336)
T ss_pred cCHHHHhcC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=244.06 Aligned_cols=211 Identities=23% Similarity=0.321 Sum_probs=156.7
Q ss_pred ccCCCCCCcccceEEEEeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|+.++||||+++++++... ...|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ +
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 129 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---V 129 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5678999999999988654 34799999995 799999875 467999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.. ..++.++|||||||++|+|++|..
T Consensus 130 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred ecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999997643221 12233457889999998875 468899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccc-----------c------CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKD-----------R------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~-----------~------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
||....... ........... . ........+.+.. ........+.+++.+||+.+|++||
T Consensus 208 pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp 283 (337)
T cd07858 208 LFPGKDYVH---QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRI 283 (337)
T ss_pred CCCCCChHH---HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhcc
Confidence 996542110 00000000000 0 0000000010010 1123456788999999999999999
Q ss_pred CHHHHHHH
Q 016913 219 LIGDVVTA 226 (380)
Q Consensus 219 t~~evl~~ 226 (380)
|+.+|++.
T Consensus 284 s~~ell~h 291 (337)
T cd07858 284 TVEEALAH 291 (337)
T ss_pred CHHHHHcC
Confidence 99999976
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=235.87 Aligned_cols=214 Identities=27% Similarity=0.333 Sum_probs=159.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++...+..++||||++ ++|.+++.. ....+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l 124 (282)
T cd07829 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDL 124 (282)
T ss_pred HHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 567889999999999999999999999997 699999986 2257999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
+|+||+++.++.++|+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|..||...
T Consensus 125 ~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 125 KPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999976432211 22234467789999998776 7899999999999999999999999654
Q ss_pred CCCCCcch-hhhhh-------hccc----ccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNL-VAWAR-------PLFK----DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~-~~~~~-------~~~~----~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
........ ..... .... ....++........... ......+.+++..||+.+|++||++.+|+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 203 SEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 32111000 00000 0000 00011111111110011 112467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=238.35 Aligned_cols=199 Identities=25% Similarity=0.391 Sum_probs=153.4
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKS 83 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDIkp 83 (380)
..||||++++++|..+...|+||||+. ++|.+++.. ....+++..+..++.|++.||.|||+ .+ |+|+||+|
T Consensus 71 ~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p 143 (296)
T cd06618 71 HDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKP 143 (296)
T ss_pred cCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcH
Confidence 359999999999999999999999995 688887765 24579999999999999999999997 57 99999999
Q ss_pred CcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC----CCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 84 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 84 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
+||++++++.++|+|||++..+.... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 144 ~nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 144 SNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred HHEEEcCCCCEEECccccchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999987542211 122345788999999987553 78899999999999999999999964
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.... ..... ...... ..... ........+.+++.+||+.+|.+||++.+|+...
T Consensus 221 ~~~~--~~~~~---~~~~~~--~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 221 CKTE--FEVLT---KILQEE--PPSLP-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred chhH--HHHHH---HHhcCC--CCCCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 3211 01111 111110 00000 0012345788999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=239.54 Aligned_cols=215 Identities=26% Similarity=0.291 Sum_probs=154.9
Q ss_pred ccCCCCCCcccceEEEEeCC----------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 016913 2 LSLLHHSNLVNLIGYCADGD----------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 71 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~----------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~ 71 (380)
++.++||||+++++++.... ..++|+||++ ++|..++.. ....+++..++.++.||+.||.|||+.
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~ 135 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK 135 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccC-ccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56789999999999987654 7899999997 578887765 245799999999999999999999999
Q ss_pred CCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHH
Q 016913 72 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 72 ~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~el 150 (380)
+ |+|+||||+||++++++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 136 ~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el 211 (302)
T cd07864 136 N---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211 (302)
T ss_pred C---eecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence 9 99999999999999999999999999976432221 11222346778999998865 3578999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhh-h-hcccccCC---CCCC--CC------ccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWA-R-PLFKDRRK---FPKM--AD------PLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~-~-~~~~~~~~---~~~~--~~------~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
++|..||...........+... . +....... .+.. .+ ..+... ....+..+.+++..||+.+|.+|
T Consensus 212 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R 290 (302)
T cd07864 212 FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKR 290 (302)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhC
Confidence 9999999754321111111100 0 00000000 0000 00 000000 01234678899999999999999
Q ss_pred CCHHHHHH
Q 016913 218 PLIGDVVT 225 (380)
Q Consensus 218 Pt~~evl~ 225 (380)
|++.+|+.
T Consensus 291 p~~~~il~ 298 (302)
T cd07864 291 CTAEEALN 298 (302)
T ss_pred CCHHHHhc
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=239.55 Aligned_cols=217 Identities=24% Similarity=0.299 Sum_probs=154.4
Q ss_pred ccCCCCCCcccceEEEEeCC--------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGD--------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~--------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
|+.++||||+++++++.... .+++||||+. ++|..++.. ....+++..+..++.|++.||.|||+.+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~- 135 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH- 135 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 56789999999999875433 4699999996 678887765 3457999999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc---------ccccccccccccchhhhhcC-CCCCcCceeeh
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH---------VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSF 143 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~Sl 143 (380)
|+|+||||+||++++++.++|+|||++.......... ......++..|+|||++.+. .++.++|||||
T Consensus 136 --i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 213 (311)
T cd07866 136 --ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGI 213 (311)
T ss_pred --eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHH
Confidence 9999999999999999999999999997643221111 11234568889999988654 58899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchhhh-hhhc----ccccCCCCCCCCccccCCCC-------hhhHHHHHHHHHHhhh
Q 016913 144 GVVFLELITGRKAIDNTRPPGEHNLVAW-ARPL----FKDRRKFPKMADPLLQGRYP-------MRGLYQALAVAAMCLQ 211 (380)
Q Consensus 144 Gvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~ 211 (380)
||++|||++|..||...........+.. .... +.....++...+.......+ ......+.+++.+||+
T Consensus 214 G~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 293 (311)
T cd07866 214 GCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293 (311)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcc
Confidence 9999999999999975433211111100 0000 00000011111000000000 1223578899999999
Q ss_pred hCCCCCCCHHHHHH
Q 016913 212 EQAATRPLIGDVVT 225 (380)
Q Consensus 212 ~~P~~RPt~~evl~ 225 (380)
.+|.+|||+.|++.
T Consensus 294 ~~p~~R~t~~ell~ 307 (311)
T cd07866 294 LDPYKRLTASDALE 307 (311)
T ss_pred cCcccCcCHHHHhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=243.41 Aligned_cols=216 Identities=22% Similarity=0.277 Sum_probs=158.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl 145 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDL 145 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 567899999999999999999999999996 799999865 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCC------------CccccccccccccccchhhhhcC-CCCCcCceeehHHHHH
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGD------------KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFL 148 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~ 148 (380)
+|+||+++.++.++|+|||++....... .........++..|+|||++.+. .++.++|||||||++|
T Consensus 146 ~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 225 (335)
T PTZ00024 146 SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFA 225 (335)
T ss_pred cHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHH
Confidence 9999999999999999999997643110 01111223467889999998764 4689999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchh-hhhhhc----ccccCCCC------CCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 149 ELITGRKAIDNTRPPGEHNLV-AWARPL----FKDRRKFP------KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 149 elltG~~p~~~~~~~~~~~~~-~~~~~~----~~~~~~~~------~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
+|++|..||...........+ ...... +.....++ ....+.+.. ........+.+++.+||+.+|++|
T Consensus 226 el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 226 ELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhc
Confidence 999999999755332111000 000000 00000000 000000000 011234678899999999999999
Q ss_pred CCHHHHHHH
Q 016913 218 PLIGDVVTA 226 (380)
Q Consensus 218 Pt~~evl~~ 226 (380)
|+++||+..
T Consensus 305 ~s~~~~l~~ 313 (335)
T PTZ00024 305 ISAKEALKH 313 (335)
T ss_pred cCHHHHhcC
Confidence 999999963
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=245.43 Aligned_cols=217 Identities=24% Similarity=0.285 Sum_probs=160.2
Q ss_pred ccCCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|+.++||||+++++++...+ ..|+||||+. ++|.+++.. ...+++..++.++.+|+.||.|||+.+ |
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i 124 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---V 124 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 56789999999999998775 7899999996 689999875 448999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~ 154 (380)
+|+||||.|||++.++.++|+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|.
T Consensus 125 ~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~ 204 (330)
T cd07834 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204 (330)
T ss_pred ecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999865433210 112335678899999999887 8899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhccc-------ccCCCCCCCCc------cccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFK-------DRRKFPKMADP------LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
.||...........+........ ........+.. .-...........+.+++.+||+.+|.+||++.
T Consensus 205 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 284 (330)
T cd07834 205 PLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284 (330)
T ss_pred CCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH
Confidence 99975543211110000000000 00000000000 000000112356788999999999999999999
Q ss_pred HHHHH
Q 016913 222 DVVTA 226 (380)
Q Consensus 222 evl~~ 226 (380)
+++..
T Consensus 285 ~ll~~ 289 (330)
T cd07834 285 EALAH 289 (330)
T ss_pred HHHhC
Confidence 99974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=241.36 Aligned_cols=215 Identities=22% Similarity=0.260 Sum_probs=153.1
Q ss_pred ccCC-CCCCcccceEEEEeC----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLL-HHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|+++ +||||+++++++... ...++++||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---i 126 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---V 126 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 3455 599999999976433 45789999995 799999865 467999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG 153 (380)
+|+||||+|||++.++.++|+|||++......... .......|+..|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 127 vH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g 206 (332)
T cd07857 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206 (332)
T ss_pred ccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999754322111 11233568999999998876 4689999999999999999999
Q ss_pred CCCCCCCCCCCCcchhh---------hhhhccccc-----CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 154 RKAIDNTRPPGEHNLVA---------WARPLFKDR-----RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~---------~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
..||...........+. ....+.... ..........+.. ........+.+++.+||+.+|.+|||
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t 285 (332)
T cd07857 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRIS 285 (332)
T ss_pred CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCC
Confidence 99997543211000000 000000000 0000000000000 01122457889999999999999999
Q ss_pred HHHHHH
Q 016913 220 IGDVVT 225 (380)
Q Consensus 220 ~~evl~ 225 (380)
+.+++.
T Consensus 286 ~~~ll~ 291 (332)
T cd07857 286 VEEALE 291 (332)
T ss_pred HHHHhc
Confidence 999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=235.60 Aligned_cols=206 Identities=27% Similarity=0.400 Sum_probs=159.8
Q ss_pred CccCCCCCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|.+.|.||.||++|+||.-+ +-+|-|.|||+|.+|+-||+. .+.+++..+..|+.||+.||.||.+. ++||||-
T Consensus 520 IHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHY 594 (775)
T KOG1151|consen 520 IHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHY 594 (775)
T ss_pred hhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeee
Confidence 45678999999999999554 567899999999999999986 67899999999999999999999988 5899999
Q ss_pred CCCCCcEEEcC---CCCeEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhcC----CCCCcCceeehHHHH
Q 016913 80 DLKSSNILLDE---GFHPKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVF 147 (380)
Q Consensus 80 DIkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~SlGvvl 147 (380)
||||.||||.. .|.+||.||||+++|....... .+....||++|++||++.-+ +.+.|.||||+|||+
T Consensus 595 DLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 595 DLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred ccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 99999999954 4779999999999986544332 23557899999999998754 578899999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhhhhcccc-cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 016913 148 LELITGRKAIDNTRPPGEHNLVAWARPLFKD-RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 224 (380)
|..+.|+.||....... .++.. ..+++. +..|+. . +-....+.++|.+||++..++|.+.-++.
T Consensus 675 yQClYGrKPFGhnqsQQ--dILqe-NTIlkAtEVqFP~--K--------PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 675 YQCLYGRKPFGHNQSQQ--DILQE-NTILKATEVQFPP--K--------PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhhccCCCCCCchhHH--HHHhh-hchhcceeccCCC--C--------CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 99999999998653321 11111 111111 111111 1 12345778999999999999997665543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=238.20 Aligned_cols=223 Identities=30% Similarity=0.444 Sum_probs=169.4
Q ss_pred CCCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------C
Q 016913 4 LLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA------N 73 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------~ 73 (380)
.++|+||+.++++-..+. +++||+||.+.|+|.+||+. ..++|....+|+..+++||+|||+.- +
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~K 334 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHK 334 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCC
Confidence 579999999999876655 89999999999999999986 78999999999999999999999842 6
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCC-----CcCceeehHHHH
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLT-----LKSDVYSFGVVF 147 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~~sDV~SlGvvl 147 (380)
|+|+|||||+.||||..|+++.|+|||+|..+............+||.+|||||++.+. .+. .+.||||+|.||
T Consensus 335 p~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 335 PPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred CccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999887655444445558999999999999875 233 358999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcch-----------hhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC
Q 016913 148 LELITGRKAIDNTRPPGEHNL-----------VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~ 216 (380)
|||++...-++. .+....++ +...+.+.-..+..+.+.+..... ..+..+.+.+..||..||+.
T Consensus 415 WEi~SRC~~~~~-~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeA 489 (534)
T KOG3653|consen 415 WEIASRCTDADP-GPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEA 489 (534)
T ss_pred HHHHhhcccccC-CCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhh
Confidence 999986544421 11111000 011111111112222333322221 45678889999999999999
Q ss_pred CCCHHHHHHHHHHhhhccCC
Q 016913 217 RPLIGDVVTALTYLASQTYD 236 (380)
Q Consensus 217 RPt~~evl~~L~~~~~~~~~ 236 (380)
|-|+.=|-+++..+.....+
T Consensus 490 RLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 490 RLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hhhhHHHHHHHHHHhccCCc
Confidence 99999999999887654443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=241.21 Aligned_cols=211 Identities=23% Similarity=0.330 Sum_probs=154.7
Q ss_pred CccCCCCCCcccceEEEEe-CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|+.++||||++++++|.. ....++||||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ |+|+
T Consensus 62 ~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~ 132 (328)
T cd07856 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHR 132 (328)
T ss_pred HHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 3567899999999999865 56789999999 5799998864 46889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|+||+++.++.++|+|||++..... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 133 dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 133 DLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred CCCHHHEeECCCCCEEeCccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999875321 1123456788999998766 568999999999999999999999996
Q ss_pred CCCCCCCcch-hh--------hhhhcccccCCCCCCCCccccCCCC-----hhhHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 016913 159 NTRPPGEHNL-VA--------WARPLFKDRRKFPKMADPLLQGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVV 224 (380)
Q Consensus 159 ~~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl 224 (380)
.......... .. +...... .........-......+ ......+.+++.+||+.+|++|||+.+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 208 GKDHVNQFSIITDLLGTPPDDVINTICS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhccc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 5432111000 00 0000000 00000000000001111 12346788999999999999999999997
Q ss_pred HH
Q 016913 225 TA 226 (380)
Q Consensus 225 ~~ 226 (380)
..
T Consensus 287 ~~ 288 (328)
T cd07856 287 AH 288 (328)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=246.77 Aligned_cols=222 Identities=24% Similarity=0.281 Sum_probs=162.7
Q ss_pred CccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|++|+|||||+++++=++. ...++|||||.||+|..+|.. +.+...|++..++.++.+++.||.|||+++
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~-- 140 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG-- 140 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 57899999999999875443 356899999999999999976 556677999999999999999999999999
Q ss_pred CeEecCCCCCcEEEc--CCCC--eEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHH
Q 016913 75 PVIYRDLKSSNILLD--EGFH--PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 75 ~iiHrDIkp~NILl~--~~~~--~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~e 149 (380)
|+||||||.||++- +++. .||+|||.|+..... .......||..|++||.+.. +.|+..+|.|||||++|+
T Consensus 141 -IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ 216 (732)
T KOG4250|consen 141 -IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYE 216 (732)
T ss_pred -ceeccCCCCcEEEeecCCCceEEeeecccccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHH
Confidence 99999999999984 3343 699999999965433 35567899999999999994 889999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCc----------cccC--CCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP----------LLQG--RYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~l~~--~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
+.||..||..........-+.|... .+..........+ .+.. .........+-.++..+|..+|.+|
T Consensus 217 caTG~lPF~p~~~pk~~~~~~~~~~-tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~ 295 (732)
T KOG4250|consen 217 CATGELPFIPFGGPKNNKEIMWHII-TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKR 295 (732)
T ss_pred HhccCCCCCcCCCccccchhhhhhh-ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHh
Confidence 9999999975443322111222111 1110000000111 1110 1122334466678888899999999
Q ss_pred C--CHHHHHHHHHHh
Q 016913 218 P--LIGDVVTALTYL 230 (380)
Q Consensus 218 P--t~~evl~~L~~~ 230 (380)
- .+.++...+..+
T Consensus 296 ~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 296 GHEGFDRFFAEVDDI 310 (732)
T ss_pred CCCCcchHHHHHHHH
Confidence 8 666666555554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=243.87 Aligned_cols=207 Identities=23% Similarity=0.307 Sum_probs=155.3
Q ss_pred ccCCCCCCcccceEEEEeCCe------EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQ------RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~------~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|++++||||+++++++...+. .++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g--- 138 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG--- 138 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999998866554 89999999 6899999965 56999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus 139 i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~ 213 (343)
T cd07851 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213 (343)
T ss_pred eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999764222 2234578889999998753 6789999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhccccc-----------------CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDR-----------------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
.||........ +.......... ...+....+.+... .......+.+++.+||+.+|++|
T Consensus 214 ~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 214 TLFPGSDHIDQ---LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred CCCCCCChHHH---HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhC
Confidence 99975433211 11000000000 00000000000000 01235678999999999999999
Q ss_pred CCHHHHHHH
Q 016913 218 PLIGDVVTA 226 (380)
Q Consensus 218 Pt~~evl~~ 226 (380)
||+.+|+..
T Consensus 290 pt~~ell~h 298 (343)
T cd07851 290 ITAAEALAH 298 (343)
T ss_pred CCHHHHhcC
Confidence 999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=235.27 Aligned_cols=205 Identities=20% Similarity=0.250 Sum_probs=155.7
Q ss_pred cccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEc
Q 016913 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD 89 (380)
Q Consensus 10 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~ 89 (380)
+|.+.+||.-.++.|||+|.+ |-|++++|.. +...+++..++..++.|++.+++|||+.+ ++|.||||+|||+.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfv 226 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFV 226 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEe
Confidence 567788899999999999999 6899999987 55677999999999999999999999999 99999999999994
Q ss_pred C--------------------CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHH
Q 016913 90 E--------------------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 90 ~--------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~e 149 (380)
. +..++|+|||.|+.. .......+.|.+|.|||++.+-.++.++||||+||||+|
T Consensus 227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVE 301 (415)
T ss_pred ccceEEEeccCCccceeccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEE
Confidence 2 234899999999852 222355778999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhhh--------------cccccCCC--------------CCCCCcccc-CCCChhhHH
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWARP--------------LFKDRRKF--------------PKMADPLLQ-GRYPMRGLY 200 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~~--------------~~~~~~~~--------------~~~~~~~l~-~~~~~~~~~ 200 (380)
|.+|...|+.........+...+.. .+... .+ .+...|+-. -.....+..
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~ 380 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV 380 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence 9999999976543221111111100 00000 00 000011000 011335667
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 201 QALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 201 ~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+|++|+.+||.+||.+|+|+.|++..
T Consensus 381 ~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 381 QLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHHHccCccccccHHHHhcC
Confidence 89999999999999999999999863
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=240.90 Aligned_cols=210 Identities=24% Similarity=0.325 Sum_probs=154.3
Q ss_pred CccCCCCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|+.++||||+++++++..+. ..++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g-- 138 (343)
T cd07880 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG-- 138 (343)
T ss_pred HHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367889999999999987653 458999999 7899998864 56999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhC
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG 153 (380)
|+|+||||+||+++.++.++|+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 139 -i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 212 (343)
T cd07880 139 -IIHRDLKPGNLAVNEDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212 (343)
T ss_pred -eecCCCCHHHEEEcCCCCEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999975322 1223457889999999876 4588999999999999999999
Q ss_pred CCCCCCCCCCCCcch-hh--------hhhhcccc-----cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 154 RKAIDNTRPPGEHNL-VA--------WARPLFKD-----RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~-~~--------~~~~~~~~-----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
..||........... .. +...+... ...++......+. .........+.+++.+||+.+|.+|||
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t 291 (343)
T cd07880 213 KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRIT 291 (343)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCC
Confidence 999975432110000 00 00000000 0000000000000 011233456889999999999999999
Q ss_pred HHHHHH
Q 016913 220 IGDVVT 225 (380)
Q Consensus 220 ~~evl~ 225 (380)
+.+++.
T Consensus 292 ~~~~l~ 297 (343)
T cd07880 292 AAEALA 297 (343)
T ss_pred HHHHhc
Confidence 999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=222.38 Aligned_cols=200 Identities=33% Similarity=0.421 Sum_probs=160.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+++++|+||+++++++......++||||+++++|.+++.. ...+++..++.++.+++.+|.+||..+ ++|+||
T Consensus 41 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i 113 (244)
T smart00220 41 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDL 113 (244)
T ss_pred HHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCc
Confidence 4677999999999999999999999999998899999976 233899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+|.||+++.++.++|+|||++....... ......++..|++||.+....++.++|||+||+++++|++|..||....
T Consensus 114 ~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 190 (244)
T smart00220 114 KPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD 190 (244)
T ss_pred CHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998643321 2334567889999999998889999999999999999999999986531
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
. ........ ......... . .......+.+++.+||..+|++||++.++++
T Consensus 191 ~--~~~~~~~~---~~~~~~~~~---~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 191 Q--LLELFKKI---GKPKPPFPP---P------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred c--HHHHHHHH---hccCCCCcc---c------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1 11111111 110000000 0 0003467889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=239.97 Aligned_cols=213 Identities=22% Similarity=0.325 Sum_probs=153.5
Q ss_pred ccCCCCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||++++++|.... ..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+.+
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~--- 137 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG--- 137 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999987543 4699999995 68877662 35899999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
++||||||+||+++.++.++|+|||++..... ......++..|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875322 1223457889999999876 46889999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhh--------cccc------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 155 KAIDNTRPPGEHNLVAWARP--------LFKD------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.||...........+..... .... ....+......+...+ ......+.+++.+||+.||++||++
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~ 291 (342)
T cd07879 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTA 291 (342)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99975432111110000000 0000 0000000000000000 1234568899999999999999999
Q ss_pred HHHHHH--HHHh
Q 016913 221 GDVVTA--LTYL 230 (380)
Q Consensus 221 ~evl~~--L~~~ 230 (380)
.+|+.. ++.+
T Consensus 292 ~e~l~h~~f~~~ 303 (342)
T cd07879 292 TEALEHPYFDSF 303 (342)
T ss_pred HHHhcCcchhhc
Confidence 999854 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=240.53 Aligned_cols=216 Identities=22% Similarity=0.327 Sum_probs=151.9
Q ss_pred CccCCCCCCcccceEEEEeC--------------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 016913 1 MLSLLHHSNLVNLIGYCADG--------------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 66 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--------------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~ 66 (380)
+|++++||||+++++++... ...|+||||++ ++|.+++.. ..+++..++.++.||+.||.
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~ 128 (342)
T cd07854 55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLK 128 (342)
T ss_pred HHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHH
Confidence 36788999999999876554 35789999996 699988864 46899999999999999999
Q ss_pred HHhhCCCCCeEecCCCCCcEEEcC-CCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhc-CCCCCcCceeeh
Q 016913 67 YLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSF 143 (380)
Q Consensus 67 ~LH~~~~~~iiHrDIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~Sl 143 (380)
|||+.+ |+|+||||+||+++. ++.++|+|||++......... .......++..|+|||++.. ..++.++|||||
T Consensus 129 ~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl 205 (342)
T cd07854 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205 (342)
T ss_pred HHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence 999999 999999999999974 557899999998753221111 11123457889999998754 568889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchhhhhhhccc--ccCC----CCCCCC-ccccCC-----CChhhHHHHHHHHHHhhh
Q 016913 144 GVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK--DRRK----FPKMAD-PLLQGR-----YPMRGLYQALAVAAMCLQ 211 (380)
Q Consensus 144 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~~~-~~l~~~-----~~~~~~~~l~~li~~cl~ 211 (380)
||++|+|++|..||................+... .... +..... ...... ........+.+++.+||+
T Consensus 206 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 285 (342)
T cd07854 206 GCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILT 285 (342)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhC
Confidence 9999999999999975543211111000000000 0000 000000 000000 011234578899999999
Q ss_pred hCCCCCCCHHHHHH
Q 016913 212 EQAATRPLIGDVVT 225 (380)
Q Consensus 212 ~~P~~RPt~~evl~ 225 (380)
.+|.+|||+.+|+.
T Consensus 286 ~dP~~R~t~~ell~ 299 (342)
T cd07854 286 FNPMDRLTAEEALM 299 (342)
T ss_pred CCchhccCHHHHhC
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=238.76 Aligned_cols=211 Identities=23% Similarity=0.310 Sum_probs=153.8
Q ss_pred ccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|++++||||+++++++... ...|+|++++ +++|.+++.. ..+++..++.++.|++.||.|||+.+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--- 140 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--- 140 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999988643 3468899888 7899988864 46999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+|+||||+||+++.++.+||+|||++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 141 ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred eeecCCChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875321 2233467889999999876 46889999999999999999999
Q ss_pred CCCCCCCCCCCcchh-hhhh----hc---cccc------CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 155 KAIDNTRPPGEHNLV-AWAR----PL---FKDR------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~-~~~~----~~---~~~~------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.||...........+ .... .. .... ..++......+. .........+.+++..||+.+|.+||++
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~ 294 (345)
T cd07877 216 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITA 294 (345)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence 999643321111000 0000 00 0000 000000000000 0001234568899999999999999999
Q ss_pred HHHHHHH
Q 016913 221 GDVVTAL 227 (380)
Q Consensus 221 ~evl~~L 227 (380)
.+++..-
T Consensus 295 ~e~l~h~ 301 (345)
T cd07877 295 AQALAHA 301 (345)
T ss_pred HHHhcCh
Confidence 9998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=244.82 Aligned_cols=201 Identities=27% Similarity=0.324 Sum_probs=168.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||...+.|.||++|-.|.+..++|++||-|-||.|+..|.+ .+.|+..++..++..+++|++|||.++ ||+||
T Consensus 473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRD 545 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRD 545 (732)
T ss_pred HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceecc
Confidence 34566899999999999999999999999999999999987 788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|++|+.+|.+||.|||+|+....+. .+..++||+.|.|||++.+..-+.+.|.|+||+++||||+|.+||...
T Consensus 546 LKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 546 LKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred CChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999765443 345689999999999999999999999999999999999999999987
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTAL 227 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~L 227 (380)
++....+++--....+ .+|........+|+.+....+|.+|-- +.+|-..-
T Consensus 623 dpmktYn~ILkGid~i----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 623 DPMKTYNLILKGIDKI----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred chHHHHHHHHhhhhhh----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 7765554432221111 122233456778999999999999974 56665443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=254.34 Aligned_cols=208 Identities=25% Similarity=0.395 Sum_probs=163.3
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHhhC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PD-------K--EPLDWNTRMKIAAGAAKGLEYLHDK 71 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~qia~aL~~LH~~ 71 (380)
..+|||||.++|+|...+..++|+||+..|+|..+|.... .. . ..|+....+.++.|||.|++||++.
T Consensus 358 ~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~ 437 (609)
T KOG0200|consen 358 LGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV 437 (609)
T ss_pred hcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence 3479999999999999999999999999999999999743 00 0 2399999999999999999999999
Q ss_pred CCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcccccccc--ccccccchhhhhcCCCCCcCceeehHHHHHH
Q 016913 72 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM--GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 72 ~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~e 149 (380)
. +|||||-..|||+.++..+||+|||+++.......... .... -...|||||.+....|+.++|||||||+|||
T Consensus 438 ~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 438 P---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWE 513 (609)
T ss_pred C---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHH
Confidence 9 99999999999999999999999999985433322211 1111 2346999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 150 LIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 150 llt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|++ |..||..... ...+..+ ...+. +-..|..+..++.+|+..||+.+|++||++.++++.|.
T Consensus 514 ifsLG~~PYp~~~~--~~~l~~~----l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPP--TEELLEF----LKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred HhhCCCCCCCCCCc--HHHHHHH----HhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 997 5677764211 1111111 11111 11223445677889999999999999999999999998
Q ss_pred Hhh
Q 016913 229 YLA 231 (380)
Q Consensus 229 ~~~ 231 (380)
...
T Consensus 578 ~~l 580 (609)
T KOG0200|consen 578 KHL 580 (609)
T ss_pred HHH
Confidence 853
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=249.40 Aligned_cols=200 Identities=28% Similarity=0.384 Sum_probs=166.2
Q ss_pred CCCCCCcccceEEEEe-----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 4 LLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
.-.|||++.+|++|.. ++++|||||||.+||+.++++... ...+.|..+..|+..++.||.+||... +||
T Consensus 72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viH 146 (953)
T KOG0587|consen 72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIH 146 (953)
T ss_pred ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eee
Confidence 3479999999999854 468999999999999999999854 778999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-----CCCCcCceeehHHHHHHHHhC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~SlGvvl~elltG 153 (380)
||||-.|||++.++.+||+|||++.... ..........||+.|||||++.+. .|+..+|+||||++..||--|
T Consensus 147 RDikG~NiLLT~e~~VKLvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG 224 (953)
T KOG0587|consen 147 RDIKGQNVLLTENAEVKLVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEG 224 (953)
T ss_pred ecccCceEEEeccCcEEEeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCC
Confidence 9999999999999999999999987532 222334557899999999999865 477889999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.+|+-+..+. +.+|.- ...|...-.-|.....++.++|..||.+|.+.||++.++++
T Consensus 225 ~PPl~DmHPm---------raLF~I------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 225 APPLCDMHPM---------RALFLI------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCccCcchh---------hhhccC------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 9999876552 222222 12222222345677889999999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=250.85 Aligned_cols=208 Identities=28% Similarity=0.419 Sum_probs=173.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|.+|+||||++|+++|.... +.||++||++|+|.+|++. .+..+-....+.|+.||++|+.|||++. ++|||
T Consensus 751 ~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrd 823 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRD 823 (1177)
T ss_pred HHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhh
Confidence 367899999999999998765 8899999999999999997 5778999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|-..||||.+-..+||.|||+++...............-.+-|||-|.+....|+.++|||||||++||+|| |..|++.
T Consensus 824 LaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 824 LAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred hhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 999999999999999999999998655544444444445678999999999999999999999999999987 7888876
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
....+..+ +++.+ .+-..|+.....+..++.+||..|+..||+++++.+.+..++.
T Consensus 904 i~~~eI~d-------lle~g----------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 904 IPAEEIPD-------LLEKG----------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCHHHhhH-------HHhcc----------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 54332222 12221 1222345567889999999999999999999999999987754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=223.27 Aligned_cols=208 Identities=23% Similarity=0.365 Sum_probs=155.7
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
-|+||+.|+++|+++...|||||.|.||+|.++++. ...|++..+-.+..+|+.||.|||.+| |.||||||+|
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPEN 206 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPEN 206 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccc
Confidence 599999999999999999999999999999999987 678999999999999999999999999 9999999999
Q ss_pred EEEcCCCC---eEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhc-----CCCCCcCceeehHHHHHHHHh
Q 016913 86 ILLDEGFH---PKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 86 ILl~~~~~---~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~ellt 152 (380)
||...-+. +|||||.+...+....... .....+|+..|||||+..- ..|+.++|.||||+|+|-||+
T Consensus 207 iLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 207 ILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred eeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 99976554 7999999875432221111 1134678899999998752 368899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCC--CChhh----HHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR--YPMRG----LYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~----~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|.+||.+.=..+ ..|-+.-. -+.-...++..+..+. +|+++ .....+++...|..++.+|-++.+++.
T Consensus 287 GYpPFvG~Cg~d----CGWdrGe~-Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 287 GYPPFVGHCGAD----CGWDRGEV-CRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCCccCccCCc----CCccCCCc-cHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 999996431111 11100000 0000001122222222 33333 456778999999999999999888876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=226.94 Aligned_cols=217 Identities=25% Similarity=0.308 Sum_probs=163.9
Q ss_pred CCCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCC
Q 016913 4 LLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-----KANP 74 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~ 74 (380)
.|+|+||+.+++....++ ++|||++|.+.|||.+||.. ..++.+..++++..+|.||++||. +|+|
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKP 335 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKP 335 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCc
Confidence 479999999999875543 68999999999999999976 789999999999999999999996 5789
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC--ccccccccccccccchhhhhcC------CCCCcCceeehHHH
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK--THVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVV 146 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlGvv 146 (380)
.|.|||||+.||||.+++.+.|+|+|||........ .......+||.+|||||++... .--..+||||||+|
T Consensus 336 aIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 336 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred hhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 999999999999999999999999999976432211 1123457899999999998643 11245899999999
Q ss_pred HHHHHhC----------CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCcccc-CCCChhhHHHHHHHHHHhhhhCCC
Q 016913 147 FLELITG----------RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ-GRYPMRGLYQALAVAAMCLQEQAA 215 (380)
Q Consensus 147 l~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~~P~ 215 (380)
+||+... +.||...-+.+.... .. +..+-. .. +.|.+. ...+.+.+..+.+|+..||..||.
T Consensus 416 lWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e-eM-rkVVCv----~~-~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 416 LWEIARRCESGGIVEEYQLPYYDVVPSDPSFE-EM-RKVVCV----QK-LRPNIPNRWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred HHHHHHHhhcCCEehhhcCCcccCCCCCCCHH-HH-hcceee----cc-cCCCCCcccccCHHHHHHHHHHHHhhcCCch
Confidence 9999752 456654433322111 00 001100 01 111111 223457788999999999999999
Q ss_pred CCCCHHHHHHHHHHhhh
Q 016913 216 TRPLIGDVVTALTYLAS 232 (380)
Q Consensus 216 ~RPt~~evl~~L~~~~~ 232 (380)
.|-|+--|-+.|.++..
T Consensus 489 aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 489 ARLTALRIKKTLAKLSN 505 (513)
T ss_pred hhhHHHHHHHHHHHHhc
Confidence 99999999999988763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=222.13 Aligned_cols=224 Identities=22% Similarity=0.235 Sum_probs=163.4
Q ss_pred ccCCCCCCcccceEEEEe-CCeEEEEEeccCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPP-DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
++-|+||||+.+..+|.. +..+++++||.+ -+|+..++-... ....++...+..|++||+.|+.|||++- |+||
T Consensus 81 ~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHR 156 (438)
T KOG0666|consen 81 LRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHR 156 (438)
T ss_pred HHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeec
Confidence 567899999999999877 678899999997 799998876432 3356999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCC----CCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhC
Q 016913 80 DLKSSNILLDEG----FHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 80 DIkp~NILl~~~----~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG 153 (380)
||||.||||..+ |.+||+|||+++++...-..- ....++-|.+|.|||.+.+. .|+.+.|||++|||+.||++.
T Consensus 157 DLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 157 DLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999999999877 899999999999865544333 22446789999999999875 699999999999999999999
Q ss_pred CCCCCCCCCCCCcc---hhhhhhhccccc--------CCCCCCCCc-----ccc-CCCCh-----------hhHHHHHHH
Q 016913 154 RKAIDNTRPPGEHN---LVAWARPLFKDR--------RKFPKMADP-----LLQ-GRYPM-----------RGLYQALAV 205 (380)
Q Consensus 154 ~~p~~~~~~~~~~~---~~~~~~~~~~~~--------~~~~~~~~~-----~l~-~~~~~-----------~~~~~l~~l 205 (380)
++.|.+........ ..+....+++.- ..+..+.+- -++ ..+.. .-....++|
T Consensus 237 ~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~L 316 (438)
T KOG0666|consen 237 EPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDL 316 (438)
T ss_pred CccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHH
Confidence 88886543321111 011111111110 000000000 000 00000 011237789
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 206 AAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 206 i~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
+.++|+.||.+|.|+++.++..-.
T Consensus 317 L~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 317 LQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHhccCchhhccHHHHhccccc
Confidence 999999999999999999886544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=249.91 Aligned_cols=95 Identities=34% Similarity=0.463 Sum_probs=89.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..||||||+.+++|.+++.. ...+++..++.++.||+.||.|||..+ ||||||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDL 130 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDL 130 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCc
Confidence 5678999999999999999999999999999999999975 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcc
Q 016913 82 KSSNILLDEGFHPKLSDFGLAK 103 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~ 103 (380)
||+||||+.++.+||+|||+++
T Consensus 131 KP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 131 KPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred cHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=234.34 Aligned_cols=162 Identities=27% Similarity=0.341 Sum_probs=139.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||.--..+-||+||..|.+++.+|+||+|++||++-.+|.. .+.|.+..+..++..+..|+++.|..| +||||
T Consensus 682 ILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRD 754 (1034)
T KOG0608|consen 682 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRD 754 (1034)
T ss_pred hHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecc
Confidence 45556788899999999999999999999999999999987 578999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCC--------Ccc----------------c----------------ccccccc
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGD--------KTH----------------V----------------STRVMGT 120 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~--------~~~----------------~----------------~~~~~gt 120 (380)
|||+|||||.+|.+||.|||||.-+.... .+. + ....+||
T Consensus 755 iKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt 834 (1034)
T KOG0608|consen 755 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGT 834 (1034)
T ss_pred cCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCC
Confidence 99999999999999999999996532110 000 0 0114699
Q ss_pred ccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchh
Q 016913 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV 169 (380)
Q Consensus 121 ~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~ 169 (380)
..|+|||++....|+..+|.||.|||||||+.|+.||-...+.+.+..+
T Consensus 835 ~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 835 PNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred CcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeee
Confidence 9999999999999999999999999999999999999877666554433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=262.46 Aligned_cols=197 Identities=16% Similarity=0.224 Sum_probs=142.1
Q ss_pred cCCCC-CCcccceEEE-------EeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 3 SLLHH-SNLVNLIGYC-------ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 3 ~~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+.++| .||++++++| .....+++++||+ +++|.++|.. ....+++..++.++.||+.||.|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 45678 7999999988 3334567889988 5899999975 2456999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCC-------------------CCeEEeecCCcccCCCCCC--------------ccccccccccc
Q 016913 75 PVIYRDLKSSNILLDEG-------------------FHPKLSDFGLAKLGPVGDK--------------THVSTRVMGTY 121 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~-------------------~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~ 121 (380)
|+||||||+||||+.. +.+||+|||+++....... ........||+
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999653 4456666666653210000 00011245888
Q ss_pred cccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHH
Q 016913 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQ 201 (380)
Q Consensus 122 ~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 201 (380)
.|+|||++.+..|+.++|||||||+||||++|..|+..... ........ ...+.. ......
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~----------~~~~~~-----~~~~~~ 240 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR----------VLPPQI-----LLNWPK 240 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh----------hcChhh-----hhcCHH
Confidence 99999999999999999999999999999998877642110 00000000 001100 111234
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 202 ALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 202 l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+..++.+||+.+|.+||++.||++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 568889999999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=225.47 Aligned_cols=208 Identities=23% Similarity=0.280 Sum_probs=159.8
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+.-+.||||++||.+..++.+||.||+|+ .||+.+-+.. .-.+..++++.+-+|....+.||+||-+.-+ ||||||
T Consensus 118 ks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDv 194 (361)
T KOG1006|consen 118 KSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDV 194 (361)
T ss_pred hhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccC
Confidence 44578999999999999999999999995 8887655431 1345679999999999999999999998654 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||+||||+..|.+||||||++-.... ....+...|-..|||||-+.. ..|+.+|||||||++|||+.||..|+..
T Consensus 195 KPSNILldr~G~vKLCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 195 KPSNILLDRHGDVKLCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred ChhheEEecCCCEeeecccchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 99999999999999999999965321 123355678889999998864 3589999999999999999999999987
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+... ......... ...+.+. ...-..+....+..++.-||.+|-.+||.+.++.++-
T Consensus 272 w~sv-----feql~~Vv~--gdpp~l~----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 272 WDSV-----FEQLCQVVI--GDPPILL----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred HHHH-----HHHHHHHHc--CCCCeec----CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 6441 111111111 1111111 1111234567889999999999999999999998754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=225.15 Aligned_cols=186 Identities=28% Similarity=0.401 Sum_probs=156.3
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+-|.++.++.+|..-+.+|+||||+.||+|--+++. -+.+.+..+..++..|+.||-|||+++ ||+||||.+|
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDN 480 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 480 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccc
Confidence 467889999999999999999999999999988876 567888899999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~ 165 (380)
|||+.+|.+||+|||+++...... ..+...+||+.|+|||++...+|+.+.|.|+|||+|||||.|++||+.....
T Consensus 481 vmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-- 556 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-- 556 (683)
T ss_pred eEeccCCceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--
Confidence 999999999999999998633322 3345689999999999999999999999999999999999999999864322
Q ss_pred cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
.+ +..+..... .||...+.++.+|+...|.++|.+|-
T Consensus 557 -el---F~aI~ehnv------------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 557 -EL---FQAIMEHNV------------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -HH---HHHHHHccC------------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 111222211 24555667889999999999999995
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=218.20 Aligned_cols=193 Identities=25% Similarity=0.379 Sum_probs=156.5
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
-+||.+|.+..+|..+..+++|.||++||+|--+++. ...|+++.+..+...|+.||.|||+.| ||+||||.+
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkld 380 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLD 380 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeecccc
Confidence 4799999999999999999999999999999888865 567999999999999999999999999 999999999
Q ss_pred cEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 85 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
|||++..+.+||.|+|+++... .....+...+||+.|+|||++.+..|....|.|+|||+|+||+.|+.||+--.-..
T Consensus 381 nvlldaeghikltdygmcke~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred ceEEccCCceeecccchhhcCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 9999999999999999998632 23344567899999999999999999999999999999999999999997322111
Q ss_pred -Ccchhhh-hhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 165 -EHNLVAW-ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 165 -~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
.++..++ +..++.. .++ .|.....++..++...|.+||.+|-
T Consensus 459 ~d~ntedylfqvilek----------qir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 459 PDMNTEDYLFQVILEK----------QIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccchhHHHHHHHhhh----------ccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1122222 1212221 111 1223345666788999999999985
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=244.93 Aligned_cols=196 Identities=26% Similarity=0.297 Sum_probs=156.1
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+.+=||.++..|.++.++|+|||||+||+|..++.. ..++++..+..++..|+.||.-||+.| +|||||||+|
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDN 205 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDN 205 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcce
Confidence 455688888899999999999999999999999987 347999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----CCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+..|.+||+|||.|..+.... +-.+...+|||-|++||++.. +.|+..+|.||+||++|||+.|..||...
T Consensus 206 vLld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 206 VLLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred eEecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 999999999999999997654322 233456789999999999963 57999999999999999999999999743
Q ss_pred CCCCCcchhhhhhhcccc--cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKD--RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL---IGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~~ 226 (380)
+++.-...+... .-.||... ..+..+.+||...+. +|+.|-. +.+|-..
T Consensus 285 ------slveTY~KIm~hk~~l~FP~~~----------~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 285 ------SLVETYGKIMNHKESLSFPDET----------DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ------HHHHHHHHHhchhhhcCCCccc----------ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 344433333333 22233221 234677788877765 6777776 7777554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=216.45 Aligned_cols=212 Identities=24% Similarity=0.334 Sum_probs=169.4
Q ss_pred ccCCCCCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhc----CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHD----LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|.-+.||||+.+.+++.+. ...+++|.++.-|+|+.+|.. -+.....++-.+...++.|++.|++|||.++ |
T Consensus 341 ly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---V 417 (563)
T KOG1024|consen 341 LYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---V 417 (563)
T ss_pred HhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 4567899999999998654 567999999999999999982 1234456788889999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~ 155 (380)
||.||...|++|++...+||+|=.+++-.-..+.+...........||+||.+....|+.++||||||++||||+| |+.
T Consensus 418 iHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~ 497 (563)
T KOG1024|consen 418 IHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKL 497 (563)
T ss_pred ccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999875433333333333445678999999999999999999999999999987 778
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
|+..-+|.+....+ +++.. -..|.+++.+++.++.-||...|++||++++++..|..+-.+
T Consensus 498 PyaeIDPfEm~~yl-------kdGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 498 PYAEIDPFEMEHYL-------KDGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred CccccCHHHHHHHH-------hccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 88655443322211 22211 122446788999999999999999999999999999877543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=237.46 Aligned_cols=199 Identities=25% Similarity=0.343 Sum_probs=150.5
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+|||||++|+.=.+..+.||+.|.|. .+|.+++...........-...+.++.|++.||++||+.+ ||||||||+|
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQN 636 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQN 636 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCce
Confidence 69999999999888899999999995 9999999862111111111455788999999999999999 9999999999
Q ss_pred EEEcC---C--CCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhC-CCCCC
Q 016913 86 ILLDE---G--FHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG-RKAID 158 (380)
Q Consensus 86 ILl~~---~--~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG-~~p~~ 158 (380)
|||+. + ..++|+|||+++....+...- ......||.+|+|||++....-+.+.||||||||+|++++| ..||.
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99976 2 468999999998865443322 23557899999999999998888899999999999999987 78997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.....+ .++......+..+ .+ ..++ .+.+||.+|+..+|..||++.+|+.
T Consensus 717 d~~~R~--------~NIl~~~~~L~~L-~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 717 DSLERQ--------ANILTGNYTLVHL-EP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred chHHhh--------hhhhcCccceeee-cc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 542211 1111111111111 00 0111 7789999999999999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=226.91 Aligned_cols=200 Identities=25% Similarity=0.307 Sum_probs=159.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++++||.||.+...|+..+.+|+|||.+. |++.+.+-. ..+++|++.....++.||+.||.|||-++ |+|+|
T Consensus 616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCD 689 (888)
T KOG4236|consen 616 ILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCD 689 (888)
T ss_pred HHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeecc
Confidence 5889999999999999999999999999996 555555544 47889999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEG---FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+||||... ..+||||||+|++++... ....++||+.|+|||++..+.|...-|+||.|||+|.-|+|..||
T Consensus 690 LKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPF 766 (888)
T KOG4236|consen 690 LKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPF 766 (888)
T ss_pred CCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccC
Confidence 99999999654 468999999999865433 345578999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... .+.++-+ .| +..+.. -.+....+++||...||..=.+|.+....+.
T Consensus 767 NEdEdI--ndQIQNA--aF--------MyPp~P----W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 767 NEDEDI--NDQIQNA--AF--------MYPPNP----WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCccch--hHHhhcc--cc--------ccCCCc----hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 743221 1111110 00 111110 1133457889999999999999998877654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=208.66 Aligned_cols=223 Identities=23% Similarity=0.355 Sum_probs=163.7
Q ss_pred CccCCCCCCcccceEEEEeC--------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG--------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 72 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 72 (380)
||..|+|+|++.+++.|... ..+|+||.+|+ -+|.-+|.+ -+.+++..++.+++.++..||.|+|...
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k 144 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK 144 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 57789999999999988442 24799999996 789988876 4577999999999999999999999999
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc--ccccccccccccchhhhhcC-CCCCcCceeehHHHHHH
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~e 149 (380)
|+|||+|+.|+||+.++.+||+|||+++.+....... ..+..+-|..|.+||.+.+. .|+++.|||.-|||+.|
T Consensus 145 ---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimae 221 (376)
T KOG0669|consen 145 ---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAE 221 (376)
T ss_pred ---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHH
Confidence 9999999999999999999999999997654332221 22345569999999999875 79999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhh-----hcccccCCCC---CC-CCccccCCCC--hhh------HHHHHHHHHHhhhh
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWAR-----PLFKDRRKFP---KM-ADPLLQGRYP--MRG------LYQALAVAAMCLQE 212 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---~~-~~~~l~~~~~--~~~------~~~l~~li~~cl~~ 212 (380)
|+++.+-++.........++...- ..+..-..++ .+ ..|..++.+. .+. -...++|+.++|..
T Consensus 222 Mwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~ 301 (376)
T KOG0669|consen 222 MWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKL 301 (376)
T ss_pred HHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhcc
Confidence 999998887654433222222110 0000000000 00 1111111111 011 12678999999999
Q ss_pred CCCCCCCHHHHHHHHHHh
Q 016913 213 QAATRPLIGDVVTALTYL 230 (380)
Q Consensus 213 ~P~~RPt~~evl~~L~~~ 230 (380)
||.+|+++.+++...-..
T Consensus 302 DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 302 DPTKRIDADQALNHDFFW 319 (376)
T ss_pred CcccCcchHhhhchhhhh
Confidence 999999999998765443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-27 Score=215.43 Aligned_cols=207 Identities=25% Similarity=0.309 Sum_probs=157.7
Q ss_pred ccCCCCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+..++|+||++++.+|.-.. ..|+|||||. .+|...+. ..++-.++..|+.|++.|++|||+.+
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~--- 138 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG--- 138 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---
Confidence 56789999999999996543 4699999995 89999886 35788899999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|+||||||+||++..+..+||+|||+++.- +..-..+.-+.|..|.|||++.+..|.+..||||+||++.||++|..
T Consensus 139 IihRdLkPsnivv~~~~~lKi~dfg~ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~V 215 (369)
T KOG0665|consen 139 IIHRDLKPSNIVVNSDCTLKILDFGLARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTV 215 (369)
T ss_pred eeecccCcccceecchhheeeccchhhccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceE
Confidence 999999999999999999999999999852 12223445667889999999999889999999999999999999998
Q ss_pred CCCCCCCCCCcchhhhhhhccccc--------------------------CCCCC-CCCccccCC--CChhhHHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDR--------------------------RKFPK-MADPLLQGR--YPMRGLYQALAVA 206 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~-~~~~~l~~~--~~~~~~~~l~~li 206 (380)
.|.+... +-+|.+..-..+ ..+.+ +.|..+... .+......+.+++
T Consensus 216 lf~g~d~-----idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll 290 (369)
T KOG0665|consen 216 LFPGKDH-----IDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLL 290 (369)
T ss_pred EecCchH-----HHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHH
Confidence 8863322 222211110000 01111 111111111 1123455788999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 016913 207 AMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 207 ~~cl~~~P~~RPt~~evl~~ 226 (380)
.+||-.||++|.++.++|..
T Consensus 291 ~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 291 SKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhccChhhcccHHHHhcC
Confidence 99999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=196.52 Aligned_cols=168 Identities=21% Similarity=0.149 Sum_probs=126.6
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc
Q 016913 33 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 112 (380)
Q Consensus 33 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 112 (380)
|+|.+++.. .+..+++..++.|+.||+.||.|||+.+ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 689999975 3457999999999999999999999986 999999999999999 9998764321
Q ss_pred ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccC
Q 016913 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 192 (380)
Q Consensus 113 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 192 (380)
...|++.|+|||++.+..++.++|||||||++|||++|..||....... ..+..+. ...... .+.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~----~~~~~~----~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILL----NGMPAD----DPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHH----HHhccC----Cccc-c
Confidence 1258899999999999999999999999999999999999996432211 0111111 100000 0000 0
Q ss_pred CCChhhHH--HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 193 RYPMRGLY--QALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 193 ~~~~~~~~--~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
..+..... .+.+++.+||+.+|.+||++.+|++.+..+.
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 01112222 5899999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-27 Score=201.42 Aligned_cols=155 Identities=26% Similarity=0.330 Sum_probs=132.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+....+|.+|.+||.......++|.||.|+ .||..+-.+....+..+++..+-+|+..++.||.|||++-+ +||||+
T Consensus 99 ~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDv 175 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDV 175 (282)
T ss_pred ccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccC
Confidence 345679999999999888899999999995 89988877766677889999999999999999999999765 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc----CCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||+|||++.+|.+|+||||++-...+. -..+...|-.-|||||.+.. ..|+.++||||||+++.||.+++.||
T Consensus 176 KPsNiLIn~~GqVKiCDFGIsG~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY 252 (282)
T KOG0984|consen 176 KPSNILINYDGQVKICDFGISGYLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY 252 (282)
T ss_pred CcceEEEccCCcEEEcccccceeehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence 999999999999999999998754221 11233557778999998864 37899999999999999999999999
Q ss_pred CCCCC
Q 016913 158 DNTRP 162 (380)
Q Consensus 158 ~~~~~ 162 (380)
+.+..
T Consensus 253 ~~w~t 257 (282)
T KOG0984|consen 253 ESWGT 257 (282)
T ss_pred cccCC
Confidence 87654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=229.71 Aligned_cols=198 Identities=21% Similarity=0.230 Sum_probs=131.4
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 18 ADGDQRLLVYEFMPLGSLEDHLHDLPP----------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 18 ~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
..+...+|||||+.+++|.+++..... .........+..++.||+.||.|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 455678999999999999999975210 0011123456689999999999999999 999999
Q ss_pred CCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC----------------------CCCCcC
Q 016913 82 KSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG----------------------QLTLKS 138 (380)
Q Consensus 82 kp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~s 138 (380)
||+|||++. ++.+||+|||+++.+.... ........+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 5789999999997543221 2233446789999999976422 234567
Q ss_pred ceeehHHHHHHHHhCCCCCCCCCC-------CCCcchhhhhhhcccccCCCCCCCCccccCCC--ChhhHHHHHHHHHHh
Q 016913 139 DVYSFGVVFLELITGRKAIDNTRP-------PGEHNLVAWARPLFKDRRKFPKMADPLLQGRY--PMRGLYQALAVAAMC 209 (380)
Q Consensus 139 DV~SlGvvl~elltG~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~l~~li~~c 209 (380)
||||||||+|||+++..+++.... ........|...... ...+.+...+ .........+|+.+|
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-------RASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-------ccchhhhhhhhhccccchHHHHHHHHH
Confidence 999999999999987665432100 000011112111000 0000000000 001122455899999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 016913 210 LQEQAATRPLIGDVVTA 226 (380)
Q Consensus 210 l~~~P~~RPt~~evl~~ 226 (380)
|+.||.+|||+.++++.
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999873
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=235.81 Aligned_cols=182 Identities=24% Similarity=0.332 Sum_probs=134.2
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCCC-CHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeec
Q 016913 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPL-DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 99 (380)
Q Consensus 21 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l-~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DF 99 (380)
..+||=||||+..+|.+++.. +... ....+|.++.+|++||.|+|+.| +|||||||.||||++++.+||+||
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDF 741 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDF 741 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeeccc
Confidence 357999999997777777765 2222 57889999999999999999999 999999999999999999999999
Q ss_pred CCcccCC----------------CCCCccccccccccccccchhhhhcC---CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 100 GLAKLGP----------------VGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 100 Gla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|+|.... .+......+..+||.-|+|||++.+. .|+.|.|+||||||++||+. ||...
T Consensus 742 GLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts 818 (1351)
T KOG1035|consen 742 GLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS 818 (1351)
T ss_pred ccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch
Confidence 9997611 01111123567899999999999865 49999999999999999984 56532
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
. .-+.....+. ...++.. ..+..+....-..+|.+|++.||.+|||+.|+|.
T Consensus 819 M-----ERa~iL~~LR--~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 819 M-----ERASILTNLR--KGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred H-----HHHHHHHhcc--cCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1 1111111111 1122221 1122233445568999999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=193.41 Aligned_cols=168 Identities=36% Similarity=0.530 Sum_probs=147.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.+.|++|+++++++......++||||+.+++|.+++... ...+++..++.++.+++.+|.+||+.+ ++|+||
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl 118 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDL 118 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 56789999999999999999999999999999999999762 146899999999999999999999999 999999
Q ss_pred CCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 82 KSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
+|.||+++. ++.++|+|||.+........ ......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 119 ~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 119 KPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred CHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence 999999999 89999999999986432211 12335578899999999887 888999999999999999
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ----------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=189.09 Aligned_cols=216 Identities=22% Similarity=0.260 Sum_probs=159.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.|+|.|||+++++...+..+-+|+|||+ .+|..|+.. .++.++.+.+..++.|+++||.|+|+++ ++|||
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrd 126 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRD 126 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhcc
Confidence 4678999999999999999999999999995 899999876 6788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
+||+|+||+.+|.+||+|||+++-+.. ...+....+-|.+|.+|.++.+. -|+...|+||-|||+.|+.. |.+.|.
T Consensus 127 lkpqnllin~ngelkladfglarafgi--pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 127 LKPQNLLINRNGELKLADFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred CCcceEEeccCCcEEecccchhhhcCC--ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 999999999999999999999997543 23344556678999999999876 57889999999999999985 555566
Q ss_pred CCCCCCCcchhhhhhhccc--ccCCCCCCCCccccCCCCh---------hhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFK--DRRKFPKMADPLLQGRYPM---------RGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~---------~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+....+....+-|...... .......+.|-..-.-||. +....-.+++.+.|.-+|..|.++++.++
T Consensus 205 g~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 205 GNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 5433222211111111100 0011111111111111111 11223346888888889999999988765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=197.16 Aligned_cols=199 Identities=23% Similarity=0.342 Sum_probs=147.6
Q ss_pred CCCCcccceEE-EEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 6 HHSNLVNLIGY-CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 6 ~HpnIv~l~~~-~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
.|.||+..|++ |...+.+++++||++.|+|.+-+.. ..+-+.....++.|+++||.|||+++ +||||||.+
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~e 150 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAE 150 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccc
Confidence 58999988874 6777889999999999999998865 56888889999999999999999999 999999999
Q ss_pred cEEEc--CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-----CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 85 NILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 85 NILl~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||||- +..++||||||+.+.. .........+..|++||..... ...+.+|||.||+|+|.+|+|..||
T Consensus 151 NiLif~~df~rvKlcDFG~t~k~-----g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 151 NILIFDADFYRVKLCDFGLTRKV-----GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred eEEEecCCccEEEeeeccccccc-----CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 99994 3357999999998742 1222223345679999987643 3467899999999999999999999
Q ss_pred CCCCCCCCc--chhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 158 DNTRPPGEH--NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
+.....+.. ...+|.... ...++..+.+ ....++.+..+-|..++++|=-+.++-.+...
T Consensus 226 Qka~~~d~~Y~~~~~w~~rk---~~~~P~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 226 QKASIMDKPYWEWEQWLKRK---NPALPKKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred hhhhccCchHHHHHHHhccc---CccCchhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 854333322 122232211 1122222222 23577788899999999999555555554443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=216.79 Aligned_cols=203 Identities=21% Similarity=0.267 Sum_probs=140.1
Q ss_pred CcccceEEEEe--------CCeEEEEEeccCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHH
Q 016913 9 NLVNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPP--------------------DKEPLDWNTRMKIAAG 60 (380)
Q Consensus 9 nIv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~q 60 (380)
+++++++||.. .+..+|||||+++++|.++++.... ....+++..+..++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 34677787753 3467999999999999999975211 1123567889999999
Q ss_pred HHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC-------
Q 016913 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ------- 133 (380)
Q Consensus 61 ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------- 133 (380)
++.+|.|||..+ |+||||||+|||++.++.+||+|||++..+..... .......+++.|+|||.+....
T Consensus 318 l~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~ 393 (507)
T PLN03224 318 VLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPRAPA 393 (507)
T ss_pred HHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCccch
Confidence 999999999999 99999999999999999999999999975432211 1112234578999999875422
Q ss_pred -------------C--CCcCceeehHHHHHHHHhCCC-CCCCCCCCCC------cchhhhhhhcccccCCCCCCCCcccc
Q 016913 134 -------------L--TLKSDVYSFGVVFLELITGRK-AIDNTRPPGE------HNLVAWARPLFKDRRKFPKMADPLLQ 191 (380)
Q Consensus 134 -------------~--s~~sDV~SlGvvl~elltG~~-p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~ 191 (380)
+ ..+.||||+|||+|+|+++.. |+........ .....|.. .......+
T Consensus 394 ~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~~~~~~--------- 463 (507)
T PLN03224 394 PAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKGQKYDF--------- 463 (507)
T ss_pred hhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcccCCCc---------
Confidence 1 234699999999999999875 6643221111 01111110 00000001
Q ss_pred CCCChhhHHHHHHHHHHhhhhCC---CCCCCHHHHHHH
Q 016913 192 GRYPMRGLYQALAVAAMCLQEQA---ATRPLIGDVVTA 226 (380)
Q Consensus 192 ~~~~~~~~~~l~~li~~cl~~~P---~~RPt~~evl~~ 226 (380)
...........+|+.+||..+| .+|+|+.|+++.
T Consensus 464 -~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 464 -SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0112234678899999999866 689999999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-26 Score=204.66 Aligned_cols=216 Identities=22% Similarity=0.300 Sum_probs=159.3
Q ss_pred CccCCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
||..++|.|++..++...-.+ +.|+|+|+|. .+|...+-. ...|+...+.-+++||++||+|||+.+
T Consensus 105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~--- 176 (449)
T KOG0664|consen 105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN--- 176 (449)
T ss_pred HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---
Confidence 467789999999998765443 4689999995 788887764 678999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||.|+|++.+-.+||||||+++.-.. +.....+..+-|..|.|||++++. .|+.+.||||.|||+.||+..+
T Consensus 177 ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRr 255 (449)
T KOG0664|consen 177 ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRK 255 (449)
T ss_pred hhhccCCCccEEeccCceEEecccccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhh
Confidence 99999999999999999999999999986322 222334556678899999999975 7999999999999999999988
Q ss_pred CCCCCCCCCCCcchhhhhhhcccc-----------c-------CCC-CCCCCccccCCCChhhHHHHHHHHHHhhhhCCC
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKD-----------R-------RKF-PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA 215 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~-----------~-------~~~-~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~ 215 (380)
..|+...+....+++. .++.. + ... ......+..-..+.......+.++..+|..+|.
T Consensus 256 ILFQAq~PiqQL~lIt---dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d 332 (449)
T KOG0664|consen 256 ILFQAAGPIEQLQMII---DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD 332 (449)
T ss_pred hhhhccChHHHHHHHH---HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence 8887665543332221 11100 0 000 000000111111223344567788889999999
Q ss_pred CCCCHHHHHHHHH
Q 016913 216 TRPLIGDVVTALT 228 (380)
Q Consensus 216 ~RPt~~evl~~L~ 228 (380)
.|.+.++.+..+.
T Consensus 333 kris~~~A~~~~~ 345 (449)
T KOG0664|consen 333 KRISVEEALQHRY 345 (449)
T ss_pred ccccHhhhccccc
Confidence 9999888776553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=208.86 Aligned_cols=145 Identities=24% Similarity=0.265 Sum_probs=124.0
Q ss_pred CCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEE
Q 016913 8 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 87 (380)
Q Consensus 8 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NIL 87 (380)
-|+|+|+-.|...+++|||||.+ ..+|.++|+.+. .+-.|....+..++.|+..||..|-..+ |+|.||||+|||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiL 568 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNIL 568 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceE
Confidence 37889999999999999999999 599999999864 3345889999999999999999999999 999999999999
Q ss_pred EcCC-CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 88 LDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 88 l~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
|++. ..+||||||.|........+. -.-+..|.|||++.+..|+...|+||.||+||||.||+..|.+..
T Consensus 569 VNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred eccCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 9876 557999999997643332221 223457999999999999999999999999999999998886543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=208.68 Aligned_cols=147 Identities=26% Similarity=0.383 Sum_probs=129.8
Q ss_pred CccCCC---CCCcccceEEEEeCCeEEEEEecc-CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLH---HSNLVNLIGYCADGDQRLLVYEFM-PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~---HpnIv~l~~~~~~~~~~~lV~E~~-~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
||..|+ |+||++++++|++++++||+||.. ++.+|.+++.- +..+++..+..|+.|++.|+++||+.+ |
T Consensus 619 Ila~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---i 691 (772)
T KOG1152|consen 619 ILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---I 691 (772)
T ss_pred HHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---c
Confidence 345555 999999999999999999999996 67799999965 788999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~ 155 (380)
||||||-+||.++.+|-+||+|||.+-....+ ..-.++||..|.|||++.+..| +...|||+||++||-++....
T Consensus 692 vhrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 692 VHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred eecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 99999999999999999999999998753222 2345789999999999999876 566899999999999998888
Q ss_pred CCC
Q 016913 156 AID 158 (380)
Q Consensus 156 p~~ 158 (380)
||.
T Consensus 768 pyy 770 (772)
T KOG1152|consen 768 PYY 770 (772)
T ss_pred CCc
Confidence 875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-24 Score=209.52 Aligned_cols=203 Identities=25% Similarity=0.325 Sum_probs=160.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|++-.+|||||.+++.+...+.++|+||||.+|+|.+.-+- -++|++.++-.++...+.||+|||..+ -+|||
T Consensus 65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRd 137 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRD 137 (829)
T ss_pred eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---ccccc
Confidence 45677999999999999999999999999999999997765 678999999999999999999999999 89999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||-.|||+++.+.+||.|||.+-.+.. .-.....+.||+.|||||+.. .+.|...+|||++|+...|+-..++|.
T Consensus 138 iKGanilltd~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 138 IKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred ccccceeecccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 999999999999999999999865321 222335578999999999875 457999999999999999998777765
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
-...+... .. -..+.....+.+-|+ ......+.++++.||.++|++||+++-++.
T Consensus 216 fdlhpmr~---l~---LmTkS~~qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 216 FDLHPMRA---LF---LMTKSGFQPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccchHHH---HH---HhhccCCCCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 43322111 00 011111222222222 234567889999999999999999987653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=196.14 Aligned_cols=78 Identities=26% Similarity=0.396 Sum_probs=69.1
Q ss_pred CCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 7 HSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 7 HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
-.+||+|+++|.. +.++|+|+|++ |.+|..+|.. .....++...+..|+.||+.||.|||.+.. |||.|||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlK 215 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLK 215 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCC
Confidence 4579999999965 45899999999 7999999987 456779999999999999999999998764 9999999
Q ss_pred CCcEEEc
Q 016913 83 SSNILLD 89 (380)
Q Consensus 83 p~NILl~ 89 (380)
|+|||+.
T Consensus 216 PENvLl~ 222 (590)
T KOG1290|consen 216 PENVLLC 222 (590)
T ss_pred cceeeee
Confidence 9999993
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=182.77 Aligned_cols=150 Identities=33% Similarity=0.397 Sum_probs=130.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP-LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~-l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+..++|+|++++++++......++|+||+++++|.+++... .. +++..++.++.+++.+|.+||..+ ++|+|
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~d 123 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRD 123 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 45679999999999999999999999999988999999762 23 899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhh-hcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|+|.||+++.++.++|+|||++........ .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 124 i~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 124 LKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999999999999999999999986543220 122335677889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=208.09 Aligned_cols=206 Identities=23% Similarity=0.256 Sum_probs=160.6
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
..|+|||++..+..+.+....+-+||||++ +|..++.. ...+....+..++.|++.||+|||..| |.|||||
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK 447 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLK 447 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCc
Confidence 468999999988888777777667999998 99999976 357889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhcCCCCC-cCceeehHHHHHHHHhCCCCCCC
Q 016913 83 SSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTL-KSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 83 p~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-~sDV~SlGvvl~elltG~~p~~~ 159 (380)
++|+++..++.+||+|||.+..+...... .......|...|+|||++....|.+ ..||||.|+|++.|++|+.||..
T Consensus 448 ~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 448 LENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred cccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 99999999999999999999875444333 5556788999999999999998876 47999999999999999999976
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....+........ ........-...+ ....+.....++.+||+.+|.+|.|+.+|++
T Consensus 528 a~~~~~~~~~~~~----~~~~~~~~~~~~~-----~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 528 AKKSDNSFKTNNY----SDQRNIFEGPNRL-----LSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccchhhhcc----ccccccccChHHH-----HHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 5443322100000 0000000000000 1123456678999999999999999999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-22 Score=175.02 Aligned_cols=212 Identities=18% Similarity=0.245 Sum_probs=151.2
Q ss_pred CccCCC-CCCcccceEEEEeCC--eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 1 MLSLLH-HSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 1 iL~~l~-HpnIv~l~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
||..|. ||||+++++.+.+.. ...||+||+++.+...+.. .|+.-.+...+.++++||.|+|+.| |+
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---Im 154 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IM 154 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cc
Confidence 456677 999999999987653 5689999999888877664 4777788999999999999999999 99
Q ss_pred ecCCCCCcEEEcCC-CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCC
Q 016913 78 YRDLKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 78 HrDIkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||+||.|++|+.. -.++|+|+|+|..+..+... ...+.+..|--||.+... .|+-+-|+|||||++..|+..+.
T Consensus 155 HRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrke 231 (338)
T KOG0668|consen 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 231 (338)
T ss_pred cccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccC
Confidence 99999999999854 56999999999875443322 223345567789988654 67888999999999999999998
Q ss_pred CCCCCCCCCCcchhhhhhhcc-----cccCCCCCCCCccccC----------------CCChhhHHHHHHHHHHhhhhCC
Q 016913 156 AIDNTRPPGEHNLVAWARPLF-----KDRRKFPKMADPLLQG----------------RYPMRGLYQALAVAAMCLQEQA 214 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~----------------~~~~~~~~~l~~li~~cl~~~P 214 (380)
||-.... .-.+++..++.+= .......-.++|.+.. ....-...++++++-+.|..|-
T Consensus 232 pFFhG~d-N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 232 PFFHGHD-NYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred cccCCCC-CHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 8753322 1223333222110 0000011112221111 1111123678899999999999
Q ss_pred CCCCCHHHHHHH
Q 016913 215 ATRPLIGDVVTA 226 (380)
Q Consensus 215 ~~RPt~~evl~~ 226 (380)
.+|+|+.|....
T Consensus 311 qeRlTakEam~H 322 (338)
T KOG0668|consen 311 QERLTAKEAMAH 322 (338)
T ss_pred ccccchHHHhcC
Confidence 999999998753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=187.36 Aligned_cols=217 Identities=27% Similarity=0.411 Sum_probs=166.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-EecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV-IYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i-iHrD 80 (380)
|+.+.|.||.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++.+|+.||.|||... | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 6789999999999999999999999999999999999987 4567999999999999999999999876 5 9999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC---C----CCCcCceeehHHHHHHHHhC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG---Q----LTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~s~~sDV~SlGvvl~elltG 153 (380)
+++.|++++..+.+||+|||+.................-...|.|||.+... . .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998764321111112223345679999998764 1 46789999999999999999
Q ss_pred CCCCCCCCCCCC-cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 154 RKAIDNTRPPGE-HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 154 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
..||+....... ..++..++. .. ...+-|.+.... +....++.++..||..+|..||+++.|-..+..+-.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~---~~---~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK---GG---SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh---cC---CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999986433322 223322221 11 111222221110 233478999999999999999999999888876543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-20 Score=178.57 Aligned_cols=207 Identities=20% Similarity=0.175 Sum_probs=157.6
Q ss_pred CCcccceEEE-EeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcE
Q 016913 8 SNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 86 (380)
Q Consensus 8 pnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NI 86 (380)
+++..+++.+ ..+...||||+.+ |.+|.++....+ ...++..+++.|+.|++.+|++||+.| ++||||||.|+
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~ 153 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENF 153 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHe
Confidence 5888999998 5778899999999 899999987643 578999999999999999999999999 99999999999
Q ss_pred EEcCC-----CCeEEeecCCcc--cCCCCCCc----c-c-cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhC
Q 016913 87 LLDEG-----FHPKLSDFGLAK--LGPVGDKT----H-V-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 87 Ll~~~-----~~~kL~DFGla~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG 153 (380)
++... ..++|.|||+++ .+...... . . .....||..|+++.++.+...+.+.|+||+++++.+++.|
T Consensus 154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred eecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence 99755 458999999998 32222111 1 1 2345699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
..||...........+... .... .... .....+..+.++...+-..+..++|.+..+...|+.....
T Consensus 234 ~LPW~~~~~~~~~~~~~~~--~~~~------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKD--PRKL------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred CCCCccccccchHHHHHHH--hhhh------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 9999755433221111111 0000 0000 1112235566677777778999999999999998876544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=177.64 Aligned_cols=142 Identities=27% Similarity=0.359 Sum_probs=119.3
Q ss_pred CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcE
Q 016913 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 86 (380)
Q Consensus 7 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NI 86 (380)
+.||+++.+++..++.+++|+||++.....++... ++...+..++..++.||.++|..| ||||||||.|+
T Consensus 94 ~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNF 163 (418)
T KOG1167|consen 94 SDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNF 163 (418)
T ss_pred chhhhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCcccc
Confidence 77999999999999999999999999999999865 778899999999999999999999 99999999999
Q ss_pred EEcCC-CCeEEeecCCcccCC---------C------CC-----C---------------c-------cccccccccccc
Q 016913 87 LLDEG-FHPKLSDFGLAKLGP---------V------GD-----K---------------T-------HVSTRVMGTYGY 123 (380)
Q Consensus 87 Ll~~~-~~~kL~DFGla~~~~---------~------~~-----~---------------~-------~~~~~~~gt~~y 123 (380)
|.+.. +.-.|+|||+|.... . .. . . .......||++|
T Consensus 164 L~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~Gf 243 (418)
T KOG1167|consen 164 LYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGF 243 (418)
T ss_pred ccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCC
Confidence 99754 668999999997100 0 00 0 0 000114599999
Q ss_pred cchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 124 CAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 124 ~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
.|||++.. ...+.+.||||.|||++.++++..||-
T Consensus 244 RaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 244 RAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred CchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence 99999875 467889999999999999999999984
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=168.26 Aligned_cols=201 Identities=21% Similarity=0.365 Sum_probs=156.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.+.||||+.+++.|.......+|..||+.|+|+.+|+. ...-.++-.++.+++.++++|+.|||+.. |-|.--.|
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~l 317 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYL 317 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhc
Confidence 5667899999999999999999999999999999999998 34555788899999999999999999975 32333468
Q ss_pred CCCcEEEcCCCCeEEe--ecCCcccCCCCCCccccccccccccccchhhhhcCCC---CCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLS--DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL---TLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDV~SlGvvl~elltG~~p 156 (380)
++..|+++++.+.+|. |--++ -......-.+.||+||.+...+- -.++|+|||.+++|||.|...|
T Consensus 318 ns~hvmidedltarismad~kfs---------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevp 388 (448)
T KOG0195|consen 318 NSKHVMIDEDLTARISMADTKFS---------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVP 388 (448)
T ss_pred ccceEEecchhhhheecccceee---------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccc
Confidence 9999999999887764 32111 11223445789999999987643 3679999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
|....+...--.+. -..++-..|+.....+..|+.-|+..||.+||.+..|+-.|+.+
T Consensus 389 fadlspmecgmkia----------------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 389 FADLSPMECGMKIA----------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCchhhhhhhh----------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 98776643322221 11222333444556778999999999999999999999998865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=162.98 Aligned_cols=215 Identities=31% Similarity=0.396 Sum_probs=159.6
Q ss_pred ccCCCCC-CcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHS-NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+..+.|+ ||+++++++......+++++|+.+++|.+++...... ..+.......++.|++.++.|+|..+ ++|||
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd 126 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRD 126 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4567777 7999999998777789999999999999777652111 37899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-CeEEeecCCcccCCCCCCcc----ccccccccccccchhhhhc---CCCCCcCceeehHHHHHHHHh
Q 016913 81 LKSSNILLDEGF-HPKLSDFGLAKLGPVGDKTH----VSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 81 Ikp~NILl~~~~-~~kL~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlGvvl~ellt 152 (380)
|||+||+++... .++++|||++.......... ......|+..|++||.+.. ..++...|+|++|++++++++
T Consensus 127 ~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~ 206 (384)
T COG0515 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206 (384)
T ss_pred CCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999988 69999999998544333221 3456789999999999987 578899999999999999999
Q ss_pred CCCCCCCCCCC-CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 153 GRKAIDNTRPP-GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 153 G~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
|..||...... .......... ..... .................+.+++..|+..+|..|.+..+....
T Consensus 207 ~~~p~~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 207 GLPPFEGEKNSSATSQTLKIIL---ELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCCCCCCCccccHHHHHHHHH---hcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 99997644321 0111111111 11000 000000000002223578899999999999999998887765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=165.02 Aligned_cols=209 Identities=18% Similarity=0.198 Sum_probs=162.5
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
-.++|..+|.|...+.+..||+|++ |.||++++.- ++..|+..++..++.|++.-++|+|++. +|+|||||+|
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdN 154 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDN 154 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccc
Confidence 3678888888888888889999999 8999998876 7888999999999999999999999999 9999999999
Q ss_pred EEEcC-----CCCeEEeecCCcccCCCCCCccc-----cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 86 ILLDE-----GFHPKLSDFGLAKLGPVGDKTHV-----STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 86 ILl~~-----~~~~kL~DFGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+||.. ...+.|+|||+|+.+.+..+... .....||.+||+-..+.+.+.+...|+-+||-|+++.|-|..
T Consensus 155 FLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsL 234 (449)
T KOG1165|consen 155 FLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 234 (449)
T ss_pred eeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCC
Confidence 99964 34589999999998765433221 245779999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
||++...........-+.. ..+. .-+.. | ....+.++...+...-..+-.+-|+++-+...+..+.
T Consensus 235 PWQGLKA~tnK~kYeKIGe---~Kr~--T~i~~-L----c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 235 PWQGLKADTNKEKYEKIGE---TKRS--TPIEV-L----CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ccccccCcchHHHHHHhcc---cccc--CCHHH-H----HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 9998765443332222111 0000 01111 1 1223456666777777778888899998888877764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-19 Score=165.63 Aligned_cols=200 Identities=23% Similarity=0.202 Sum_probs=142.1
Q ss_pred CCCCCCcccceEEEEe---------------------------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHH
Q 016913 4 LLHHSNLVNLIGYCAD---------------------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~ 56 (380)
.-+|||||.+..+|.+ +..+|+||.-++ .+|..|+-. ...+..+..-
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~ 345 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRV 345 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHH
Confidence 3589999999988754 235799999995 899999976 4566777788
Q ss_pred HHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEc--CC--CCeEEeecCCcccCCC----CCCccccccccccccccchhh
Q 016913 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD--EG--FHPKLSDFGLAKLGPV----GDKTHVSTRVMGTYGYCAPEY 128 (380)
Q Consensus 57 i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~--~~--~~~kL~DFGla~~~~~----~~~~~~~~~~~gt~~y~aPE~ 128 (380)
++.|+++|+.|||.++ |.|||+|++||||. +| ..++|+|||++---.. -.........-|.-..||||+
T Consensus 346 ~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 9999999999999999 99999999999993 33 3478999998853111 000111122346678899999
Q ss_pred hhcCC------CCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHH
Q 016913 129 AMTGQ------LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQA 202 (380)
Q Consensus 129 ~~~~~------~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 202 (380)
+...+ --.|+|.|+.|.+.||+++...||....... +. .+...+.--| ..|...+..+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~---------~r~Yqe~qLP----alp~~vpp~~ 486 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LD---------TRTYQESQLP----ALPSRVPPVA 486 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---ec---------hhhhhhhhCC----CCcccCChHH
Confidence 86532 2368999999999999999999997632211 10 0111111111 2233455677
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 203 LAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 203 ~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.+|+...|+.||.+|++..-....|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 79999999999999998766555554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.5e-19 Score=155.35 Aligned_cols=206 Identities=19% Similarity=0.193 Sum_probs=159.6
Q ss_pred CcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEE
Q 016913 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 88 (380)
Q Consensus 9 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl 88 (380)
.|..+..|+.+.++-.+||+++ |.||++++.- +...++..+++-++.|++.-|+|+|.++ +|||||||+|+|+
T Consensus 72 GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLM 144 (341)
T KOG1163|consen 72 GIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLM 144 (341)
T ss_pred CCchhhhhccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceee
Confidence 3455667778888899999999 8999999875 6678999999999999999999999999 9999999999999
Q ss_pred cCC---CCeEEeecCCcccCCCCCCccc-----cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 89 DEG---FHPKLSDFGLAKLGPVGDKTHV-----STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 89 ~~~---~~~kL~DFGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
.-+ ..+.|+|||+++.+.+...... .....||.+|.+-..+.+...+...|+-|+|+|+.++.-|..||+..
T Consensus 145 Glgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 145 GLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 654 5689999999987654332211 23467999999999888888999999999999999999999999987
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
......+....+. +. +....+ ..+... .+.++...+..|-...-++-|+..-+.+.+.-+-
T Consensus 225 ka~tk~QKyEkI~---Ek--K~s~~i-e~LC~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 225 KAATKKQKYEKIS---EK--KMSTPI-EVLCKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred chhhHHHHHHHHH---Hh--hcCCCH-HHHhCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 7665544433221 11 111111 122222 3456777889999999999999988887776553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.4e-19 Score=170.77 Aligned_cols=174 Identities=25% Similarity=0.342 Sum_probs=130.5
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 016913 22 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 101 (380)
Q Consensus 22 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGl 101 (380)
.+||.|++|.-.+|.++|... ......++...+.++.|++.|++| ++ .+|+|+||.||++..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999752 244567889999999999999999 77 99999999999999999999999999
Q ss_pred cccCCCCC----CccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcc
Q 016913 102 AKLGPVGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLF 176 (380)
Q Consensus 102 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 176 (380)
........ .....+...||..||+||.+.+..|+.++|||+||+|++||+. -...++.. .... .+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------~t~~-d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------ATLT-DI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------Hhhh-hh
Confidence 97654333 1123456789999999999999999999999999999999997 22222211 0000 00
Q ss_pred cccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 177 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
. ...++|.+...+| .-..|+.+++...|.+||++.+
T Consensus 473 r-----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 R-----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred h-----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 0 1122222222232 2347899999999999994443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-18 Score=167.45 Aligned_cols=187 Identities=27% Similarity=0.293 Sum_probs=149.7
Q ss_pred CCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 4 LLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 4 ~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
..+ ||.+|++...+..+...+++.+|..|+.|...+.. ...++..........++.+++++|+.+ ++|+|+|
T Consensus 52 ~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k 124 (612)
T KOG0603|consen 52 FVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYK 124 (612)
T ss_pred hccCCCceeeeeeeeccccchhHhhhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhccc
Confidence 344 99999999999999999999999999999988865 456778888888999999999999999 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 83 SSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 83 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
++||+++.+|.+++.|||+.+....... .+||..|||||++. ......|.||||++++||++|..||..
T Consensus 125 ~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--- 193 (612)
T KOG0603|consen 125 LENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--- 193 (612)
T ss_pred ccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---
Confidence 9999999999999999999986432221 27999999999998 457889999999999999999999975
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH--HHHHHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI--GDVVTAL 227 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~--~evl~~L 227 (380)
.....+.+... .+|.+....+-.++..++..+|..|--. ..+.+..
T Consensus 194 -------~~~~~Il~~~~------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 194 -------DTMKRILKAEL------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred -------HHHHHHhhhcc------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 11112222111 2334445566788999999999999644 3444444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-18 Score=179.81 Aligned_cols=199 Identities=23% Similarity=0.247 Sum_probs=145.7
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
..++|||++.+.-+-+.+...|||-+|+. -+|.+.|.. ..-|...+..-|+.||+.||..+|..+ |+|+|||
T Consensus 76 ~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIK 147 (1431)
T KOG1240|consen 76 ALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIK 147 (1431)
T ss_pred HhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccc
Confidence 35689999999888888888899999995 799999976 556778888899999999999999999 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCcccC--CCCCCcccc---ccccccccccchhhhhcC----------C-CCCcCceeehHHH
Q 016913 83 SSNILLDEGFHPKLSDFGLAKLG--PVGDKTHVS---TRVMGTYGYCAPEYAMTG----------Q-LTLKSDVYSFGVV 146 (380)
Q Consensus 83 p~NILl~~~~~~kL~DFGla~~~--~~~~~~~~~---~~~~gt~~y~aPE~~~~~----------~-~s~~sDV~SlGvv 146 (380)
.+||||+.=+-+.|+||.-.+-. +..+..... -....-.+|+|||-+-.. . ++++-||||+|||
T Consensus 148 sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCV 227 (1431)
T KOG1240|consen 148 SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCV 227 (1431)
T ss_pred cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHH
Confidence 99999999999999999876532 111111111 112234589999987541 2 6788999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhhhhhh-cccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 016913 147 FLELIT-GRKAIDNTRPPGEHNLVAWARP-LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224 (380)
Q Consensus 147 l~ellt-G~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 224 (380)
+.||++ |.++|+-. ++..+-.. .......+.++-|+ .+..++..|++.||..|-+++++|
T Consensus 228 iaELf~Eg~PlF~LS------QL~aYr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 228 IAELFLEGRPLFTLS------QLLAYRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred HHHHHhcCCCcccHH------HHHhHhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHH
Confidence 999987 57777522 22222110 00000011122222 456899999999999999999999
Q ss_pred HHH
Q 016913 225 TAL 227 (380)
Q Consensus 225 ~~L 227 (380)
+--
T Consensus 290 ~~y 292 (1431)
T KOG1240|consen 290 QKY 292 (1431)
T ss_pred Hhh
Confidence 863
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-17 Score=154.25 Aligned_cols=164 Identities=20% Similarity=0.290 Sum_probs=110.2
Q ss_pred EEEEEeccCCCCHHHHHhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeec
Q 016913 23 RLLVYEFMPLGSLEDHLHDL---PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 99 (380)
Q Consensus 23 ~~lV~E~~~ggsL~~~l~~~---~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DF 99 (380)
.+++|+-+. ++|.+++... ......+....++.+..|+++.+++||..| |+|+||+|+|+|++.+|.++|+||
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence 378899884 8998886531 122234556777888899999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCCccccccccccccccchhhhhcC--------CCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 016913 100 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--------QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 171 (380)
Q Consensus 100 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~ 171 (380)
+....... .. .. ...+..|.+||..... .++.+.|.|+||+++|.|+|+..||+...+......
T Consensus 190 ~~~~r~g~--~~--~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 190 SSLVRAGT--RY--RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGEEETTE--EE--EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred HHHeecCc--ee--ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 88764211 11 11 3445789999987552 578899999999999999999999985422211100
Q ss_pred hhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 172 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
.+ ..+. +.++.+..||..+|+.||.+|
T Consensus 262 -----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred -----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 11 1222 556788899999999999987
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.3e-17 Score=155.96 Aligned_cols=115 Identities=17% Similarity=0.085 Sum_probs=87.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|+||+..+.. .+..|||||||+|++|.. +.. .. ...++.+++.+|.|||+.+ |+|||
T Consensus 74 iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~~~----~~------~~~~~~~i~~aL~~lH~~g---IiHrD 136 (365)
T PRK09188 74 ALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL-ARP----HG------DPAWFRSAHRALRDLHRAG---ITHND 136 (365)
T ss_pred HHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH-hCc----cc------hHHHHHHHHHHHHHHHHCC---CeeCC
Confidence 4678899999953322 245799999999999963 211 11 1467889999999999999 99999
Q ss_pred C-CCCcEEEcCCCCeEEeecCCcccCCCCCCccc------cccccccccccchhhhhcC
Q 016913 81 L-KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV------STRVMGTYGYCAPEYAMTG 132 (380)
Q Consensus 81 I-kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 132 (380)
| ||+|||++.++.+||+|||+++.+........ .....+++.|+|||++.-.
T Consensus 137 L~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 137 LAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9 99999999999999999999987543322111 1346688889999988643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.9e-16 Score=137.39 Aligned_cols=140 Identities=20% Similarity=0.171 Sum_probs=103.9
Q ss_pred CccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++|. |++|++++++ +..+++|||+.|.+|...+.. . ...++.+++.+|.++|..| |+||
T Consensus 54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~G---IvHr 115 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCG---VAHN 115 (218)
T ss_pred HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCc---CccC
Confidence 356774 5889999887 446999999999998754421 1 1357789999999999999 9999
Q ss_pred CC-CCCcEEEcCCCCeEEeecCCcccCCCCCCc----cc-------cccccccccccchhhhhcC-CCC-CcCceeehHH
Q 016913 80 DL-KSSNILLDEGFHPKLSDFGLAKLGPVGDKT----HV-------STRVMGTYGYCAPEYAMTG-QLT-LKSDVYSFGV 145 (380)
Q Consensus 80 DI-kp~NILl~~~~~~kL~DFGla~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~s-~~sDV~SlGv 145 (380)
|| ||+|||++.++.++|+|||++......... .. ......++.|+.|+...-- ..+ ...+.++.|+
T Consensus 116 DL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~ 195 (218)
T PRK12274 116 DLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGK 195 (218)
T ss_pred CCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence 99 799999999999999999999854322210 00 1223467788888865432 333 4567789999
Q ss_pred HHHHHHhCCCCCC
Q 016913 146 VFLELITGRKAID 158 (380)
Q Consensus 146 vl~elltG~~p~~ 158 (380)
.+|.++|+..+.-
T Consensus 196 ~~~~~~~~~~~~~ 208 (218)
T PRK12274 196 PVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHhccCCcc
Confidence 9999999987653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.8e-16 Score=139.91 Aligned_cols=121 Identities=12% Similarity=0.199 Sum_probs=93.3
Q ss_pred ccCCCCCCcccceEEEEeC--------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCADG--------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
+.++.||+|..+.+++... ...+|||||++|.+|.++.. ++. ..+.+++.+|..||..+
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g- 155 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG- 155 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC-
Confidence 4567899999999986643 34789999999999988742 222 24568999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
++|+||+|.||+++.++ ++|+|||......... . ...++....|..++|+|+||+++..+..
T Consensus 156 --i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~--a------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 156 --MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK--A------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred --CccCCCChHHEEEeCCC-EEEEECCCcccccchh--h------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 99999999999999888 9999999887532111 0 0113445567789999999999887653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.8e-15 Score=154.81 Aligned_cols=140 Identities=20% Similarity=0.198 Sum_probs=118.8
Q ss_pred CcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEE
Q 016913 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 88 (380)
Q Consensus 9 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl 88 (380)
-|..+.......+..+||+||.+.|||.+++.. .+.+++..++.++.|++..|+.||..+ |||+||||+|+||
T Consensus 755 ~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll 827 (974)
T KOG1166|consen 755 SIMHISSAHVFQNASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLL 827 (974)
T ss_pred chHHHHHHHccCCcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEe
Confidence 344555555667788999999999999999974 678999999999999999999999999 9999999999999
Q ss_pred cC-------CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 89 DE-------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 89 ~~-------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
.. ...++|+|||.+.-|..-.....-...++|-.+-++|...++.++...|.|.|+.+++-||.|+.
T Consensus 828 ~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 828 RREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 42 34589999999965543333334456788999999999999999999999999999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.1e-15 Score=130.25 Aligned_cols=92 Identities=15% Similarity=0.101 Sum_probs=71.5
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEecCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL-HDKANPPVIYRDL 81 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~iiHrDI 81 (380)
..+.|+++.....+.. ...+|||||+++++|...+.. ...++...+..++.|++.+|.+| |..+ |+||||
T Consensus 74 ~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDl 144 (190)
T cd05147 74 KRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADL 144 (190)
T ss_pred HHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 3455666543333222 223899999988777655332 35789999999999999999999 7999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCccc
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~ 104 (380)
||+|||++ ++.++|+|||++..
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CHHHEEEE-CCcEEEEEcccccc
Confidence 99999998 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.5e-15 Score=138.87 Aligned_cols=202 Identities=23% Similarity=0.301 Sum_probs=142.1
Q ss_pred CCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 4 LLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
++-|-|||+++.|+.+.. ...+++|||..|+|.++|+....+...+....-.+|+.||+.||.|||+. .|||+|
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppiih 201 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIH 201 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcccc
Confidence 457999999999986654 46899999999999999998777778899999999999999999999998 589999
Q ss_pred cCCCCCcEEEcCCCCeEEeec--CCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDF--GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DF--Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
+++..+.|++..++-+|+.-- ......-............+-++|.+||+=..-..+-++|||+||...++|.-+..-
T Consensus 202 gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 202 GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 999999999998888887421 111100000001112234567899999987777888899999999999998776532
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
-........ ..+.... .+..+-+.+-+ .++.+|++-.|..||+|.+++-.
T Consensus 282 ~tnseS~~~-~ee~ia~-------~i~~len~lqr------------~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 282 STNSESKVE-VEENIAN-------VIIGLENGLQR------------GSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred cCCCcceee-hhhhhhh-------heeeccCcccc------------CcCcccccCCCCCCcchhhhhcC
Confidence 211111000 0000000 11111122222 46788999999999999988643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.3e-14 Score=126.33 Aligned_cols=92 Identities=18% Similarity=0.153 Sum_probs=73.3
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH-LHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrD 80 (380)
.++.|++|.....+... ..+|||||++|+++... +. ...++...+..++.+++.+|.+||. .+ |+|||
T Consensus 74 ~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrD 143 (190)
T cd05145 74 KRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGD 143 (190)
T ss_pred HHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 45567776544444333 24899999988755443 33 2467888999999999999999999 99 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLG 105 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~ 105 (380)
|||+|||++ ++.++|+|||++...
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceec
Confidence 999999999 789999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.5e-14 Score=127.87 Aligned_cols=88 Identities=19% Similarity=0.211 Sum_probs=70.8
Q ss_pred CCCCcccceEEEEeCC---eEE-EEEec--cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEe
Q 016913 6 HHSNLVNLIGYCADGD---QRL-LVYEF--MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL-EYLHDKANPPVIY 78 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~---~~~-lV~E~--~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~iiH 78 (380)
.||||+++++++.++. .++ +|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||+++ |+|
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---Ivh 128 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVT 128 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---Eee
Confidence 6899999999998874 333 78999 557999999965 236655 35677888787 9999999 999
Q ss_pred cCCCCCcEEEcC----CCCeEEeecCCcc
Q 016913 79 RDLKSSNILLDE----GFHPKLSDFGLAK 103 (380)
Q Consensus 79 rDIkp~NILl~~----~~~~kL~DFGla~ 103 (380)
|||||+|||++. +..++|+||+.+.
T Consensus 129 rDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 129 MELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred cCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 999999999974 2379999955443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.3e-15 Score=152.99 Aligned_cols=201 Identities=27% Similarity=0.307 Sum_probs=154.7
Q ss_pred CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEecCCCCCc
Q 016913 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-DKANPPVIYRDLKSSN 85 (380)
Q Consensus 7 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~iiHrDIkp~N 85 (380)
|+|++.+++.....+..+++++|..++++.+.+.. ......+...+-..+.|+..+|.|+| ..+ +.|+||||+|
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n 154 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSN 154 (601)
T ss_pred cccccccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCcc
Confidence 99999999999999999999999999999988832 12225666677788999999999999 888 9999999999
Q ss_pred EEEcCCC-CeEEeecCCcccCCC-CCCccccccccc-cccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 86 ILLDEGF-HPKLSDFGLAKLGPV-GDKTHVSTRVMG-TYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 86 ILl~~~~-~~kL~DFGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
.+++..+ .+++.|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+...
T Consensus 155 ~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 155 SLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred chhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 9999999 999999999987665 333344455678 9999999998884 45678999999999999999999998655
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.... ....|.... ..+.. ..........++++.+++..+|..|.+.+++..
T Consensus 235 ~~~~-~~~~~~~~~----~~~~~--------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 235 RKDG-RYSSWKSNK----GRFTQ--------LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccc-cceeecccc----ccccc--------CccccCChhhhhcccccccCCchhccccccccc
Confidence 4432 112221110 00000 011122346678899999999999998887754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.5e-14 Score=148.99 Aligned_cols=139 Identities=27% Similarity=0.409 Sum_probs=105.6
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccc-------------cccccccccccchhh
Q 016913 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-------------STRVMGTYGYCAPEY 128 (380)
Q Consensus 62 a~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-------------~~~~~gt~~y~aPE~ 128 (380)
+.+++|||..+ |+|||+||+|++|+.-|.+|+.|||+.++......+.. ...++||+.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78899999999 99999999999999999999999999976322111110 134689999999999
Q ss_pred hhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHH
Q 016913 129 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAM 208 (380)
Q Consensus 129 ~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~ 208 (380)
+.-+.|....|.|++|+|+||.+-|..||....+..... .++.+...+++- +. ....++.+++.+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd~i~wpE~-de--------a~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISDDIEWPEE-DE--------ALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhhhcccccc-Cc--------CCCHHHHHHHHH
Confidence 999999999999999999999999999997654432211 112222222222 11 123577789999
Q ss_pred hhhhCCCCCC
Q 016913 209 CLQEQAATRP 218 (380)
Q Consensus 209 cl~~~P~~RP 218 (380)
.|+.+|..|-
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999995
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.8e-13 Score=118.91 Aligned_cols=91 Identities=24% Similarity=0.384 Sum_probs=79.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|..+.|+||+....++...+..++||||++|++|.+++.. . .. .+..++.+++.+|.+||..+ ++|+|+
T Consensus 53 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl 121 (211)
T PRK14879 53 MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSAG---IIHGDL 121 (211)
T ss_pred HHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 4456788998888888778889999999999999999865 1 12 78899999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCccc
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~ 104 (380)
+|.|||++ ++.++|+|||++..
T Consensus 122 ~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 122 TTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcccEEEE-CCCEEEEECCcccC
Confidence 99999999 78899999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=134.33 Aligned_cols=87 Identities=24% Similarity=0.347 Sum_probs=78.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|++|+..+.++......++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDl 454 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDL 454 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCC
Confidence 567899999988888888778899999999999999885 34678999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCccc
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~ 104 (380)
||+|||+ .++.++|+|||+++.
T Consensus 455 kp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 455 TTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ChHHEEE-ECCcEEEEeCccccc
Confidence 9999999 577899999999974
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.9e-12 Score=126.06 Aligned_cols=137 Identities=19% Similarity=0.239 Sum_probs=106.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.|+||||+++++.++..+..|||+|-+ -.|..++.+ +....+.--+.||+.||.|||..++ ++|++|
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv 131 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNV 131 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccE
Confidence 67899999999999999999999999998 588888876 3356677788999999999986554 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG 153 (380)
.-+.|+|++.|..||++|.++........ ......--..|..|+.+.... -..|.|.|||+++|++.|
T Consensus 132 ~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 132 CKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99999999999999999998864222111 111111122355666443222 346999999999999998
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.1e-12 Score=115.14 Aligned_cols=88 Identities=25% Similarity=0.363 Sum_probs=74.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|..++|+++....-++...+..++||||++|++|.+++.. .. . .++.+++.+|.+||..+ ++|+|+
T Consensus 51 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~----~~-~------~~~~~i~~~l~~lH~~g---i~H~Dl 116 (199)
T TIGR03724 51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEE----GN-D------ELLREIGRLVGKLHKAG---IVHGDL 116 (199)
T ss_pred HHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhh----cH-H------HHHHHHHHHHHHHHHCC---eecCCC
Confidence 3456777777666666777778999999999999998865 11 1 78999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCccc
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~ 104 (380)
+|.||+++ ++.++|+|||++..
T Consensus 117 ~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 117 TTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CcceEEEE-CCcEEEEECCCCcC
Confidence 99999999 78999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.2e-12 Score=117.68 Aligned_cols=91 Identities=25% Similarity=0.214 Sum_probs=72.3
Q ss_pred ccCCCCCCc--ccceEEEEeCCe----EEEEEeccCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLLHHSNL--VNLIGYCADGDQ----RLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l~HpnI--v~l~~~~~~~~~----~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+.+|.|++| +..++++..... .+|||||++| .+|.+++.. ..++.. .+.+|+.+|.+||+.|
T Consensus 94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G-- 162 (239)
T PRK01723 94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG-- 162 (239)
T ss_pred HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC--
Confidence 456777775 667776544322 2599999997 699998864 345544 3568999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
|+|+||||.|||++.++.++|+|||.+..
T Consensus 163 -I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 163 -VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred -CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999888999999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.1e-12 Score=124.23 Aligned_cols=195 Identities=24% Similarity=0.228 Sum_probs=146.9
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEecCC
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~iiHrDI 81 (380)
.|+|.++.+..++..+..|+-+|+| +.+|.++.+. ...-++...++..+.+... ||.++|... ++|-|+
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~ 248 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDL 248 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---cccccc
Confidence 4899999999999999999999999 5999999987 3344777788888888888 999999999 999999
Q ss_pred CCCcEEEcCC-CCeEEeecCCcccCCCCCCccc---cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||.||++..+ ..++++|||+...+........ .....|...|++||...+ -++..+|||+||.|+++..++...+
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999999 7899999999987665543322 233478889999998655 6789999999999999999987665
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... ..|.. . ..-.++..+.......+..++..|++.+|-.|++.+.+..
T Consensus 328 ~~g~~------~~W~~----~-------r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 328 SVGKN------SSWSQ----L-------RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCCCC------CCccc----c-------ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 43211 11210 1 1111222222223345555889999999999997776643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.25 E-value=1e-11 Score=114.19 Aligned_cols=76 Identities=16% Similarity=0.160 Sum_probs=64.5
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 016913 22 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 101 (380)
Q Consensus 22 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGl 101 (380)
..+|||||+++.+|..++.. ...+....+..++.|++.+|.+||..+. |+|+||||+||+++ ++.++|+|||.
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~-~~~i~LiDFg~ 194 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH-DGKVVIIDVSQ 194 (237)
T ss_pred CceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE-CCCEEEEEChh
Confidence 35899999998888765532 3446667778999999999999999874 99999999999999 78999999999
Q ss_pred ccc
Q 016913 102 AKL 104 (380)
Q Consensus 102 a~~ 104 (380)
+..
T Consensus 195 a~~ 197 (237)
T smart00090 195 SVE 197 (237)
T ss_pred hhc
Confidence 874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-11 Score=108.94 Aligned_cols=71 Identities=15% Similarity=0.106 Sum_probs=61.3
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 016913 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 100 (380)
Q Consensus 21 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFG 100 (380)
...++||||++|++|..+... .....++.+++.++.++|..+ |+|+||+|.||++++++.++|+|||
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg 170 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWP 170 (198)
T ss_pred CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECC
Confidence 345899999999998765421 235678899999999999999 9999999999999999999999999
Q ss_pred Cccc
Q 016913 101 LAKL 104 (380)
Q Consensus 101 la~~ 104 (380)
++..
T Consensus 171 ~~~~ 174 (198)
T cd05144 171 QMVS 174 (198)
T ss_pred cccc
Confidence 9964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-11 Score=101.40 Aligned_cols=90 Identities=22% Similarity=0.241 Sum_probs=75.1
Q ss_pred CCCC--CCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 4 LLHH--SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 4 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
.++| .++++++.++...+..+++|||+++..+..+ +......++.+++.+|.+||......++|+||
T Consensus 47 ~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl 115 (155)
T cd05120 47 LLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115 (155)
T ss_pred HHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCC
Confidence 4444 5888999988888889999999987777543 45667788999999999999863334999999
Q ss_pred CCCcEEEcCCCCeEEeecCCccc
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~ 104 (380)
+|.||++++.+.++|+|||.+..
T Consensus 116 ~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 116 HPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CcceEEEECCcEEEEEecccccC
Confidence 99999999988999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.3e-09 Score=94.37 Aligned_cols=73 Identities=22% Similarity=0.198 Sum_probs=58.0
Q ss_pred eEEEEEeccCCCCHHH-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCcEEEcCCCCeEEeec
Q 016913 22 QRLLVYEFMPLGSLED-HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDF 99 (380)
Q Consensus 22 ~~~lV~E~~~ggsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kL~DF 99 (380)
..++||||++++++.. .+.. .... ..+..++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+||
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDf 158 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDV 158 (187)
T ss_pred CCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEEC
Confidence 4589999999844321 1111 0011 5678899999999999999 88 99999999999999 889999999
Q ss_pred CCccc
Q 016913 100 GLAKL 104 (380)
Q Consensus 100 Gla~~ 104 (380)
|.+..
T Consensus 159 g~a~~ 163 (187)
T cd05119 159 PQAVE 163 (187)
T ss_pred ccccc
Confidence 99974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1e-09 Score=115.18 Aligned_cols=194 Identities=24% Similarity=0.262 Sum_probs=138.5
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||-++.....+.-....+||++|+.+++|...|+.. ..++.+-+...+..+..++++||... ++|+|++|.|
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~ 934 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDS 934 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccch---hhcccccccc
Confidence 4455555444445566789999999999999999873 34565666667777888999999998 8999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCC----CC-------------------------ccccccccccccccchhhhhcCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVG----DK-------------------------THVSTRVMGTYGYCAPEYAMTGQLTL 136 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~----~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ 136 (380)
+|+..++..++.||++....... .. ........+|+.|.+||...+..-..
T Consensus 935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen 935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence 99999999999999843321100 00 00122356899999999999999999
Q ss_pred cCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC
Q 016913 137 KSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 137 ~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~ 216 (380)
.+|.|++|++++|.++|.+||....+.... +.+... .-+.. .-+....+.+.+++...+..+|.+
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq~~f------~ni~~~-------~~~~p--~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQQIF------ENILNR-------DIPWP--EGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcchhhhh------hccccC-------CCCCC--CCccccChhhhhhhhhhhccCchh
Confidence 999999999999999999999755443211 111110 00000 112334556678888899999999
Q ss_pred CCCHH
Q 016913 217 RPLIG 221 (380)
Q Consensus 217 RPt~~ 221 (380)
|-.+.
T Consensus 1080 r~~a~ 1084 (1205)
T KOG0606|consen 1080 RLGAK 1084 (1205)
T ss_pred ccCcc
Confidence 97655
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1e-07 Score=91.86 Aligned_cols=205 Identities=16% Similarity=0.174 Sum_probs=129.2
Q ss_pred EEEEEeccCCC-CHHHHHhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeec
Q 016913 23 RLLVYEFMPLG-SLEDHLHD--LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 99 (380)
Q Consensus 23 ~~lV~E~~~gg-sL~~~l~~--~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DF 99 (380)
.-++|..+.+. .+..++.. .........|...+.++..++.+.+-||+.| .+-+|++++|+|+.+++.+.|+|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 45777777654 22332221 1223445789999999999999999999999 899999999999999999999875
Q ss_pred CCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhC-CCCCCCCCCCCCc--chh-h
Q 016913 100 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITG-RKAIDNTRPPGEH--NLV-A 170 (380)
Q Consensus 100 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG-~~p~~~~~~~~~~--~~~-~ 170 (380)
.-..+. .........+|...|.+||.-. +..-+...|.|.||+++++||.| .+||.+....... -.. +
T Consensus 162 Dsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 443321 1222233467889999999754 33557789999999999999887 8998743221110 000 1
Q ss_pred hhhhcccccCCCCCCCCccccCCCChh-hHHHHHHHHHHhhhh--CCCCCCCHHHHHHHHHHhhhcc
Q 016913 171 WARPLFKDRRKFPKMADPLLQGRYPMR-GLYQALAVAAMCLQE--QAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~--~P~~RPt~~evl~~L~~~~~~~ 234 (380)
.+.-.+.+......-..+. ....|.. ....+-.|..+|+.. ++.-|||++.-+.+|..+..+.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcceeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1111111100000000000 0011111 123455677888765 3678999999999998875543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.8e-08 Score=88.33 Aligned_cols=75 Identities=16% Similarity=0.140 Sum_probs=58.7
Q ss_pred CeEEEEEeccCCCCHH-HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 016913 21 DQRLLVYEFMPLGSLE-DHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL-HDKANPPVIYRDLKSSNILLDEGFHPKLSD 98 (380)
Q Consensus 21 ~~~~lV~E~~~ggsL~-~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~iiHrDIkp~NILl~~~~~~kL~D 98 (380)
...+|||||+.+..+. ..+.+ ..++......+..+++.+|..| |..+ |||+||++.|||+. ++.++|+|
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iID 167 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFID 167 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEE
Confidence 4568999999654332 22332 2355566778889999999999 8999 99999999999997 46799999
Q ss_pred cCCccc
Q 016913 99 FGLAKL 104 (380)
Q Consensus 99 FGla~~ 104 (380)
||.+..
T Consensus 168 F~qav~ 173 (197)
T cd05146 168 VSQSVE 173 (197)
T ss_pred CCCcee
Confidence 999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.6e-08 Score=89.93 Aligned_cols=89 Identities=18% Similarity=0.205 Sum_probs=70.6
Q ss_pred ccceEEEEe-----CCeEEEEEeccCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 11 VNLIGYCAD-----GDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 11 v~l~~~~~~-----~~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
+.++++++. ....+||||++++. +|.+++.... ....+......++.+++..+..||..| |+|+|+++.
T Consensus 93 P~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~ 167 (268)
T PRK15123 93 MTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYIC 167 (268)
T ss_pred CCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChh
Confidence 344555543 23578999999876 8999986421 234566778899999999999999999 999999999
Q ss_pred cEEEcC-------CCCeEEeecCCccc
Q 016913 85 NILLDE-------GFHPKLSDFGLAKL 104 (380)
Q Consensus 85 NILl~~-------~~~~kL~DFGla~~ 104 (380)
||||+. +..+.|+||+.+..
T Consensus 168 NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 168 HFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred hEEEeccccCCCCCceEEEEECCcccc
Confidence 999975 46789999998863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.9e-09 Score=102.76 Aligned_cols=191 Identities=21% Similarity=0.165 Sum_probs=137.5
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
.-|.|++.++..+....+.||=-|||+++++...+.. ...++...++.+..|++.++.++|+.. ++|.|+||+
T Consensus 323 ~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~ps 395 (524)
T KOG0601|consen 323 GSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPS 395 (524)
T ss_pred hcccccCCCCCCccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhccccccc
Confidence 3588889888888777888899999999998877743 566888899999999999999999999 999999999
Q ss_pred cEEEcCC-CCeEEeecCCcccCCCCCCcccccccccccccc--chhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 85 NILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC--APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 85 NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||++..+ +..++.|||+...+.... .....+-++. ++.......+..+.|+|+||..+.+.+++...-..
T Consensus 396 ni~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-- 468 (524)
T KOG0601|consen 396 NILISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-- 468 (524)
T ss_pred ceeeccchhhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcc--
Confidence 9999875 778999999986422211 1122333444 55555667889999999999999999998643221
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.+.|.... .-.-+.+. ....++..+...++..++..||.+.++..+..
T Consensus 469 ------~~~~~~i~--------~~~~p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 469 ------GVQSLTIR--------SGDTPNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ------cccceeee--------cccccCCC-----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111100 00011111 11245667788889999999999888765543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.1e-09 Score=104.62 Aligned_cols=157 Identities=20% Similarity=0.233 Sum_probs=106.9
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC-------ccccccccccccccc
Q 016913 53 TRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK-------THVSTRVMGTYGYCA 125 (380)
Q Consensus 53 ~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~~~~gt~~y~a 125 (380)
....=+.+++.||.|+|...+ +||++|.|++|.++..+..||+.|+.+........ ............|.|
T Consensus 100 ~~f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred HhhhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 334445667799999998765 99999999999999999999999998865322111 011122335568999
Q ss_pred hhhhhcCCCCCcCceeehHHHHHHHHhCCCC-CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHH
Q 016913 126 PEYAMTGQLTLKSDVYSFGVVFLELITGRKA-IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALA 204 (380)
Q Consensus 126 PE~~~~~~~s~~sDV~SlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 204 (380)
||++...-.+.++|+||||+++|.+..|..+ +.......... +....+..-...++.+.+.++.+
T Consensus 178 pE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 178 PEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRE 243 (700)
T ss_pred chhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHH
Confidence 9999998889999999999999999955443 33221111111 11111111111233455678888
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 016913 205 VAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 205 li~~cl~~~P~~RPt~~evl~ 225 (380)
=+.+++..++..||++.++..
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHhcCCcccCcchhhhhc
Confidence 899999999999997777643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.6e-08 Score=85.48 Aligned_cols=76 Identities=32% Similarity=0.472 Sum_probs=63.4
Q ss_pred eEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCC
Q 016913 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 93 (380)
Q Consensus 14 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~ 93 (380)
+=|+.+.+...|+|||++|..|.+++... ...++..+-.-+.-||..+ |+|+||.++||++..+.
T Consensus 65 ~v~dvD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~- 129 (204)
T COG3642 65 IVYDVDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR- 129 (204)
T ss_pred eEEEEcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-
Confidence 33556667789999999999999999761 2456677777788999999 99999999999998775
Q ss_pred eEEeecCCccc
Q 016913 94 PKLSDFGLAKL 104 (380)
Q Consensus 94 ~kL~DFGla~~ 104 (380)
+.++||||+..
T Consensus 130 i~~IDfGLg~~ 140 (204)
T COG3642 130 IYFIDFGLGEF 140 (204)
T ss_pred EEEEECCcccc
Confidence 99999999974
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.6e-08 Score=87.31 Aligned_cols=79 Identities=25% Similarity=0.243 Sum_probs=58.3
Q ss_pred ccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecCCCCCcEEE
Q 016913 11 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYRDLKSSNILL 88 (380)
Q Consensus 11 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~iiHrDIkp~NILl 88 (380)
.+++.++. ...++||||++|.++... . . ....++.+++.+|..||..+ ...++|+|++|.||++
T Consensus 56 P~~~~~~~--~~~~lv~e~i~G~~l~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~ 121 (170)
T cd05151 56 PKLYYFDP--ETGVLITEFIEGSELLTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL 121 (170)
T ss_pred CceEEEeC--CCCeEEEEecCCCccccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE
Confidence 34554433 345899999998887543 1 0 11245678999999999987 1225999999999999
Q ss_pred cCCCCeEEeecCCccc
Q 016913 89 DEGFHPKLSDFGLAKL 104 (380)
Q Consensus 89 ~~~~~~kL~DFGla~~ 104 (380)
+ ++.++|+||+.+..
T Consensus 122 ~-~~~~~liDf~~a~~ 136 (170)
T cd05151 122 D-DGRLWLIDWEYAGM 136 (170)
T ss_pred E-CCeEEEEecccccC
Confidence 9 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-07 Score=93.62 Aligned_cols=132 Identities=19% Similarity=0.246 Sum_probs=101.2
Q ss_pred CccCCCCCCcccceEEEEeC----CeEEEEEeccCC-CCHHHHHhcCC-----------CCCCCCCHHHHHHHHHHHHHH
Q 016913 1 MLSLLHHSNLVNLIGYCADG----DQRLLVYEFMPL-GSLEDHLHDLP-----------PDKEPLDWNTRMKIAAGAAKG 64 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~----~~~~lV~E~~~g-gsL~~~l~~~~-----------~~~~~l~~~~~~~i~~qia~a 64 (380)
+++++.|+|||++.++|... .-+++||+|+++ ++|.++-.... ..+..+++..+|.++.|+..|
T Consensus 326 ~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaa 405 (655)
T KOG3741|consen 326 AWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAA 405 (655)
T ss_pred HHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHH
Confidence 36789999999999988632 347899999875 47877766532 223457789999999999999
Q ss_pred HHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehH
Q 016913 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFG 144 (380)
Q Consensus 65 L~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG 144 (380)
|.++|+.| +.-+-|.+.+||++.+.+++|+..|+-.+...... +.+.. -.+.|.=-||
T Consensus 406 L~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG 463 (655)
T KOG3741|consen 406 LYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------EPLES---QQQNDLRDLG 463 (655)
T ss_pred HHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC----------------cchhH---HhhhhHHHHH
Confidence 99999999 99999999999999998999987776654322110 11111 2356788899
Q ss_pred HHHHHHHhCC
Q 016913 145 VVFLELITGR 154 (380)
Q Consensus 145 vvl~elltG~ 154 (380)
.+++-|.||.
T Consensus 464 ~ll~aLAt~~ 473 (655)
T KOG3741|consen 464 LLLLALATGT 473 (655)
T ss_pred HHHHHHhhcc
Confidence 9999999985
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.5e-08 Score=98.74 Aligned_cols=76 Identities=24% Similarity=0.209 Sum_probs=59.7
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeec
Q 016913 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK-GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 99 (380)
Q Consensus 21 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DF 99 (380)
...+|||||++|++|.++.... ...++ ...++..++. .+..+|..| ++|+|++|.||+++.++.++|+||
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDf 301 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDF 301 (437)
T ss_pred CCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeC
Confidence 4569999999999998876531 11222 2345555555 478899999 999999999999999999999999
Q ss_pred CCcccC
Q 016913 100 GLAKLG 105 (380)
Q Consensus 100 Gla~~~ 105 (380)
|++..+
T Consensus 302 G~~~~l 307 (437)
T TIGR01982 302 GIVGRL 307 (437)
T ss_pred CCeeEC
Confidence 999754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.5e-07 Score=83.26 Aligned_cols=88 Identities=27% Similarity=0.344 Sum_probs=72.5
Q ss_pred cccceEEEEeCC----eEEEEEeccCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 10 LVNLIGYCADGD----QRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 10 Iv~l~~~~~~~~----~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
+.+.+++.+... ..+||+|++++. +|.+++... ..++......++.+++..+.-||..| |+|+|+++.
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~ 147 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPS 147 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcc
Confidence 345566665532 458999999874 899999762 22677788899999999999999999 999999999
Q ss_pred cEEEcCCC---CeEEeecCCccc
Q 016913 85 NILLDEGF---HPKLSDFGLAKL 104 (380)
Q Consensus 85 NILl~~~~---~~kL~DFGla~~ 104 (380)
|||++.+. .+.|+||+.++.
T Consensus 148 NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 148 NILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cEEEeCCCCceeEEEEcchhcee
Confidence 99999887 799999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.8e-07 Score=78.43 Aligned_cols=84 Identities=26% Similarity=0.336 Sum_probs=64.9
Q ss_pred EEEeCCeEEEEEeccCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCC-
Q 016913 16 YCADGDQRLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH- 93 (380)
Q Consensus 16 ~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~- 93 (380)
++.+...-.|+|||++| .++.+++... ............++..|-..|.-||..+ |||+||..+||+|..++.
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCc
Confidence 45566677899999975 3888888762 2222333334678888999999999999 999999999999976543
Q ss_pred --eEEeecCCccc
Q 016913 94 --PKLSDFGLAKL 104 (380)
Q Consensus 94 --~kL~DFGla~~ 104 (380)
+.|+|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 58999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.2e-07 Score=91.90 Aligned_cols=89 Identities=16% Similarity=0.086 Sum_probs=57.4
Q ss_pred CCCcccceEEEEe-CCeEEEEEeccCCCCHHHHH--hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 7 HSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 7 HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l--~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
+.+.+.+-.++.+ ....+|||||++|+.|.++- .........+....+..++.| +...| ++|+|+||
T Consensus 219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~G---ffHaDpHP 288 (537)
T PRK04750 219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDG---FFHADMHP 288 (537)
T ss_pred CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCC---eeeCCCCh
Confidence 3333443333322 34568999999999998742 220000112333333333333 44578 99999999
Q ss_pred CcEEEcCCC----CeEEeecCCcccC
Q 016913 84 SNILLDEGF----HPKLSDFGLAKLG 105 (380)
Q Consensus 84 ~NILl~~~~----~~kL~DFGla~~~ 105 (380)
.||+++.++ .++++|||++...
T Consensus 289 GNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 289 GNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHeEEecCCCCCCeEEEEecceEEEC
Confidence 999999887 8999999998764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.9e-07 Score=79.91 Aligned_cols=92 Identities=24% Similarity=0.302 Sum_probs=70.7
Q ss_pred CCcccceEEEEeCC---eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------
Q 016913 8 SNLVNLIGYCADGD---QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA------------ 72 (380)
Q Consensus 8 pnIv~l~~~~~~~~---~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------ 72 (380)
.++.+++.++.... ..++||||++|.+|.+.+.. ..++......++.+++.+|..||+..
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~ 131 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRP 131 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCC
Confidence 44567777766542 56899999999888775531 35777788888888888888888521
Q ss_pred -----------------------------------------CCCeEecCCCCCcEEEcC--CCCeEEeecCCccc
Q 016913 73 -----------------------------------------NPPVIYRDLKSSNILLDE--GFHPKLSDFGLAKL 104 (380)
Q Consensus 73 -----------------------------------------~~~iiHrDIkp~NILl~~--~~~~kL~DFGla~~ 104 (380)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 132 GGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.2e-06 Score=77.56 Aligned_cols=82 Identities=22% Similarity=0.273 Sum_probs=52.4
Q ss_pred CcccceEEEEeCCeEEEEEeccC--CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEecCCCCCc
Q 016913 9 NLVNLIGYCADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY-LHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 9 nIv~l~~~~~~~~~~~lV~E~~~--ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~iiHrDIkp~N 85 (380)
++.+++++- ..+|||||++ |..+..+... .++......++.+++..+.. +|..| |+|+||.+.|
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~N 137 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYN 137 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTS
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhh
Confidence 344555442 3479999998 6556554432 11133455677777775555 57898 9999999999
Q ss_pred EEEcCCCCeEEeecCCccc
Q 016913 86 ILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~ 104 (380)
||++++ .+.|+|||.+..
T Consensus 138 Ilv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 138 ILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp EEEETT-CEEE--GTTEEE
T ss_pred EEeecc-eEEEEecCccee
Confidence 999988 999999999874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.4e-06 Score=74.00 Aligned_cols=98 Identities=26% Similarity=0.289 Sum_probs=75.2
Q ss_pred ccCCCC-CCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.+.+ +++++++|+|-. ++|.||+..+++...-... ..-...+|..+.+|+.+++..+++|+..-...+.-.|
T Consensus 13 l~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcD 87 (188)
T PF12260_consen 13 LQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCD 87 (188)
T ss_pred HHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEee
Confidence 445555 599999999953 7899999766664210000 0113468999999999999999999986544588899
Q ss_pred CCCCcEEEcCCCCeEEeecCCccc
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~ 104 (380)
++++|+-+++++.+|++|...+..
T Consensus 88 v~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 88 VSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cchHHeEEeCCCcEEEEechhcch
Confidence 999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.8e-05 Score=71.25 Aligned_cols=67 Identities=18% Similarity=0.255 Sum_probs=53.1
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 016913 22 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 101 (380)
Q Consensus 22 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGl 101 (380)
..++||||++|..|.++.. ++. .++..+..++.-||..| ++|+|+.|.|++++.+ .++++||+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~ 180 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQG 180 (229)
T ss_pred EEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcc
Confidence 4578999999988876542 222 24456778899999999 9999999999999855 599999987
Q ss_pred ccc
Q 016913 102 AKL 104 (380)
Q Consensus 102 a~~ 104 (380)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.3e-05 Score=68.42 Aligned_cols=78 Identities=17% Similarity=0.086 Sum_probs=64.4
Q ss_pred eEEEEEeccCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCC--eEEee
Q 016913 22 QRLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH--PKLSD 98 (380)
Q Consensus 22 ~~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~--~kL~D 98 (380)
..+||+|-+.| .+|.+++.+. .-.+.+......++.+|+.+|.-||..+ +.|+|+.+.|||++.++. ++++|
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 46899997743 5899988652 2235677888899999999999999999 999999999999986666 89999
Q ss_pred cCCccc
Q 016913 99 FGLAKL 104 (380)
Q Consensus 99 FGla~~ 104 (380)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 987764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=6.5e-06 Score=83.31 Aligned_cols=143 Identities=20% Similarity=0.153 Sum_probs=105.1
Q ss_pred CccCCCCCC-cccceEEEEeCCeEEEEEeccCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSN-LVNLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
||.+++||| .+..++-+..++..+++++++.++ +....... ....+..-+...++..-.++|++||+.. -+|
T Consensus 286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~ 359 (829)
T KOG0576|consen 286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVH 359 (829)
T ss_pred HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccC
Confidence 578899999 777777788888899999999766 22221211 1223444455566667788899999886 588
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
+| ||+..+ ...++.||+....+.... ......+++.++|||+.....+..+.|+|++++---++--|.+|-
T Consensus 360 ~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 360 RD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 88 777665 578999999887654433 334567899999999999999999999999998666666665553
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.68 E-value=6.9e-05 Score=80.68 Aligned_cols=190 Identities=21% Similarity=0.191 Sum_probs=131.5
Q ss_pred ccCCCCCCcccceEEEEeCCeE----EEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 2 LSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~----~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
+.++.|+|++.++.|-...... .+..|+|..-++...+.. ...++..+...+..++.+||.|+|+.. +.
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~ 308 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSLS---LE 308 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHhc---cc
Confidence 5678999999999987654432 456788888888888876 577899999999999999999999987 66
Q ss_pred ecCCCCC---cEEEcCCCCeEEe--ecCCcccCCCCCCccccccccccccccchhhhhcCCCCC--cCceeehHHHHHHH
Q 016913 78 YRDLKSS---NILLDEGFHPKLS--DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL--KSDVYSFGVVFLEL 150 (380)
Q Consensus 78 HrDIkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDV~SlGvvl~el 150 (380)
|.-+... +..++..+.+.++ ||+........... ....-...+.++|......+.. ..|+|.+|.....+
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 6665555 4444555566665 88777654333221 2233445667777766554444 47999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
..|..+-... .....+.+.... ....+...+|+..+++.|+++.++++..-
T Consensus 386 ~~~~~i~~~~-------------------~~~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 386 SQGEDISEKS-------------------AVPVSLLDVLST--------SELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhcCcccccc-------------------cchhhhhccccc--------hhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 9886543211 011111111111 14557788999999999999999988653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00019 Score=66.23 Aligned_cols=72 Identities=19% Similarity=0.156 Sum_probs=55.5
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 016913 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 100 (380)
Q Consensus 21 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFG 100 (380)
+.-++||||++|.-|...- ++....-.++..|+.-+..+-..| |||+|+++-||++++++.++|+||-
T Consensus 180 nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCc
Confidence 4568999999976664322 234445566666777777666888 9999999999999999999999997
Q ss_pred Cccc
Q 016913 101 LAKL 104 (380)
Q Consensus 101 la~~ 104 (380)
.+..
T Consensus 248 Q~v~ 251 (304)
T COG0478 248 QAVP 251 (304)
T ss_pred cccc
Confidence 7753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0018 Score=59.09 Aligned_cols=30 Identities=13% Similarity=0.111 Sum_probs=26.4
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
+.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 3578999999999999887 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0011 Score=60.87 Aligned_cols=31 Identities=26% Similarity=0.264 Sum_probs=27.1
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
+.++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4599999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0022 Score=58.62 Aligned_cols=73 Identities=23% Similarity=0.276 Sum_probs=54.2
Q ss_pred EEEEEeccCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 016913 23 RLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFG 100 (380)
Q Consensus 23 ~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kL~DFG 100 (380)
..|||||+... .-.-.|.+ -.+.......+..+++..+.-|-. .+ +||+||+.-|||+. ++.+.|+||+
T Consensus 141 nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~ 211 (268)
T COG1718 141 NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVS 211 (268)
T ss_pred CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECc
Confidence 47999999533 11112221 223333677788888888888888 66 99999999999999 7899999999
Q ss_pred Cccc
Q 016913 101 LAKL 104 (380)
Q Consensus 101 la~~ 104 (380)
.+..
T Consensus 212 QaV~ 215 (268)
T COG1718 212 QAVT 215 (268)
T ss_pred cccc
Confidence 9874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0021 Score=65.38 Aligned_cols=77 Identities=21% Similarity=0.192 Sum_probs=56.0
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 016913 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 100 (380)
Q Consensus 21 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFG 100 (380)
...+|+|||++|..+.+...- ....++...+...+.++. +..+-..| +.|.|..|.||+++.++.+.+.|||
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfG 310 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFG 310 (517)
T ss_pred CCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHhcC---ccccCCCccceEEecCCcEEEEcCc
Confidence 456899999999999988532 123455443333333322 44444567 9999999999999999999999999
Q ss_pred CcccC
Q 016913 101 LAKLG 105 (380)
Q Consensus 101 la~~~ 105 (380)
+....
T Consensus 311 i~g~l 315 (517)
T COG0661 311 IVGRL 315 (517)
T ss_pred ceecC
Confidence 98754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0094 Score=53.20 Aligned_cols=88 Identities=24% Similarity=0.271 Sum_probs=64.4
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccC------CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMP------LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~------ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
...+.+|.+++|+..++...-+|+|.+. ..||.+++.. ..++. .....+. .-..||-+.. |+
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~---~f~~~l~~~~---Iv 140 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALD---EFKRYLLDHH---IV 140 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHH---HHHHHHHHcC---Ce
Confidence 3458899999999999999999999863 3478899865 44665 3333333 4457777888 99
Q ss_pred ecCCCCCcEEEcCC---C-CeEEee-cCCcc
Q 016913 78 YRDLKSSNILLDEG---F-HPKLSD-FGLAK 103 (380)
Q Consensus 78 HrDIkp~NILl~~~---~-~~kL~D-FGla~ 103 (380)
.+|++|.||++... . .++|+| ||-..
T Consensus 141 ~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 141 IRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 99999999999543 2 577887 44443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.0037 Score=67.83 Aligned_cols=30 Identities=17% Similarity=0.318 Sum_probs=24.6
Q ss_pred CeEecCCCCCcEEEcCC-CC-eEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEG-FH-PKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~-~~-~kL~DFGla~~ 104 (380)
.+||+|+++.||+++.+ .. +-|.||.++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 39999999999999753 33 57899999875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0045 Score=56.55 Aligned_cols=30 Identities=27% Similarity=0.405 Sum_probs=25.8
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.||+++.+...-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 389999999999998766567999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.00023 Score=78.58 Aligned_cols=152 Identities=11% Similarity=0.010 Sum_probs=110.8
Q ss_pred CCCCCCcccceEEEE--eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEec
Q 016913 4 LLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYR 79 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~iiHr 79 (380)
...|++++..+.=.. .....+++++|+.+|.+.+.+.+.......++..-+...-.+......-+|... ..-.+|+
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence 356777776655432 234568999999999999999875444455555555544444455666655532 2235899
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
++|+-|.+|..+..+|+.++|+.++. ...........+++.|+.+++...-.++.++|+|..++.+|++..|..+|
T Consensus 1365 ~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1365 SLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999999999999999999999841 11222234567888899999988889999999999999999998877665
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0046 Score=62.94 Aligned_cols=76 Identities=22% Similarity=0.190 Sum_probs=54.9
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcC----CCCeEEe
Q 016913 22 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE----GFHPKLS 97 (380)
Q Consensus 22 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~----~~~~kL~ 97 (380)
..+|+||||+|..+.++-.- ....++...+...+.++. ++.|-..| ++|+|-.|.||++.. +..+.+.
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~--~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivll 347 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAY--LEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLL 347 (538)
T ss_pred ceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHH--HHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEE
Confidence 56899999999877665432 234566665555444432 34444567 999999999999984 5679999
Q ss_pred ecCCcccC
Q 016913 98 DFGLAKLG 105 (380)
Q Consensus 98 DFGla~~~ 105 (380)
|||+....
T Consensus 348 DhGl~~~i 355 (538)
T KOG1235|consen 348 DHGLYAVI 355 (538)
T ss_pred cccccccc
Confidence 99998753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.0011 Score=66.24 Aligned_cols=40 Identities=30% Similarity=0.431 Sum_probs=33.2
Q ss_pred CccCCCCCCcccceEEEEeCC-eEEEEEeccCCCCHHHHHhc
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHD 41 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~ 41 (380)
+|+.+.|+|+..++++-.... ...+|+|++ +.||++++..
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 467889999999999875543 468999999 6999999976
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.021 Score=51.15 Aligned_cols=31 Identities=35% Similarity=0.402 Sum_probs=21.2
Q ss_pred CCeEecCCCCCcEEEc-CCCCeEEeecCCccc
Q 016913 74 PPVIYRDLKSSNILLD-EGFHPKLSDFGLAKL 104 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~-~~~~~kL~DFGla~~ 104 (380)
..++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 3499999999999999 556667999988763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.021 Score=55.20 Aligned_cols=72 Identities=22% Similarity=0.215 Sum_probs=57.7
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 016913 22 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 101 (380)
Q Consensus 22 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGl 101 (380)
+.|++|++. |++|.. + +.-.+++++.++.+++..+.-+..+- ++-|||+.-.||||+ +|.+-|+||-+
T Consensus 300 y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 457888876 566543 2 23468899999999988877777654 489999999999999 88999999999
Q ss_pred cccC
Q 016913 102 AKLG 105 (380)
Q Consensus 102 a~~~ 105 (380)
++..
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9863
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.0073 Score=57.41 Aligned_cols=71 Identities=18% Similarity=0.104 Sum_probs=52.9
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 016913 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 100 (380)
Q Consensus 21 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFG 100 (380)
+.-++|||++.|..|...-+- .+..++ ...+..-+.-|-.+| +||+|++-=||+|.++..++++||-
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~v-------~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRHV-------EDPPTL---YDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFP 247 (465)
T ss_pred cceeeHHHhhcccceeeeeec-------CChHHH---HHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeech
Confidence 455899999998888654422 233333 334444466777889 9999999999999999999999997
Q ss_pred Cccc
Q 016913 101 LAKL 104 (380)
Q Consensus 101 la~~ 104 (380)
....
T Consensus 248 QmvS 251 (465)
T KOG2268|consen 248 QMVS 251 (465)
T ss_pred Hhhc
Confidence 6654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.024 Score=54.27 Aligned_cols=31 Identities=29% Similarity=0.550 Sum_probs=28.4
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
+.++|+|+.+.||+++.+..+-|.||+++.+
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 4799999999999999888899999999975
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.056 Score=49.95 Aligned_cols=29 Identities=21% Similarity=0.189 Sum_probs=25.7
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
-++|+|+.|.||++++++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.1 Score=49.64 Aligned_cols=29 Identities=17% Similarity=0.172 Sum_probs=22.4
Q ss_pred CCCeEecCCCCCcEEEcCC-CC-eEEeecCC
Q 016913 73 NPPVIYRDLKSSNILLDEG-FH-PKLSDFGL 101 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~-~~-~kL~DFGl 101 (380)
.+-++|+|+.+.||+++.+ +. +.|+|...
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa~ 222 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPGL 222 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECchH
Confidence 4569999999999999864 43 67777653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.099 Score=47.34 Aligned_cols=41 Identities=24% Similarity=0.111 Sum_probs=34.1
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcc
Q 016913 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 103 (380)
Q Consensus 62 a~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~ 103 (380)
+++|.-+|+.. ...+|+|..|+||+.++.|.+||.|-+...
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll 191 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL 191 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh
Confidence 56788899542 349999999999999999999999976543
|
The function of this family is unknown. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.1 Score=47.31 Aligned_cols=30 Identities=30% Similarity=0.317 Sum_probs=26.5
Q ss_pred CeEecCCCCCcEEEcC-CCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDE-GFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~-~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.|||++. +..+.|+||..+..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 4999999999999997 57899999988863
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.17 Score=47.80 Aligned_cols=31 Identities=32% Similarity=0.263 Sum_probs=27.1
Q ss_pred CCeEecCCCCCcEEEcCC----CCeEEeecCCccc
Q 016913 74 PPVIYRDLKSSNILLDEG----FHPKLSDFGLAKL 104 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~----~~~kL~DFGla~~ 104 (380)
..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 358999999999999975 7899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.37 E-value=0.12 Score=49.16 Aligned_cols=30 Identities=33% Similarity=0.309 Sum_probs=26.5
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 499999999999999887678999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.78 E-value=0.25 Score=46.83 Aligned_cols=29 Identities=24% Similarity=0.306 Sum_probs=25.2
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 4999999999999987 5789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.57 E-value=0.22 Score=46.59 Aligned_cols=48 Identities=25% Similarity=0.188 Sum_probs=35.1
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 56 ~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
+.+..+-.++.-++..- --++|+|+.|.|+++++.+.++|+||..|..
T Consensus 136 ~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 136 KKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 34444444454444440 1289999999999999999999999988864
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.35 E-value=0.12 Score=45.62 Aligned_cols=29 Identities=17% Similarity=0.181 Sum_probs=25.5
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
-.+|+|+.|.||++++++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 369999999999998776 89999999863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.31 E-value=0.18 Score=47.43 Aligned_cols=30 Identities=33% Similarity=0.303 Sum_probs=26.5
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.|.||+++++..+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 399999999999999887778999988863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.90 E-value=0.28 Score=46.76 Aligned_cols=30 Identities=30% Similarity=0.272 Sum_probs=25.8
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.+||+|+.+.||+++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 399999999999999765568999998863
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.92 E-value=0.16 Score=45.46 Aligned_cols=29 Identities=34% Similarity=0.421 Sum_probs=20.9
Q ss_pred eEecCCCCCcEEE-cCCCCeEEeecCCccc
Q 016913 76 VIYRDLKSSNILL-DEGFHPKLSDFGLAKL 104 (380)
Q Consensus 76 iiHrDIkp~NILl-~~~~~~kL~DFGla~~ 104 (380)
++|+|+.+.|||+ +.++.++|+||..+..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 8999999999999 8889999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=90.26 E-value=0.42 Score=46.42 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=26.0
Q ss_pred CeEecCCCCCcEEEcC-CCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDE-GFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~-~~~~kL~DFGla~~ 104 (380)
-++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 4899999999999986 46799999988863
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=90.24 E-value=0.94 Score=40.50 Aligned_cols=76 Identities=29% Similarity=0.381 Sum_probs=51.4
Q ss_pred ccCCCCCCc--ccceEEEEeC------------------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 016913 2 LSLLHHSNL--VNLIGYCADG------------------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61 (380)
Q Consensus 2 L~~l~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi 61 (380)
|+.+.+.++ |+++||..-. -...||.||++... .+.. .-+.+|
T Consensus 111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~ 173 (207)
T PF13095_consen 111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQM 173 (207)
T ss_pred HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHH
Confidence 344556666 7888876222 12357888775332 2232 334566
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCc
Q 016913 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 102 (380)
Q Consensus 62 a~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla 102 (380)
.+-|..+|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 174 ~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 77788999999 999999999986 4589999864
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.05 E-value=0.71 Score=44.56 Aligned_cols=29 Identities=31% Similarity=0.476 Sum_probs=26.0
Q ss_pred eEecCCCCCcEEEcCCCC-eEEeecCCccc
Q 016913 76 VIYRDLKSSNILLDEGFH-PKLSDFGLAKL 104 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~-~kL~DFGla~~ 104 (380)
+||+|+.|.||+++.+.. +-++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 899999999999998875 88999998863
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=89.14 E-value=0.31 Score=45.79 Aligned_cols=31 Identities=32% Similarity=0.450 Sum_probs=25.9
Q ss_pred CCeEecCCCCCcEEEcCCCC-eEEeecCCccc
Q 016913 74 PPVIYRDLKSSNILLDEGFH-PKLSDFGLAKL 104 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~-~kL~DFGla~~ 104 (380)
+-++|+|+++.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 46999999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=89.12 E-value=0.37 Score=42.72 Aligned_cols=30 Identities=27% Similarity=0.268 Sum_probs=25.4
Q ss_pred CeEecCCCCCcEEEcCCC-----CeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGF-----HPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~-----~~kL~DFGla~~ 104 (380)
-++|+|+.+.||++..+. .+.|+||..+..
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 489999999999997543 589999998874
|
subfamily of choline kinases |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.56 E-value=0.41 Score=46.09 Aligned_cols=52 Identities=25% Similarity=0.250 Sum_probs=32.9
Q ss_pred HHHHHHHHHHHHHHHHHHhh--C-CCCCeEecCCCCCcEEEcCC------------------CCeEEeecCCccc
Q 016913 51 WNTRMKIAAGAAKGLEYLHD--K-ANPPVIYRDLKSSNILLDEG------------------FHPKLSDFGLAKL 104 (380)
Q Consensus 51 ~~~~~~i~~qia~aL~~LH~--~-~~~~iiHrDIkp~NILl~~~------------------~~~kL~DFGla~~ 104 (380)
.+-+..++.|+| |-|+-- . +-..++|-||||+||||-++ -.++|.||.++++
T Consensus 274 ~~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 274 VEYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 344556667765 444221 1 11139999999999999432 2367888888875
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=88.51 E-value=0.8 Score=43.60 Aligned_cols=30 Identities=23% Similarity=0.232 Sum_probs=27.4
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 399999999999999998999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=85.19 E-value=1.7 Score=43.05 Aligned_cols=29 Identities=24% Similarity=0.338 Sum_probs=25.5
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.|||+..+ .++|+||.++..
T Consensus 224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred ceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 49999999999999876 699999988764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=85.13 E-value=0.78 Score=44.25 Aligned_cols=30 Identities=27% Similarity=0.289 Sum_probs=25.8
Q ss_pred CeEecCCCCCcEEEcC-CCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDE-GFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~-~~~~kL~DFGla~~ 104 (380)
-++|+|+.+.|||+++ ++.++|+||..|-.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999975 46899999998863
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=84.65 E-value=1.3 Score=49.45 Aligned_cols=29 Identities=41% Similarity=0.411 Sum_probs=24.9
Q ss_pred eEecCCCCCcEEEcCCC--CeE-EeecCCccc
Q 016913 76 VIYRDLKSSNILLDEGF--HPK-LSDFGLAKL 104 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~--~~k-L~DFGla~~ 104 (380)
+||+|+++.|||++.+. .+. |+|||-+..
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 99999999999998775 454 999998864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.55 E-value=1.6 Score=42.04 Aligned_cols=28 Identities=25% Similarity=0.350 Sum_probs=23.9
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.+||+|+.+.|||++ + .+.|+||+-+..
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 389999999999995 4 578999998864
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=84.18 E-value=3 Score=43.92 Aligned_cols=86 Identities=16% Similarity=0.108 Sum_probs=67.3
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
++.||..+|+++..++.-++++|+... .+|.+...+ ..++.-+.+.|+.||+.--.-|...+ +..-=|.++
T Consensus 178 ~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~-----~~~~~l~~l~Wl~q~~~LW~~l~~~~---~~~sll~~~ 249 (645)
T PRK14559 178 FPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQD-----QTLPTLQILYWLNQMTQLWKALEPWG---CCQSLLELE 249 (645)
T ss_pred ccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhh-----cCCcHHHHHHHHHHHHHHHHHHHhcC---eehhccchh
Confidence 445699999999888888899898632 234444332 34667889999999999999999999 888889999
Q ss_pred cEEEcCCCCeEEeec
Q 016913 85 NILLDEGFHPKLSDF 99 (380)
Q Consensus 85 NILl~~~~~~kL~DF 99 (380)
|+-|+++..+.|..|
T Consensus 250 nlrv~~~~~~~l~~l 264 (645)
T PRK14559 250 NLRVDEDQTLGLQQL 264 (645)
T ss_pred heeeCCCceehHhhh
Confidence 999998777666544
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=83.86 E-value=2.9 Score=41.49 Aligned_cols=62 Identities=18% Similarity=0.058 Sum_probs=47.1
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcC
Q 016913 22 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE 90 (380)
Q Consensus 22 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~ 90 (380)
...||=+|+.|.++..++.. +..++....+++.-.+.||..|---.+ ++|.|+.|.||++..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEe
Confidence 34677888999999999976 445666677777777777665554433 999999999999953
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=83.08 E-value=7.6 Score=37.72 Aligned_cols=82 Identities=18% Similarity=0.228 Sum_probs=58.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhh
Q 016913 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 128 (380)
Q Consensus 49 l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 128 (380)
+.....++++.+.+..|.-+-.. -.|-=|.|+||+++.+..+.+.-||+-...+.. =+.||.
T Consensus 82 ~~k~~Klr~a~~~I~~l~e~~~t----r~~~~laPeNilf~~~l~p~~vH~Glk~~lpPy--------------e~tee~ 143 (434)
T COG4499 82 KEKTRKLRLALQNIATLSELNNT----RYTFFLAPENILFDGGLTPFFVHRGLKNSLPPY--------------EMTEER 143 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcc----ceeEEecchheEEcCCCceEEEecchhccCCCC--------------CCCHHH
Confidence 55666777788887777766544 366678899999999999999999987653221 245555
Q ss_pred hhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 129 AMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 129 ~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+.. .+-+++..++.|..+|+
T Consensus 144 f~~----------~ykA~~~~~fn~k~~Fe 163 (434)
T COG4499 144 FLK----------EYKALAIYAFNGKFSFE 163 (434)
T ss_pred HHH----------HHHHHHHHHHcCCccHH
Confidence 544 45667777778887775
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=82.69 E-value=1.8 Score=40.59 Aligned_cols=30 Identities=30% Similarity=0.298 Sum_probs=25.1
Q ss_pred CeEecCCCCCcEEEcCC--C---CeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEG--F---HPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~--~---~~kL~DFGla~~ 104 (380)
-|+|+|+..+|||+..+ + .++++||.+++.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 38999999999999654 3 589999998874
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=81.97 E-value=3.1 Score=40.15 Aligned_cols=40 Identities=20% Similarity=0.029 Sum_probs=25.1
Q ss_pred HHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCcEEEcC
Q 016913 51 WNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDE 90 (380)
Q Consensus 51 ~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDIkp~NILl~~ 90 (380)
.+-+..++.|++.-.-.+-+ .+-..++|-||||+||||-.
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 34556677777654323311 11123999999999999943
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 380 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 439 bits (1132), Expect = e-156
Identities = 90/232 (38%), Positives = 129/232 (55%), Gaps = 8/232 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+++ H NLV L+G+ +DGD LVY +MP GSL D L PL W+ R KIA G
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQG 141
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AA G+ +LH+ I+RD+KS+NILLDE F K+SDFGLA+ +T +++R++GT
Sbjct: 142 AANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y APE + G++T KSD+YSFGVV LE+ITG A+D R L+ + + +
Sbjct: 199 TAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIEDEEK 255
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232
D + + +VA+ CL E+ RP I V L + +
Sbjct: 256 TIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 431 bits (1111), Expect = e-152
Identities = 95/229 (41%), Positives = 134/229 (58%), Gaps = 4/229 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
LS H +LV+LIG+C + ++ +L+Y++M G+L+ HL+ + W R++I G
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AA+GL YLH +I+RD+KS NILLDE F PK++DFG++K G D+TH+ST V GT
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
GY PEY + G+LT KSDVYSFGVV E++ R AI + P NL WA
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NG 263
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229
+ ++ DP L + L + A CL + RP +GDV+ L Y
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 418 bits (1077), Expect = e-147
Identities = 100/230 (43%), Positives = 141/230 (61%), Gaps = 4/230 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
M+S+ H NL+ L G+C +RLLVY +M GS+ L + P + PLDW R +IA G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+A+GL YLHD +P +I+RD+K++NILLDE F + DFGLAKL D THV+T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGT 198
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH--NLVAWARPLFKD 178
G+ APEY TG+ + K+DV+ +GV+ LELITG++A D R + L+ W + L K+
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 179 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228
++ + D LQG Y + Q + VA +C Q RP + +VV L
Sbjct: 259 KK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 6e-75
Identities = 66/255 (25%), Positives = 93/255 (36%), Gaps = 26/255 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
L + H N++ IG G L+ F GSL D L + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 57 IAAGAAKGLEYLH-------DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 109
IA A+GL YLH D P + +RD+KS N+LL ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 110 KTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164
+ +GT Y APE L+ D+Y+ G+V EL + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 165 EHNLVA--WARPLFKDRRKF--PKMADPLLQGRYPMRGLYQALA-VAAMCLQEQAATRPL 219
P +D ++ K P+L+ + L C A R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 220 IGDVVTALTYLASQT 234
G V +T + T
Sbjct: 306 AGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-54
Identities = 73/246 (29%), Positives = 114/246 (46%), Gaps = 26/246 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H N+V +G +V E++ GSL LH +E LD R+ +A
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYD 145
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AKG+ YLH++ NPP+++R+LKS N+L+D+ + K+ DFGL++L + S GT
Sbjct: 146 VAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP-PGEHNL-VAWARPLFKD 178
+ APE KSDVYSFGV+ EL T ++ P + V A FK
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ------PWGNLNPAQVVAAV-GFKC 255
Query: 179 RR-KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDP 237
+R + P+ +P + + + C + RP ++ L L P
Sbjct: 256 KRLEIPRNLNP------QVAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
Query: 238 NAASNL 243
S+L
Sbjct: 304 PNRSDL 309
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-52
Identities = 57/283 (20%), Positives = 99/283 (34%), Gaps = 49/283 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM 55
+ L+ H N+ I + LLV E+ P GSL +L DW +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSC 114
Query: 56 KIAAGAAKGLEYLH------DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK------ 103
++A +GL YLH D P + +RDL S N+L+ +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 104 LGPVGDKTHVSTRVMGTYGYCAPEYAM-------TGQLTLKSDVYSFGVVFLELITGRKA 156
L G++ + + +GT Y APE + D+Y+ G+++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 157 IDNTRPPGEHNL----VAWARPLFKDRRK----------FPKMADPLLQGRYPMRGLYQA 202
+ E+ + P F+D + FP+ ++ +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 203 LAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSN 245
C + A R + L + S ++
Sbjct: 295 ------CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-51
Identities = 74/262 (28%), Positives = 105/262 (40%), Gaps = 28/262 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
LS ++H N+V L G C + LV E+ GSL + LH P M
Sbjct: 54 QLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
++G+ YLH +I+RDLK N+LL G K+ DFG A D T G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKG 165
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 179
+ + APE + K DV+S+G++ E+IT RK D P + WA +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA--VHNGT 221
Query: 180 R-KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPN 238
R K P+ L C + + RP + ++V +T+L Y P
Sbjct: 222 RPPLIKNLPK------PIESLMT------RCWSKDPSQRPSMEEIVKIMTHL--MRYFPG 267
Query: 239 AASNLSNRVGPSTPRNRDDRRS 260
A L S P D R
Sbjct: 268 ADEPLQYPCQHSLPPGEDGRVE 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-50
Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++S L+H N+V L G + +V EF+P G L L D P+ W+ ++++
Sbjct: 76 IMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEG-----FHPKLSDFGLAKLGPVGDKTHVST 115
A G+EY+ ++ NPP+++RDL+S NI L K++DFGL++ H +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 116 RVMGTYGYCAPEYAMTGQL---TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 172
++G + + APE + + T K+D YSF ++ ++TG D + +
Sbjct: 185 GLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFI 239
Query: 173 RP-LFKDRR-KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230
+ R P+ P +R + + +C RP +V L+ L
Sbjct: 240 NMIREEGLRPTIPEDCPP------RLRNVIE------LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-49
Identities = 54/162 (33%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ ++L H N++ L G C LV EF G L L + + + + A
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQ 113
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP--------KLSDFGLAKLGPVGDKTH 112
A+G+ YLHD+A P+I+RDLKSSNIL+ + K++DFGLA+ +T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTT 170
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ G Y + APE + SDV+S+GV+ EL+TG
Sbjct: 171 KMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-49
Identities = 41/183 (22%), Positives = 75/183 (40%), Gaps = 31/183 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
L + H N++ ++G C + +MP GSL + LH+ +D + +K A
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFA 117
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A+G+ +LH P + L S ++++DE ++S + + S M
Sbjct: 118 LDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRM 169
Query: 119 GTYGYCAPEYAMTGQ----LTLKSDVYSFGVVFLELITGRK--------------AIDNT 160
+ APE A+ + +D++SF V+ EL+T A++
Sbjct: 170 YAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228
Query: 161 RPP 163
RP
Sbjct: 229 RPT 231
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L H N++ +GY Q +V ++ SL HLH + + + IA
Sbjct: 73 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQ 128
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A+G++YLH K +I+RDLKS+NI L E K+ DFGLA +H ++ G+
Sbjct: 129 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 121 YGYCAPE---YAMTGQLTLKSDVYSFGVVFLELITGR 154
+ APE + + +SDVY+FG+V EL+TG+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-46
Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 30/257 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
L+ H N++ I G Q L+ ++ GSL D+L LD + +K
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLK 138
Query: 57 IAAGAAKGLEYLH-----DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 111
+A + GL +LH + P + +RDLKS NIL+ + ++D GLA
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 112 H--VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITG---RKAIDNT 160
+GT Y PE Q + +D+YSFG++ E+ ++
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 161 RPPGEHNLVAWARPLFKDRRKF--PKMADPLLQGRYPMRGLYQALA-VAAMCLQEQAATR 217
+ P ++ + + P ++D R+ K P R+ + + + C A+R
Sbjct: 259 QLP--YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 218 PLIGDVVTALTYLASQT 234
V L ++
Sbjct: 317 LTALRVKKTLAKMSESQ 333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-46
Identities = 40/166 (24%), Positives = 63/166 (37%), Gaps = 19/166 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
H N+V +G C ++ +L + D K LD N +IA
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQE 138
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL---GPVGDKTHVSTRV 117
KG+ YLH ++++DLKS N+ D G ++DFGL + G +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 118 MGTYGYCAPEYAMTGQL---------TLKSDVYSFGVVFLELITGR 154
G + APE + SDV++ G ++ EL
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-45
Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 22/179 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
+L H N++ I Q L+ + +GSL D+L LD + ++
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLR 109
Query: 57 IAAGAAKGLEYLH-----DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 111
I A GL +LH + P + +RDLKS NIL+ + ++D GLA +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 112 HV--STRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162
+ +GT Y APE + D+++FG+V E+ +
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-45
Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 35/247 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H N++ IG + + E++ G+L + W+ R+ A
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKD 116
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL------------GPVG 108
A G+ YLH +I+RDL S N L+ E + ++DFGLA+L
Sbjct: 117 IASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 109 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 168
V+G + APE K DV+SFG+V E+I A P
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRT 229
Query: 169 VAWARPLFKDRRKF-PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
+ + + ++ P P + C RP + L
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWL 277
Query: 228 TYLASQT 234
L
Sbjct: 278 ETLRMHL 284
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-44
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
+L H N++ I + Q LV ++ GSL D+L+ + + +K
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 143
Query: 57 IAAGAAKGLEYLH-----DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 111
+A A GL +LH + P + +RDLKS NIL+ + ++D GLA T
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 112 H--VSTRVMGTYGYCAPEYAMTGQL-------TLKSDVYSFGVVFLELITGRKAIDNTRP 162
+GT Y APE + + ++D+Y+ G+VF E+ R +I
Sbjct: 204 IDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHE 261
Query: 163 P 163
Sbjct: 262 D 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
H N+V LIG C +V E + G L + L T +++ AA G
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAG 225
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+EYL K I+RDL + N L+ E K+SDFG+++ G +
Sbjct: 226 MEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELIT 152
APE G+ + +SDV+SFG++ E +
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFS 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
+ + ++ L+G C L+ + MP G L D++ + K+ + + AKG
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKG 129
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+ YL D+ +++RDL + N+L+ H K++DFGLAKL +K + + +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
A E + T +SDV+S+GV EL+T G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
+ H NLV L+G C ++ EFM G+L D+L + +++ + + +A +
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 330
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+EYL K I+R+L + N L+ E K++DFGL++L GD +
Sbjct: 331 MEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWT 386
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELIT 152
APE + ++KSDV++FGV+ E+ T
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 54/159 (33%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L H N+V G C +R L+ E++P GSL D+L KE +D ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYT 120
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+ KG+EYL K I+RDL + NIL++ K+ DFGL K+ P +
Sbjct: 121 SQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK--- 174
Query: 119 GTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
G + APE + ++ SDV+SFGVV EL T
Sbjct: 175 -EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 54/159 (33%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L H N+V G C +R L+ E++P GSL D+L KE +D ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYT 151
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+ KG+EYL K I+RDL + NIL++ K+ DFGL K+ P + +
Sbjct: 152 SQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK--- 205
Query: 119 GTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
G + APE + ++ SDV+SFGVV EL T
Sbjct: 206 -EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L+H N+V G C + L+ EF+P GSL+++L +K ++ ++K A
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYA 132
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
KG++YL + ++RDL + N+L++ K+ DFGL K + +
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK--- 186
Query: 119 GTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE M + + SDV+SFGV EL+T
Sbjct: 187 -DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 1 MLSLLHHSNLVNLIGYCAD---GDQRLLVY-EFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
ML L H N+V G + +++ E M G+L+ +L +
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRS 133
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVS 114
KGL++LH + PP+I+RDLK NI + G K+ D GLA L + +
Sbjct: 134 WCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLK----RASFA 187
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWA 172
V+GT + APE + DVY+FG+ LE+ T P N
Sbjct: 188 KAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATS-------EYPYSECQNAAQIY 239
Query: 173 RPLFKDR--RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
R + F K+A P ++ + C+++ R
Sbjct: 240 RRVTSGVKPASFDKVAIPEVK------------EIIEGCIRQNKDERY 275
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L LH +V G ++ LV E++P G L D L + LD + + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYS 133
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+ KG+EYL + ++RDL + NIL++ H K++DFGLAKL P+ +V
Sbjct: 134 SQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR--- 187
Query: 119 GTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
G + APE + +SDV+SFGVV EL T
Sbjct: 188 -EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H+++V L+G C G LV +++PLGSL DH+ + L + AKG
Sbjct: 72 LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKG 127
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+ YL + +++R+L + N+LL +++DFG+A L P DK + + +
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
A E G+ T +SDV+S+GV EL+T G +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L+H +++ G C D LV E++PLGSL D+L + + + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFA 140
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+G+ YLH + I+RDL + N+LLD K+ DFGLAK P G + + +
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RV 193
Query: 119 GTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
G + APE + SDV+SFGV EL+T
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
+ + ++ L+G C L+ + MP G L D++ + K+ + + AKG
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKG 129
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+ YL D+ +++RDL + N+L+ H K++DFGLAKL +K + + +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
A E + T +SDV+S+GV EL+T G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L + +V E+M GSL D L + L + +AA
Sbjct: 232 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 288
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A G+ Y+ ++RDL+++NIL+ E K++DFGLA+L ++
Sbjct: 289 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFP 344
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE A+ G+ T+KSDV+SFG++ EL T
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 50/155 (32%), Positives = 69/155 (44%), Gaps = 13/155 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H NL+ L G +V E PLGSL D L + T + A A+G
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 133
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
+ YL K I+RDL + N+LL K+ DFGL + P D +V +
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+CAPE T + SD + FGV E+ T G++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 49/240 (20%), Positives = 86/240 (35%), Gaps = 38/240 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
M L +H N++ L+ YC L+ F G+L + + L L + +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
+ G +GLE +H +RDLK +NILL + P L D G + +
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 117 VM-------GTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 163
+ T Y APE + + + ++DV+S G V ++ G D
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 164 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
G+ +A +++ P+ R+ + + RP I +
Sbjct: 253 GDSVALA-----VQNQLSIPQ------SPRHS----SALWQLLNSMMTVDPHQRPHIPLL 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 35/161 (21%), Positives = 67/161 (41%), Gaps = 14/161 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE----PLDWNTRMK 56
+++ + + + G + D+ ++YE+M S+ + +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
I Y+H++ N + +RD+K SNIL+D+ KLSDFG ++ K S
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGS-- 210
Query: 117 VMGTYGYCAPEYAMTGQLT---LKSDVYSFGVVFLELITGR 154
GTY + PE + + + K D++S G+ +
Sbjct: 211 -RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+++ L HSNLV L+G + L +V E+M GSL D+L + L + +K +
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 296
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV-- 117
+ +EYL ++RDL + N+L+ E K+SDFGL K T + ++
Sbjct: 297 DVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPV 350
Query: 118 --MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
APE + + KSDV+SFG++ E+ +
Sbjct: 351 KWT------APEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV L G C + LV EFM G L D+L + T + + +G
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEG 116
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
+ YL + VI+RDL + N L+ E K+SDFG+ + V D + T GT
Sbjct: 117 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPV 169
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ +PE + + KSDV+SFGV+ E+ + G+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------HDLPPDKEPLDWNTR 54
++ + ++V L+G + G L++ E M G L+ +L P P +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+++A A G+ YL+ ++RDL + N ++ E F K+ DFG+ + D
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 115 TRV------MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ M +PE G T SDV+SFGVV E+ T
Sbjct: 198 GKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 12/155 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
H N++ L G G ++V E+M GSL+ L + + G G
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAG 163
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
+ YL D ++RDL + N+L+D K+SDFGL+++ + D + G
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPI 218
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ APE + SDV+SFGVV E++ G +
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L + +V E+M GSL D L + L + +AA
Sbjct: 315 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 371
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A G+ Y+ ++RDL+++NIL+ E K++DFGLA+L ++
Sbjct: 372 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFP 427
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE A+ G+ T+KSDV+SFG++ EL T
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L + +V LIG C + +LV E G L L +E + + ++ + G
Sbjct: 67 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMG 122
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-- 122
++YL +K ++RDL + N+LL + K+SDFGL+K D + +
Sbjct: 123 MKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGK 174
Query: 123 ----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ APE + + +SDV+S+GV E ++ G+K
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H N+V++I + D LV E++ +L +++ PL +T + G
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDG 123
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST-RVMGTYGY 123
+++ HD +++RD+K NIL+D K+ DFG+AK + + + T V+GT Y
Sbjct: 124 IKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQY 178
Query: 124 CAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+PE A +D+YS G+V E++ G
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
+ H NLV L+G C ++ EFM G+L D+L + +++ + + +A +
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 123
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
+EYL K I+RDL + N L+ E K++DFGL++L + T+ + G
Sbjct: 124 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPI 176
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE + ++KSDV++FGV+ E+ T
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
H N++ L G + +++ E+M G+L+ L + + + G A G
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAG 159
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
++YL + ++RDL + NIL++ K+SDFGL+++ + D + G
Sbjct: 160 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPI 214
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ APE + T SDV+SFG+V E++T G +
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV G C+ +V E++ G L ++L + L+ + +++ +G
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEG 116
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
+ +L I+RDL + N L+D K+SDFG+ + V D + +GT
Sbjct: 117 MAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPV 169
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ APE + + KSDV++FG++ E+ + G+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 33/240 (13%), Positives = 73/240 (30%), Gaps = 48/240 (20%)
Query: 1 MLSLLHHSNLVNLIGYCADGD--QRLLVYEFM--PLGSLEDHLHDLPPDKEPLDWNTRMK 56
++ ++ + D R +Y M L + + L + L + R++
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
+ + L LH +++ L+ +I+LD+ L+ F +
Sbjct: 211 LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGARVV 261
Query: 117 VMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVFLELITGRKAIDNTRPP-G 164
+ G+ PE +T D ++ G+V + P
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA-------DLPIT 314
Query: 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224
+ + + +F+ + P+ LL+G L+ R L +
Sbjct: 315 KDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPKEDRLLPLQAM 358
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L + +V +IG C + + +LV E LG L +L + +++ + G
Sbjct: 75 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMG 129
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-- 122
++YL + ++RDL + N+LL + K+SDFGL+K + + +
Sbjct: 130 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGK 181
Query: 123 ----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ APE + + KSDV+SFGV+ E + G+K
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+++ L HSNLV L+G + L +V E+M GSL D+L + L + +K +
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 124
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV-- 117
+ +EYL ++RDL + N+L+ E K+SDFGL K T + ++
Sbjct: 125 DVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPV 178
Query: 118 --MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
APE + + KSDV+SFG++ E+ + GR
Sbjct: 179 KWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
H N++ L G ++V E+M GSL+ L + + G A G
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASG 159
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
++YL D ++RDL + NIL++ K+SDFGL ++ + D + G
Sbjct: 160 MKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPI 214
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ +PE + T SDV+S+G+V E+++ G +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 13/155 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L + ++ EFM GSL D L + + +A
Sbjct: 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQ 292
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A+G+ ++ + I+RDL+++NIL+ K++DFGLA++ + D + T G
Sbjct: 293 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGA 345
Query: 121 ---YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE G T+KSDV+SFG++ +E++T
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEP 48
M + H N++NL+G C ++ E+ G+L ++L +E
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
+ + + A+G+EYL + I+RDL + N+L+ E K++DFGLA+
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 109 D--KTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D K + R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 211 DYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
++ L+H N++ LIG + ++ +M G L + + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGL 131
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
A+G+EYL ++ ++RDL + N +LDE F K++DFGLA+ + V
Sbjct: 132 QVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 120 ------TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
T A E T + T KSDV+SFGV+ EL+T
Sbjct: 189 RLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H LV L G C ++ E+M G L ++L + + +++ +
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEA 132
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
+EYL K ++RDL + N L+++ K+SDFGL++ V D + T +G+
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPV 185
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ PE M + + KSD+++FGV+ E+ +
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEP 48
+L+ L H ++V G C DGD ++V+E+M G L L K
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L + + IA+ A G+ YL + ++RDL + N L+ K+ DFG+++
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 109 DKTHVSTRV------MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D V M PE M + T +SDV+SFGV+ E+ T
Sbjct: 187 DYYRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 39/158 (24%), Positives = 68/158 (43%), Gaps = 21/158 (13%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L H ++V LIG + + ++ E P G L +L +K L T + + K
Sbjct: 70 LDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKA 125
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-- 122
+ YL ++RD+ NIL+ KL DFGL++ + D+ +
Sbjct: 126 MAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTR 175
Query: 123 ----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ +PE + T SDV+ F V E+++ G++
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 13/155 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L + ++ E+M GSL D L P L N + +AA
Sbjct: 61 LMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A+G+ ++ ++ I+RDL+++NIL+ + K++DFGLA+L + D + T G
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGA 170
Query: 121 ---YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE G T+KSDV+SFG++ E++T
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEP 48
+ L HH N++NL+G C L E+ P G+L D L
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L + AA A+G++YL K I+RDL + NIL+ E + K++DFGL++ V
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195
Query: 109 DKTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
K R+ M A E T SDV+S+GV+ E+++
Sbjct: 196 VKKT-MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 26/169 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-----------HDLPPDKEPL 49
+L++L H ++V G C +G L+V+E+M G L L PL
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 50 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 109
+ +A+ A G+ YL ++RDL + N L+ +G K+ DFG+++ D
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 110 KTHVSTRV------MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
V R M PE + + T +SDV+SFGVV E+ T
Sbjct: 213 YYRVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 37/174 (21%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR------ 54
M L H N+VNL+G C G L++ E+ G L + L E
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 55 ----MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 110
+ ++ A+G+ +L K I+RD+ + N+LL G K+ DFGLA+
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD------ 213
Query: 111 THVSTRVMGTYGYC------------APEYAMTGQLTLKSDVYSFGVVFLELIT 152
+M Y APE T++SDV+S+G++ E+ +
Sbjct: 214 ------IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 43/289 (14%), Positives = 80/289 (27%), Gaps = 53/289 (18%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMP-------LGSLEDHLHDLPPDKEPLDWNTR 54
L+ +I D ++ F L + + L + L + R
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+++ + L LH +++ L+ +I+LD+ L+ F G S
Sbjct: 214 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----S 264
Query: 115 TRVMGTYGYCAPEY----------AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164
G+ PE +T D ++ G+ + P
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------LPNT 318
Query: 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224
+ + + +F+ + P+ LL+G L+ R L +
Sbjct: 319 DDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPKEDRLLPLQAM 362
Query: 225 TALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGR 273
Y +T A P G PDE G
Sbjct: 363 ETPEYEQLRTELSAALPLYQ---TDGEPTREGGAP--PSGTSQPDEAGA 406
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEP 48
+ + L H N+V L+G +++ + G L + L D K
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L+ + + A A G+EYL V+++DL + N+L+ + + K+SD GL +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 109 D--KTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D K ++ + M APE M G+ ++ SD++S+GVV E+ +
Sbjct: 182 DYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEP 48
M + H N++NL+G C ++ E+ G+L ++L +E
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
+ + + A+G+EYL + I+RDL + N+L+ E K++DFGLA+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 109 D--KTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D K + R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 257 DYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR-----LLVYEFMPLGSLEDHL--HDLPPDKEPLDWNT 53
+ H N++ L+G C + + +++ FM G L +L L + + T
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--KT 111
+K A G+EYL ++ ++RDL + N +L + ++DFGL+K GD +
Sbjct: 149 LLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 112 HVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
++ + A E T KSDV++FGV E+ T
Sbjct: 206 GRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 39/166 (23%), Positives = 71/166 (42%), Gaps = 23/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHL--HDLPPDKEPLDWN 52
+ H ++ L+G + +++ FM G L L + + L
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 53 TRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--K 110
T ++ A G+EYL + I+RDL + N +L E ++DFGL++ GD +
Sbjct: 138 TLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 111 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
++++ + A E T+ SDV++FGV E++T
Sbjct: 195 QGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
++ H N+++L+G C + L+V +M G L + + + + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGL 135
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
AKG++YL K ++RDL + N +LDE F K++DFGLA+ + V +
Sbjct: 136 QVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 120 ------TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
A E T + T KSDV+SFGV+ EL+T
Sbjct: 193 KLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 34/171 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
M+S L H +LV G C GD+ +LV EF+ GSL+ +L +K ++ ++++A
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQ 121
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP--------KLSDFGLAKLGPVGDKTH 112
A + +L + +I+ ++ + NILL KLSD G++
Sbjct: 122 LAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------- 170
Query: 113 VSTRVMGTYGY------CAPEYAMTGQL-TLKSDVYSFGVVFLELIT-GRK 155
V+ PE + L +D +SFG E+ + G K
Sbjct: 171 ----VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L + +V LIG C + +LV E G L L +E + + ++ + G
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMG 448
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---Y 121
++YL +K ++R+L + N+LL + K+SDFGL+K D + +
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPL 503
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ APE + + +SDV+S+GV E ++ G+K
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-24
Identities = 47/154 (30%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ S L H N++ L GY D + L+ E+ PLG++ L L E T
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR---TA-TYITE 117
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A L Y H K VI+RD+K N+LL K++DFG + P + GT
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GT 170
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
Y PE K D++S GV+ E + G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 37/155 (23%), Positives = 55/155 (35%), Gaps = 11/155 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ H V L +G L E SL+ H L
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRD 165
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
L +LH + +++ D+K +NI L KL DFGL +G + G
Sbjct: 166 TLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GD 219
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155
Y APE + G +DV+S G+ LE+ +
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 43/158 (27%), Positives = 68/158 (43%), Gaps = 11/158 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ L +V L G +G + E + GSL + + E +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQ 158
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAK-LGPVGDKTHVSTR-- 116
A +GLEYLH + +++ D+K+ N+LL +G L DFG A L P G + T
Sbjct: 159 ALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ GT + APE M K D++S + L ++ G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-24
Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 9/158 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---PLDWNTRMKI 57
++S +H N+V IG R ++ E M G L+ L + P L + +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVS 114
A A G +YL + I+RD+ + N LL G K+ DFG+A+
Sbjct: 146 ARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
M + PE M G T K+D +SFGV+ E+ +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 6/160 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L H N+V D L V E+ G L + +++ LD +++
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 59 AGAAKGLEYLHDKANPP--VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
L+ H +++ V++RDLK +N+ LD + KL DFGLA++ + T +
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKT 175
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 156
+GT Y +PE KSD++S G + EL
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-24
Identities = 50/172 (29%), Positives = 74/172 (43%), Gaps = 29/172 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--------------HDLPPDK 46
+ L +H N+VNL+G C G L++ E+ G L + L + D+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 47 EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 106
LD + + AKG+ +L K I+RDL + NILL G K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 107 VGDKTHVST------RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
V + M APE T +SDV+S+G+ EL +
Sbjct: 197 NDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 48/223 (21%), Positives = 85/223 (38%), Gaps = 21/223 (9%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L+H N++ + ++ +V E G L + K + T K
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121
LE++H + V++RD+K +N+ + KL D GL + KT + ++GT
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTP 200
Query: 122 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK-DRR 180
Y +PE KSD++S G + E+ + P + + K ++
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAAL-------QSPFYGDKMNLYSLCKKIEQC 253
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+P PL Y + + MC+ RP + V
Sbjct: 254 DYP----PLPSDHYS----EELRQLVNMCINPDPEKRPDVTYV 288
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
++ H N+++L+G C + L+V +M G L + + + + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGL 199
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
AKG+++L K ++RDL + N +LDE F K++DFGLA+ + V +
Sbjct: 200 QVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 120 ------TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
A E T + T KSDV+SFGV+ EL+T
Sbjct: 257 KLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 18/153 (11%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
H ++V LIG + ++ E LG L L K LD + + A +
Sbjct: 448 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTA 503
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-- 122
L YL K ++RD+ + N+L+ KL DFGL++ + D T+ G
Sbjct: 504 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKL 554
Query: 123 ---YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
+ APE + T SDV+ FGV E++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 42/211 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-------------LVYEFMPLGSLEDHLHDLPPDKE 47
+L+ L+H +V + + + E+ G+L D +H +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENL 111
Query: 48 PLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--- 104
+ ++ + L Y+H + +I+RDLK NI +DE + K+ DFGLAK
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 105 ----------GPVGDKTHVSTRVMGTYGYCAPE-YAMTGQLTLKSDVYSFGVVFLELITG 153
G ++++ + GT Y A E TG K D+YS G++F E+I
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 184
V + L +FP
Sbjct: 228 --------FSTGMERVNILKKLRSVSIEFPP 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEP 48
M + H N++NL+G C ++ E+ G+L ++L + +E
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L + A A+G+EYL K I+RDL + N+L+ E K++DFGLA+
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 109 D--KTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
D K + R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 245 DYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 8/150 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
L ++V + + Q + + L L + PL + I
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSA 146
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
L+ H +RD+K NIL+ L DFG+A T + +GT Y
Sbjct: 147 LDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYM 202
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELITGR 154
APE T ++D+Y+ V E +TG
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGS 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 42/158 (26%), Positives = 65/158 (41%), Gaps = 21/158 (13%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
H ++V LIG + ++ E LG L L LD + + A +
Sbjct: 73 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTA 128
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-- 122
L YL K ++RD+ + N+L+ KL DFGL++ + D T+
Sbjct: 129 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGK 178
Query: 123 ----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 155
+ APE + T SDV+ FGV E++ G K
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 19/163 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---PLDWNTRMKI 57
++S +H N+V IG R ++ E M G L+ L + P L + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVS 114
A A G +YL + I+RD+ + N LL G K+ DFG+A+ D
Sbjct: 187 ARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAG 238
Query: 115 TRVMGTYGY-----CAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
G PE M G T K+D +SFGV+ E+ +
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-A 58
+L+ +H +V+L Y + L LV M G + H++++ D R
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYT 295
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A GLE+LH + +IYRDLK N+LLD+ + ++SD GLA G
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA- 350
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT G+ APE + + D ++ GV E+I R
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 41/154 (26%), Positives = 62/154 (40%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ S L H N++ + Y D + L+ EF P G L L E +
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR---SA-TFMEE 122
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A L Y H++ VI+RD+K N+L+ K++DFG + P + GT
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GT 175
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
Y PE K D++ GV+ E + G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-23
Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 28/171 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQ-RLLVYEFMPLGSLEDHL------------HDLPPDKE 47
++ + HH N+VNL+G C +++ EF G+L +L K+
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 48 PLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 107
L + + AKG+E+L + I+RDL + NILL E K+ DFGLA+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 108 GD--KTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
R+ M APE T++SDV+SFGV+ E+ +
Sbjct: 201 DPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 5e-23
Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPD--KEPLDWNTRMKI 57
+L ++ +V+L Y + L LV M G L+ H++ + E R
Sbjct: 237 ILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVF 290
Query: 58 -AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
AA GLE LH + ++YRDLK NILLD+ H ++SD GLA P G R
Sbjct: 291 YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GR 345
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
V GT GY APE + T D ++ G + E+I G+
Sbjct: 346 V-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-23
Identities = 51/301 (16%), Positives = 103/301 (34%), Gaps = 37/301 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L+ + H N+V + +V ++ G L ++ + +
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQ 133
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
L+++HD+ +++RD+KS NI L + +L DFG+A++ + ++ +GT
Sbjct: 134 ICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGT 188
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y +PE KSD+++ G V EL T + A + +
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII--------SG 240
Query: 181 KFPKMADPLLQGRYP--MRGLYQALAVAAMCLQEQAATRPLIGDVV-------TALTYLA 231
FP + Y +R L + RP + ++ +L+
Sbjct: 241 SFPP-----VSLHYSYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289
Query: 232 SQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGR--VGRHGSPSTHKNSPDY 289
Q ++ G + P + ++G P +K D
Sbjct: 290 PQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDK 349
Query: 290 R 290
+
Sbjct: 350 K 350
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 52/239 (21%), Positives = 87/239 (36%), Gaps = 46/239 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL----------------LVYEFMPLGSLEDHLHDLPP 44
L+ L H N+V+ G D + EF G+LE +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR- 115
Query: 45 DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104
E LD +++ KG++Y+H K +I RDLK SNI L + K+ DFGL
Sbjct: 116 -GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT- 170
Query: 105 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164
TR GT Y +PE + + D+Y+ G++ EL+
Sbjct: 171 --SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV----------- 217
Query: 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
F+ + F + D ++ + + + L ++ RP ++
Sbjct: 218 -------CDTAFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 18/158 (11%)
Query: 5 LHHSNLVNL--IGYCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
L+H +V + G A+ L Y E++ +L D +H + P+ +++ A
Sbjct: 69 LNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIA 123
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR--- 116
A + L + H +I+RD+K +NI++ K+ DFG+A+ + D + T+
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAA 178
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
V+GT Y +PE A + +SDVYS G V E++TG
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 35/178 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--------------------H 40
+L ++H +++ L G C+ LL+ E+ GSL L
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 41 DLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 100
PD+ L + A ++G++YL + +++RDL + NIL+ EG K+SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFG 195
Query: 101 LAKLGPVGD--KTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
L++ D R+ M A E T +SDV+SFGV+ E++T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 55/160 (34%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 1 MLSLLHHSN---LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
MLSL+ + +V + Y +L + + M G L HL E M+
Sbjct: 242 MLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMR 295
Query: 57 I-AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
AA GLE++H++ V+YRDLK +NILLDE H ++SD GLA K H
Sbjct: 296 FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--A 349
Query: 116 RVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
V GT+GY APE G S D +S G + +L+ G
Sbjct: 350 SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 49/177 (27%), Positives = 78/177 (44%), Gaps = 34/177 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-------------------HD 41
M L H N+VNL+G C L++E+ G L ++L +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 42 LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 101
D L + + A AKG+E+L K+ ++RDL + N+L+ G K+ DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 102 AKLGPVGD--KTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
A+ + R+ M APE G T+KSDV+S+G++ E+ +
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 35/178 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--------------------H 40
+++ + N+V L+G CA G L++E+M G L + L
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 41 DLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 100
P PL ++ IA A G+ YL ++ ++RDL + N L+ E K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFG 219
Query: 101 LAKLGPVGD--KTHVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
L++ D K + + M PE + T +SDV+++GVV E+ +
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 6e-22
Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 17/164 (10%)
Query: 3 SLLHHSNLVNLIGYCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+ + N +G ++ +Y + +L+D ++ ++ + + I
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGVCLHIFI 171
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK----------LGPVGD 109
A+ +E+LH K +++RDLK SNI K+ DFGL +
Sbjct: 172 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 110 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
T +GT Y +PE + K D++S G++ EL+
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-22
Identities = 37/167 (22%), Positives = 62/167 (37%), Gaps = 22/167 (13%)
Query: 1 MLSLLHHSNL--VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
L+ L + + L Y +V E L L K+ +D R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYW 133
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+ + +H +++ DLK +N L+ +G KL DFG+A + V +
Sbjct: 134 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 119 GTYGYCAPE-----------YAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y PE +++ KSDV+S G + + G+
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 9e-22
Identities = 27/166 (16%), Positives = 52/166 (31%), Gaps = 15/166 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEPLDWNTRMKIAA 59
L + + +LV E G+L + ++ ++ + + A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-----------KLSDFGLAKLGPVG 108
+E +HD +I+ D+K N +L GF L D G + +
Sbjct: 180 RMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 109 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
K + T T G+ E + D + ++ G
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 38/166 (22%), Positives = 63/166 (37%), Gaps = 21/166 (12%)
Query: 1 MLSLLHHS-NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+ L HS ++ L Y +V E L L K+ +D R
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWK 115
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
+ + +H +++ DLK +N L+ +G KL DFG+A + V +G
Sbjct: 116 NMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 120 TYGYCAPE-----------YAMTGQLTLKSDVYSFGVVFLELITGR 154
T Y PE +++ KSDV+S G + + G+
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 41/159 (25%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ + V G + E M SL+ + + + + KIA
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMG 119
K LE+LH K + VI+RD+K SN+L++ K+ DFG+ L G
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAG 171
Query: 120 TYGYCAPE----YAMTGQLTLKSDVYSFGVVFLELITGR 154
Y APE ++KSD++S G+ +EL R
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 2 LSLLHHSNLVNLIGYCADGD---------QRLLVY---EFMPLGSLEDHLHDLPPDKEPL 49
L+ L H +V + + ++ +Y + +L+D ++ +E
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER- 115
Query: 50 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL----- 104
+ + + I A+ +E+LH K +++RDLK SNI K+ DFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 105 -----GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152
T +GT Y +PE + K D++S G++ EL+
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 28/230 (12%), Positives = 55/230 (23%), Gaps = 23/230 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD--QRLLVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRMK 56
+++ L D LL+ L L L + +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
+ A + L K +++ N+ + L D VG + S+
Sbjct: 199 LTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS- 252
Query: 117 VMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 174
Y E+ T T + + G+ + P
Sbjct: 253 --VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL-------FLPFGLVTPGIKGS 303
Query: 175 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224
+ + P P+ + L + L R L + +
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTL-IGRF-LNFDRRRRLLPLEAM 351
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 39/166 (23%), Positives = 62/166 (37%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--KEPLDWNTRMKIA 58
+ L +H N+V ++ +V FM GS +D + D E IA
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IA 131
Query: 59 A---GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG-LAKLGPVGDKTHV- 113
G K L+Y+H ++R +K+S+IL+ LS + G + V
Sbjct: 132 YILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 114 ---STRVMGTYGYCAPEYAMTGQL--TLKSDVYSFGVVFLELITGR 154
+ + +PE KSD+YS G+ EL G
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 21/211 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + +V G + + E M GSL+ L E + K++
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIA 139
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD---KTHVSTRV 117
KGL YL +K +++RD+K SNIL++ KL DFG++ G + D + V
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV---- 191
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR-----KAIDNTRPPGEHNLVAWA 172
GT Y +PE +++SD++S G+ +E+ GR + A
Sbjct: 192 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250
Query: 173 RPLFKDRRKFPKMADPLLQGRYPMRGLYQAL 203
R + + P +++ L
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 37/223 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+LS + G + ++ E++ GS D L PLD I
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILRE 127
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMG 119
KGL+YLH + I+RD+K++N+LL E KL+DFG+ +L K + +G
Sbjct: 128 ILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVG 181
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFK 177
T + APE K+D++S G+ +EL G PP H + + LF
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARG-------EPPHSELHPM----KVLF- 229
Query: 178 DRRKFPKMADPLLQGRY--PMRGLYQALAVAAMCLQEQAATRP 218
PK P L+G Y P++ CL ++ + RP
Sbjct: 230 ---LIPKNNPPTLEGNYSKPLKEF------VEACLNKEPSFRP 263
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 22/167 (13%)
Query: 1 MLSLLHHSNL--VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
L+ L + + L Y +V E L L K+ +D R
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYW 161
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+ + +H +++ DLK +N L+ +G KL DFG+A + V +
Sbjct: 162 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 119 GTYGYCAPE-----------YAMTGQLTLKSDVYSFGVVFLELITGR 154
G Y PE +++ KSDV+S G + + G+
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 33/233 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWN-TRMKIAA 59
+S HH N+V+ D+ LV + + GS+ D + + E IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 60 ---GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVST 115
+GLEYLH I+RD+K+ NILL E +++DFG+ A L GD T
Sbjct: 126 ILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 116 R--VMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVA 170
R +GT + APE + K+D++SFG+ +EL TG P +
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG-------AAPYHKYPPM-- 233
Query: 171 WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVA-----AMCLQEQAATRP 218
+ L + P L+ + + + + ++CLQ+ RP
Sbjct: 234 --KVLM----LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 27/195 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ ++V G +V E+ GS+ D + + L + I
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQS 133
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMG 119
KGLEYLH I+RD+K+ NILL+ H KL+DFG+ +L K + V+G
Sbjct: 134 TLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIG 187
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFK 177
T + APE +D++S G+ +E+ G +PP H + R +F
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG-------KPPYADIHPM----RAIF- 235
Query: 178 DRRKFPKMADPLLQG 192
P P +
Sbjct: 236 ---MIPTNPPPTFRK 247
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-20
Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 27/185 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEPLDWNTRMKI 57
+ L H N+V +G ++ + E +P GSL L D E +I
Sbjct: 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVST 115
+GL+YLHD +++RD+K N+L++ G K+SDFG +K + +
Sbjct: 132 ----LEGLKYLHDNQ---IVHRDIKGDNVLINTYSG-VLKISDFGTSKR--LAGINPCTE 181
Query: 116 RVMGTYGYCAPE---YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 172
GT Y APE G +D++S G +E+ TG +PP + L
Sbjct: 182 TFTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATG-------KPP-FYELGEPQ 232
Query: 173 RPLFK 177
+FK
Sbjct: 233 AAMFK 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 9/155 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
++S L H V L D ++ + G L ++ K T + A
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTA 137
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
LEYLH K +I+RDLK NILL+E H +++DFG AK+ K + +G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
T Y +PE SD+++ G + +L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 35/155 (22%), Positives = 56/155 (36%), Gaps = 22/155 (14%)
Query: 5 LHHSNLVNLIGYCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+ H ++V + + D+ +V E++ SL+ + L +
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLL 189
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
L YLH ++Y DLK NI+L E KL D G + G
Sbjct: 190 EILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYG 239
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
T G+ APE T+ +D+Y+ G L
Sbjct: 240 TPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 44/160 (27%), Positives = 65/160 (40%), Gaps = 13/160 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEPLDWNTRMKIAA 59
++ +V G + E M S + + + + KI
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVM 118
K L +L + +I+RD+K SNILLD + KL DFG+ +L + TR
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDA 186
Query: 119 GTYGYCAPE----YAMTGQLTLKSDVYSFGVVFLELITGR 154
G Y APE A ++SDV+S G+ EL TGR
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ + N+VN + GD+ +V E++ GSL D + + +D +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRE 124
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMG 119
+ LE+LH VI+RD+KS NILL KL+DFG A++ P K T V G
Sbjct: 125 CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-G 178
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
T + APE K D++S G++ +E+I G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 16/162 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ H N++ D + + E +L++++ L+ T ++
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---Q 126
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDE-----GFHPKLSDFGLAK-LGPVGDKTHVS 114
GL +LH +++RDLK NIL+ +SDFGL K L
Sbjct: 127 TTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 115 TRVMGTYGYCAPEY---AMTGQLTLKSDVYSFGVVFLELITG 153
+ V GT G+ APE T D++S G VF +I+
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 22/174 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPL-----GSLEDHLHDLPPDKEPLDWNT 53
M L H N+V + G + EF+ L G L + L + + PL +T
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDT 137
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA---KLGPVGDK 110
+KI + ++++H + PP+I+RDLK N+LL KL DFG A P
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 111 THVSTRVM-------GTYGYCAPE---YAMTGQLTLKSDVYSFGVVFLELITGR 154
+ ++ T Y PE + K D+++ G + L +
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA- 59
++ H N+V + G++ ++ EF+ G+L D + + + E +IA
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN-EE-------QIATV 146
Query: 60 --GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTR 116
+ L YLH + VI+RD+KS +ILL KLSDFG A++ K +
Sbjct: 147 CEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SL 201
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153
V GT + APE + D++S G++ +E++ G
Sbjct: 202 V-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-A 58
++ L H LVNL Y ++ + +V + + G L HL KE +K+
Sbjct: 68 IMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-----TVKLFI 121
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
L+YL ++ +I+RD+K NILLDE H ++DF +A + P + T +
Sbjct: 122 CELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMA 175
Query: 119 GTYGYCAPE--YAMTGQLTLKS-DVYSFGVVFLELITGR 154
GT Y APE + G + D +S GV EL+ GR
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 47/163 (28%), Positives = 70/163 (42%), Gaps = 16/163 (9%)
Query: 1 MLSLLHHSNLVNLI------GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
++ L+H N+V+ A D LL E+ G L +L+ + L
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPI 123
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP---KLSDFGLAKLGPVGDKT 111
+ + + L YLH+ +I+RDLK NI+L G K+ D G AK +
Sbjct: 124 RTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGE 178
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ V GT Y APE + T+ D +SFG + E ITG
Sbjct: 179 LCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 47/154 (30%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L H ++V G+ D D +V E SL + EP R
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---AR-YYLRQI 124
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGT 120
G +YLH VI+RDLK N+ L+E K+ DFGLA K+ G++ V GT
Sbjct: 125 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GT 178
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
Y APE + + DV+S G + L+ G+
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 52/156 (33%), Positives = 66/156 (42%), Gaps = 14/156 (8%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
L H L L Y RL V E+ G L HL E R + A
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA 255
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM- 118
L+YLH + N V+YRDLK N++LD+ H K++DFGL K G T +
Sbjct: 256 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFC 310
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y APE D + GVV E++ GR
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 47/154 (30%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L H ++V G+ D D +V E SL + EP R
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---AR-YYLRQI 150
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGT 120
G +YLH VI+RDLK N+ L+E K+ DFGLA K+ G++ V GT
Sbjct: 151 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GT 204
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
Y APE + + DV+S G + L+ G+
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L H +++ L Y D + LV E G + +L + K + R
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEAR-HFMHQI 121
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGT 120
G+ YLH +++RDL SN+LL + K++DFGLA +L +K + GT
Sbjct: 122 ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GT 175
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
Y +PE A L+SDV+S G +F L+ GR
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 51/157 (32%), Positives = 68/157 (43%), Gaps = 17/157 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
L H L L Y RL V E+ G L HL E R + A
Sbjct: 59 LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA 112
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM- 118
LEYLH + V+YRD+K N++LD+ H K++DFGL K G T +
Sbjct: 113 EIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFC 166
Query: 119 GTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
GT Y APE + ++ D + GVV E++ GR
Sbjct: 167 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 21/168 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL--LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L+H N+V L + R L+ EF P GSL L + P + L + + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVL 118
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP----KLSDFGLAKLGPVGDKTHVS 114
G+ +L + +++R++K NI+ G KL+DFG A+ + D
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV 173
Query: 115 TRVMGTYGYCAPE--------YAMTGQLTLKSDVYSFGVVFLELITGR 154
+ GT Y P+ + D++S GV F TG
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 45/160 (28%), Positives = 64/160 (40%), Gaps = 16/160 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L +V G + E M + + P E + K+
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI----LGKMTVA 132
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMG 119
K L YL +K VI+RD+K SNILLDE KL DFG+ +L R G
Sbjct: 133 IVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSAG 186
Query: 120 TYGYCAPE-----YAMTGQLTLKSDVYSFGVVFLELITGR 154
Y APE +++DV+S G+ +EL TG+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 27/165 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAA 59
+L+ H +V L+G + ++ EF P G+++ + +L EP +I
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQV 121
Query: 60 ---GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDK--THV 113
+ L +LH K +I+RDLK+ N+L+ +L+DFG+ AK K + +
Sbjct: 122 VCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 114 STRVMGTYGYCAPEYAMTGQLT-----LKSDVYSFGVVFLELITG 153
GT + APE M + K+D++S G+ +E+
Sbjct: 179 -----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 21/168 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL--LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L+H N+V L + R L+ EF P GSL L + P + L + + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVL 118
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP----KLSDFGLAKLGPVGDKTHVS 114
G+ +L + +++R++K NI+ G KL+DFG A+ + D
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV 173
Query: 115 TRVMGTYGYCAPE--------YAMTGQLTLKSDVYSFGVVFLELITGR 154
+ GT Y P+ + D++S GV F TG
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
+L ++ LV L D +V E++ G + HL + EP + AA
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----HARFYAA 148
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
EYLH +IYRDLK N+L+D+ + +++DFG AK V +T + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCG 200
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
T APE ++ D ++ GV+ E+ G
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 9e-18
Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
L ++H +V L Y + +L L+ +F+ G L L E +K A
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLA 133
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM- 118
A L++LH +IYRDLK NILLDE H KL+DFGL+K +K
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFC 187
Query: 119 GTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
GT Y APE + + +S D +SFGV+ E++TG
Sbjct: 188 GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 15/148 (10%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEY 67
L ++ + L V E++ G L H+ R AA GL++
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILGLQF 133
Query: 68 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAP 126
LH K ++YRDLK NILLD+ H K++DFG+ K +GD T GT Y AP
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAP 187
Query: 127 EYAMTGQLTLKSDVYSFGVVFLELITGR 154
E + + D +SFGV+ E++ G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 32/174 (18%), Positives = 62/174 (35%), Gaps = 29/174 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
L HS++V A+ D L+ E+ GSL D + + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG-----------LAKLGPVGD 109
+GL Y+H + +++ D+K SNI + P + + K+G +G
Sbjct: 124 VGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 110 KTHVSTR--VMGTYGYCAPE-------YAMTGQLTLKSDVYSFGVVFLELITGR 154
T +S+ G + A E + K+D+++ + +
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAE 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 48/156 (30%), Positives = 66/156 (42%), Gaps = 15/156 (9%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
L + H +V+LI Y +L L+ E++ G L L E A
Sbjct: 75 LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TACFYLA 128
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM- 118
+ L +LH K +IYRDLK NI+L+ H KL+DFGL K T
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFC 182
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y APE M D +S G + +++TG
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 41/179 (22%), Positives = 66/179 (36%), Gaps = 31/179 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA- 59
+ H N++ + E +L+D + E L +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 60 --GAAKGLEYLHDKANPPVIYRDLKSSNILLD-------------EGFHPKLSDFGLAKL 104
A G+ +LH +I+RDLK NIL+ E +SDFGL K
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 105 ---GPVGDKTHVSTRVMGTYGYCAPE-------YAMTGQLTLKSDVYSFGVVFLELITG 153
G +T+++ GT G+ APE +LT D++S G VF +++
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 52/153 (33%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 6 HHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAK 63
L L C RL V E++ G L H+ + KEP AA A
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAI 132
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYG 122
GL +L K +IYRDLK N++LD H K++DFG+ K T T+ GT
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 186
Query: 123 YCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
Y APE + Q KS D ++FGV+ E++ G+
Sbjct: 187 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 52/149 (34%), Positives = 67/149 (44%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEY 67
L L C RL V EF+ G L H+ E R + AA L +
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEIISALMF 139
Query: 68 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAP 126
LHDK +IYRDLK N+LLD H KL+DFG+ K G T T GT Y AP
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAP 193
Query: 127 EYAMTGQLTLKS-DVYSFGVVFLELITGR 154
E + L + D ++ GV+ E++ G
Sbjct: 194 E-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 49/152 (32%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 6 HHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAK 63
L L C RL V E++ G L H+ + KEP AA A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAI 453
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYG 122
GL +L K +IYRDLK N++LD H K++DFG+ K T T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 507
Query: 123 YCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
Y APE D ++FGV+ E++ G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 50/149 (33%), Positives = 66/149 (44%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEY 67
LV L + +L V +++ G L HL EP R + AA A L Y
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGY 154
Query: 68 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAP 126
LH ++YRDLK NILLD H L+DFGL K + T T GT Y AP
Sbjct: 155 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAP 208
Query: 127 EYAMTGQLTLKS-DVYSFGVVFLELITGR 154
E + Q ++ D + G V E++ G
Sbjct: 209 E-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 8e-17
Identities = 57/156 (36%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AA 59
MLS++ H ++ + G D Q ++ +++ G L L K N K AA
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAA 113
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
LEYLH K +IYRDLK NILLD+ H K++DFG AK V D T+ T + G
Sbjct: 114 EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCG 165
Query: 120 TYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 154
T Y APE ++ + KS D +SFG++ E++ G
Sbjct: 166 TPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEY 67
LV L C + RL V E++ G L H+ E + +A + L Y
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNY 125
Query: 68 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAP 126
LH++ +IYRDLK N+LLD H KL+D+G+ K G T T GT Y AP
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAP 179
Query: 127 EYAMTGQLTLKS-DVYSFGVVFLELITGR 154
E + G+ S D ++ GV+ E++ GR
Sbjct: 180 E-ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 47/161 (29%), Positives = 69/161 (42%), Gaps = 22/161 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N++ L D LV EF G L + + + E AA
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE--------CDAAN 150
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
K G+ YLH +++RD+K NILL + + K+ DFGL+ K +
Sbjct: 151 IMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYK 204
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+GT Y APE + + K DV+S GV+ L+ G
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 22/161 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N++ L + D LV E G L D + E AA
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE--------VDAAR 130
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
+ G+ Y+H +++RDLK N+LL + + ++ DFGL+ + +
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKK 184
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+GT Y APE + G K DV+S GV+ L++G
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 48/161 (29%), Positives = 69/161 (42%), Gaps = 22/161 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L LL H N++ L + D LV E G L D + E AA
Sbjct: 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE--------VDAAV 140
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
K G+ YLH +++RDLK N+LL ++ K+ DFGL+ + K
Sbjct: 141 IIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK- 196
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+GT Y APE + + K DV+S GV+ L+ G
Sbjct: 197 --ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 28/164 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H NLVNL+ C + LV+EF+ ++ D L P LD+ K
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP---NGLDYQVVQKYLFQ 132
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTH-VSTRV 117
G+ + H +I+RD+K NIL+ + KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 154
Y APE L + Y V + E+ G
Sbjct: 189 ----WYRAPE------LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 46/235 (19%)
Query: 1 MLSLLHHSNLVNLIG-----YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
+ HH N+ G D +L LV EF GS+ D + + + +W
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--- 130
Query: 55 MKIAA---GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDK 110
IA +GL +LH VI+RD+K N+LL E KL DFG+ A+L +
Sbjct: 131 --IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 111 THVSTRVMGTYGYCAPEYAMTGQLT-----LKSDVYSFGVVFLELITGRKAIDNTRPP-- 163
+ +GT + APE + KSD++S G+ +E+ G PP
Sbjct: 186 RNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-------APPLC 235
Query: 164 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
H + R LF P+ P L+ + + + CL + + RP
Sbjct: 236 DMHPM----RALF----LIPRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRP 279
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEY 67
LV L C + RL V E++ G L H+ E + +A + L Y
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNY 168
Query: 68 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAP 126
LH++ +IYRDLK N+LLD H KL+D+G+ K G T T GT Y AP
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAP 222
Query: 127 EYAMTGQLTLKS-DVYSFGVVFLELITGR 154
E + G+ S D ++ GV+ E++ GR
Sbjct: 223 E-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 45/164 (27%), Positives = 66/164 (40%), Gaps = 28/164 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
ML L H NLVNL+ + LV+E+ ++ L + + I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVKSITWQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTH-VSTRV 117
+ + + H I+RD+K NIL+ + KL DFG A+L GP V+TR
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR- 166
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 154
Y +PE L + Y V VF EL++G
Sbjct: 167 ----WYRSPE------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 47/153 (30%), Positives = 65/153 (42%), Gaps = 14/153 (9%)
Query: 6 HHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAK 63
LV L Y + +L L+ +++ G L HL E ++I
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIYVGEIVL 170
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
LE+LH +IYRD+K NILLD H L+DFGL+K + GT Y
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226
Query: 124 CAPEYAMTGQLTLKSDV--YSFGVVFLELITGR 154
AP+ G V +S GV+ EL+TG
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 51/161 (31%), Positives = 70/161 (43%), Gaps = 26/161 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA- 59
L L H N + G LV E+ GS D L +PL ++IAA
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQ---EVEIAAV 159
Query: 60 --GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR- 116
GA +GL YLH +I+RD+K+ NILL E KL DFG A + ++
Sbjct: 160 THGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPAN 208
Query: 117 -VMGTYGYCAPEYAMTGQLT---LKSDVYSFGVVFLELITG 153
+GT + APE + K DV+S G+ +EL
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 38/162 (23%), Positives = 58/162 (35%), Gaps = 18/162 (11%)
Query: 2 LSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
L + L + A D + LV E+ G L L ++ P + R A
Sbjct: 115 LVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSK-FGERIPAEM-ARF-YLA 169
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
++ +H ++RD+K NILLD H +L+DFG V G
Sbjct: 170 EIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-G 225
Query: 120 TYGYCAPEYAMTGQLTLKSDVY-------SFGVVFLELITGR 154
T Y +PE + Y + GV E+ G+
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 39/161 (24%), Positives = 61/161 (37%), Gaps = 16/161 (9%)
Query: 1 MLSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L + L + A D + LV ++ G L L D+ P + R
Sbjct: 127 VLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM-ARF-YL 181
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A ++ +H ++RD+K NIL+D H +L+DFG S V
Sbjct: 182 AEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV- 237
Query: 119 GTYGYCAPEYAMTGQLTLKS-----DVYSFGVVFLELITGR 154
GT Y +PE + D +S GV E++ G
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 25/165 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRMKIA 58
++ L H N+V L ++ LV+EFM L D + L+ N
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVKYFQ 114
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTR 116
+GL + H+ +++RDLK N+L+++ KL DFGLA+ PV +
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---E 168
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 154
V+ T Y AP+ + + S YS + + E+ITG+
Sbjct: 169 VV-TLWYRAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 26/166 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N+V L + LV+EF L+ + LD
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVM 118
KGL + H + V++RDLK N+L++ KL++FGLA+ PV + V+
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV 163
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGRKAI 157
T Y P+ + + +YS + +F EL + +
Sbjct: 164 -TLWYRPPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 19/161 (11%)
Query: 1 MLSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI- 57
+++ + +V L + A D +V E+MP G L + + + +
Sbjct: 122 IMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVP-EKWARFY 173
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
A L+ +H I+RD+K N+LLD+ H KL+DFG T V
Sbjct: 174 TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 118 MGTYGYCAPE----YAMTGQLTLKSDVYSFGVVFLELITGR 154
GT Y +PE G + D +S GV E++ G
Sbjct: 231 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 19/164 (11%)
Query: 1 MLSLLHHSNLVNLIGY-----CADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
++ ++ H N+V+L + + L LV E++P ++ K+ +
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLI 143
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK-LGPVGDKTH 112
+ L Y+H + +RD+K N+LLD KL DFG AK L
Sbjct: 144 KLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 113 -VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
+ +R Y Y APE T D++S G V EL+ G+
Sbjct: 201 YICSR----Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 47/166 (28%), Positives = 70/166 (42%), Gaps = 20/166 (12%)
Query: 1 MLSLLHHSNLVNLI------GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNT 53
L++LHH N+V L G D L +V E++P +L + +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 54 RMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK-LGPVGDK 110
+ + LH N V +RD+K N+L++E KL DFG AK L P
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 111 TH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
+ +R Y Y APE Q T D++S G +F E++ G
Sbjct: 189 VAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 46/160 (28%), Positives = 66/160 (41%), Gaps = 22/160 (13%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H N++ L D +V E G L D + E AA
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------HDAARI 126
Query: 62 AK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVS 114
K G+ Y+H +++RDLK NILL ++ K+ DFGL+ +
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKM 180
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+GT Y APE + G K DV+S GV+ L++G
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 8e-15
Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 26/163 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L LHH N+V+LI LV+EFM L+ L + L +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQ 127
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVM 118
+G+ + H +++RDLK N+L++ KL+DFGLA+ PV TH V+
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV 181
Query: 119 GTYGYCAPEYAMTGQLTLKS-------DVYSFGVVFLELITGR 154
T Y AP+ + + S D++S G +F E+ITG+
Sbjct: 182 -TLWYRAPD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 46/197 (23%), Positives = 68/197 (34%), Gaps = 47/197 (23%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ LHH N+ L D LV E G L D L+ D +K
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 61 -----------------------------AAK-------GLEYLHDKANPPVIYRDLKSS 84
+ L YLH++ + +RD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPE 197
Query: 85 NILL--DEGFHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPE--YAMTGQLTLK 137
N L ++ F KL DFGL+K G+ ++T+ GT + APE K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPK 256
Query: 138 SDVYSFGVVFLELITGR 154
D +S GV+ L+ G
Sbjct: 257 CDAWSAGVLLHLLLMGA 273
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 1e-14
Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 26/163 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L HSN+V L + +LV+E + L+ L L+ T
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQ 108
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVM 118
G+ Y HD+ V++RDLK N+L++ K++DFGLA+ PV TH ++
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV 162
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 154
T Y AP+ + + S YS + +F E++ G
Sbjct: 163 -TLWYRAPD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 37/126 (29%), Positives = 56/126 (44%), Gaps = 3/126 (2%)
Query: 27 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 86
E L +E+ K+ L + + AKG+E+L + I+RDL + NI
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 224
Query: 87 LLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
LL E K+ DFGLA+ + APE T++SDV+SFGV+
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
Query: 147 FLELIT 152
E+ +
Sbjct: 285 LWEIFS 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 32/155 (20%), Positives = 60/155 (38%), Gaps = 23/155 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK--EPLDWNTRMKIA 58
+ ++NL + + +L+ E+ G + + E
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDV 133
Query: 59 AGAAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKT 111
K G+ YLH +++ DLK NILL K+ DFG+++ +G
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHAC 188
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
+ + GT Y APE +T +D+++ G++
Sbjct: 189 ELREIM-GTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 26/162 (16%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H+N+V L LV+E++ L+ +L D ++ +
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG---NIINMHNVKLFLFQL 109
Query: 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVMG 119
+GL Y H + V++RDLK N+L++E KL+DFGLA+ P + V+
Sbjct: 110 LRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV- 162
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 154
T Y P+ + L S YS + +F E+ TGR
Sbjct: 163 TLWYRPPD------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 19/164 (11%)
Query: 1 MLSLLHHSNLVNLIGY-CADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
++ L H N+V L + + G+++ LV +++P ++ K+ L
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYV 158
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK-LGPVGDKTH 112
+ L Y+H + +RD+K N+LLD KL DFG AK L
Sbjct: 159 KLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 113 -VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
+ +R Y Y APE T DV+S G V EL+ G+
Sbjct: 216 YICSR----Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 45/167 (26%), Positives = 69/167 (41%), Gaps = 30/167 (17%)
Query: 1 MLSLLHHSNLVNLI----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM 55
L H N+V L D + +L LV+E + DL LD
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEP 115
Query: 56 KIAAGAAK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 107
+ K GL++LH V++RDLK NIL+ KL+DFGLA+
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IY 170
Query: 108 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ +++ V+ T Y APE + D++S G +F E+ +
Sbjct: 171 SFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 37/161 (22%), Positives = 59/161 (36%), Gaps = 34/161 (21%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM----- 55
+ + H N++ L LV++ M G L D+ T
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLSE 123
Query: 56 KIAAGAAK----GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 111
K + + LH +++RDLK NILLD+ + KL+DFG + +
Sbjct: 124 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGE 178
Query: 112 HVSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVV 146
+ GT Y APE + D++S GV+
Sbjct: 179 KLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 50/210 (23%), Positives = 82/210 (39%), Gaps = 44/210 (20%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L+H ++ + + D + +V E M G L D + KE
Sbjct: 193 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE--------ATCKL 243
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
++YLH+ +I+RDLK N+LL +E K++DFG +K+ +G+ + +
Sbjct: 244 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLM 298
Query: 114 STRVMGTYGYCAPE---YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA 170
T GT Y APE T D +S GV+ ++G PP
Sbjct: 299 RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-------YPP------- 343
Query: 171 WARPLFKDRRKFPKMADPLLQGRYPMRGLY 200
F + R + D + G+Y
Sbjct: 344 -----FSEHRTQVSLKDQITSGKYNFIPEV 368
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 2 LSLLHHSNLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
L L H N+V L + + D +V+E + G + + P +PL +
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQ 144
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
KG+EYLH + +I+RD+K SN+L+ E H K++DFG++ D +S V G
Sbjct: 145 DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTV-G 199
Query: 120 TYGYCAPEYAMTGQLTL----KSDVYSFGVVFLELITGR 154
T + APE +++ + DV++ GV + G+
Sbjct: 200 TPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 51/171 (29%), Positives = 71/171 (41%), Gaps = 44/171 (25%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H N++ L+ LV++FM DL + + + + +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFME--------TDL---EVIIK-DNSLVLTPSH 113
Query: 62 AK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKT 111
K GLEYLH +++RDLK +N+LLDE KL+DFGLAK P T
Sbjct: 114 IKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 112 H-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 154
H V TR Y APE L + +Y GV + EL+
Sbjct: 171 HQVVTR-----WYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 43/153 (28%), Positives = 61/153 (39%), Gaps = 18/153 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N++ + D +V E G L + + + L A
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS----EGYVAE 128
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
K L Y H + V+++DLK NIL K+ DFGLA+L H
Sbjct: 129 LMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHS 183
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
+ GT Y APE +T K D++S GVV
Sbjct: 184 TNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVV 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 7e-14
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 30/167 (17%)
Query: 1 MLSLLHHSNLVNLI----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM 55
L H N+V L+ D + ++ LV+E + DL + LD
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPP 115
Query: 56 KIAAGAAK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 107
+ A K GL++LH +++RDLK NIL+ G KL+DFGLA+
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IY 170
Query: 108 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ ++ V+ T Y APE + D++S G +F E+ +
Sbjct: 171 SYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 1 MLSLLHHSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
++ ++H N+++L+ + LV E M + +L + + LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERM 166
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--H 112
+ G+++LH A +I+RDLK SNI++ K+ DFGLA+ +
Sbjct: 167 SYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
V TR Y APE + D++S G + E++ +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 25/163 (15%)
Query: 1 MLSLLHHSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
++ ++H N++ L+ + +V E M + +L + + LD + R
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVI--QMELD-HER 128
Query: 55 MK-IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKT- 111
M + G+++LH A +I+RDLK SNI++ K+ DFGLA G T
Sbjct: 129 MSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+V TR Y APE + D++S G + E+I G
Sbjct: 186 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 40/173 (23%), Positives = 68/173 (39%), Gaps = 44/173 (25%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H N++ L + L++E+ +DL K+ +D N + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIK 135
Query: 62 A------KGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-----KLSDFGLAKL--GPVG 108
+ G+ + H + ++RDLK N+LL K+ DFGLA+ P+
Sbjct: 136 SFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192
Query: 109 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 154
TH ++ T Y PE + L S YS V ++ E++
Sbjct: 193 QFTH---EII-TLWYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 22/163 (13%)
Query: 2 LSLLHHSNLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
L L H N++ L + Y + + +V E+ G E + D P+K R +
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQ 110
Query: 60 GAAK------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV 113
GLEYLH + ++++D+K N+LL G K+S G+A+
Sbjct: 111 AHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 114 STRVMGTYGYCAPEYAMTGQL--TLKSDVYSFGVVFLELITGR 154
G+ + PE A K D++S GV + TG
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 37/213 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ H N++ LI + + D+ LV+E M GS+ H+H E A+
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE--------LEASV 115
Query: 61 A----AKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAK-LGPVGDKTH 112
A L++LH+K + +RDLK NIL ++ K+ DF L + GD +
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 113 VSTRVM----GTYGYCAPEYAMTGQLTLKS-----DVYSFGVVFLELITGRKAIDNTRPP 163
+ST + G+ Y APE D++S GV+ L++G PP
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG-------YPP 225
Query: 164 --GEHNLVAWARPLFKDRRKFPKMADPLLQGRY 194
G + + + +G+Y
Sbjct: 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 43/159 (27%), Positives = 66/159 (41%), Gaps = 20/159 (12%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS-LEDHLHDLPPDKEPLDWNTRMK---I 57
LS + H+N++ ++ + LV E G L + P EPL +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL---ASYIFRQL 139
Query: 58 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+ + YL K +I+RD+K NI++ E F KL DFG A G +
Sbjct: 140 VSA----VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-- 190
Query: 118 MGTYGYCAPEYAMTGQLTL--KSDVYSFGVVFLELITGR 154
GT YCAPE + G + +++S GV L+
Sbjct: 191 -GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 2 LSLLHHSNLVNLIG-YCADGDQRL-LVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRM-- 55
L L H N+++L + + D+++ L++++ L + +K+P+ M
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP----KLSDFGLAKL--GPVGD 109
+ G+ YLH V++RDLK +NIL+ K++D G A+L P+
Sbjct: 132 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 110 KTHVSTRVMGTYGYCAPEYAMTGQLTLKS-------DVYSFGVVFLELITGR 154
+ V+ T+ Y APE L L + D+++ G +F EL+T
Sbjct: 189 LADLDPVVV-TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 22/153 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L + H N++ L + +L+ E + G L D L +KE L T + A
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESL---TEDE-ATQF 113
Query: 62 AK----GLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHV 113
K G+ YLH K + + DLK NI+L KL DFG+A +
Sbjct: 114 LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEF 168
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
GT + APE L L++D++S GV+
Sbjct: 169 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 46/152 (30%), Positives = 64/152 (42%), Gaps = 22/152 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H N++ L D +V E G L D + E AA
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------HDAARI 126
Query: 62 AK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVS 114
K G+ Y+H +++RDLK NILL ++ K+ DFGL+ T +
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK 181
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
R+ GT Y APE + G K DV+S GV+
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 20/153 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ H N+V L D LV E + G L + + E A+
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE--------TEASY 110
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
+ + ++HD V++RDLK N+L ++ K+ DFG A+L P ++ +
Sbjct: 111 IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
T T Y APE D++S GV+
Sbjct: 167 KTPC-FTLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 36/165 (21%), Positives = 59/165 (35%), Gaps = 42/165 (25%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ + H +++ LI LV++ M G L D+L
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-----------------TEKV 195
Query: 61 ------AAK-------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 107
+ +LH +++RDLK NILLD+ +LSDFG + +
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--L 250
Query: 108 GDKTHVSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVV 146
+ GT GY APE + D+++ GV+
Sbjct: 251 EPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 25/152 (16%), Positives = 59/152 (38%), Gaps = 23/152 (15%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIAA 59
L++ H N+++L ++ ++++EF+ + + + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---------NTSAFELNEREIV 105
Query: 60 GAAK----GLEYLHDKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTHV 113
L++LH + + D++ NI+ K+ +FG A+ GD +
Sbjct: 106 SYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 145
+ Y APE ++ +D++S G
Sbjct: 163 ---LFTAPEYYAPEVHQHDVVSTATDMWSLGT 191
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 22/154 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + H N++ L + +L+ E + G L D L KE L + A
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATS 119
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTH 112
K G+ YLH K + + DLK NI+L H KL DFGLA G +
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
+ GT + APE L L++D++S GV+
Sbjct: 177 N---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 32/166 (19%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
+L+H N+V G+ +G+ + L E+ G L D + + M A
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD-A 107
Query: 62 AK-------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ G+ YLH + +RD+K N+LLDE + K+SDFGLA + ++ +
Sbjct: 108 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 115 TRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGR 154
++ GT Y APE + + DV+S G+V ++ G
Sbjct: 165 NKMCGTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 42/154 (27%), Positives = 61/154 (39%), Gaps = 21/154 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L H N++ L DG +V E M G L D + E + A+
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE--------REASA 120
Query: 61 A----AKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHP-KLSDFGLAKLGPVGDKTH 112
K +EYLH + V++RDLK SNIL ++ DFG AK +
Sbjct: 121 VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL- 176
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
+ T T + APE D++S GV+
Sbjct: 177 LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 22/153 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + H N+V L LV + + G L D + + E K A+
Sbjct: 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTE--------KDASL 110
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
+ ++YLH+ +++RDLK N+L +E ++DFGL+K+ ++ +
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGI 163
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
+ GT GY APE + D +S GV+
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 46/153 (30%), Positives = 65/153 (42%), Gaps = 22/153 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L + H N++ L + +L+ E + G L D L KE L + A
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSF 120
Query: 62 AK----GLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHV 113
K G+ YLH K + + DLK NI+L H KL DFGLA + D
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
GT + APE L L++D++S GV+
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 33/157 (21%), Positives = 59/157 (37%), Gaps = 24/157 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
++V ++ + L++ E M G L + + + + R
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE----RGDQAFTERE- 129
Query: 57 IAAGA----AKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGD 109
AA +++LH + +RD+K N+L ++ KL+DFG AK
Sbjct: 130 -AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 110 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
+ T T Y APE + D++S GV+
Sbjct: 186 ---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 33/165 (20%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
+ +L+H N+V L L+ E+ G + D+L + RMK
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----------HGRMKEKEAR 117
Query: 62 AK------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
+K ++Y H K +++RDLK+ N+LLD + K++DFG + VG K
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC 174
Query: 116 RVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGR 154
G Y APE Y G + DV+S GV+ L++G
Sbjct: 175 ---GAPPYAAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGS 211
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 35/154 (22%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIA 58
+++ LHH L+NL D + +L+ EF+ G L D + + +M
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---------AAEDYKMSEAEV 151
Query: 59 AGAAK----GLEYLHDKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTH 112
+ GL+++H+ + +++ D+K NI+ + K+ DFGLA +
Sbjct: 152 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEI 206
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
V T + APE + +D+++ GV+
Sbjct: 207 VKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 23/153 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIA 58
+S+L H LVNL D ++ +++YEFM G L + + D + +M A
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEA 257
Query: 59 AGAAK----GLEYLHDKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTH 112
+ GL ++H+ ++ DLK NI+ KL DFGL
Sbjct: 258 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 145
V GT + APE A + +D++S GV
Sbjct: 315 V---TTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 24/156 (15%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL----HDLPPDKEPLDWNTRMKI 57
+L H ++V L+ + +V+EFM L + E +
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--------AV 131
Query: 58 AAGAAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDK 110
A+ + L Y HD +I+RD+K +LL + KL FG+A +G+
Sbjct: 132 ASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGES 186
Query: 111 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
V+ +GT + APE DV+ GV+
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 32/166 (19%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
+L+H N+V G+ +G+ + L E+ G L D + + M A
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD-A 107
Query: 62 AK-------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ G+ YLH + +RD+K N+LLDE + K+SDFGLA + ++ +
Sbjct: 108 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 115 TRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGR 154
++ GT Y APE + + DV+S G+V ++ G
Sbjct: 165 NKMCGTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 21/153 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N++ L + LV E + G L D + + E + AA
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE--------RDAAD 152
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
A K + YLH+ +++RDLK N+L K++DFGL+K+ V + +
Sbjct: 153 AVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLM 207
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
T GT GYCAPE + D++S G++
Sbjct: 208 KTVC-GTPGYCAPEILRGCAYGPEVDMWSVGII 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 21/152 (13%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L H N+V L + LV++ + G L + + E A+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHC 110
Query: 62 AK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ + Y H +++R+LK N+LL +G KL+DFGLA V D
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWH 165
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
GT GY +PE + D+++ GV+
Sbjct: 166 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 40/153 (26%), Positives = 61/153 (39%), Gaps = 22/153 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L + H N++ L + +L+ E + G L D L + E + A
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEF 119
Query: 62 AK----GLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHV 113
K G+ YLH + + DLK NI+L K+ DFGLA +
Sbjct: 120 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEF 174
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
GT + APE L L++D++S GV+
Sbjct: 175 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 47/179 (26%), Positives = 70/179 (39%), Gaps = 46/179 (25%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL--------LVYEFMPLGSLEDHLHDLPPDKEPLDWN 52
+L LL H N+VNLI C LV++F HDL L N
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-N 116
Query: 53 TRMKIAAGAAK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104
+K K GL Y+H +++RD+K++N+L+ KL+DFGLA+
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 105 --GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS-------DVYSFGVVFLELITGR 154
+ + T + T Y PE L L D++ G + E+ T
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 41/153 (26%), Positives = 58/153 (37%), Gaps = 22/153 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H N++ L D LV E G L + + +E AA
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE--------SDAAR 110
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
K + Y H V +RDLK N L KL DFGLA +
Sbjct: 111 IMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMM 165
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
T+V GT Y +P+ + G + D +S GV+
Sbjct: 166 RTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVM 196
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 1 MLSLLHHSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
+L + H N++ L+ + D LV FM L L E L +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLM-KHEKLGEDRI 130
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ KGL Y+H A +I+RDLK N+ ++E K+ DFGLA+ +V
Sbjct: 131 QFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 115 TRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
TR Y APE + T D++S G + E+ITG+
Sbjct: 188 TRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 24/162 (14%)
Query: 1 MLSLLHHSNLVNLI-----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
+L + H N++ L+ LV FM + L +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIM--GLKFSEEKI 128
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-V 113
+ KGL+Y+H A V++RDLK N+ ++E K+ DFGLA+ + T V
Sbjct: 129 QYLVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYV 184
Query: 114 STRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
TR Y APE ++ D++S G + E++TG+
Sbjct: 185 VTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 6e-12
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 33/165 (20%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H +++ L + +V E++ G L D++ + R++
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEMEAR 114
Query: 62 AK------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
++Y H V++RDLK N+LLD + K++DFGL+ + G+ S
Sbjct: 115 RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171
Query: 116 RVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGR 154
G+ Y APE YA G + D++S GV+ L+ G
Sbjct: 172 ---GSPNYAAPEVISGRLYA--G---PEVDIWSCGVILYALLCGT 208
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 11/94 (11%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTY 121
+GL+Y+H A+ +I+RDLK SN+ ++E K+ DFGLA+ + T +V+TR
Sbjct: 143 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVATRW---- 194
Query: 122 GYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
Y APE + D++S G + EL+TGR
Sbjct: 195 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 56/210 (26%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED------HLHDLPPDKEPLDWNTR 54
+L L+H ++ + + D + +V E M G L D L KE
Sbjct: 68 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL------KE------- 113
Query: 55 MKIAAGAAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPV 107
++YLH+ +I+RDLK N+LL +E K++DFG +K+ +
Sbjct: 114 -ATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--L 167
Query: 108 GDKTHVSTRVMGTYGYCAPE---YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164
G+ + + T GT Y APE T D +S GV+ ++G PP
Sbjct: 168 GETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-------YPP- 218
Query: 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRY 194
F + R + D + G+Y
Sbjct: 219 -----------FSEHRTQVSLKDQITSGKY 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 21/152 (13%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L H N+V L + LV++ + G L + + E A+
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHC 133
Query: 62 AK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ + Y H +++R+LK N+LL +G KL+DFGLA V D
Sbjct: 134 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWH 188
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
GT GY +PE + D+++ GV+
Sbjct: 189 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 23/153 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIA 58
+++ L H+NL+ L + +LV E++ G L D + +D + +
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---------IDESYNLTELDT 189
Query: 59 AGAAK----GLEYLHDKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTH 112
K G+ ++H +++ DLK NIL + K+ DFGLA+ +K
Sbjct: 190 ILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 145
V GT + APE ++ +D++S GV
Sbjct: 247 V---NFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 32/95 (33%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKT-HVSTRVMGT 120
GL LH+ A V++RDL NILL + + DF LA + +KT +V+ R
Sbjct: 145 LGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW--- 198
Query: 121 YGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154
Y APE M T D++S G V E+ +
Sbjct: 199 --YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 13/134 (9%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84
++ E++P +L L + N + + ++H + +RD+K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQ 170
Query: 85 NILLDEGFHP-KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDV 140
N+L++ + KL DFG AK L P + +R + Y APE + T D+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDL 225
Query: 141 YSFGVVFLELITGR 154
+S G VF ELI G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY 121
+GL+Y+H AN V++RDLK SN+LL+ K+ DFGLA+ P D T T + T
Sbjct: 139 RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 122 GYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
Y APE + + T D++S G + E+++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 37/153 (24%), Positives = 63/153 (41%), Gaps = 20/153 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ LL H N+V L ++ L+++ + G L + + E A+
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE--------ADASH 114
Query: 61 AAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHV 113
+ + + H V++R+LK N+LL +G KL+DFGLA V +
Sbjct: 115 CIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQA 169
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
GT GY +PE D+++ GV+
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVI 202
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLG-PVGDKTH-VSTRVMG 119
K L+Y H +++RD+K N+++D E +L D+GLA+ P + V++R
Sbjct: 141 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 120 TYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGRKAI 157
+ PE + Q+ S D++S G + +I ++
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 34/159 (21%), Positives = 59/159 (37%), Gaps = 27/159 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDK--EPLDWNTR 54
++V ++ + L+V E + G L + D E
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE------- 160
Query: 55 MKIAAGA----AKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPV 107
+ A+ + ++YLH + +RD+K N+L KL+DFG AK
Sbjct: 161 -REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 108 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146
+ ++T T Y APE + D++S GV+
Sbjct: 217 HNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 12/101 (11%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA----KLGPVGDKTHVSTRVM 118
+ ++ LH +N VI+RDLK SN+L++ K+ DFGLA + + M
Sbjct: 123 RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 119 GTY----GYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
+ Y APE +T + DV+S G + EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 123
+EY H +++RDLK N+LLD+ + K++DFGL+ + G+ S G+ Y
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 173
Query: 124 CAPEYAMTGQL--TLKSDVYSFGVVFLELITGR 154
APE + G+L + DV+S G+V ++ GR
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 19/99 (19%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLDEGFHP--KLSDFGLAKLGPVGDKTHVSTRVMGTY 121
G+ Y H + +RDLK N LLD P K+ DFG +K + + + V GT
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTP 181
Query: 122 GYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGR 154
Y APE Y G+ +DV+S GV ++ G
Sbjct: 182 AYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGT 120
+GL+Y+H AN V++RDLK +N+ ++ E K+ DFGLA+ + P + + T
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 121 YGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
Y +P ++ T D+++ G +F E++TG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 33/165 (20%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 61
L L H +++ L + +V E++ G L D++ N R+
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----------NGRLDEKESR 119
Query: 62 AK------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 115
G++Y H V++RDLK N+LLD + K++DFGL+ + G+ S
Sbjct: 120 RLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176
Query: 116 RVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGR 154
G+ Y APE YA G + D++S GV+ L+ G
Sbjct: 177 ---GSPNYAAPEVISGRLYA--G---PEVDIWSSGVILYALLCGT 213
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 35/160 (21%), Positives = 58/160 (36%), Gaps = 32/160 (20%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
G ++H+ + +I+RDLK +N LL++ K+ DFGLA+ T++ +
Sbjct: 140 LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 123 YCAPEYAMTGQLT--------------LKS-------DVYSFGVVFLELITGRKAIDNTR 161
+ QLT L D++S G +F EL+ ++ N
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQ 201
PLF FP D + + Q
Sbjct: 257 TNR--------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQ 288
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 36/158 (22%), Positives = 65/158 (41%), Gaps = 16/158 (10%)
Query: 2 LSLLHHS--NLVNLIGYCADGDQRLLVYEF-MPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
L + ++ L+ + D +L+ E P+ L D + + +E L R
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---AR-SFF 155
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
+ + + H+ V++RD+K NIL+D KL DFG L T +
Sbjct: 156 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD 209
Query: 118 MGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGR 154
GT Y PE+ + + V+S G++ +++ G
Sbjct: 210 -GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 11/94 (11%)
Query: 64 GLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGD-KTHVSTRVMGTY 121
+++ H + V++RD+K NIL+D KL DFG L GT
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-----GTR 202
Query: 122 GYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGR 154
Y PE+ Q L + V+S G++ +++ G
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 28/112 (25%), Positives = 49/112 (43%), Gaps = 23/112 (20%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
K ++YLH +++RD+K SNILL+ H K++DFGL++ + + +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 123 -------------------YCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
Y APE + T D++S G + E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 32/141 (22%), Positives = 52/141 (36%), Gaps = 37/141 (26%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 122
G++Y+H A +++RDLK +N L+++ K+ DFGLA+ + + +
Sbjct: 167 VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 123 -------------------------YCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKA 156
Y APE + + T DV+S G +F EL+ K
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 157 IDNTRPPGEHNLVAWARPLFK 177
PLF
Sbjct: 284 NVAYHADR--------GPLFP 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 63 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHP------KLSDFGLAKLGPVGDKTHVSTR 116
GL+Y+H + +I+ D+K N+L++ P K++D G A + TR
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
Y +PE + +D++S + ELITG
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 16/150 (10%), Positives = 34/150 (22%), Gaps = 38/150 (25%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 64
+ + ++ L+V E++ GSL++ P ++ A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG------AIRAMQSLAAA 141
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+ H V S + + L+
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TM 176
Query: 125 APEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ D+ G L+ R
Sbjct: 177 PDA-------NPQDDIRGIGASLYALLVNR 199
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 7e-07
Identities = 24/137 (17%), Positives = 36/137 (26%), Gaps = 19/137 (13%)
Query: 19 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78
DQ +V EF G + + + T I L +
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR--FEH 185
Query: 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV------STRVMGTYGYC------AP 126
RDL N+LL + KL K + + + G
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 127 EYAMTGQLTLKSDVYSF 143
E TG + D+Y
Sbjct: 246 EDLFTGDGDYQFDIYRL 262
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 37/180 (20%), Positives = 54/180 (30%), Gaps = 61/180 (33%)
Query: 25 LVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83
+V+E LG L + PL KI +GL+YLH K +I+ D+K
Sbjct: 122 MVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 84 SNILL-------------------------------------------------DEGFHP 94
NILL E
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 95 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
K++D G A + TR Y + E + +D++S + EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 14/98 (14%)
Query: 12 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 70
+ + G +V E LG SLED L DL L T + IA +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 71 KANPPVIYRDLKSSNILLDEGFHPK-----LSDFGLAK 103
K +IYRD+K N L+ + + DF LAK
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 45/153 (29%), Positives = 65/153 (42%), Gaps = 19/153 (12%)
Query: 12 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 70
+ A+GD ++V E LG SLED L + K L T + +A +EY+H
Sbjct: 69 TIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRKFSL--KTVLLLADQMISRIEYIHS 123
Query: 71 KANPPVIYRDLKSSNILLDEGFHPK---LSDFGLAKL-GPVGDKTHVSTR----VMGTYG 122
K I+RD+K N L+ G + DFGLAK H+ R + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 123 YCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154
Y A G + + + D+ S G V + G
Sbjct: 181 Y-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 21/155 (13%)
Query: 12 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 70
N+ + +G +LV + LG SLED L DL K + T A ++ +H+
Sbjct: 70 NVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCGRKFSV--KTVAMAAKQMLARVQSIHE 124
Query: 71 KANPPVIYRDLKSSNILLDEGFHPK-----LSDFGLAKL-GPVGDKTHVSTR----VMGT 120
K+ ++YRD+K N L+ + DFG+ K K H+ R + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 121 YGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154
Y G + + + D+ + G VF+ + G
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 24/116 (20%), Positives = 42/116 (36%), Gaps = 24/116 (20%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDK--EPLDWNTR 54
++V ++ + L+V E + G L + D E
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE------- 116
Query: 55 MKIAAGA----AKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAK 103
+ A+ + ++YLH + +RD+K N+L KL+DFG AK
Sbjct: 117 -REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 24/106 (22%), Positives = 43/106 (40%), Gaps = 11/106 (10%)
Query: 2 LSLLHHSNLVNLIGY-CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAA 59
L + +G+ R LV LG SL+ L P K L + +++A
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSP--KHVLSERSVLQVAC 166
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK--LSDFGLAK 103
LE+LH+ ++ ++ + NI +D + L+ +G A
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 12 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 70
N+ + +GD +LV + LG SLED L + K L T + +A +E++H
Sbjct: 67 NVRWFGVEGDYNVLVMDL--LGPSLED-LFNFCSRKLSL--KTVLMLADQMINRVEFVHS 121
Query: 71 KANPPVIYRDLKSSNILLDEGFHPK---LSDFGLAKL-GPVGDKTHVSTR----VMGTYG 122
K+ ++RD+K N L+ G + DFGLAK H+ R + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 123 YCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154
Y A G + + + D+ S G V + + G
Sbjct: 179 Y-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 14/103 (13%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP--KLSDFGLAKLGPVGDK--T 111
K A + L+ LH +I+ DLK NILL + K+ DFG + + T
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYT 258
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
++ +R Y APE + + + D++S G + EL+TG
Sbjct: 259 YIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 5/41 (12%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPK--LSDFGLAK 103
LEY+H+ ++ D+K++N+LL + L+D+GL+
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 15/41 (36%), Positives = 25/41 (60%), Gaps = 5/41 (12%)
Query: 65 LEYLHDKANPPVIYRDLKSSNILLDEGFHPK--LSDFGLAK 103
LEY+H+ ++ D+K+SN+LL+ + L D+GLA
Sbjct: 165 LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 12/103 (11%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP--KLSDFGLAKLGPVGDK--T 111
K A L +L +I+ DLK NILL K+ DFG + +G +
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQ 217
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
++ +R Y +PE + L D++S G + +E+ TG
Sbjct: 218 YIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.63 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.36 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.01 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.7 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.48 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.52 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.57 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.96 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.14 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.81 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 87.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 87.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 86.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 86.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 84.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.56 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.14 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=363.78 Aligned_cols=213 Identities=28% Similarity=0.462 Sum_probs=166.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+ +.+|||||||++|+|.++|+. ....+++..++.|+.|||.||+|||+++ |||||
T Consensus 85 il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRD 157 (307)
T 3omv_A 85 VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRD 157 (307)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred HHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCc
Confidence 4789999999999999865 568999999999999999976 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC---CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+||||++++.+||+|||+|+...............||+.|||||++.+. .|+.++||||||||+|||+||+.||
T Consensus 158 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp CCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999875433333344557899999999999743 5899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
....... .+.. ....... .|.+ ...+...+..+.+|+.+||+.||++||||.||++.|+.+..
T Consensus 238 ~~~~~~~---~~~~---~~~~~~~-----~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 238 SHINNRD---QIIF---MVGRGYA-----SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TTCCCHH---HHHH---HHHTTCC-----CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCChHH---HHHH---HHhcCCC-----CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 7543221 1111 1111111 1111 11233455788899999999999999999999999988753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=364.47 Aligned_cols=213 Identities=27% Similarity=0.414 Sum_probs=175.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---------PDKEPLDWNTRMKIAAGAAKGLEYLHDK 71 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~aL~~LH~~ 71 (380)
+|++|+|||||+++++|.+++..|||||||++|+|.++|+... .....|++..++.|+.||+.||+|||++
T Consensus 68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4789999999999999999999999999999999999997631 2245799999999999999999999999
Q ss_pred CCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHH
Q 016913 72 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 72 ~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ell 151 (380)
+ ||||||||+||||++++.+||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+
T Consensus 148 ~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 148 H---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9 9999999999999999999999999998654333333334467999999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 152 T-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 152 t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
| |+.||...... .+...+ ... .. ...|...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 225 t~G~~Pf~~~~~~---~~~~~i---~~~-~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 225 TYGKQPWYQLSNN---EVIECI---TQG-RV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp TTTCCTTTTSCHH---HHHHHH---HHT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHH---HHHHHH---HcC-CC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 8 89999754321 112111 111 10 012334456888999999999999999999999999987
Q ss_pred hhc
Q 016913 231 ASQ 233 (380)
Q Consensus 231 ~~~ 233 (380)
...
T Consensus 288 ~~~ 290 (299)
T 4asz_A 288 AKA 290 (299)
T ss_dssp HHH
T ss_pred Hhc
Confidence 653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=365.10 Aligned_cols=212 Identities=29% Similarity=0.468 Sum_probs=167.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHh
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-----------DKEPLDWNTRMKIAAGAAKGLEYLH 69 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH 69 (380)
+|++|+|||||+++++|.+++..|||||||++|+|.++++.... ...+|++.+++.|+.||+.||.|||
T Consensus 96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 47899999999999999999999999999999999999986322 2356999999999999999999999
Q ss_pred hCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHH
Q 016913 70 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 70 ~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~e 149 (380)
+.+ ||||||||+||||++++.+||+|||+++...............||+.|||||++.+..|+.++||||||||+||
T Consensus 176 ~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 176 GLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 999 99999999999999999999999999987544443344456789999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 150 LIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 150 llt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
|+| |+.||...... .++..+ .. ... ...|...+..+.+|+.+||+.||++|||+.||++.|+
T Consensus 253 llt~G~~Pf~~~~~~---~~~~~i---~~-g~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 253 IFTYGKQPWYQLSNT---EAIDCI---TQ-GRE----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp HHTTSCCTTCSSCHH---HHHHHH---HH-TCC----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred HHcCCCCCCCCCCHH---HHHHHH---Hc-CCC----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 998 89999754321 112111 11 111 1123344567889999999999999999999999999
Q ss_pred Hhhh
Q 016913 229 YLAS 232 (380)
Q Consensus 229 ~~~~ 232 (380)
.+..
T Consensus 316 ~l~~ 319 (329)
T 4aoj_A 316 ALAQ 319 (329)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 8864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=358.30 Aligned_cols=212 Identities=20% Similarity=0.202 Sum_probs=172.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.|+|||||+++++|.+++.+|||||||+||+|.++|.. ...|++..+..++.||+.||+|||+++ |||||
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 175 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGD 175 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 57899999999999999999999999999999999999986 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-CeEEeecCCcccCCCCCCcc---ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 81 LKSSNILLDEGF-HPKLSDFGLAKLGPVGDKTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 81 Ikp~NILl~~~~-~~kL~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||+||||+.++ .+||+|||+++......... .....+||+.|||||++.+..|+.++||||||||+|||++|..|
T Consensus 176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 255 (336)
T 4g3f_A 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255 (336)
T ss_dssp CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999999887 69999999998754322111 12346799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhcc
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 234 (380)
|...........+. .....+. ..+...+..+.+|+.+||+.||++|||+.||++.|.......
T Consensus 256 f~~~~~~~~~~~i~------~~~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 256 WTQYFRGPLCLKIA------SEPPPIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp STTTCCSCCHHHHH------HSCCGGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHH------cCCCCch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 98654433222111 1111000 122334567889999999999999999999999998765543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=364.23 Aligned_cols=210 Identities=25% Similarity=0.395 Sum_probs=174.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
+|++|+|||||+++|+|.+++..+||||||++|+|.++|..... ....|++..++.|+.|||.||+||
T Consensus 82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999975321 135699999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+++ ||||||||+||||++++.+||+|||+++...............||+.|||||++.+..|+.++||||||||+|
T Consensus 162 H~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 162 SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 9999 9999999999999999999999999998654333333445578999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||+| |..||...... .+...+. .+.. .+.|..++..+.+|+.+||+.||++||||.||++.|
T Consensus 239 El~t~g~~Pf~~~~~~---~~~~~i~----~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 239 EVFSYGLQPYCGYSNQ---DVVEMIR----NRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHTTTCCTTTTCCHH---HHHHHHH----TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH---HHHHHHH----cCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 89999754321 2222211 1111 112344567889999999999999999999999999
Q ss_pred HHh
Q 016913 228 TYL 230 (380)
Q Consensus 228 ~~~ 230 (380)
+++
T Consensus 302 ~a~ 304 (308)
T 4gt4_A 302 RAW 304 (308)
T ss_dssp HTS
T ss_pred Hhc
Confidence 864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=360.47 Aligned_cols=202 Identities=20% Similarity=0.340 Sum_probs=166.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++|+|||||+++++|.+++.+|||||||+||+|.++|.. .....+++..+..|+.||+.||+|||+++ |||||
T Consensus 76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 150 (350)
T 4b9d_A 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRD 150 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETT
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 46789999999999999999999999999999999999976 23456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++.... ........+||+.|||||++.+..|+.++||||||||+|||++|..||...
T Consensus 151 lKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 151 IKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp CCGGGEEECTTCCEEECSTTEESCCCH--HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCHHHEEECCCCCEEEcccccceeecC--CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999986321 112234567999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. ......+... .++ ..+...+..+.+|+.+||+.||++|||+.||++.
T Consensus 229 ~~------~~~~~~i~~~--~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 229 SM------KNLVLKIISG--SFP---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp SH------HHHHHHHHHT--CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CH------HHHHHHHHcC--CCC---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22 1111111111 111 1122345678899999999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=351.18 Aligned_cols=200 Identities=25% Similarity=0.324 Sum_probs=169.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++|+|||||+++++|.+++.+|||||||+||+|.+++.. .+.+++..+..++.||+.||+|||+++ |||||
T Consensus 85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRD 157 (311)
T 4aw0_A 85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRD 157 (311)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 47889999999999999999999999999999999999986 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||++|..||...
T Consensus 158 lKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998764443334445678999999999999999999999999999999999999999753
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.. ......+......+ |......+.+|+.+||+.||++|||+.|++.
T Consensus 238 ~~------~~~~~~i~~~~~~~------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 238 NE------GLIFAKIIKLEYDF------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp SH------HHHHHHHHHTCCCC------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CH------HHHHHHHHcCCCCC------------CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 22 11112222221112 2233467889999999999999999999754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=354.45 Aligned_cols=200 Identities=24% Similarity=0.333 Sum_probs=166.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++++|||||+++++|.+++.+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||+++ |||||
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 195 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 195 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 46789999999999999999999999999999999999976 56999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++..... .......+||+.|||||++.+..|+.++||||||||+|||++|..||...
T Consensus 196 lKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 196 IKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEECCCCCEEEecCcCceecCCC--CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999999864322 22344578999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... ..... +.... . +.+ ..+......+.+|+.+||+.||++|||+.||++
T Consensus 274 ~~~---~~~~~---i~~~~---~----~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 274 PPL---KAMKM---IRDNL---P----PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHH---HHHHH---HHHSS---C----CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHH---HHHHH---HHcCC---C----CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221 11111 11110 0 000 112234568889999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=344.97 Aligned_cols=222 Identities=25% Similarity=0.295 Sum_probs=166.0
Q ss_pred ccCCCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----
Q 016913 2 LSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA----- 72 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----- 72 (380)
+.+++|||||+++++|.+++ .+|||||||++|+|.++++. ..+++..++.++.|++.||+|||++.
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~ 125 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTC
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccC
Confidence 56789999999999998764 57999999999999999986 56999999999999999999999871
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc--ccccccccccccchhhhhcC------CCCCcCceeehH
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFG 144 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlG 144 (380)
.++||||||||+||||+.++.+||+|||+++......... ......||+.|||||++.+. .++.++||||||
T Consensus 126 ~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp BCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 2339999999999999999999999999998653332211 22346799999999999764 467899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCc--------chhhhhhhcccccCCCCCCCCccccCC-CChhhHHHHHHHHHHhhhhCCC
Q 016913 145 VVFLELITGRKAIDNTRPPGEH--------NLVAWARPLFKDRRKFPKMADPLLQGR-YPMRGLYQALAVAAMCLQEQAA 215 (380)
Q Consensus 145 vvl~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~ 215 (380)
||+|||+||..||......... ........... .....|.+... .+.+.+..+.+|+.+||+.||+
T Consensus 206 vvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~ 280 (303)
T 3hmm_A 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGG
T ss_pred HHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHh-----cccCCCCCCccccchHHHHHHHHHHHHHcccCHh
Confidence 9999999998877543221100 00000000000 01111222111 1234567889999999999999
Q ss_pred CCCCHHHHHHHHHHhhhc
Q 016913 216 TRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 216 ~RPt~~evl~~L~~~~~~ 233 (380)
+||||.||++.|+.+..+
T Consensus 281 ~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 281 ARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GSCCHHHHHHHHHHHHHC
T ss_pred HCcCHHHHHHHHHHHHHH
Confidence 999999999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=344.31 Aligned_cols=198 Identities=28% Similarity=0.328 Sum_probs=163.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++.+|||||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |||||
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 151 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRD 151 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 57899999999999999999999999999999999999986 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||+|+..... ........||+.|||||++.+..|+.++|||||||++|||++|..||...
T Consensus 152 lKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 152 LKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp CCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHeEEcCCCCEEecccccceeccCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999863322 12234568999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI-----GDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 225 (380)
... .....+......+ |...+..+.+|+.+||+.||++|||+ +||++
T Consensus 230 ~~~------~~~~~i~~~~~~~------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 230 DRK------ETMTMILKAKLGM------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp SHH------HHHHHHHHCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CHH------HHHHHHHcCCCCC------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 221 1111222221112 22334678899999999999999985 56653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=344.48 Aligned_cols=200 Identities=26% Similarity=0.396 Sum_probs=159.2
Q ss_pred CccCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
+|++|+|||||+++++|.+ ++.+|||||||+||+|.+++.. ...+++..+..|+.||+.||+|||+++ ++|
T Consensus 78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~I 152 (290)
T 3fpq_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 152 (290)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCE
Confidence 4678999999999999865 3457999999999999999986 567999999999999999999999985 459
Q ss_pred EecCCCCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 77 IYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||||||+||||+. ++.+||+|||+|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||..
T Consensus 153 iHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~ 227 (290)
T 3fpq_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp CCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999974 78999999999986322 22345689999999998865 69999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
||...... ..+.. .+... . .+ +.+ +...+..+.+|+.+||+.||++|||+.||++
T Consensus 228 Pf~~~~~~--~~~~~---~i~~~-~-~~----~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 228 PYSECQNA--AQIYR---RVTSG-V-KP----ASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTTCSSH--HHHHH---HHTTT-C-CC----GGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCcH--HHHHH---HHHcC-C-CC----CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99643221 11111 11111 0 00 111 1122356889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=353.56 Aligned_cols=200 Identities=23% Similarity=0.313 Sum_probs=166.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||+.|+|||||+++++|.+++.+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||+++ |||||
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRD 272 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 272 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 46789999999999999999999999999999999999976 56999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+|+.+... .......+||+.|||||++.+..|+.++||||||||+|||++|..||...
T Consensus 273 iKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 273 IKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp CSTTTEEECTTCCEEECCCTTCEECCSS--CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEEcCCCCEEEecCccceECCCC--CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999999864322 22334578999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... .....+ .... .+.+ ..+......+.+|+.+||+.||++|||+.||++
T Consensus 351 ~~~---~~~~~i---~~~~-------~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 351 PPL---KAMKMI---RDNL-------PPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHH---HHHHHH---HHSC-------CCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHH---HHHHHH---HcCC-------CCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 321 111111 1110 0000 111233567889999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=356.13 Aligned_cols=212 Identities=27% Similarity=0.370 Sum_probs=170.9
Q ss_pred ccCCC-CCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHH
Q 016913 2 LSLLH-HSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEY 67 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~ 67 (380)
|++++ |||||+++++|.+. +.+|||||||++|+|.++|+.... .+..|++..++.++.|||.||+|
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 45565 59999999999764 568999999999999999976321 23568999999999999999999
Q ss_pred HhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHH
Q 016913 68 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVF 147 (380)
Q Consensus 68 LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl 147 (380)
||+++ ||||||||+||||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++
T Consensus 201 LH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 201 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99999 999999999999999999999999999875444333344557799999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 148 LELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 148 ~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
|||+| |..||....... .+...+ ..... ...|...+..+.+|+.+||+.||++|||+.||++.
T Consensus 278 ~El~t~G~~Pf~~~~~~~--~~~~~i----~~g~~----------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDE--EFCRRL----KEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHTTTSCCSSTTCCCSH--HHHHHH----HHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHH--HHHHHH----HcCCC----------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99998 899997643321 111111 11111 11223345678899999999999999999999999
Q ss_pred HHHhhh
Q 016913 227 LTYLAS 232 (380)
Q Consensus 227 L~~~~~ 232 (380)
|+.+..
T Consensus 342 L~~llq 347 (353)
T 4ase_A 342 LGNLLQ 347 (353)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 988753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=334.79 Aligned_cols=197 Identities=23% Similarity=0.334 Sum_probs=155.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||++++++.+++.+||||||| +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRD 137 (275)
T 3hyh_A 66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRD 137 (275)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 367899999999999999999999999999 6899999976 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+||||+.++.+||+|||+|+..... .......||+.|+|||++.+..| +.++|||||||++|+|++|..||..
T Consensus 138 iKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 138 LKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp CCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CChHHeEECCCCCEEEeecCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999864322 22345689999999999998876 5799999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
... ......+......+ |...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 215 ~~~------~~~~~~i~~~~~~~------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 215 ESI------PVLFKNISNGVYTL------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SSH------HHHHHHHHHTCCCC------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCH------HHHHHHHHcCCCCC------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 321 11122222221112 12234678899999999999999999999873
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.17 Aligned_cols=202 Identities=23% Similarity=0.314 Sum_probs=148.8
Q ss_pred CccCCCCCCcccceEEEEeCC------------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 1 MLSLLHHSNLVNLIGYCADGD------------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~------------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
+|++|+|||||+++++|.+.+ .+|||||||++|+|.+++.... .....++..++.++.||+.||+||
T Consensus 56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yl 134 (299)
T 4g31_A 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFL 134 (299)
T ss_dssp HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHH
Confidence 478899999999999987654 3699999999999999998621 122356778999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc----------cccccccccccccchhhhhcCCCCCcC
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT----------HVSTRVMGTYGYCAPEYAMTGQLTLKS 138 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~s 138 (380)
|+++ ||||||||+||||+.++.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++
T Consensus 135 H~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~ 211 (299)
T 4g31_A 135 HSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211 (299)
T ss_dssp HHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHH
T ss_pred HHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHH
Confidence 9999 999999999999999999999999999875332211 112345799999999999999999999
Q ss_pred ceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 139 DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 139 DV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
||||||||+|||++ ||... ............ ..++ +. .......+.+|+.+||+.||++||
T Consensus 212 DiwSlGvilyell~---Pf~~~-----~~~~~~~~~~~~--~~~p----~~-----~~~~~~~~~~li~~~L~~dP~~Rp 272 (299)
T 4g31_A 212 DIFSLGLILFELLY---PFSTQ-----MERVRTLTDVRN--LKFP----PL-----FTQKYPCEYVMVQDMLSPSPMERP 272 (299)
T ss_dssp HHHHHHHHHHHHHS---CCSSH-----HHHHHHHHHHHT--TCCC----HH-----HHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHcc---CCCCc-----cHHHHHHHHHhc--CCCC----CC-----CcccCHHHHHHHHHHcCCChhHCc
Confidence 99999999999996 66421 111111111100 0111 11 112334567899999999999999
Q ss_pred CHHHHHH
Q 016913 219 LIGDVVT 225 (380)
Q Consensus 219 t~~evl~ 225 (380)
|+.||++
T Consensus 273 s~~eil~ 279 (299)
T 4g31_A 273 EAINIIE 279 (299)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=313.80 Aligned_cols=228 Identities=42% Similarity=0.714 Sum_probs=194.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|.+.+..++||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+|+|
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~d 164 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRD 164 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCC
Confidence 467899999999999999999999999999999999999764434456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+|||++.++.+||+|||++................||..|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 165 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 99999999999999999999998644333333344566899999999999999999999999999999999999999877
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.+........|...... ...+...+++.+....+......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCCCHHHHTHHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHhhhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 76666666655443322 234556667777777778889999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.34 Aligned_cols=149 Identities=26% Similarity=0.354 Sum_probs=127.8
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.+ +|||||+++++|.+.+.+|||||||++++|.+++. .+++..+..++.||+.||+|||+++ |+|||
T Consensus 73 l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRD 142 (361)
T 4f9c_A 73 LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRD 142 (361)
T ss_dssp HHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCc
Confidence 3444 79999999999999999999999999999999994 3899999999999999999999999 99999
Q ss_pred CCCCcEEEcCC-CCeEEeecCCcccCCCCCCc--------------------------cccccccccccccchhhhhcC-
Q 016913 81 LKSSNILLDEG-FHPKLSDFGLAKLGPVGDKT--------------------------HVSTRVMGTYGYCAPEYAMTG- 132 (380)
Q Consensus 81 Ikp~NILl~~~-~~~kL~DFGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~- 132 (380)
|||+||||+.+ +.+||+|||+|+........ ......+||+.|+|||++.+.
T Consensus 143 iKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 143 VKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred CCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 99999999876 78999999999754322110 111235799999999999875
Q ss_pred CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 133 QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 133 ~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
.|+.++||||+|||+|||++|+.||...
T Consensus 223 ~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 223 NQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 5899999999999999999999999543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=307.07 Aligned_cols=225 Identities=44% Similarity=0.742 Sum_probs=190.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---CCCCeE
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK---ANPPVI 77 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~---~~~~ii 77 (380)
+|+.++||||++++++|...+..++||||+++++|.+++.........+++..++.++.|++.||.|||+. + |+
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---iv 156 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---II 156 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EE
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eE
Confidence 46789999999999999999999999999999999999998655666799999999999999999999999 7 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|+||||+|||++.++.+||+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred eCCCchhhEEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence 99999999999999999999999998653222 22334456999999999999999999999999999999999999999
Q ss_pred CCCC--CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 158 DNTR--PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 158 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
+... .........|....... ..+....+..+...++......+.+++.+||+.+|.+|||+.||++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 236 DLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CHHHHTTTSCSBHHHHHTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred cccccccccchhHHHHHHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 6321 11233444554444332 445666777777788889999999999999999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=321.76 Aligned_cols=216 Identities=22% Similarity=0.287 Sum_probs=159.8
Q ss_pred CccCCCCCCcccceEEEEe------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|+.|+|||||++++++.. .+.+|||||||+ |+|.+++.. ...+++..+..++.||+.||.|||+++
T Consensus 106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~-- 178 (398)
T 4b99_A 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ-- 178 (398)
T ss_dssp HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence 4678999999999999764 357899999995 789999976 568999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC--ccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHH
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK--THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~ell 151 (380)
||||||||+|||++.++.+||+|||+++.+..... .......+||+.|+|||++.+. .++.++||||||||+|||+
T Consensus 179 -iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 179 -VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp -CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred -CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence 99999999999999999999999999986432211 2223457899999999998875 5699999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhhhhcccc--c------------CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 152 TGRKAIDNTRPPGEHNLVAWARPLFKD--R------------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 152 tG~~p~~~~~~~~~~~~~~~~~~~~~~--~------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
+|..||...........+......... . ..++......+. .........+.+|+.+||+.||++|
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R 336 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWE-TVYPGADRQALSLLGRMLRFEPSAR 336 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHH-HhCCCCCHHHHHHHHHHCcCChhHC
Confidence 999999764332211111100000000 0 000000000000 0001234578899999999999999
Q ss_pred CCHHHHHH
Q 016913 218 PLIGDVVT 225 (380)
Q Consensus 218 Pt~~evl~ 225 (380)
||+.|+++
T Consensus 337 ~ta~e~L~ 344 (398)
T 4b99_A 337 ISAAAALR 344 (398)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=335.92 Aligned_cols=198 Identities=26% Similarity=0.290 Sum_probs=164.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++|||||+++++|.+.+.+|||||||+||+|.++|.. ...|++..+..++.||+.||+|||+++ ||||||
T Consensus 246 l~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDL 318 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDL 318 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999986 567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||||+.++.+||+|||+|+.+... .....+||+.|||||++.. ..|+.++||||||||+|||++|..||...
T Consensus 319 KPeNILld~~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 319 KPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred chHHeEEeCCCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999865322 2234689999999999964 57999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 225 (380)
.......+. ......... +|......+.+||.+||+.||.+|++ +.||++
T Consensus 395 ~~~~~~~i~---~~i~~~~~~------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 395 KTKDKHEID---RMTLTMAVE------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp GCCCHHHHH---HHHHHCCCC------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ChHHHHHHH---HhhcCCCCC------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 333222111 111111111 22234567889999999999999998 677764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.64 Aligned_cols=202 Identities=23% Similarity=0.291 Sum_probs=165.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.|+|||||+++++|.+.+.+|||||||+||+|.++|.. ....|++..+..++.||+.||+|||+++ |+|||
T Consensus 207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRD 280 (573)
T 3uto_A 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 280 (573)
T ss_dssp HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 46789999999999999999999999999999999999975 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC--CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDEG--FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~--~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||+||||+.+ +.+||+|||+++.+... ......+||+.|||||++.+..|+.++|||||||++|||++|..||.
T Consensus 281 lKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp CCGGGEEESSSSCCCEEECCCSSCEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CChhhccccCCCCCCEEEeeccceeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999854 78999999999875322 22344679999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... .. ...+......++. + ........+.+||.+||+.||.+|||+.|+++
T Consensus 358 ~~~~~---~~---~~~i~~~~~~~~~---~-----~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 358 GENDD---ET---LRNVKSCDWNMDD---S-----AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSSHH---HH---HHHHHTTCCCCCS---G-----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcCHH---HH---HHHHHhCCCCCCc---c-----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 54321 11 1111111111111 1 11123467889999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=306.88 Aligned_cols=224 Identities=28% Similarity=0.364 Sum_probs=170.8
Q ss_pred CccCCCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----
Q 016913 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK----- 71 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~----- 71 (380)
+|++++|||||++++++.... .+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~ 145 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLK 145 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEET
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 478899999999999998754 46999999999999999976 4599999999999999999999999
Q ss_pred -----CCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-----CCCCcCcee
Q 016913 72 -----ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVY 141 (380)
Q Consensus 72 -----~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~ 141 (380)
+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||
T Consensus 146 ~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 222 (322)
T 3soc_A 146 DGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222 (322)
T ss_dssp TEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHH
T ss_pred cccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhH
Confidence 8 999999999999999999999999999765443333334446799999999999863 566788999
Q ss_pred ehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccc----cCCCCCCCCccccCC-CChhhHHHHHHHHHHhhhhCCCC
Q 016913 142 SFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD----RRKFPKMADPLLQGR-YPMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 142 SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~~ 216 (380)
||||++|||++|..||..................... .........+.+... ........+.+|+.+||+.||++
T Consensus 223 slG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 302 (322)
T 3soc_A 223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302 (322)
T ss_dssp HHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhh
Confidence 9999999999999999765433222111110000000 000000111111111 12245667999999999999999
Q ss_pred CCCHHHHHHHHHHhhh
Q 016913 217 RPLIGDVVTALTYLAS 232 (380)
Q Consensus 217 RPt~~evl~~L~~~~~ 232 (380)
|||+.||++.|+.+..
T Consensus 303 Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 303 RLSAGCVGERITQMQR 318 (322)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.52 Aligned_cols=212 Identities=25% Similarity=0.347 Sum_probs=170.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||++++++|.+++..++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+|+|
T Consensus 60 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~d 133 (310)
T 3s95_A 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRD 133 (310)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 36788999999999999999999999999999999999986 3567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCcc------------ccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|||+|||++.++.+||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|
T Consensus 134 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 213 (310)
T 3s95_A 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213 (310)
T ss_dssp CSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999999998653322111 011457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 149 ELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 149 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
+|++|..||.............. ...+....+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 214 el~~g~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 214 EIIGRVNADPDYLPRTMDFGLNV---------------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp HHHHTCCSSTTTSCBCTTSSBCH---------------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCCCCcchhhhHHHHhhhh---------------hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999875543322111100 000001112223346789999999999999999999999999
Q ss_pred Hhhhc
Q 016913 229 YLASQ 233 (380)
Q Consensus 229 ~~~~~ 233 (380)
.+...
T Consensus 279 ~l~~~ 283 (310)
T 3s95_A 279 TLRMH 283 (310)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 88644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.27 Aligned_cols=213 Identities=25% Similarity=0.398 Sum_probs=172.8
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
|+.+ +|||||+++++|.+.+..|+||||+++++|.+++..... ....+++..++.++.||+.||.||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 899999999999999999999999999999999987321 124589999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+++ |+||||||+||||+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|
T Consensus 220 H~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 220 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred HhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999998654433333334456788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++ |..||...... ....... ... ....+......+.+|+.+||+.+|.+|||+.||++.|
T Consensus 297 ellt~g~~p~~~~~~~---~~~~~~~----~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 297 EIFTLGGSPYPGIPVE---ELFKLLK----EGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp HHHTTSCCSSTTCCGG---GHHHHHH----TTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHH---HHHHHHh----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 99999754321 1111111 100 0112233456788999999999999999999999999
Q ss_pred HHhhhcc
Q 016913 228 TYLASQT 234 (380)
Q Consensus 228 ~~~~~~~ 234 (380)
+.+....
T Consensus 360 ~~il~~~ 366 (370)
T 2psq_A 360 DRILTLT 366 (370)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9886543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.70 Aligned_cols=211 Identities=25% Similarity=0.383 Sum_probs=169.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|.+++..||||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|||
T Consensus 103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 176 (325)
T 3kul_A 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRD 176 (325)
T ss_dssp HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 36788999999999999999999999999999999999975 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||+||||+.++.+||+|||++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 177 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999875432221 12233456788999999999999999999999999999999 999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhcc
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 234 (380)
..... ...... .. .. ....+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+....
T Consensus 257 ~~~~~---~~~~~~---~~-~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 257 NMTNR---DVISSV---EE-GY----------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TSCHH---HHHHHH---HT-TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred cCCHH---HHHHHH---Hc-CC----------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 54221 111111 11 00 01122334568889999999999999999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=300.52 Aligned_cols=213 Identities=32% Similarity=0.467 Sum_probs=162.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Di 165 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNL 165 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTC
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCC
Confidence 567899999999999999999999999999999999998611 1123999999999999999999999985 45999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 166 kp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 166 KSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp CGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999753221 122344679999999999999999999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhcc
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 234 (380)
... ...... ..... ...+......+.+|+.+||+.+|.+|||+.+|++.|+.+....
T Consensus 244 ~~~---~~~~~~-~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 244 PAQ---VVAAVG-FKCKR------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHH---HHHHHH-HSCCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHH---HHHHHH-hcCCC------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 211 111110 00000 1122234467889999999999999999999999999886543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=299.93 Aligned_cols=207 Identities=28% Similarity=0.458 Sum_probs=166.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|.. +..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||
T Consensus 69 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Di 141 (325)
T 3kex_A 69 IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNL 141 (325)
T ss_dssp HHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCcc
Confidence 467899999999999864 568999999999999999976 3457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 142 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 142 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp SSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred chheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999987654444334455678889999999999999999999999999999999 99999865
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
........+... .....+. .....+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 222 ~~~~~~~~~~~~-----~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 222 RLAEVPDLLEKG-----ERLAQPQ------------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CTTHHHHHHHTT-----CBCCCCT------------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHcC-----CCCCCCC------------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 432221111110 0011111 122346689999999999999999999999998854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=302.57 Aligned_cols=207 Identities=25% Similarity=0.405 Sum_probs=167.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||++++++|..+. .++|+||+.+++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Di 143 (327)
T 3poz_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDL 143 (327)
T ss_dssp HHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCC
Confidence 56789999999999998765 7899999999999999987 3567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 144 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp CGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 99999999999999999999987544433333445567889999999999999999999999999999999 99999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ...... ... ....+......+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 224 ~~~~---~~~~~~----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 224 PASE---ISSILE----KGE----------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CGGG---HHHHHH----TTC----------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CHHH---HHHHHH----cCC----------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3321 111111 100 011223345678899999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=298.13 Aligned_cols=212 Identities=25% Similarity=0.405 Sum_probs=172.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHH
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------------------DKEPLDWNTRMKIAAG 60 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~q 60 (380)
+|+.++||||+++++++.+.+..++||||+++++|.+++..... ....+++..++.++.|
T Consensus 79 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 158 (314)
T 2ivs_A 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158 (314)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred HHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence 36788999999999999999999999999999999999987322 1234899999999999
Q ss_pred HHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCce
Q 016913 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDV 140 (380)
Q Consensus 61 ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV 140 (380)
|+.||.|||+++ |+|+||||+|||++.++.+||+|||++................+++.|+|||++.+..++.++||
T Consensus 159 i~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 235 (314)
T 2ivs_A 159 ISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235 (314)
T ss_dssp HHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhH
Confidence 999999999999 99999999999999999999999999986543333233344567889999999999999999999
Q ss_pred eehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 141 YSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 141 ~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
||||+++|+|++ |..||....... ...... ... ....+......+.+|+.+||+.||.+|||
T Consensus 236 ~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 236 WSFGVLLWEIVTLGGNPYPGIPPER---LFNLLK----TGH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHH---HHHHhh----cCC----------cCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999 999997543321 111111 100 01112234567889999999999999999
Q ss_pred HHHHHHHHHHhhh
Q 016913 220 IGDVVTALTYLAS 232 (380)
Q Consensus 220 ~~evl~~L~~~~~ 232 (380)
+.+|++.|+.+..
T Consensus 299 ~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 299 FADISKDLEKMMV 311 (314)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=295.88 Aligned_cols=200 Identities=25% Similarity=0.358 Sum_probs=164.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|..++..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dl 142 (297)
T 3fxz_A 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 142 (297)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCC
Confidence 5678999999999999999999999999999999999976 46999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 143 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997643222 22344679999999999999999999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.... . ........ ... ..+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 221 ~~~~---~---~~~~~~~~--~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 221 PLRA---L---YLIATNGT--PEL-------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHH---H---HHHHHHCS--CCC-------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHH---H---HHHHhCCC--CCC-------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2111 1 01111100 011 1123345678899999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.31 Aligned_cols=209 Identities=25% Similarity=0.374 Sum_probs=168.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|..++..|||||||++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+|||
T Consensus 165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 238 (377)
T 3cbl_A 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238 (377)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcc
Confidence 36789999999999999999999999999999999999976 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||||+.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 239 lkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986332211111122345778999999999999999999999999999998 9999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ...... ..... ...+...+..+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 319 ~~~~---~~~~~~----~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 319 LSNQ---QTREFV----EKGGR----------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp SCHH---HHHHHH----HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHH---HHHHHH----HcCCC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 4321 111111 11110 11222345678899999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=292.28 Aligned_cols=222 Identities=41% Similarity=0.648 Sum_probs=176.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 159 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDI 159 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCC
Confidence 56789999999999999999999999999999999999752 12356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++................|++.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 160 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 160 KSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999999999999986543333333345679999999998865 58999999999999999999999998654
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
..... ..+..........+...+++.+ ...+......+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus 239 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 239 EPQLL--LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SSSBT--THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred chHHH--HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 43221 1111111111111222222222 2345567788999999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.57 Aligned_cols=203 Identities=26% Similarity=0.391 Sum_probs=164.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||||++++++.+++..|+|||||++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dl 131 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDI 131 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 5678999999999999999999999999999999999865 557999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.+||+|||++..+.............||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 132 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred chHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986543333333345679999999999988765 78899999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..... ....+... . ....+ .......+.+|+.+||+.||.+|||+.||++.
T Consensus 212 ~~~~~-~~~~~~~~-----~---~~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 212 SDSCQ-EYSDWKEK-----K---TYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp CTTSH-HHHHHHTT-----C---TTSTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred chHHH-HHHHHhcc-----c---ccCCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 33211 11111110 0 00010 12334678899999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=305.85 Aligned_cols=210 Identities=23% Similarity=0.384 Sum_probs=160.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||++++++|.+.+..+|||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|||
T Consensus 99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 172 (373)
T 2qol_A 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRD 172 (373)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 36788999999999999999999999999999999999986 3457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||+||||+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 173 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp CCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred CCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998653322111 1122345778999999999999999999999999999998 999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
..... ....... .. .....+...+..+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 253 ~~~~~---~~~~~i~----~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 253 EMSNQ---DVIKAVD----EG----------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TCCHH---HHHHHHH----TT----------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCHH---HHHHHHH----cC----------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 54221 1111111 00 01112233456789999999999999999999999999988653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.65 Aligned_cols=217 Identities=26% Similarity=0.394 Sum_probs=175.0
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
|+++ +|||||+++++|..++..++||||+++++|.+++..... ....+++..++.++.||+.||.||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4455 899999999999999999999999999999999987421 124699999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ |+||||||+||||+.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|
T Consensus 208 H~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 208 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp HHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred HhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 9999 9999999999999999999999999998654433333344566788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+|++ |..||...... ....... ... ....+......+.+|+.+||+.+|++|||+.||++.|
T Consensus 285 ellt~g~~p~~~~~~~---~~~~~~~----~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 285 EIFTLGGSPYPGVPVE---ELFKLLK----EGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHTTSCCSSTTCCHH---HHHHHHH----TTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH---HHHHHHH----cCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 99999754221 1111111 100 0011223456788999999999999999999999999
Q ss_pred HHhhhccCCCC
Q 016913 228 TYLASQTYDPN 238 (380)
Q Consensus 228 ~~~~~~~~~~~ 238 (380)
+.+........
T Consensus 348 ~~~~~~~~~~~ 358 (382)
T 3tt0_A 348 DRIVALTSNQE 358 (382)
T ss_dssp HHHHHHSCSCC
T ss_pred HHHHHHHhcCC
Confidence 99876554333
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.31 Aligned_cols=215 Identities=18% Similarity=0.190 Sum_probs=171.2
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+++ +||||+++++++..++..++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+|||
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrD 130 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRD 130 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4566 8999999999999999999999999 8999999986 2467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCC-----eEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhcCCCCCcCceeehHHHHHHH
Q 016913 81 LKSSNILLDEGFH-----PKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 81 Ikp~NILl~~~~~-----~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~el 150 (380)
|||+||||+.++. +||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 131 lkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 131 VKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHH
Confidence 9999999998876 9999999998654332211 12456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
++|..||..............+.. ..... ....+. ...+ .+.+|+..||+.+|.+||++.+|++.|+.+
T Consensus 211 l~g~~Pf~~~~~~~~~~~~~~i~~---~~~~~---~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 211 LRGSLPWQGLKADTLKERYQKIGD---TKRAT---PIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHSSCTTTTCCCSSHHHHHHHHHH---HHHHS---CHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hcCCCCccccccccHHHHHHHHHh---hhccC---CHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 999999987644332222221110 00000 000011 1123 788999999999999999999999999987
Q ss_pred hhcc
Q 016913 231 ASQT 234 (380)
Q Consensus 231 ~~~~ 234 (380)
....
T Consensus 280 ~~~~ 283 (330)
T 2izr_A 280 FDRK 283 (330)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 5443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=296.35 Aligned_cols=197 Identities=22% Similarity=0.344 Sum_probs=163.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDl 140 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDL 140 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCC
Confidence 5678999999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCC-CcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.+||+|||++...... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...
T Consensus 141 kp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 141 KAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp CGGGEEECTTSCEEECSTTCCGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEEcCCCCEEEeeccCceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999764332 223446799999999999988765 7899999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
... .....+...... .|......+.+|+.+||+.||.+|||+.||++.
T Consensus 218 ~~~------~~~~~i~~~~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 218 NLK------ELRERVLRGKYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp SHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CHH------HHHHHHHhCCCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 321 111111111111 122234678899999999999999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=296.60 Aligned_cols=209 Identities=25% Similarity=0.404 Sum_probs=163.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||++++++|..+. .++|+||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|||
T Consensus 70 ~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 142 (327)
T 3lzb_A 70 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRD 142 (327)
T ss_dssp HHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCC
Confidence 367889999999999998765 7899999999999999987 3567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+|||++.++.+||+|||++................+|..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 143 ikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp CCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999987543333333344567889999999999999999999999999999999 9999976
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
..... ...... ... ....+......+.+|+.+||+.+|.+|||+.||++.|+.+...
T Consensus 223 ~~~~~---~~~~~~----~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 223 IPASE---ISSILE----KGE----------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCGGG---HHHHHH----TTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCHHH---HHHHHH----cCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 43321 111111 100 0111223456788999999999999999999999999988643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=289.39 Aligned_cols=207 Identities=28% Similarity=0.423 Sum_probs=168.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~di 132 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 132 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCc
Confidence 5788999999999999999999999999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 133 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 133 AARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999998642211 112233556788999999999999999999999999999999 89999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
... ..... +... .. ...+......+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 212 ~~~---~~~~~---~~~~---~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 212 SNS---EVVED---ISTG---FR--------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CHH---HHHHH---HHTT---CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH---HHHHH---HhcC---cc--------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 221 11111 1111 00 01112234678899999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=300.44 Aligned_cols=212 Identities=24% Similarity=0.442 Sum_probs=169.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC--------------------CCCCCHHHHHHHHHHH
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--------------------KEPLDWNTRMKIAAGA 61 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi 61 (380)
|++++||||++++++|.+++..++||||+++++|.+++...... ...+++..++.++.||
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 56889999999999999999999999999999999999873211 2679999999999999
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCcee
Q 016913 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVY 141 (380)
Q Consensus 62 a~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~ 141 (380)
+.||.|||+++ |+|+||||+|||++.++.+||+|||++................++..|+|||++.+..++.++|||
T Consensus 184 ~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 260 (343)
T 1luf_A 184 AAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260 (343)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccH
Confidence 99999999999 999999999999999999999999999764322222223445688999999999999999999999
Q ss_pred ehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 142 SFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 142 SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
|||+++|+|++ |..||...... ...... ... ... ..+...+..+.+|+.+||+.+|.+|||+
T Consensus 261 slG~il~el~t~g~~p~~~~~~~---~~~~~~---~~~--~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 261 AYGVVLWEIFSYGLQPYYGMAHE---EVIYYV---RDG--NIL---------ACPENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHH---HHHHHH---HTT--CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHhcCCCcCCCCChH---HHHHHH---hCC--CcC---------CCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 99999999999 99999753221 111111 110 000 1122345678899999999999999999
Q ss_pred HHHHHHHHHhhhc
Q 016913 221 GDVVTALTYLASQ 233 (380)
Q Consensus 221 ~evl~~L~~~~~~ 233 (380)
.+|++.|+.+...
T Consensus 324 ~~~~~~L~~~~~~ 336 (343)
T 1luf_A 324 CSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHHTTC-
T ss_pred HHHHHHHHHHHhh
Confidence 9999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.93 Aligned_cols=213 Identities=25% Similarity=0.380 Sum_probs=169.4
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC-------------------CCCCCHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------------------KEPLDWNTRMKIAAGA 61 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi 61 (380)
|+++ +||||+++++++...+..++||||+++++|.+++...... ...+++..++.++.||
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 4566 8999999999999999999999999999999999873211 1348999999999999
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCcee
Q 016913 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVY 141 (380)
Q Consensus 62 a~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~ 141 (380)
+.||.|||+.+ |+|+||||+||||+.++.+||+|||++................+|+.|+|||++.+..++.++|||
T Consensus 182 ~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 182 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 99999999999 999999999999999999999999999865433322333445678899999999999999999999
Q ss_pred ehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 142 SFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 142 SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
|||+++|+|++ |..||....... ....... ... ....+......+.+|+.+||+.||.+|||+
T Consensus 259 slG~il~el~t~g~~p~~~~~~~~--~~~~~~~----~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPVDA--NFYKLIQ----NGF----------KMDQPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHcCCCCCcccCCcHH--HHHHHHh----cCC----------CCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 99999999998 999997653221 1111111 100 011122335678899999999999999999
Q ss_pred HHHHHHHHHhhhc
Q 016913 221 GDVVTALTYLASQ 233 (380)
Q Consensus 221 ~evl~~L~~~~~~ 233 (380)
.+|++.|+.+...
T Consensus 323 ~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 323 PNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHHHHHC--
T ss_pred HHHHHHHHHHHHH
Confidence 9999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=302.55 Aligned_cols=212 Identities=27% Similarity=0.389 Sum_probs=168.1
Q ss_pred ccCC-CCCCcccceEEEEeCCe-EEEEEeccCCCCHHHHHhcCCCC----------------------------------
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQ-RLLVYEFMPLGSLEDHLHDLPPD---------------------------------- 45 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~~---------------------------------- 45 (380)
|+++ +|||||+++++|.+.+. .++|||||++++|.+++......
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred HHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 3455 79999999999987654 89999999999999999874221
Q ss_pred ----------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEe
Q 016913 46 ----------------------------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 97 (380)
Q Consensus 46 ----------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~ 97 (380)
...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~ 235 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 235 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEE
Confidence 122899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcc
Q 016913 98 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLF 176 (380)
Q Consensus 98 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 176 (380)
|||++................||..|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus 236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~---- 309 (359)
T 3vhe_A 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRL---- 309 (359)
T ss_dssp CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHH----
T ss_pred eccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHH----
Confidence 9999986543333333445678899999999999999999999999999999998 999997543321 111111
Q ss_pred cccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 177 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
..... ...+......+.+|+.+||+.+|.+|||+.||++.|+.+..
T Consensus 310 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 310 KEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCC----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11000 01122234678899999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.78 Aligned_cols=219 Identities=15% Similarity=0.158 Sum_probs=169.1
Q ss_pred ccCCCCCCcccceEEEEeC----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 2 LSLLHHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
++.++||||+++++++... ...||||||| +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ii 174 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YV 174 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 4578999999999998764 4589999999 9999999986 3467999999999999999999999999 99
Q ss_pred ecCCCCCcEEEc--CCCCeEEeecCCcccCCCCCCc-----cccccccccccccchhhhhcCCCCCcCceeehHHHHHHH
Q 016913 78 YRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 78 HrDIkp~NILl~--~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~el 150 (380)
||||||+||||+ .++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence 999999999999 8899999999999764322111 111335599999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
++|..||....... ..+....... ...+..+.++.+. ....+..+.+|+..||+.+|.+||++.+|++.|+.+
T Consensus 255 ~~g~~Pf~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 255 LTGHLPWEDNLKDP--KYVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHSCCTTGGGTTCH--HHHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HhCCCCccccccCH--HHHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 99999997432211 1111111000 0111112221111 112346788999999999999999999999999987
Q ss_pred hhcc
Q 016913 231 ASQT 234 (380)
Q Consensus 231 ~~~~ 234 (380)
....
T Consensus 328 ~~~~ 331 (364)
T 3op5_A 328 LKAI 331 (364)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 6543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=287.00 Aligned_cols=213 Identities=24% Similarity=0.313 Sum_probs=163.2
Q ss_pred CCCCCCcccceEEEEeC----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hC
Q 016913 4 LLHHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH--------DK 71 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~ 71 (380)
.++||||+++++++... ...++||||+++++|.+++.. ..+++..++.++.||+.||.||| +.
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 132 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 47999999999987553 457999999999999999964 57999999999999999999999 88
Q ss_pred CCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc--ccccccccccccchhhhhcC------CCCCcCceeeh
Q 016913 72 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSF 143 (380)
Q Consensus 72 ~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~Sl 143 (380)
+ |+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||
T Consensus 133 ~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 133 A---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp E---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred C---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 8 9999999999999999999999999997643322211 12334799999999999876 45579999999
Q ss_pred HHHHHHHHhC----------CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhC
Q 016913 144 GVVFLELITG----------RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 213 (380)
Q Consensus 144 Gvvl~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~ 213 (380)
||++|||++| ..||............ . ..........+.. ....++......+.+|+.+||+.|
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~-~-~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~d 283 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED-M-RKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQN 283 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH-H-HHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSS
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCcchhh-h-hHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcC
Confidence 9999999999 7777654333221111 1 1111111111111 111123456788999999999999
Q ss_pred CCCCCCHHHHHHHHHHh
Q 016913 214 AATRPLIGDVVTALTYL 230 (380)
Q Consensus 214 P~~RPt~~evl~~L~~~ 230 (380)
|++|||+.+|++.|+.+
T Consensus 284 P~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 284 PSARLTALRIKKTLTKI 300 (301)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHhcc
Confidence 99999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.86 Aligned_cols=210 Identities=25% Similarity=0.354 Sum_probs=164.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+++++||||+++++++.+++..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dl 137 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDI 137 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5788999999999999999999999999999999999976 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 138 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 138 KPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp CGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998643221 112234569999999999999999999999999999999999999997542
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhhh
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-LIGDVVTALTYLAS 232 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~~ 232 (380)
.. ......... ..+. +....+...+..+.+++.+||+.||.+|| ++.++.+.|..+..
T Consensus 217 ~~------~~~~~~~~~--~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 217 AV------SIAIKHIQD--SVPN-----VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HH------HHHHHHHSS--CCCC-----HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hH------HHHHHHhhc--cCCC-----cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 21 111011110 0100 00111223356788999999999999998 99999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=293.30 Aligned_cols=198 Identities=27% Similarity=0.325 Sum_probs=164.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|.+.+..|+||||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 131 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 131 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcC
Confidence 5678999999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 132 kp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 132 KLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEECCCCCEEEeeccchhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 999999999999999999999853221 122345679999999999999999999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
. ......+...... ++......+.+|+.+||+.||.+|| ++.||++.
T Consensus 210 ~------~~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 210 H------ERLFELILMEEIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp H------HHHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred H------HHHHHHHHcCCCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1 1111111111111 1223346788999999999999999 89998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=305.99 Aligned_cols=211 Identities=24% Similarity=0.347 Sum_probs=168.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
|++++|||||++++++.+....++|||||++++|.+++.... .....+++..++.++.||+.||.|||+++ |+|
T Consensus 128 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 204 (367)
T 3l9p_A 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIH 204 (367)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeC
Confidence 567899999999999999999999999999999999998632 22346999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCC---CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CC
Q 016913 79 RDLKSSNILLDEGF---HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154 (380)
Q Consensus 79 rDIkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~ 154 (380)
|||||+||||+.++ .+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 205 rDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999998544 599999999975322222222334567899999999999999999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.||...... ...... ... .. ...+......+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 285 ~pf~~~~~~---~~~~~i---~~~-~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 285 MPYPSKSNQ---EVLEFV---TSG-GR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CSSTTCCHH---HHHHHH---HTT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHH---HHHHHH---HcC-CC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 999754221 111111 111 00 01122334678899999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=293.18 Aligned_cols=213 Identities=28% Similarity=0.421 Sum_probs=171.0
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------------DKEPLDWNTRMKIAAGAAKGLE 66 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qia~aL~ 66 (380)
|+++ +||||++++++|..++..++||||+++++|.+++..... ....+++..++.++.||+.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4556 899999999999999999999999999999999987321 1235999999999999999999
Q ss_pred HHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHH
Q 016913 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146 (380)
Q Consensus 67 ~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvv 146 (380)
|||+.+ |+|+||||+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||++
T Consensus 160 ~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 999999 99999999999999999999999999986544333223344567889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 147 FLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 147 l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+|+|++ |..||....... ....... .. . ....+...+..+.+|+.+||+.||.+|||+.||++
T Consensus 237 l~ellt~g~~p~~~~~~~~--~~~~~~~----~~--~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDS--KFYKMIK----EG--F--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSH--HHHHHHH----HT--C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCcccchh--HHHHHhc----cC--C--------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999998 999997543221 1111111 10 0 00112233467889999999999999999999999
Q ss_pred HHHHhhhc
Q 016913 226 ALTYLASQ 233 (380)
Q Consensus 226 ~L~~~~~~ 233 (380)
.|+.+...
T Consensus 301 ~L~~~~~~ 308 (313)
T 1t46_A 301 LIEKQISE 308 (313)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99987654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=286.88 Aligned_cols=215 Identities=26% Similarity=0.303 Sum_probs=164.3
Q ss_pred CCCCCCcccceEEEEeC----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------
Q 016913 4 LLHHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-------- 71 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-------- 71 (380)
.++||||+++++++... ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 161 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence 46999999999999888 789999999999999999976 4699999999999999999999998
Q ss_pred CCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc--ccccccccccccchhhhhcCCCCCc------Cceeeh
Q 016913 72 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQLTLK------SDVYSF 143 (380)
Q Consensus 72 ~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDV~Sl 143 (380)
+ |+||||||+|||++.++.+||+|||++.......... ......||..|+|||++.+..++.. +|||||
T Consensus 162 ~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 162 A---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp C---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred C---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 7 9999999999999999999999999997643222111 1124579999999999988776665 999999
Q ss_pred HHHHHHHHhC----------CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccC-CCChhhHHHHHHHHHHhhhh
Q 016913 144 GVVFLELITG----------RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG-RYPMRGLYQALAVAAMCLQE 212 (380)
Q Consensus 144 Gvvl~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~ 212 (380)
||++|||++| ..||............ ....... ....+.+.. ..+......+.+|+.+||+.
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 311 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED--MREIVCI-----KKLRPSFPNRWSSDECLRQMGKLMTECWAH 311 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH--HHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCCchhh--hHHHHhh-----hccCccccccchhhHHHHHHHHHHHHhhhh
Confidence 9999999999 5555443322211110 0000000 001111111 11235678899999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhc
Q 016913 213 QAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 213 ~P~~RPt~~evl~~L~~~~~~ 233 (380)
||.+|||+.+|++.|+.+...
T Consensus 312 dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 312 NPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SGGGSCCHHHHHHHHHHHHHT
T ss_pred ChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999988653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=294.28 Aligned_cols=201 Identities=26% Similarity=0.316 Sum_probs=163.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||++++++|.+.+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 68 il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 140 (361)
T 2yab_A 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFD 140 (361)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 36788999999999999999999999999999999999975 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC----CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 81 LKSSNILLDEGF----HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 81 Ikp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||+|||++.++ .+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~P 217 (361)
T 2yab_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (361)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCHHHEEEeCCCCCccCEEEEecCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999998776 7999999999864332 122346799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|...... .....+......+ ++.. .......+.+|+.+||+.||.+|||+.|+++
T Consensus 218 f~~~~~~------~~~~~i~~~~~~~----~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 218 FLGDTKQ------ETLANITAVSYDF----DEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SCCSSHH------HHHHHHHTTCCCC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHH------HHHHHHHhcCCCC----Cchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9753221 1111111111111 1111 1123457889999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=286.06 Aligned_cols=207 Identities=22% Similarity=0.351 Sum_probs=167.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 130 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDL 130 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSC
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCc
Confidence 5678999999999999999999999999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 131 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp SGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 99999999999999999999986433221 12233456778999999999999999999999999999999 99999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
..... . ....... ... .+......+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 210 ~~~~~---~---~~~~~~~----~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 210 TNSEV---V---LKVSQGH----RLY-------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CHHHH---H---HHHHTTC----CCC-------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ChHHH---H---HHHHcCC----CCC-------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 32111 1 1111100 000 111224578899999999999999999999999988753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=288.56 Aligned_cols=213 Identities=28% Similarity=0.451 Sum_probs=156.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++ .....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+|
T Consensus 73 ~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~D 145 (289)
T 3og7_A 73 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145 (289)
T ss_dssp HHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 36789999999999975 45678999999999999999975 3567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+|||++.++.+||+|||++................||..|+|||++. ...++.++||||||+++|+|++|..||
T Consensus 146 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp CCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 99999999999999999999997643322223334467999999999986 567888999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
....... ...... ... ....... ......+..+.+|+.+||+.+|.+|||+.+|++.|+.++.
T Consensus 226 ~~~~~~~--~~~~~~----~~~-~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 226 SNINNRD--QIIEMV----GRG-SLSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SSCCCHH--HHHHHH----HHT-SCCCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccchHH--HHHHHh----ccc-ccCcchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 7543211 111111 110 0101000 1122345688999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=291.62 Aligned_cols=213 Identities=21% Similarity=0.331 Sum_probs=160.5
Q ss_pred ccCCCCCCcccceEEEEeCCeE------EEEEeccCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~------~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
|+.++||||+++++++...... ++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~- 157 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 6788999999999999887665 99999999999999996521 12236999999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT- 152 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt- 152 (380)
|+||||||+|||++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 158 --ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 158 --FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp --CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 99999999999999999999999999986543333333344567889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
|..||....... ..... ... .. ...+......+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 236 g~~p~~~~~~~~---~~~~~---~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 236 GQTPYAGIENAE---IYNYL---IGG-NR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp SCCTTTTCCGGG---HHHHH---HTT-CC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccccChHH---HHHHH---hcC-CC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 899997543321 11111 110 00 01122345678899999999999999999999999999876
Q ss_pred cc
Q 016913 233 QT 234 (380)
Q Consensus 233 ~~ 234 (380)
..
T Consensus 299 ~~ 300 (323)
T 3qup_A 299 HL 300 (323)
T ss_dssp C-
T ss_pred Hh
Confidence 44
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=304.90 Aligned_cols=206 Identities=28% Similarity=0.379 Sum_probs=167.2
Q ss_pred CccCCCCCCcccceEEEEeCC-eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++++|||||++++++...+ ..|||||||++++|.+++... ....+++..++.++.||+.||+|||+++ |+||
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHr 313 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCC
Confidence 367899999999999987765 789999999999999999862 2334799999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
||||+||||+.++.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 314 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 314 DLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999853211 122356889999999999999999999999999999998 999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
....... ...+. ... ....+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus 389 ~~~~~~~---~~~i~----~~~----------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 389 RIPLKDV---VPRVE----KGY----------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TSCTTTH---HHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHH---HHHHH----cCC----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 6543221 11111 100 0112234457888999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=291.19 Aligned_cols=203 Identities=15% Similarity=0.228 Sum_probs=164.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..++|||||++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dl 128 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDI 128 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 5678999999999999999999999999999999999975 3457999999999999999999999999 999999
Q ss_pred CCCcEEEcC--CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 82 KSSNILLDE--GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||+|||++. ++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 129 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 129 RPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CHHHEEEccCCCCCEEEEECCCCeECCCC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 999999987 789999999999865332 223446789999999999998899999999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.... .....+......+. ... ....+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 206 ~~~~------~~~~~i~~~~~~~~----~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 206 ETNQ------QIIENIMNAEYTFD----EEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp SSHH------HHHHHHHHTCCCCC----HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCHH------HHHHHHHcCCCCCC----hhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 3221 11111111111110 000 012346788999999999999999999999743
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=283.62 Aligned_cols=215 Identities=16% Similarity=0.164 Sum_probs=170.4
Q ss_pred cCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 3 SLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 3 ~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+.+ +|+||+++++++..+...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||
T Consensus 60 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dl 132 (298)
T 1csn_A 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDI 132 (298)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 345 7999999999999999999999999 8999999986 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC-----eEEeecCCcccCCCCCCc-----cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHH
Q 016913 82 KSSNILLDEGFH-----PKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 82 kp~NILl~~~~~-----~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ell 151 (380)
||+|||++.++. +||+|||++......... .......||+.|+|||++.+..++.++||||||+++|||+
T Consensus 133 kp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 212 (298)
T 1csn_A 133 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 212 (298)
T ss_dssp CGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 999999987765 999999999875433221 1124467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 152 TGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 152 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
+|..||..................... .. .+.+ ....+..+.+|+.+||+.+|.+|||+.+|++.|+.+.
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 213 RGSLPWQGLKAATNKQKYERIGEKKQS-TP-----LREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHHH-SC-----HHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCCCcchhhccccHHHHHHHHhhccC-cc-----HHHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 999999865443322222111100000 00 0001 1123467889999999999999999999999999886
Q ss_pred hcc
Q 016913 232 SQT 234 (380)
Q Consensus 232 ~~~ 234 (380)
...
T Consensus 283 ~~~ 285 (298)
T 1csn_A 283 ERL 285 (298)
T ss_dssp HHT
T ss_pred Hhc
Confidence 543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.74 Aligned_cols=208 Identities=24% Similarity=0.388 Sum_probs=170.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|...+..|||||||++++|.+++... ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 269 ~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrD 343 (495)
T 1opk_A 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRN 343 (495)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 356789999999999999999999999999999999999862 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||||+.++.+||+|||+++...... ........++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 344 lkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 344 LAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp CSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998653221 112233456789999999999999999999999999999999 8999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
.... .+..... .. .....+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+.
T Consensus 423 ~~~~---~~~~~~~----~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 423 IDLS---QVYELLE----KD----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCGG---GHHHHHH----TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCHH---HHHHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 4322 1111111 10 111123344578889999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=295.54 Aligned_cols=213 Identities=26% Similarity=0.399 Sum_probs=161.4
Q ss_pred CccCCCCCCcccceEEEEe-CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++++||||++++++|.. ++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 216 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHR 216 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 5788999999999998754 4578999999999999999976 3456899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKA 156 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p 156 (380)
||||+||||+.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 217 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp CCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 99999999999999999999999864322211 12234567889999999999999999999999999999999 6777
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccCC
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 236 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 236 (380)
|........ ..... .. .. . ..+...+..+.+|+.+||+.+|.+|||+.||++.|+.+......
T Consensus 297 ~~~~~~~~~---~~~~~---~~-~~---~-------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 297 YPDVNTFDI---TVYLL---QG-RR---L-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CTTSCSSCH---HHHHH---TT-CC---C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCHHHH---HHHHH---cC-CC---C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 765433221 11111 10 00 0 01123346788999999999999999999999999998765543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=287.97 Aligned_cols=206 Identities=22% Similarity=0.347 Sum_probs=157.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 70 l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 142 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDI 142 (281)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 56789999999999984 5678999999999999999986 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||++........ .......+++.|+|||++....++.++||||||+++|||++ |..||...
T Consensus 143 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 143 AARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp SGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 99999999999999999999986432211 12233456789999999999999999999999999999996 89999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
... ....... .. .. ...+...+..+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 222 ~~~---~~~~~i~---~~-~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 222 KNN---DVIGRIE---NG-ER----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CGG---GHHHHHH---TT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH---HHHHHHH---cC-CC----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 322 1111111 00 00 01223345678899999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=288.35 Aligned_cols=194 Identities=28% Similarity=0.411 Sum_probs=163.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 132 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDL 132 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999986 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 133 kp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 133 KPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChheEEEcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986422 2234679999999999999999999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
. ......+...... ++......+.+|+.+||+.||.+|| ++.+|++
T Consensus 208 ~------~~~~~~i~~~~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 208 T------MKTYEKILNAELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp H------HHHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred H------HHHHHHHHhCCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 2 1111122221111 1223346788999999999999999 8888875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.43 Aligned_cols=204 Identities=22% Similarity=0.251 Sum_probs=162.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||||+++++|.+.+..|||||||++++|.+++.........+++..+..++.||+.||.|||+++ |+||||
T Consensus 80 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDl 156 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDV 156 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccC
Confidence 56789999999999999999999999999999999888753333456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC---eEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFH---PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|||++.++. +||+|||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 157 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 157 KPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp SGGGEEECSSSTTCCEEECCCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChHHeEEecCCCCCcEEEecCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 999999986554 999999999864332 122344679999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... .... ..+...... ..+... ......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~----~~~~---~~i~~~~~~----~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 235 GTK----ERLF---EGIIKGKYK----MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SSH----HHHH---HHHHHTCCC----CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcH----HHHH---HHHHcCCCC----CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 531 1111 111111000 010000 123467889999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=286.68 Aligned_cols=202 Identities=24% Similarity=0.407 Sum_probs=160.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 139 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNV 139 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCc
Confidence 5788999999999999999999999999999999999987 3344999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC--------eEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHh
Q 016913 82 KSSNILLDEGFH--------PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 82 kp~NILl~~~~~--------~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~ellt 152 (380)
||+|||++.++. +||+|||++.... ......++..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEecCCcccccccceeeeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 999999998877 9999999987431 1223457889999999987 678999999999999999999
Q ss_pred CCC-CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 153 GRK-AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 153 G~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
|.. ||..... ...... ......++... ...+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 214 g~~~~~~~~~~---~~~~~~----~~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 214 GGDKPLSALDS---QRKLQF----YEDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TTCCTTTTSCH---HHHHHH----HHTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred CCCCCccccch---HHHHHH----hhccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 654 4433211 111111 11111111111 234678999999999999999999999999875
Q ss_pred hcc
Q 016913 232 SQT 234 (380)
Q Consensus 232 ~~~ 234 (380)
...
T Consensus 275 ~p~ 277 (289)
T 4fvq_A 275 TPD 277 (289)
T ss_dssp ---
T ss_pred CCC
Confidence 433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=288.35 Aligned_cols=207 Identities=22% Similarity=0.367 Sum_probs=168.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 146 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDL 146 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSC
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 5678999999999999999999999999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 147 AARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp SGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999997643211 112233456788999999999999999999999999999998 99999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ... .+... . ....+......+.+|+.+||+.+|.+|||+.+|++.|..+..
T Consensus 226 ~~~~---~~~---~~~~~---~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 226 TNSE---TAE---HIAQG---L--------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CHHH---HHH---HHHTT---C--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChhH---HHH---HHhcc---c--------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 3211 111 11110 0 001112224678899999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=294.56 Aligned_cols=209 Identities=25% Similarity=0.393 Sum_probs=163.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..+|||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 173 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDL 173 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 5678999999999999999999999999999999999976 3467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
||+|||++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 174 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp CGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999864332211 11223456788999999999999999999999999999998 9999964
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
.... ...... ...... ..+......+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 254 ~~~~---~~~~~~----~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 254 LSNH---EVMKAI----NDGFRL----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCHH---HHHHHH----HTTCCC----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCHH---HHHHHH----HCCCcC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3221 111111 111000 11223456788999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=299.11 Aligned_cols=203 Identities=22% Similarity=0.277 Sum_probs=164.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||++++++.+++..|+|||||++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 63 il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrD 135 (444)
T 3soa_A 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRN 135 (444)
T ss_dssp HHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 35678999999999999999999999999999999999987 467999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+|||++ .++.+||+|||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 136 lKp~NIll~~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf 213 (444)
T 3soa_A 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213 (444)
T ss_dssp CSSTTEEESBSSTTCCEEECCCSSCBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCHHHEEEeccCCCCcEEEccCceeEEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 999999998 4578999999999764322 22234467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...... ... ..+......++. + ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 214 ~~~~~~---~~~---~~i~~~~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 214 WDEDQH---RLY---QQIKAGAYDFPS---P-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCSSHH---HHH---HHHHHTCCCCCT---T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCccHH---HHH---HHHHhCCCCCCc---c-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 653211 111 111111111111 1 011234678899999999999999999999873
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=289.04 Aligned_cols=200 Identities=26% Similarity=0.336 Sum_probs=162.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||
T Consensus 68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dl 140 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDL 140 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCC
Confidence 5678999999999999999999999999999999999975 567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGF----HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||+|||++.++ .+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 141 kp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp CGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 99999998877 79999999998653221 223457999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... .... .+......+ ... +.......+.+|+.+||+.||.+|||+.||++
T Consensus 218 ~~~~~~---~~~~---~~~~~~~~~---~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 218 LGDTKQ---ETLA---NVSAVNYEF---EDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCSSHH---HHHH---HHHHTCCCC---CHH-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHH---HHHH---HHHhcCCCc---Ccc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 653221 1111 111110001 000 01123457889999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=285.65 Aligned_cols=204 Identities=30% Similarity=0.458 Sum_probs=158.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|.+++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+|+|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~di 134 (271)
T 3dtc_A 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134 (271)
T ss_dssp HHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCC
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Confidence 5678999999999999999999999999999999999964 57999999999999999999999998556889999
Q ss_pred CCCcEEEcC--------CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhC
Q 016913 82 KSSNILLDE--------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 82 kp~NILl~~--------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG 153 (380)
||+|||++. ++.+||+|||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp SGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred chHHEEEecccccccccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999986 677999999999754322 12245689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
..||...... ...+. ..... .....+......+.+++.+||+.+|.+|||+.||++.|+.+
T Consensus 211 ~~p~~~~~~~----~~~~~--~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 211 EVPFRGIDGL----AVAYG--VAMNK----------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCTTTTSCHH----HHHHH--HHTSC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCCHH----HHHHh--hhcCC----------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 9999753221 11100 00000 01112233456788999999999999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=285.30 Aligned_cols=200 Identities=22% Similarity=0.306 Sum_probs=163.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|...+..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 167 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDI 167 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 6788999999999999999999999999999999999864 56999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999764322 122344679999999999999999999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. ...... .... .+.. ..+......+.+++.+||+.||++|||+.||++.
T Consensus 246 ~~---~~~~~~---~~~~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 246 PV---QAMKRL---RDSP--PPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH---HHHHHH---HHSS--CCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH---HHHHHH---hcCC--CCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21 111111 1110 0000 0112334678899999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=287.32 Aligned_cols=216 Identities=28% Similarity=0.410 Sum_probs=164.5
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++||||++++++|... ...++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 138 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHR 138 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccC
Confidence 6788999999999998653 458999999999999999987 3446999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+|||++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 139 Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp CCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred CCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 99999999999999999999999865332211 12233457788999999999999999999999999999999998886
Q ss_pred CCCCC---------CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 159 NTRPP---------GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 159 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
..... ............... ......+...+..+.+|+.+||+.+|++|||+.||++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKN----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp SHHHHHHHHHCTTCCTHHHHHHHHHHHHT----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CChHHHHhhhcCccccchhHHHHHHHHhc----------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 32110 000000000011111 01112233455789999999999999999999999999998
Q ss_pred hhhc
Q 016913 230 LASQ 233 (380)
Q Consensus 230 ~~~~ 233 (380)
+...
T Consensus 289 l~~~ 292 (295)
T 3ugc_A 289 IRDN 292 (295)
T ss_dssp HHHC
T ss_pred HHHh
Confidence 8654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.29 Aligned_cols=199 Identities=26% Similarity=0.325 Sum_probs=164.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHr 79 (380)
+|+.++||||++++++|...+..|||||||++++|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHr 273 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYR 273 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCC
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEEC
Confidence 57889999999999999999999999999999999999976 4679999999999999999999998 88 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++||||||||+|||++|..||..
T Consensus 274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 274 DLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEECCCCCEEEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 99999999999999999999999753221 2223456799999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
.... .....+...... ++......+.+|+.+||+.||.+|| ++.||++.
T Consensus 352 ~~~~------~~~~~i~~~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 352 QDHE------KLFELILMEEIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp SSHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCHH------HHHHHHHhCCCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 3221 111111111111 1222346788999999999999999 99999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.46 Aligned_cols=214 Identities=23% Similarity=0.339 Sum_probs=162.2
Q ss_pred ccCCCCCCcccceEEEEeCCe-----EEEEEeccCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQ-----RLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~-----~~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
|++++||||+++++++...+. .++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 167 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-- 167 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 567899999999999987653 499999999999999995422 23467999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-C
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-G 153 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G 153 (380)
|+|+||||+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 168 -ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 246 (313)
T 3brb_A 168 -FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246 (313)
T ss_dssp -CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999986543322223344567889999999999999999999999999999999 8
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
..||....... ..... ... . ....+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus 247 ~~p~~~~~~~~---~~~~~---~~~-~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 247 MTPYPGVQNHE---MYDYL---LHG-H----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCSSTTCCGGG---HHHHH---HTT-C----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccCCHHH---HHHHH---HcC-C----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 88987543221 11111 110 0 0011223456788999999999999999999999999998765
Q ss_pred cC
Q 016913 234 TY 235 (380)
Q Consensus 234 ~~ 235 (380)
.+
T Consensus 310 lp 311 (313)
T 3brb_A 310 LP 311 (313)
T ss_dssp C-
T ss_pred cC
Confidence 43
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.92 Aligned_cols=214 Identities=18% Similarity=0.215 Sum_probs=167.4
Q ss_pred ccCCCC-CCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.|+| ++|+.+..++...+..+|||||+ +++|.+++.. ....+++..++.|+.||+.||+|||+++ |||||
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrD 128 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRD 128 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecc
Confidence 445665 56666677778888999999999 8999999985 3467999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCCeEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 81 LKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 81 Ikp~NILl---~~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
|||+|||| +.++.+||+|||+++.+....... ......||..|+|||++.+..++.++||||||||+|||++
T Consensus 129 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt 208 (483)
T 3sv0_A 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR 208 (483)
T ss_dssp CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 99999999 688999999999998754332211 1235679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
|..||...........+..+..... ...... +. ...+..+.+|+..||+.+|++||++.+|++.|+.+..
T Consensus 209 G~~Pf~~~~~~~~~~~~~~i~~~~~-----~~~~~~-l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 209 GSLPWQGLKAGTKKQKYEKISEKKV-----ATSIEA-LC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp SSCTTSSCCCSSHHHHHHHHHHHHH-----HSCHHH-HH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCCccccchhHHHHHHHHhhccc-----cccHHH-Hh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 9999987654433322222111000 000110 10 1224578899999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=287.11 Aligned_cols=208 Identities=25% Similarity=0.391 Sum_probs=170.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..++||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~di 137 (288)
T 3kfa_A 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137 (288)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 5678999999999999999999999999999999999987 23456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 138 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 138 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998653222 222344567889999999999999999999999999999999 99999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ....... . .....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 217 ~~~~---~~~~~~~---~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 217 DLSQ---VYELLEK---D-----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CGGG---HHHHHHT---T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHH---HHHHHhc---c-----------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 3221 1111110 0 0111222345678899999999999999999999999988754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=290.32 Aligned_cols=210 Identities=28% Similarity=0.419 Sum_probs=168.2
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------PDKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
|+++ +||||+++++++.+.+..++||||+++++|.+++.... .....+++..++.++.||+.||.||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 5677 89999999999999999999999999999999998632 2235799999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ |+|+||||+|||++.++.+||+|||++..... ........++..|+|||++.+..++.++||||||+++|
T Consensus 159 H~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 159 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 9999 99999999999999999999999999974221 11223345688999999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+|++ |..||...... ... ..+... . ....+......+.+|+.+||+.+|.+|||+.+|++.|
T Consensus 233 ellt~g~~pf~~~~~~---~~~---~~~~~~-~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCA---ELY---EKLPQG-Y----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp HHHTTSCCTTTTCCHH---HHH---HHGGGT-C----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCcHH---HHH---HHhhcC-C----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9998 99999754221 111 111110 0 0112223456788999999999999999999999999
Q ss_pred HHhhhcc
Q 016913 228 TYLASQT 234 (380)
Q Consensus 228 ~~~~~~~ 234 (380)
..+....
T Consensus 296 ~~~~~~~ 302 (327)
T 1fvr_A 296 NRMLEER 302 (327)
T ss_dssp HHHHHSS
T ss_pred HHHHHhh
Confidence 9886543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=292.15 Aligned_cols=201 Identities=21% Similarity=0.277 Sum_probs=162.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||||+++++|.+.+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dl 154 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNL 154 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999999975 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCC---CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEG---FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|||++.+ +.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 155 kp~NIll~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 155 KPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCBCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred chHHEEEecCCCCCCEEEeecCcceEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999765 45999999999864322 12234679999999999999899999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..... .... .+......++. + ........+.+|+.+||+.||.+|||+.++++.
T Consensus 232 ~~~~~---~~~~---~i~~~~~~~~~---~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 232 DEDQH---RLYA---QIKAGAYDYPS---P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CSSHH---HHHH---HHHHTCCCCCT---T-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCHH---HHHH---HHHhCCCCCCc---c-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 53211 1111 11111111111 0 011234678899999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=295.41 Aligned_cols=196 Identities=28% Similarity=0.375 Sum_probs=158.0
Q ss_pred cCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 3 SLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 3 ~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+.+ +||||++++++|.+.+..|||||||++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||
T Consensus 78 ~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDl 150 (353)
T 3txo_A 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDL 150 (353)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCC
Confidence 344 799999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||||+.++.+||+|||+++.... .........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 151 kp~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 151 KLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEECCCCCEEEccccceeeccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999985322 1223345679999999999999899999999999999999999999997542
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI------GDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~------~evl~ 225 (380)
.. .....+...... ++......+.+|+.+||+.||.+||++ .||++
T Consensus 229 ~~------~~~~~i~~~~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 229 ED------DLFEAILNDEVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HH------HHHHHHHcCCCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 21 111222222111 122234678899999999999999998 66664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=283.73 Aligned_cols=214 Identities=24% Similarity=0.357 Sum_probs=171.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++ ..+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 64 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 136 (287)
T 1u59_A 64 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDL 136 (287)
T ss_dssp HHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCC
Confidence 5678999999999999 45678999999999999999975 3466999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
||+|||++.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 137 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999865332221 11233456889999999998899999999999999999998 9999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccCCCCc
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNA 239 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~ 239 (380)
.... ....... .. . ....+...+..+.+|+.+||+.+|.+||++.+|++.|+.+......+.+
T Consensus 217 ~~~~---~~~~~i~---~~-~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 217 MKGP---EVMAFIE---QG-K----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp CCTH---HHHHHHH---TT-C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CCHH---HHHHHHh---cC-C----------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 4322 1111111 10 0 0112234456888999999999999999999999999988655544433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=292.74 Aligned_cols=215 Identities=25% Similarity=0.387 Sum_probs=171.1
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~aL~~L 68 (380)
|+++ +||||++++++|...+..++||||+++++|.+++...... ...+++..++.++.||+.||.||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3455 8999999999999999999999999999999999873221 23489999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ |+|+||||+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|
T Consensus 174 H~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 174 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp HHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999998654333222334456788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+|++ |..||...... ...... ... .. ...+......+.+|+.+||+.+|.+|||+.+|++.|
T Consensus 251 ellt~g~~p~~~~~~~---~~~~~~---~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 251 EIFTLGGSPYPGIPVE---ELFKLL---KEG-HR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHTTSCCSSTTCCHH---HHHHHH---HHT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCcCcCCHH---HHHHHH---hcC-CC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999 99999754221 111111 110 00 011223456788999999999999999999999999
Q ss_pred HHhhhccCC
Q 016913 228 TYLASQTYD 236 (380)
Q Consensus 228 ~~~~~~~~~ 236 (380)
+.+......
T Consensus 314 ~~l~~~~~~ 322 (334)
T 2pvf_A 314 DRILTLTTN 322 (334)
T ss_dssp HHHHHHHC-
T ss_pred HHHHhcccc
Confidence 998665433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=285.42 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=166.5
Q ss_pred ccCCCCCCcccceEEEE-eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|++++||||++++++|. .++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+|
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~d 153 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 153 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 57889999999999864 45678999999999999999976 4567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCC--ccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~ 157 (380)
|||+|||++.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ +.+||
T Consensus 154 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 233 (298)
T 3f66_A 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233 (298)
T ss_dssp CSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999986433221 112234567889999999999999999999999999999999 55666
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccCC
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 236 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 236 (380)
...........+ ..... . ..+...+..+.+++.+||+.+|.+|||+.+|++.|+.+......
T Consensus 234 ~~~~~~~~~~~~------~~~~~---~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 234 PDVNTFDITVYL------LQGRR---L--------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp TTSCTTTHHHHH------HTTCC---C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ccCCHHHHHHHH------hcCCC---C--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 544332211111 11000 0 01122345788999999999999999999999999998765543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=286.63 Aligned_cols=212 Identities=24% Similarity=0.307 Sum_probs=161.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+++..++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||
T Consensus 73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Di 145 (311)
T 3niz_A 73 LKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDL 145 (311)
T ss_dssp HHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 567899999999999999999999999997 689888876 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.+||+|||++...... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 146 kp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 146 KPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CGGGEEECTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chHhEEECCCCCEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999864322 122334578999999999876 56899999999999999999999999765
Q ss_pred CCCCCcchhhhhhhccccc--CCCC-------------CCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDR--RKFP-------------KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~--~~~~-------------~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
........+.. ..... ...+ ..................+.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~i~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 224 TDDDQLPKIFS---ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp STTTHHHHHHH---HHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ChHHHHHHHHH---HHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 44332211110 00000 0000 000000000011223457889999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.97 Aligned_cols=212 Identities=25% Similarity=0.385 Sum_probs=168.5
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP----------DKEPLDWNTRMKIAAGAAKGLEYLHD 70 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~ 70 (380)
|+.+ +||||++++++|.+++..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 4566 899999999999999999999999999999999975210 13468999999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHH
Q 016913 71 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 71 ~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~el 150 (380)
.+ |+|+||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|
T Consensus 183 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 183 KN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp TT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99 999999999999999999999999999864333222223445678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 151 IT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 151 lt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
++ |..||........ ..... ..... ...+...+..+.+|+.+||+.+|.+|||+.+|++.|+.
T Consensus 260 ~t~g~~p~~~~~~~~~--~~~~~----~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSK--FYKLV----KDGYQ----------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp TTTSCCSSTTCCSSHH--HHHHH----HHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCCCCcccchhHH--HHHHH----hcCCC----------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 98 8899975432211 11111 11100 01112234678899999999999999999999999998
Q ss_pred hhh
Q 016913 230 LAS 232 (380)
Q Consensus 230 ~~~ 232 (380)
+..
T Consensus 324 ~~~ 326 (333)
T 2i1m_A 324 QAQ 326 (333)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=295.54 Aligned_cols=195 Identities=26% Similarity=0.367 Sum_probs=158.2
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
.+|||||+++++|.+.+..|||||||++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+
T Consensus 110 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~ 182 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD 182 (396)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred CCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHH
Confidence 3899999999999999999999999999999999986 467999999999999999999999999 999999999
Q ss_pred cEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 85 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
||||+.++.+||+|||+++.... .........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 183 NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~ 260 (396)
T 4dc2_A 183 NVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260 (396)
T ss_dssp GEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--
T ss_pred HEEECCCCCEEEeecceeeeccc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccc
Confidence 99999999999999999985222 1223445689999999999999999999999999999999999999997432221
Q ss_pred C---cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 165 E---HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 165 ~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
. .........+...... +|......+.+|+.+||+.||.+||++
T Consensus 261 ~~~~~~~~~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 261 NPDQNTEDYLFQVILEKQIR------------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCHHHHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccchhhHHHHHHHHhccccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 0111111111111111 222345678899999999999999996
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=293.58 Aligned_cols=200 Identities=27% Similarity=0.362 Sum_probs=163.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+.+..|+||||+.+++|..++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 68 il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 140 (384)
T 4fr4_A 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRD 140 (384)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 36788999999999999999999999999999999999986 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc---CCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+||||+.++.+||+|||++...... .......||+.|+|||++.. ..++.++|||||||++|||++|..||
T Consensus 141 lkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 141 MKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 9999999999999999999999864322 22345679999999999874 45899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-IGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~ 225 (380)
................ .... .++......+.+|+.+||+.||.+||+ +.+|++
T Consensus 218 ~~~~~~~~~~~~~~~~---~~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 218 HIRSSTSSKEIVHTFE---TTVV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHH---HCCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCCccHHHHHHHHh---hccc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 7544332222222111 1111 122334567889999999999999998 666553
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=284.14 Aligned_cols=221 Identities=21% Similarity=0.242 Sum_probs=169.2
Q ss_pred ccCCCCCCcccceEEEEeCC--eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++||||+++++++...+ ..+|||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 136 (319)
T 4euu_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHR 136 (319)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 56789999999999998765 7899999999999999998621 2233999999999999999999999999 9999
Q ss_pred CCCCCcEEE----cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh--------cCCCCCcCceeehHHHH
Q 016913 80 DLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM--------TGQLTLKSDVYSFGVVF 147 (380)
Q Consensus 80 DIkp~NILl----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDV~SlGvvl 147 (380)
||||+|||| +.++.+||+|||+++...... ......||..|+|||++. ...++.++|||||||++
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp CCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred CCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 999999999 777789999999998643322 223456999999999987 56889999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhhhhcccccC-CCC----CC------C--CccccCCCChhhHHHHHHHHHHhhhhCC
Q 016913 148 LELITGRKAIDNTRPPGEHNLVAWARPLFKDRR-KFP----KM------A--DPLLQGRYPMRGLYQALAVAAMCLQEQA 214 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~------~--~~~l~~~~~~~~~~~l~~li~~cl~~~P 214 (380)
|||++|..||...........+ ...+..... ... .. . .-.....++......+.+|+.+||+.||
T Consensus 214 ~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 291 (319)
T 4euu_A 214 YHAATGSLPFRPFEGPRRNKEV--MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (319)
T ss_dssp HHHHHSSCSEECTTCGGGCHHH--HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHhCCCCCCCCCccchhHHH--HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCCh
Confidence 9999999999754332211111 111111000 000 00 0 0011123445677789999999999999
Q ss_pred CCCCCHHHHHHHHHHhh
Q 016913 215 ATRPLIGDVVTALTYLA 231 (380)
Q Consensus 215 ~~RPt~~evl~~L~~~~ 231 (380)
++|||+.|+++.....+
T Consensus 292 ~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 292 EKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTSCCHHHHHHHHHHHT
T ss_pred hhhccHHHhhhccHHHh
Confidence 99999999999988654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=293.10 Aligned_cols=199 Identities=26% Similarity=0.277 Sum_probs=163.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++|||||+++++|.+.+..|+||||++|++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDl 165 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDL 165 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5778999999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 166 kp~NIll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 166 KPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CGGGEEECTTSCEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CHHHEEECCCCCEEEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999999853221 122345679999999999999999999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
. ......+...... ++......+.+|+.+||+.||.+||++.+.++.+
T Consensus 244 ~------~~~~~~i~~~~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 244 T------AEMYDNILNKPLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp H------HHHHHHHHHSCCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred H------HHHHHHHHhcccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 2 1111122221111 1223346788999999999999999986544433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=286.23 Aligned_cols=209 Identities=23% Similarity=0.318 Sum_probs=155.3
Q ss_pred CccCCCCCCcccceEEEEeCCe----EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQ----RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~----~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
+|++++||||+++++++..... .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 137 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---I 137 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 4778999999999999876543 4999999999999999976 457999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+|+||||+|||++.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 138 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 217 (311)
T 3ork_A 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217 (311)
T ss_dssp CCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999764332211 12234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHH-HHHHHh
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV-TALTYL 230 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl-~~L~~~ 230 (380)
||....... ............ .... .......+.+|+.+||+.||.+||+..+++ ..|..+
T Consensus 218 pf~~~~~~~------~~~~~~~~~~~~----~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 218 PFTGDSPVS------VAYQHVREDPIP----PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp SCCCSSHHH------HHHHHHHCCCCC----HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCChHH------HHHHHhcCCCCC----cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 997542211 111111110000 0000 112346788999999999999999777665 444443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=290.09 Aligned_cols=196 Identities=23% Similarity=0.289 Sum_probs=163.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++.+.+..||||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 94 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 166 (350)
T 1rdq_E 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36788999999999999999999999999999999999986 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 167 lkp~NIll~~~g~~kL~DFg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 167 LKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccceEEECCCCCEEEcccccceeccC-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 999999999999999999999986432 123467999999999999999999999999999999999999999753
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~ 226 (380)
.. ......+...... ++......+.+|+.+||+.||.+||+ +.+|++.
T Consensus 242 ~~------~~~~~~i~~~~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 242 QP------IQIYEKIVSGKVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SH------HHHHHHHHHCCCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CH------HHHHHHHHcCCCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 22 1111111111111 12233567889999999999999998 7887653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=283.67 Aligned_cols=212 Identities=25% Similarity=0.346 Sum_probs=168.1
Q ss_pred ccCCCCCCcccceEEEEeCCeE-EEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQR-LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~-~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.++||||+++++++.+.+.. ++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+|
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~d 149 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRD 149 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 5678999999999999876655 999999999999999976 4567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCC--ccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC-C
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA-I 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p-~ 157 (380)
|||+|||++.++.+||+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++|..| |
T Consensus 150 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 150 LAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp CSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred CCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 999999999999999999999975432211 1122345678899999999999999999999999999999996555 4
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccCC
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 236 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 236 (380)
...... ....... .... ...+......+.+|+.+||+.+|.+|||+.+|++.|+.+......
T Consensus 230 ~~~~~~---~~~~~~~----~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 230 RHIDPF---DLTHFLA----QGRR----------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp TTSCGG---GHHHHHH----TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ccCCHH---HHHHHhh----cCCC----------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 432221 1111111 0000 011223346788999999999999999999999999998765543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=293.65 Aligned_cols=215 Identities=15% Similarity=0.141 Sum_probs=166.1
Q ss_pred ccCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 2 LSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
++.++||||+++++++.. ....||||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.+ |+
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 173 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YV 173 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 456799999999999988 77899999999 9999999976 347999999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCC--CeEEeecCCcccCCCCCC-----ccccccccccccccchhhhhcCCCCCcCceeehHHHHHHH
Q 016913 78 YRDLKSSNILLDEGF--HPKLSDFGLAKLGPVGDK-----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 78 HrDIkp~NILl~~~~--~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~el 150 (380)
||||||+||||+.++ .+||+|||+++.+..... ........||..|+|||++.+..++.++|||||||++|||
T Consensus 174 H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 253 (345)
T 2v62_A 174 HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRW 253 (345)
T ss_dssp CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999998877 999999999976432211 1112446799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
++|..||....... ........... ..++........ ....+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 254 l~g~~pf~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 254 LCGKLPWEQNLKDP-VAVQTAKTNLL---DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHSSCTTGGGTTCH-HHHHHHHHHHH---HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HhCCCCcccccccc-HHHHHHHHhhc---ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 99999996422111 11111111100 011111100000 113346789999999999999999999999999875
Q ss_pred h
Q 016913 231 A 231 (380)
Q Consensus 231 ~ 231 (380)
.
T Consensus 327 ~ 327 (345)
T 2v62_A 327 G 327 (345)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=283.24 Aligned_cols=213 Identities=26% Similarity=0.426 Sum_probs=167.5
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.++||||+++++++... +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 150 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHR 150 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccC
Confidence 5688999999999999876 668999999999999999965 3466999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+|||++.++.+||+|||++......... .......+|..|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 151 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 99999999999999999999999875433221 22344568888999999999999999999999999999999998864
Q ss_pred CCC--------CC-CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 159 NTR--------PP-GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 159 ~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
... +. .......... .... ......+...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 231 SPMALFLKMIGPTHGQMTVTRLVN-TLKE----------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp SHHHHHHHHHCSCCGGGHHHHHHH-HHHT----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred chhhHHhhccCCcccccCHHHHHH-HHhc----------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 221 00 0001111110 0111 01112233445788999999999999999999999999987
Q ss_pred hh
Q 016913 230 LA 231 (380)
Q Consensus 230 ~~ 231 (380)
+.
T Consensus 300 ll 301 (302)
T 4e5w_A 300 LL 301 (302)
T ss_dssp HH
T ss_pred Hh
Confidence 64
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=282.84 Aligned_cols=213 Identities=24% Similarity=0.334 Sum_probs=159.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 125 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4778999999999999999999999999997 599999976 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 126 LKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHHHEEEcCCCCEEEeECccccccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999764321 1122345689999999999764 589999999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcc-------cccCCCCCCCCcccc-------CCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLF-------KDRRKFPKMADPLLQ-------GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~-------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... +.......- ......+. .++.+. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 204 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 204 VSEADQ--LMRIFRILGTPNSKNWPNVTELPK-YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp SSHHHH--HHHHHHHHCCCCTTTSTTGGGSTT-CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHH--HHHHHHHHCCCChhhchhhhcccc-cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 432111 111000000 00000000 000000 0111234567889999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=293.80 Aligned_cols=219 Identities=19% Similarity=0.214 Sum_probs=162.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+++..|+|||||++++|.+++.. .....+++..+..++.||+.||.|||+.+ |+|||
T Consensus 79 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 153 (389)
T 3gni_B 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRS 153 (389)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 35678999999999999999999999999999999999987 23456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCC-----Cccccccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHhC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGD-----KTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG 153 (380)
|||+||||+.++.+||+|||++....... .........||..|+|||++.+ ..++.++|||||||++|||++|
T Consensus 154 lkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 233 (389)
T 3gni_B 154 VKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233 (389)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHC
Confidence 99999999999999999999886532111 1111233578999999999987 5799999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhccc---ccCCCC------------------CCC---------CccccCCCChhhHHHHH
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFK---DRRKFP------------------KMA---------DPLLQGRYPMRGLYQAL 203 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~------------------~~~---------~~~l~~~~~~~~~~~l~ 203 (380)
..||......... ......... .....+ ... .......++......+.
T Consensus 234 ~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 311 (389)
T 3gni_B 234 HVPFKDMPATQML--LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311 (389)
T ss_dssp SCTTTTCCSTTHH--HHC--------------------------------------------------------CCHHHH
T ss_pred CCCCCCCCHHHHH--HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHH
Confidence 9999764332211 110000000 000000 000 00000112334456799
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 016913 204 AVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 204 ~li~~cl~~~P~~RPt~~evl~~ 226 (380)
+|+.+||+.||++|||+.||++.
T Consensus 312 ~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 312 HFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHhhcCcccCCCHHHHhcC
Confidence 99999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=282.42 Aligned_cols=207 Identities=28% Similarity=0.424 Sum_probs=168.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 130 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSC
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5678999999999999999999999999999999999986 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+||+++.++.+||+|||++...... .........++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 131 ~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 131 AARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chheEEECCCCCEEEcccccccccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 999999999999999999999764221 1112233557788999999999999999999999999999999 89999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
... .... .+... ... ..+......+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 210 ~~~---~~~~---~i~~~---~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 210 SNS---EVVE---DISTG---FRL--------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CHH---HHHH---HHHTT---CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH---HHHH---HHhcC---CcC--------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221 1111 11111 000 1112234678899999999999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=291.88 Aligned_cols=202 Identities=21% Similarity=0.294 Sum_probs=163.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+.+..++|||||++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|||
T Consensus 101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 174 (387)
T 1kob_A 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174 (387)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 36789999999999999999999999999999999999975 3457999999999999999999999999 99999
Q ss_pred CCCCcEEEcC--CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDE--GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||+|||++. .+.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 175 lkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 175 IKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cchHHeEEecCCCCceEEEecccceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 9999999974 467999999999864322 12234579999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... .... .+......+.. .........+.+|+.+||+.||.+|||+.||++
T Consensus 252 ~~~~~---~~~~---~i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 252 GEDDL---ETLQ---NVKRCDWEFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSHH---HHHH---HHHHCCCCCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCHH---HHHH---HHHhCCCCCCc--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 54221 1111 11111111110 111233467889999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=280.18 Aligned_cols=214 Identities=20% Similarity=0.245 Sum_probs=160.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++.+++..+|||||++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|||
T Consensus 54 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~d 126 (292)
T 3o0g_A 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126 (292)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHhcCCCCCEeeEEeEEEeCCEEEEEEecCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 3678899999999999999999999999997 577776655 3567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC-CCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||++...... ........||..|+|||++.+.. ++.++|||||||++|+|++|..||-.
T Consensus 127 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 127 LKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred CCHHHEEEcCCCCEEEeecccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 9999999999999999999999864322 22234467899999999998765 89999999999999999998887533
Q ss_pred CCCCCCcchhhhhhhcccc--cC------------CCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKD--RR------------KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~--~~------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.... ............. .. ..+..................+.+|+.+||+.||++|||++|+++
T Consensus 205 ~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 205 GNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCH--HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 2211 1111111000000 00 000000000011122345568889999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=284.64 Aligned_cols=221 Identities=23% Similarity=0.301 Sum_probs=163.5
Q ss_pred ccCCCCCCcccceEEEEe-----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----
Q 016913 2 LSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK----- 71 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~----- 71 (380)
+..++||||+++++++.. ...++||||||++++|.+++.. ..+++..++.++.||+.||.|||+.
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~ 135 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGD 135 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGG
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhcccc
Confidence 456899999999986643 2257899999999999999976 4568999999999999999999999
Q ss_pred ----CCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC------ccccccccccccccchhhhhc-------CCC
Q 016913 72 ----ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK------THVSTRVMGTYGYCAPEYAMT-------GQL 134 (380)
Q Consensus 72 ----~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~ 134 (380)
+ |+||||||+||||+.++.+||+|||++..+..... ........||..|+|||++.+ ..+
T Consensus 136 ~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 212 (336)
T 3g2f_A 136 HYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212 (336)
T ss_dssp GCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH
T ss_pred ccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc
Confidence 8 99999999999999999999999999986532211 111234569999999999986 456
Q ss_pred CCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchh-h----------hhhhcccccCCCCCCCCccccCC--CChhhHHH
Q 016913 135 TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-A----------WARPLFKDRRKFPKMADPLLQGR--YPMRGLYQ 201 (380)
Q Consensus 135 s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~-~----------~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~ 201 (380)
+.++|||||||++|||++|..||............ . .......... ..+.+... ........
T Consensus 213 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 287 (336)
T 3g2f_A 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRS 287 (336)
T ss_dssp HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHH
T ss_pred ccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHH
Confidence 78899999999999999997776433222111110 0 0000000000 01111111 12245668
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccC
Q 016913 202 ALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 235 (380)
Q Consensus 202 l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 235 (380)
+.+|+.+||+.||++|||+.||++.|+.+.....
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999875443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.80 Aligned_cols=208 Identities=24% Similarity=0.381 Sum_probs=167.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++ ..+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 72 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~di 143 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDL 143 (291)
T ss_dssp HHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCC
Confidence 5678999999999999 56778999999999999999986 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
||+|||++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 144 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999865332221 11223456789999999999899999999999999999999 9999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhcc
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 234 (380)
.... ....... ... ....+......+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus 224 ~~~~---~~~~~~~----~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 224 MKGS---EVTAMLE----KGE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CCHH---HHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCHH---HHHHHHH----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 4321 1111111 100 01122334567889999999999999999999999999886544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=289.33 Aligned_cols=198 Identities=24% Similarity=0.331 Sum_probs=162.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..++||||+ +|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 62 ~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~D 133 (336)
T 3h4j_B 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRD 133 (336)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 367889999999999999999999999999 6899999876 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 134 lkp~NIll~~~~~~kl~DFG~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 134 LKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp CSTTTEEECTTCCEEECCSSCTBTTTTS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred CchhhEEEcCCCCEEEEEeccceeccCC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999864322 22344579999999999988776 6899999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.........+ ... ....+......+.+|+.+||+.||.+|||+.||++.-
T Consensus 211 ~~~~~~~~~i----------------~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 211 EFIPNLFKKV----------------NSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp SSSTTCBCCC----------------CSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred ccHHHHHHHH----------------HcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 4322111100 000 0112233456788999999999999999999998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=280.27 Aligned_cols=204 Identities=28% Similarity=0.517 Sum_probs=162.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.. ++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+|+||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~di 150 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDL 150 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCC
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCC
Confidence 57789999999999987655 799999999999999976 3567999999999999999999999985 45999999
Q ss_pred CCCcEEEcCCCC-----eEEeecCCcccCCCCCCccccccccccccccchhhhh--cCCCCCcCceeehHHHHHHHHhCC
Q 016913 82 KSSNILLDEGFH-----PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 82 kp~NILl~~~~~-----~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
||+|||++.++. +||+|||++.... .......||+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 151 kp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp SGGGEEESCCCTTCSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CcceEEEeccCCCCceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999987776 9999999997532 2234467899999999984 456789999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
.||.......... .... ... . .....+......+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 226 ~pf~~~~~~~~~~-~~~~---~~~--~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 226 GPFDEYSYGKIKF-INMI---REE--G--------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CTTTTCCCCHHHH-HHHH---HHS--C--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCccccccHHHH-HHHH---hcc--C--------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9997543321111 1111 110 0 01112233456788999999999999999999999999753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=283.14 Aligned_cols=218 Identities=21% Similarity=0.314 Sum_probs=163.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..++||||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl 162 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDI 162 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCC
Confidence 56789999999999999999999999999999999999753334567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++...... ........|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 163 ~p~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 163 KPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp CGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cHHHEEEcCCCCEEEEeccceeeecCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999999764322 112234568999999999999999999999999999999999999996432
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccCCCC
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPN 238 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~ 238 (380)
. ........+.. ..++... .......+.+|+.+||+.||.+|||+.+|++.|+.+......+.
T Consensus 241 ~----~~~~~~~~~~~--~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 241 M----NLYSLCKKIEQ--CDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp C----CHHHHHHHHHT--TCSCCCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred h----hHHHHHHHhhc--ccCCCCc--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 1 11111111111 0111111 11234678899999999999999999999999999976665543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=291.42 Aligned_cols=202 Identities=21% Similarity=0.260 Sum_probs=163.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|...+..+||||||++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|||
T Consensus 139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 212 (373)
T 2x4f_A 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLD 212 (373)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36789999999999999999999999999999999999976 3456999999999999999999999999 99999
Q ss_pred CCCCcEEE--cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||+|||+ +.++.+||+|||++....... ......||+.|+|||++....++.++|||||||++|||++|..||.
T Consensus 213 lkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 213 LKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999 566789999999998653322 2234569999999999999899999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... .....+......+. ... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 290 ~~~~~------~~~~~i~~~~~~~~---~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 290 GDNDA------ETLNNILACRWDLE---DEE-----FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSSHH------HHHHHHHHTCCCSC---SGG-----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHH------HHHHHHHhccCCCC---hhh-----hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 54221 11111111111111 110 1123467889999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=287.34 Aligned_cols=197 Identities=28% Similarity=0.357 Sum_probs=158.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..||||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||
T Consensus 75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dl 147 (327)
T 3a62_A 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDL 147 (327)
T ss_dssp HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccC
Confidence 5678999999999999999999999999999999999976 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 148 kp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 148 KPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp CTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CHHHeEECCCCcEEEEeCCcccccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999753221 122334679999999999999999999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
.. .....+...... ++......+.+|+.+||+.||.+|| ++.||++
T Consensus 226 ~~------~~~~~i~~~~~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 226 RK------KTIDKILKCKLN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HH------HHHHHHHHTCCC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HH------HHHHHHHhCCCC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 21 111111111111 1223346788999999999999999 6777765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=279.50 Aligned_cols=205 Identities=23% Similarity=0.350 Sum_probs=164.0
Q ss_pred CccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+|++++||||++++++|.+. +..++||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+ ++|+|
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H 136 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPR 136 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTT
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcCC-Cceec
Confidence 46788999999999999887 778999999999999999987 23336999999999999999999999975 45999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCC---cCceeehHHHHHHHHhCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL---KSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDV~SlGvvl~elltG~~ 155 (380)
+||||+|||++.++.++|+|||+..... .....||+.|+|||++.+..++. ++||||||+++|||++|..
T Consensus 137 ~dikp~Nil~~~~~~~~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 137 HALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp CCCSGGGEEECTTSCEEEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred CCCccceEEEcCCcceeEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999888875321 12356899999999998765554 7999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
||....... ......... .....+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 210 p~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 210 PFADLSNME------IGMKVALEG----------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TTTTSCHHH------HHHHHHHSC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CccccChHH------HHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 997542211 111111110 001122234567889999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=306.99 Aligned_cols=208 Identities=25% Similarity=0.398 Sum_probs=166.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||++++++. .+..+||||||++++|.+++... ....+++..++.++.||+.||.|||+++ |+|||
T Consensus 236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 309 (454)
T 1qcf_A 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 309 (454)
T ss_dssp HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 367899999999999986 56789999999999999999751 2236899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||||+.++.+||+|||+++...... ........++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 310 lkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 310 LRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998643211 111223446788999999999999999999999999999999 9999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ...... .. ... ...+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 389 ~~~~---~~~~~i---~~-~~~----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 389 MSNP---EVIRAL---ER-GYR----------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCHH---HHHHHH---HH-TCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCHH---HHHHHH---Hc-CCC----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 4221 111111 11 100 11123345678899999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.86 Aligned_cols=210 Identities=24% Similarity=0.362 Sum_probs=166.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.. +..+||||||++++|.+++.. ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrD 461 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRN 461 (613)
T ss_dssp HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCc
Confidence 4678999999999999976 568999999999999999975 3567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||+||||+.++.+||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 462 lkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp CSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999998653322111 1223345689999999999999999999999999999998 999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhcc
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 234 (380)
..... .+...+. ... ....+...+..+.+|+.+||+.+|++||++.+|++.|+.+....
T Consensus 542 ~~~~~---~~~~~i~----~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 542 KMKGP---EVMAFIE----QGK----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TCCSH---HHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHH---HHHHHHH----cCC----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 64332 1221111 110 01123345578899999999999999999999999999875433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=293.78 Aligned_cols=207 Identities=20% Similarity=0.238 Sum_probs=156.6
Q ss_pred cCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 3 SLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+.++||||++++++|.. .+.+|||||||++++|.+++.. .....+++..+..++.||+.||.|||+.+ |+|
T Consensus 110 ~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 184 (400)
T 1nxk_A 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 184 (400)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 34689999999999876 5678999999999999999986 22346999999999999999999999999 999
Q ss_pred cCCCCCcEEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 79 RDLKSSNILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 79 rDIkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||||+||||+. ++.+||+|||+++..... .......||+.|+|||++.+..++.++||||||||+|+|++|..
T Consensus 185 rDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 261 (400)
T 1nxk_A 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCcceEEEecCCCCccEEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 999999999987 788999999999864321 12344678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcc-hhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 156 AIDNTRPPGEHN-LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 156 p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
||.......... ....+ ......++. + ........+.+|+.+||+.||.+|||+.||++.-.
T Consensus 262 pf~~~~~~~~~~~~~~~i---~~~~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 262 PFYSNHGLAISPGMKTRI---RMGQYEFPN---P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp SCCCCTTCSSCCSHHHHH---HHTCCCCCT---T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCCCCccccccHHHHHHH---HcCcccCCC---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 997654332211 11111 001011110 0 01123467889999999999999999999998543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=288.48 Aligned_cols=197 Identities=25% Similarity=0.361 Sum_probs=158.0
Q ss_pred cCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 3 SLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 3 ~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+++ +|||||+++++|.+.+..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||
T Consensus 64 ~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 136 (345)
T 3a8x_A 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDL 136 (345)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 344 899999999999999999999999999999999976 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 137 kp~NIll~~~g~~kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 137 KLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp CGGGEEECTTSCEEECCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred CHHHEEECCCCCEEEEeccccccccCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 999999999999999999999853221 122345679999999999999999999999999999999999999997432
Q ss_pred CCCC---cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 162 PPGE---HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 162 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.... .........+...... +|......+.+|+.+||+.||.+||++
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVILEKQIR------------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C-------CHHHHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cccccccccHHHHHHHHHcCCCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 2111 0111111111111111 222345678899999999999999996
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=277.38 Aligned_cols=198 Identities=27% Similarity=0.395 Sum_probs=142.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 138 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDL 138 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSC
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5788999999999999999999999999999999999986 3467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 139 ~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 139 TLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 9999999999999999999998643221 12234568999999999998899999999999999999999999997543
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....... .... + ...+......+.+|+.+||+.||++|||+.+|++
T Consensus 217 ~~~~~~~------~~~~--------~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 217 VKNTLNK------VVLA--------D----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC-----------CCSS--------C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHH------Hhhc--------c----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2211100 0000 0 0122234467889999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=288.19 Aligned_cols=207 Identities=22% Similarity=0.278 Sum_probs=143.3
Q ss_pred ccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.+. ||||++++++|.++...||||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 131 (325)
T 3kn6_A 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRD 131 (325)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecC
Confidence 34555 99999999999999999999999999999999987 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC---CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGF---HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+|||++.++ .+||+|||++...... ........||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 132 lkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 209 (325)
T 3kn6_A 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209 (325)
T ss_dssp CCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHEEEecCCCcccEEEeccccceecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 999999997665 7999999999864322 12233456899999999999999999999999999999999999999
Q ss_pred CCCCCCCC-cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGE-HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
........ .........+......+. . .........+.+|+.+||+.||.+|||+.||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~~~~~~---~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 210 QSHDRSLTCTSAVEIMKKIKKGDFSFE---G-----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp C-------CCCHHHHHHHHTTTCCCCC---S-----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCccccccccHHHHHHHHHcCCCCCC---c-----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 75433211 111111111111110000 0 001123567889999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=288.79 Aligned_cols=213 Identities=27% Similarity=0.388 Sum_probs=168.4
Q ss_pred ccCC-CCCCcccceEEEEeCC-eEEEEEeccCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPD------------KEPLDWNTRMKIAAGAAKGLEY 67 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~aL~~ 67 (380)
|+++ +||||++++++|...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 3445 7999999999987755 489999999999999999873221 2238999999999999999999
Q ss_pred HhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHH
Q 016913 68 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVF 147 (380)
Q Consensus 68 LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl 147 (380)
||+.+ |+|+||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++
T Consensus 164 lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 164 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 99999 999999999999999999999999999865433333333456678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 148 LELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 148 ~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
|+|++ |..||....... ...... ..... ...+......+.+++.+||+.+|.+|||+.+|++.
T Consensus 241 ~~l~t~g~~p~~~~~~~~--~~~~~~----~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 241 WEIFSLGASPYPGVKIDE--EFCRRL----KEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTTSCCSSTTCCCSH--HHHHHH----HHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCcccchhH--HHHHHh----ccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99998 999997543221 111111 11000 01112234678899999999999999999999999
Q ss_pred HHHhhhc
Q 016913 227 LTYLASQ 233 (380)
Q Consensus 227 L~~~~~~ 233 (380)
|+.+...
T Consensus 305 L~~~~~~ 311 (316)
T 2xir_A 305 LGNLLQA 311 (316)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 9987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=284.47 Aligned_cols=198 Identities=24% Similarity=0.354 Sum_probs=157.8
Q ss_pred ccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.++||||+++++++.+ .+..|+||||+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 568899999999999987 568999999999999987653 357999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC---CCCcCceeehHHHHHHHHhCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~SlGvvl~elltG~~p 156 (380)
||||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999998643221 2234467999999999987654 47889999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|..... ......+......++. .......+.+|+.+||+.||.+|||+.||++
T Consensus 240 f~~~~~------~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERI------MCLHSKIKSQALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSH------HHHHHHHHHCCCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccH------HHHHHHHhcccCCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 974321 1111111111111110 1123467889999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=286.16 Aligned_cols=219 Identities=24% Similarity=0.306 Sum_probs=162.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+|+.++|||||++++++..++..+|||||++ ++|.+++.... .....+++..+..++.||+.||.|||+.+ |+|
T Consensus 56 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH 131 (317)
T 2pmi_A 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILH 131 (317)
T ss_dssp HHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 3678999999999999999999999999997 69999987521 22346999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||||+|||++.++.+||+|||++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus 132 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 209 (317)
T 2pmi_A 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209 (317)
T ss_dssp CCCCGGGEEECTTCCEEECCCSSCEETTSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCChHHeEEcCCCCEEECcCccceecCCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999864322 1222345789999999999764 6899999999999999999999999
Q ss_pred CCCCCCCCcchhhh-hhh----cccccCCCCCC-----------CCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 158 DNTRPPGEHNLVAW-ARP----LFKDRRKFPKM-----------ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 158 ~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~-----------~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
...........+.. ... .+......+.. +...+....+......+.+|+.+||+.||++|||+.
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 289 (317)
T 2pmi_A 210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK 289 (317)
T ss_dssp CCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHH
Confidence 75432211111000 000 00000000000 000011111123346789999999999999999999
Q ss_pred HHHH
Q 016913 222 DVVT 225 (380)
Q Consensus 222 evl~ 225 (380)
|+++
T Consensus 290 e~l~ 293 (317)
T 2pmi_A 290 QALH 293 (317)
T ss_dssp HHTT
T ss_pred HHhC
Confidence 9986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.09 Aligned_cols=212 Identities=23% Similarity=0.390 Sum_probs=169.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|+.++||||+++++++.+++..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++
T Consensus 81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 158 (322)
T 1p4o_A 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158 (322)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3678899999999999999999999999999999999997521 11246799999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-C
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-G 153 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G 153 (380)
|+||||||+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 159 -i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 159 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999975432222222334567889999999999999999999999999999999 8
Q ss_pred CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
..||...... ...... ... ... ..+...+..+.+|+.+||+.+|.+|||+.||++.|+.+..
T Consensus 238 ~~p~~~~~~~---~~~~~~---~~~--~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 238 EQPYQGLSNE---QVLRFV---MEG--GLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCTTTTSCHH---HHHHHH---HTT--CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCccccCCHH---HHHHHH---HcC--CcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 8898754221 111111 110 000 1122345678899999999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=291.01 Aligned_cols=193 Identities=27% Similarity=0.421 Sum_probs=159.9
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
++||||+++++++.+.+..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~ 147 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLD 147 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChh
Confidence 4899999999999999999999999999999999976 457999999999999999999999999 999999999
Q ss_pred cEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 85 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 148 NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~- 224 (345)
T 1xjd_A 148 NILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE- 224 (345)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred hEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999998532211 2234567999999999999999999999999999999999999999754221
Q ss_pred CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 016913 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG-DVV 224 (380)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-evl 224 (380)
... ..+...... ++......+.+|+.+||+.||.+||++. +|+
T Consensus 225 --~~~---~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 225 --ELF---HSIRMDNPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --HHH---HHHHHCCCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --HHH---HHHHhCCCC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111 111111111 1222346788999999999999999997 664
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=290.53 Aligned_cols=214 Identities=28% Similarity=0.425 Sum_probs=168.7
Q ss_pred ccCCCCCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.++||||+++++++.+. ...++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~ 158 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHR 158 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 5678999999999999884 678999999999999999976 45999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+|||++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 159 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 99999999999999999999999875433221 12334567888999999999999999999999999999999999986
Q ss_pred CCCCC---------CCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 159 NTRPP---------GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 159 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
..... ....... ..... ........+...+..+.+|+.+||+.+|.+|||+.||++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 239 SPPTKFLELIGIAQGQMTVLR-LTELL----------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp SHHHHHHHHHCSCCHHHHHHH-HHHHH----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhhhhhhcccccchhHHH-HHHHH----------hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 42110 0000000 00000 1111112233445789999999999999999999999999998
Q ss_pred hhhcc
Q 016913 230 LASQT 234 (380)
Q Consensus 230 ~~~~~ 234 (380)
+....
T Consensus 308 l~~~~ 312 (318)
T 3lxp_A 308 VHEKY 312 (318)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 86544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.66 Aligned_cols=201 Identities=23% Similarity=0.298 Sum_probs=154.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||++++++|...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||
T Consensus 102 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di 174 (349)
T 2w4o_A 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDL 174 (349)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 5678999999999999999999999999999999999975 466999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|||++. ++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 175 kp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp CGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CcccEEEecCCCCCCEEEccCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 999999975 789999999999864221 12234678999999999999999999999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... ... ..+......+ .. .........+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~--~~~---~~i~~~~~~~---~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 252 DERGDQ--FMF---RRILNCEYYF---IS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTTCHH--HHH---HHHHTTCCCC---CT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccH--HHH---HHHHhCCCcc---CC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 432211 011 1111111110 11 111234567889999999999999999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=287.77 Aligned_cols=197 Identities=25% Similarity=0.348 Sum_probs=161.2
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|..+ +||||+++++++.+.+..|+||||++|++|.+++.. ...+++..++.++.||+.||+|||+.+ |+|||
T Consensus 74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 146 (353)
T 2i0e_A 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 146 (353)
T ss_dssp HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecc
Confidence 3444 899999999999999999999999999999999976 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 147 lkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 147 LKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEcCCCcEEEEeCCcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999853221 12234567999999999999999999999999999999999999999753
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 225 (380)
.. ......+...... +|......+.+|+.+||+.||.+||+ +.+|++
T Consensus 225 ~~------~~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 225 DE------DELFQSIMEHNVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SH------HHHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CH------HHHHHHHHhCCCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 22 1111122221111 22234567889999999999999996 466654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=281.56 Aligned_cols=211 Identities=30% Similarity=0.412 Sum_probs=160.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh---CCCCCeEe
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD---KANPPVIY 78 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~---~~~~~iiH 78 (380)
|++++||||+++++++.+ ..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+ ++ |+|
T Consensus 55 l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH 128 (307)
T 2eva_A 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIH 128 (307)
T ss_dssp HHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCC
T ss_pred HhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eec
Confidence 567899999999998873 4799999999999999998621 12347899999999999999999999 77 999
Q ss_pred cCCCCCcEEEcCCCC-eEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 79 RDLKSSNILLDEGFH-PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 79 rDIkp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||||+|||++.++. +||+|||++..... ......||..|+|||++.+..++.++||||||+++|||++|..||
T Consensus 129 ~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 203 (307)
T 2eva_A 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203 (307)
T ss_dssp CCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred CCCChhHEEEeCCCCEEEEccccccccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999999999988876 79999999975321 123346899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccCCC
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDP 237 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 237 (380)
....... ....+. ... ...+ ..+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+.......
T Consensus 204 ~~~~~~~--~~~~~~--~~~--~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 204 DEIGGPA--FRIMWA--VHN--GTRP---------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp TTTCSSH--HHHHHH--HHT--TCCC---------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred hhhCccH--HHHHHH--Hhc--CCCC---------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 7542211 111111 000 0001 111233467889999999999999999999999999987655443
Q ss_pred C
Q 016913 238 N 238 (380)
Q Consensus 238 ~ 238 (380)
.
T Consensus 269 ~ 269 (307)
T 2eva_A 269 D 269 (307)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=279.61 Aligned_cols=212 Identities=23% Similarity=0.275 Sum_probs=159.6
Q ss_pred CCCCCCcccceEEEEeCC-----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 4 LLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
.++||||++++++|.... ..++||||+. ++|.+++... ....+++..++.++.||+.||+|||+.+ |+|
T Consensus 70 ~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH 143 (308)
T 3g33_A 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVH 143 (308)
T ss_dssp HHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred hcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 346999999999998765 5799999996 7999999872 3344999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||||+|||++.++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999864322 22344678999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCC---CCccccC-------CCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKM---ADPLLQG-------RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~-------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..........+........ ....+.. ....+.. ....+....+.+|+.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 221 GNSEADQLGKIFDLIGLPP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSHHHHHHHHHHHHCCCC-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHhCCCC-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 5432211111100000000 0000000 0000000 011234567889999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=290.16 Aligned_cols=204 Identities=22% Similarity=0.296 Sum_probs=154.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||||++++++.+.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dl 142 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDL 142 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCC
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999976 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC--eEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCc-CceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFH--PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK-SDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDV~SlGvvl~elltG~~p~~ 158 (380)
||+||||+.++. +||+|||+++.... ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.
T Consensus 143 kp~Nill~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 143 KLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp CGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CHHHEEEcCCCCceEEEeecCccccccc---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 999999987765 99999999974221 122334579999999999998887655 899999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
........ ......+......++. .......+.+|+.+||+.+|.+|||+.||++.-
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 220 DPEEPRDY--RKTIQRILSVKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp ----CCCH--HHHHHHHHTTCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCccHHHH--HHHHHHHhcCCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 64432221 1111111111111111 112346788999999999999999999998753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=292.03 Aligned_cols=218 Identities=27% Similarity=0.350 Sum_probs=167.9
Q ss_pred ccCCCCCCcccceEEEE--eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++||||+++++++. +....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~ 151 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHR 151 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 57889999999999987 45678999999999999999976 2346999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+||||+.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 152 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 152 DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999875433221 12234568888999999999999999999999999999999999985
Q ss_pred CCCCCC--------CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 159 NTRPPG--------EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 159 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
...... ............ ........+......+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 232 SPSAEFLRMMGCERDVPALSRLLELL----------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp SHHHHHHHHCC----CCHHHHHHHHH----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred cccchhhhhcccccccccHHHHHHHh----------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 321100 000000000000 01111122344567889999999999999999999999999987
Q ss_pred hhccC
Q 016913 231 ASQTY 235 (380)
Q Consensus 231 ~~~~~ 235 (380)
.....
T Consensus 302 ~~~~~ 306 (327)
T 3lxl_A 302 WSGSR 306 (327)
T ss_dssp -----
T ss_pred Hhhhc
Confidence 65443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=283.59 Aligned_cols=192 Identities=25% Similarity=0.319 Sum_probs=160.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++++||||++++++|.+.+..++||||+.++ +|.+++.. ...+++..++.++.||+.||.|||+.+ |+||
T Consensus 82 ~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 154 (335)
T 3dls_A 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHR 154 (335)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEe
Confidence 367889999999999999999999999998666 99999976 457999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 155 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 155 DIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred ccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 999999999999999999999998643322 2234569999999999988876 789999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.... ...... ..+......+.+|+.+||+.||.+|||+.+|++.
T Consensus 232 ~~~~------------~~~~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 232 ELEE------------TVEAAI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SGGG------------GTTTCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hHHH------------HHhhcc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4210 000000 0111234578899999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=276.68 Aligned_cols=197 Identities=26% Similarity=0.412 Sum_probs=160.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||++++++|.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dl 135 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDI 135 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCC
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccC
Confidence 5788999999999999999999999999999999999976 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.++|+|||++..... .......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 136 kp~Nili~~~~~~~l~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 136 KPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp CGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChHhEEEcCCCCEEEEeccccccCCc----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 99999999999999999999864322 12234578999999999999999999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
... .. ..+...... ++......+.+|+.+||+.+|.+|||+.||++.-
T Consensus 212 ~~~---~~---~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 212 YQE---TY---KRISRVEFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHH---HH---HHHHHTCCC------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHH---HH---HHHHhCCCC------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 211 11 111111111 1222346788999999999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=302.33 Aligned_cols=208 Identities=27% Similarity=0.391 Sum_probs=162.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++.+ +..+||||||++++|.+++.. .....+++..++.++.||+.||+|||+++ |+|||
T Consensus 232 ~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrD 305 (452)
T 1fmk_A 232 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 305 (452)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 3678899999999999876 678999999999999999975 12356999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+|||++.++.+||+|||+++...... ........++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 306 lkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 306 LRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp CSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998643221 112233456789999999999999999999999999999999 8999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... .....+ .... ....+...+..+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 385 ~~~~---~~~~~i----~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 385 MVNR---EVLDQV----ERGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCHH---HHHHHH----HTTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCHH---HHHHHH----HcCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 4221 111111 1110 011223445678899999999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=281.58 Aligned_cols=206 Identities=22% Similarity=0.320 Sum_probs=163.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+ +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 67 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 139 (281)
T 3cc6_A 67 MKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDI 139 (281)
T ss_dssp HHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 567899999999999865 457899999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 140 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 140 AVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp SGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 99999999999999999999986432211 12233557889999999999999999999999999999998 99999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ...... ..... ..+......+.+|+.+||+.+|.+|||+.||++.|+.+..
T Consensus 219 ~~~~---~~~~~~----~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 219 ENKD---VIGVLE----KGDRL----------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CGGG---HHHHHH----HTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChHH---HHHHHh----cCCCC----------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 3221 111111 00000 1112234678899999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=286.83 Aligned_cols=202 Identities=24% Similarity=0.279 Sum_probs=160.9
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
.+||||++++++|.+++..|+|||||++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 73 ~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~ 145 (342)
T 2qr7_A 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPS 145 (342)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred cCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHH
Confidence 3799999999999999999999999999999999976 467999999999999999999999999 999999999
Q ss_pred cEEEcCC----CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 85 NILLDEG----FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 85 NILl~~~----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+..+ +.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 146 NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 146 NILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp GEEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred HEEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 9998543 349999999998643321 2233467899999999999888999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.......+...+ ......+ ...+.......+.+|+.+||+.||++|||+.+|++.
T Consensus 224 ~~~~~~~~~~~i---~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 224 PDDTPEEILARI---GSGKFSL--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTSCHHHHHHHH---HHCCCCC--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CcCCHHHHHHHH---ccCCccc--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 322222222111 1111111 111222345678899999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=275.87 Aligned_cols=216 Identities=19% Similarity=0.233 Sum_probs=168.4
Q ss_pred ccCCCCCCcccceEEE-EeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++.++|+|++..+.++ ..++..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 130 (296)
T 4hgt_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 130 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4567788877776655 6778889999999 8999999985 3456999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCCeEEeecCCcccCCCCCCc-----cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 81 LKSSNILL---DEGFHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 81 Ikp~NILl---~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
|||+|||+ +.++.+||+|||++......... .......||..|+|||++.+..++.++|||||||++|+|++
T Consensus 131 lkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 4hgt_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp CSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc
Confidence 99999999 78899999999999875433221 12234679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
|..||..................... . ..+.+. ...+..+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 211 GSLPWQGLKAATKRQKYERISEKKMS---T---PIEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHHHH---S---CHHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCCcccchhhhhhhhhhhhccccc---c---hhhhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 99999865544333332221110000 0 000011 1224578899999999999999999999999998865
Q ss_pred cc
Q 016913 233 QT 234 (380)
Q Consensus 233 ~~ 234 (380)
..
T Consensus 281 ~~ 282 (296)
T 4hgt_A 281 RQ 282 (296)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=286.31 Aligned_cols=191 Identities=21% Similarity=0.181 Sum_probs=153.5
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
++||||++++++|.+++..||||||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~ 186 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPA 186 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH
Confidence 48999999999999999999999999 6899999876 3457999999999999999999999999 999999999
Q ss_pred cEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCC
Q 016913 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 164 (380)
Q Consensus 85 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~ 164 (380)
||||+.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|||++|..|+...
T Consensus 187 NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---- 258 (311)
T 3p1a_A 187 NIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---- 258 (311)
T ss_dssp GEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----
T ss_pred HEEECCCCCEEEccceeeeecccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----
Confidence 999999999999999999764322 22344569999999999876 7899999999999999999997665321
Q ss_pred CcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 165 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... . . ....+. ++......+.+|+.+||+.||++|||+.||++
T Consensus 259 -~~~~~~----~-~-----~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 259 -EGWQQL----R-Q-----GYLPPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HHHHHH----T-T-----TCCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cHHHHH----h-c-----cCCCcc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011000 0 0 001111 11233467899999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=285.72 Aligned_cols=213 Identities=23% Similarity=0.333 Sum_probs=164.6
Q ss_pred ccCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 2 LSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
|++++||||+++++++.. ....++||||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---iv 156 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YA 156 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 567899999999999873 34789999999999999999864445677999999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc-------ccccccccccccchhhhhcCC---CCCcCceeehHHHH
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-------VSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVF 147 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~SlGvvl 147 (380)
|+||||+|||++.++.+||+|||++.......... ......||..|+|||++.... ++.++||||||+++
T Consensus 157 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999987532111100 012345799999999987653 68999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 148 LELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
|+|++|..||........ ....... ....+ ..+......+.+|+.+||+.||.+|||+.+|++.|
T Consensus 237 ~el~~g~~p~~~~~~~~~-~~~~~~~----~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 237 YAMMFGEGPYDMVFQKGD-SVALAVQ----NQLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHHSSCTTHHHHHTTS-CHHHHHH----CC--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhhhcccc-hhhHHhh----ccCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 999999999953211111 1111000 00000 11123346788999999999999999999999999
Q ss_pred HHhhh
Q 016913 228 TYLAS 232 (380)
Q Consensus 228 ~~~~~ 232 (380)
+.+..
T Consensus 302 ~~~~~ 306 (317)
T 2buj_A 302 EALQP 306 (317)
T ss_dssp HHTCC
T ss_pred hhcCC
Confidence 98753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=281.47 Aligned_cols=214 Identities=26% Similarity=0.338 Sum_probs=166.0
Q ss_pred CCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCC
Q 016913 5 LHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH--------DKA 72 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~ 72 (380)
++||||+++++++.... ..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 167 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC
Confidence 79999999999998876 78999999999999999976 46999999999999999999999 788
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc--ccccccccccccchhhhhcC------CCCCcCceeehH
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFG 144 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlG 144 (380)
|+|+||||+||||+.++.+||+|||++.......... ......||..|+|||++.+. .++.++||||||
T Consensus 168 ---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 244 (342)
T 1b6c_B 168 ---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244 (342)
T ss_dssp ---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHH
T ss_pred ---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHH
Confidence 9999999999999999999999999997643322111 22345799999999999875 334789999999
Q ss_pred HHHHHHHhC----------CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCC-CChhhHHHHHHHHHHhhhhC
Q 016913 145 VVFLELITG----------RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR-YPMRGLYQALAVAAMCLQEQ 213 (380)
Q Consensus 145 vvl~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~~ 213 (380)
|++|||++| ..||......... ...+...... ....+.+... ........+.+|+.+||+.|
T Consensus 245 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 317 (342)
T 1b6c_B 245 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317 (342)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSS
T ss_pred HHHHHHHhccCcCCcccccccCccccCcCccc-HHHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccC
Confidence 999999999 6677644332211 1111111111 0111111111 12356778999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 016913 214 AATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 214 P~~RPt~~evl~~L~~~~~~ 233 (380)
|++|||+.+|++.|+.+..+
T Consensus 318 p~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 318 GAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp GGGSCCHHHHHHHHHHHHHT
T ss_pred hhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=281.91 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=163.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dl 167 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDL 167 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCC
Confidence 5678999999999999999999999999999999999876 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++....... .......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 168 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 168 KLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CchhEEEcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 9999999999999999999998643221 22344678999999999999999999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. .....+......+ +......+.+|+.+||+.||++|||+.||++.
T Consensus 246 ~~------~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 246 LK------ETYLRIKKNEYSI------------PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HH------HHHHHHHHTCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HH------HHHHHHhcCCCCC------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1111111111111 12234567899999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=281.34 Aligned_cols=208 Identities=20% Similarity=0.206 Sum_probs=158.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 160 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDV 160 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCC
Confidence 5788999999999999999999999999999999999986 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++....... ........|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 161 KPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp CGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 9999999999999999999997643221 112234568999999999999899999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhhh
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-LIGDVVTALTYLAS 232 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~~ 232 (380)
.. ... ........... ..+...+..+.+|+.+||+.||++|| ++.++++.|+.+..
T Consensus 240 ~~---~~~----~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 240 LS---VMG----AHINQAIPRPS--------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp HH---HHH----HHHHSCCCCGG--------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred HH---HHH----HHhccCCCCcc--------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 11 111 11111000000 11122345788999999999999999 99999999987643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=292.82 Aligned_cols=201 Identities=21% Similarity=0.269 Sum_probs=162.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||||+++++|.+.+.+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDL 194 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 194 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999999976 46999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC----CCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||+||||+.++.+||+|||+++...... ........||+.|+|||++.... ++.++|||||||++|||++|..||
T Consensus 195 Kp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 195 KPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred CHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 9999999999999999999998643221 11233567999999999998765 889999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhccccc--CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDR--RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTAL 227 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~L 227 (380)
...... .....+.... ..++. .......+.+|+.+||+.+|.+ ||++.||++.-
T Consensus 274 ~~~~~~------~~~~~i~~~~~~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 274 YADSLV------GTYSKIMNHKNSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCSSHH------HHHHHHHTHHHHCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred CCCChh------hHHHHHHhccccccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 754221 1111111110 01111 1123467889999999999988 99999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.49 Aligned_cols=198 Identities=25% Similarity=0.381 Sum_probs=163.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 69 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 141 (476)
T 2y94_A 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRD 141 (476)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCccc
Confidence 36789999999999999999999999999999999999975 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 142 Lkp~NIll~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 142 LKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccHHHEEEecCCCeEEEeccchhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999865332 22334579999999999988765 6899999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.... .. ...+...... .+......+.+|+.+||+.||.+|||+.||++.
T Consensus 219 ~~~~---~~---~~~i~~~~~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 219 DHVP---TL---FKKICDGIFY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp SSSH---HH---HHHHHTTCCC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCHH---HH---HHHHhcCCcC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 4321 11 1111111111 112234578899999999999999999999973
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=277.76 Aligned_cols=202 Identities=26% Similarity=0.314 Sum_probs=156.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..++||||+++++|.+++.........+++..++.++.||+.||+|||+.+ |+|+||
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~di 150 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDL 150 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCC
Confidence 67889999999999999999999999999999999999653223467999999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|||+ +.++.+||+|||++...... .......|+..|+|||++. ..++.++||||||+++|+|++|..||.
T Consensus 151 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 151 KPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp SGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCCEEEEeeecceecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 9999999 44578999999999764322 2234466899999999876 578999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
............ .....+.... ......+.+|+.+||+.||.+|||+.||++
T Consensus 227 ~~~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 227 GTSLEEVQQKAT------YKEPNYAVEC---------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CSSHHHHHHHHH------HCCCCCCC-----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHhhhc------cCCccccccc---------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 543211111111 1111111100 012357889999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=313.07 Aligned_cols=207 Identities=24% Similarity=0.378 Sum_probs=164.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.. +..+||||||++++|.+++.. ...+++..++.|+.||+.||+|||+++ |||||
T Consensus 423 il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrD 494 (635)
T 4fl3_A 423 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRD 494 (635)
T ss_dssp HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCC
Confidence 3667899999999999975 558899999999999999976 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||+||||+.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 495 Lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 495 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp CSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865432221 22233457789999999999999999999999999999998 999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
..... .....+. ... ....+...+..+.+|+..||+.||++|||+.+|++.|+.+..
T Consensus 575 ~~~~~---~~~~~i~----~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 575 GMKGS---EVTAMLE----KGE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp TCCHH---HHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHH---HHHHHHH----cCC----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 54321 1111111 100 111223445788999999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=280.88 Aligned_cols=209 Identities=27% Similarity=0.443 Sum_probs=166.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.. +..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 135 (279)
T 1qpc_A 62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135 (279)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 567899999999999864 568999999999999999975 11236999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 136 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 136 RAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986533221 12233456789999999998899999999999999999999 89999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhcc
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 234 (380)
... ...... ... .. ...+......+.+|+.+||+.+|++|||+.+|++.|+.+....
T Consensus 215 ~~~---~~~~~~---~~~---~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 215 TNP---EVIQNL---ERG---YR--------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CHH---HHHHHH---HTT---CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHH---HHHHHH---hcc---cC--------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 221 111111 110 00 0112234568889999999999999999999999999886543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=274.95 Aligned_cols=199 Identities=25% Similarity=0.336 Sum_probs=164.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 141 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDL 141 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999876 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+|||++.++.+||+|||++....... .......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 142 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 142 KLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChHhEEEcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998643221 22334678999999999999899999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
.. .....+...... .+......+.+|+.+||+.||++|||+.||++.-
T Consensus 220 ~~------~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 220 LK------ETYLRIKKNEYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HH------HHHHHHHTTCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred HH------HHHHHHhhccCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 21 111111111111 1222345788999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=289.83 Aligned_cols=203 Identities=21% Similarity=0.292 Sum_probs=154.8
Q ss_pred ccCCCC--CCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHH--SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.++| |||+++++++..++..||||||. +++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||
T Consensus 61 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHr 132 (343)
T 3dbq_A 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 132 (343)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHhhhhcCCceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 445665 99999999999999999999965 7999999987 567999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----------CCCCCcCceeehHHHHH
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~SlGvvl~ 148 (380)
||||+||||+ ++.+||+|||++................||+.|+|||++.+ ..++.++|||||||++|
T Consensus 133 Dikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ 211 (343)
T 3dbq_A 133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211 (343)
T ss_dssp CCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHH
T ss_pred CCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHH
Confidence 9999999997 57899999999987543333333345679999999999975 67899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 149 ELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 149 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
+|++|..||..... .......... +.....++......+.+|+.+||+.||.+|||+.||++...
T Consensus 212 ell~g~~pf~~~~~-----~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 212 YMTYGKTPFQQIIN-----QISKLHAIID----------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHHHSSCTTTTCCS-----HHHHHHHHHC----------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHhCCCcchhhhh-----HHHHHHHHhc----------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 99999999964321 1111111111 11111222233457889999999999999999999997643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.19 Aligned_cols=203 Identities=21% Similarity=0.214 Sum_probs=163.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||||+++++|.+.+.+|||||||++|+|.+++.. ....+++..+..++.||+.||.|||+.+ ||||||
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDL 201 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDI 201 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccc
Confidence 5678999999999999999999999999999999999976 3467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||+||||+.++.+||+|||+++...... ........||+.|+|||++. ...++.++|||||||++|||++|..|
T Consensus 202 Kp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P 280 (437)
T 4aw2_A 202 KPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280 (437)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred CHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence 9999999999999999999997643222 22234467999999999997 45789999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccc--cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKD--RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTA 226 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 226 (380)
|........ . ..+... ...++... ......+.+|+.+||+.+|+. ||+++||++.
T Consensus 281 f~~~~~~~~---~---~~i~~~~~~~~~p~~~---------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 281 FYAESLVET---Y---GKIMNHKERFQFPTQV---------TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp TCCSSHHHH---H---HHHHTHHHHCCCCSSC---------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCCCChhHH---H---HhhhhccccccCCccc---------ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 975432111 1 111110 11111111 123467889999999988888 9999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=279.93 Aligned_cols=201 Identities=26% Similarity=0.348 Sum_probs=163.3
Q ss_pred ccCCCCCCcccceEEEEe----------------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 016913 2 LSLLHHSNLVNLIGYCAD----------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 65 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~----------------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL 65 (380)
|++++||||+++++++.. ....++||||+++++|.+++... ....+++..++.++.||+.||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l 135 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGV 135 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHH
Confidence 567899999999999865 34579999999999999999762 235799999999999999999
Q ss_pred HHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHH
Q 016913 66 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 145 (380)
Q Consensus 66 ~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGv 145 (380)
.|||+.+ |+|+||||+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++||||||+
T Consensus 136 ~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (284)
T 2a19_B 136 DYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209 (284)
T ss_dssp HHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHH
T ss_pred HHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHH
Confidence 9999999 9999999999999999999999999998643322 223456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 146 VFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 146 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
++|+|++|..|+... ......+. . .. .+......+.+|+.+||+.||.+|||+.||++
T Consensus 210 il~~l~~~~~~~~~~--------~~~~~~~~-~-~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 267 (284)
T 2a19_B 210 ILAELLHVCDTAFET--------SKFFTDLR-D-GI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267 (284)
T ss_dssp HHHHHHSCCSSHHHH--------HHHHHHHH-T-TC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCcchhH--------HHHHHHhh-c-cc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999998876421 11111110 0 01 11123356789999999999999999999999
Q ss_pred HHHHhhh
Q 016913 226 ALTYLAS 232 (380)
Q Consensus 226 ~L~~~~~ 232 (380)
.|..+..
T Consensus 268 ~l~~~~~ 274 (284)
T 2a19_B 268 TLTVWKK 274 (284)
T ss_dssp HHHHHTC
T ss_pred HHHHHhh
Confidence 9998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=281.32 Aligned_cols=210 Identities=22% Similarity=0.305 Sum_probs=160.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+|
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~d 155 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 36788999999999999999999999999999999999976 3457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCC---Cccccccccccccccchhhhhc---------CCCCCcCceeehHHHHH
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEYAMT---------GQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDV~SlGvvl~ 148 (380)
|||+|||++ ++.+||+|||++....... .........|+..|+|||++.. ..++.++||||||+++|
T Consensus 156 lkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 234 (319)
T 2y4i_B 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234 (319)
T ss_dssp CCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred CChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence 999999998 6799999999987542211 1122234568999999999874 35788999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 149 ELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 149 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
+|++|..||...... ..... .... ..+.... ......+.+|+.+||+.+|.+|||+.+|++.|+
T Consensus 235 el~~g~~p~~~~~~~---~~~~~---~~~~--~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 235 ELHAREWPFKTQPAE---AIIWQ---MGTG--MKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp HHHHSSCSSSSCCHH---HHHHH---HHTT--CCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred HHHhCCCCCCCCCHH---HHHHH---hccC--CCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 999999999753221 11111 1110 0011111 112345789999999999999999999999999
Q ss_pred Hhhhc
Q 016913 229 YLASQ 233 (380)
Q Consensus 229 ~~~~~ 233 (380)
.+...
T Consensus 299 ~l~~~ 303 (319)
T 2y4i_B 299 KLPKR 303 (319)
T ss_dssp TC---
T ss_pred HHHHh
Confidence 87544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=288.47 Aligned_cols=211 Identities=25% Similarity=0.375 Sum_probs=166.6
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
|++++||||+++++++...+..||||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H 163 (327)
T 2yfx_A 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIH 163 (327)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eec
Confidence 5678999999999999999999999999999999999987322 1245999999999999999999999999 999
Q ss_pred cCCCCCcEEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CC
Q 016913 79 RDLKSSNILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GR 154 (380)
Q Consensus 79 rDIkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~ 154 (380)
+||||+|||++. +..+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 164 ~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 243 (327)
T 2yfx_A 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 243 (327)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999984 45699999999975433222223344567899999999999999999999999999999998 88
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.||...... ...... ... .. ...+......+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 244 ~p~~~~~~~---~~~~~~---~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 244 MPYPSKSNQ---EVLEFV---TSG-GR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CSSTTCCHH---HHHHHH---HTT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCHH---HHHHHH---hcC-CC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 999754221 111111 110 00 01122334678899999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=280.55 Aligned_cols=200 Identities=26% Similarity=0.299 Sum_probs=162.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~di 141 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDL 141 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGF----HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||+|||++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 142 kp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp SGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred ChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC
Confidence 99999999887 79999999998643321 223456899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... ... ..+..... ..++.+. ......+.+|+.+||+.||.+|||+.|+++
T Consensus 219 ~~~~~~---~~~---~~i~~~~~----~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 219 LGDTKQ---ETL---ANITSVSY----DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCSSHH---HHH---HHHHTTCC----CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCHH---HHH---HHHHhccc----ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 753211 111 11111100 0111111 123457889999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=281.50 Aligned_cols=216 Identities=24% Similarity=0.292 Sum_probs=158.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dl 128 (311)
T 4agu_A 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDV 128 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 5678999999999999999999999999999999998875 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.+||+|||++...... ........||..|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 129 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 129 KPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ChhhEEEcCCCCEEEeeCCCchhccCc--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999864322 122234578999999999986 57899999999999999999999999754
Q ss_pred CCCCCcchhhhh-h-------hcccccCCCCC--CCCccccCC---CChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWA-R-------PLFKDRRKFPK--MADPLLQGR---YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~-~-------~~~~~~~~~~~--~~~~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
........+... . ..+.....+.. ..++..... ........+.+|+.+||+.||.+|||+.||++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 332211111100 0 00000000000 000000000 001345578899999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=273.25 Aligned_cols=199 Identities=23% Similarity=0.257 Sum_probs=160.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||++++++|.+++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 132 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDL 132 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 5688999999999999999999999999999999999976 466999999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 133 kp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp SGGGEEESSSSTTCCEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCcEEEEecccceeccCc---cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCC
Confidence 9999999 77889999999999764322 22334568999999999876 48999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... ... ..+......++. .. .......+.+|+.+||+.||.+|||+.++++
T Consensus 209 ~~~~~---~~~---~~~~~~~~~~~~---~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 209 APTDS---EVM---LKIREGTFTFPE---KD-----WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CSSHH---HHH---HHHHHCCCCCCH---HH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCHH---HHH---HHHHhCCCCCCc---hh-----hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 53221 111 111111111100 00 0023467889999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=273.11 Aligned_cols=201 Identities=21% Similarity=0.279 Sum_probs=161.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di 131 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNL 131 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCC
Confidence 5678999999999999999999999999999999999876 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC---eEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFH---PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+||+++.++. +||+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 132 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 132 KPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CGGGEEESSSSTTCCEEECCCTTCEECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCcEEEeeceeeEEcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 999999976655 999999999764322 22234678999999999999999999999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..... .... .........+. + ........+.+|+.+||+.+|.+|||+.|+++.
T Consensus 209 ~~~~~---~~~~---~~~~~~~~~~~---~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 209 DEDQH---RLYA---QIKAGAYDYPS---P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CSSHH---HHHH---HHHHTCCCCCT---T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCchh---HHHH---HHHhccccCCc---h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 53221 1111 11111111110 0 011234678899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=283.94 Aligned_cols=207 Identities=15% Similarity=0.116 Sum_probs=167.0
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
...|+||+.+++++...+..|||||||++++|.+++..... ....+++..++.++.||+.||+|||+.+ |||||||
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiK 199 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIK 199 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCS
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCC
Confidence 34599999999999999999999999999999999974222 2467999999999999999999999999 9999999
Q ss_pred CCcEEEcC-----------CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHH
Q 016913 83 SSNILLDE-----------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 83 p~NILl~~-----------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ell 151 (380)
|+||||+. ++.+||+|||+++.+.............||..|+|||++.+..++.++||||||||+|||+
T Consensus 200 p~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 279 (365)
T 3e7e_A 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279 (365)
T ss_dssp GGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred HHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH
Confidence 99999998 8999999999997643333333445577999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHh
Q 016913 152 TGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR-PLIGDVVTALTYL 230 (380)
Q Consensus 152 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R-Pt~~evl~~L~~~ 230 (380)
+|..||....... ......+.. + .....+.+++..||+.+|.+| |++.++.+.|+.+
T Consensus 280 tg~~pf~~~~~~~-----------~~~~~~~~~---------~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 280 FGTYMKVKNEGGE-----------CKPEGLFRR---------L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp HSSCCCEEEETTE-----------EEECSCCTT---------C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred hCCCccccCCCCc-----------eeechhccc---------c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 9999985321100 000000111 1 124567789999999999999 6888899988887
Q ss_pred hhccC
Q 016913 231 ASQTY 235 (380)
Q Consensus 231 ~~~~~ 235 (380)
..+..
T Consensus 338 l~~~~ 342 (365)
T 3e7e_A 338 FQQHY 342 (365)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 65543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=280.51 Aligned_cols=205 Identities=27% Similarity=0.384 Sum_probs=159.9
Q ss_pred ccCCCCCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|++++||||+++++++... +..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 142 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 142 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 6788999999999997654 4789999999999999999761 1223899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.+||+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 143 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 143 LAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp CSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998753221 223457889999999999999999999999999999998 9999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
.... ....... .. .....+...+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 218 ~~~~---~~~~~~~----~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 218 IPLK---DVVPRVE----KG----------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp SCGG---GHHHHHT----TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHH---HHHHHHh----cC----------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 4321 1111110 00 00112233456788999999999999999999999999988654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=278.17 Aligned_cols=202 Identities=25% Similarity=0.378 Sum_probs=163.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
++.++||||+++++++.+++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 131 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDI 131 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 5678999999999999999999999999999999999865 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||+++.++.+||+|||++................|+..|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 132 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred ChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999976433222223345678999999999987765 78899999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... ....+.. . .. ... ........+.+|+.+||+.||.+|||+.||++
T Consensus 212 ~~~~~-~~~~~~~----~-~~---~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 212 SDSCQ-EYSDWKE----K-KT---YLN------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CTTSH-HHHHHHT----T-CT---TST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chHHH-HHHHhhh----c-cc---ccC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 33211 1111111 0 00 000 01233467889999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=283.81 Aligned_cols=208 Identities=24% Similarity=0.214 Sum_probs=157.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCC------------------------------------
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------------------------------ 45 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------------------------------------ 45 (380)
|+.++|||||+++++|.+.+..++|||||++++|.+++......
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 56789999999999999999999999999999999999631100
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCC--CeEEeecCCcccCCCCCCc--cccccccccc
Q 016913 46 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF--HPKLSDFGLAKLGPVGDKT--HVSTRVMGTY 121 (380)
Q Consensus 46 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~--~~kL~DFGla~~~~~~~~~--~~~~~~~gt~ 121 (380)
...+++..++.++.||+.||+|||+.+ |+|+||||+||||+.++ .+||+|||++..+...... .......||+
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 238 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence 123467889999999999999999999 99999999999998766 8999999999764322111 1234567999
Q ss_pred cccchhhhhc--CCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhH
Q 016913 122 GYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGL 199 (380)
Q Consensus 122 ~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 199 (380)
.|+|||++.+ ..++.++|||||||++|||++|..||...... ............+ ..+.. ....
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~---~~~~~-----~~~~ 304 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF---ENPNY-----NVLS 304 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT---TSGGG-----GGSC
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc---CCccc-----ccCC
Confidence 9999999975 67899999999999999999999999754321 1111111111111 11111 1234
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 200 YQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 200 ~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..+.+|+.+||+.+|.+|||+.++++.
T Consensus 305 ~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 305 PLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 678899999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=284.31 Aligned_cols=215 Identities=19% Similarity=0.264 Sum_probs=155.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++.+++..+|||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~D 157 (329)
T 3gbz_A 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRD 157 (329)
T ss_dssp HGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCC
Confidence 3678999999999999999999999999997 699999987 456999999999999999999999999 99999
Q ss_pred CCCCcEEEc-----CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLD-----EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~-----~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||+||||+ ..+.+||+|||++...... ........||..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 158 lkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 235 (329)
T 3gbz_A 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235 (329)
T ss_dssp CCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEecCCCCccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999994 4556999999999764321 1223345689999999999874 5899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccc------------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKD------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
.||...........+......... ...++......+....+......+.+|+.+||+.||.+|||+.|
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 315 (329)
T 3gbz_A 236 PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315 (329)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 999754321111100000000000 00011111111111111123467889999999999999999999
Q ss_pred HHH
Q 016913 223 VVT 225 (380)
Q Consensus 223 vl~ 225 (380)
|++
T Consensus 316 ~l~ 318 (329)
T 3gbz_A 316 ALE 318 (329)
T ss_dssp HHT
T ss_pred HhC
Confidence 986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=271.27 Aligned_cols=216 Identities=19% Similarity=0.234 Sum_probs=167.7
Q ss_pred ccCCCCCCcccceEEE-EeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
++.++|++++..+.++ ..++..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 130 (296)
T 3uzp_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 130 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCC
Confidence 4567888877666655 6677889999999 8999999975 3457999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCCeEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 81 LKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 81 Ikp~NILl---~~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
|||+|||+ +.++.+||+|||++.......... ......||..|+|||++.+..++.++|||||||++|+|++
T Consensus 131 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 3uzp_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh
Confidence 99999999 488899999999998754332211 1244679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
|..||..................... . ..+.+. ...+..+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 211 GSLPWQGLKAATKRQKYERISEKKMS---T---PIEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHHHH---S---CHHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcCchhhhhhhhhhcccccC---C---chHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 99999865544333222221110000 0 000011 1234678899999999999999999999999998765
Q ss_pred cc
Q 016913 233 QT 234 (380)
Q Consensus 233 ~~ 234 (380)
..
T Consensus 281 ~~ 282 (296)
T 3uzp_A 281 RQ 282 (296)
T ss_dssp HT
T ss_pred hc
Confidence 43
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=288.53 Aligned_cols=145 Identities=28% Similarity=0.363 Sum_probs=130.2
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
+.|||||++++++...+..+|||||+ +++|.+++.. .....+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 166 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPE 166 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcc
Confidence 45999999999999999999999999 8999999987 23346999999999999999999999999 999999999
Q ss_pred cEEEcC-------------------------CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCc
Q 016913 85 NILLDE-------------------------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 139 (380)
Q Consensus 85 NILl~~-------------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sD 139 (380)
||||+. ++.+||+|||++..... ......||+.|+|||++.+..++.++|
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccc
Confidence 999975 78899999999986322 223467899999999999999999999
Q ss_pred eeehHHHHHHHHhCCCCCCCC
Q 016913 140 VYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 140 V~SlGvvl~elltG~~p~~~~ 160 (380)
||||||++|+|++|..||...
T Consensus 242 iwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCCS
T ss_pred hHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=285.85 Aligned_cols=216 Identities=25% Similarity=0.362 Sum_probs=159.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||++++++|.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dl 150 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDI 150 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCc
Confidence 5678999999999999999999999999998889888764 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||||+.++.+||+|||++...... ........|+..|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 151 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 151 KPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp CGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ChheEEEcCCCcEEEEeCCCceeecCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999764322 1223345689999999999875 7899999999999999999999999754
Q ss_pred CCCCCcchhhh--------hhhcccccCCCCCCCCccccCCC-----ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAW--------ARPLFKDRRKFPKMADPLLQGRY-----PMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
........+.. ....+.....+.....+.+.... .......+.+|+.+||+.||.+|||+.||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 32211100000 00000000001111111111111 12345689999999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=297.99 Aligned_cols=202 Identities=25% Similarity=0.350 Sum_probs=164.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+.+.+|+|||||+|++|.+++.........+++..++.++.||+.||.|||+.+ |+|||
T Consensus 238 iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrD 314 (543)
T 3c4z_A 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRD 314 (543)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccC
Confidence 356789999999999999999999999999999999999875444567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 315 LKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 315 LKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CChHHEEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998643322 1223457999999999999999999999999999999999999999765
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
...... ......+..... .++......+.+|+.+||+.||.+||++.
T Consensus 393 ~~~~~~--~~~~~~i~~~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 393 GEKVEN--KELKQRVLEQAV------------TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp TCCCCH--HHHHHHHHHCCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ccchhH--HHHHHHHhhccc------------CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 332111 111111121111 12233456788999999999999999763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=273.90 Aligned_cols=196 Identities=24% Similarity=0.342 Sum_probs=163.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 140 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDI 140 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5678999999999999999999999999999999999986 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.+||+|||++...... ......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 141 ~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 141 KPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999998754321 1234568999999999999999999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. .....+..... .++......+.+|+.+||+.+|.+|||+.+|++.
T Consensus 217 ~~------~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 217 HT------ETHRRIVNVDL------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HH------HHHHHHHTTCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred Hh------HHHHHHhcccc------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11 11111111111 1122334678899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=277.10 Aligned_cols=214 Identities=27% Similarity=0.397 Sum_probs=160.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL----PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~----~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
+|+.++||||+++++++...+..++||||+++++|.+++... ......+++..++.++.||+.||.|||+.+ |
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 142 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---Q 142 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 467889999999999999999999999999999999999741 112456999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC---ccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHh
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK---THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~ellt 152 (380)
+|+||||+||+++.++.+||+|||++........ ........||+.|+|||++.. ..++.++||||||+++|+|++
T Consensus 143 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 222 (303)
T 2vwi_A 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222 (303)
T ss_dssp CCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999876432211 111234578999999999876 568999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|..||........ ... ..... ....................+.+|+.+||+.||.+|||+.+|++
T Consensus 223 g~~pf~~~~~~~~---~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 223 GAAPYHKYPPMKV---LML--TLQND---PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCTTTTSCGGGH---HHH--HHTSS---CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCccCchhhH---HHH--HhccC---CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9999976433211 100 00011 01111111111122234467889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=283.18 Aligned_cols=213 Identities=23% Similarity=0.330 Sum_probs=157.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++||||+++++++...+..++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 125 (324)
T 3mtl_A 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRD 125 (324)
T ss_dssp HHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESS
T ss_pred HHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCC
Confidence 3678899999999999999999999999996 699999986 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||++...... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 126 LKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp CCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCHHHEEECCCCCEEEccCcccccccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999753221 122234568999999999876 5789999999999999999999999976
Q ss_pred CCCCCCcchhhhhhhcccc--cCCCCCCCCc---------cccC----CCChhhHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKD--RRKFPKMADP---------LLQG----RYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---------~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 224 (380)
...... ...+...... ....+..... .... .........+.+|+.+||+.||.+|||+.||+
T Consensus 204 ~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 204 STVEEQ---LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp SSHHHH---HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCHHHH---HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 432211 1111111000 0000000000 0000 00112346788999999999999999999998
Q ss_pred H
Q 016913 225 T 225 (380)
Q Consensus 225 ~ 225 (380)
+
T Consensus 281 ~ 281 (324)
T 3mtl_A 281 K 281 (324)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=280.74 Aligned_cols=208 Identities=27% Similarity=0.393 Sum_probs=164.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++.... .++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di 147 (291)
T 1u46_A 75 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDL 147 (291)
T ss_dssp HHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 56789999999999998765 8999999999999999976 2356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
||+|||++.++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 148 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 148 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999998754332221 2234567889999999999899999999999999999999 9999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... .... .+....... ..+...+..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus 228 ~~~~---~~~~---~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 228 LNGS---QILH---KIDKEGERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCHH---HHHH---HHHTSCCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCHH---HHHH---HHHccCCCC----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 4321 1111 111111110 1122345678999999999999999999999999988643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=292.41 Aligned_cols=202 Identities=20% Similarity=0.280 Sum_probs=154.8
Q ss_pred ccCCC--CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLH--HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++ |||||++++++...+..|||||+ .+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||
T Consensus 108 l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHr 179 (390)
T 2zmd_A 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179 (390)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCC
T ss_pred HHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 34454 69999999999999999999995 57999999987 457899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----------CCCCCcCceeehHHHHH
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~SlGvvl~ 148 (380)
||||+||||+ ++.+||+|||+++.+.............||+.|+|||++.+ ..++.++||||||||+|
T Consensus 180 Dlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ 258 (390)
T 2zmd_A 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258 (390)
T ss_dssp CCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHH
Confidence 9999999996 57899999999986543322223345679999999999875 36889999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++|..||..... .......+... .....++......+.+|+.+||+.||.+|||+.||++.-
T Consensus 259 ell~G~~Pf~~~~~-----~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 259 YMTYGKTPFQQIIN-----QISKLHAIIDP----------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHHSSCTTTTCCC-----HHHHHHHHHCT----------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHCCCcchhhhH-----HHHHHHHHhCc----------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 99999999964321 11111111111 111111222245788999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.91 Aligned_cols=202 Identities=23% Similarity=0.298 Sum_probs=155.8
Q ss_pred CccCCCCCCcccceEEEEeCC---------------------------------------------------------eE
Q 016913 1 MLSLLHHSNLVNLIGYCADGD---------------------------------------------------------QR 23 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~---------------------------------------------------------~~ 23 (380)
+|++++|||||+++++|.+.. ..
T Consensus 57 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (332)
T 3qd2_B 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL 136 (332)
T ss_dssp HHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEE
T ss_pred HHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceE
Confidence 367899999999999986643 37
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcc
Q 016913 24 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 103 (380)
Q Consensus 24 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~ 103 (380)
++|||||++++|.+++.... .....++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.
T Consensus 137 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 212 (332)
T 3qd2_B 137 YIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212 (332)
T ss_dssp EEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCccc
Confidence 99999999999999998732 2234677789999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc----------cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 016913 104 LGPVGDKT----------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 173 (380)
Q Consensus 104 ~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 173 (380)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+.. ......
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~ 284 (332)
T 3qd2_B 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIIT 284 (332)
T ss_dssp ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHH
T ss_pred ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHH
Confidence 75433211 122345799999999999999999999999999999999998665421 111110
Q ss_pred hcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 174 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.... ..++. ........+.+|+.+||+.||.+|||+.||++
T Consensus 285 ~~~~--~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 285 DVRN--LKFPL---------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHT--TCCCH---------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred Hhhc--cCCCc---------ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0000 00000 01233456789999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.97 Aligned_cols=220 Identities=17% Similarity=0.178 Sum_probs=168.2
Q ss_pred ccCCCCCCccc---------------ceEEEEe-CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 016913 2 LSLLHHSNLVN---------------LIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 65 (380)
Q Consensus 2 L~~l~HpnIv~---------------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL 65 (380)
|++++||||++ +++++.. ++..||||||+ +++|.+++... ....+++..++.++.||+.||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L 172 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDAL 172 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHH
Confidence 45667887776 7888876 67899999999 89999999862 236799999999999999999
Q ss_pred HHHhhCCCCCeEecCCCCCcEEEcCCC--CeEEeecCCcccCCCCCCc-----cccccccccccccchhhhhcCCCCCcC
Q 016913 66 EYLHDKANPPVIYRDLKSSNILLDEGF--HPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKS 138 (380)
Q Consensus 66 ~~LH~~~~~~iiHrDIkp~NILl~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~s 138 (380)
.|||+++ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++
T Consensus 173 ~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 249 (352)
T 2jii_A 173 EFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS 249 (352)
T ss_dssp HHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHH
T ss_pred HHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchh
Confidence 9999999 99999999999999988 8999999999764322111 112335799999999999999999999
Q ss_pred ceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 139 DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 139 DV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
|||||||++|||++|..||....... ............. ...+..... ........+.+|+.+||+.||.+||
T Consensus 250 Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 250 DLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMKQKQKFVDK---PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHS---CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred hHHHHHHHHHHHHhCCCCcccCCcCH-HHHHHHHHhccCC---hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCC
Confidence 99999999999999999997543211 1111111111111 111111110 0112346788999999999999999
Q ss_pred CHHHHHHHHHHhhhcc
Q 016913 219 LIGDVVTALTYLASQT 234 (380)
Q Consensus 219 t~~evl~~L~~~~~~~ 234 (380)
|+.+|++.|+.+....
T Consensus 323 s~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 323 PYAMLRNNLEALLQDL 338 (352)
T ss_dssp CHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHhc
Confidence 9999999999886554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=298.86 Aligned_cols=204 Identities=28% Similarity=0.367 Sum_probs=165.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+.+..|||||||+||+|.+++... ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 237 iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrD 311 (576)
T 2acx_A 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRD 311 (576)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccC
Confidence 366789999999999999999999999999999999999862 2345999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 312 LKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 312 LKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred CchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999998653322 223457999999999999999999999999999999999999999865
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 226 (380)
........+ ...+..... .++......+.+|+.+||+.||.+|| ++.||++.
T Consensus 389 ~~~~~~~~i--~~~i~~~~~------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 389 KKKIKREEV--ERLVKEVPE------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp SSCCCHHHH--HHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccchhHHHH--HHHhhcccc------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 332211111 111111111 12223456788999999999999999 77888753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=272.26 Aligned_cols=205 Identities=24% Similarity=0.302 Sum_probs=161.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 134 (283)
T 3bhy_A 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDL 134 (283)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 5678999999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 82 KSSNILLDEGF----HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 82 kp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||+||+++.++ .+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 135 ~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 135 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp SGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence 99999998876 79999999998643221 223456899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHh
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT--ALTYL 230 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~ 230 (380)
...... ... ..+...... ..... .......+.+|+.+||+.||.+|||+.++++ .++.+
T Consensus 212 ~~~~~~---~~~---~~~~~~~~~----~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 212 LGETKQ---ETL---TNISAVNYD----FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCSSHH---HHH---HHHHTTCCC----CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCcchH---HHH---HHhHhcccC----Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 753221 111 111110000 01111 1123457889999999999999999999997 44444
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=307.39 Aligned_cols=207 Identities=27% Similarity=0.389 Sum_probs=166.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++|+|||||+++++|.+ +..|||||||++++|.+++.. .....+++..++.|+.||+.||.|||+++ |+|||
T Consensus 315 ~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrD 388 (535)
T 2h8h_A 315 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 388 (535)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 3678899999999999876 678999999999999999975 12346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||||+.++.+||+|||+++...... ........++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 389 lkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 389 LRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998643211 111223456789999999999999999999999999999999 8999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
.... .+...+. ... ....+......+.+|+.+||+.+|++|||+.+|++.|+.+.
T Consensus 468 ~~~~---~~~~~i~----~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 468 MVNR---EVLDQVE----RGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCHH---HHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCHH---HHHHHHH----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 4221 1111111 110 01122344567889999999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=278.03 Aligned_cols=206 Identities=23% Similarity=0.302 Sum_probs=154.8
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
++||||+++++++.+++..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~ 140 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPE 140 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHH
Confidence 5799999999999999999999999999999999986 457999999999999999999999999 999999999
Q ss_pred cEEEcCCCC---eEEeecCCcccCCCCCCc-----cccccccccccccchhhhhc-----CCCCCcCceeehHHHHHHHH
Q 016913 85 NILLDEGFH---PKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 85 NILl~~~~~---~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlGvvl~ell 151 (380)
|||++.++. +||+|||++......... .......||..|+|||++.. ..++.++|||||||++|+|+
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 999988765 999999998754322111 11223569999999999975 46889999999999999999
Q ss_pred hCCCCCCCCCCCCCcch---------hhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 016913 152 TGRKAIDNTRPPGEHNL---------VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD 222 (380)
Q Consensus 152 tG~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 222 (380)
+|..||........... ......+......++ .... ......+.+|+.+||+.||.+|||+.|
T Consensus 221 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 221 SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP---DKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp HSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC---HHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC---chhc-----ccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 99999976543221000 000011111100000 0000 123457889999999999999999999
Q ss_pred HHH
Q 016913 223 VVT 225 (380)
Q Consensus 223 vl~ 225 (380)
|++
T Consensus 293 ~l~ 295 (316)
T 2ac3_A 293 VLQ 295 (316)
T ss_dssp HHH
T ss_pred Hhc
Confidence 987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=282.16 Aligned_cols=216 Identities=29% Similarity=0.424 Sum_probs=166.7
Q ss_pred ccCCCCCCcccceEEEEeCC--eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++||||+++++++...+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 169 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHR 169 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---Eecc
Confidence 56789999999999986654 68999999999999999987 3456999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||||+|||++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 170 dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 170 DLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred CCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999875432221 11233457788999999999899999999999999999999998875
Q ss_pred CCCC---------CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 159 NTRP---------PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 159 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... .................. ....+...+..+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp SHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHhhccccchhhhHHHHHHHhhcCC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 3210 000000000001111100 111223445788999999999999999999999999998
Q ss_pred hhhc
Q 016913 230 LASQ 233 (380)
Q Consensus 230 ~~~~ 233 (380)
+..+
T Consensus 320 l~~~ 323 (326)
T 2w1i_A 320 IRDQ 323 (326)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=290.63 Aligned_cols=202 Identities=23% Similarity=0.192 Sum_probs=160.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|..++||||++++++|.+.+.+|||||||++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDL 188 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDI 188 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccc
Confidence 5568999999999999999999999999999999999976 2347999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-------cCCCCCcCceeehHHHHHHHHhCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-------TGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
||+||||+.++.+||+|||+++...... ........||+.|+|||++. ...++.++|||||||++|||++|.
T Consensus 189 Kp~NILld~~g~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 189 KPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred CHHHeeecCCCCEEEeechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence 9999999999999999999998643321 11223467999999999997 357899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccc--cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKD--RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR---PLIGDVVTA 226 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Pt~~evl~~ 226 (380)
.||........ ...+... ...++. .+......+.+|+.+||+ +|.+| |+++||++.
T Consensus 268 ~Pf~~~~~~~~------~~~i~~~~~~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 268 TPFYADSTAET------YGKIVHYKEHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CTTCCSSHHHH------HHHHHTHHHHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCCCCCCHHHH------HHHHHhcccCcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 99975432111 1111110 011111 011234678899999999 99998 588888653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=291.57 Aligned_cols=213 Identities=23% Similarity=0.301 Sum_probs=156.6
Q ss_pred ccCCC-CCCcccceEEEEeCC--eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLLH-HSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
|+.+. |||||++++++...+ .+|+|||||+ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|
T Consensus 62 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH 132 (388)
T 3oz6_A 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLH 132 (388)
T ss_dssp HHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEe
Confidence 44565 999999999998654 6899999996 799999976 57999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCC-------------------Cccccccccccccccchhhhhc-CCCCCcC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGD-------------------KTHVSTRVMGTYGYCAPEYAMT-GQLTLKS 138 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~s 138 (380)
|||||+||||+.++.+||+|||+++...... .........||+.|+|||++.+ ..++.++
T Consensus 133 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 212 (388)
T 3oz6_A 133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212 (388)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHH
T ss_pred CCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChh
Confidence 9999999999999999999999998643211 0111234579999999999986 6789999
Q ss_pred ceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccc----------------------------cCCCCCCCCc--
Q 016913 139 DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD----------------------------RRKFPKMADP-- 188 (380)
Q Consensus 139 DV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~-- 188 (380)
||||||||+|||++|..||...........+ ...... .......+..
T Consensus 213 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (388)
T 3oz6_A 213 DMWSLGCILGEILCGKPIFPGSSTMNQLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWK 289 (388)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchh
Confidence 9999999999999999999754322111111 000000 0000000000
Q ss_pred --cccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 189 --LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 189 --~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
......+......+.+|+.+||+.||++|||+.|+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 290 NLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 00000011234678999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=270.95 Aligned_cols=202 Identities=21% Similarity=0.256 Sum_probs=158.3
Q ss_pred ccCCCCCCcccceEEEE--eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|+.++||||+++++++. +.+..++||||++++ |.+++... ....+++..++.++.||+.||.|||+++ |+|+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~ 133 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHK 133 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 67889999999999984 445789999999755 88888763 3467999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC--CCCcCceeehHHHHHHHHhCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||||+|||++.++.+||+|||++................|+..|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus 134 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (305)
T 2wtk_C 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213 (305)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998654332333334567999999999998654 377999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
..... ......+...... .+......+.+|+.+||+.||.+|||+.||++.-
T Consensus 214 ~~~~~------~~~~~~i~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 214 EGDNI------YKLFENIGKGSYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp CCSSH------HHHHHHHHHCCCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CCchH------HHHHHHHhcCCCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 75321 1111111111111 1223346788999999999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=284.42 Aligned_cols=198 Identities=29% Similarity=0.369 Sum_probs=160.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++|||||+++++|..++..+|||||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||
T Consensus 108 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dl 180 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 180 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCC
Confidence 567899999999999999999999999996 789888864 3467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+||||+.++.+||+|||++..... .....||+.|+|||++. ...++.++|||||||++|||++|..||.
T Consensus 181 kp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 181 KAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp SGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999976422 23357899999999985 4678999999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
..... .....+.... .+... +......+.+|+.+||+.+|++|||+.+|++...
T Consensus 255 ~~~~~------~~~~~~~~~~--~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 255 NMNAM------SALYHIAQNE--SPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp TSCHH------HHHHHHHHSC--CCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCChH------HHHHHHHhcC--CCCCC--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 54221 1111111110 01111 1123457889999999999999999999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=287.41 Aligned_cols=222 Identities=20% Similarity=0.236 Sum_probs=169.5
Q ss_pred ccCCCCCCcccceEEEEeCC--eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++||||+++++++...+ ..++|||||++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 136 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHR 136 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEC
Confidence 56789999999999998765 7799999999999999997621 1233999999999999999999999999 9999
Q ss_pred CCCCCcEEE----cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc--------CCCCCcCceeehHHHH
Q 016913 80 DLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--------GQLTLKSDVYSFGVVF 147 (380)
Q Consensus 80 DIkp~NILl----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~SlGvvl 147 (380)
||||+|||+ +.++.+||+|||+++..... .......||..|+|||++.. ..++.++|||||||++
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp CCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEeecCCCceeEEEecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 999999999 77778999999999864322 22234679999999999875 5678899999999999
Q ss_pred HHHHhCCCCCCCCCCCCCc-chhhhhhhccccc-CCCCC----C------C--CccccCCCChhhHHHHHHHHHHhhhhC
Q 016913 148 LELITGRKAIDNTRPPGEH-NLVAWARPLFKDR-RKFPK----M------A--DPLLQGRYPMRGLYQALAVAAMCLQEQ 213 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~----~------~--~~~l~~~~~~~~~~~l~~li~~cl~~~ 213 (380)
|||++|..||......... ..... +.... ..... . . ........+......+.+++.+||+.|
T Consensus 214 ~el~tg~~Pf~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~d 290 (396)
T 4eut_A 214 YHAATGSLPFRPFEGPRRNKEVMYK---IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290 (396)
T ss_dssp HHHHHSSCSEECTTCTTTCHHHHHH---HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHHHCCCCCCCCCcccchHHHHHH---HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccC
Confidence 9999999999754332221 11111 11100 00000 0 0 001111334567778899999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 016913 214 AATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 214 P~~RPt~~evl~~L~~~~~~ 233 (380)
|++||++.++++.+..+...
T Consensus 291 P~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 291 QEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTTSCCHHHHHHHHHHHHTC
T ss_pred hhhhccHHHHHHHHHHHhhc
Confidence 99999999999999887654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=283.35 Aligned_cols=204 Identities=26% Similarity=0.322 Sum_probs=161.9
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.+ +||||+++++++...+..+|||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 184 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRD 184 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 3445 699999999999999999999999999999999976 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||+||||+.++.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 185 lkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 185 IKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999999997642211 122334679999999999986 357899999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTAL 227 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~L 227 (380)
........ ............ .++......+.+|+.+||+.||.+|| ++.||++..
T Consensus 264 ~~~~~~~~--~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 264 VDGEKNSQ--AEISRRILKSEP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CTTSCCCH--HHHHHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cCCccchH--HHHHHHHhccCC------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 54332221 111111111111 12233456788999999999999999 899998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=277.76 Aligned_cols=200 Identities=26% Similarity=0.344 Sum_probs=164.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 74 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 145 (303)
T 3a7i_A 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDI 145 (303)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 5678999999999999999999999999999999999964 57999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.+||+|||++....... .......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 146 ~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 146 KAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 9999999999999999999997643221 12234578999999999999999999999999999999999999997542
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
.. ...... ... . .+.+ +......+.+|+.+||+.+|.+|||+.+|++...
T Consensus 224 ~~---~~~~~~---~~~--~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 224 PM---KVLFLI---PKN--N-----PPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HH---HHHHHH---HHS--C-----CCCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred HH---HHHHHh---hcC--C-----CCCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 21 111111 000 0 0111 1223457889999999999999999999997543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=287.76 Aligned_cols=216 Identities=22% Similarity=0.269 Sum_probs=161.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHr 79 (380)
+|+.++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+|+
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~ 156 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHR 156 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCS
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcC
Confidence 46788999999999999999999999999999999999986 45799999999999999999999996 8 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||||+||||+.++.+||+|||++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 157 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 157 DVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CccHHHEEECCCCCEEEEECCCCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999864311 122345789999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhhhhh---------hcccccCCCC-------------CCCCc----cccCCCChhhHHHHHHHHHHhhhhC
Q 016913 160 TRPPGEHNLVAWAR---------PLFKDRRKFP-------------KMADP----LLQGRYPMRGLYQALAVAAMCLQEQ 213 (380)
Q Consensus 160 ~~~~~~~~~~~~~~---------~~~~~~~~~~-------------~~~~~----~l~~~~~~~~~~~l~~li~~cl~~~ 213 (380)
.............. ........+. ...+. ......+......+.+|+.+||+.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 312 (360)
T 3eqc_A 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312 (360)
T ss_dssp CCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSS
T ss_pred CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcC
Confidence 43211100000000 0000000000 00000 0000011123457889999999999
Q ss_pred CCCCCCHHHHHHHH
Q 016913 214 AATRPLIGDVVTAL 227 (380)
Q Consensus 214 P~~RPt~~evl~~L 227 (380)
|.+|||+.|+++.-
T Consensus 313 P~~Rpt~~ell~hp 326 (360)
T 3eqc_A 313 PAERADLKQLMVHA 326 (360)
T ss_dssp TTTSCCHHHHHTSH
T ss_pred hhhCCCHHHHhhCh
Confidence 99999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=279.78 Aligned_cols=202 Identities=23% Similarity=0.316 Sum_probs=151.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrD 80 (380)
++.++||||+++++++.+++..++||||++ ++|.+++.........+++..++.++.||+.||.|||++ + |+|+|
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~d 135 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRD 135 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCC
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCC
Confidence 567899999999999999999999999997 699888765333457899999999999999999999998 9 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhh----hcCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA----MTGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||+|||++.++.+||+|||++...... .......||+.|+|||++ ....++.++||||||+++|+|++|..|
T Consensus 136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 136 VKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp CSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred CCHHHEEECCCCCEEEeecCCccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999764322 122334689999999996 456789999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|...... ..... ...... .... .+......+.+|+.+||+.+|++|||+.||++
T Consensus 213 ~~~~~~~----~~~~~-~~~~~~--~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 213 YDSWGTP----FQQLK-QVVEEP--SPQL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCCSCH----HHHHH-HHHHSC--CCCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccccCch----HHHHH-HHhccC--CCCc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 9753221 11111 111110 0111 01123467889999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=276.13 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=163.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 151 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDI 151 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCc
Confidence 5678999999999999999999999999999999999974 2467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||+++.++.+||+|||++...... ........|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 152 ~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 152 KAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCCEEEeecccchhhhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999764322 122334578999999999999899999999999999999999999997532
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. ..... .... ..... ..+......+.+|+.+||+.||.+|||+.+|++.
T Consensus 230 ~~---~~~~~---~~~~--~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 230 PM---RAIFM---IPTN--PPPTF-------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HH---HHHHH---HHHS--CCCCC-------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred hH---HHHHH---HhcC--CCccc-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 21 11100 0000 00011 1122334678899999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=288.83 Aligned_cols=192 Identities=17% Similarity=0.195 Sum_probs=150.5
Q ss_pred ccCCCCCCcccce-------EEEEeCCe-----------------EEEEEeccCCCCHHHHHhcCC---CCCCCCCHHHH
Q 016913 2 LSLLHHSNLVNLI-------GYCADGDQ-----------------RLLVYEFMPLGSLEDHLHDLP---PDKEPLDWNTR 54 (380)
Q Consensus 2 L~~l~HpnIv~l~-------~~~~~~~~-----------------~~lV~E~~~ggsL~~~l~~~~---~~~~~l~~~~~ 54 (380)
|+.++|||||+++ +++...+. .||||||+ +|+|.+++.... .....+++..+
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~ 208 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR 208 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence 5677999999998 77766542 78999999 689999998521 11223446889
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC--
Q 016913 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-- 132 (380)
Q Consensus 55 ~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 132 (380)
+.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++... .......| ..|+|||++.+.
T Consensus 209 ~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhccccc
Confidence 999999999999999999 9999999999999999999999999998521 12334567 999999999987
Q ss_pred ---------CCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHH
Q 016913 133 ---------QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQAL 203 (380)
Q Consensus 133 ---------~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 203 (380)
.++.++|||||||++|||++|..||...........+ ... .......+.
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~----------------~~~~~~~~~ 337 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI------FRS----------------CKNIPQPVR 337 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG------GSS----------------CCCCCHHHH
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh------hhh----------------ccCCCHHHH
Confidence 8999999999999999999999999754332211110 000 012246788
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 016913 204 AVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 204 ~li~~cl~~~P~~RPt~~evl~ 225 (380)
+|+.+||+.||.+|||+.+|++
T Consensus 338 ~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=272.41 Aligned_cols=191 Identities=18% Similarity=0.232 Sum_probs=153.1
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||||+++++++.+.+..++||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+|+||||+|
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~N 145 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSN 145 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHH
Confidence 8999999999999999999999999999999999863222367999999999999999999999999 9999999999
Q ss_pred EEEcCC-------------------CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHH
Q 016913 86 ILLDEG-------------------FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGV 145 (380)
Q Consensus 86 ILl~~~-------------------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGv 145 (380)
||++.+ ..+||+|||++...... ....||..|+|||++.+. .++.++|||||||
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALAL 219 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence 999844 47999999999864322 224589999999999876 6678999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 146 VFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 146 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
++|+|++|.+++... ....... . ..++ ..+......+.+|+.+||+.||.+|||+.+|++
T Consensus 220 il~~l~~~~~~~~~~-----~~~~~~~----~--~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 220 TVVCAAGAEPLPRNG-----DQWHEIR----Q--GRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHTTCCCCCSSS-----HHHHHHH----T--TCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCCCcch-----hHHHHHH----c--CCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 999999998766422 1111110 0 0111 112233467889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=292.49 Aligned_cols=145 Identities=26% Similarity=0.359 Sum_probs=121.2
Q ss_pred CccCCCCCCcccceEEEEeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|+.++|||||+++++|... ..+||||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+
T Consensus 105 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~--- 176 (458)
T 3rp9_A 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG--- 176 (458)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36678999999999999543 5689999999 5899999976 567999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-------------------------cccccccccccccchhhhh
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-------------------------HVSTRVMGTYGYCAPEYAM 130 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~ 130 (380)
||||||||+||||+.++.+||+|||+++........ .......||+.|+|||++.
T Consensus 177 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 999999999999999999999999999865322111 1123457899999999874
Q ss_pred -cCCCCCcCceeehHHHHHHHHhC
Q 016913 131 -TGQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 131 -~~~~s~~sDV~SlGvvl~elltG 153 (380)
...|+.++||||||||+|||++|
T Consensus 257 ~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 257 LQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCcHhHHHHHHHHHHHHHHh
Confidence 56799999999999999999993
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=285.31 Aligned_cols=216 Identities=21% Similarity=0.310 Sum_probs=161.6
Q ss_pred CccCCCCCCcccceEEEEe--------------------------------------CCeEEEEEeccCCCCHHHHHhcC
Q 016913 1 MLSLLHHSNLVNLIGYCAD--------------------------------------GDQRLLVYEFMPLGSLEDHLHDL 42 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~--------------------------------------~~~~~lV~E~~~ggsL~~~l~~~ 42 (380)
+|+.++|||||+++++|.. ....++||||++ ++|.+++...
T Consensus 53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 131 (383)
T 3eb0_A 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF 131 (383)
T ss_dssp HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHH
T ss_pred HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH
Confidence 3678999999999999844 334889999997 6888887654
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEc-CCCCeEEeecCCcccCCCCCCccccccccccc
Q 016913 43 PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 121 (380)
Q Consensus 43 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~ 121 (380)
......+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++...... ......||.
T Consensus 132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~ 205 (383)
T 3eb0_A 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSR 205 (383)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCS
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCC
Confidence 344678999999999999999999999999 99999999999997 68899999999998643222 223456899
Q ss_pred cccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhc--------cc-----ccCCCCCCCC
Q 016913 122 GYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL--------FK-----DRRKFPKMAD 187 (380)
Q Consensus 122 ~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~-----~~~~~~~~~~ 187 (380)
.|+|||++.+. .++.++|||||||++|||++|..||......+. +....... .. ....++....
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 283 (383)
T 3eb0_A 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283 (383)
T ss_dssp SCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCC
T ss_pred CccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCc
Confidence 99999998875 589999999999999999999999975432211 11110000 00 0011111111
Q ss_pred ccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 188 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 188 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
......++......+.+|+.+||+.||.+|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111233345667999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=274.24 Aligned_cols=200 Identities=26% Similarity=0.394 Sum_probs=157.9
Q ss_pred CccCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
+|+.++||||++++++|.. +...++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i 152 (290)
T 1t4h_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 152 (290)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCE
Confidence 3678899999999999876 3568999999999999999976 467999999999999999999999985 349
Q ss_pred EecCCCCCcEEEc-CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 77 IYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+|+||||+|||++ .++.+||+|||++...... ......|++.|+|||++.+ .++.++||||||+++|+|++|..
T Consensus 153 ~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~ 227 (290)
T 1t4h_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999997 7889999999999753221 2234568999999998864 68999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
||...... .......... .....+ +......+.+|+.+||+.+|.+|||+.||++
T Consensus 228 pf~~~~~~-----~~~~~~~~~~------~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 228 PYSECQNA-----AQIYRRVTSG------VKPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTTCSSH-----HHHHHHHTTT------CCCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcCcH-----HHHHHHHhcc------CCcccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99753221 1111111110 000111 1122357889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=289.79 Aligned_cols=201 Identities=26% Similarity=0.347 Sum_probs=160.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+....|+|||||++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 161 (494)
T 3lij_A 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRD 161 (494)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 36789999999999999999999999999999999999876 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEG---FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+||||+.. +.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 162 lkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CChhhEEEeCCCCCCcEEEEECCCCeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCC
Confidence 99999999764 45999999999864322 2234467999999999986 47999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...... ... ..+......+ ..+.. ......+.+|+.+||+.+|.+|||+.++++.
T Consensus 238 ~~~~~~---~~~---~~i~~~~~~~---~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 238 GGQTDQ---EIL---RKVEKGKYTF---DSPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSSHH---HHH---HHHHHTCCCC---CSGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCHH---HHH---HHHHhCCCCC---Cchhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 754321 111 1111111111 11111 1234678899999999999999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=273.24 Aligned_cols=200 Identities=22% Similarity=0.314 Sum_probs=162.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~di 132 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDL 132 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSC
T ss_pred HHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999976 457999999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|||+ +.++.+||+|||++..... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 133 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 133 KPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CGGGCEESSSSTTCCEEBCSCSTTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CHHHEEEecCCCCCCEEEccCCcceecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999 7788999999999975321 12233568999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..... ... ..+......++ ..........+.+|+.+||+.||.+|||+.++++.
T Consensus 209 ~~~~~---~~~---~~i~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 209 EETES---KLF---EKIKEGYYEFE--------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TSCHH---HHH---HHHHHCCCCCC--------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHH---HHH---HHHHcCCCCCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 53221 111 11111111111 11122345678899999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=270.08 Aligned_cols=197 Identities=23% Similarity=0.356 Sum_probs=153.9
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 137 (276)
T 2h6d_A 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDL 137 (276)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCC
T ss_pred HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 5678999999999999999999999999999999999976 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.+||+|||++...... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 138 ~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 138 KPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ChhhEEECCCCCEEEeecccccccCCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999864322 12234568999999999987765 68999999999999999999999753
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
... ... ..+...... .+......+.+++.+||+.||.+|||+.+|++.
T Consensus 215 ~~~---~~~---~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 215 HVP---TLF---KKIRGGVFY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SHH---HHH---HHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cHH---HHH---HHhhcCccc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 211 111 111111111 112234578899999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=279.81 Aligned_cols=215 Identities=25% Similarity=0.287 Sum_probs=162.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||++++++|.+.+..++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 138 (346)
T 1ua2_A 66 LQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDL 138 (346)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCS-EEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhhCCCCCCCeEEEEEeeCCceEEEEEcCC-CCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCC
Confidence 567899999999999999999999999997 599999876 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+|||++.++.+||+|||++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 139 KPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEEcCCCCEEEEecccceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999864322 2223446789999999999764 5899999999999999999999998754
Q ss_pred CCCCCcchhhhhhhccc-ccCCCCC---CCCccccCC---CC-----hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFK-DRRKFPK---MADPLLQGR---YP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~l~~~---~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
..... +.......-. .....+. ..+...... .+ ......+.+|+.+||+.||.+|||+.|+++.-
T Consensus 217 ~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 217 SDLDQ--LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SHHHH--HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CHHHH--HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 32111 1111100000 0000000 000000000 11 23346899999999999999999999998743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=277.89 Aligned_cols=208 Identities=25% Similarity=0.327 Sum_probs=161.8
Q ss_pred ccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeE
Q 016913 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--NPPVI 77 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ii 77 (380)
|++++||||+++++++.. +...++||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ..+|+
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv 138 (279)
T 2w5a_A 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 138 (279)
T ss_dssp HHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------C
T ss_pred HHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE
Confidence 567899999999998854 56889999999999999999864334456999999999999999999999976 23499
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|+||||+|||++.++.+||+|||++...... ........|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 139 H~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp CCCCSGGGEEECSSSCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeccchhhEEEcCCCCEEEecCchheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999764321 11223456899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 228 (380)
...... ..... +... ... ..+......+.+|+.+||+.+|.+|||+.||++.+.
T Consensus 217 ~~~~~~---~~~~~---i~~~--~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 217 TAFSQK---ELAGK---IREG--KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCSSHH---HHHHH---HHHT--CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cccCHH---HHHHH---Hhhc--ccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 754221 11111 1111 011 112234567889999999999999999999998664
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=288.82 Aligned_cols=216 Identities=23% Similarity=0.321 Sum_probs=159.0
Q ss_pred CccCCCCCCcccceEEEEeCCe------EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQ------RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~------~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|+.++|||||+++++|...+. .++||||++ ++|...+.........+++..+..++.||+.||.|||+.+
T Consensus 85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-- 161 (394)
T 4e7w_A 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-- 161 (394)
T ss_dssp HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS-EEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC-ccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3678899999999999965443 789999997 4555544432223567999999999999999999999999
Q ss_pred CeEecCCCCCcEEEc-CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHh
Q 016913 75 PVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 75 ~iiHrDIkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~ellt 152 (380)
|+||||||+||||+ .++.+||+|||+++...... ......||..|+|||++.+. .++.++|||||||++|||++
T Consensus 162 -ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 237 (394)
T 4e7w_A 162 -ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237 (394)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999 78999999999998643222 22345689999999999765 58999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhh--------------hcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 153 GRKAIDNTRPPGEHNLVAWAR--------------PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
|..||....... .+..... +.+ ....++......+...++......+.+|+.+||+.||.+||
T Consensus 238 g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (394)
T 4e7w_A 238 GQPLFPGESGID--QLVEIIKVLGTPSREQIKTMNPNY-MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL 314 (394)
T ss_dssp SSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCGGG-SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChhh-hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC
Confidence 999997543211 1111100 000 00111111111111112233456899999999999999999
Q ss_pred CHHHHHHH
Q 016913 219 LIGDVVTA 226 (380)
Q Consensus 219 t~~evl~~ 226 (380)
|+.|+++.
T Consensus 315 t~~e~l~h 322 (394)
T 4e7w_A 315 TAIEALCH 322 (394)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=277.83 Aligned_cols=217 Identities=22% Similarity=0.294 Sum_probs=158.8
Q ss_pred ccCCCCCCcccceEEEEe--------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 2 LSLLHHSNLVNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
|+.++||||+++++++.. .+..++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+.+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~- 144 (351)
T 3mi9_A 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK- 144 (351)
T ss_dssp HHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 567899999999999987 446899999997 688888876 3456999999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC--ccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHH
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK--THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~el 150 (380)
|+||||||+||||+.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 145 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 222 (351)
T 3mi9_A 145 --ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222 (351)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred --eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHH
Confidence 99999999999999999999999999986532221 122244678999999999876 4689999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCC--------CccccCCCCh-h------hHHHHHHHHHHhhhhCCC
Q 016913 151 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA--------DPLLQGRYPM-R------GLYQALAVAAMCLQEQAA 215 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~l~~~~~~-~------~~~~l~~li~~cl~~~P~ 215 (380)
++|..||...........+......... ...+... .......... . ....+.+|+.+||+.||+
T Consensus 223 l~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 301 (351)
T 3mi9_A 223 WTRSPIMQGNTEQHQLALISQLCGSITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301 (351)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGG
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCh-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChh
Confidence 9999999764322111111110000000 0000000 0000000000 0 134588999999999999
Q ss_pred CCCCHHHHHHH
Q 016913 216 TRPLIGDVVTA 226 (380)
Q Consensus 216 ~RPt~~evl~~ 226 (380)
+|||+.|+++.
T Consensus 302 ~R~t~~e~l~h 312 (351)
T 3mi9_A 302 QRIDSDDALNH 312 (351)
T ss_dssp GSCCHHHHHTS
T ss_pred hCCCHHHHhCC
Confidence 99999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=288.94 Aligned_cols=217 Identities=24% Similarity=0.284 Sum_probs=158.8
Q ss_pred CccCCCCCCcccceEEEEeC----C--eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG----D--QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~----~--~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|+.++|||||+++++|... + .+++||||++ ++|.+++.........+++..+..++.||+.||.|||+.+
T Consensus 100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-- 176 (420)
T 1j1b_A 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-- 176 (420)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 36789999999999998542 2 3679999997 5777776543334577999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCC-CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHh
Q 016913 75 PVIYRDLKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~ellt 152 (380)
|+||||||+||||+.+ +.+||+|||+++...... ......||..|+|||++.+. .++.++||||||||+|||++
T Consensus 177 -ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 177 -ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh
Confidence 9999999999999965 568999999998643222 22345789999999999765 79999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhc--------ccccCCCCCCCCcccc-----CCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPL--------FKDRRKFPKMADPLLQ-----GRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~-----~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
|+.||....... .+......+ ......+....-+.+. ..++......+.+|+.+||+.||.+|||
T Consensus 253 G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 253 GQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp SSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 999997543211 111111100 0000011111111111 0122334578999999999999999999
Q ss_pred HHHHHHH
Q 016913 220 IGDVVTA 226 (380)
Q Consensus 220 ~~evl~~ 226 (380)
+.|+++.
T Consensus 331 ~~e~l~h 337 (420)
T 1j1b_A 331 PLEACAH 337 (420)
T ss_dssp HHHHHTS
T ss_pred HHHHhCC
Confidence 9999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=301.27 Aligned_cols=193 Identities=25% Similarity=0.346 Sum_probs=161.2
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||||+.+++++.+.+.+||||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ||||||||+|
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~N 472 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDN 472 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTT
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhh
Confidence 799999999999999999999999999999999986 467999999999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCC
Q 016913 86 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 165 (380)
Q Consensus 86 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~ 165 (380)
|||+.++.+||+|||+++..... ........||+.|+|||++.+..|+.++||||||||+|||++|..||.....
T Consensus 473 ILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--- 547 (674)
T 3pfq_A 473 VMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--- 547 (674)
T ss_dssp EEECSSSCEEECCCTTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred EEEcCCCcEEEeecceeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---
Confidence 99999999999999999863222 2234456899999999999999999999999999999999999999975322
Q ss_pred cchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 016913 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI-----GDVVT 225 (380)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 225 (380)
......+...... +|......+.+|+.+||+.||++||++ .||++
T Consensus 548 ---~~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 548 ---DELFQSIMEHNVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---HHHHHHHHSSCCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---HHHHHHHHhCCCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1112222222111 223345678899999999999999997 55554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.89 Aligned_cols=201 Identities=24% Similarity=0.310 Sum_probs=162.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+.+..|+|||||.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+|||
T Consensus 79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 151 (484)
T 3nyv_A 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRD 151 (484)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCC
Confidence 36789999999999999999999999999999999999976 467999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 152 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp CCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCC
Confidence 99999999 567889999999997643222 2334579999999999876 6899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...... .....+ ......+. .+ ........+.+|+.+||+.+|.+|||+.|+++.
T Consensus 228 ~~~~~~---~~~~~i---~~~~~~~~---~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 228 NGANEY---DILKKV---EKGKYTFE---LP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCSSHH---HHHHHH---HHCCCCCC---SG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHH---HHHHHH---HcCCCCCC---Cc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 754321 111111 11111110 00 012335678899999999999999999999964
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.87 Aligned_cols=203 Identities=25% Similarity=0.344 Sum_probs=159.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+|+||
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 148 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDI 148 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCC
Confidence 567899999999999999999999999999999999998621 2235779999999999999999999999 999999
Q ss_pred CCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC--CCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+|||++. ++.+||+|||++....... .......|+..|+|||++.... ++.++||||||+++|+|++|..||.
T Consensus 149 ~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 149 KGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp SGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred ChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 999999987 8899999999998643221 1223457899999999997653 8899999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... ....+........ ...+......+.+|+.+||+.||++|||+.+|++
T Consensus 227 ~~~~~---~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 227 ELGEP---QAAMFKVGMFKVH------------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp GGSSH---HHHHHHHHHHCCC------------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCCch---hHHHHhhcccccc------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 43211 1111110011100 1122234567889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=285.26 Aligned_cols=199 Identities=11% Similarity=-0.034 Sum_probs=142.8
Q ss_pred CCCCcccce-------EEEEeC-----------------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHH------H
Q 016913 6 HHSNLVNLI-------GYCADG-----------------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR------M 55 (380)
Q Consensus 6 ~HpnIv~l~-------~~~~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~------~ 55 (380)
+||||++++ +++... ...|||||||+ ++|.+++... ...+++..+ +
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~ 197 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALH 197 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHH
Confidence 799987755 555543 23799999998 8999999862 234555566 7
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc--CC
Q 016913 56 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQ 133 (380)
Q Consensus 56 ~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~ 133 (380)
.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++... .......+|+.|+|||++.+ ..
T Consensus 198 ~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 198 ILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp HHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEE
T ss_pred HHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCC
Confidence 88899999999999999 9999999999999999999999999998632 11224567799999999987 68
Q ss_pred CCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhC
Q 016913 134 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 213 (380)
Q Consensus 134 ~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~ 213 (380)
++.++|||||||++|||++|..||....+......... .........+...........+.+|+.+||+.|
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 340 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCC
Confidence 99999999999999999999999986543221110000 000001111111112244578899999999999
Q ss_pred CCCCCCHHHHHH
Q 016913 214 AATRPLIGDVVT 225 (380)
Q Consensus 214 P~~RPt~~evl~ 225 (380)
|++|||+.++++
T Consensus 341 P~~Rpt~~e~l~ 352 (371)
T 3q60_A 341 RRRRLLPLEAME 352 (371)
T ss_dssp TTTCCCHHHHTT
T ss_pred hhhCCCHHHHhc
Confidence 999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=276.17 Aligned_cols=199 Identities=19% Similarity=0.224 Sum_probs=156.9
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
+||||++++++|.+.+..++||||+++++|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~N 161 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQN 161 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHH
Confidence 579999999999999999999999999999999865 33567999999999999999999999999 9999999999
Q ss_pred EEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 86 ILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 86 ILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
||++. ++.+||+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 162 Il~~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 162 ILLSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp EEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEecCCCCCcEEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99987 789999999999864322 122345799999999999999999999999999999999999999975422
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.. ... .+......+.. .........+.+|+.+||+.||.+|||+.+|++.
T Consensus 239 ~~---~~~---~i~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 239 QE---TYL---NISQVNVDYSE--------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HH---HHH---HHHHTCCCCCT--------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hH---HHH---HHHhcccccCc--------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11 111 11111111110 1112334678899999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=274.70 Aligned_cols=200 Identities=24% Similarity=0.299 Sum_probs=157.3
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++..++ .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 140 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDL 140 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 56789999999999997765 8999999999999999975 567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC---eEEeecCCcccCCCCCCccccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHHhCCC
Q 016913 82 KSSNILLDEGFH---PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 82 kp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
||+|||++.++. +||+|||++..... ........||..|+|||++. ...++.++|||||||++|+|++|..
T Consensus 141 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 141 KPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp SGGGEEESSSSSSCCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEecCCCCCeEEEccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999987654 99999999986422 11223456899999999975 4578999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
||........ +..... ..... ..+.. .......+.+|+.+||+.||.+|||+.++++
T Consensus 218 pf~~~~~~~~--~~~~~~---~~~~~----~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 218 PFSEHRTQVS--LKDQIT---SGKYN----FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SSCSTTCSSC--HHHHHH---HTCCC----CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccchHHH--HHHHHH---hCccc----cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9975433211 111111 00000 00101 0123467889999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=279.20 Aligned_cols=199 Identities=24% Similarity=0.368 Sum_probs=159.4
Q ss_pred cCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 3 SLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 3 ~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+.+ +||||+++++++......|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||
T Consensus 154 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dl 226 (365)
T 2y7j_A 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDL 226 (365)
T ss_dssp HHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 445 799999999999999999999999999999999976 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC------CCCCcCceeehHHHHHHHHhCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlGvvl~elltG~~ 155 (380)
||+|||++.++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 227 kp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 227 KPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 9999999999999999999997643222 22346799999999998743 58899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
||...... ..... +...... ...+.. ......+.+|+.+||+.||++|||+.+|++
T Consensus 304 pf~~~~~~---~~~~~---i~~~~~~---~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 304 PFWHRRQI---LMLRM---IMEGQYQ---FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSCCSSHH---HHHHH---HHHTCCC---CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCHH---HHHHH---HHhCCCC---CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99653211 11111 1111000 000000 122456889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=281.30 Aligned_cols=206 Identities=24% Similarity=0.333 Sum_probs=159.3
Q ss_pred ccCCCCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||+++++++...+ ..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+
T Consensus 78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~--- 148 (367)
T 1cm8_A 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG--- 148 (367)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999997763 469999999 7999999976 56999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||+|||++.++.+||+|||+++.... ......+|..|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 149 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 223 (367)
T 1cm8_A 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223 (367)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccCcCHHHEEEcCCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986422 2234578999999999987 68999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccc-----------------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKD-----------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
.||...........+ ...... ...++......+. .........+.+|+.+||+.||.+|
T Consensus 224 ~pf~~~~~~~~l~~i---~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R 299 (367)
T 1cm8_A 224 TLFKGSDHLDQLKEI---MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQR 299 (367)
T ss_dssp CSSCCSSHHHHHHHH---HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred CCCCCCCHHHHHHHH---HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHC
Confidence 999754321111000 000000 0000111111111 1112345678999999999999999
Q ss_pred CCHHHHHH
Q 016913 218 PLIGDVVT 225 (380)
Q Consensus 218 Pt~~evl~ 225 (380)
||+.|+++
T Consensus 300 ~t~~e~l~ 307 (367)
T 1cm8_A 300 VTAGEALA 307 (367)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.92 Aligned_cols=213 Identities=23% Similarity=0.277 Sum_probs=153.5
Q ss_pred CccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|+.++|||||+++++|... ...|||||||+ ++|.+++.. .+++..+..++.||+.||+|||+.+
T Consensus 114 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~-~~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~-- 184 (464)
T 3ttj_A 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-- 184 (464)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 35678999999999999655 35799999996 568777743 4899999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCC
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||+||||+.++.+||+|||+++.... ........||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 185 -iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 260 (464)
T 3ttj_A 185 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260 (464)
T ss_dssp -CCCCCCCGGGEEECTTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -cccCCCChHhEEEeCCCCEEEEEEEeeeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986432 12234467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhh----------------hhhhcccccCCCCCC-----CCccccCC---CChhhHHHHHHHHHHhh
Q 016913 155 KAIDNTRPPGEHNLVA----------------WARPLFKDRRKFPKM-----ADPLLQGR---YPMRGLYQALAVAAMCL 210 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~-----~~~~l~~~---~~~~~~~~l~~li~~cl 210 (380)
.||...........+. ............... ....+... ........+.+|+.+||
T Consensus 261 ~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL 340 (464)
T 3ttj_A 261 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340 (464)
T ss_dssp CSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHc
Confidence 9997643211110000 000000000000000 00000000 00112567899999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 016913 211 QEQAATRPLIGDVVTA 226 (380)
Q Consensus 211 ~~~P~~RPt~~evl~~ 226 (380)
+.||++|||++|+++.
T Consensus 341 ~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 341 VIDPAKRISVDDALQH 356 (464)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred CCChhhCCCHHHHhcC
Confidence 9999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=288.74 Aligned_cols=201 Identities=23% Similarity=0.300 Sum_probs=159.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||++++++.+....|+|||||.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 74 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~D 146 (486)
T 3mwu_A 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRD 146 (486)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 36778999999999999999999999999999999999976 467999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+|||++ .++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 147 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp CSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CchHHEEEecCCCCCCEEEEECCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999995 4567999999999764322 22334579999999999876 5899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...... ..... +......+. .+ ........+.+|+.+||+.+|.+|||+.++++.
T Consensus 223 ~~~~~~---~~~~~---i~~~~~~~~---~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 223 YGKNEY---DILKR---VETGKYAFD---LP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCSSHH---HHHHH---HHHTCCCSC---SG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCHH---HHHHH---HHhCCCCCC---Cc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 754221 11111 111110000 00 011234678899999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=290.02 Aligned_cols=201 Identities=25% Similarity=0.316 Sum_probs=161.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+....|||||||++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 99 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 171 (504)
T 3q5i_A 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRD 171 (504)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 36788999999999999999999999999999999999976 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC---CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGF---HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+|||++.++ .+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 172 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 247 (504)
T 3q5i_A 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247 (504)
T ss_dssp CSGGGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CcHHHEEEecCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCC
Confidence 999999998775 6999999999864322 2234467999999999987 46899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
...... ..... +......+ +... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~---~~~~~---i~~~~~~~----~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 248 GGQNDQ---DIIKK---VEKGKYYF----DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCSSHH---HHHHH---HHHCCCCC----CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHH---HHHHH---HHcCCCCC----Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 754321 11111 11110000 0000 01234678899999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=276.17 Aligned_cols=210 Identities=20% Similarity=0.243 Sum_probs=163.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHH------HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH------LHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANP 74 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~ 74 (380)
|+.++||||+++++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-- 172 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-- 172 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC--
Confidence 6788999999999999999999999999999999998 543 225779999999999999999999999 98
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCC-cCceeehHHHHHHHHh
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTL-KSDVYSFGVVFLELIT 152 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDV~SlGvvl~ellt 152 (380)
|+|+||||+|||++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|+|++
T Consensus 173 -i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 173 -ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred -EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999864322 23446789999999999887 6666 9999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCC----CCcccc---CCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM----ADPLLQ---GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|..||...... ....... ......++.. ..+... ..........+.+|+.+||+.||.+|||+.|+++
T Consensus 248 g~~pf~~~~~~--~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 248 NVVPFSLKISL--VELFNNI---RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCSSCCSSCS--HHHHHHH---TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCcH--HHHHHHH---hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999754331 1111111 1111111110 000000 0111334568899999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.08 Aligned_cols=201 Identities=23% Similarity=0.318 Sum_probs=151.4
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++|||||++++++.. +..|+|||||++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 194 l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDl 265 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDL 265 (419)
T ss_dssp HHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 567899999999999864 568999999999999998865 567999999999999999999999999 999999
Q ss_pred CCCcEEEcCC---CCeEEeecCCcccCCCCCCccccccccccccccchhhhhc---CCCCCcCceeehHHHHHHHHhCCC
Q 016913 82 KSSNILLDEG---FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 82 kp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
||+||||+.+ ..+||+|||+++.... ........||+.|+|||++.. ..++.++|||||||++|+|++|..
T Consensus 266 kp~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 266 KPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp CGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred ChHhEEEecCCCcceEEEeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999654 4599999999986432 222344679999999999853 578899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||........ +..... ... . ... +.. .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 343 pf~~~~~~~~--~~~~i~---~~~--~-~~~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 343 PFSEHRTQVS--LKDQIT---SGK--Y-NFI-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SSCCCSSSCC--HHHHHH---TTC--C-CCC-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCcchHH--HHHHHh---cCC--C-CCC-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 9975432211 111110 000 0 000 000 01234678899999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=278.24 Aligned_cols=210 Identities=23% Similarity=0.270 Sum_probs=145.2
Q ss_pred ccCCC-CCCcccceEEEEe--------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 016913 2 LSLLH-HSNLVNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 72 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 72 (380)
|+++. ||||+++++++.. ....++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+.+
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK 156 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34554 9999999999953 335799999995 89999886521 2356999999999999999999999975
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc----------ccccccccccccchhhh---hcCCCCCcCc
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH----------VSTRVMGTYGYCAPEYA---MTGQLTLKSD 139 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sD 139 (380)
++|+|+||||+||||+.++.+||+|||++.......... ......||+.|+|||++ .+..++.++|
T Consensus 157 -~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D 235 (337)
T 3ll6_A 157 -PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235 (337)
T ss_dssp -SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHH
T ss_pred -CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHh
Confidence 359999999999999999999999999998654322111 11134589999999998 5667899999
Q ss_pred eeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 140 VYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 140 V~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
||||||++|+|++|..||........ . .. ......+......+.+|+.+||+.+|.+|||
T Consensus 236 v~slG~il~el~~g~~p~~~~~~~~~---~-------~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 295 (337)
T 3ll6_A 236 IWALGCILYLLCFRQHPFEDGAKLRI---V-------NG----------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLS 295 (337)
T ss_dssp HHHHHHHHHHHHHSSCCC--------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHHHHHhCCCCCcchhHHHh---h-------cC----------cccCCcccccchHHHHHHHHHccCChhhCcC
Confidence 99999999999999999974322110 0 00 0000011112234678999999999999999
Q ss_pred HHHHHHHHHHhhhcc
Q 016913 220 IGDVVTALTYLASQT 234 (380)
Q Consensus 220 ~~evl~~L~~~~~~~ 234 (380)
+.||++.|+.+....
T Consensus 296 ~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 296 IAEVVHQLQEIAAAR 310 (337)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcc
Confidence 999999999886543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=267.90 Aligned_cols=200 Identities=25% Similarity=0.298 Sum_probs=160.4
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+++ .||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+|
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 149 (298)
T 1phk_A 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRD 149 (298)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 3455 499999999999999999999999999999999976 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh------cCCCCCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM------TGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||+||+++.++.+||+|||++....... ......|+..|+|||++. ...++.++||||||+++|+|++|.
T Consensus 150 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 150 LKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence 99999999999999999999997643221 223456899999999986 456889999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.||...... .. ...+......+. . .........+.+|+.+||+.||.+|||+.||++
T Consensus 227 ~p~~~~~~~---~~---~~~~~~~~~~~~---~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 227 PPFWHRKQM---LM---LRMIMSGNYQFG---S-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CSSCCSSHH---HH---HHHHHHTCCCCC---T-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCcCccHH---HH---HHHHhcCCcccC---c-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 999653211 11 111111111110 0 111234567889999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=270.60 Aligned_cols=212 Identities=22% Similarity=0.305 Sum_probs=159.3
Q ss_pred CCCCCCcccceEEEE-----eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 4 LLHHSNLVNLIGYCA-----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
.++||||++++++|. .....++||||++ ++|.+++... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H 143 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVH 143 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 358999999999987 4567899999997 7999999872 2345999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 79 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 79 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+||||+|||++.++.+||+|||++..... ........|+..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 144 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 144 RDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCHHHeEEcCCCCEEEecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999975321 122344678999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchh-hhhhh----cccccC-----CCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLV-AWARP----LFKDRR-----KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~-~~~~~----~~~~~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..........+ ..... .+.... .+.......+ ..+.......+.+|+.+||+.||.+|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 221 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 54321111000 00000 000000 0000000000 1122234567889999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=279.05 Aligned_cols=209 Identities=19% Similarity=0.199 Sum_probs=158.5
Q ss_pred CCCCcccceEEEE----eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecC
Q 016913 6 HHSNLVNLIGYCA----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (380)
Q Consensus 6 ~HpnIv~l~~~~~----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrD 80 (380)
.||||++++++|. .+...||||||+ +++|.+++.. .....+++..++.++.||+.||.|||++ + |+|||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrD 172 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTD 172 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCC
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 4899999999987 456789999999 5777777765 2345699999999999999999999998 8 99999
Q ss_pred CCCCcEEEcCCC-------------------------------------------------CeEEeecCCcccCCCCCCc
Q 016913 81 LKSSNILLDEGF-------------------------------------------------HPKLSDFGLAKLGPVGDKT 111 (380)
Q Consensus 81 Ikp~NILl~~~~-------------------------------------------------~~kL~DFGla~~~~~~~~~ 111 (380)
|||+||||+.++ .+||+|||++.....
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---- 248 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---- 248 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----
Confidence 999999998765 799999999986422
Q ss_pred cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhc----------------
Q 016913 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL---------------- 175 (380)
Q Consensus 112 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~---------------- 175 (380)
......||..|+|||++.+..++.++|||||||++|||++|..||.................+
T Consensus 249 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 249 -HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp -CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred -cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 223457899999999999999999999999999999999999999865443321111110000
Q ss_pred -----ccccCCCCCCCCcc---------ccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 176 -----FKDRRKFPKMADPL---------LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 176 -----~~~~~~~~~~~~~~---------l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+.....+..+.... -....+......+.+|+.+||+.||++|||+.||++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 11100111110000 001234566778999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=283.89 Aligned_cols=150 Identities=26% Similarity=0.331 Sum_probs=125.3
Q ss_pred CccCCCCCCcccceEEEEeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|+.++||||+++++++... +..||||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+
T Consensus 78 ~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g--- 149 (432)
T 3n9x_A 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG--- 149 (432)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36678999999999999776 56899999996 799999976 567999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc--------------------cccccccccccccchhhh-hcCCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--------------------HVSTRVMGTYGYCAPEYA-MTGQL 134 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~ 134 (380)
|+||||||+||||+.++.+||+|||+++........ .......||..|+|||++ ....+
T Consensus 150 ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 229 (432)
T 3n9x_A 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229 (432)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCC
T ss_pred CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCC
Confidence 999999999999999999999999999875332211 112456789999999986 45579
Q ss_pred CCcCceeehHHHHHHHHhCCCCCC
Q 016913 135 TLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 135 s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+.++||||||||+|||++|..||.
T Consensus 230 ~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 230 TKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccchHHHHHHHHHhcccccc
Confidence 999999999999999998655543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.00 Aligned_cols=206 Identities=22% Similarity=0.345 Sum_probs=163.5
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++|||||++++++. ++..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||
T Consensus 445 l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDi 517 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDI 517 (656)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccc
Confidence 56789999999999985 4568999999999999999986 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~~ 160 (380)
||+|||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 518 kp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 518 AARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp SGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999986432221 12233456789999999999999999999999999999997 89999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
... ....... .. .. ...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 597 ~~~---~~~~~i~---~~-~~----------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 597 KNN---DVIGRIE---NG-ER----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CHH---HHHHHHH---HT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH---HHHHHHH---cC-CC----------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 321 1111111 10 00 01223345678899999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=272.85 Aligned_cols=206 Identities=24% Similarity=0.284 Sum_probs=142.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEec
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYR 79 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHr 79 (380)
++.++||||+++++++...+..++||||++ ++|.+++.... .....+++..+..++.|++.||.|||+. + |+|+
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~ 150 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHR 150 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCS
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeEC
Confidence 567899999999999999999999999997 58888876311 1246799999999999999999999998 9 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhh----hcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA----MTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
||||+|||++.++.+||+|||++...... .......||..|+|||++ .+..++.++||||||+++|+|++|..
T Consensus 151 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 151 DIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp CCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred CCCHHHEEEcCCCCEEEccCCCceecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999764322 122334689999999998 45678999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||........ ....... ...+.+...........+.+|+.+||+.||.+|||+.+|++.
T Consensus 228 pf~~~~~~~~-----~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 228 PYPKWNSVFD-----QLTQVVK-------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSSCC------------CCCCC-------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcchHHH-----HHHHHhc-------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 9975422100 0000000 001111111122345688999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=283.25 Aligned_cols=147 Identities=21% Similarity=0.283 Sum_probs=130.6
Q ss_pred CCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
..+|+||++++++|...+..++||||+. ++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp 228 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKP 228 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSG
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 3489999999999999999999999995 799999987 23345999999999999999999999999 99999999
Q ss_pred CcEEEcCCCC--eEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 84 SNILLDEGFH--PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 84 ~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+||||+.++. +||+|||++..... ......||+.|+|||++.+..++.++||||||||+|||++|..||....
T Consensus 229 ~NILl~~~~~~~vkL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 229 ENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHeEEccCCCcceEEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999887 99999999975322 2234578999999999999999999999999999999999999997543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=275.53 Aligned_cols=206 Identities=18% Similarity=0.200 Sum_probs=139.9
Q ss_pred cCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 3 SLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+.+.||||+++++++.. +...+||||||++++|.+++.. .....+++..++.++.||+.||.|||+.+ |+|
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH 151 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAH 151 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 46789999999999876 4458999999999999999987 23357999999999999999999999999 999
Q ss_pred cCCCCCcEEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 79 RDLKSSNILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 79 rDIkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||||+||||+. ++.+||+|||++...... ......||+.|+|||++....++.++||||||+++|+|++|..
T Consensus 152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999976 455999999999764321 2234568999999999988899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||............. ........ .+...........+.+|+.+||+.||.+|||+.||++.-
T Consensus 228 pf~~~~~~~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 228 PFYSNTGQAISPGMK--RRIRLGQY--------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CC-------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCCCccchhhhhhHH--Hhhhcccc--------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 997543321110000 00000000 000111123456788999999999999999999999743
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=270.81 Aligned_cols=210 Identities=19% Similarity=0.228 Sum_probs=158.8
Q ss_pred ccCCC-CCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLLH-HSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
|+.++ ||||+++++++.+ ....++||||+++++|.+++.. +++..+..++.||+.||.|||+.+ |+|
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH 153 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMH 153 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 45565 9999999999988 6678999999999999999853 899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCC-CeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCC
Q 016913 79 RDLKSSNILLDEGF-HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 79 rDIkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||||+|||++.++ .+||+|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 154 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 230 (330)
T 3nsz_A 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230 (330)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred CCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999776 89999999998643322 2234568999999999987 6789999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhh--------ccc-cc------------CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCC
Q 016913 157 IDNTRPPGEHNLVAWARP--------LFK-DR------------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA 215 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~--------~~~-~~------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~ 215 (380)
|....... ..+...... ... .. ..........+....+......+.+|+.+||+.||.
T Consensus 231 ~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 309 (330)
T 3nsz_A 231 FFHGHDNY-DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309 (330)
T ss_dssp SSCCSSHH-HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG
T ss_pred cccCCchH-HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc
Confidence 95432210 000000000 000 00 000011111222222333567899999999999999
Q ss_pred CCCCHHHHHH
Q 016913 216 TRPLIGDVVT 225 (380)
Q Consensus 216 ~RPt~~evl~ 225 (380)
+|||++||++
T Consensus 310 ~Rpta~e~l~ 319 (330)
T 3nsz_A 310 SRLTAREAME 319 (330)
T ss_dssp GSCCHHHHHT
T ss_pred cCCCHHHHhc
Confidence 9999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=273.59 Aligned_cols=202 Identities=26% Similarity=0.377 Sum_probs=153.0
Q ss_pred ccCC-CCCCcccceEEEEe------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 2 LSLL-HHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
|+++ +||||+++++++.. .+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 149 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK-- 149 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3445 79999999999987 46889999999999999999862 2357999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHH
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~e 149 (380)
|+|+||||+|||++.++.+||+|||++...... ........|+..|+|||++. ...++.++|||||||++|+
T Consensus 150 -ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 150 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp -CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred -ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 999999999999999999999999999754221 11223456899999999987 5678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
|++|..||...... ..... +... ..+... +......+.+|+.+||+.||.+|||+.+|++.
T Consensus 227 l~~g~~p~~~~~~~---~~~~~---~~~~--~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 227 MAEGAPPLCDMHPM---RALFL---IPRN--PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHSSCTTTTSCHH---HHHHH---HHHS--CCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCCCCCcHH---HHHHH---hhcC--ccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 99999999653221 11110 1110 111111 11234678899999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=271.17 Aligned_cols=201 Identities=22% Similarity=0.331 Sum_probs=156.8
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||
T Consensus 70 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 143 (302)
T 2j7t_A 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDL 143 (302)
T ss_dssp HHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCC
Confidence 5678999999999999999999999999999999999875 3466999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
||+|||++.++.+||+|||++..... .........|+..|+|||++. ...++.++||||||+++|+|++|..|
T Consensus 144 kp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 221 (302)
T 2j7t_A 144 KAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221 (302)
T ss_dssp SGGGEEECTTSCEEECCCHHHHHHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred CHHHEEECCCCCEEEEECCCCccccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999998753110 011123356899999999984 56789999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|...... .......... .+.. ..+......+.+|+.+||+.||.+|||+.+|++
T Consensus 222 ~~~~~~~------~~~~~~~~~~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 222 HHELNPM------RVLLKIAKSD--PPTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp TTTSCHH------HHHHHHHHSC--CCCC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccCCHH------HHHHHHhccC--Cccc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9754321 1111111110 0111 112233567889999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=275.08 Aligned_cols=218 Identities=21% Similarity=0.253 Sum_probs=158.1
Q ss_pred ccCCCCCCcccceEEEEeCCe-------EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQ-------RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH--DKA 72 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~-------~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH--~~~ 72 (380)
|+.++||||++++++|...+. .++||||++ ++|...+.........+++..+..++.|++.||.||| +.+
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ 151 (360)
T 3e3p_A 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN 151 (360)
T ss_dssp HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCS-CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred HHhcCCCCcccHHHhhhccccccccceeEEEEeeccc-ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 356799999999999976443 789999997 5666655543334677999999999999999999999 888
Q ss_pred CCCeEecCCCCCcEEEcC-CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHH
Q 016913 73 NPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~el 150 (380)
|+||||||+||||+. ++.+||+|||++....... ......||..|+|||++.+. .++.++|||||||++|+|
T Consensus 152 ---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el 225 (360)
T 3e3p_A 152 ---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225 (360)
T ss_dssp ---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred ---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999997 8899999999998643222 22345689999999998765 489999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhh-h--------hhcccccCCCC-----CCCCccccCCCChhhHHHHHHHHHHhhhhCCCC
Q 016913 151 ITGRKAIDNTRPPGEHNLVAW-A--------RPLFKDRRKFP-----KMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 151 ltG~~p~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~ 216 (380)
++|..||...........+.. . ........... ...-..+....+......+.+|+.+||+.||.+
T Consensus 226 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccc
Confidence 999999976432211111100 0 00000000000 000000111122345678999999999999999
Q ss_pred CCCHHHHHHH
Q 016913 217 RPLIGDVVTA 226 (380)
Q Consensus 217 RPt~~evl~~ 226 (380)
|||+.||++.
T Consensus 306 Rpt~~e~l~h 315 (360)
T 3e3p_A 306 RMKPYEALCH 315 (360)
T ss_dssp SCCHHHHTTS
T ss_pred cCCHHHHhcC
Confidence 9999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=280.90 Aligned_cols=220 Identities=20% Similarity=0.235 Sum_probs=150.9
Q ss_pred CccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLP-----PDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
+|+.++|||||+++++|.. ....||||||+. ++|.+++.... .....+++..++.++.||+.||.|||+.+
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 148 (405)
T 3rgf_A 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 148 (405)
T ss_dssp HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3677899999999999965 668999999996 78988886311 12235999999999999999999999999
Q ss_pred CCeEecCCCCCcEEE----cCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcC-CCCCcCceeehHHHH
Q 016913 74 PPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVF 147 (380)
Q Consensus 74 ~~iiHrDIkp~NILl----~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl 147 (380)
|+||||||+|||| +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||||||+
T Consensus 149 --ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 149 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp --CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred --EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 9999999999999 67789999999999865322111 222446789999999999874 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCCC------cchhhhhhhcccccCCCCCCCCc-----------------cccC--------CCCh
Q 016913 148 LELITGRKAIDNTRPPGE------HNLVAWARPLFKDRRKFPKMADP-----------------LLQG--------RYPM 196 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~-----------------~l~~--------~~~~ 196 (380)
|+|++|..||........ ...+..+...+.. ........ .... ....
T Consensus 227 ~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~--p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (405)
T 3rgf_A 227 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF--PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304 (405)
T ss_dssp HHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCC--CCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTC
T ss_pred HHHHhCCCCCCCccccccccccchHHHHHHHHHhhCC--CChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCC
Confidence 999999999975433110 0011100000000 00000000 0000 0000
Q ss_pred hhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 197 RGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 197 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.....+.+|+.+||+.||.+|||+.||++.
T Consensus 305 ~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp CTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 113467899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=263.63 Aligned_cols=202 Identities=23% Similarity=0.328 Sum_probs=151.2
Q ss_pred ccCCCCCCcccceEEEEe-------------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLLHHSNLVNLIGYCAD-------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~-------------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
|++++||||+++++++.+ .+..|+||||+++++|.+++.. ....+++..++.++.||+.||.||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L 132 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYI 132 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHH
Confidence 678899999999999865 3567999999999999999986 345688999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC------------ccccccccccccccchhhhhcC-CCC
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK------------THVSTRVMGTYGYCAPEYAMTG-QLT 135 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s 135 (380)
|+++ |+|+||||+|||++.++.+||+|||++........ ........|+..|+|||++.+. .++
T Consensus 133 H~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 209 (303)
T 1zy4_A 133 HSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209 (303)
T ss_dssp HHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCC
T ss_pred HhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCc
Confidence 9999 99999999999999999999999999976432110 1122345689999999999865 689
Q ss_pred CcCceeehHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCC
Q 016913 136 LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA 215 (380)
Q Consensus 136 ~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~ 215 (380)
.++|||||||++|+|++ ||... .........+...... +...++......+.+|+.+||+.||.
T Consensus 210 ~~~Di~slG~il~~l~~---p~~~~-----~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (303)
T 1zy4_A 210 EKIDMYSLGIIFFEMIY---PFSTG-----MERVNILKKLRSVSIE--------FPPDFDDNKMKVEKKIIRLLIDHDPN 273 (303)
T ss_dssp THHHHHHHHHHHHHHHS---CCSSH-----HHHHHHHHHHHSTTCC--------CCTTCCTTTSHHHHHHHHHHTCSSGG
T ss_pred chhhHHHHHHHHHHHHh---ccCCc-----hhHHHHHHhccccccc--------cCccccccchHHHHHHHHHHHhcCcc
Confidence 99999999999999998 44311 1111111111111111 11123334456788999999999999
Q ss_pred CCCCHHHHHH
Q 016913 216 TRPLIGDVVT 225 (380)
Q Consensus 216 ~RPt~~evl~ 225 (380)
+|||+.+|++
T Consensus 274 ~Rps~~~ll~ 283 (303)
T 1zy4_A 274 KRPGARTLLN 283 (303)
T ss_dssp GSCCHHHHHH
T ss_pred cCcCHHHHhC
Confidence 9999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=278.39 Aligned_cols=213 Identities=22% Similarity=0.236 Sum_probs=151.6
Q ss_pred ccCCCCCCcccceEEEEeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|++++||||++++++|... ...|+||||+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 155 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---V 155 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 5678999999999998553 36899999997 799998876 4557999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+|+||||+|||++.++.+||+|||++..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 156 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 156 VHRDLHPGNILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCChHHEEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 9999999999999999999999999975322 122334578999999999987 678999999999999999999999
Q ss_pred CCCCCCCCCCcchh-hhhhh------------ccc-c-cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 156 AIDNTRPPGEHNLV-AWARP------------LFK-D-RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 156 p~~~~~~~~~~~~~-~~~~~------------~~~-~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
||...........+ ..... ... . .......... ............+.+|+.+||+.||.+|||+
T Consensus 233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 233 LFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR-AWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC-CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh-hHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 99754321111000 00000 000 0 0000000000 0001112334678899999999999999999
Q ss_pred HHHHH
Q 016913 221 GDVVT 225 (380)
Q Consensus 221 ~evl~ 225 (380)
.||++
T Consensus 312 ~ell~ 316 (362)
T 3pg1_A 312 EQALR 316 (362)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 99986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=267.23 Aligned_cols=209 Identities=19% Similarity=0.238 Sum_probs=158.2
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 85 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~N 85 (380)
.|++|+++++++...+..++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 148 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPEN 148 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 4556999999999999999999999 8999999987 23346899999999999999999999999 9999999999
Q ss_pred EEEcC-------------------CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHH
Q 016913 86 ILLDE-------------------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146 (380)
Q Consensus 86 ILl~~-------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvv 146 (380)
||++. ++.+||+|||++..... ......||..|+|||++.+..++.++|||||||+
T Consensus 149 il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 223 (339)
T 1z57_A 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223 (339)
T ss_dssp EEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHH
T ss_pred EEEeccccccccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHH
Confidence 99987 66799999999986322 2234578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhhhhhhccc-----ccC----------CCCC----------CCCccc-cCCCChhhHH
Q 016913 147 FLELITGRKAIDNTRPPGEHNLVAWARPLFK-----DRR----------KFPK----------MADPLL-QGRYPMRGLY 200 (380)
Q Consensus 147 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----~~~----------~~~~----------~~~~~l-~~~~~~~~~~ 200 (380)
+|||++|..||...........+........ ... .... ...+.. ....+.....
T Consensus 224 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (339)
T 1z57_A 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303 (339)
T ss_dssp HHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHH
Confidence 9999999999975432211111100000000 000 0000 000000 0112335567
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 201 QALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 201 ~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.+.+|+.+||+.||.+|||+.||++
T Consensus 304 ~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 304 RLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHhCcCcccccCHHHHhc
Confidence 8999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=276.51 Aligned_cols=213 Identities=23% Similarity=0.286 Sum_probs=150.9
Q ss_pred ccCCCCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||+++++++...+ ..|+||||++ ++|.+++.. .+++..+..++.||+.||.|||+.+
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~--- 147 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--- 147 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999997765 7899999996 689888853 4899999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|+||||||+|||++.++.+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 148 ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 224 (371)
T 2xrw_A 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224 (371)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred eecccCCHHHEEEcCCCCEEEEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999754221 12334678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhh----------------hhhhcccccCCCCC-----CCCccccCC---CChhhHHHHHHHHHHhhh
Q 016913 156 AIDNTRPPGEHNLVA----------------WARPLFKDRRKFPK-----MADPLLQGR---YPMRGLYQALAVAAMCLQ 211 (380)
Q Consensus 156 p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~-----~~~~~l~~~---~~~~~~~~l~~li~~cl~ 211 (380)
||...........+. ...........+.. .....+... .+......+.+|+.+||+
T Consensus 225 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 304 (371)
T 2xrw_A 225 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304 (371)
T ss_dssp SSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCc
Confidence 997543211000000 00000000000000 000000000 011235678999999999
Q ss_pred hCCCCCCCHHHHHHHH
Q 016913 212 EQAATRPLIGDVVTAL 227 (380)
Q Consensus 212 ~~P~~RPt~~evl~~L 227 (380)
.||.+|||+.|+++.-
T Consensus 305 ~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 305 IDASKRISVDEALQHP 320 (371)
T ss_dssp SSGGGSCCHHHHHHSH
T ss_pred CChhhCCCHHHHhCCc
Confidence 9999999999998743
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=273.16 Aligned_cols=215 Identities=22% Similarity=0.283 Sum_probs=159.1
Q ss_pred ccCCCCCCcccceEEEEeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|++++||||+++++++... ...|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---i 149 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---V 149 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999765 36899999996 799999976 56999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC-ccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
+||||||+||||+.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 150 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999986432211 111234579999999998764 45899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhh-hhcccc-------------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 155 KAIDNTRPPGEHNLVAWA-RPLFKD-------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~-~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.||...........+... ...... ...++.. ...............+.+|+.+||+.||.+|||+
T Consensus 230 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 308 (364)
T 3qyz_A 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308 (364)
T ss_dssp CSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCc-cCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence 999765432221111000 000000 0000000 0000000011234678899999999999999999
Q ss_pred HHHHHH
Q 016913 221 GDVVTA 226 (380)
Q Consensus 221 ~evl~~ 226 (380)
.|+++.
T Consensus 309 ~e~l~h 314 (364)
T 3qyz_A 309 EQALAH 314 (364)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=262.35 Aligned_cols=199 Identities=24% Similarity=0.297 Sum_probs=158.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl 147 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDL 147 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5688999999999999999999999999999999999876 357999999999999999999999999 999999
Q ss_pred CCCcEEEcCC---CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 82 KSSNILLDEG---FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 82 kp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+||+++.+ +.+||+|||++....... ......++..|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 148 ~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp CGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 9999999754 469999999997643221 1233458899999999876 58999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... .... .+......+. .+. .......+.+++.+||+.+|.+|||+.||++
T Consensus 224 ~~~~~---~~~~---~~~~~~~~~~---~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 224 GKNEY---DILK---RVETGKYAFD---LPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSSHH---HHHH---HHHHCCCCCC---SGG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHH---HHHH---HHHcCCCCCC---chh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 54221 1111 1111110000 000 0123467889999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=271.77 Aligned_cols=202 Identities=21% Similarity=0.287 Sum_probs=152.2
Q ss_pred ccCCC--CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 2 LSLLH--HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 2 L~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
|++++ ||||+++++++..++..++|||+. +++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 151 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 151 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEecC-CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 34455 699999999999999999999954 7999999986 467999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-----------CCCCCcCceeehHHHHH
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~SlGvvl~ 148 (380)
||||+|||+++ +.+||+|||++................|++.|+|||++.+ ..++.++||||||+++|
T Consensus 152 dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 152 DLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp CCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred CCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 99999999964 7899999999986543322222344578999999999875 46888999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
+|++|..||...... .......... .....++......+.+|+.+||+.||.+|||+.||++.-
T Consensus 231 el~~g~~pf~~~~~~-----~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 231 YMTYGKTPFQQIINQ-----ISKLHAIIDP----------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHSSCTTTTCCSH-----HHHHHHHHCT----------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhCCCchhhHHHH-----HHHHHHHHhc----------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 999999999643211 1111111111 111112222345788999999999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=273.90 Aligned_cols=209 Identities=18% Similarity=0.240 Sum_probs=155.2
Q ss_pred CCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecC
Q 016913 6 HHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrD 80 (380)
.||||+++++++...+ ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+|||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~D 157 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTD 157 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSC
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 4999999999997654 789999999 89999999873 345599999999999999999999998 9 99999
Q ss_pred CCCCcEEEcC------CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLDE------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~~------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||+||||+. .+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 9999999953 34799999999986432 223357899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhc---------------------ccccCCCCCCCCc---------cccCCCChhhHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPL---------------------FKDRRKFPKMADP---------LLQGRYPMRGLYQALA 204 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~---------~l~~~~~~~~~~~l~~ 204 (380)
.||.................+ +.....+...... .....++......+.+
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence 999754322111110000000 0000000000000 0011345567788999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 016913 205 VAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 205 li~~cl~~~P~~RPt~~evl~ 225 (380)
|+.+||+.||.+|||+.||++
T Consensus 313 li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHhccCccccCCHHHHhh
Confidence 999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=274.31 Aligned_cols=211 Identities=20% Similarity=0.269 Sum_probs=156.9
Q ss_pred ccCCCCCCcccceEEEEeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
|+.++||||+++++++... ...++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---i 133 (353)
T 2b9h_A 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---V 133 (353)
T ss_dssp HHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999998764 67899999996 799999976 56999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc--------ccccccccccccchhhhhc-CCCCCcCceeehHHHH
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--------VSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVF 147 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl 147 (380)
+||||||+|||++.++.+||+|||++.......... ......||..|+|||++.. ..++.++|||||||++
T Consensus 134 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 213 (353)
T 2b9h_A 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213 (353)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHH
T ss_pred ecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHH
Confidence 999999999999999999999999998653221111 1123568999999998865 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhhhhcccccC------------------CCCCCCCccccCCCChhhHHHHHHHHHHh
Q 016913 148 LELITGRKAIDNTRPPGEHNLVAWARPLFKDRR------------------KFPKMADPLLQGRYPMRGLYQALAVAAMC 209 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~~~~~~~~~~l~~li~~c 209 (380)
|+|++|..||........ ............ .++......+. .........+.+|+.+|
T Consensus 214 ~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 289 (353)
T 2b9h_A 214 AELFLRRPIFPGRDYRHQ---LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRM 289 (353)
T ss_dssp HHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCcHHH---HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHh
Confidence 999999999975432110 000000000000 00000000000 00123456788999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 016913 210 LQEQAATRPLIGDVVT 225 (380)
Q Consensus 210 l~~~P~~RPt~~evl~ 225 (380)
|+.||.+|||+.||++
T Consensus 290 L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 290 LVFDPAKRITAKEALE 305 (353)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred cCcCcccCCCHHHHhc
Confidence 9999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=276.66 Aligned_cols=207 Identities=23% Similarity=0.306 Sum_probs=145.3
Q ss_pred ccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||+++++++... ...|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--- 152 (367)
T 2fst_X 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--- 152 (367)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999999754 5679999999 6999998864 56999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||+||||+.++.+||+|||+++.... ......||..|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 153 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 227 (367)
T 2fst_X 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227 (367)
T ss_dssp CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSS
T ss_pred eeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986322 2234578999999999987 68899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhccccc-----------------CCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDR-----------------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
.||........... +....... ..+.......+. .........+.+|+.+||+.||.+|
T Consensus 228 ~pf~~~~~~~~l~~---i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R 303 (367)
T 2fst_X 228 TLFPGTDHIDQLKL---ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKR 303 (367)
T ss_dssp CSCCCSSHHHHHHH---HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred CCCCCCCHHHHHHH---HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccC
Confidence 99976432111111 00000000 000000000000 0001234578899999999999999
Q ss_pred CCHHHHHHH
Q 016913 218 PLIGDVVTA 226 (380)
Q Consensus 218 Pt~~evl~~ 226 (380)
||+.|+++.
T Consensus 304 ~t~~e~L~h 312 (367)
T 2fst_X 304 ITAAQALAH 312 (367)
T ss_dssp CCHHHHHTS
T ss_pred cCHHHHhcC
Confidence 999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=279.23 Aligned_cols=204 Identities=22% Similarity=0.276 Sum_probs=147.9
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP---LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~---l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
.+|||||++++++.+++..|||||||. ++|.+++......... ..+..++.++.||+.||+|||+.+ |+||||
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDL 141 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDL 141 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 489999999999999999999999995 7999999863221111 133356789999999999999999 999999
Q ss_pred CCCcEEEcCC-------------CCeEEeecCCcccCCCCCCcc--ccccccccccccchhhhhc-------CCCCCcCc
Q 016913 82 KSSNILLDEG-------------FHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMT-------GQLTLKSD 139 (380)
Q Consensus 82 kp~NILl~~~-------------~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~sD 139 (380)
||+||||+.+ ..+||+|||++.......... ......||+.|+|||++.+ ..++.++|
T Consensus 142 kp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 221 (434)
T 2rio_A 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID 221 (434)
T ss_dssp SGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH
T ss_pred ChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh
Confidence 9999999754 479999999998754332111 1234579999999999976 57899999
Q ss_pred eeehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC
Q 016913 140 VYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218 (380)
Q Consensus 140 V~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 218 (380)
||||||++|||++ |..||...... ...... ....+.. +....+......+.+|+.+||+.||.+||
T Consensus 222 iwSlG~il~ellt~g~~Pf~~~~~~----~~~i~~----~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 288 (434)
T 2rio_A 222 IFSMGCVFYYILSKGKHPFGDKYSR----ESNIIR----GIFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRP 288 (434)
T ss_dssp HHHHHHHHHHHHTTSCCTTCSTTTH----HHHHHH----TCCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred hHhHHHHHHHHHhCCCCCCCCchhh----HHHHhc----CCCCccc-----ccccccccchHHHHHHHHHHhhCChhhCC
Confidence 9999999999999 89999643221 111111 1111111 11112335567899999999999999999
Q ss_pred CHHHHHH
Q 016913 219 LIGDVVT 225 (380)
Q Consensus 219 t~~evl~ 225 (380)
|+.+|++
T Consensus 289 s~~eil~ 295 (434)
T 2rio_A 289 TAMKVLR 295 (434)
T ss_dssp CHHHHHT
T ss_pred CHHHHHh
Confidence 9999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=269.71 Aligned_cols=205 Identities=17% Similarity=0.216 Sum_probs=155.0
Q ss_pred CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcE
Q 016913 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 86 (380)
Q Consensus 7 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NI 86 (380)
|++++.+++++...+..+|||||+ +++|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NI 154 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENI 154 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGE
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence 334999999999999999999999 6788888876 23357999999999999999999999999 99999999999
Q ss_pred EE-------------------cCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHH
Q 016913 87 LL-------------------DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVF 147 (380)
Q Consensus 87 Ll-------------------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl 147 (380)
|| +.++.+||+|||++..... ......||..|+|||++.+..++.++|||||||++
T Consensus 155 ll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 155 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp EESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEecccccccccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHH
Confidence 99 5678899999999986322 22345789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhhhhcccc------------------cCCCCCC----------CCcc-ccCCCChhh
Q 016913 148 LELITGRKAIDNTRPPGEHNLVAWARPLFKD------------------RRKFPKM----------ADPL-LQGRYPMRG 198 (380)
Q Consensus 148 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~----------~~~~-l~~~~~~~~ 198 (380)
|||++|..||........ .......... ....... ..+. .........
T Consensus 230 ~el~~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENREH---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306 (355)
T ss_dssp HHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred HHHHhCCCCCCCCCHHHH---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchh
Confidence 999999999975432111 1111000000 0000000 0000 000112344
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 199 LYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 199 ~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...+.+|+.+||+.||++|||+.||++
T Consensus 307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 307 HVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 668899999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=266.00 Aligned_cols=216 Identities=20% Similarity=0.296 Sum_probs=155.5
Q ss_pred ccCCCCCCcccceEEEE--------------eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 016913 2 LSLLHHSNLVNLIGYCA--------------DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 67 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~--------------~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~ 67 (380)
|+.++||||+++++++. +....++||||++ ++|.+++.. ..+++..++.++.||+.||.|
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~ 135 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKY 135 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHH
Confidence 57889999999999873 4467899999997 799999964 569999999999999999999
Q ss_pred HhhCCCCCeEecCCCCCcEEEc-CCCCeEEeecCCcccCCCCCC-ccccccccccccccchhhhhc-CCCCCcCceeehH
Q 016913 68 LHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFG 144 (380)
Q Consensus 68 LH~~~~~~iiHrDIkp~NILl~-~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG 144 (380)
||+.+ |+|+||||+|||++ .++.+||+|||++........ ........++..|+|||++.. ..++.++||||||
T Consensus 136 lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 212 (320)
T 2i6l_A 136 IHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212 (320)
T ss_dssp HHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHH
T ss_pred HHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHH
Confidence 99999 99999999999997 567899999999986432211 112234567899999999876 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhhhhcccc------cCCCCCCCCcccc-C-----CCChhhHHHHHHHHHHhhhh
Q 016913 145 VVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD------RRKFPKMADPLLQ-G-----RYPMRGLYQALAVAAMCLQE 212 (380)
Q Consensus 145 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~-~-----~~~~~~~~~l~~li~~cl~~ 212 (380)
+++|+|++|..||...........+....+.... ...++........ . .........+.+|+.+||+.
T Consensus 213 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (320)
T 2i6l_A 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292 (320)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCC
Confidence 9999999999999754321111100000000000 0000000000000 0 00112356789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 016913 213 QAATRPLIGDVVTA 226 (380)
Q Consensus 213 ~P~~RPt~~evl~~ 226 (380)
||.+|||+.||++.
T Consensus 293 dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 293 SPMDRLTAEEALSH 306 (320)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred CccccCCHHHHhCC
Confidence 99999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=279.16 Aligned_cols=202 Identities=22% Similarity=0.277 Sum_probs=149.0
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.+ +|||||++++++.+.+..|||||||. ++|.+++.. ....+....++.++.||+.||.|||+.+ |+|||
T Consensus 71 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 143 (432)
T 3p23_A 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRD 143 (432)
T ss_dssp HHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCC
Confidence 4456 79999999999999999999999996 799999986 2334555567899999999999999999 99999
Q ss_pred CCCCcEEEcC-----CCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhh---cCCCCCcCceeehHHHHHHHH
Q 016913 81 LKSSNILLDE-----GFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 81 Ikp~NILl~~-----~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlGvvl~ell 151 (380)
|||+||||+. ...+||+|||+++........ .......||+.|+|||++. ...++.++|||||||++|||+
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence 9999999953 235789999999865432211 2234467999999999997 456788999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 152 T-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 152 t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+ |..||...... ..... .. ..... .. ..+......+.+|+.+||+.||.+|||+.+|++
T Consensus 224 t~g~~pf~~~~~~----~~~~~---~~-~~~~~-~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 224 SEGSHPFGKSLQR----QANIL---LG-ACSLD-CL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCBTTBSTTTH----HHHHH---TT-CCCCT-TS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCcchhhHH----HHHHH---hc-cCCcc-cc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9 88998543211 11110 00 00000 00 011234556889999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=262.88 Aligned_cols=201 Identities=25% Similarity=0.324 Sum_probs=149.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrD 80 (380)
++.++||||+++++++.+.+..++||||+ ++.+..++.. ....+++..++.++.||+.||.|||+. + |+|+|
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~d 150 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRD 150 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCC
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCC
Confidence 46789999999999999999999999999 5677766654 246799999999999999999999995 8 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||+|||++.++.+||+|||++...... .......|+..|+|||++. ...++.++||||||+++|+|++|..
T Consensus 151 lkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 151 VKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEECCCCCEEEEECCCchhccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 9999999999999999999999754322 1223456899999999994 4578899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||...... ... .......... .. . ........+.+|+.+||+.||.+|||+.+|++.
T Consensus 228 pf~~~~~~--~~~---~~~~~~~~~~--~~-~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 228 PYKNCKTD--FEV---LTKVLQEEPP--LL-P------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp TTTTCCSH--HHH---HHHHHHSCCC--CC-C------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCCCcc--HHH---HHHHhccCCC--CC-C------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 99753221 111 1111111100 00 0 011234678899999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.69 Aligned_cols=206 Identities=22% Similarity=0.307 Sum_probs=153.8
Q ss_pred ccCCCCCCcccceEEEEeCCeE------EEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~------~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||++++++|...+.. |+||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+
T Consensus 95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~--- 164 (371)
T 4exu_A 95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG--- 164 (371)
T ss_dssp HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999999887654 99999996 79998884 34999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||+||||+.++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 165 ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 239 (371)
T 4exu_A 165 VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239 (371)
T ss_dssp CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999975322 2234568999999999987 68899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhccccc-----C------------CCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDR-----R------------KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~-----~------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
.||........ ........... . .+.......+. .........+.+|+.+||+.||.+|
T Consensus 240 ~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R 315 (371)
T 4exu_A 240 TLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKR 315 (371)
T ss_dssp CSCCCSSHHHH---HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred CCCCCCChHHH---HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhc
Confidence 99975432111 10000000000 0 00000000000 0112335688999999999999999
Q ss_pred CCHHHHHHH
Q 016913 218 PLIGDVVTA 226 (380)
Q Consensus 218 Pt~~evl~~ 226 (380)
||+.|+++.
T Consensus 316 pt~~ell~h 324 (371)
T 4exu_A 316 LTAAQALTH 324 (371)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=270.66 Aligned_cols=145 Identities=24% Similarity=0.272 Sum_probs=126.3
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh--CCCCCeEecCCCC
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD--KANPPVIYRDLKS 83 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~--~~~~~iiHrDIkp 83 (380)
.|++|+++++++...+..||||||+. ++|.+++... ....+++..+..++.||+.||.|||. .+ |+||||||
T Consensus 114 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp 187 (382)
T 2vx3_A 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKP 187 (382)
T ss_dssp GGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSG
T ss_pred cceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCc
Confidence 34569999999999999999999996 6999999872 33569999999999999999999994 67 99999999
Q ss_pred CcEEEc--CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 84 SNILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 84 ~NILl~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
+||||+ .++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 188 ~NIll~~~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 188 ENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccEEEecCCCCcEEEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999995 467899999999986432 2234678999999999999999999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-33 Score=266.12 Aligned_cols=186 Identities=21% Similarity=0.310 Sum_probs=154.7
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
.||||+++++++...+..++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~ 178 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDE 178 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHH
Confidence 369999999999999999999999976 899999976 467999999999999999999999999 999999999
Q ss_pred cEEEc-CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 85 NILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 85 NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
||||+ .++.+||+|||++...... ......||..|+|||++.+..+ +.++||||||+++|||++|..||....
T Consensus 179 NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~- 253 (320)
T 3a99_A 179 NILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE- 253 (320)
T ss_dssp GEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred HEEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-
Confidence 99999 7789999999999864322 2234568999999999987765 688999999999999999999996421
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
. . ...... ++......+.+|+.+||+.||.+|||+.+|++.
T Consensus 254 ----~---~----~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 ----E---I----IRGQVF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----H---H----HHCCCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----h---h----hccccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 001000 112234678899999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-33 Score=264.21 Aligned_cols=186 Identities=24% Similarity=0.408 Sum_probs=151.0
Q ss_pred CCCCcccceEEEEeCCeEEEEEec-cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEF-MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~ 84 (380)
+||||+++++++...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 168 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDE 168 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGG
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChh
Confidence 899999999999999999999999 789999999986 456999999999999999999999999 999999999
Q ss_pred cEEEc-CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCC-CcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 85 NILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 85 NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
|||++ .++.+||+|||++...... ......|+..|+|||++.+..+. .++||||||+++|+|++|..||....
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~- 243 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ- 243 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred hEEEeCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-
Confidence 99999 7889999999999864322 22345689999999999877664 58999999999999999999996321
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
. ....... ++......+.+|+.+||+.+|++|||+.||++.
T Consensus 244 ----~-------~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ----E-------ILEAELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----H-------HHHTCCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----H-------HhhhccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111111 122334578899999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=264.82 Aligned_cols=205 Identities=22% Similarity=0.304 Sum_probs=153.5
Q ss_pred ccCCCCCCcccceEEEEeCCe------EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQ------RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~------~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|+.++||||+++++++...+. .|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+++
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~--- 146 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG--- 146 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999999987654 499999996 78887764 34999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+|+||||+|||++.++.+||+|||++..... ......+|..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 147 ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 221 (353)
T 3coi_A 147 VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221 (353)
T ss_dssp CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999975321 1234578999999999987 67899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccc-----------------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCC
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKD-----------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 217 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 217 (380)
.||........ .......... ...++....+.+. .........+.+|+.+||+.||.+|
T Consensus 222 ~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R 297 (353)
T 3coi_A 222 TLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKR 297 (353)
T ss_dssp CSSBSSCHHHH---HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTS
T ss_pred CCCCCCCHHHH---HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccC
Confidence 99975432111 1000000000 0000000000010 1122446788999999999999999
Q ss_pred CCHHHHHH
Q 016913 218 PLIGDVVT 225 (380)
Q Consensus 218 Pt~~evl~ 225 (380)
||+.++++
T Consensus 298 pt~~e~l~ 305 (353)
T 3coi_A 298 LTAAQALT 305 (353)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=255.11 Aligned_cols=184 Identities=13% Similarity=0.074 Sum_probs=142.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++||||+++++++.+++..||||||++|++|.+++.. . .....+..++.||+.||+|||+++ |+||||
T Consensus 85 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Di 155 (286)
T 3uqc_A 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSID 155 (286)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 5678999999999999999999999999999999999954 2 356678999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~ 161 (380)
||+||||+.++.+||++++ |++ .++.++|||||||++|||++|..||....
T Consensus 156 kp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 156 HPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp SGGGEEEETTSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred CcccEEEcCCCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 9999999999999997443 333 36889999999999999999999998654
Q ss_pred CCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhccC
Q 016913 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 235 (380)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 235 (380)
........ ... ......+ ........+..+.+|+.+||+.||.+| |+.|+++.|+.+.....
T Consensus 207 ~~~~~~~~---~~~------~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 207 VRSGLAPA---ERD------TAGQPIE--PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BCCCSEEC---CBC------TTSCBCC--HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred cchhhHHH---HHH------hccCCCC--hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 32211000 000 0000000 000112334678899999999999999 99999999998765443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=283.33 Aligned_cols=190 Identities=22% Similarity=0.304 Sum_probs=150.9
Q ss_pred CccCCCCCCcccceEEEEeCCe-----EEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQ-----RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~-----~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|+.++|||||+++++|...+. .|||||||+|++|.+++. ..+++..++.|+.||+.||.|||+++
T Consensus 132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g--- 202 (681)
T 2pzi_A 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG--- 202 (681)
T ss_dssp GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4678999999999999987665 799999999999988774 26999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
||||||||+||||+.+ .+||+|||+++..... ....||+.|+|||++.+.. +.++||||||||+|+|++|..
T Consensus 203 iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCC
T ss_pred CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCC
Confidence 9999999999999986 8999999999864322 3457999999999998754 889999999999999999988
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-HHHHHHHHHHhh
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-IGDVVTALTYLA 231 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~~L~~~~ 231 (380)
||...... .++. ..........+.+|+.+||+.||.+||+ ++++...|..+.
T Consensus 275 ~~~~~~~~-----------------~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 275 TRNGRYVD-----------------GLPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp EETTEECS-----------------SCCT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCcccccc-----------------cccc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 87632110 0000 0001122357889999999999999995 666667666553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=250.68 Aligned_cols=181 Identities=18% Similarity=0.266 Sum_probs=141.8
Q ss_pred cCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 3 SLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+.++||||+++++++.. ....+|||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+ |+|
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H 140 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 140 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 45689999999999987 6778999999999999999987 23357999999999999999999999999 999
Q ss_pred cCCCCCcEEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 79 RDLKSSNILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 79 rDIkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+||||+|||++. ++.+||+|||++.... +..++.++|||||||++|+|++|..
T Consensus 141 ~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~ 196 (299)
T 3m2w_A 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYP 196 (299)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999998 7889999999997421 2356789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCC----hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP----MRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||............ ......... ..+ ......+.+|+.+||+.||.+|||+.||++.
T Consensus 197 pf~~~~~~~~~~~~------------~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 197 PFYSNHGLAISPGM------------KTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCCC-------CCS------------CCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCcchhhhHHH------------HHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 99754322110000 000000000 011 1345678999999999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=276.48 Aligned_cols=219 Identities=25% Similarity=0.283 Sum_probs=163.0
Q ss_pred ccCCCCCCcccceEEEEe------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 2 LSLLHHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
|++++||||+++++++.. ++..++|||||++++|.+++.... ....+++..++.++.||+.||.|||+.+
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g--- 141 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR--- 141 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999998755 667899999999999999998632 2336899999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCC---eEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 76 VIYRDLKSSNILLDEGFH---PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
|+|+||||+|||++.++. +||+|||++...... .......||..|+|||++.+..++.++|||||||++|+|++
T Consensus 142 IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred CccCCCCHHHeEeecCCCceeEEEcccccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 999999999999987654 899999999864322 22344678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCC-------C--CCCCCc--cccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRK-------F--PKMADP--LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~--~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
|..||.... ....|.......... . ...... ......+......+.+|+.+||+.||++|||+.
T Consensus 219 G~~Pf~~~~-----~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~ 293 (676)
T 3qa8_A 219 GFRPFLPNW-----QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293 (676)
T ss_dssp SCSSCCSSC-----HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred CCCCCCccc-----chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence 999996431 111111111000000 0 000000 111223455778999999999999999999998
Q ss_pred H-----HHHHHHHhhh
Q 016913 222 D-----VVTALTYLAS 232 (380)
Q Consensus 222 e-----vl~~L~~~~~ 232 (380)
+ .++.+..+..
T Consensus 294 elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 294 QNPNVGCFQALDSILS 309 (676)
T ss_dssp TCCCCTTHHHHHHHHC
T ss_pred HHhcCHHHHHHHHHHh
Confidence 8 4566666543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=258.27 Aligned_cols=172 Identities=17% Similarity=0.206 Sum_probs=134.6
Q ss_pred eEEEEEeccCCCCHHHHHhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 016913 22 QRLLVYEFMPLGSLEDHLHDL---PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSD 98 (380)
Q Consensus 22 ~~~lV~E~~~ggsL~~~l~~~---~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~D 98 (380)
.++++|+++ +++|.+++... ......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEe
Confidence 467888877 69999999521 123456889999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCCccccccccccccccchhhh----------hcCCCCCcCceeehHHHHHHHHhCCCCCCCCCCCCCcch
Q 016913 99 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA----------MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 168 (380)
Q Consensus 99 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~~~~~~~ 168 (380)
||+++.... ......| +.|+|||++ ....++.++|||||||++|||++|..||........
T Consensus 255 FG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~--- 325 (413)
T 3dzo_A 255 FEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG--- 325 (413)
T ss_dssp GGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC---
T ss_pred ccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh---
Confidence 999875321 1344567 999999999 455688899999999999999999999975432111
Q ss_pred hhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 169 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....+... ...+..+.+|+.+||+.||++||++.++++
T Consensus 326 ---~~~~~~~~----------------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 326 ---SEWIFRSC----------------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp ---SGGGGSSC----------------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHhhc----------------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111100 012367889999999999999999877753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-30 Score=246.52 Aligned_cols=174 Identities=16% Similarity=0.056 Sum_probs=130.1
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEecCCCCCcEEEcCCC------
Q 016913 20 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-DKANPPVIYRDLKSSNILLDEGF------ 92 (380)
Q Consensus 20 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~iiHrDIkp~NILl~~~~------ 92 (380)
.+..|||||||++|+|.+.+.. ..+++..+..++.||+.||.||| +.+ |+||||||+||||+.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~ 205 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHY 205 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEE
T ss_pred cCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceee
Confidence 6789999999999977776643 56899999999999999999999 899 99999999999999887
Q ss_pred --------------CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHH-HHHHHhCCCCC
Q 016913 93 --------------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV-FLELITGRKAI 157 (380)
Q Consensus 93 --------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvv-l~elltG~~p~ 157 (380)
.+||+|||+++.... ....||+.|+|||++.+.. +.++|||||+++ .+++++|..||
T Consensus 206 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 206 TLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp EETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred eccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence 899999999986432 2347999999999998766 889999998777 67788898888
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 224 (380)
... .........+... ...... .....+......+.+|+.+||+.+ |+.|++
T Consensus 278 ~~~-----~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 278 SNV-----LWLHYLTDKMLKQ-MTFKTK----CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHH-----HHHHHHHHHHHHT-CCCSSC----CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred cch-----hhhhHHHHhhhhh-hccCcc----cchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 421 0000000011100 011110 011122356778999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=256.68 Aligned_cols=141 Identities=20% Similarity=0.187 Sum_probs=106.2
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+++ .|+||+++++++++++..|||||||+|++|.++|.. ..+++.. .|+.||+.||+|||++| |||||
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRD 364 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDD 364 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESC
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceecc
Confidence 5666 799999999999999999999999999999999986 5667765 47899999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||+||||+.++.+||+|||+++..... .......+||+.|+|||++.+ .+..++|+|++|++++++.++..
T Consensus 365 IKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 365 VRPWNVMVDARQHARLIDFGSIVTTPQD--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CchHhEEECCCCCEEEeecccCeeCCCC--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 9999999999999999999999864322 222345679999999999876 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.6e-23 Score=208.85 Aligned_cols=140 Identities=19% Similarity=0.235 Sum_probs=118.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++||||+++..++...+..|||||||++++|.+++.. +..++.|++.||.|||+++ |+|||
T Consensus 392 il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrD 456 (540)
T 3en9_A 392 YLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHND 456 (540)
T ss_dssp HHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTT
T ss_pred HHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCC
Confidence 35678999999877777788888999999999999999964 5689999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhc--CCCCCcCceeehHHHHHHHHhC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlGvvl~elltG 153 (380)
|||+|||++. .+||+|||+++......... ......||+.|+|||++.. ..|+..+|+|+..+-.++-+.+
T Consensus 457 iKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~ 534 (540)
T 3en9_A 457 LTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVER 534 (540)
T ss_dssp CCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHT
T ss_pred CCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHh
Confidence 9999999998 99999999998753221111 1235679999999999987 5788899999999998888877
Q ss_pred CCCC
Q 016913 154 RKAI 157 (380)
Q Consensus 154 ~~p~ 157 (380)
+.+|
T Consensus 535 r~rY 538 (540)
T 3en9_A 535 RARY 538 (540)
T ss_dssp CSCC
T ss_pred cccc
Confidence 6655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-17 Score=151.75 Aligned_cols=96 Identities=13% Similarity=0.051 Sum_probs=77.7
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++ | +++++++.. +..|+|||||+|++|.+ +.. .....++.|++.||.|||+.+ |+||||
T Consensus 158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDl 219 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDL 219 (282)
T ss_dssp HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCC
Confidence 34555 5 677776654 45699999999999988 421 124579999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 131 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 131 (380)
||+|||++ ++.+||+|||+++. +..+.|||++..
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999 99999999999973 345789998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.2e-13 Score=125.39 Aligned_cols=87 Identities=18% Similarity=0.201 Sum_probs=67.7
Q ss_pred ccCCCCCCc--ccceEEEEeCCeEEEEEeccCC-C----CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCC
Q 016913 2 LSLLHHSNL--VNLIGYCADGDQRLLVYEFMPL-G----SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-DKAN 73 (380)
Q Consensus 2 L~~l~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~ 73 (380)
|+.++|++| +.++++ +..+|||||+.+ | +|.++... +++..+..++.||+.||.||| ..+
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g- 191 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE- 191 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence 345566654 333332 356899999932 3 78877643 234567889999999999999 999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
|+||||||.|||++. .++|+|||++..
T Consensus 192 --ivHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 192 --LVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp --EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred --EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999998 999999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2.3e-11 Score=117.89 Aligned_cols=68 Identities=16% Similarity=0.118 Sum_probs=56.4
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCC----------C
Q 016913 24 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF----------H 93 (380)
Q Consensus 24 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~----------~ 93 (380)
+|||||++|.+|..+... .....++.||+.+|.+||+.+ ||||||||.||||++++ .
T Consensus 187 ~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp EEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred eEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccc
Confidence 799999998888654321 123567899999999999999 99999999999998776 3
Q ss_pred eEEeecCCccc
Q 016913 94 PKLSDFGLAKL 104 (380)
Q Consensus 94 ~kL~DFGla~~ 104 (380)
+.|+||+.+..
T Consensus 254 ~~iID~~Q~V~ 264 (397)
T 4gyi_A 254 PIIIXFPQMVS 264 (397)
T ss_dssp EEECCCTTCEE
T ss_pred eEEEEeCCccc
Confidence 89999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=2.2e-08 Score=91.37 Aligned_cols=89 Identities=16% Similarity=0.106 Sum_probs=70.9
Q ss_pred CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------
Q 016913 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA-------------- 72 (380)
Q Consensus 7 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------- 72 (380)
|.++.++++++.+.+..|+||||++|.+|.+.+.. ......++.+++.+|..||...
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 139 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRL 139 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHH
Confidence 67788999999999999999999999999876421 1123467889999999999811
Q ss_pred ------------------------------------------CCCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 73 ------------------------------------------NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 73 ------------------------------------------~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.+.++|+|+++.|||++.+..+.|+||+.+..
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 140 AELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 02399999999999998765567999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.48 E-value=8.3e-08 Score=91.94 Aligned_cols=92 Identities=15% Similarity=0.233 Sum_probs=73.0
Q ss_pred CCCcccceEEEEeC---CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------
Q 016913 7 HSNLVNLIGYCADG---DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA----------- 72 (380)
Q Consensus 7 HpnIv~l~~~~~~~---~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------- 72 (380)
+..+.+++.++.+. +..|+||||++|..|.+.. ...++......++.+++..|..||...
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~ 170 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGK 170 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCC
Confidence 45678889988776 3479999999987774321 234788888999999999999999831
Q ss_pred --------------------------------------------CCCeEecCCCCCcEEEcCCCC--eEEeecCCccc
Q 016913 73 --------------------------------------------NPPVIYRDLKSSNILLDEGFH--PKLSDFGLAKL 104 (380)
Q Consensus 73 --------------------------------------------~~~iiHrDIkp~NILl~~~~~--~kL~DFGla~~ 104 (380)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 171 PGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999987653 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.36 E-value=1.4e-07 Score=88.30 Aligned_cols=139 Identities=18% Similarity=0.164 Sum_probs=87.5
Q ss_pred ccceEEEEeCC---eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------
Q 016913 11 VNLIGYCADGD---QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--------------- 72 (380)
Q Consensus 11 v~l~~~~~~~~---~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--------------- 72 (380)
.+++.++...+ ..|+|||+++|.+|.+... ..++...+..++.+++..|..||...
T Consensus 76 P~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~ 149 (304)
T 3sg8_A 76 PEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREK 149 (304)
T ss_dssp CCEEEECCCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHH
T ss_pred CceEeecCCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHH
Confidence 34444443333 2489999999988875433 23677888888999999999998621
Q ss_pred ----------------------------------------CCCeEecCCCCCcEEEcC--CCCeEEeecCCcccCCCCCC
Q 016913 73 ----------------------------------------NPPVIYRDLKSSNILLDE--GFHPKLSDFGLAKLGPVGDK 110 (380)
Q Consensus 73 ----------------------------------------~~~iiHrDIkp~NILl~~--~~~~kL~DFGla~~~~~~~~ 110 (380)
.+.++|+|+++.||+++. ...+.|+||+.+........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D 229 (304)
T 3sg8_A 150 INEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND 229 (304)
T ss_dssp HHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH
T ss_pred HHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH
Confidence 134899999999999998 45678999999875211000
Q ss_pred cccc------------ccccccccccc-hhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 111 THVS------------TRVMGTYGYCA-PEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 111 ~~~~------------~~~~gt~~y~a-PE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
-... ......++... |+..... ....+.|+++.++|.+.+|..+|
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000 00001111122 2222111 12257899999999999997655
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.34 E-value=3.3e-07 Score=82.88 Aligned_cols=83 Identities=17% Similarity=0.178 Sum_probs=63.1
Q ss_pred cccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------
Q 016913 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA----------------- 72 (380)
Q Consensus 10 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------------- 72 (380)
+.++++++..++..++||||++|.+|. ... .+ ...++.+++..|..||...
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~ 144 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERA 144 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Confidence 556888888888899999999998884 211 12 2256777888888888743
Q ss_pred --------------------------------------CCCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 73 --------------------------------------NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 73 --------------------------------------~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
...++|+|++|.|||++.+..+.|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 145 RTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998776667999999863
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=6.7e-05 Score=68.27 Aligned_cols=87 Identities=21% Similarity=0.208 Sum_probs=65.9
Q ss_pred cccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------
Q 016913 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA----------------- 72 (380)
Q Consensus 10 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------------- 72 (380)
+.++++++.+.+..|+|||+++|.++.+..... ......++.+++..|..||...
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~ 153 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQA 153 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhH
Confidence 568899999999999999999999988766431 1223356666777777777521
Q ss_pred --------------------------------------CCCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 73 --------------------------------------NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 73 --------------------------------------~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.+-++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 154 QSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999877677999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0002 Score=66.80 Aligned_cols=89 Identities=17% Similarity=0.153 Sum_probs=62.4
Q ss_pred cccceEEEE-eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------
Q 016913 10 LVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA---------------- 72 (380)
Q Consensus 10 Iv~l~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------- 72 (380)
+.+++.++. ..+..|+||||++|.+|..... ..++......++.+++..|..||...
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~ 147 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKN 147 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHH
Confidence 456666664 3456789999999988876432 12455566666666666666666532
Q ss_pred -----------------------------------------CCCeEecCCCCCcEEEcC---CCC-eEEeecCCccc
Q 016913 73 -----------------------------------------NPPVIYRDLKSSNILLDE---GFH-PKLSDFGLAKL 104 (380)
Q Consensus 73 -----------------------------------------~~~iiHrDIkp~NILl~~---~~~-~kL~DFGla~~ 104 (380)
.+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 148 KILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223699999999999987 355 48999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0011 Score=58.53 Aligned_cols=100 Identities=15% Similarity=0.114 Sum_probs=66.4
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc
Q 016913 32 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 111 (380)
Q Consensus 32 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 111 (380)
.-||.+.|.. .+.+|+++++|.++.|++.+|.-+-....+ ..+=+.|..|+|..+|.+-+.+ ..+.
T Consensus 32 ~vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence 3489999987 578999999999999999998776322211 1233556899999999888753 1110
Q ss_pred cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 112 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
.....+.+||... ...+.+.-|||||++||.-+-
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466787653 244677889999999998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0003 Score=66.75 Aligned_cols=31 Identities=19% Similarity=0.378 Sum_probs=25.9
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 3499999999999999644578999998863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.014 Score=54.62 Aligned_cols=30 Identities=30% Similarity=0.321 Sum_probs=26.5
Q ss_pred CeEecCCCCCcEEEcCC----CCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEG----FHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~----~~~kL~DFGla~~ 104 (380)
.++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999874 6789999999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.57 E-value=0.017 Score=53.68 Aligned_cols=30 Identities=20% Similarity=0.211 Sum_probs=26.9
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 399999999999998788899999998853
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.031 Score=52.21 Aligned_cols=92 Identities=15% Similarity=0.201 Sum_probs=55.4
Q ss_pred CCcccceEEEEeCCeEEEEEeccCCCCHH--------H---HHhcCCC-CC-----------------CCCCHHHHHH--
Q 016913 8 SNLVNLIGYCADGDQRLLVYEFMPLGSLE--------D---HLHDLPP-DK-----------------EPLDWNTRMK-- 56 (380)
Q Consensus 8 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~~-- 56 (380)
..+.+++.++...+..++||||+++..+. . .|+.... .. ..-+|.....
T Consensus 91 v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~ 170 (312)
T 3jr1_A 91 INVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSEN 170 (312)
T ss_dssp SBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHH
T ss_pred CCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHH
Confidence 45778888888888899999999987641 1 2333211 00 0113443220
Q ss_pred -HH----------------HHHHHHH-HHHhh-CCCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 016913 57 -IA----------------AGAAKGL-EYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFG 100 (380)
Q Consensus 57 -i~----------------~qia~aL-~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kL~DFG 100 (380)
+. ..++..+ ..|.. ...+.+||+|+.+.||+++.++ +.|+||.
T Consensus 171 Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 171 RIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp THHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 1112122 23332 2245699999999999999887 8899974
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.34 E-value=0.092 Score=48.19 Aligned_cols=29 Identities=21% Similarity=0.213 Sum_probs=24.9
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
-++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5566789999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.82 E-value=0.052 Score=52.55 Aligned_cols=28 Identities=14% Similarity=0.274 Sum_probs=25.8
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
++|+|+++.|||++.++ ++|+||+.+..
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 99999999999998776 99999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.49 E-value=0.085 Score=48.68 Aligned_cols=44 Identities=25% Similarity=0.225 Sum_probs=31.3
Q ss_pred HHHHHHHHhhC----CCCCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 61 AAKGLEYLHDK----ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 61 ia~aL~~LH~~----~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
+...+++|... ....++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 34445555532 122499999999999998875568999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.14 E-value=0.17 Score=46.72 Aligned_cols=28 Identities=25% Similarity=0.266 Sum_probs=24.7
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 389999999999999 4 899999988864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.57 E-value=0.71 Score=40.49 Aligned_cols=115 Identities=11% Similarity=0.083 Sum_probs=76.2
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEecCCCCC
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE-YLHDKANPPVIYRDLKSS 84 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~-~LH~~~~~~iiHrDIkp~ 84 (380)
.||++ -...-.+++.+.|.|+.-+++.=...+. .++...++.++..|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 3444467778888888764443333443 3788899999999887655 4433 478899999
Q ss_pred cEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 85 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 85 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
||+++.++.++|.-.|+-..++... +.+|.+. -++=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP~e--------------~~ee~fl----------~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPPDE--------------WDDERLL----------REVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSSCS--------------CCHHHHH----------HHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccCCCCC--------------CCHHHHH----------HHHHHHHHHHHcCCCCHH
Confidence 9999999999998777644321110 1222222 256778888888776664
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.81 E-value=0.29 Score=45.82 Aligned_cols=30 Identities=17% Similarity=0.221 Sum_probs=27.0
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999999888899999988764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.86 E-value=0.72 Score=40.33 Aligned_cols=116 Identities=9% Similarity=0.092 Sum_probs=79.0
Q ss_pred CCCCCcccceEEEEeCCeEEEEEeccC-CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 016913 5 LHHSNLVNLIGYCADGDQRLLVYEFMP-LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 83 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~~~~~lV~E~~~-ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIkp 83 (380)
..||+++.. .+-.+.+.+.|.|+.-+ +.++.. + ..++....+.++..|+....+++. -+|--|.|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 368888876 56677777777777654 223333 3 347889999999999987755443 37889999
Q ss_pred CcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 84 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 84 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
+||+++.++.+++.-.|+-..+.... +.+|.+ +-.+=|++..+++++..|+
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~P~~--------------~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVDPLP--------------VSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBSCCC--------------CCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccCCCCCC--------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999998777644321110 111222 2256788888999887775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=87.21 E-value=0.27 Score=46.42 Aligned_cols=29 Identities=24% Similarity=0.331 Sum_probs=24.3
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.|||++.+. +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 489999999999998654 89999988863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=87.16 E-value=0.44 Score=46.75 Aligned_cols=15 Identities=40% Similarity=0.293 Sum_probs=14.1
Q ss_pred CeEecCCCCCcEEEc
Q 016913 75 PVIYRDLKSSNILLD 89 (380)
Q Consensus 75 ~iiHrDIkp~NILl~ 89 (380)
-++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 489999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=86.28 E-value=0.29 Score=47.59 Aligned_cols=30 Identities=33% Similarity=0.370 Sum_probs=24.6
Q ss_pred CeEecCCCCCcEEEcCC----------------------------CCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEG----------------------------FHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~----------------------------~~~kL~DFGla~~ 104 (380)
-++|+|+.+.|||++.+ ..+.|+||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 48999999999999875 6789999988763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=86.15 E-value=0.69 Score=43.99 Aligned_cols=29 Identities=28% Similarity=0.314 Sum_probs=25.3
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.++|+|+.+.|||++.+ .++|+||..+..
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 39999999999999876 489999988864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=84.37 E-value=0.48 Score=45.28 Aligned_cols=30 Identities=27% Similarity=0.255 Sum_probs=26.5
Q ss_pred CeEecCCCCCcEEEcCC----CCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEG----FHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~----~~~kL~DFGla~~ 104 (380)
-++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 49999999999999876 6899999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.14 E-value=0.76 Score=44.02 Aligned_cols=29 Identities=31% Similarity=0.344 Sum_probs=24.7
Q ss_pred eEecCCCCCcEEE------cCCCCeEEeecCCccc
Q 016913 76 VIYRDLKSSNILL------DEGFHPKLSDFGLAKL 104 (380)
Q Consensus 76 iiHrDIkp~NILl------~~~~~~kL~DFGla~~ 104 (380)
++|+|+.+.|||+ +++..++|+||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3456799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 380 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-29 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-61
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 22/234 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L H N++ +GY Q +V ++ SL HLH + + + + IA
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 112
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A+G++YLH K +I+RDLKS+NI L E K+ DFGLA + +H ++ G+
Sbjct: 113 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 121 YGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 177
+ APE + +SDVY+FG+V EL+TG+ N + + L
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
Query: 178 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231
D K ++ + A CL+++ RPL ++ ++ LA
Sbjct: 230 DLSKVRSNCPKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-51
Identities = 54/254 (21%), Positives = 91/254 (35%), Gaps = 26/254 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
+L H N++ I + Q LV ++ GSL D+L+ + + +K
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 104
Query: 57 IAAGAAKGLEYLHDKA-----NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 111
+A A GL +LH + P + +RDLKS NIL+ + ++D GLA T
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 112 --HVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVFLELITGRKAIDNT--- 160
+GT Y APE + ++D+Y+ G+VF E+
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 161 -RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219
P + + + K+ + L + C A R
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 220 IGDVVTALTYLASQ 233
+ L+ L+ Q
Sbjct: 285 ALRIKKTLSQLSQQ 298
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 2e-49
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 27/229 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L + ++ E+M GSL D L P L N + +AA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A+G+ ++ ++ I+RDL+++NIL+ + K++DFGLA+L ++
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFP 173
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE--HNLVAWARPLFKD 178
+ APE G T+KSDV+SFG++ E++T + E NL R + D
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233
Query: 179 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
P+ + + +C +E+ RP + + L
Sbjct: 234 --NCPE----------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-49
Identities = 57/246 (23%), Positives = 93/246 (37%), Gaps = 37/246 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------------------D 41
M L H N+VNL+G C L++E+ G L ++L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 42 LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 101
D L + + A AKG+E+L K ++RDL + N+L+ G K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 102 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 161
A+ V + APE G T+KSDV+S+G++ E+ +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----N 265
Query: 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221
P + A L ++ K P + + C + RP
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 222 DVVTAL 227
++ + L
Sbjct: 316 NLTSFL 321
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-48
Identities = 48/228 (21%), Positives = 83/228 (36%), Gaps = 23/228 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+L L H N+V D L V E+ G L + +++ LD +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 59 AGAAKGLEYLHDK--ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 116
L+ H + V++RDLK +N+ LD + KL DFGLA++ + T +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF 176
+GT Y +PE KSD++S G + EL +
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGKIRE 228
Query: 177 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224
R+ P + + L + RP + +++
Sbjct: 229 GKFRRIPYRYSD------------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-48
Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + +V G + + E M GSL+ L + K++
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 112
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
KGL YL +K +++RD+K SNIL++ KL DFG++ ++ +GT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGT 166
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158
Y +PE +++SD++S G+ +E+ GR I
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-48
Identities = 49/228 (21%), Positives = 91/228 (39%), Gaps = 25/228 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L G C ++ E+M G L ++L + +++
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKD 108
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+ +EYL K ++RDL + N L+++ K+SDFGL++ D+ S
Sbjct: 109 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFP 164
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE-HNLVAWARPLFKDR 179
+ PE M + + KSD+++FGV+ E+ + K E +A L++
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224
Query: 180 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
K+ + C E+A RP +++ +
Sbjct: 225 LASEKVYT-----------------IMYSCWHEKADERPTFKILLSNI 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-48
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 23/231 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L G C + LV+EFM G L D+L + T + +
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLD 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+G+ YL + VI+RDL + N L+ E K+SDFG+ + D+ ST
Sbjct: 110 VCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFP 165
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
+ +PE + + KSDV+SFGV+ E+ + K R E + +D
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDIS 216
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231
++ P L + C +E+ RP ++ L +A
Sbjct: 217 TGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 6e-48
Identities = 51/250 (20%), Positives = 89/250 (35%), Gaps = 39/250 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD------------------- 41
+++ + N+V L+G CA G L++E+M G L + L
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 42 -LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 100
P PL ++ IA A G+ YL ++RDL + N L+ E K++DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 101 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160
L++ D + PE + T +SDV+++GVV E+ +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY-- 243
Query: 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220
G + + P+ + + +C + A RP
Sbjct: 244 --YGMAHEEVIYYVRDGNILACPENCPL------------ELYNLMRLCWSKLPADRPSF 289
Query: 221 GDVVTALTYL 230
+ L +
Sbjct: 290 CSIHRILQRM 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-47
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 27/234 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+++ L HSNLV L+G + L +V E+M GSL D+L + L + +K +
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 110
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
+ +EYL ++RDL + N+L+ E K+SDFGL K + +
Sbjct: 111 DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKL 162
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 179
+ APE + + KSDV+SFG++ E+ + R P + P +
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG------RVPYPRIPLKDVVPRVEKG 216
Query: 180 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233
K P V C AA RP + L ++ +
Sbjct: 217 YKMD----------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-47
Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 25/241 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR-LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
++ H N+++L+G C + L+V +M G L + + + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGL 137
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRV 117
AKG+++L + ++RDL + N +LDE F K++DFGLA+ D H T
Sbjct: 138 QVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 177
+ A E T + T KSDV+SFGV+ EL+T P + N L +
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQ 249
Query: 178 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDP 237
RR LLQ Y LY+ V C +A RP ++V+ ++ + S
Sbjct: 250 GRR--------LLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
Query: 238 N 238
+
Sbjct: 299 H 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-47
Identities = 60/248 (24%), Positives = 92/248 (37%), Gaps = 32/248 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD--------------LPPDK 46
+ L +H N+VNL+G C G L++ E+ G L + L + D+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 47 EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 106
LD + + AKG+ +L K I+RDL + NILL G K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 107 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH 166
V + APE T +SDV+S+G+ EL + + P
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255
Query: 167 NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226
KF KM + P + + C RP +V
Sbjct: 256 --------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 227 LTYLASQT 234
+ S++
Sbjct: 302 IEKQISES 309
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-47
Identities = 54/224 (24%), Positives = 87/224 (38%), Gaps = 29/224 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ S L H N++ L GY D + L+ E+ PLG++ L D
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 114
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A L Y H K VI+RD+K N+LL K++DFG + P + T + GT
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 167
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y PE K D++S GV+ E + G+ P + + + +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEF 221
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224
FP A + + L+ + RP++ +V+
Sbjct: 222 TFPDFVTE------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-46
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 25/225 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ +L+H N+V G+ +G+ + L E+ G L D + + +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQ 111
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
G+ YLH + +RD+K N+LLDE + K+SDFGLA + ++ + ++ GT
Sbjct: 112 LMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 121 YGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPG-EHNLVAWARPLFKD 178
Y APE + DV+S G+V ++ G D E++ +
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 179 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+K LL L E + R I D+
Sbjct: 229 WKKIDSAPLALLHK----------------ILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-46
Identities = 59/246 (23%), Positives = 95/246 (38%), Gaps = 36/246 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD------------LPPDKEP 48
+ L HH N++NL+G C L E+ P G+L D L
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L + AA A+G++YL K I+RDL + NIL+ E + K++DFGL++ V
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 109 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 168
K T + A E T SDV+S+GV+ E+++ P
Sbjct: 181 VKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTC 232
Query: 169 VAWARPLFKDRR-KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
L + R + P D + + C +E+ RP ++ +L
Sbjct: 233 AELYEKLPQGYRLEKPLNCDD------------EVYDLMRQCWREKPYERPSFAQILVSL 280
Query: 228 TYLASQ 233
+ +
Sbjct: 281 NRMLEE 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (395), Expect = 1e-45
Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 28/242 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ H N+++L G +++ EFM GSL+ L + + + G
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRG 136
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV--- 117
A G++YL + ++RDL + NIL++ K+SDFGL++ T
Sbjct: 137 IAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 118 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 177
+ APE + T SDV+S+G+V E+++ + RP + + +
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMTNQDVINAIEQ 248
Query: 178 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDP 237
D R P PM + C Q+ RP G +V L + +P
Sbjct: 249 DYRLPP-----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR---NP 294
Query: 238 NA 239
N+
Sbjct: 295 NS 296
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-45
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 34/231 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
ML L H N+V + +LV E M G+L+ +L + +
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRS 116
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILL-DEGFHPKLSDFGLAKLGPVGDKTHVST 115
KGL++LH + PP+I+RDLK NI + K+ D GLA L + +
Sbjct: 117 WCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 171
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE--HNLVAWAR 173
V+GT + APE + DVY+FG+ LE+ T + + + + +
Sbjct: 172 AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230
Query: 174 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224
P D+ P++ + + C+++ R I D++
Sbjct: 231 PASFDKVAIPEVKE-----------------IIEGCIRQNKDERYSIKDLL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-45
Identities = 52/229 (22%), Positives = 91/229 (39%), Gaps = 26/229 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L + +V LIG C + +LV E G L L +E + + ++
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMG 119
+ G++YL +K ++RDL + N+LL + K+SDFGL+K LG +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP-PGEHNLVAWARPLFKD 178
+ APE + + +SDV+S+GV E ++ + +P A
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGK 229
Query: 179 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
R + P P + A+ + C + RP V +
Sbjct: 230 RMECPPECPP------------ELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (391), Expect = 4e-45
Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 22/234 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ + H NLV L+G C ++ EFM G+L D+L + +++ + + +A
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQ 123
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+ +EYL K I+RDL + N L+ E K++DFGL++L GD
Sbjct: 124 ISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
+ APE + ++KSDV++FGV+ E+ T P D
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGI----------DLS 223
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234
+ ++ + + P + + C Q + RP ++ A + ++
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-45
Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 27/229 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L + +V +IG C + + +LV E LG L +L + +++
Sbjct: 61 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQ 115
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMG 119
+ G++YL + ++RDL + N+LL + K+SDFGL+K L + T
Sbjct: 116 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 179
+ APE + + KSDV+SFGV+ E + + +P L K
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGE 227
Query: 180 R-KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
R P + + +C RP V L
Sbjct: 228 RMGCPAGCPR------------EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-44
Identities = 61/272 (22%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+++ + + ++ L+G C +L + + MP G L D++ + K+ + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQ 119
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
AKG+ YL D+ +++RDL + N+L+ H K++DFGLAKL +K + +
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
+ A E + T +SDV+S+GV EL+T +P + L K R
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASEISSILEKGER 231
Query: 181 -KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNA 239
P + + C A +RP +++ + +A DP
Sbjct: 232 LPQPPICTI------------DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR---DPQR 276
Query: 240 ASNLSN--RVGPSTPRNRDDRRSMADGQDSPD 269
+ R+ +P + + R++ D +D D
Sbjct: 277 YLVIQGDERMHLPSPTDSNFYRALMDEEDMDD 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-44
Identities = 47/229 (20%), Positives = 82/229 (35%), Gaps = 30/229 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L+ H N+V L+ + ++ EF G+++ + +L + PL + +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQ 118
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
L YLHD +I+RDLK+ NIL KL+DFG++ +GT
Sbjct: 119 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGT 173
Query: 121 YGYCAPEYAMTGQL-----TLKSDVYSFGVVFLELITGRKAIDNTRPPGE-HNLVAWARP 174
+ APE M K+DV+S G+ +E+ P + P
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
Query: 175 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
++ L+ CL++ R +
Sbjct: 234 TLAQPSRWSSNFKDFLKK----------------CLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 1e-43
Identities = 54/227 (23%), Positives = 82/227 (36%), Gaps = 32/227 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
L L H N + G LV E+ + + K+PL + G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHG 123
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A +GL YLH +I+RD+K+ NILL E KL DFG A + + +GT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGT 174
Query: 121 YGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 177
+ APE + GQ K DV+S G+ +EL + + N +A
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 178 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 224
+ + + CLQ+ RP ++
Sbjct: 235 QSGHWSEYFRNFVDS----------------CLQKIPQDRPTSEVLL 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-43
Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 26/246 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ H N++ L G + +++ E+M G+L+ L + + + G
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRG 118
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMG 119
A G++YL N ++RDL + NIL++ K+SDFGL++ L + T+ ++
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 179
+ APE + T SDV+SFG+V E++T + E
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------------- 221
Query: 180 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNA 239
K + + PM + C Q++ A RP D+V+ L L P++
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR---APDS 276
Query: 240 ASNLSN 245
L++
Sbjct: 277 LKTLAD 282
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-43
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ L H LV L + +V E+M GSL D L + L + +AA
Sbjct: 65 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 121
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
A G+ Y+ ++RDL+++NIL+ E K++DFGLA+L ++
Sbjct: 122 IASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFP 177
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
+ APE A+ G+ T+KSDV+SFG++ EL T + PG N + R
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRM 233
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
P + C +++ RP + L
Sbjct: 234 PCPPECPE------------SLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-42
Identities = 59/229 (25%), Positives = 85/229 (37%), Gaps = 23/229 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ L H NL+ L G ++ V E PLGSL D L + T + A
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQ 119
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMG 119
A+G+ YL K I+RDL + N+LL K+ DFGL + P D +V
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 179
+ +CAPE T + SD + FGV E+ T + P N + K+
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEG 231
Query: 180 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228
+ P+ P V C + RP + L
Sbjct: 232 ERLPR----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-42
Identities = 57/243 (23%), Positives = 92/243 (37%), Gaps = 31/243 (12%)
Query: 1 MLSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHD------------LPPDKE 47
++ + HH N+VNL+G C G +++ EF G+L +L K+
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 48 PLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 107
L + + AKG+E+L + I+RDL + NILL E K+ DFGLA+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 108 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN 167
+ APE T++SDV+SFGV+ E+ + P
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVK 241
Query: 168 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
+ K+ + P + C + + RP ++V L
Sbjct: 242 IDEEFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 228 TYL 230
L
Sbjct: 292 GNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 3e-41
Identities = 60/246 (24%), Positives = 95/246 (38%), Gaps = 31/246 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEP 48
M + H N++NL+G C ++ E+ G+L ++L P +E
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 108
L + A A+G+EYL K I+RDL + N+L+ E K++DFGLA+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 109 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 168
D +T + APE T +SDV+SFGV+ E+ T P
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYPGVP 242
Query: 169 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 228
V L K+ + P + + C + RP +V L
Sbjct: 243 VEELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 229 YLASQT 234
+ + T
Sbjct: 293 RIVALT 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-41
Identities = 51/233 (21%), Positives = 91/233 (39%), Gaps = 25/233 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------PLDWNTR 54
++ + ++V L+G + G L++ E M G L+ +L L P P +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+++A A G+ YL+ ++RDL + N ++ E F K+ DFG+ + D
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 174
+ + + +PE G T SDV+SFGVV E+ T + G N
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY----QGLSNEQVLRFV 248
Query: 175 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227
+ P + MC Q RP ++++++
Sbjct: 249 MEGGLLDKPDNCPD------------MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 5e-41
Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 27/224 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++ + N+VN + GD+ +V E++ GSL D + + +D +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRE 124
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+ LE+LH VI+RD+KS NILL KL+DFG + + + ++GT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE-HNLVAWARPLFKDR 179
+ APE K D++S G++ +E+I G N P + + P ++
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 180 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
K + L CL R ++
Sbjct: 240 EKLSAIFRDFLNR----------------CLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 50/235 (21%), Positives = 86/235 (36%), Gaps = 28/235 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ H ++V LIG + + ++ E LG L L K LD + + A
Sbjct: 61 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQ 116
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+ L YL K ++RD+ + N+L+ KL DFGL++ + +++
Sbjct: 117 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 172
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKD 178
+ APE + T SDV+ FGV E++ P G N R +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHG------VKPFQGVKNNDVIGRIENGE 226
Query: 179 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233
R P P ++ C + RP ++ L+ + +
Sbjct: 227 RLPMPPNCPP------------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-39
Identities = 52/218 (23%), Positives = 80/218 (36%), Gaps = 25/218 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++S L H V L D ++ + G L ++ D A
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAE 116
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
LEYLH +I+RDLK NILL+E H +++DFG AK+ K + +GT
Sbjct: 117 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y +PE SD+++ G + +L+ G P N + + K
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEY 227
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
FP+ P +A + L A R
Sbjct: 228 DFPEKFFP------------KARDLVEKLLVLDATKRL 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (332), Expect = 9e-36
Identities = 51/194 (26%), Positives = 78/194 (40%), Gaps = 13/194 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
++S +V + D+ + + M G L HL E AA
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAAE 115
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
GLE++H++ V+YRDLK +NILLDE H ++SD GLA +GT
Sbjct: 116 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGT 168
Query: 121 YGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-AWARPLFKD 178
+GY APE G +D +S G + +L+ G + +H + +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 228
Query: 179 RRKFPKMADPLLQG 192
F LL+G
Sbjct: 229 PDSFSPELRSLLEG 242
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (325), Expect = 1e-35
Identities = 50/229 (21%), Positives = 78/229 (34%), Gaps = 30/229 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ + H N++ L LV++ M G L D+L + K L KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRA 118
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+ + LH +++RDLK NILLD+ + KL+DFG + D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGT 172
Query: 121 YGYCAPEYAMTGQL------TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 174
Y APE + D++S GV+ L+ G P + R
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRM 226
Query: 175 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+ +F + + L Q R +
Sbjct: 227 IMSGNYQFGSPEWDDYSD--------TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-35
Identities = 51/218 (23%), Positives = 83/218 (38%), Gaps = 27/218 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ H L ++ + V E++ G L H+ D + AA
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAE 111
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
GL++LH K ++YRDLK NILLD+ H K++DFG+ K +GD GT
Sbjct: 112 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGT 166
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y APE + + D +SFGV+ E++ G+ P + + D
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNP 220
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
+P+ + +A + + R
Sbjct: 221 FYPRWLEK------------EAKDLLVKLFVREPEKRL 246
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 129 bits (326), Expect = 4e-35
Identities = 51/220 (23%), Positives = 81/220 (36%), Gaps = 25/220 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+S+L H LVNL D ++ +++YEFM G L + + D + + + ++
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQ 132
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
KGL ++H+ ++ DLK NI+ KL DFGL D
Sbjct: 133 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTT 186
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 178
GT + APE A + +D++S GV+ L++G P G N R +
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSC 240
Query: 179 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
A + L TR
Sbjct: 241 DWNMDDSAFSGISE--------DGKDFIRKLLLADPNTRM 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-34
Identities = 35/225 (15%), Positives = 85/225 (37%), Gaps = 25/225 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L++ H N+++L ++ ++++EF+ + + ++ L+ +
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+ L++LH + + D++ NI+ K+ +FG A+ GD + +
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LF 164
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 178
Y APE ++ +D++S G + L++G + A F D
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-D 223
Query: 179 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
F +++ +A+ L ++ +R +
Sbjct: 224 EEAFKEISI-------------EAMDFVDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 128 bits (322), Expect = 2e-34
Identities = 57/287 (19%), Positives = 117/287 (40%), Gaps = 33/287 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+++ LHH L+NL D + +L+ EF+ G L D + + + +
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQ 135
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
A +GL+++H+ +++ D+K NI+ + + K+ DFGLA +
Sbjct: 136 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTT 189
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 178
T + APE + +D+++ GV+ L++G P + + + + +
Sbjct: 190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRC 243
Query: 179 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPN 238
+F + A + +A LQ++ R + D + +L
Sbjct: 244 DWEFDEDAFSSVSP--------EAKDFIKNLLQKEPRKRLTVHDAL-EHPWLKGDH---- 290
Query: 239 AASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKN 285
SNL++R+ PS+ N+ ++ D P +GR + S+ +
Sbjct: 291 --SNLTSRI-PSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRK 334
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 126 bits (317), Expect = 2e-34
Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 26/223 (11%)
Query: 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
+ L+H +V + G +V E++ +L D +H + P+ ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIE 115
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVST 115
+ A A + L + H +I+RD+K +NI++ K+ DFG+A+ + G+ +
Sbjct: 116 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 116 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 175
V+GT Y +PE A + +SDVYS G V E++TG P + V+ A
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQH 226
Query: 176 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
++ P L AV L + R
Sbjct: 227 VREDPIPPSARHEGLSA--------DLDAVVLKALAKNPENRY 261
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 2e-33
Identities = 45/218 (20%), Positives = 73/218 (33%), Gaps = 21/218 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + H N+V L G L+ + + G L D + + K ++
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQ 115
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
++YLHD + LDE +SDFGL+K+ D V + GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGT 172
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
GY APE + D +S GV+ L+ G P + N + K
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEY 226
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
+F + A +++ R
Sbjct: 227 EFDSPYWDDISD--------SAKDFIRHLMEKDPEKRF 256
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (311), Expect = 3e-33
Identities = 54/191 (28%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
MLS++ H ++ + G D Q ++ +++ L L + AA
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAE 112
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
LEYLH K +IYRDLK NILLD+ H K++DFG AK P V+ + GT
Sbjct: 113 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGT 164
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y APE T D +SFG++ E++ G P + N + +
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT------PFYDSNTMKTYEKILNAEL 218
Query: 181 KFPKMADPLLQ 191
+FP + ++
Sbjct: 219 RFPPFFNEDVK 229
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 4e-31
Identities = 54/233 (23%), Positives = 85/233 (36%), Gaps = 28/233 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N++ L+ LV++FM D + + L +
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLM 108
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+GLEYLH +++RDLK +N+LLDE KL+DFGLAK G T + T
Sbjct: 109 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVT 163
Query: 121 YGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR------------KAIDNT--RPPGE 165
Y APE ++ + D+++ G + EL+ I T P E
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
+ P + + FP + + L + R
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD----DLLDLIQGLFLFNPCARI 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 6e-31
Identities = 51/238 (21%), Positives = 85/238 (35%), Gaps = 25/238 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL--EDHLHDLPPDKEPLDWNTRMKIA 58
L H N+V L C + + + + + + T +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 118
+GL++LH V++RDLK NIL+ KL+DFGLA++ T V+
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 176
Query: 119 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR-------------KAIDNTRPPGE 165
T Y APE + D++S G +F E+ + K +D PGE
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+ W R + R+ F + ++ ++ + CL A R
Sbjct: 237 ED---WPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-31
Identities = 42/230 (18%), Positives = 73/230 (31%), Gaps = 25/230 (10%)
Query: 1 MLSLLHHSNLVNLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 56
++V ++ A L+V E + G L + D + +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASE 115
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHV 113
I + ++YLH + +RD+K N+L KL+DFG AK +
Sbjct: 116 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT- 171
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 173
T Y APE + D++S GV+ L+ G H L
Sbjct: 172 --TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-----YSNHGLAISPG 224
Query: 174 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+ R + +P + + L+ + R I +
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSE-----EVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-30
Identities = 49/229 (21%), Positives = 82/229 (35%), Gaps = 32/229 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + H N++ L + +L+ E + L D +KE L +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQ 121
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDE----GFHPKLSDFGLAKLGPVGDKTHVSTR 116
G+ YLH + + DLK NI+L + K+ DFGLA G++
Sbjct: 122 ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 117 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF 176
+ GT + APE L L++D++S GV+ L++G V+ F
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 177 KDRR--KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+D +A ++ L + R I D
Sbjct: 236 EDEYFSNTSALAKDFIRR----------------LLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-30
Identities = 48/237 (20%), Positives = 82/237 (34%), Gaps = 26/237 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
++ L H N+V L + ++ LV +++P H K+ L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYV 124
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHV 113
+ L Y+H + +RD+K N+LLD + KL DFG AK +
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPN 179
Query: 114 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR------------KAIDNTR 161
+ + Y T DV+S G V EL+ G+ I
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 162 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
+ P + + KFP++ + R +A+A+ + L+ R
Sbjct: 240 GTPTREQIREMNPNYTE-FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 115 bits (289), Expect = 3e-30
Identities = 36/253 (14%), Positives = 71/253 (28%), Gaps = 34/253 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
L + + N+ + +G +LV + + L T A
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-----KLSDFGLAKL-----GPVGDK 110
++ +H+K ++YRD+K N L+ + DFG+ K
Sbjct: 110 MLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 111 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA 170
+ GT Y + + + + + D+ + G VF+ + G +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY- 225
Query: 171 WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-------LIGDV 223
+ K L +P + P L V
Sbjct: 226 -----ERIGEKKQSTPLRELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
Query: 224 VTALTYLASQTYD 236
+ L + +D
Sbjct: 277 LERLNTTEDENFD 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-29
Identities = 43/220 (19%), Positives = 77/220 (35%), Gaps = 36/220 (16%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 65
S ++ L+ + D +L+ E L D ++ L + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAV 123
Query: 66 EYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 124
+ H+ V++RD+K NIL+D KL DFG L K V T GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYS 176
Query: 125 APEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 183
PE+ + + V+S G++ +++ G P + + F+ R
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQR--VS 228
Query: 184 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
L++ CL + + RP ++
Sbjct: 229 SECQHLIRW----------------CLALRPSDRPTFEEI 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 5e-29
Identities = 48/238 (20%), Positives = 87/238 (36%), Gaps = 19/238 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L H N++ + + ++ + L+ L + L +
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMG 119
+GL+Y+H V++RDLK SN+LL+ K+ DFGLA+ P D T T +
Sbjct: 118 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 120 TYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR-------------KAIDNTRPPGE 165
T Y APE + + KS D++S G + E+++ R + P +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 166 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+L ++ + + R +AL + L R +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 6e-29
Identities = 40/227 (17%), Positives = 74/227 (32%), Gaps = 26/227 (11%)
Query: 1 MLSLLHHSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 59
+ ++ + I +C A+GD ++V E + + T + +A
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLAD 110
Query: 60 GAAKGLEYLHDKANPPVIYRDLKSSNIL---LDEGFHPKLSDFGLAKL-----GPVGDKT 111
+EY+H K I+RD+K N L +G + DFGLAK
Sbjct: 111 QMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 171
+ + GT Y + + + + + D+ S G V + G + +
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-- 225
Query: 172 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 218
+ K +L YP + C + +P
Sbjct: 226 ----ERISEKKMSTPIEVLCKGYPS----EFATYLNFCRSLRFDDKP 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-28
Identities = 51/191 (26%), Positives = 72/191 (37%), Gaps = 15/191 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L H L L D+ V E+ G L HL + A
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAE 113
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
LEYLH + V+YRD+K N++LD+ H K++DFGL K G T GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
Y APE D + GVV E++ GR P + + +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEI 222
Query: 181 KFPKMADPLLQ 191
+FP+ P +
Sbjct: 223 RFPRTLSPEAK 233
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 106 bits (265), Expect = 6e-27
Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 8/154 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L HSN+V L + +LV+E + + + L+ T
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQ 108
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
G+ Y HD+ V++RDLK N+L++ K++DFGLA+ + + + ++
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTL 164
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ + + + D++S G +F E++ G
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 7e-27
Identities = 46/236 (19%), Positives = 82/236 (34%), Gaps = 22/236 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L+H N+V L+ ++ LV+EF+ + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+GL + H V++RDLK N+L++ KL+DFGLA+ V +T+ + V+
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTL 166
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR-------------KAIDNTRPPGEHN 167
+ + D++S G +F E++T R + P E
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 168 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+ + FPK A P ++ + L R
Sbjct: 227 WPGVTS-MPDYKPSFPKWARQDFSKVVPPLDE-DGRSLLSQMLHYDPNKRISAKAA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 9e-26
Identities = 46/243 (18%), Positives = 80/243 (32%), Gaps = 32/243 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--------LLVYEFMPLGSLEDHLHDLPPDKEPLDWN 52
+L LL H N+VNLI C LV++F + L +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLS 117
Query: 53 TRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 112
++ GL Y+H +++RD+K++N+L+ KL+DFGLA+ + +
Sbjct: 118 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 113 VS--TRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTR-------- 161
+ T + T Y PE + + D++ G + E+ T +
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 162 ------PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA 215
E L++ + AL + L A
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 216 TRP 218
R
Sbjct: 295 QRI 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-25
Identities = 45/214 (21%), Positives = 76/214 (35%), Gaps = 8/214 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L L H N+V L + LV+EF +D LD
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
KGL + H + V++RDLK N+L++ KL++FGLA+ + + + S V+
Sbjct: 110 LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTL 165
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
+ + D++S G +F EL + + + +
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 181 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQA 214
++P M YPM +L L
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (257), Expect = 2e-25
Identities = 45/191 (23%), Positives = 72/191 (37%), Gaps = 18/191 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L ++ LV L D +V E++ G + HL AA
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQ 149
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
EYLH +IYRDLK N+L+D+ + +++DFG AK T + GT
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGT 201
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 180
APE ++ D ++ GV+ E+ G P + + +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKV 255
Query: 181 KFPKMADPLLQ 191
+FP L+
Sbjct: 256 RFPSHFSSDLK 266
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 7e-25
Identities = 44/237 (18%), Positives = 79/237 (33%), Gaps = 22/237 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + H N++ L+ + +F + E L + +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
KGL Y+H +RDLK N+ ++E K+ DFGLA+ + ++ V+
Sbjct: 130 MLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTR 182
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR------------KAIDNT--RPPGEH 166
+ + T D++S G + E+ITG+ K I PP E
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 167 NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 223
+ + P++ A+ + L A R G+
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASP-LAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 7e-23
Identities = 51/193 (26%), Positives = 79/193 (40%), Gaps = 12/193 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+ + LV L + L+ +++ G L HL +E +
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGE 137
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
LE+LH +IYRD+K NILLD H L+DFGL+K V D+T + GT
Sbjct: 138 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGT 193
Query: 121 YGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 178
Y AP+ G D +S GV+ EL+TG +++ +R + K
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKS 251
Query: 179 RRKFPKMADPLLQ 191
+P+ L +
Sbjct: 252 EPPYPQEMSALAK 264
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.1 bits (233), Expect = 3e-22
Identities = 32/158 (20%), Positives = 61/158 (38%), Gaps = 17/158 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL--LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 58
+ +L N++ L D R LV+E + + L
Sbjct: 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYM 135
Query: 59 AGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRV 117
K L+Y H +++RD+K N+++D E +L D+GLA+ G +
Sbjct: 136 YEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVR 189
Query: 118 MGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 154
+ + + PE + Q+ D++S G + +I +
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 5e-19
Identities = 34/154 (22%), Positives = 61/154 (39%), Gaps = 7/154 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
+L + H N++ L+ + + L + + L + +
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 120
+GL+Y+H +RDLK SN+ ++E K+ DFGLA+ +V+TR
Sbjct: 130 ILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR---- 182
Query: 121 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
+ D++S G + EL+TGR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (205), Expect = 2e-18
Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 19/160 (11%)
Query: 1 MLSLLHHSNLVNLIGYCA------DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 54
++ ++H N+++L+ + LV E M + LD
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERM 121
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 114
+ G+++LH + +I+RDLK SNI++ K+ DFGLA+ + +
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMM 175
Query: 115 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
T + T Y APE + D++S G + E++ +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.4 bits (202), Expect = 4e-18
Identities = 29/155 (18%), Positives = 60/155 (38%), Gaps = 4/155 (2%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL-DWNTRMKIAAG 60
+ ++++ L+ + + + E+ L + + +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 119
GL+Y+H + +I+ D+K N+L++ L +A LG T +
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 120 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154
T Y +PE + +D++S + ELITG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.2 bits (119), Expect = 6e-08
Identities = 12/103 (11%), Positives = 29/103 (28%), Gaps = 19/103 (18%)
Query: 5 LHHSNLVNLIGYCA----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 60
L L G + ++ E + L ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDM 111
Query: 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 103
+ + + + +++ DL N+L+ E + DF +
Sbjct: 112 ILEEVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.57 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.89 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 86.34 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=344.07 Aligned_cols=214 Identities=29% Similarity=0.464 Sum_probs=165.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||++++++.. +..+||||||++|+|.+++.. .+..+++..++.++.||+.||+|||+++ |||||
T Consensus 57 ~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrD 129 (276)
T d1uwha_ 57 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129 (276)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---Eeccc
Confidence 4688999999999999764 568999999999999999976 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC---CCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+||||+.++.+||+|||+++...............||+.|+|||++.+. .|+.++|||||||++|||+||+.||
T Consensus 130 lKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp CCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 9999999999999999999999875443333344557899999999999753 5889999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
........ ..... ......+. + ...+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 210 ~~~~~~~~--~~~~~----~~~~~~p~-----~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 210 SNINNRDQ--IIFMV----GRGYLSPD-----L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TTCCCHHH--HHHHH----HHTSCCCC-----G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCChHHH--HHHHH----hcCCCCCc-----c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 76433211 11111 11111111 0 011223456788999999999999999999999999988653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-45 Score=342.58 Aligned_cols=209 Identities=24% Similarity=0.394 Sum_probs=162.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++.++||||||++|+|.+++.. ....+++.+++.++.||+.||.|||+++ |+|||
T Consensus 80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrD 153 (299)
T d1jpaa_ 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRD 153 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCc
Confidence 47889999999999999999999999999999999999876 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccc---cccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKA 156 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p 156 (380)
|||+||||+.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence 999999999999999999999986543222111 123457899999999999999999999999999999998 8999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
|...... .+...+. .. . ....+...+..+.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus 234 f~~~~~~---~~~~~i~---~~-~----------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 234 YWDMTNQ---DVINAIE---QD-Y----------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTTCCHH---HHHHHHH---TT-C----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHH---cC-C----------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 9754322 2222111 11 0 011233455778899999999999999999999999988754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=336.76 Aligned_cols=203 Identities=25% Similarity=0.394 Sum_probs=165.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||++++++.+++..|||||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrD 128 (271)
T d1nvra_ 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 128 (271)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCc
Confidence 46789999999999999999999999999999999999965 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+||||++++.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 129 iKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987544433334456789999999999998876 6789999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....... ..... ...... . ........+.+|+.+||+.||++|||++||++
T Consensus 209 ~~~~~~~-~~~~~-----~~~~~~---~------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 209 PSDSCQE-YSDWK-----EKKTYL---N------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SSTTSHH-HHHHH-----TTCTTS---T------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHHH-HHHHh-----cCCCCC---C------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4332111 11110 100000 0 01123467889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=331.17 Aligned_cols=196 Identities=27% Similarity=0.426 Sum_probs=165.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||++++++.+++..|||||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrD 131 (263)
T d2j4za1 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRD 131 (263)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeee
Confidence 36789999999999999999999999999999999999976 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 132 iKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 132 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccccceecCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 9999999999999999999999764322 233467999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... .. ...+...... +|...+..+.+|+.+||+.||++|||+.||++
T Consensus 208 ~~~---~~---~~~i~~~~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 208 TYQ---ET---YKRISRVEFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SHH---HH---HHHHHTTCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHH---HH---HHHHHcCCCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 221 11 1111111111 12233467889999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=343.10 Aligned_cols=209 Identities=26% Similarity=0.395 Sum_probs=168.9
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC-------------------CCCCCCHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------------------DKEPLDWNTRMKIAAGA 61 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi 61 (380)
|+++ +|||||+++++|.+.+..|||||||++|+|.+++..... ....+++..++.++.||
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 3455 899999999999999999999999999999999976321 12458999999999999
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCcee
Q 016913 62 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVY 141 (380)
Q Consensus 62 a~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~ 141 (380)
+.||+|||+++ ||||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus 174 ~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 250 (325)
T d1rjba_ 174 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceecc
Confidence 99999999999 999999999999999999999999999865444333334456789999999999999999999999
Q ss_pred ehHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 142 SFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 142 SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
||||++|||++ |..||....... .+.... .... ....|...+..+.+|+.+||+.||++|||+
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~--~~~~~~----~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDA--NFYKLI----QNGF----------KMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSH--HHHHHH----HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHH--HHHHHH----hcCC----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999997 899997543321 111111 1111 111233345688999999999999999999
Q ss_pred HHHHHHHHH
Q 016913 221 GDVVTALTY 229 (380)
Q Consensus 221 ~evl~~L~~ 229 (380)
+||++.|..
T Consensus 315 ~ei~~~L~~ 323 (325)
T d1rjba_ 315 PNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhC
Confidence 999999863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=333.30 Aligned_cols=207 Identities=27% Similarity=0.404 Sum_probs=159.2
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|++++|||||+++++|..++..+||||||++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDl 127 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 127 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTC
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeeccc
Confidence 5788999999999999999999999999999999999876 4567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCC-CCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR-KAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~-~p~~~~ 160 (380)
||+||||++++.+||+|||+++....... .......||+.|+|||++.+..|+.++|||||||++|||+|+. +||...
T Consensus 128 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 128 AARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp SGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred chhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999986533221 2233467899999999999999999999999999999999964 555432
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.. ..+...+. .. . .. ..|......+.+|+.+||+.||++|||++||++.|+.++.
T Consensus 207 ~~---~~~~~~i~---~~-~---~~-------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 207 SN---SEVVEDIS---TG-F---RL-------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CH---HHHHHHHH---HT-C---CC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CH---HHHHHHHH---hc-C---CC-------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11 11121111 11 0 01 1122334678899999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-44 Score=336.41 Aligned_cols=209 Identities=24% Similarity=0.357 Sum_probs=170.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++..+||||||++|+|.+++.. .....+++..++.++.||+.||+|||+++ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrD 140 (287)
T d1opja_ 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 140 (287)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCc
Confidence 36789999999999999999999999999999999999976 34567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||++++.+||+|||+++..... .........|++.|+|||++.+..|+.++|||||||++|||++|..||...
T Consensus 141 lKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 141 LAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CSGGGEEECGGGCEEECCCCCTTTCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccCeEEECCCCcEEEccccceeecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999864332 222334456899999999999999999999999999999999977665432
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
.. .......+ ... .....+...+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 220 ~~--~~~~~~~i----~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 220 ID--LSQVYELL----EKD----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CC--HHHHHHHH----HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ch--HHHHHHHH----hcC----------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 21 11111111 111 111223344568899999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=332.92 Aligned_cols=207 Identities=25% Similarity=0.381 Sum_probs=169.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.. +..|||||||++|+|.+++.. .+..+++..++.++.||+.||+|||+++ |+|||
T Consensus 62 il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrD 134 (285)
T d1u59a_ 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRD 134 (285)
T ss_dssp HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCc
Confidence 3678999999999999875 468999999999999999865 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||+||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 135 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~ 214 (285)
T d1u59a_ 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214 (285)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence 9999999999999999999999875433222 22334568999999999999999999999999999999998 899997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
..... .+...+. .+.. ...|...+..+.+|+.+||+.+|++|||+.+|++.|+...
T Consensus 215 ~~~~~---~~~~~i~----~~~~----------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 215 KMKGP---EVMAFIE----QGKR----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp TCCTH---HHHHHHH----TTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHH---HHHHHHH----cCCC----------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 64322 1221111 1110 1122344567889999999999999999999999998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=333.35 Aligned_cols=205 Identities=24% Similarity=0.389 Sum_probs=166.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.. +..+||||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |||||
T Consensus 61 il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrD 132 (277)
T d1xbba_ 61 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRD 132 (277)
T ss_dssp HHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCC
Confidence 4678999999999999965 457899999999999999986 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||+||||+.++.+||+|||+++........ .......||+.|+|||++....++.++|||||||++|||++ |..||.
T Consensus 133 lKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 9999999999999999999999875433222 22344678999999999999999999999999999999998 899997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
..... .+...+. ... ....|...+..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 213 ~~~~~---~~~~~i~----~~~----------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 213 GMKGS---EVTAMLE----KGE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCHH---HHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHH---HHHHHHH----cCC----------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 54321 1111111 110 0112233456788999999999999999999999988764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=333.38 Aligned_cols=201 Identities=24% Similarity=0.324 Sum_probs=164.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++..|||||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |||||
T Consensus 61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrD 133 (288)
T d1uu3a_ 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRD 133 (288)
T ss_dssp HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCc
Confidence 36789999999999999999999999999999999999876 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||++++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|..||...
T Consensus 134 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 99999999999999999999998754433333444567999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
... .. ...+...... +|......+.+|+.+||+.||.+|||++|++..
T Consensus 214 ~~~---~~---~~~i~~~~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 214 NEY---LI---FQKIIKLEYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp SHH---HH---HHHHHTTCCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CHH---HH---HHHHHcCCCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 221 11 1111111111 122334678899999999999999999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=331.95 Aligned_cols=200 Identities=25% Similarity=0.359 Sum_probs=165.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++..|||||||+||+|.+++.. ..+++..+..++.||+.||+|||+++ |+|||
T Consensus 70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrD 141 (293)
T d1yhwa1 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141 (293)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccC
Confidence 36789999999999999999999999999999999999876 56999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..|+.++|||||||++|+|++|..||...
T Consensus 142 iKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 142 IKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CcHHHeEECCCCcEeeccchhheeeccc--cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 9999999999999999999999864322 22334567999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
... .... ....... +.. ..+......+.+|+.+||+.||.+|||+.||++
T Consensus 220 ~~~---~~~~---~~~~~~~--~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 220 NPL---RALY---LIATNGT--PEL-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHH---HHHH---HHHHHCS--CCC-------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHH---HHHH---HHHhCCC--CCC-------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 321 1111 1111110 001 112334567889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=331.04 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=163.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++..|||||||++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+|||
T Consensus 62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrD 135 (288)
T d2jfla1 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRD 135 (288)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEee
Confidence 36789999999999999999999999999999999999865 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhh-----cCCCCCcCceeehHHHHHHHHhCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||+||||+.++.+||+|||++..... .........||+.|+|||++. ...|+.++|||||||++|||++|..
T Consensus 136 iKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 136 LKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSC
T ss_pred cChhheeECCCCCEEEEechhhhccCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCC
Confidence 999999999999999999999975311 111233567999999999984 4568899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
||........ .. .+.... .+.+ ..+...+..+.+|+.+||+.||++|||+.||++
T Consensus 214 Pf~~~~~~~~---~~---~i~~~~--~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 214 PHHELNPMRV---LL---KIAKSE--PPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp TTTTSCGGGH---HH---HHHHSC--CCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHHH---HH---HHHcCC--CCCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9976533221 11 111111 1111 112334568889999999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=333.13 Aligned_cols=206 Identities=25% Similarity=0.345 Sum_probs=153.9
Q ss_pred CccCCCCCCcccceEEEEe--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCe
Q 016913 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--NPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~i 76 (380)
+|++++|||||++++++.+ ++.+|||||||++|+|.+++......+..+++..++.++.||+.||.|||+++ ..+|
T Consensus 56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I 135 (269)
T d2java1 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135 (269)
T ss_dssp HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence 4788999999999999865 45689999999999999999753334567999999999999999999999864 2349
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||||||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..|+.++|||||||++|||++|..|
T Consensus 136 iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~P 213 (269)
T d2java1 136 LHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213 (269)
T ss_dssp ----CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCcCchhhcCcCCCCcEEEeeccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCC
Confidence 99999999999999999999999999874322 2223457799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|...... .+.. .+... .+. ..+...+..+.+|+.+||+.||.+|||+.||++
T Consensus 214 f~~~~~~---~~~~---~i~~~--~~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 214 FTAFSQK---ELAG---KIREG--KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCSSHH---HHHH---HHHHT--CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCHH---HHHH---HHHcC--CCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 9753221 1111 11111 111 112233467889999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=328.82 Aligned_cols=210 Identities=25% Similarity=0.373 Sum_probs=163.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+.+..++|||||.+++|.+++.. ....+++..++.++.||+.||+|||+.+ |+|||
T Consensus 62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrD 135 (283)
T d1mqba_ 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRD 135 (283)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCc
Confidence 46789999999999999999999999999999999998876 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 136 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 9999999999999999999999875432221 223345689999999999999999999999999999999997666543
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
.... ..+...+ ... .....+...+..+.+|+.+||+.+|++|||+.||++.|+.+..
T Consensus 216 ~~~~--~~~~~~i----~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 216 ELSN--HEVMKAI----NDG----------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TCCH--HHHHHHH----HTT----------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCH--HHHHHHH----hcc----------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2211 1111111 111 1112233445678999999999999999999999999988754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-42 Score=326.86 Aligned_cols=201 Identities=24% Similarity=0.344 Sum_probs=154.4
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||++++++.+++.+|||||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrD 132 (307)
T d1a06a_ 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRD 132 (307)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEE
Confidence 46789999999999999999999999999999999999976 567999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+|||+. +++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|..||
T Consensus 133 iKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp CCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecccceeecccCCCceEEEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence 999999995 5788999999999854222 2234467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... ... ..+......++ ...+...+..+.+|+.+||+.||++|||+.||++
T Consensus 210 ~~~~~~---~~~---~~i~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 210 YDENDA---KLF---EQILKAEYEFD--------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCSSHH---HHH---HHHHTTCCCCC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHH---HHH---HHHhccCCCCC--------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 753221 111 11111111111 1112234567899999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=328.72 Aligned_cols=208 Identities=25% Similarity=0.403 Sum_probs=165.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||++++++.+ +..+||||||++|+|.+++.. .....+++..++.++.||+.||.|||+++ |+|||
T Consensus 61 ~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrD 134 (272)
T d1qpca_ 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134 (272)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCc
Confidence 3678899999999998865 567999999999999998865 22346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||++++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+||..|+...
T Consensus 135 iKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 135 LRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998754322 22234467899999999999999999999999999999999976554322
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
.. .......+. . .. ....|...+..+.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus 214 ~~--~~~~~~~i~---~-~~----------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 214 MT--NPEVIQNLE---R-GY----------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CC--HHHHHHHHH---T-TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC--HHHHHHHHH---h-cC----------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11 111111111 1 00 01112234467889999999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=333.00 Aligned_cols=216 Identities=22% Similarity=0.310 Sum_probs=163.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHr 79 (380)
+|++++|||||+++++|.+.+..|||||||++|+|.+++.. ...+++..+..++.||+.||.|||+ ++ |+||
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHR 129 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHR 129 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCS
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcc
Confidence 57899999999999999999999999999999999999976 4679999999999999999999997 48 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
||||+||||+.++.+||+|||+|+.... .......||+.|+|||++.+..|+.++||||||||+|||++|+.||..
T Consensus 130 DiKP~NILl~~~~~vkl~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 130 DVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ccCHHHeeECCCCCEEEeeCCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999986321 122346899999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhhhhhhcccccCCCC------------CCC------------Ccccc---CCC-ChhhHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFP------------KMA------------DPLLQ---GRY-PMRGLYQALAVAAMCLQ 211 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~------------~~~l~---~~~-~~~~~~~l~~li~~cl~ 211 (380)
....... .. +...........+ ... +.... ... .......+.+|+.+||+
T Consensus 206 ~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 283 (322)
T d1s9ja_ 206 PDAKELE-LM-FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283 (322)
T ss_dssp CCTTHHH-HH-C------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTC
T ss_pred CCHHHHH-HH-HHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcC
Confidence 4321110 00 0000000000000 000 00000 000 01234678899999999
Q ss_pred hCCCCCCCHHHHHH--HHHH
Q 016913 212 EQAATRPLIGDVVT--ALTY 229 (380)
Q Consensus 212 ~~P~~RPt~~evl~--~L~~ 229 (380)
.||++|||++|+++ .|+.
T Consensus 284 ~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 284 KNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp SSTTTSCCHHHHHTSHHHHH
T ss_pred CChhHCcCHHHHhhCHhhCc
Confidence 99999999999987 3544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=324.98 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=158.9
Q ss_pred CccCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
+|++++|||||+++++|.. +..+|||||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++|
T Consensus 61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~I 135 (270)
T d1t4ha_ 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 135 (270)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCE
Confidence 4788999999999999865 3467999999999999999976 467999999999999999999999975 459
Q ss_pred EecCCCCCcEEEc-CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 77 IYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+||||||+||||+ +++.+||+|||+++.... .......||+.|+|||++.+ .++.++|||||||++|||++|+.
T Consensus 136 iHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~ 210 (270)
T d1t4ha_ 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 210 (270)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EeCCcChhhceeeCCCCCEEEeecCcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCC
Confidence 9999999999996 578999999999986322 22345679999999999865 69999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
||...... ..+.. .+... . ..+.+ +......+.+|+.+||+.||++|||+.||++
T Consensus 211 Pf~~~~~~--~~~~~---~i~~~-~-----~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 211 PYSECQNA--AQIYR---RVTSG-V-----KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTTCSSH--HHHHH---HHTTT-C-----CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcccH--HHHHH---HHHcC-C-----CCccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 99743221 11111 11110 0 00111 1123456889999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-42 Score=328.98 Aligned_cols=196 Identities=28% Similarity=0.345 Sum_probs=161.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++..|||||||.+++|..++.. +..+++..+..++.||+.||.|||+++ |||||
T Consensus 68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrD 140 (309)
T d1u5ra_ 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 140 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccC
Confidence 47889999999999999999999999999999999877765 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc---CCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
|||+||||+.++.+||+|||++..... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..||
T Consensus 141 iKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 141 VKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp CSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 999999999999999999999985322 234679999999999864 46899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...... ......... ..+... +...+..+.+|+.+||+.||.+|||++||++
T Consensus 215 ~~~~~~------~~~~~i~~~--~~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 215 FNMNAM------SALYHIAQN--ESPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTSCHH------HHHHHHHHS--CCCCCS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHH------HHHHHHHhC--CCCCCC--------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 753221 111111111 111111 1123467889999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=319.82 Aligned_cols=205 Identities=22% Similarity=0.375 Sum_probs=169.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 52 ~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~d 125 (258)
T d1k2pa_ 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRD 125 (258)
T ss_dssp HHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSC
T ss_pred HHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---ccccc
Confidence 36788999999999999999999999999999999999876 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||||+.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 126 lk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp CSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccceeEEEcCCCcEEECcchhheeccCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 99999999999999999999998654332 223344678999999999999999999999999999999998 7899975
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
.... .+...+ ... . .. ..|...+..+.+|+.+||+.||++|||+.+|++.|..
T Consensus 205 ~~~~---~~~~~i---~~~-~---~~-------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 205 FTNS---ETAEHI---AQG-L---RL-------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp SCHH---HHHHHH---HTT-C---CC-------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCHH---HHHHHH---HhC-C---CC-------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 5322 111111 111 0 01 1122334678899999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-41 Score=326.67 Aligned_cols=203 Identities=23% Similarity=0.288 Sum_probs=164.9
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++|+|||||+++++|.+++.+|||||||+||+|.+++.. ....+++..+..++.||+.||+|||+++ |||||
T Consensus 76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrD 149 (350)
T d1koaa2 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149 (350)
T ss_dssp HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---Ceeee
Confidence 36789999999999999999999999999999999999965 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcC--CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDE--GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||+||||+. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 150 iKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CCGGGEEESSTTSCCEEECCCTTCEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred echhHeeeccCCCCeEEEeecchheecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 9999999964 578999999999864322 23345679999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..... .. ...+......++.. ........+.+|+.+||+.||++|||++||++.
T Consensus 227 ~~~~~---~~---~~~i~~~~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 227 GENDD---ET---LRNVKSCDWNMDDS--------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CSSHH---HH---HHHHHHTCCCSCCG--------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCHH---HH---HHHHHhCCCCCCcc--------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 54221 11 11111111111111 111234678899999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-41 Score=326.07 Aligned_cols=202 Identities=21% Similarity=0.299 Sum_probs=165.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++|+|||||+++++|.+++.+|||||||+||+|.+++.. ....|++..+..|+.||+.||+|||+++ |||||
T Consensus 79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRD 152 (352)
T d1koba_ 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 152 (352)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 47889999999999999999999999999999999998865 3457999999999999999999999999 99999
Q ss_pred CCCCcEEEc--CCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||+||||+ .++.+||+|||++...... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.
T Consensus 153 iKp~NILl~~~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 153 IKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cccccccccccCCCeEEEeecccceecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 999999997 5689999999999865322 23345679999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
..... ... ..+......++. ......+..+.+|+.+||+.||.+|||+.||++
T Consensus 230 ~~~~~---~~~---~~i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 230 GEDDL---ETL---QNVKRCDWEFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSHH---HHH---HHHHHCCCCCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCHH---HHH---HHHHhCCCCCCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 54221 111 111111111111 111233567889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=321.02 Aligned_cols=207 Identities=22% Similarity=0.350 Sum_probs=159.2
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|. .+..|+|||||++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+|||
T Consensus 61 ~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrD 133 (273)
T d1mp8a_ 61 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRD 133 (273)
T ss_dssp HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccc
Confidence 367899999999999996 4678999999999999999876 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||+++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||..
T Consensus 134 lKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 134 IAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp CSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cchhheeecCCCcEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 99999999999999999999998643222 222344668999999999999999999999999999999998 8889976
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
..... +...+. . .... ..+...+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 213 ~~~~~---~~~~i~---~-~~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 213 VKNND---VIGRIE---N-GERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCGGG---HHHHHH---T-TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH---HHHHHH---c-CCCC----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 54322 221111 1 1000 1223345678999999999999999999999999988753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=326.64 Aligned_cols=208 Identities=25% Similarity=0.409 Sum_probs=166.6
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.++ ..++|+||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |||||
T Consensus 64 ~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrD 136 (317)
T d1xkka_ 64 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRD 136 (317)
T ss_dssp HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCc
Confidence 36788999999999999875 56778889989999998886 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~~ 159 (380)
|||+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |..||..
T Consensus 137 lKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 137 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp CCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999987654444434445678999999999999999999999999999999998 7888875
Q ss_pred CCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 160 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
..... +...+ ..+.. ...|...+..+.+|+.+||+.||.+|||+.||++.|..+..
T Consensus 217 ~~~~~---~~~~i----~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 217 IPASE---ISSIL----EKGER----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp SCGGG---HHHHH----HHTCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH---HHHHH----HcCCC----------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 43221 11111 11110 11233445678899999999999999999999999988754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=317.93 Aligned_cols=201 Identities=25% Similarity=0.318 Sum_probs=163.7
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+.+.+|||||||++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrD 138 (293)
T d1jksa_ 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFD 138 (293)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecc
Confidence 36788999999999999999999999999999999999976 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC----CeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCC
Q 016913 81 LKSSNILLDEGF----HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 81 Ikp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||+|||++.++ .+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccceEEEecCCCcccceEecchhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 999999998776 4999999999864322 223446789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|...... ... ..+......++ +. .+...+..+.+|+.+||+.||++|||++||++
T Consensus 216 f~~~~~~---~~~---~~i~~~~~~~~----~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 216 FLGDTKQ---ETL---ANVSAVNYEFE----DE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SCCSSHH---HHH---HHHHTTCCCCC----HH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCHH---HHH---HHHHhcCCCCC----ch----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9754221 111 11111111111 00 11123467889999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=322.38 Aligned_cols=208 Identities=27% Similarity=0.402 Sum_probs=171.4
Q ss_pred CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 016913 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKAN 73 (380)
Q Consensus 6 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 73 (380)
+|||||+++++|.+++..++|||||++|+|.+++..... ....+++.+++.++.||+.||+|||+.+
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~- 155 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 155 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence 899999999999999999999999999999999976321 2356999999999999999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-
Q 016913 74 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT- 152 (380)
Q Consensus 74 ~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt- 152 (380)
||||||||+|||++.++.+||+|||+++...............+++.|+|||++.+..|+.++||||||||+|||++
T Consensus 156 --ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 156 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp --CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 99999999999999999999999999987544444444456778999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 232 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 232 (380)
|..||...... .+...+ .....+ ..+...+..+.+|+.+||+.||.+|||+.||++.|+.+.+
T Consensus 234 g~~p~~~~~~~---~~~~~i----~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 234 GGSPYPGVPVE---ELFKLL----KEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp SCCSSTTCCHH---HHHHHH----HTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH---HHHHHH----HcCCCC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 68888654321 111111 111111 1122344678999999999999999999999999998865
Q ss_pred c
Q 016913 233 Q 233 (380)
Q Consensus 233 ~ 233 (380)
.
T Consensus 297 ~ 297 (299)
T d1fgka_ 297 L 297 (299)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=321.54 Aligned_cols=198 Identities=27% Similarity=0.334 Sum_probs=165.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++.+|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |||||
T Consensus 58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRD 130 (337)
T d1o6la_ 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRD 130 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccc
Confidence 46789999999999999999999999999999999999986 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..|+.++|||||||++|||++|..||...
T Consensus 131 lKP~NILl~~~g~vkl~DFG~a~~~~~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 131 IKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCHHHeEecCCCCEEEeecccccccccC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 9999999999999999999999864322 22334578999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 225 (380)
... .....+......+ |...+..+.+|+.+||+.||.+||+ +.||++
T Consensus 209 ~~~------~~~~~i~~~~~~~------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 209 DHE------RLFELILMEEIRF------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SHH------HHHHHHHHCCCCC------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CHH------HHHHHHhcCCCCC------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 321 1112222221122 2233467889999999999999995 777765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=321.88 Aligned_cols=208 Identities=26% Similarity=0.371 Sum_probs=160.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+ +..++|||||++|+|..++.. .....+++..++.++.||+.||+|||+.+ |+|||
T Consensus 65 ~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~D 138 (285)
T d1fmka3 65 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 138 (285)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhhh---eeccc
Confidence 3678999999999999854 568999999999999999875 23456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++...... ........||+.|+|||++....++.++|||||||++|||++|..|+...
T Consensus 139 lKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 139 LRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp CSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998643222 22234467899999999999999999999999999999999976665432
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
.. .......+. . .. ....+...+..+.+|+.+||+.||++|||+.+|+++|+...
T Consensus 218 ~~--~~~~~~~i~---~-~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 218 MV--NREVLDQVE---R-GY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CC--HHHHHHHHH---T-TC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CC--HHHHHHHHH---h-cC----------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 21 111122111 0 00 01122334567889999999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=317.77 Aligned_cols=206 Identities=27% Similarity=0.387 Sum_probs=161.5
Q ss_pred CccCCCCCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++++|||||+++++|.+. +.+++||||+++|+|.+++.. .....+++..++.|+.||+.||.|||+.+ |+||
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~ 127 (262)
T d1byga_ 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 127 (262)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhccccccCc---eecc
Confidence 46889999999999998654 568999999999999999975 12335899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
||||+|||++.++.+||+|||+++.... ......++..|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 128 DLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp CCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccchHhheecCCCCEeecccccceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999985322 2233567899999999999999999999999999999998 677776
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhc
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 233 (380)
..... +....+.. . .....+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 203 ~~~~~---~~~~~i~~----~----------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 203 RIPLK---DVVPRVEK----G----------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TSCGG---GHHHHHTT----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHH---HHHHHHHc----C----------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 53222 22222211 0 11122333456788999999999999999999999999987643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=321.29 Aligned_cols=209 Identities=27% Similarity=0.361 Sum_probs=160.3
Q ss_pred CCCCCCcccceEEEEeC-CeEEEEEeccCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 016913 4 LLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHD 70 (380)
Q Consensus 4 ~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~ 70 (380)
..+|||||.+++++... +.+++|||||++|+|.+++..... ....+++..++.++.||+.||+|||+
T Consensus 73 ~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 152 (299)
T d1ywna1 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 152 (299)
T ss_dssp HCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred hcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh
Confidence 34799999999998664 468999999999999999975321 13458999999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHH
Q 016913 71 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 150 (380)
Q Consensus 71 ~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~el 150 (380)
++ ||||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~el 229 (299)
T d1ywna1 153 RK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229 (299)
T ss_dssp TT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHH
Confidence 99 999999999999999999999999999865444333344557899999999999999999999999999999999
Q ss_pred HhCC-CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 016913 151 ITGR-KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 229 (380)
Q Consensus 151 ltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 229 (380)
++|. .||....... .+.... ..... ...+...+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 230 lt~~~~p~~~~~~~~--~~~~~~----~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 230 FSLGASPYPGVKIDE--EFCRRL----KEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HTTSCCSSTTCCCSH--HHHHHH----HHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHH--HHHHHH----hcCCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9875 5776443221 111111 11111 11222345678899999999999999999999999998
Q ss_pred hh
Q 016913 230 LA 231 (380)
Q Consensus 230 ~~ 231 (380)
+.
T Consensus 294 il 295 (299)
T d1ywna1 294 LL 295 (299)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-41 Score=317.46 Aligned_cols=195 Identities=29% Similarity=0.413 Sum_probs=164.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++++|||||++++++.+++.+|+|||||+|++|..++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrD 129 (316)
T d1fota_ 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRD 129 (316)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccc
Confidence 46789999999999999999999999999999999999987 667899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++.... ......||+.|+|||++.+..|+.++|||||||++|||++|..||...
T Consensus 130 iKp~NILl~~~g~vkL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 130 LKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCchheeEcCCCCEEEecCccceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 999999999999999999999987432 233467999999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
... .....+......+ |...+..+.+++.+||+.||.+|+ |+++|++
T Consensus 205 ~~~------~~~~~i~~~~~~~------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 205 NTM------KTYEKILNAELRF------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SHH------HHHHHHHHCCCCC------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHH------HHHHHHHcCCCCC------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 221 1111112211111 222345788999999999999996 8999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-41 Score=319.32 Aligned_cols=211 Identities=24% Similarity=0.436 Sum_probs=168.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC--------------------CCCCCCCHHHHHHHHHH
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--------------------PDKEPLDWNTRMKIAAG 60 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~q 60 (380)
+|++++||||++++++|...+..++||||+++|+|.+++.... .....+++..++.++.|
T Consensus 69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 3678999999999999999999999999999999999997521 12345899999999999
Q ss_pred HHHHHHHHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCce
Q 016913 61 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDV 140 (380)
Q Consensus 61 ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV 140 (380)
|+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+.............|++.|+|||++.+..|+.++||
T Consensus 149 i~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV 225 (301)
T d1lufa_ 149 VAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225 (301)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence 999999999999 99999999999999999999999999986543333334455678999999999999999999999
Q ss_pred eehHHHHHHHHhCC-CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 141 YSFGVVFLELITGR-KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 141 ~SlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
||||||+|||++|. +||...... .....+ . .. ..+ ..+...+..+.+|+.+||+.+|++|||
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~~~---e~~~~v---~-~~-~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMAHE---EVIYYV---R-DG-NIL---------ACPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH---H-TT-CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccchhhHHHHHccCCCCCCCCCHH---HHHHHH---H-cC-CCC---------CCCccchHHHHHHHHHHcCCChhHCcC
Confidence 99999999999996 567644222 111111 1 11 111 112334567889999999999999999
Q ss_pred HHHHHHHHHHhh
Q 016913 220 IGDVVTALTYLA 231 (380)
Q Consensus 220 ~~evl~~L~~~~ 231 (380)
|.||+++|+.+.
T Consensus 289 ~~ev~~~L~~i~ 300 (301)
T d1lufa_ 289 FCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHHhc
Confidence 999999998763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-41 Score=315.20 Aligned_cols=222 Identities=25% Similarity=0.294 Sum_probs=165.9
Q ss_pred ccCCCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----
Q 016913 2 LSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA----- 72 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----- 72 (380)
+++++|||||+++++|.+.+ .+|+|||||++|+|.++++. ..+++..++.++.|++.||.|||...
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~ 125 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTC
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence 56789999999999997754 57999999999999999986 46999999999999999999999741
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCcc--ccccccccccccchhhhhcCC------CCCcCceeehH
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQ------LTLKSDVYSFG 144 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~SlG 144 (380)
..+||||||||+||||+.++.+||+|||+++......... ......||+.|+|||++.... ++.++||||||
T Consensus 126 ~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp BCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 1229999999999999999999999999998754332221 224567999999999987643 67789999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcc--------hhhhhhhcccccCCCCCCCCccccCC-CChhhHHHHHHHHHHhhhhCCC
Q 016913 145 VVFLELITGRKAIDNTRPPGEHN--------LVAWARPLFKDRRKFPKMADPLLQGR-YPMRGLYQALAVAAMCLQEQAA 215 (380)
Q Consensus 145 vvl~elltG~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~~P~ 215 (380)
|++|||+||..||.......... ........... ....|.+... .+.+....+.+|+.+||+.||+
T Consensus 206 vvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~ 280 (303)
T d1vjya_ 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGG
T ss_pred HHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHh
Confidence 99999999988875332211100 00111111111 1111111111 1234566789999999999999
Q ss_pred CCCCHHHHHHHHHHhhhc
Q 016913 216 TRPLIGDVVTALTYLASQ 233 (380)
Q Consensus 216 ~RPt~~evl~~L~~~~~~ 233 (380)
+|||+.||++.|+++..+
T Consensus 281 ~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 281 ARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHHh
Confidence 999999999999988654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-40 Score=321.38 Aligned_cols=198 Identities=25% Similarity=0.279 Sum_probs=163.0
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|+.++|||||+++++|.+.+.+|||||||+||+|.+++.. ...+++..+..++.||+.||.|||+++ ||||||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDl 133 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDL 133 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceee
Confidence 5678999999999999999999999999999999999976 567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
||+||||+.++.+||+|||+++..... ......||+.|+|||++.. ..|+.++|||||||++|||++|..||...
T Consensus 134 KP~NILl~~~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 134 KPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp SGGGEEECSSSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccceeEEcCCCcEEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999864322 2334679999999999975 56899999999999999999999999865
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 225 (380)
.......+.. ....... ..+...+..+.+|+.+||+.||.+||| ++||++
T Consensus 210 ~~~~~~~~~~---~~~~~~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 210 KTKDKHEIDR---MTLTMAV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CSSCHHHHHH---HSSSCCC------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CHHHHHHHHH---hcccCCC------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 4332221111 1111111 112233467889999999999999999 577765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=316.00 Aligned_cols=207 Identities=27% Similarity=0.385 Sum_probs=164.8
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+ ...++|||||++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|||
T Consensus 64 ~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrD 136 (273)
T d1u46a_ 64 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRD 136 (273)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---Eeeee
Confidence 3678999999999999976 467899999999999998876 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCcc-ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh-CCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt-G~~p~~ 158 (380)
|||+||||+.++.+||+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998754433322 2234567889999999999999999999999999999998 899997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
..... .....+ ......+ ..+...+..+.+|+.+||+.||++|||+.||++.|...
T Consensus 217 ~~~~~---~~~~~i---~~~~~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 217 GLNGS---QILHKI---DKEGERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCHH---HHHHHH---HTSCCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCHH---HHHHHH---HhCCCCC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 43221 112111 1111111 11223346788999999999999999999999999764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=314.46 Aligned_cols=212 Identities=26% Similarity=0.398 Sum_probs=169.7
Q ss_pred CccCCCCCCcccceEEEEe-CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 016913 1 MLSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 79 (380)
+|++++|||||+++++|.. ++..++|||||++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||
T Consensus 81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHr 154 (311)
T d1r0pa_ 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHR 154 (311)
T ss_dssp HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccC
Confidence 3678999999999999876 4588999999999999999986 4566889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 80 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 80 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||||+||||++++.+||+|||+++........ .......||..|+|||++....++.++||||||+++|||++|..||
T Consensus 155 DLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~ 234 (311)
T d1r0pa_ 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234 (311)
T ss_dssp CCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence 99999999999999999999999875433222 2223467899999999999999999999999999999999988877
Q ss_pred CCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhcc
Q 016913 158 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 234 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 234 (380)
...... .....++ ... .. . ..|......+.+|+.+||+.||++||++.||++.|+.+....
T Consensus 235 ~~~~~~--~~~~~~i---~~g-~~---~-------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 235 YPDVNT--FDITVYL---LQG-RR---L-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CC--------CHHHH---HTT-CC---C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCH--HHHHHHH---HcC-CC---C-------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 643211 1122221 111 00 0 111233467889999999999999999999999999987543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-41 Score=316.35 Aligned_cols=209 Identities=27% Similarity=0.388 Sum_probs=167.8
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------PDKEPLDWNTRMKIAAGAAKGLEYL 68 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~~L 68 (380)
|+++ +|||||+++++|.+++..+|||||+++|+|.++++... .....|++..++.++.||+.||.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 5677 79999999999999999999999999999999997631 2346799999999999999999999
Q ss_pred hhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHH
Q 016913 69 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 69 H~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
|+.+ |+||||||+|||++.++.+||+|||+++.... ........||..|+|||.+....++.++|||||||++|
T Consensus 144 H~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 144 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred hcCC---ccccccccceEEEcCCCceEEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 9999 99999999999999999999999999975322 12223456899999999999999999999999999999
Q ss_pred HHHhCC-CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 016913 149 ELITGR-KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 227 (380)
Q Consensus 149 elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 227 (380)
||++|. +||...... .+...+ .. .. ....+...+..+.+|+.+||+.||++|||+.||++.|
T Consensus 218 ell~~~~~p~~~~~~~---~~~~~i---~~-~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 218 EIVSLGGTPYCGMTCA---ELYEKL---PQ-GY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp HHHTTSCCTTTTCCHH---HHHHHG---GG-TC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCCCCCCCCHH---HHHHHH---Hh-cC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999976 466543221 111111 11 10 0112233456889999999999999999999999999
Q ss_pred HHhhhc
Q 016913 228 TYLASQ 233 (380)
Q Consensus 228 ~~~~~~ 233 (380)
+.+..+
T Consensus 281 ~~i~~~ 286 (309)
T d1fvra_ 281 NRMLEE 286 (309)
T ss_dssp HHHHHS
T ss_pred HHHHhc
Confidence 998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-40 Score=308.81 Aligned_cols=210 Identities=23% Similarity=0.331 Sum_probs=160.9
Q ss_pred CccCCCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
+|+.++|||||++++++...+ ..|||||||+|++|.+++.. ...+++..++.++.||+.||+|||+++ |
T Consensus 60 ~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---i 132 (277)
T d1o6ya_ 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---I 132 (277)
T ss_dssp HHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 367899999999999987654 47999999999999999976 567999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCC-ccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
+||||||+||||+.++.++|+|||.+........ ........||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 133 iHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 133 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp ECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC
Confidence 9999999999999999999999999875433222 122345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhh
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-LIGDVVTALTYLA 231 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~ 231 (380)
||...... .............+.. .....+..+.+|+.+||+.||.+|| |++++++.|..+.
T Consensus 213 Pf~~~~~~------~~~~~~~~~~~~~~~~--------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 213 PFTGDSPV------SVAYQHVREDPIPPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SCCCSSHH------HHHHHHHHCCCCCGGG--------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCcCHH------HHHHHHHhcCCCCCch--------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 99754221 1111111111111111 1122346788999999999999999 8999999888763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=318.88 Aligned_cols=213 Identities=27% Similarity=0.397 Sum_probs=170.3
Q ss_pred ccCC-CCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC--------------CCCCCCCHHHHHHHHHHHHHHHH
Q 016913 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--------------PDKEPLDWNTRMKIAAGAAKGLE 66 (380)
Q Consensus 2 L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~~~l~~~~~~~i~~qia~aL~ 66 (380)
++++ +|||||+++++|.+++..+||||||++|+|.+++.... .....+++..++.++.||+.||+
T Consensus 80 ~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 3445 79999999999999999999999999999999998632 12346999999999999999999
Q ss_pred HHhhCCCCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHH
Q 016913 67 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 146 (380)
Q Consensus 67 ~LH~~~~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvv 146 (380)
|||+++ +|||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+
T Consensus 160 ~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (311)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHH
Confidence 999999 99999999999999999999999999987654444444556789999999999999999999999999999
Q ss_pred HHHHHhC-CCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 147 FLELITG-RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 147 l~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
+|||+|+ .+||........ +.... ... .....+...+..+.+|+.+||+.||++|||+++|++
T Consensus 237 l~ellt~g~p~~~~~~~~~~--~~~~i----~~~----------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 237 LWELFSLGSSPYPGMPVDSK--FYKMI----KEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTTTCCSSTTCCSSHH--HHHHH----HHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHH--HHHHH----hcC----------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999995 555544322211 11111 111 111122233467889999999999999999999999
Q ss_pred HHHHhhhc
Q 016913 226 ALTYLASQ 233 (380)
Q Consensus 226 ~L~~~~~~ 233 (380)
+|+.....
T Consensus 301 ~L~~~i~~ 308 (311)
T d1t46a_ 301 LIEKQISE 308 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHhhcc
Confidence 99876543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=318.42 Aligned_cols=206 Identities=18% Similarity=0.214 Sum_probs=160.1
Q ss_pred cCCCCCCcccceEEEEe----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 3 SLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
+.++|||||+++++|.+ +..+|||||||+||+|.+++.. .....|++..+..++.||+.||+|||+.+ |+|
T Consensus 60 ~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiH 134 (335)
T d2ozaa1 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 134 (335)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccc
Confidence 34689999999999876 4568999999999999999986 23457999999999999999999999999 999
Q ss_pred cCCCCCcEEEcC---CCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCC
Q 016913 79 RDLKSSNILLDE---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 155 (380)
Q Consensus 79 rDIkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~ 155 (380)
|||||+|||++. .+.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 135 RDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred ccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 999999999975 4579999999998643322 2345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 156 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
||............ ...+...... +........+..+.+|+.+||+.||++|||+.||++.
T Consensus 212 Pf~~~~~~~~~~~~--~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 212 PFYSNHGLAISPGM--KTRIRMGQYE--------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCEETTCC----------CCCSCSSS--------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCHHHHHHHH--HHHHhcCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 99754332211100 0000000000 0001112345678999999999999999999999873
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-40 Score=316.55 Aligned_cols=195 Identities=24% Similarity=0.295 Sum_probs=164.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||++++++.+.+..++||||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ |||||
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRD 166 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCc
Confidence 47889999999999999999999999999999999999976 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 160 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~ 160 (380)
|||+||||+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 167 IKP~NILl~~~g~ikL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 167 LKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHcccCCCCCEEeeeceeeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 999999999999999999999986432 233467999999999999999999999999999999999999999753
Q ss_pred CCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 016913 161 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 225 (380)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 225 (380)
.. ......+......+ +......+.+|+.+||+.||.+|+ |+++|++
T Consensus 242 ~~------~~~~~~i~~~~~~~------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 QP------IQIYEKIVSGKVRF------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SH------HHHHHHHHHCCCCC------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CH------HHHHHHHhcCCCCC------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 22 11111111111111 223346788999999999999994 8999876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.7e-40 Score=305.92 Aligned_cols=200 Identities=25% Similarity=0.298 Sum_probs=162.7
Q ss_pred ccCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|++++ |||||+++++|.+++..|||||||++++|.+++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrD 135 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRD 135 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---Ccccc
Confidence 45665 99999999999999999999999999999999976 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhc------CCCCCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||+||||+.++.+||+|||+++..... .......||..|+|||++.+ ..++.++||||||||+|||++|.
T Consensus 136 lkp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 136 LKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccceEEEcCCCCeEEccchheeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 9999999999999999999999865332 22344679999999999864 34688999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.||....... .. ..+......++ .......+..+.+|+.+||+.||++|||++||++
T Consensus 213 ~Pf~~~~~~~---~~---~~i~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 213 PPFWHRKQML---ML---RMIMSGNYQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CSSCCSSHHH---HH---HHHHHTCCCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCCCHHH---HH---HHHHhCCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 9998543211 11 11111111111 1112234568999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=315.22 Aligned_cols=196 Identities=26% Similarity=0.396 Sum_probs=163.2
Q ss_pred cCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 016913 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 82 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDIk 82 (380)
+.++|||||++++++.+++..|||||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+|||||
T Consensus 58 ~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDik 130 (320)
T d1xjda_ 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLK 130 (320)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCC
T ss_pred HhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 368999999999999999999999999999999999976 567999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCCCCCC
Q 016913 83 SSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 162 (380)
Q Consensus 83 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~~~~~ 162 (380)
|+|||+++++.+||+|||+++..... ........||+.|+|||++.+..|+.++|||||||++|||++|..||.....
T Consensus 131 p~NiL~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 131 LDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceeecCCCceeccccchhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999864322 2233456799999999999999999999999999999999999999975432
Q ss_pred CCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 016913 163 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG-DVVT 225 (380)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-evl~ 225 (380)
. .+. ..+......+ |...+..+.+|+.+||+.||++|||+. +|++
T Consensus 209 ~---~~~---~~i~~~~~~~------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 209 E---ELF---HSIRMDNPFY------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp H---HHH---HHHHHCCCCC------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred H---HHH---HHHHcCCCCC------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 111 1111111111 222345788999999999999999995 6754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=312.72 Aligned_cols=203 Identities=16% Similarity=0.243 Sum_probs=164.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+++.+|||||||+|++|.+++.. .+..+++..+..++.||+.||+|||+++ |+|||
T Consensus 54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrD 127 (321)
T d1tkia_ 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCccc
Confidence 46789999999999999999999999999999999999976 3457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC--CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDEG--FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~--~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||+|||++.+ ..+||+|||+++..... .......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.
T Consensus 128 lKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccceeecCCCceEEEEcccchhhccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 99999999854 57999999999864322 22344678999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
..... .....+......++.... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 205 ~~~~~------~~~~~i~~~~~~~~~~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 205 AETNQ------QIIENIMNAEYTFDEEAF--------KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CSSHH------HHHHHHHHTCCCCCHHHH--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHH------HHHHHHHhCCCCCChhhc--------cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 54321 111111211111111000 1224568899999999999999999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=309.42 Aligned_cols=216 Identities=22% Similarity=0.222 Sum_probs=160.5
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|.+++..|||||||.++++..++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrD 125 (299)
T d1ua2a_ 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRD 125 (299)
T ss_dssp HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eeccc
Confidence 36788999999999999999999999999987776666543 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++... .|+.++|||||||++|||++|..||..
T Consensus 126 iKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 126 LKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcceEEecCCCccccccCccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 99999999999999999999997643322 223345799999999998754 679999999999999999999999975
Q ss_pred CCCCCCcchhhhh-h----hcccccCCCCCCCCccccCCCC-----hhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWA-R----PLFKDRRKFPKMADPLLQGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
....+....+... . ..+...........-......+ ......+.+|+.+||+.||++|||+.|+++
T Consensus 204 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 4322111111000 0 0000000000000000000001 123467899999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=310.63 Aligned_cols=210 Identities=23% Similarity=0.377 Sum_probs=170.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|++++|||||+++++|..++..++|||||++|+|.+++.... .....+++..+..++.|++.||.|||+++
T Consensus 76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-- 153 (308)
T d1p4oa_ 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 153 (308)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 4788999999999999999999999999999999999987421 12245799999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCC
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||+||||++++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++|.
T Consensus 154 -ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 154 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 9999999999999999999999999998654433333345567899999999999999999999999999999999985
Q ss_pred -CCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 016913 155 -KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 230 (380)
Q Consensus 155 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 230 (380)
.||...... .....+ .. ... . ..+...+..+.+|+.+||+.+|.+|||+.+|++.|+..
T Consensus 233 ~~p~~~~~~~---~~~~~i---~~-~~~-~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 233 EQPYQGLSNE---QVLRFV---ME-GGL-L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CCTTTTSCHH---HHHHHH---HT-TCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCCCCCHH---HHHHHH---Hh-CCC-C---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 667543221 111111 11 110 0 11223346799999999999999999999999999765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=302.65 Aligned_cols=218 Identities=20% Similarity=0.233 Sum_probs=161.0
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
||++++|||||+++++|.+++.+|+||||+. +++.+++.. .....+++..+..++.||+.||+|||+++ |||||
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrD 127 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRD 127 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecC-Cchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccc
Confidence 4789999999999999999999999999996 566666544 24567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC-CCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.... ++.++|||||||++|+|++|..||..
T Consensus 128 iKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 128 LKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp CCGGGEEECTTSCEEECSTTHHHHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCchheeecccCcceeccCCcceeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 9999999999999999999999864322 22334467999999999987765 57899999999999999999999975
Q ss_pred CCCCCCcchhh-hhhh-------cccccCCCCCCCCccccCC---CChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 016913 160 TRPPGEHNLVA-WARP-------LFKDRRKFPKMADPLLQGR---YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 226 (380)
Q Consensus 160 ~~~~~~~~~~~-~~~~-------~~~~~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 226 (380)
.........+. .... ................... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 43211100000 0000 0000000000000000000 011234678899999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=299.15 Aligned_cols=189 Identities=21% Similarity=0.320 Sum_probs=155.2
Q ss_pred ccCCC--CCCcccceEEEEeCCeEEEEEeccCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLLH--HSNLVNLIGYCADGDQRLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
|++++ |||||+++++|.+.+..++||||+.+ +++.+++.. ...+++..+..++.||+.||+|||+++ |+|
T Consensus 61 l~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiH 133 (273)
T d1xwsa_ 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLH 133 (273)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 34444 99999999999999999999999975 688888875 567999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCC-CCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCC-CCcCceeehHHHHHHHHhCCCC
Q 016913 79 RDLKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 79 rDIkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlGvvl~elltG~~p 156 (380)
|||||+|||++.+ +.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|..|
T Consensus 134 rDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (273)
T d1xwsa_ 134 RDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209 (273)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence 9999999999854 78999999999864322 2344679999999999987765 5779999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 157 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
|.... . + ...... ++...+..+.+|+.+||+.||++|||++||++
T Consensus 210 f~~~~-----~-i------~~~~~~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 210 FEHDE-----E-I------IRGQVF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCSHH-----H-H------HHCCCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCch-----H-H------hhcccC------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 96421 1 1 111111 11123467889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=299.34 Aligned_cols=213 Identities=21% Similarity=0.243 Sum_probs=158.2
Q ss_pred cCCCCCCcccceEEEEe-----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 016913 3 SLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (380)
Q Consensus 3 ~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 77 (380)
+.++|||||+++++|.. ....+++||||+++.+...... ....+++..+..++.|++.||+|||+++ |+
T Consensus 65 ~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---iv 138 (305)
T d1blxa_ 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VV 138 (305)
T ss_dssp HHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred hhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 34589999999999853 2467999999987666555443 4567999999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCCCCC
Q 016913 78 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 157 (380)
Q Consensus 78 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~~p~ 157 (380)
||||||+|||++.++.+||+|||++.... .........||+.|+|||++.+..|+.++||||||||+|||++|..||
T Consensus 139 HrDiKp~NILi~~~~~~kl~dfg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 139 HRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCCCGGGEEECTTCCEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecCCCccEEEEcCCCCeeecchhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 99999999999999999999999987532 223345678999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhh-h----cccccCC-----CCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 158 DNTRPPGEHNLVAWAR-P----LFKDRRK-----FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 158 ~~~~~~~~~~~~~~~~-~----~~~~~~~-----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
...........+.... . .+..... +...... ....+.......+.+|+.+||+.||++|||+.|+++
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcccccc-chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 7543221111110000 0 0000000 0000000 000112234567889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.6e-38 Score=292.88 Aligned_cols=216 Identities=22% Similarity=0.274 Sum_probs=158.1
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|++++|||||+++++|...+..++||||+.++.+..+... ...+++..+..++.||+.||+|||+.+ |||||
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrD 125 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecC
Confidence 57899999999999999999999999999976666666543 577999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+||||+.++.+||+|||++...... ........+++.|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 126 iKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 126 LKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCceeeEcCCCCEEecccccceecccC--ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 9999999999999999999999864322 1223345689999999998764 568999999999999999999999975
Q ss_pred CCCCCCcchhhhhhh-----cccccCCCCCC------CCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARP-----LFKDRRKFPKM------ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~------~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.........+..... .+......... ..+.............+.+|+.+||+.||++|||+.||++
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 432111111000000 00000000000 0000001112234567889999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-37 Score=294.23 Aligned_cols=218 Identities=23% Similarity=0.248 Sum_probs=156.7
Q ss_pred CccCCCCCCcccceEEEEeC------CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|++++|||||+++++|... .++|||||||+++ +...+.........+++..+..++.||+.||+|||+++
T Consensus 66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-- 142 (350)
T d1q5ka_ 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-- 142 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 46789999999999998543 3478999999754 44444322224567999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCC-CeEEeecCCcccCCCCCCccccccccccccccchhhhhc-CCCCCcCceeehHHHHHHHHh
Q 016913 75 PVIYRDLKSSNILLDEGF-HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlGvvl~ellt 152 (380)
|+||||||+||||+.++ .+||+|||++...... .......||..|+|||.+.+ ..++.++|||||||++|||++
T Consensus 143 -IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 143 -ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp -EECCCCCGGGEEECTTTCCEEECCCTTCEECCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -CcccCCCcceEEEecCCCceeEecccchhhccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhh
Confidence 99999999999999775 8999999999864322 22334679999999998875 478999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhh---------hhhhccc--ccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHH
Q 016913 153 GRKAIDNTRPPGEHNLVA---------WARPLFK--DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 221 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~---------~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 221 (380)
|..||...........+- +...... ....++..................+.+|+.+||+.||++|||+.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 999997543221111100 0000000 00111111111111111223456789999999999999999999
Q ss_pred HHHH
Q 016913 222 DVVT 225 (380)
Q Consensus 222 evl~ 225 (380)
|+++
T Consensus 299 e~L~ 302 (350)
T d1q5ka_ 299 EACA 302 (350)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-36 Score=283.71 Aligned_cols=213 Identities=19% Similarity=0.194 Sum_probs=159.6
Q ss_pred ccCCCCCCccc-ceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHHSNLVN-LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~HpnIv~-l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|+.++|+|+|. +.+++.+++..++||||+ +++|...+.. ....+++..+..++.|++.||+|||+++ |||||
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrD 128 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 55677776555 455668888999999999 5777777765 3567999999999999999999999999 99999
Q ss_pred CCCCcEEEcC---CCCeEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHh
Q 016913 81 LKSSNILLDE---GFHPKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 152 (380)
Q Consensus 81 Ikp~NILl~~---~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ellt 152 (380)
|||+|||++. +..+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t 208 (299)
T d1ckia_ 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208 (299)
T ss_dssp CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh
Confidence 9999999853 4579999999998754333221 2244679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 153 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 153 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
|..||...........+......... ...+.+. ...+..+.+|+..||+.+|++||++.+|.+.|+.+.
T Consensus 209 g~~P~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 209 GSLPWQGLKAATKRQKYERISEKKMS------TPIEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp SSCTTCCCC-------HHHHHHHHHH------SCHHHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCcccccchHHHHHHHHHhhcccCC------CChhHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 99999865544332222111100000 0001111 123457889999999999999999999999988763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-36 Score=288.28 Aligned_cols=211 Identities=23% Similarity=0.313 Sum_probs=159.1
Q ss_pred CccCCCCCCcccceEEEEeCC------eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|+.++|||||+++++|...+ .+||||||| +.+|..++.. ..|++..+..++.||+.||+|||+++
T Consensus 70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~-- 141 (346)
T d1cm8a_ 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG-- 141 (346)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367899999999999997654 579999999 6889888865 57999999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhC
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITG 153 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG 153 (380)
|+||||||+|||++.++.+||+|||+++.... ..+...||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 142 -IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g 215 (346)
T d1cm8a_ 142 -IIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215 (346)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred -CcccccCcchhhcccccccccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHC
Confidence 99999999999999999999999999986422 23446799999999998864 578999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhcc--------------cccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC
Q 016913 154 RKAIDNTRPPGEHNLVAWARPLF--------------KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 219 (380)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 219 (380)
..||................... .....++......+. .........+.+|+.+||+.||.+|||
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~t 294 (346)
T d1cm8a_ 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVT 294 (346)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred cCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcC
Confidence 99997543211110000000000 000000111111111 011233457889999999999999999
Q ss_pred HHHHHHH
Q 016913 220 IGDVVTA 226 (380)
Q Consensus 220 ~~evl~~ 226 (380)
+.||++.
T Consensus 295 a~eiL~H 301 (346)
T d1cm8a_ 295 AGEALAH 301 (346)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.9e-36 Score=281.52 Aligned_cols=213 Identities=16% Similarity=0.178 Sum_probs=167.0
Q ss_pred cCCC-CCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 3 SLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 3 ~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
+.|. |+|++.+++++..+...++||||+ +++|.+++.. ....++..++..++.|++.||+|||+.+ |+||||
T Consensus 55 ~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDi 127 (293)
T d1csna_ 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDI 127 (293)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccC
Confidence 4455 599999999999999999999999 6999999976 3457999999999999999999999999 999999
Q ss_pred CCCcEEEcC-----CCCeEEeecCCcccCCCCCCcc-----ccccccccccccchhhhhcCCCCCcCceeehHHHHHHHH
Q 016913 82 KSSNILLDE-----GFHPKLSDFGLAKLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI 151 (380)
Q Consensus 82 kp~NILl~~-----~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~ell 151 (380)
||+||||+. ++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 128 Kp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell 207 (293)
T d1csna_ 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 207 (293)
T ss_dssp CGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHH
Confidence 999999974 5679999999998754332211 123467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 016913 152 TGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 231 (380)
Q Consensus 152 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 231 (380)
+|..||.................... .... +.+. ...+..+.+|+..|+..+|++||++..+.+.|+.+.
T Consensus 208 tg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~-----~~l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 208 RGSLPWQGLKAATNKQKYERIGEKKQ-STPL-----RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHH-HSCH-----HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hCCCcCCCccchhHHHHHHHHHhccC-CCCh-----HHhc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 99999986544433222211111000 0000 0111 122357889999999999999999999999988764
Q ss_pred h
Q 016913 232 S 232 (380)
Q Consensus 232 ~ 232 (380)
.
T Consensus 278 ~ 278 (293)
T d1csna_ 278 E 278 (293)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=284.27 Aligned_cols=218 Identities=21% Similarity=0.264 Sum_probs=155.6
Q ss_pred CccCCCCCCcccceEEEEe--------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 016913 1 MLSLLHHSNLVNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 72 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 72 (380)
+|++++||||+++++++.. ++..|+|||||.++.+..+.. ....++...+..++.||+.||.|||+.+
T Consensus 62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~ 137 (318)
T d3blha1 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK 137 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCC
Confidence 3678999999999998855 345799999998666655443 3567999999999999999999999999
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc--cccccccccccccchhhhhcC-CCCCcCceeehHHHHHH
Q 016913 73 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLE 149 (380)
Q Consensus 73 ~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~e 149 (380)
|+||||||+||||+.++.+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++||
T Consensus 138 ---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~e 214 (318)
T d3blha1 138 ---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214 (318)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred ---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeee
Confidence 999999999999999999999999999764432221 122335799999999999865 68999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhhhhcccccCCCCCCCCc--------cccCCCCh-------hhHHHHHHHHHHhhhhCC
Q 016913 150 LITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP--------LLQGRYPM-------RGLYQALAVAAMCLQEQA 214 (380)
Q Consensus 150 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~l~~~~~~-------~~~~~l~~li~~cl~~~P 214 (380)
|++|+.||...........+......... ......... ......+. .....+++|+.+||+.||
T Consensus 215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 215 MWTRSPIMQGNTEQHQLALISQLCGSITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCT-TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhcCCCCh-hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 99999999754322111111111000000 000000000 00000011 113456789999999999
Q ss_pred CCCCCHHHHHHH
Q 016913 215 ATRPLIGDVVTA 226 (380)
Q Consensus 215 ~~RPt~~evl~~ 226 (380)
++|||+.|+++.
T Consensus 294 ~~R~sa~elL~H 305 (318)
T d3blha1 294 AQRIDSDDALNH 305 (318)
T ss_dssp TTSCCHHHHHHS
T ss_pred hHCcCHHHHHcC
Confidence 999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-36 Score=286.08 Aligned_cols=202 Identities=26% Similarity=0.323 Sum_probs=161.8
Q ss_pred ccCCCC-CCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 2 LSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 2 L~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
|++++| |||+++++++.+....++|||||.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|||
T Consensus 82 l~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrD 154 (322)
T d1vzoa_ 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRD 154 (322)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEecc
Confidence 566766 8999999999999999999999999999999987 567889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC--CCCCcCceeehHHHHHHHHhCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKAID 158 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlGvvl~elltG~~p~~ 158 (380)
|||+||||+.++.+||+|||+++.+.... ........|++.|++||.+... .++.++|||||||++|+|++|..||.
T Consensus 155 iKp~Nill~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 155 IKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCccceeecCCCCEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999997643322 2223446799999999999764 46889999999999999999999998
Q ss_pred CCCCCCCcchhhhhhhcccccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 016913 159 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 225 (380)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 225 (380)
..........+.. ....... .++......+.+|+.+||+.||++||| ++||++
T Consensus 234 ~~~~~~~~~~i~~--~~~~~~~------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 234 VDGEKNSQAEISR--RILKSEP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CTTSCCCHHHHHH--HHHHCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCHHHHHHHHHH--hcccCCC------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 6654433222211 1111111 122334578889999999999999994 788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-35 Score=275.02 Aligned_cols=214 Identities=20% Similarity=0.213 Sum_probs=162.3
Q ss_pred CccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 016913 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 80 (380)
+|+.++|||||+++++|.+.+..++|+|++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+|||
T Consensus 54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrD 126 (292)
T d1unla_ 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126 (292)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCcCCEEeeccccccccceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---Eeeec
Confidence 46789999999999999999999999999998888888765 577899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCC-CCCcCceeehHHHHHHHHhCCCCCCC
Q 016913 81 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDN 159 (380)
Q Consensus 81 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlGvvl~elltG~~p~~~ 159 (380)
|||+|||++.++.+||+|||.++...... .......++..|+|||++.... ++.++|||||||++|||++|..||..
T Consensus 127 iKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 127 LKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ccCcccccccCCceeeeecchhhcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 99999999999999999999998743322 2233445778899999988665 68999999999999999999998743
Q ss_pred CCCCCCcchhhhhhhcccc--------------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 016913 160 TRPPGEHNLVAWARPLFKD--------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 225 (380)
.... ......+...... .......................+.+|+.+||+.||.+|||++||++
T Consensus 205 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 205 GNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCH--HHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3221 1111110000000 00000000001111122344567889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-36 Score=286.12 Aligned_cols=217 Identities=20% Similarity=0.249 Sum_probs=156.1
Q ss_pred CccCCCCCCcccceEEEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 016913 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 76 (380)
||++|+|||||++++++.... ..+++++|+.+++|.+++.. ..+++..+..++.||+.||+|||+++ |
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---i 130 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---V 130 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 467899999999999997653 23444455568999999976 46999999999999999999999999 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCc-cccccccccccccchhhhh-cCCCCCcCceeehHHHHHHHHhCC
Q 016913 77 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 77 iHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||||||+||||+.++.+||+|||++......... .......||+.|+|||++. ...++.++||||+||++|+|++|.
T Consensus 131 iHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~ 210 (345)
T d1pmea_ 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210 (345)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence 99999999999999999999999999764322111 2234567999999999985 456789999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhcccc--------------cCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFKD--------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.||......+.............. ....+........ .........+.+|+.+||+.||.+|||+
T Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ta 289 (345)
T d1pmea_ 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEV 289 (345)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHH-HhCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 999754321111111000000000 0000000000000 0011223578899999999999999999
Q ss_pred HHHHHH
Q 016913 221 GDVVTA 226 (380)
Q Consensus 221 ~evl~~ 226 (380)
.|+++.
T Consensus 290 ~e~L~h 295 (345)
T d1pmea_ 290 EQALAH 295 (345)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-35 Score=280.76 Aligned_cols=211 Identities=17% Similarity=0.215 Sum_probs=155.0
Q ss_pred ccCCC-CCCcccceEEEEeC--CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 016913 2 LSLLH-HSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (380)
Q Consensus 2 L~~l~-HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 78 (380)
|++++ ||||++++++|... ...++|||||.+++|..+. +.+++..+..++.||+.||+|||+++ |+|
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvH 152 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMH 152 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---ccc
Confidence 55664 99999999999854 4689999999999986653 45999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCC-CeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCCCC
Q 016913 79 RDLKSSNILLDEGF-HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKA 156 (380)
Q Consensus 79 rDIkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~~p 156 (380)
|||||+||||+.++ .+||+|||+++..... .......+|..|+|||.+.+. .++.++|||||||++|+|++|..|
T Consensus 153 rDiKp~NILi~~~~~~vkl~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~p 229 (328)
T d3bqca1 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229 (328)
T ss_dssp CCCSGGGEEEETTTTEEEECCGGGCEECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccccccceEEcCCCCeeeecccccceeccCC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCC
Confidence 99999999998655 6899999999864322 223446789999999998875 579999999999999999999999
Q ss_pred CCCCCCCCCcc-hh----------hhhhh-cccccCCC--------CCCCCccccCCCChhhHHHHHHHHHHhhhhCCCC
Q 016913 157 IDNTRPPGEHN-LV----------AWARP-LFKDRRKF--------PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 216 (380)
Q Consensus 157 ~~~~~~~~~~~-~~----------~~~~~-~~~~~~~~--------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~ 216 (380)
|.......... .+ .+... .......+ ...................+.+|+.+||+.||++
T Consensus 230 f~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 309 (328)
T d3bqca1 230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309 (328)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGG
T ss_pred CCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhH
Confidence 97543211100 00 00000 00000000 0011111111222234567899999999999999
Q ss_pred CCCHHHHHH
Q 016913 217 RPLIGDVVT 225 (380)
Q Consensus 217 RPt~~evl~ 225 (380)
|||++|+++
T Consensus 310 R~ta~e~L~ 318 (328)
T d3bqca1 310 RLTAREAME 318 (328)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=276.25 Aligned_cols=213 Identities=23% Similarity=0.279 Sum_probs=150.3
Q ss_pred CccCCCCCCcccceEEEEe------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 74 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 74 (380)
+|++++|||||+++++|.. ...+|+|||||. ++|.+.+. ..+++..+..++.||+.||.|||+.+
T Consensus 69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~-~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g-- 139 (355)
T d2b1pa1 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG-- 139 (355)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccc-hHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc--
Confidence 3678899999999999964 368899999996 55555553 35899999999999999999999999
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCC
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||+|||++.++.+||+|||+++.... ........+|+.|+|||++.+..++.++||||+||++|+|++|.
T Consensus 140 -iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~ 215 (355)
T d2b1pa1 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -cccccCCccccccccccceeeechhhhhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCC
Confidence 99999999999999999999999999875332 22334567899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhh----------------hhhhcccccCCCC-----CCCCccccCC---CChhhHHHHHHHHHHhh
Q 016913 155 KAIDNTRPPGEHNLVA----------------WARPLFKDRRKFP-----KMADPLLQGR---YPMRGLYQALAVAAMCL 210 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~-----~~~~~~l~~~---~~~~~~~~l~~li~~cl 210 (380)
.||...........+. ............. .......... ........+.+|+.+||
T Consensus 216 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL 295 (355)
T d2b1pa1 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295 (355)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 9996543211100000 0000000000000 0000001000 11234567899999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 016913 211 QEQAATRPLIGDVVTA 226 (380)
Q Consensus 211 ~~~P~~RPt~~evl~~ 226 (380)
+.||++|||++||++.
T Consensus 296 ~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 296 VIDPAKRISVDDALQH 311 (355)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred cCChhHCcCHHHHhcC
Confidence 9999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-34 Score=275.19 Aligned_cols=211 Identities=21% Similarity=0.265 Sum_probs=151.6
Q ss_pred CccCCCCCCcccceEEEEeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 016913 1 MLSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 75 (380)
Q Consensus 1 iL~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 75 (380)
+|++++|||||++++++... ...++|++|+.+++|.+++.. ..+++..+..++.||+.||+|||+++
T Consensus 70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g--- 141 (348)
T d2gfsa1 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--- 141 (348)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 46789999999999998643 234566677779999999964 56999999999999999999999999
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccchhhhhcC-CCCCcCceeehHHHHHHHHhCC
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlGvvl~elltG~ 154 (380)
|+||||||+|||++.++.+||+|||++... ........|+..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 142 iiHrDiKp~NILi~~~~~~kl~dfg~a~~~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~ 216 (348)
T d2gfsa1 142 IIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216 (348)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCC----CC-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CcccccCCccccccccccccccccchhccc-----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCC
Confidence 999999999999999999999999999752 2233456789999999987775 4689999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhccc--------------ccCCCCCCCCccccCCCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 016913 155 KAIDNTRPPGEHNLVAWARPLFK--------------DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 220 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 220 (380)
.||...........+........ ....+.......+.. ........+.+|+.+||+.||.+|||+
T Consensus 217 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta 295 (348)
T d2gfsa1 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITA 295 (348)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCH
Confidence 99975432111111100000000 000000000000000 001234578899999999999999999
Q ss_pred HHHHH
Q 016913 221 GDVVT 225 (380)
Q Consensus 221 ~evl~ 225 (380)
.|+++
T Consensus 296 ~elL~ 300 (348)
T d2gfsa1 296 AQALA 300 (348)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=3.9e-30 Score=246.73 Aligned_cols=210 Identities=19% Similarity=0.221 Sum_probs=146.8
Q ss_pred CCCCCcccceEEEEeC--CeEEEEEeccCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 016913 5 LHHSNLVNLIGYCADG--DQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (380)
Q Consensus 5 l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrD 80 (380)
+.|+|||++++++... ...++||+++... ....+... .....+++..+..++.||+.||.|||+ .+ |+|||
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrD 151 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTD 151 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSC
T ss_pred cCcCceEEEEEEeeeccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---ccccc
Confidence 3579999999988653 4556666665444 33333333 345678999999999999999999998 88 99999
Q ss_pred CCCCcEEEcCCCC------eEEeecCCcccCCCCCCccccccccccccccchhhhhcCCCCCcCceeehHHHHHHHHhCC
Q 016913 81 LKSSNILLDEGFH------PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 154 (380)
Q Consensus 81 Ikp~NILl~~~~~------~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlGvvl~elltG~ 154 (380)
|||+||||+.++. ++|+|||.+.... .......||+.|+|||++....++.++|||||||++++|++|+
T Consensus 152 lKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CChhHeeeeccCcccccceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCC
Confidence 9999999986543 8999999997532 2234467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchh----hhhh-----------------hcccccCCCCCCCCc----------cccCCCChhhHHHHH
Q 016913 155 KAIDNTRPPGEHNLV----AWAR-----------------PLFKDRRKFPKMADP----------LLQGRYPMRGLYQAL 203 (380)
Q Consensus 155 ~p~~~~~~~~~~~~~----~~~~-----------------~~~~~~~~~~~~~~~----------~l~~~~~~~~~~~l~ 203 (380)
.||............ .... ..+... ........ ......+......+.
T Consensus 227 ~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (362)
T d1q8ya_ 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR-GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305 (362)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC---CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHH
T ss_pred CCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccc-hhhhccccccCCchhhhcccccccCcccCHHHH
Confidence 999754332111110 0000 000000 00000000 011223456677899
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 016913 204 AVAAMCLQEQAATRPLIGDVVT 225 (380)
Q Consensus 204 ~li~~cl~~~P~~RPt~~evl~ 225 (380)
+|+.+||+.||.+|||++||++
T Consensus 306 dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 306 DFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.57 E-value=2.7e-16 Score=136.25 Aligned_cols=117 Identities=13% Similarity=0.092 Sum_probs=84.1
Q ss_pred ccCCCCCCcccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 016913 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 81 (380)
Q Consensus 2 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDI 81 (380)
|.++.|++++..+++. ..++||||+++..+.. ++...+..++.|++.+|.|||+++ |+||||
T Consensus 68 l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDi 129 (191)
T d1zara2 68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDL 129 (191)
T ss_dssp HHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHccCCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccC
Confidence 3467889998887653 2379999998755432 334456788999999999999999 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCcccCCCCCCccccccccccccccc------hhhhhcCCCCCcCceeehHHHHH
Q 016913 82 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA------PEYAMTGQLTLKSDVYSFGVVFL 148 (380)
Q Consensus 82 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~sDV~SlGvvl~ 148 (380)
||+|||++++ .++|+|||++......... .|+. .+. ..+.|+.++|+||+.--++
T Consensus 130 KP~NILv~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 130 SQYNVLVSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp STTSEEEETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ChhheeeeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence 9999999965 5899999999753222110 1111 112 2357788999999865544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.49 E-value=0.00012 Score=64.02 Aligned_cols=86 Identities=16% Similarity=0.121 Sum_probs=61.8
Q ss_pred cccceEEEEeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------
Q 016913 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA----------------- 72 (380)
Q Consensus 10 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------------- 72 (380)
+.+++.++..++..++||++++|.++.+.... ... ...++.+++..|..||+..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~ 142 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTT------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEecccccccccccc------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhH
Confidence 56778888888999999999999888765532 011 2234555566666666411
Q ss_pred ---------------------------------------CCCeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 73 ---------------------------------------NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 73 ---------------------------------------~~~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999999876667999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.89 E-value=0.00033 Score=60.71 Aligned_cols=29 Identities=24% Similarity=0.291 Sum_probs=25.5
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 79999999999999876678999998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.36 E-value=0.0076 Score=55.83 Aligned_cols=28 Identities=29% Similarity=0.324 Sum_probs=25.2
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 76 VIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 76 iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
++|+|+.+.|||++++ .++|+||..+..
T Consensus 225 LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 225 LIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred eeccCCcCCceeEcCC-ceEEechhhccc
Confidence 9999999999999876 489999998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.84 E-value=0.059 Score=47.51 Aligned_cols=30 Identities=30% Similarity=0.194 Sum_probs=26.5
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.+||+|+.++||+++.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 399999999999999887778999998863
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=86.34 E-value=0.37 Score=42.46 Aligned_cols=28 Identities=29% Similarity=0.392 Sum_probs=23.4
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCccc
Q 016913 75 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 104 (380)
Q Consensus 75 ~iiHrDIkp~NILl~~~~~~kL~DFGla~~ 104 (380)
.+||+|+.+.|||++.+ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 48999999999999754 45899998864
|